data_1ahm_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ahm _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.1 p30 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.418 0.628 . . . . 3.9500000000000002 109.713 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.522 ' HB3' ' HG2' ' A' ' 17' ' ' MET . 1.4 pt20 -117.4 -168.36 1.47 Allowed 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.369 -0.832 . . . . 2.1000000000000001 109.436 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.569 HG13 ' CA ' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -135.84 -173.4 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 108.53 -0.915 . . . . 1.3799999999999999 108.53 179.024 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.87 41.58 1.58 Allowed 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.203 -0.935 . . . . 1.01 109.057 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.9 m -54.02 161.9 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.372 -0.83 . . . . 1.22 109.408 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.47 ' O ' ' C ' ' A' ' 7' ' ' ASP . 11.2 mmtm -87.61 52.44 2.49 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.151 -0.968 . . . . 3.54 109.574 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.47 ' C ' ' O ' ' A' ' 6' ' ' LYS . 5.3 p30 -38.78 156.1 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 109.327 -0.62 . . . . 1.46 109.327 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -153.08 34.35 0.47 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.986 -1.072 . . . . 1.4199999999999999 110.531 -179.253 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.528 ' HB3' ' HA ' ' A' ' 118' ' ' ALA . . . -69.59 -174.05 0.66 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.592 -1.317 . . . . 2.1200000000000001 109.048 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.583 ' O ' ' CB ' ' A' ' 11' ' ' ASN . 0.7 OUTLIER -54.56 -53.33 55.96 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 108.342 -0.985 . . . . 2.9900000000000002 108.342 178.174 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.583 ' CB ' ' O ' ' A' ' 10' ' ' ASN . 12.3 p30 147.19 40.88 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.036 -1.098 . . . . 8.1400000000000006 108.036 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.456 ' HB2' ' OD2' ' A' ' 42' ' ' ASP . 7.2 mt-10 -147.33 8.3 0.91 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.178 -0.951 . . . . 2.6800000000000002 110.654 -178.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.514 ' HA ' ' HA ' ' A' ' 41' ' ' PHE . 36.1 mt -44.59 148.35 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.891 -1.13 . . . . 0.70999999999999996 108.798 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.467 ' N ' HG21 ' A' ' 13' ' ' ILE . 0.2 OUTLIER -97.82 -19.33 18.21 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.423 -0.798 . . . . 2.9100000000000001 109.462 -179.582 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.444 ' HB2' ' HE2' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -172.65 134.95 0.65 Allowed 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 118.725 -1.19 . . . . 1.29 110.631 -177.854 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.52 ' O ' ' CG1' ' A' ' 16' ' ' VAL . 0.9 OUTLIER -139.02 104.26 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 107.246 -1.39 . . . . 2.8599999999999999 107.246 179.158 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.522 ' HG2' ' HB3' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -149.46 140.73 23.15 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 118.901 -1.12 . . . . 1.99 111.234 -177.805 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.52 ' CG2' ' HA ' ' A' ' 37' ' ' LEU . 39.6 t -118.2 132.53 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 108.236 -1.024 . . . . 2.4399999999999999 108.236 178.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -76.84 79.65 3.43 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.193 -0.942 . . . . 1.6100000000000001 110.213 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.553 ' O ' ' CB ' ' A' ' 21' ' ' CYS . . . 87.9 121.98 1.72 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 110.014 -1.234 . . . . 0.75 110.014 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.553 ' CB ' ' O ' ' A' ' 20' ' ' GLY . 0.0 OUTLIER 157.24 -41.46 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.629 -0.924 . . . . 0.37 109.298 179.319 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.569 ' CA ' HG13 ' A' ' 3' ' ' VAL . 0.9 OUTLIER 80.73 122.69 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.293 -0.879 . . . . 1.47 110.248 -179.547 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.472 ' O ' ' HB3' ' A' ' 24' ' ' SER . . . -96.85 178.74 33.75 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.622 -1.391 . . . . 0.53000000000000003 109.622 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.505 ' O ' ' O ' ' A' ' 25' ' ' ASP . 27.7 t 63.63 -91.32 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.223 -1.163 . . . . 1.6799999999999999 110.217 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.618 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.1 OUTLIER -50.18 -175.33 0.01 OUTLIER Pre-proline 0 C--N 1.305 -1.369 0 N-CA-C 108.83 -0.804 . . . . 0.45000000000000001 108.83 179.681 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.618 ' HD2' ' CB ' ' A' ' 25' ' ' ASP . 28.4 Cg_endo -70.14 84.8 0.7 Allowed 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 121.462 1.442 . . . . 0.58999999999999997 108.552 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 22' ' ' HIS . 0.9 OUTLIER -28.54 95.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 115.325 -0.852 . . . . 0.28000000000000003 112.453 -178.039 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.534 ' O ' ' O ' ' A' ' 21' ' ' CYS . 23.3 mm -90.92 137.6 21.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 105.289 -2.115 . . . . 0.54000000000000004 105.289 175.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.539 ' CG2' ' HA ' ' A' ' 21' ' ' CYS . 0.2 OUTLIER -119.69 177.69 2.79 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 O-C-N 120.553 -1.342 . . . . 0.37 112.898 -175.556 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 51.2 m-70 -112.37 158.13 20.18 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.916 0.865 . . . . 1.5 110.817 -179.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.538 ' CB ' ' O ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -111.3 141.32 44.99 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.123 -1.066 . . . . 4.2599999999999998 108.123 178.408 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.446 ' HA2' ' O ' ' A' ' 95' ' ' PRO . . . 101.11 3.34 54.48 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.469 -1.452 . . . . 0.67000000000000004 109.469 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.599 ' N ' HG13 ' A' ' 94' ' ' VAL . 1.9 mtmt -133.87 144.51 52.04 Favored Pre-proline 0 C--N 1.305 -1.355 0 O-C-N 121.42 -1.047 . . . . 0.69999999999999996 108.328 179.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.411 ' HA ' ' HB ' ' A' ' 94' ' ' VAL . 28.5 Cg_endo -69.62 81.4 0.79 Allowed 'Trans proline' 0 C--N 1.301 -1.944 0 C-N-CA 122.346 2.031 . . . . 0.90000000000000002 111.175 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.585 ' O ' ' CD1' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -59.58 122.84 15.07 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.998 -1.112 . . . . 3.29 107.998 178.974 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.51 ' CG2' ' HA ' ' A' ' 91' ' ' THR . 88.0 m -141.19 91.83 2.43 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.11 -0.994 . . . . 1.8400000000000001 110.226 -178.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.52 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 1.2 pp -64.26 137.78 58.1 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.294 -0.879 . . . . 1.22 108.714 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.531 ' HG2' ' CG ' ' A' ' 89' ' ' LYS . 4.3 mt-10 -128.0 168.17 15.66 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.134 -0.979 . . . . 1.95 109.731 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.488 ' HB1' ' O ' ' A' ' 38' ' ' GLU . . . 176.83 74.01 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.984 0.897 . . . . 0.88 109.407 178.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.568 ' N ' HD11 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -67.76 169.98 8.72 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 109.529 -0.545 . . . . 0.70999999999999996 109.529 179.931 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.748 ' CE2' ' CD2' ' A' ' 86' ' ' TYR . 1.4 p90 -165.85 162.42 18.36 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.156 -0.965 . . . . 0.70999999999999996 108.674 177.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.456 ' OD2' ' HB2' ' A' ' 12' ' ' GLU . 4.3 p30 -120.03 115.93 24.72 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 122.037 0.923 . . . . 4.9500000000000002 109.022 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.58 ' CB ' ' O ' ' A' ' 81' ' ' VAL . . . -42.2 115.43 0.68 Allowed 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 108.854 -0.795 . . . . 0.37 108.854 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.4 ' OD1' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -124.31 -0.87 8.2 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.364 -0.835 . . . . 1.0 109.968 -178.608 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.616 ' O ' ' N ' ' A' ' 82' ' ' LYS . 2.5 pt20 -92.59 -142.63 0.21 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.384 -0.822 . . . . 0.72999999999999998 109.017 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.73 ' HA ' ' HB ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -155.62 71.41 0.76 Allowed 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.174 -0.954 . . . . 0.71999999999999997 109.561 179.002 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.51 ' O ' HG11 ' A' ' 81' ' ' VAL . 4.8 t -150.15 121.6 7.93 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 119.959 -1.713 . . . . 0.93000000000000005 111.123 -178.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.602 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 7.0 mtmt -68.63 -7.55 34.08 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.785 -1.197 . . . . 3.7200000000000002 109.186 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.438 ' OG1' ' OG1' ' A' ' 47' ' ' THR . 0.0 OUTLIER -87.85 158.88 18.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.176 -0.952 . . . . 1.95 109.492 -179.812 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.622 ' O ' ' CA ' ' A' ' 71' ' ' ASN . . . -151.66 135.08 16.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.369 -0.832 . . . . 1.02 108.882 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.578 ' O ' ' CB ' ' A' ' 72' ' ' ALA . 0.1 OUTLIER -117.64 -158.99 0.73 Allowed 'General case' 0 C--N 1.298 -1.662 0 O-C-N 120.564 -1.335 . . . . 3.1400000000000001 108.028 178.475 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.474 ' HB ' ' O ' ' A' ' 51' ' ' LYS . 1.5 tt -177.93 161.74 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 C-N-CA 118.647 -1.221 . . . . 0.90000000000000002 110.481 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.535 ' O ' ' CE ' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -160.33 40.0 0.17 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.804 -0.813 . . . . 0.54000000000000004 108.804 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.605 HG22 ' CZ ' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -72.77 148.01 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.138 -0.976 . . . . 0.40999999999999998 109.801 -179.656 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.597 ' HG3' ' O ' ' A' ' 54' ' ' ILE . 0.3 OUTLIER -163.19 94.62 0.82 Allowed 'General case' 0 C--N 1.287 -2.121 0 O-C-N 121.282 -0.886 . . . . 2.3100000000000001 109.005 178.515 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.511 ' O ' HG13 ' A' ' 63' ' ' ILE . . . -119.77 120.01 35.28 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 119.639 -0.824 . . . . 1.76 110.584 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.461 ' O ' HG11 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -101.47 124.62 47.44 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.012 -1.107 . . . . 1.23 108.012 178.572 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.59 HD22 ' CE3' ' A' ' 92' ' ' TRP . 0.0 OUTLIER -119.87 169.1 10.46 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.844 -1.16 . . . . 5.2699999999999996 110.109 -178.517 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.477 ' HB2' ' CB ' ' A' ' 101' ' ' SER . 67.4 t0 -77.79 80.4 4.25 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.546 -0.909 . . . . 4.9100000000000001 108.546 179.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.08 1.41 41.77 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 108.537 -1.825 . . . . 1.47 108.537 -178.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.536 ' HG ' ' CD1' ' A' ' 92' ' ' TRP . 0.4 OUTLIER -136.64 59.53 1.69 Allowed 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.027 -1.101 . . . . 1.71 108.027 179.397 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -69.11 81.87 0.33 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.714 -0.616 . . . . 1.4299999999999999 110.229 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.511 HG13 ' O ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -82.98 125.61 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 118.445 -1.302 . . . . 2.8799999999999999 108.682 178.895 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.462 ' O ' HG21 ' A' ' 65' ' ' VAL . 1.4 m-20 -128.58 164.42 22.88 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.699 -0.852 . . . . 1.49 108.699 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.604 ' HB ' ' O ' ' A' ' 54' ' ' ILE . 43.3 t -143.4 68.7 17.32 Favored Pre-proline 0 C--N 1.3 -1.551 0 O-C-N 121.01 -1.056 . . . . 0.83999999999999997 110.114 -179.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.512 ' HD2' ' CG1' ' A' ' 68' ' ' ILE . 36.4 Cg_endo -80.72 95.94 0.99 Allowed 'Trans proline' 0 C--N 1.301 -1.938 0 C-N-CA 123.063 2.509 . . . . 2.6699999999999999 110.264 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.499 ' C ' ' O ' ' A' ' 66' ' ' PRO . . . 33.53 50.08 0.54 Allowed Glycine 0 N--CA 1.497 2.702 0 N-CA-C 109.85 -1.3 . . . . 1.95 109.85 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.512 ' CG1' ' HD2' ' A' ' 66' ' ' PRO . 5.8 mt -76.08 -76.7 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.376 -1.073 . . . . 1.6799999999999999 109.842 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.568 ' HB3' ' HB2' ' A' ' 74' ' ' HIS . 15.1 p30 -59.26 157.62 10.46 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.329 -0.857 . . . . 1.27 109.262 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.464 ' O ' ' CG ' ' A' ' 71' ' ' ASN . 20.0 p -77.4 -20.2 54.99 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.843 -1.169 . . . . 1.76 107.843 178.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.622 ' CA ' ' O ' ' A' ' 50' ' ' ALA . 3.3 m120 -173.96 73.93 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.369 0.604 . . . . 3.6800000000000002 109.661 179.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.578 ' CB ' ' O ' ' A' ' 51' ' ' LYS . . . 38.85 26.59 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.547 -0.72 . . . . 0.73999999999999999 111.56 177.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.517 ' SG ' ' N ' ' A' ' 78' ' ' CYS . 2.4 t -100.85 -17.77 16.71 Favored 'General case' 0 C--N 1.29 -2.013 0 O-C-N 121.151 -0.968 . . . . 1.3600000000000001 110.433 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.568 ' HB2' ' HB3' ' A' ' 69' ' ' ASP . 3.1 t-80 -61.23 -28.97 69.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.801 -1.187 . . . . 2.9900000000000002 109.829 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -99.74 -54.83 2.81 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.696 -1.253 . . . . 2.6800000000000002 110.319 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.706 ' CG2' ' CZ ' ' A' ' 86' ' ' TYR . 8.3 m -108.67 -145.52 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 CA-C-O 121.775 0.798 . . . . 3.9100000000000001 109.186 -178.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.527 ' N ' ' CG2' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -93.1 167.68 11.62 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.124 -1.436 . . . . 4.5 107.124 177.629 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . 0.59 ' N ' ' CD ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -91.36 -43.76 0.38 Allowed Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 120.476 -1.39 . . . . 1.77 110.469 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.602 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 31.0 Cg_endo -78.65 117.02 3.89 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 121.211 1.274 . . . . 1.1100000000000001 109.385 178.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.637 HD12 ' CZ ' ' A' ' 86' ' ' TYR . 0.1 OUTLIER -97.11 -68.12 0.81 Allowed 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.375 -0.972 . . . . 1.4199999999999999 108.375 -179.074 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.73 ' HB ' ' HA ' ' A' ' 46' ' ' ASN . 1.1 m 40.9 -168.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 116.051 -0.522 . . . . 0.58999999999999997 109.812 178.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.616 ' N ' ' O ' ' A' ' 45' ' ' GLN . 0.0 OUTLIER -99.22 41.13 1.16 Allowed 'General case' 0 C--N 1.295 -1.803 0 O-C-N 120.378 -1.451 . . . . 1.78 109.972 -177.649 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -143.94 39.73 1.24 Allowed Glycine 0 C--N 1.293 -1.812 0 N-CA-C 109.95 -1.26 . . . . 0.76000000000000001 109.95 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.443 ' NE2' ' HA ' ' A' ' 84' ' ' GLN . 7.8 tp-100 -158.88 154.12 25.5 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.93 -1.335 . . . . 2.2999999999999998 110.001 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -111.85 160.44 17.37 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.65 -0.87 . . . . 3.1200000000000001 108.65 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.748 ' CD2' ' CE2' ' A' ' 41' ' ' PHE . 0.9 OUTLIER -127.45 -170.25 2.19 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.798 -1.189 . . . . 4.3899999999999997 110.546 -179.005 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.53 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 3.2 p30 174.68 39.12 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.65 -0.87 . . . . 1.97 108.65 178.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.534 ' O ' ' CB ' ' A' ' 89' ' ' LYS . 0.4 OUTLIER -53.01 -170.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.867 -0.79 . . . . 1.5700000000000001 108.867 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.596 ' O ' ' CG ' ' A' ' 90' ' ' TYR . 0.2 OUTLIER 165.81 -179.32 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 119.07 -1.052 . . . . 2.1699999999999999 110.442 -179.323 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.605 ' CZ ' HG22 ' A' ' 54' ' ' ILE . 31.1 m-85 -167.35 93.62 0.43 Allowed 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.122 -1.066 . . . . 1.0600000000000001 108.122 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.51 ' HA ' ' CG2' ' A' ' 36' ' ' THR . 0.6 OUTLIER -87.17 -162.86 0.84 Allowed 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.773 0.797 . . . . 1.8200000000000001 110.959 -178.183 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.59 ' CE3' HD22 ' A' ' 58' ' ' LEU . 7.1 t90 -175.18 90.48 0.05 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.531 -0.731 . . . . 5.2599999999999998 109.599 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.461 ' C ' ' O ' ' A' ' 92' ' ' TRP . 3.1 t-20 -45.48 108.76 0.14 Allowed 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 106.8 -1.555 . . . . 1.9199999999999999 106.8 178.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.599 HG13 ' N ' ' A' ' 33' ' ' LYS . 2.4 t -104.58 116.21 61.47 Favored Pre-proline 0 C--N 1.301 -1.508 0 C-N-CA 118.854 -1.139 . . . . 0.94999999999999996 113.128 -176.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.539 ' HD2' ' CD1' ' A' ' 97' ' ' ILE . 33.4 Cg_endo -81.08 -86.12 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 123.206 2.604 . . . . 0.56000000000000005 108.538 176.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.538 ' O ' ' CB ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -135.7 -56.14 0.78 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 105.679 -1.971 . . . . 3.1099999999999999 105.679 177.766 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.591 ' CD1' HG11 ' A' ' 94' ' ' VAL . 1.5 mp 67.91 7.32 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 113.203 0.816 . . . . 0.80000000000000004 113.203 175.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.593 ' CB ' ' HD2' ' A' ' 99' ' ' PRO . . . 52.96 177.87 0.03 OUTLIER Pre-proline 0 C--N 1.302 -1.482 0 O-C-N 120.241 -1.537 . . . . 0.65000000000000002 109.626 179.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.593 ' HD2' ' CB ' ' A' ' 98' ' ' ALA . 51.8 Cg_endo -83.59 152.78 13.46 Favored 'Trans proline' 0 C--N 1.303 -1.867 0 C-N-CA 123.751 2.968 . . . . 0.90000000000000002 110.086 -179.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.638 ' HD3' ' CB ' ' A' ' 128' ' ' ARG . 1.7 mmmp? 55.98 127.35 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.97 0 C-N-CA 119.683 -0.807 . . . . 1.3200000000000001 111.674 176.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.477 ' CB ' ' HB2' ' A' ' 59' ' ' ASP . 12.3 t -97.67 154.6 17.46 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.196 -0.94 . . . . 1.02 108.595 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.438 ' O ' ' CB ' ' A' ' 103' ' ' ASN . 76.1 mt-10 -48.85 -22.45 0.83 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.118 -0.989 . . . . 1.7 109.624 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.438 ' CB ' ' O ' ' A' ' 102' ' ' GLU . 0.4 OUTLIER 165.02 152.0 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.036 -1.098 . . . . 3.2999999999999998 108.036 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.461 HG11 ' O ' ' A' ' 57' ' ' SER . 0.1 OUTLIER -142.76 153.76 17.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 120.814 -1.179 . . . . 0.93000000000000005 110.949 -178.944 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.427 ' CG2' ' O ' ' A' ' 104' ' ' VAL . 25.4 t -157.64 104.04 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 107.561 -1.274 . . . . 1.95 107.561 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.45 ' HB ' ' CB ' ' A' ' 122' ' ' ALA . 15.7 t -103.55 111.06 31.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 120.988 -1.07 . . . . 0.92000000000000004 109.484 -178.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.431 ' HB ' ' HE2' ' A' ' 55' ' ' LYS . 0.2 OUTLIER -129.98 175.27 9.02 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 120.877 -1.139 . . . . 1.21 108.269 179.269 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.557 ' CG1' ' N ' ' A' ' 109' ' ' LYS . 1.2 t 175.07 168.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 C-N-CA 118.835 -1.146 . . . . 0.95999999999999996 110.318 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.557 ' N ' ' CG1' ' A' ' 108' ' ' VAL . 1.1 ttpt 162.94 134.63 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.838 0.828 . . . . 1.9299999999999999 109.67 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.633 HD21 ' CE2' ' A' ' 41' ' ' PHE . 9.4 tp -113.22 130.04 56.34 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 106.873 -1.528 . . . . 1.4399999999999999 106.873 178.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.452 ' HB ' ' HB2' ' A' ' 51' ' ' LYS . 9.4 mt -127.25 120.12 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.154 -0.966 . . . . 0.93999999999999995 111.737 -177.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -92.4 -114.25 2.11 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 108.812 -1.715 . . . . 0.82999999999999996 108.812 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -138.21 1.94 2.26 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.044 -1.268 . . . . 1.6200000000000001 108.004 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -112.58 -39.31 4.38 Favored 'General case' 0 C--N 1.31 -1.129 0 O-C-N 121.415 -0.803 . . . . 0.75 109.048 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -177.38 155.38 17.65 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.07 -1.612 . . . . 1.54 109.07 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.533 ' CG2' ' O ' ' A' ' 118' ' ' ALA . 0.2 OUTLIER -50.18 111.88 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.167 -1.196 . . . . 1.5800000000000001 109.82 -179.647 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.544 ' CD2' HD13 ' A' ' 80' ' ' LEU . 1.4 mt -57.49 -62.89 1.46 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.294 -0.879 . . . . 0.85999999999999999 109.666 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.533 ' O ' ' CG2' ' A' ' 116' ' ' VAL . . . -123.97 -175.26 3.19 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.13 -0.981 . . . . 0.48999999999999999 110.083 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . 0.521 ' HA ' ' HA ' ' A' ' 109' ' ' LYS . 1.9 t 172.37 150.51 0.06 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.155 -0.966 . . . . 0.84999999999999998 110.15 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.445 ' C ' HG13 ' A' ' 121' ' ' ILE . . . -170.02 130.98 1.0 Allowed 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.79 -0.818 . . . . 1.0800000000000001 108.79 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.445 HG13 ' C ' ' A' ' 120' ' ' ALA . 2.8 mt -134.15 139.47 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.177 -0.952 . . . . 0.66000000000000003 110.075 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.45 ' CB ' ' HB ' ' A' ' 106' ' ' VAL . . . -106.77 -17.92 14.08 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.487 -0.931 . . . . 2.0800000000000001 108.487 179.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 58.51 89.08 0.06 Allowed 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 121.519 0.676 . . . . 2.5800000000000001 110.196 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 61.9 -160.93 0.3 Allowed 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.724 0.773 . . . . 4.6600000000000001 110.378 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 153.91 150.61 5.52 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.346 -1.902 . . . . 1.1100000000000001 108.346 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 69.0 mttt -140.38 96.56 3.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.95 -1.323 . . . . 2.2999999999999998 109.987 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.645 ' O ' ' CB ' ' A' ' 128' ' ' ARG . 2.1 mp -46.05 152.43 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.649 -0.657 . . . . 0.80000000000000004 109.843 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.645 ' CB ' ' O ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER 141.79 -77.3 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.692 0.758 . . . . 0.96999999999999997 109.132 178.823 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.557 ' N ' ' CD ' ' A' ' 128' ' ' ARG . 0.4 OUTLIER . . . . . 0 C--N 1.301 -1.533 0 CA-C-O 118.017 -0.992 . . . . 4.2300000000000004 109.63 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . 0.478 ' O ' ' O ' ' A' ' 2' ' ' GLN . 65.7 m-20 . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.5 0.667 . . . . 4.8099999999999996 109.804 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.534 ' HA ' ' HB3' ' A' ' 17' ' ' MET . 93.6 mt-30 47.91 179.08 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 122.158 0.98 . . . . 3.8399999999999999 110.999 178.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.648 HG21 ' HA ' ' A' ' 22' ' ' HIS . 2.2 p -162.72 -149.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 108.642 -0.873 . . . . 5.2699999999999996 108.642 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.56 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 32.2 t0 -163.73 54.74 0.16 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.652 -1.28 . . . . 2.3700000000000001 110.222 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.4 m -89.12 152.39 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.031 -1.043 . . . . 1.6499999999999999 109.83 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.48 95.57 3.31 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.319 -0.863 . . . . 4.5800000000000001 109.238 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -89.88 173.97 7.95 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.358 -0.839 . . . . 1.47 109.582 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.487 ' N ' ' SG ' ' A' ' 119' ' ' CYS . 24.8 p -164.76 47.79 0.1 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.258 -0.901 . . . . 2.3999999999999999 109.696 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.554 ' O ' ' CB ' ' A' ' 10' ' ' ASN . . . -76.4 -67.31 0.7 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.304 -0.873 . . . . 0.57999999999999996 109.244 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.554 ' CB ' ' O ' ' A' ' 9' ' ' ALA . 0.7 OUTLIER 160.37 39.5 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.487 -0.931 . . . . 1.21 108.487 -178.285 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 54.4 t30 55.87 21.67 5.03 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.316 -0.994 . . . . 2.04 108.316 -178.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -104.48 -22.18 13.34 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.21 -0.663 . . . . 3.46 109.21 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.541 ' CG2' ' O ' ' A' ' 40' ' ' LEU . 3.8 mt -52.03 143.16 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.073 -1.017 . . . . 1.1299999999999999 108.925 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.428 ' N ' HG21 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -104.89 -22.7 13.11 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.351 -0.843 . . . . 3.2799999999999998 109.223 179.724 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -168.75 108.95 0.49 Allowed 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 118.426 -1.31 . . . . 3.2799999999999998 111.595 -178.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.5 ' HA ' ' HA ' ' A' ' 39' ' ' ALA . 3.2 p -118.12 94.09 2.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 N-CA-C 106.819 -1.549 . . . . 1.03 106.819 177.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.534 ' HB3' ' HA ' ' A' ' 2' ' ' GLN . 7.0 mmt -134.87 118.32 16.83 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.487 -0.885 . . . . 2.6299999999999999 111.356 -177.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.459 HG22 HG13 ' A' ' 3' ' ' VAL . 11.2 t -85.86 126.25 40.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 107.171 -1.418 . . . . 2.0899999999999999 107.171 177.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.564 ' HB3' ' CB ' ' A' ' 35' ' ' PHE . 2.0 t0 -45.8 -22.17 0.17 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.071 -1.018 . . . . 2.3500000000000001 110.396 -178.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.565 ' O ' ' CB ' ' A' ' 21' ' ' CYS . . . -177.82 135.32 2.68 Favored Glycine 0 N--CA 1.49 2.299 0 C-N-CA 118.947 -1.597 . . . . 3.0600000000000001 110.857 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.578 ' HA ' ' CG2' ' A' ' 29' ' ' ILE . 0.0 OUTLIER 153.12 -37.0 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.881 -0.776 . . . . 1.1399999999999999 109.614 178.671 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.648 ' HA ' HG21 ' A' ' 3' ' ' VAL . 42.6 t-80 53.76 102.85 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.78 -1.2 . . . . 4.3600000000000003 109.362 -179.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.523 ' O ' ' CB ' ' A' ' 24' ' ' SER . . . -90.03 -147.18 16.73 Favored Glycine 0 N--CA 1.499 2.867 0 O-C-N 121.044 -1.035 . . . . 1.8400000000000001 111.407 -178.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.525 ' N ' ' O ' ' A' ' 4' ' ' ASP . 0.1 OUTLIER 80.92 -77.9 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.626 -0.926 . . . . 1.26 108.667 -178.986 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.656 ' HB2' ' CD ' ' A' ' 26' ' ' PRO . 7.4 p30 -86.17 -152.84 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.51 0 N-CA-C 105.727 -1.953 . . . . 1.8400000000000001 105.727 178.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.656 ' CD ' ' HB2' ' A' ' 25' ' ' ASP . 28.7 Cg_endo -72.99 91.72 0.82 Allowed 'Trans proline' 0 C--N 1.319 -1.016 0 N-CA-C 108.395 -1.425 . . . . 0.48999999999999999 108.395 179.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.632 ' HA ' ' O ' ' A' ' 22' ' ' HIS . 0.3 OUTLIER -34.36 101.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.559 0.695 . . . . 0.40999999999999998 112.036 -177.202 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.528 ' O ' ' O ' ' A' ' 21' ' ' CYS . 28.4 mm -97.05 135.82 29.91 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 106.829 -1.545 . . . . 0.60999999999999999 106.829 176.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.578 ' CG2' ' HA ' ' A' ' 21' ' ' CYS . 0.5 OUTLIER -122.87 -166.77 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 O-C-N 121.005 -1.06 . . . . 1.52 111.676 -177.468 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.61 ' N ' ' CD2' ' A' ' 30' ' ' HIS . 0.0 OUTLIER -123.77 168.67 12.41 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 115.863 -0.608 . . . . 3.1099999999999999 109.446 179.628 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.534 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -115.6 -163.96 0.92 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.089 -1.007 . . . . 2.0 109.453 179.43 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 31' ' ' ARG . . . 39.19 44.62 2.17 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.902 -1.279 . . . . 1.5700000000000001 109.902 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.474 ' C ' ' HB ' ' A' ' 94' ' ' VAL . 0.1 OUTLIER -172.08 109.7 0.37 Allowed Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.153 -1.204 . . . . 3.1200000000000001 109.577 -179.742 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.557 ' HA ' ' HB ' ' A' ' 94' ' ' VAL . 29.3 Cg_endo -70.37 115.5 4.21 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.821 2.348 . . . . 4.0599999999999996 110.949 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.564 ' CB ' ' HB3' ' A' ' 19' ' ' ASP . 22.5 m-85 -100.13 -157.41 0.6 Allowed 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.773 -0.825 . . . . 9.1500000000000004 108.773 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.533 ' O ' ' HG3' ' A' ' 38' ' ' GLU . 1.8 m -175.63 102.22 0.07 Allowed 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.368 -0.833 . . . . 1.4399999999999999 108.768 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.416 ' O ' ' CG ' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -52.2 153.25 2.88 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.235 -1.024 . . . . 4.9199999999999999 108.235 179.8 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.533 ' HG3' ' O ' ' A' ' 36' ' ' THR . 63.0 mt-10 -154.38 166.75 32.24 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.791 -1.193 . . . . 0.69999999999999996 110.96 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.5 ' HA ' ' HA ' ' A' ' 16' ' ' VAL . . . 168.18 96.6 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.58 -0.896 . . . . 0.55000000000000004 108.58 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.57 ' HG ' ' HA ' ' A' ' 87' ' ' ASP . 0.5 OUTLIER -90.12 154.82 19.49 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.394 -0.595 . . . . 1.3500000000000001 109.394 -179.517 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.762 ' CE2' ' CD2' ' A' ' 86' ' ' TYR . 0.2 OUTLIER -152.52 169.87 21.56 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.056 -1.027 . . . . 0.78000000000000003 109.349 178.41 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.463 ' OD2' ' OE1' ' A' ' 85' ' ' GLN . 6.7 t0 -119.46 112.45 19.41 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 122.195 0.998 . . . . 1.5 109.206 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.56 ' CB ' ' O ' ' A' ' 81' ' ' VAL . . . -42.28 116.39 0.83 Allowed 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 115.431 -0.804 . . . . 0.73999999999999999 109.198 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.473 ' O ' ' HB3' ' A' ' 82' ' ' LYS . 11.3 p30 -126.17 -0.1 7.11 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.243 -0.911 . . . . 4.4000000000000004 109.731 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.595 ' O ' ' N ' ' A' ' 82' ' ' LYS . 3.1 pt20 -90.68 -137.61 0.14 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.413 -0.805 . . . . 0.68999999999999995 109.01 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.762 ' HA ' ' HB ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -159.23 68.87 0.44 Allowed 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 119.59 -0.844 . . . . 1.8 109.637 179.215 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.522 ' CG2' ' OE1' ' A' ' 45' ' ' GLN . 3.5 t -145.25 120.01 9.88 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.045 -1.659 . . . . 1.3700000000000001 110.764 -178.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.622 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 0.2 OUTLIER -68.74 -5.53 21.09 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.841 -1.162 . . . . 2.54 109.075 178.553 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.0 p -98.79 -177.6 3.7 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.058 -1.026 . . . . 1.6599999999999999 109.893 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.552 ' O ' ' CA ' ' A' ' 71' ' ' ASN . . . -163.94 145.62 9.01 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.442 -0.948 . . . . 0.64000000000000001 108.442 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 16.6 mtmt -138.36 91.97 2.6 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 122.964 1.364 . . . . 3.1000000000000001 109.506 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.487 HG13 HD12 ' A' ' 54' ' ' ILE . 1.2 tt -67.98 158.15 5.85 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.474 0 CA-C-N 114.063 -1.426 . . . . 2.73 110.086 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -150.93 49.16 0.85 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.33 -0.857 . . . . 2.27 109.127 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.61 ' CG1' ' CE2' ' A' ' 90' ' ' TYR . 0.2 OUTLIER -75.64 159.49 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.42 -0.8 . . . . 0.93999999999999995 108.925 -179.869 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.549 ' HD3' ' O ' ' A' ' 54' ' ' ILE . 0.4 OUTLIER -166.13 29.71 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.178 -1.009 . . . . 2.29 110.774 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.563 ' CB ' HG22 ' A' ' 63' ' ' ILE . . . -66.7 159.04 28.63 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 108.809 -0.811 . . . . 2.8900000000000001 108.809 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.15 130.08 24.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.032 -1.043 . . . . 1.23 109.736 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.569 ' CD1' ' N ' ' A' ' 59' ' ' ASP . 2.5 tm? -119.91 154.92 33.69 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.212 -0.93 . . . . 1.71 108.78 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.569 ' N ' ' CD1' ' A' ' 58' ' ' LEU . 5.6 t70 -76.93 79.24 3.49 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 107.818 -1.179 . . . . 3.9100000000000001 107.818 178.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.432 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 125.8 -5.83 7.92 Favored Glycine 0 N--CA 1.485 1.91 0 N-CA-C 108.787 -1.725 . . . . 2.2000000000000002 108.787 -178.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.471 ' O ' ' N ' ' A' ' 63' ' ' ILE . 0.4 OUTLIER -141.86 53.48 1.49 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.238 -1.154 . . . . 1.4199999999999999 109.263 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 61' ' ' LEU . 36.1 mm-40 -41.18 97.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.544 -0.722 . . . . 3.0699999999999998 109.625 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.563 HG22 ' CB ' ' A' ' 56' ' ' ALA . 0.3 OUTLIER -75.09 -2.93 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 CA-C-O 121.952 0.882 . . . . 3.1299999999999999 110.133 -179.986 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.462 ' C ' ' O ' ' A' ' 63' ' ' ILE . 0.6 OUTLIER -40.03 140.13 0.61 Allowed 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 108.925 -0.768 . . . . 3.2999999999999998 108.925 179.317 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.53 HG23 ' HB ' ' A' ' 54' ' ' ILE . 98.8 t -123.0 86.2 50.92 Favored Pre-proline 0 C--N 1.301 -1.533 0 O-C-N 121.168 -0.957 . . . . 1.96 110.556 -178.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.465 ' O ' ' C ' ' A' ' 67' ' ' GLY . 35.7 Cg_endo -79.29 89.34 1.36 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.791 2.327 . . . . 3.7200000000000002 110.422 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.465 ' C ' ' O ' ' A' ' 66' ' ' PRO . . . 37.14 68.94 0.31 Allowed Glycine 0 N--CA 1.495 2.585 0 N-CA-C 110.117 -1.193 . . . . 1.3300000000000001 110.117 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 21.2 mt -83.94 -78.03 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.13 -1.217 . . . . 3.1099999999999999 109.613 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.469 ' OD2' ' CE1' ' A' ' 75' ' ' PHE . 5.2 p30 -78.47 130.58 36.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.212 -0.93 . . . . 2.4500000000000002 109.233 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.516 ' O ' ' ND2' ' A' ' 71' ' ' ASN . 13.7 t -51.58 -23.02 3.72 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.09 -1.006 . . . . 3.79 109.715 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.552 ' CA ' ' O ' ' A' ' 50' ' ' ALA . 23.3 m-80 -168.32 76.05 0.12 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.953 -1.092 . . . . 1.73 111.225 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.455 ' CB ' ' HB2' ' A' ' 50' ' ' ALA . . . 32.02 33.75 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.283 0.563 . . . . 0.81999999999999995 111.921 176.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.535 ' N ' ' O ' ' A' ' 71' ' ' ASN . 31.0 t -109.79 21.64 16.66 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 121.179 -0.95 . . . . 1.1599999999999999 110.393 -179.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 17.6 t-160 -121.64 -18.26 7.22 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.374 -1.454 . . . . 2.8599999999999999 109.45 178.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.526 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 7.3 m-85 -104.67 -15.09 15.37 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -0.887 . . . . 2.8100000000000001 108.695 179.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.651 ' CG2' ' CE2' ' A' ' 86' ' ' TYR . 18.2 m -150.73 -153.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 N-CA-C 107.097 -1.445 . . . . 3.8500000000000001 107.097 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.483 ' O ' HG22 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -81.65 -177.65 6.63 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 106.287 -1.745 . . . . 4.0 106.287 176.325 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . 0.49 ' HB2' ' HD3' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -109.1 -51.87 0.07 OUTLIER Pre-proline 0 C--N 1.293 -1.86 0 O-C-N 120.64 -1.287 . . . . 2.0800000000000001 110.796 -179.559 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.622 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 29.6 Cg_endo -77.83 111.6 3.14 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 N-CA-C 108.506 -1.382 . . . . 1.0800000000000001 108.506 178.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.643 ' CD2' ' CE1' ' A' ' 86' ' ' TYR . 0.6 OUTLIER -93.6 -67.54 0.85 Allowed 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.622 -0.673 . . . . 3.9700000000000002 109.363 -178.1 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.762 ' HB ' ' HA ' ' A' ' 46' ' ' ASN . 1.4 m 40.8 -167.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 C-N-CA 120.46 -0.496 . . . . 0.63 110.072 177.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.595 ' N ' ' O ' ' A' ' 45' ' ' GLN . 0.0 OUTLIER -98.47 41.62 1.13 Allowed 'General case' 0 C--N 1.292 -1.91 0 O-C-N 120.629 -1.294 . . . . 1.6299999999999999 109.81 -177.45 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -150.68 46.4 0.62 Allowed Glycine 0 C--N 1.288 -2.123 0 N-CA-C 108.863 -1.695 . . . . 0.98999999999999999 108.863 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.5 ' OE1' ' O ' ' A' ' 85' ' ' GLN . 3.0 tp-100 -159.4 150.07 19.46 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.132 -1.217 . . . . 1.96 110.18 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.5 ' O ' ' OE1' ' A' ' 84' ' ' GLN . 0.0 OUTLIER -104.25 157.37 17.18 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.569 -1.271 . . . . 2.8599999999999999 107.569 178.412 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.762 ' CD2' ' CE2' ' A' ' 41' ' ' PHE . 0.4 OUTLIER -125.64 -167.65 1.72 Allowed 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.313 -1.492 . . . . 4.6799999999999997 111.592 -178.928 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.57 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER 170.98 38.44 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.409 -0.814 . . . . 3.2000000000000002 109.088 179.342 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.566 ' CD1' HG12 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -49.52 -178.01 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 108.256 -1.016 . . . . 1.0600000000000001 108.256 179.129 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.554 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 1.2 mtmt 170.5 164.56 0.07 Allowed 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 119.069 -1.052 . . . . 1.99 109.957 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.61 ' CE2' ' CG1' ' A' ' 54' ' ' ILE . 17.0 m-85 -150.58 91.21 1.71 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.467 -0.771 . . . . 1.1100000000000001 109.246 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.476 ' O ' ' O ' ' A' ' 90' ' ' TYR . 1.4 t -44.71 171.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.7 -0.625 . . . . 4.1200000000000001 109.612 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.476 ' O ' HG21 ' A' ' 94' ' ' VAL . 0.3 OUTLIER -146.36 92.53 2.19 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.147 -0.971 . . . . 4.8399999999999999 110.131 -179.938 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -65.43 112.43 3.54 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.126 -1.435 . . . . 4.5300000000000002 107.126 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.595 ' CG1' ' CD1' ' A' ' 97' ' ' ILE . 59.5 t -125.05 93.94 44.74 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 120.917 -1.115 . . . . 3.2200000000000002 112.451 -177.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.587 ' HD2' ' CD1' ' A' ' 97' ' ' ILE . 33.3 Cg_endo -73.65 -151.42 0.03 OUTLIER 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 122.105 1.87 . . . . 3.3199999999999998 108.26 176.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.534 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 2.7 mmtt -67.54 -32.61 73.51 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.215 -1.553 . . . . 3.6600000000000001 109.184 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.595 ' CD1' ' CG1' ' A' ' 94' ' ' VAL . 4.0 mt 42.39 15.87 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.125 -0.984 . . . . 2.2599999999999998 112.354 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.59 ' CB ' ' HD2' ' A' ' 99' ' ' PRO . . . 50.65 173.37 0.03 OUTLIER Pre-proline 0 C--N 1.307 -1.242 0 O-C-N 120.292 -1.505 . . . . 1.8300000000000001 109.93 179.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.708 ' O ' ' HB2' ' A' ' 100' ' ' LYS . 57.4 Cg_endo -81.66 76.29 4.43 Favored 'Trans proline' 0 C--N 1.296 -2.208 0 C-N-CA 123.163 2.575 . . . . 2.6200000000000001 108.418 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.708 ' HB2' ' O ' ' A' ' 99' ' ' PRO . 4.6 mmmm 119.2 127.11 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 123.8 0.687 . . . . 3.6299999999999999 109.751 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.512 ' O ' ' HB2' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -87.38 11.49 14.38 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.271 -0.893 . . . . 1.51 109.392 179.638 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.562 ' O ' ' CB ' ' A' ' 103' ' ' ASN . 2.1 mp0 67.63 -0.42 1.94 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.656 -0.652 . . . . 6.0999999999999996 109.906 -179.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.562 ' CB ' ' O ' ' A' ' 102' ' ' GLU . 3.3 t30 160.91 143.23 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.275 -0.89 . . . . 2.6499999999999999 109.928 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.522 ' N ' ' OD1' ' A' ' 103' ' ' ASN . 0.1 OUTLIER -159.9 158.67 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.423 -0.798 . . . . 1.1299999999999999 109.295 -179.772 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.2 t -149.33 131.22 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.042 -1.036 . . . . 1.55 109.66 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.541 ' HB ' ' CB ' ' A' ' 122' ' ' ALA . 10.5 t -119.87 130.3 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.135 -0.978 . . . . 2.2200000000000002 109.62 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.518 ' O ' ' CG2' ' A' ' 108' ' ' VAL . 0.3 OUTLIER -154.34 140.19 18.16 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.529 -0.915 . . . . 1.8799999999999999 108.529 179.711 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.541 HG12 ' CD1' ' A' ' 54' ' ' ILE . 34.7 t -158.49 151.14 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.872 -1.143 . . . . 2.0499999999999998 110.266 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 119' ' ' CYS . 6.7 ttpt -172.46 134.5 0.67 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.222 -0.924 . . . . 1.8400000000000001 110.284 178.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.59 HD21 ' CE2' ' A' ' 41' ' ' PHE . 9.8 tp -111.15 132.65 54.13 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 106.833 -1.543 . . . . 1.52 106.833 177.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.45 ' HB ' ' HB2' ' A' ' 51' ' ' LYS . 8.4 mt -133.71 113.78 19.04 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 O-C-N 121.128 -0.983 . . . . 1.3100000000000001 110.972 -177.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -76.88 -110.76 0.14 Allowed Glycine 0 N--CA 1.486 1.993 0 N-CA-C 107.944 -2.062 . . . . 0.65000000000000002 107.944 178.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -142.48 9.39 1.82 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.531 -1.285 . . . . 1.6299999999999999 107.531 178.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.498 ' OD1' ' NE2' ' A' ' 45' ' ' GLN . 0.3 OUTLIER -123.88 -31.86 3.35 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.693 0.759 . . . . 3.8999999999999999 109.362 -178.997 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -171.37 -142.87 3.81 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 108.708 -1.757 . . . . 0.76000000000000001 108.708 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.474 HG22 ' O ' ' A' ' 110' ' ' LEU . 2.4 p -114.87 131.83 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.087 -1.243 . . . . 1.1699999999999999 109.121 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.58 ' CD2' HD21 ' A' ' 80' ' ' LEU . 4.0 mt -78.85 -49.42 12.95 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.435 -0.791 . . . . 1.8100000000000001 109.78 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.509 ' HA ' ' HB3' ' A' ' 9' ' ' ALA . . . -161.4 130.61 4.61 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.302 -0.874 . . . . 2.0899999999999999 109.688 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 109' ' ' LYS . 16.4 p -129.19 -172.11 2.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.207 -0.933 . . . . 1.97 110.01 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 175.18 127.06 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.34 -0.85 . . . . 1.5700000000000001 109.206 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.2 mp -127.66 139.78 50.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.183 -0.948 . . . . 0.85999999999999999 110.385 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.541 ' CB ' ' HB ' ' A' ' 106' ' ' VAL . . . -144.71 33.32 1.15 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.061 -1.089 . . . . 1.0900000000000001 108.061 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.49 ' O ' ' O ' ' A' ' 122' ' ' ALA . 3.2 m -40.5 168.02 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.536 0.684 . . . . 5.0099999999999998 110.662 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 59.26 66.94 0.96 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.513 -0.742 . . . . 2.0 109.457 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.464 ' O ' HG21 ' A' ' 104' ' ' VAL . . . -94.86 147.2 18.51 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.313 -1.515 . . . . 1.27 109.313 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.507 ' HB3' ' HE3' ' A' ' 100' ' ' LYS . 7.6 mtmt -153.9 121.58 5.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.427 -1.043 . . . . 4.0999999999999996 108.509 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.545 ' O ' ' CD ' ' A' ' 100' ' ' LYS . 1.6 mp -90.37 118.39 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.11 -0.994 . . . . 1.26 112.102 -177.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.59 ' HB2' ' HG2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER 176.14 -62.22 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.771 -1.206 . . . . 3.8100000000000001 109.302 177.595 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.536 ' N ' ' HD3' ' A' ' 128' ' ' ARG . 6.9 t70 . . . . . 0 N--CA 1.494 1.74 0 CA-C-O 117.953 -1.023 . . . . 4.5599999999999996 109.339 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . 0.484 ' O ' ' HB3' ' A' ' 17' ' ' MET . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.524 0.678 . . . . 5.04 109.643 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.5 ' HA ' ' HB3' ' A' ' 17' ' ' MET . 31.1 mt-30 -94.77 178.77 5.47 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.901 0.858 . . . . 4.2400000000000002 110.169 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.536 ' CG2' ' CG2' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -133.58 -169.2 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.035 -1.098 . . . . 2.29 108.035 179.494 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -117.88 52.76 0.98 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.909 -1.119 . . . . 1.0800000000000001 109.017 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 26.9 m -73.33 159.34 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.414 -0.804 . . . . 1.23 110.143 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.14 74.49 9.59 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.448 -0.782 . . . . 5.3499999999999996 109.278 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.505 ' OD1' ' N ' ' A' ' 8' ' ' CYS . 0.7 OUTLIER -75.22 -170.03 1.08 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.257 -0.902 . . . . 1.8600000000000001 109.55 -179.866 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.505 ' N ' ' OD1' ' A' ' 7' ' ' ASP . 16.6 p 179.25 33.76 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.112 -0.993 . . . . 2.3799999999999999 109.58 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.533 ' HB3' ' HA ' ' A' ' 118' ' ' ALA . . . -62.88 -58.66 6.62 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.296 -0.877 . . . . 0.76000000000000001 109.607 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.503 ' CB ' ' O ' ' A' ' 9' ' ' ALA . 1.7 m-80 166.59 36.73 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.612 -0.835 . . . . 4.7800000000000002 109.398 -178.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.8 t30 51.19 34.39 11.2 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.14 -0.975 . . . . 2.5899999999999999 108.716 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.483 ' HG2' ' OD1' ' A' ' 44' ' ' ASN . 6.6 tp10 -128.73 -21.85 3.35 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.366 -0.834 . . . . 4.5199999999999996 110.034 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.472 ' CG2' ' O ' ' A' ' 40' ' ' LEU . 5.9 mt -42.51 139.25 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.146 -0.971 . . . . 1.1799999999999999 108.931 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.446 ' HD2' ' OD1' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -100.59 -31.38 11.27 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-O 121.956 0.884 . . . . 2.1200000000000001 108.813 -179.783 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.08 120.09 12.07 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 119.909 -0.716 . . . . 2.7200000000000002 109.667 -178.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.468 ' C ' ' HG2' ' A' ' 17' ' ' MET . 11.3 p -136.82 118.12 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.272 -0.892 . . . . 1.4199999999999999 108.845 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.5 ' HB3' ' HA ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -156.05 173.41 16.84 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.426 -0.796 . . . . 6.1399999999999997 109.606 -179.258 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.55 ' HB ' ' HB3' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -132.55 9.54 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 O-C-N 121.085 -1.009 . . . . 3.9100000000000001 108.975 178.34 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.537 ' CB ' ' HA ' ' A' ' 35' ' ' PHE . 7.9 t70 77.55 58.54 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 112.551 0.575 . . . . 3.1000000000000001 112.551 178.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 29' ' ' ILE . . . 70.67 31.42 67.75 Favored Glycine 0 N--CA 1.499 2.876 0 O-C-N 120.777 -1.202 . . . . 2.6899999999999999 111.811 177.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.573 ' HA ' ' CG2' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -92.96 -19.44 21.6 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.889 -1.359 . . . . 2.6899999999999999 108.247 178.839 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.591 ' N ' ' CD2' ' A' ' 22' ' ' HIS . 4.2 m170 67.65 109.69 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.515 -0.741 . . . . 5.8700000000000001 109.447 -179.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 24' ' ' SER . . . -80.88 178.18 54.11 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 110.175 -1.17 . . . . 0.82999999999999996 110.175 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.468 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 41.0 t 62.3 151.73 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.351 -1.088 . . . . 2.6800000000000002 108.509 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.593 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.2 OUTLIER 59.6 179.92 0.04 OUTLIER Pre-proline 0 C--N 1.306 -1.302 0 N-CA-C 107.336 -1.357 . . . . 5.4900000000000002 107.336 -179.644 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.593 ' HD2' ' CB ' ' A' ' 25' ' ' ASP . 26.8 Cg_endo -70.78 83.74 0.86 Allowed 'Trans proline' 0 C--N 1.296 -2.228 0 C-N-CA 121.94 1.76 . . . . 1.0800000000000001 108.404 178.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.452 ' O ' ' HA2' ' A' ' 125' ' ' GLY . 0.0 OUTLIER -33.37 115.54 0.22 Allowed 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 115.422 -0.808 . . . . 0.71999999999999997 111.982 -178.009 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.522 ' O ' ' O ' ' A' ' 21' ' ' CYS . 25.2 mm -107.72 139.56 29.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 107.46 -1.311 . . . . 0.82999999999999996 107.46 176.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.573 ' CG2' ' HA ' ' A' ' 21' ' ' CYS . 0.7 OUTLIER -122.55 -175.57 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 O-C-N 120.981 -1.074 . . . . 1.1599999999999999 111.572 -177.442 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.508 ' O ' ' CE1' ' A' ' 35' ' ' PHE . 98.1 m-70 -111.92 -171.55 1.87 Allowed 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.528 0.68 . . . . 2.3399999999999999 110.366 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.564 ' CD ' ' O ' ' A' ' 98' ' ' ALA . 0.1 OUTLIER -130.39 -160.8 1.07 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.515 -0.74 . . . . 3.79 109.103 179.51 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.48 ' O ' ' HG3' ' A' ' 33' ' ' LYS . . . 40.23 34.86 0.66 Allowed Glycine 0 N--CA 1.495 2.581 0 N-CA-C 110.08 -1.208 . . . . 0.76000000000000001 110.08 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.692 ' O ' HG13 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -167.96 129.02 1.16 Allowed Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.277 -1.131 . . . . 5.2599999999999998 108.999 -179.921 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.485 ' HA ' ' HB ' ' A' ' 94' ' ' VAL . 20.3 Cg_endo -58.74 129.43 32.23 Favored 'Trans proline' 0 C--N 1.302 -1.883 0 C-N-CA 121.603 1.535 . . . . 2.21 109.869 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.592 ' HB2' ' CD1' ' A' ' 92' ' ' TRP . 19.9 m-85 -79.36 40.95 0.45 Allowed 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 116.234 -0.439 . . . . 8.5099999999999998 110.611 -178.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.482 ' C ' ' O ' ' A' ' 35' ' ' PHE . 24.4 m -35.01 91.45 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.534 -0.729 . . . . 2.1899999999999999 110.585 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -89.9 122.49 32.99 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.941 -1.133 . . . . 1.1399999999999999 107.941 179.264 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.538 ' HG2' ' HG2' ' A' ' 89' ' ' LYS . 55.9 mt-10 -121.29 177.57 5.12 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 120.818 -1.176 . . . . 1.0 111.092 -178.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.518 ' O ' ' CD1' ' A' ' 41' ' ' PHE . . . 177.05 63.96 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 106.683 -1.599 . . . . 0.98999999999999999 106.683 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.622 ' HG ' ' CB ' ' A' ' 87' ' ' ASP . 0.6 OUTLIER -69.83 168.24 15.55 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 115.337 -0.847 . . . . 0.95999999999999996 110.31 -178.281 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.658 ' CE2' ' CE2' ' A' ' 86' ' ' TYR . 6.3 p90 -178.73 146.97 0.36 Allowed 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.299 -0.875 . . . . 0.44 109.229 179.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.589 ' O ' ' C ' ' A' ' 43' ' ' ALA . 0.4 OUTLIER -94.44 98.22 10.72 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 106.314 -1.735 . . . . 4.8700000000000001 106.314 177.664 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.589 ' C ' ' O ' ' A' ' 42' ' ' ASP . . . -17.83 122.38 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 115.38 -0.827 . . . . 1.21 110.722 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.483 ' OD1' ' HG2' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -118.97 30.74 7.01 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.317 -0.865 . . . . 2.3799999999999999 111.017 -177.866 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.666 ' O ' ' N ' ' A' ' 82' ' ' LYS . 2.0 pt20 -126.59 -142.15 0.28 Allowed 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.988 -1.115 . . . . 0.59999999999999998 107.988 179.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.729 ' HA ' ' HB ' ' A' ' 81' ' ' VAL . 0.1 OUTLIER -154.04 68.31 0.75 Allowed 'General case' 0 C--N 1.292 -1.917 0 O-C-N 121.058 -1.026 . . . . 3.6499999999999999 108.675 177.889 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.528 ' O ' ' CG2' ' A' ' 47' ' ' THR . 10.7 t -145.69 120.89 10.17 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 120.101 -1.624 . . . . 0.69999999999999996 111.96 -177.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.649 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -67.59 -25.63 65.87 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.608 -1.307 . . . . 3.8999999999999999 107.812 177.336 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.481 ' O ' ' HB1' ' A' ' 50' ' ' ALA . 66.0 p -82.63 -163.57 0.72 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.695 -0.628 . . . . 1.8799999999999999 109.373 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.588 ' O ' ' CA ' ' A' ' 71' ' ' ASN . . . 175.63 160.46 0.26 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.284 -0.885 . . . . 0.5 109.817 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.542 ' O ' ' CB ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -126.66 -160.14 0.97 Allowed 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 106.516 -1.661 . . . . 4.1500000000000004 106.516 177.581 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.467 ' HB ' ' O ' ' A' ' 51' ' ' LYS . 20.6 tt -177.56 164.41 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 C-N-CA 117.914 -1.515 . . . . 0.97999999999999998 111.641 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.513 ' O ' ' HE2' ' A' ' 55' ' ' LYS . 2.3 mt-10 -165.46 59.28 0.12 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.124 -1.065 . . . . 0.93999999999999995 108.124 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.68 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 0.4 OUTLIER -96.99 139.77 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.352 -0.842 . . . . 0.59999999999999998 109.997 -179.462 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.68 ' HG3' ' O ' ' A' ' 54' ' ' ILE . 1.9 mtmt -150.96 93.38 1.93 Allowed 'General case' 0 C--N 1.284 -2.274 0 C-N-CA 119.833 -0.747 . . . . 1.6899999999999999 109.781 178.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.497 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . . . -110.35 150.4 28.83 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 108.022 -1.103 . . . . 1.8200000000000001 108.022 178.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.48 ' HA ' ' HA ' ' A' ' 62' ' ' GLU . 0.8 OUTLIER -131.03 122.81 27.45 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.774 -1.204 . . . . 1.5600000000000001 111.392 -178.622 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.483 ' CD1' ' N ' ' A' ' 59' ' ' ASP . 2.0 tm? -110.37 158.23 18.67 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.034 -1.099 . . . . 2.3799999999999999 108.034 178.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.483 ' N ' ' CD1' ' A' ' 58' ' ' LEU . 23.4 t0 -40.89 -72.25 0.07 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.155 -0.966 . . . . 3.23 109.792 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -106.29 30.39 9.66 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.496 -1.442 . . . . 1.04 109.496 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.459 ' HB3' ' HB3' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -150.28 60.53 0.97 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.347 -1.09 . . . . 1.3700000000000001 108.996 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.48 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 0.1 OUTLIER -63.42 86.82 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.661 -0.649 . . . . 3.3999999999999999 110.653 -179.31 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.497 ' HB ' ' HB2' ' A' ' 56' ' ' ALA . 2.0 mt -54.69 160.96 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 107.442 -1.318 . . . . 0.91000000000000003 107.442 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.476 ' O ' HG21 ' A' ' 65' ' ' VAL . 17.8 t0 -168.42 146.95 4.29 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.678 -1.264 . . . . 2.6000000000000001 110.097 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.627 ' HB ' ' O ' ' A' ' 54' ' ' ILE . 4.9 t -149.0 74.83 9.99 Favored Pre-proline 0 N--CA 1.488 1.44 0 O-C-N 121.631 -0.668 . . . . 0.77000000000000002 109.285 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -80.33 -7.59 13.92 Favored 'Trans proline' 0 C--N 1.302 -1.886 0 C-N-CA 123.028 2.486 . . . . 1.05 110.465 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 135.39 56.12 0.06 OUTLIER Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.464 -1.454 . . . . 0.88 109.464 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 21.0 mt -81.46 -59.48 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.273 -1.133 . . . . 2.3900000000000001 109.729 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.483 ' OD1' ' O ' ' A' ' 69' ' ' ASP . 8.9 p30 -66.75 142.74 57.28 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.117 -0.989 . . . . 1.6499999999999999 109.228 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.416 ' O ' ' CG ' ' A' ' 71' ' ' ASN . 5.8 t -67.69 -10.27 50.91 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.084 -1.01 . . . . 3.8399999999999999 108.848 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.588 ' CA ' ' O ' ' A' ' 50' ' ' ALA . 7.4 m-20 178.02 66.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.918 . . . . 0.35999999999999999 110.347 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.542 ' CB ' ' O ' ' A' ' 51' ' ' LYS . . . 39.77 27.54 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 121.456 0.646 . . . . 0.34999999999999998 110.674 177.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.478 ' N ' ' O ' ' A' ' 71' ' ' ASN . 6.7 t -102.76 -22.34 13.93 Favored 'General case' 0 C--N 1.293 -1.885 0 O-C-N 121.447 -0.783 . . . . 0.64000000000000001 109.88 -179.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.469 ' HB2' ' HB3' ' A' ' 69' ' ' ASP . 0.4 OUTLIER -84.93 5.87 27.29 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.228 -0.92 . . . . 5.0999999999999996 109.783 -179.881 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.466 ' C ' ' CG1' ' A' ' 76' ' ' VAL . 76.5 m-85 -135.37 0.79 2.83 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.044 -1.035 . . . . 1.03 110.841 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.751 ' HB ' ' CE1' ' A' ' 86' ' ' TYR . 0.2 OUTLIER -167.92 173.66 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.362 -1.461 . . . . 0.84999999999999998 111.139 -178.094 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.618 ' N ' ' CG2' ' A' ' 76' ' ' VAL . 0.1 OUTLIER -55.03 94.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 106.264 -1.754 . . . . 4.8700000000000001 106.264 177.447 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . 0.598 ' HB2' ' HD3' ' A' ' 79' ' ' PRO . 2.4 m -33.47 -53.27 0.75 Allowed Pre-proline 0 N--CA 1.504 2.236 0 O-C-N 121.789 -0.569 . . . . 1.3600000000000001 112.382 -176.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.649 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 33.9 Cg_endo -79.75 113.08 3.0 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 120.93 1.086 . . . . 1.02 110.193 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.621 ' CB ' HD23 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -97.37 -65.7 0.95 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.229 -0.919 . . . . 0.73999999999999999 108.58 -179.59 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.729 ' HB ' ' HA ' ' A' ' 46' ' ' ASN . 1.3 m 41.38 -168.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 C-N-CA 120.32 -0.552 . . . . 0.88 109.701 178.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.666 ' N ' ' O ' ' A' ' 45' ' ' GLN . 0.0 OUTLIER -102.53 42.38 1.15 Allowed 'General case' 0 C--N 1.29 -1.982 0 O-C-N 120.133 -1.604 . . . . 1.76 110.999 -175.98 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.492 ' O ' ' OE1' ' A' ' 84' ' ' GLN . . . -151.83 31.73 0.9 Allowed Glycine 0 C--N 1.285 -2.264 0 N-CA-C 108.995 -1.642 . . . . 1.6499999999999999 108.995 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.492 ' OE1' ' O ' ' A' ' 83' ' ' GLY . 0.2 OUTLIER -137.3 121.69 18.23 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.284 -1.127 . . . . 3.96 110.726 -179.018 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -97.01 125.56 41.52 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 105.435 -2.061 . . . . 3.1299999999999999 105.435 176.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.751 ' CE1' ' HB ' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -153.51 161.08 42.59 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 117.657 -1.617 . . . . 1.01 109.759 -177.445 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.622 ' CB ' ' HG ' ' A' ' 40' ' ' LEU . 3.1 p-10 -129.23 101.09 5.85 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.97 -1.081 . . . . 0.83999999999999997 113.285 -175.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.554 ' CD1' HG13 ' A' ' 76' ' ' VAL . 3.2 tp -69.17 -160.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 107.722 -1.214 . . . . 1.28 107.722 176.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.551 ' CB ' ' O ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER 159.75 170.14 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.196 -0.94 . . . . 2.6600000000000001 109.993 179.689 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.556 ' CE2' HG22 ' A' ' 54' ' ' ILE . 10.0 m-85 -162.48 67.83 0.24 Allowed 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.944 -0.762 . . . . 1.55 108.944 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.54 ' C ' ' CD1' ' A' ' 92' ' ' TRP . 3.0 t -56.39 176.19 0.09 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.474 -0.766 . . . . 3.2999999999999998 109.94 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.667 ' N ' ' CD1' ' A' ' 92' ' ' TRP . 0.0 OUTLIER -142.36 147.79 36.85 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.229 -0.919 . . . . 7.1399999999999997 109.914 -179.377 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.506 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 25.3 m-20 -74.93 94.64 2.85 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 104.338 -2.468 . . . . 6.2999999999999998 104.338 175.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.692 HG13 ' O ' ' A' ' 33' ' ' LYS . 60.8 t -106.3 96.04 12.72 Favored Pre-proline 0 N--CA 1.488 1.466 0 C-N-CA 118.817 -1.153 . . . . 2.5 113.777 -175.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.61 ' HD2' ' CD1' ' A' ' 97' ' ' ILE . 35.2 Cg_endo -77.42 -150.11 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.538 2.158 . . . . 2.6400000000000001 107.319 174.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.553 ' O ' ' CB ' ' A' ' 31' ' ' ARG . 0.7 OUTLIER -72.12 -25.23 61.65 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.426 -1.421 . . . . 3.7400000000000002 108.561 178.485 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.616 ' CD1' ' CG1' ' A' ' 94' ' ' VAL . 4.0 mt 43.25 14.49 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.505 -0.747 . . . . 1.95 112.842 179.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.641 ' CB ' ' HD2' ' A' ' 99' ' ' PRO . . . 52.64 175.38 0.03 OUTLIER Pre-proline 0 C--N 1.304 -1.403 0 O-C-N 119.769 -1.832 . . . . 1.5 109.226 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.641 ' HD2' ' CB ' ' A' ' 98' ' ' ALA . 37.3 Cg_endo -73.1 -7.17 20.21 Favored 'Trans proline' 0 C--N 1.299 -2.055 0 C-N-CA 123.293 2.662 . . . . 4.0599999999999996 110.995 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.643 ' HD3' ' CB ' ' A' ' 128' ' ' ARG . 1.1 mmmt -149.73 126.58 11.12 Favored 'General case' 0 C--N 1.276 -2.623 0 C-N-CA 119.462 -0.895 . . . . 2.1600000000000001 109.859 -178.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.458 ' HB3' HD11 ' A' ' 127' ' ' ILE . 4.3 t -89.3 159.09 17.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.187 -0.945 . . . . 1.3300000000000001 109.642 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.63 -10.65 48.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.444 -0.785 . . . . 1.3999999999999999 110.362 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.507 ' C ' ' CG2' ' A' ' 104' ' ' VAL . 0.1 OUTLIER 175.1 146.05 0.07 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.814 -1.178 . . . . 3.5099999999999998 110.177 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.507 ' CG2' ' C ' ' A' ' 103' ' ' ASN . 0.2 OUTLIER -156.68 168.36 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.556 -0.715 . . . . 1.0700000000000001 109.804 -179.781 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.505 ' CB ' ' O ' ' A' ' 104' ' ' VAL . 0.9 OUTLIER 161.87 125.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.261 -1.015 . . . . 1.8600000000000001 108.261 -179.934 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 42.6 t -119.53 96.4 4.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 120.986 -1.071 . . . . 1.75 110.664 -179.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.51 ' O ' ' CG2' ' A' ' 108' ' ' VAL . 7.4 m -105.43 150.56 25.16 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.246 -1.39 . . . . 1.26 107.246 178.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.538 HG13 ' N ' ' A' ' 109' ' ' LYS . 75.6 t -157.84 160.76 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 C-N-CA 118.281 -1.368 . . . . 1.6799999999999999 111.545 -178.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.538 ' N ' HG13 ' A' ' 108' ' ' VAL . 1.8 ttpt 177.54 126.39 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.524 -0.917 . . . . 1.48 108.524 178.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.476 ' HB3' ' HB2' ' A' ' 117' ' ' LEU . 11.5 tp -118.35 127.6 53.84 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 107.275 -1.38 . . . . 1.5700000000000001 107.275 178.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.505 ' O ' ' CG ' ' A' ' 51' ' ' LYS . 1.7 mt -124.97 116.93 48.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 O-C-N 121.262 -0.899 . . . . 1.76 111.503 -177.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.453 ' HA2' ' HA ' ' A' ' 50' ' ' ALA . . . -86.1 -110.1 0.78 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.122 -1.991 . . . . 0.39000000000000001 108.122 177.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.407 ' O ' ' CG ' ' A' ' 113' ' ' ASP . 7.4 t70 -136.54 1.71 2.63 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.066 -1.255 . . . . 2.1099999999999999 107.71 178.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.441 ' ND2' ' N ' ' A' ' 114' ' ' ASN . 0.6 OUTLIER -116.1 -20.42 9.88 Favored 'General case' 0 C--N 1.31 -1.139 0 O-C-N 121.491 -0.756 . . . . 0.66000000000000003 109.601 -179.614 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 169.76 -161.32 34.63 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.35 -1.5 . . . . 0.52000000000000002 109.35 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.486 ' O ' HG11 ' A' ' 116' ' ' VAL . 2.5 p -90.8 105.34 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.101 -1.235 . . . . 1.78 109.517 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.621 HD23 ' CB ' ' A' ' 80' ' ' LEU . 1.4 mt -49.58 -53.23 25.02 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.219 -0.926 . . . . 1.1899999999999999 110.8 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.533 ' HA ' ' HB3' ' A' ' 9' ' ' ALA . . . -158.24 129.08 6.33 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.219 -0.926 . . . . 2.1299999999999999 110.245 -178.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . 0.435 ' HB3' HG23 ' A' ' 116' ' ' VAL . 10.2 p -134.29 169.2 17.56 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.484 -0.76 . . . . 2.1299999999999999 109.439 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.443 ' O ' HG13 ' A' ' 121' ' ' ILE . . . -173.31 138.75 0.73 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.375 -0.828 . . . . 0.81999999999999995 109.0 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 120' ' ' ALA . 2.7 mp -139.44 132.45 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.975 -1.078 . . . . 1.4099999999999999 110.437 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.466 ' O ' ' C ' ' A' ' 123' ' ' THR . . . -114.74 93.5 4.35 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.994 -1.113 . . . . 1.54 107.994 179.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.466 ' C ' ' O ' ' A' ' 122' ' ' ALA . 98.6 m -33.47 99.2 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.489 0.661 . . . . 1.97 110.835 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . 0.443 ' HA ' HG21 ' A' ' 105' ' ' VAL . 0.1 OUTLIER 53.92 176.32 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.627 -0.671 . . . . 4.21 110.111 179.704 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.488 ' O ' ' HB ' ' A' ' 104' ' ' VAL . . . -160.31 119.35 0.88 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.546 -1.422 . . . . 0.79000000000000004 109.546 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -128.61 104.72 7.83 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.14 -1.212 . . . . 3.9199999999999999 109.461 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.614 ' O ' ' CB ' ' A' ' 128' ' ' ARG . 2.8 mp -54.77 157.26 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.249 -0.907 . . . . 1.6299999999999999 109.28 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.643 ' CB ' ' HD3' ' A' ' 100' ' ' LYS . 0.0 OUTLIER 134.66 -86.2 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.446 0 N-CA-C 108.266 -1.013 . . . . 4.6299999999999999 108.266 179.37 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.477 ' N ' ' CG ' ' A' ' 128' ' ' ARG . 1.7 t0 . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 118.077 -0.963 . . . . 2.6499999999999999 109.543 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 1' ' ' ASP . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.484 0.659 . . . . 4.0 109.817 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.571 ' HA ' ' HB3' ' A' ' 17' ' ' MET . 66.7 mt-30 53.99 -179.31 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.888 0.852 . . . . 3.8500000000000001 110.887 178.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.586 ' CG1' ' N ' ' A' ' 4' ' ' ASP . 0.8 OUTLIER -170.94 -155.26 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 108.78 -0.822 . . . . 4.5800000000000001 108.78 179.85 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.586 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 17.7 m-20 -146.58 114.95 6.69 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.9 -1.125 . . . . 3.1200000000000001 110.245 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.7 m -142.21 146.42 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 120.965 -1.085 . . . . 1.22 109.792 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.477 ' O ' HG12 ' A' ' 121' ' ' ILE . 8.5 mmtt -69.59 105.3 2.62 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.319 -0.863 . . . . 4.6399999999999997 109.877 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.442 ' HA ' ' O ' ' A' ' 119' ' ' CYS . 0.8 OUTLIER -95.91 167.42 11.26 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.145 -0.972 . . . . 3.4399999999999999 108.641 179.335 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.548 ' N ' ' SG ' ' A' ' 119' ' ' CYS . 6.3 m -140.07 7.98 2.26 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.052 -1.03 . . . . 1.4099999999999999 109.755 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.517 ' CA ' ' HA ' ' A' ' 118' ' ' ALA . . . -49.62 -75.34 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.163 -0.961 . . . . 1.24 109.587 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.449 ' CB ' ' O ' ' A' ' 9' ' ' ALA . 0.9 OUTLIER 167.34 37.29 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.885 -0.783 . . . . 1.95 108.885 -178.478 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 58.41 26.27 13.93 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.908 -1.145 . . . . 3.27 107.908 -178.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.484 ' O ' ' C ' ' A' ' 13' ' ' ILE . 0.3 OUTLIER -116.98 -21.72 8.79 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.507 -0.746 . . . . 2.5899999999999999 110.414 -179.16 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.484 ' C ' ' O ' ' A' ' 12' ' ' GLU . 5.7 mt -43.09 139.87 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 108.144 -1.058 . . . . 1.52 108.144 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.41 ' N ' HG21 ' A' ' 13' ' ' ILE . 0.4 OUTLIER -94.27 -25.59 16.97 Favored 'General case' 0 C--N 1.292 -1.931 0 O-C-N 121.513 -0.742 . . . . 3.7799999999999998 109.585 -178.739 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.438 ' HG2' ' HE1' ' A' ' 17' ' ' MET . 3.7 mtmt -167.48 105.51 0.54 Allowed 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 118.006 -1.478 . . . . 1.8500000000000001 111.981 -178.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.483 ' HA ' ' HA ' ' A' ' 39' ' ' ALA . 2.2 p -116.97 94.72 3.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 N-CA-C 106.152 -1.795 . . . . 1.3999999999999999 106.152 177.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.571 ' HB3' ' HA ' ' A' ' 2' ' ' GLN . 12.3 mmt -132.46 142.51 49.27 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.558 -0.713 . . . . 3.6899999999999999 111.392 -176.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.479 HG23 ' CD2' ' A' ' 37' ' ' LEU . 16.7 t -110.84 141.02 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 107.935 -1.135 . . . . 2.52 107.935 178.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.477 ' HB3' ' HA ' ' A' ' 35' ' ' PHE . 7.4 t70 -62.95 -40.93 99.16 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.094 -1.004 . . . . 2.52 110.538 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.542 ' O ' ' CB ' ' A' ' 21' ' ' CYS . . . -156.01 139.82 6.84 Favored Glycine 0 N--CA 1.489 2.212 0 C-N-CA 119.351 -1.404 . . . . 3.1200000000000001 110.286 -179.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.545 ' HB2' HG22 ' A' ' 29' ' ' ILE . 0.0 OUTLIER 155.01 -56.76 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.572 -0.958 . . . . 0.84999999999999998 108.812 179.288 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.534 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 1.6 t60 80.66 120.57 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 107.689 -1.226 . . . . 4.7800000000000002 107.689 -177.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.539 ' HA3' ' O ' ' A' ' 4' ' ' ASP . . . -106.26 -166.88 22.97 Favored Glycine 0 N--CA 1.493 2.481 0 C-N-CA 119.25 -1.453 . . . . 1.1799999999999999 111.341 -178.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.423 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 0.5 OUTLIER 69.86 -87.9 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.499 -1.0 . . . . 1.1799999999999999 108.602 -179.241 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.618 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 3.0 p-10 -63.66 -163.61 0.01 OUTLIER Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 107.14 -1.43 . . . . 1.3500000000000001 107.14 178.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.618 ' HD2' ' CB ' ' A' ' 25' ' ' ASP . 29.6 Cg_endo -72.32 106.09 1.99 Allowed 'Trans proline' 0 C--N 1.313 -1.323 0 N-CA-C 108.545 -1.367 . . . . 1.79 108.545 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.534 ' HB2' ' O ' ' A' ' 22' ' ' HIS . 1.3 t -62.44 92.47 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.756 -0.59 . . . . 1.1000000000000001 112.579 -176.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.499 HG21 ' N ' ' A' ' 29' ' ' ILE . 1.7 mp -91.1 135.0 27.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 105.182 -2.155 . . . . 3.3300000000000001 105.182 174.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.545 HG22 ' HB2' ' A' ' 21' ' ' CYS . 0.1 OUTLIER -108.82 173.79 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.196 0 O-C-N 120.666 -1.272 . . . . 0.92000000000000004 111.147 -177.476 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.429 ' O ' ' CZ ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -102.43 132.51 48.4 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 122.2 1.0 . . . . 3.7000000000000002 111.708 -178.467 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.672 ' HD3' ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -99.21 109.9 22.51 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 115.634 -0.712 . . . . 9.9399999999999995 109.265 179.21 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.511 ' HA2' ' O ' ' A' ' 95' ' ' PRO . . . 136.18 0.71 3.02 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.556 -1.307 . . . . 1.28 110.336 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.494 ' O ' HG13 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -139.32 139.07 21.72 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 120.868 -1.372 . . . . 4.2599999999999998 109.631 179.891 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.465 ' HA ' ' HB ' ' A' ' 94' ' ' VAL . 30.5 Cg_endo -70.99 123.32 9.59 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.713 2.275 . . . . 2.7599999999999998 110.224 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.477 ' HA ' ' HB3' ' A' ' 19' ' ' ASP . 19.6 m-30 -103.91 -164.65 1.08 Allowed 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.777 0.799 . . . . 8.7200000000000006 110.32 -178.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.513 ' O ' ' HG3' ' A' ' 38' ' ' GLU . 1.3 m -179.84 90.36 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.679 -0.86 . . . . 1.73 108.679 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.479 ' CD2' HG23 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -57.35 152.7 13.71 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.086 -1.009 . . . . 4.6299999999999999 108.438 179.729 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.513 ' HG3' ' O ' ' A' ' 36' ' ' THR . 72.8 mt-10 -154.13 176.6 12.05 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.89 -1.131 . . . . 0.54000000000000004 111.015 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.483 ' HA ' ' HA ' ' A' ' 16' ' ' VAL . . . 168.71 85.89 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.252 -1.388 . . . . 0.65000000000000002 107.252 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.616 ' HG ' ' HA ' ' A' ' 87' ' ' ASP . 4.3 mp -88.22 144.52 26.4 Favored 'General case' 0 C--N 1.291 -1.97 0 O-C-N 121.85 -0.531 . . . . 1.8700000000000001 110.095 -178.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.801 ' CE2' ' CD2' ' A' ' 86' ' ' TYR . 0.1 OUTLIER -136.2 174.69 10.34 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.942 -1.099 . . . . 1.0900000000000001 108.26 176.841 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.495 ' O ' ' C ' ' A' ' 43' ' ' ALA . 0.2 OUTLIER -126.24 102.24 7.1 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 106.651 -1.611 . . . . 2.7599999999999998 106.651 178.582 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.569 ' CB ' ' O ' ' A' ' 81' ' ' VAL . . . -34.79 117.59 0.38 Allowed 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 115.548 -0.751 . . . . 0.46000000000000002 109.33 -179.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.468 ' O ' ' HB3' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -126.8 0.15 6.69 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.36 0.6 . . . . 0.79000000000000004 109.68 -178.473 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.629 ' O ' ' N ' ' A' ' 82' ' ' LYS . 3.3 pt20 -90.86 -141.64 0.17 Allowed 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.405 -0.961 . . . . 1.0 108.405 179.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.745 ' HA ' ' HB ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -156.86 71.76 0.69 Allowed 'General case' 0 C--N 1.293 -1.848 0 O-C-N 120.962 -1.086 . . . . 0.90000000000000002 109.641 178.94 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.53 ' CG2' ' OE1' ' A' ' 45' ' ' GLN . 7.5 t -150.33 122.19 8.15 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.17 -1.581 . . . . 1.48 111.003 -178.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.606 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 1.7 mtpt -69.17 -17.97 63.87 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.89 -1.131 . . . . 3.98 109.131 178.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.474 ' OG1' ' OG1' ' A' ' 47' ' ' THR . 1.1 p -76.32 176.41 8.18 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.16 -0.963 . . . . 1.6200000000000001 109.719 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.543 ' O ' ' CA ' ' A' ' 71' ' ' ASN . . . -176.23 136.89 0.29 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.242 -0.911 . . . . 0.78000000000000003 109.962 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.542 ' O ' ' CB ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -121.1 -156.26 0.67 Allowed 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.723 -1.214 . . . . 3.1400000000000001 107.723 178.393 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.452 ' CG1' HD11 ' A' ' 54' ' ' ILE . 17.3 tt -175.31 165.59 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 C-N-CA 118.616 -1.234 . . . . 1.02 111.293 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.44 ' C ' HD13 ' A' ' 54' ' ' ILE . 0.4 OUTLIER -168.09 68.94 0.08 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.718 -0.845 . . . . 3.1800000000000002 108.718 179.778 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.61 ' N ' ' CD1' ' A' ' 54' ' ' ILE . 0.7 OUTLIER -109.17 149.76 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.308 -0.87 . . . . 0.68000000000000005 110.066 -178.967 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.606 ' HG3' ' O ' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -164.98 100.73 0.76 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.331 -0.856 . . . . 2.3199999999999998 109.602 178.16 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.44 ' O ' ' O ' ' A' ' 63' ' ' ILE . . . -106.74 147.9 29.07 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.114 -0.991 . . . . 1.76 108.375 178.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.517 ' HA ' ' HA ' ' A' ' 62' ' ' GLU . 37.2 t -132.5 129.12 38.73 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.868 -1.145 . . . . 2.1299999999999999 110.315 -179.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.613 ' HG ' ' CZ2' ' A' ' 92' ' ' TRP . 0.1 OUTLIER -114.15 -152.13 0.5 Allowed 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.081 -1.081 . . . . 3.9100000000000001 108.081 179.42 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.569 ' HB3' ' CG2' ' A' ' 97' ' ' ILE . 48.4 t0 -106.72 87.73 2.59 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.71 -1.244 . . . . 4.1500000000000004 108.403 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.71 -6.93 62.94 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 108.326 -1.91 . . . . 2.5600000000000001 108.326 -178.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -128.02 49.66 2.13 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 107.581 -1.266 . . . . 2.1899999999999999 107.581 179.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.528 ' O ' ' CG ' ' A' ' 62' ' ' GLU . 1.8 tt0 -59.65 91.24 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.862 -0.524 . . . . 4.3700000000000001 109.967 -179.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.488 HD12 HG22 ' A' ' 63' ' ' ILE . 8.3 mt -55.98 159.85 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 C-N-CA 118.773 -1.171 . . . . 1.46 107.952 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.465 ' O ' HG21 ' A' ' 65' ' ' VAL . 40.2 p-10 -156.27 162.92 40.08 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.174 -0.954 . . . . 5.1200000000000001 110.202 -179.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.608 ' HB ' ' O ' ' A' ' 54' ' ' ILE . 35.4 t -146.92 66.37 10.42 Favored Pre-proline 0 C--N 1.303 -1.442 0 O-C-N 121.499 -0.751 . . . . 1.77 109.11 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.523 ' O ' ' C ' ' A' ' 67' ' ' GLY . 37.3 Cg_endo -80.25 102.72 1.46 Allowed 'Trans proline' 0 C--N 1.3 -1.979 0 C-N-CA 123.329 2.686 . . . . 4.4699999999999998 111.34 -179.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.523 ' C ' ' O ' ' A' ' 66' ' ' PRO . . . 22.99 51.8 0.02 OUTLIER Glycine 0 N--CA 1.5 2.914 0 N-CA-C 111.511 -0.635 . . . . 1.1499999999999999 111.511 179.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.415 ' N ' ' O ' ' A' ' 66' ' ' PRO . 6.6 mt -60.73 -81.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.072 -1.252 . . . . 3.6000000000000001 109.442 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.599 ' HB3' ' CG ' ' A' ' 74' ' ' HIS . 52.3 p30 -68.69 -167.62 0.1 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.342 -0.849 . . . . 2.25 109.957 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.462 ' O ' ' OD1' ' A' ' 71' ' ' ASN . 1.1 p -111.11 5.1 19.88 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.982 -0.747 . . . . 1.3999999999999999 108.982 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.543 ' CA ' ' O ' ' A' ' 50' ' ' ALA . 2.2 m-20 172.95 69.1 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.177 -0.952 . . . . 2.0299999999999998 110.972 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.542 ' CB ' ' O ' ' A' ' 51' ' ' LYS . . . 38.75 23.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 112.627 0.602 . . . . 0.45000000000000001 112.627 177.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.508 ' N ' ' O ' ' A' ' 71' ' ' ASN . 22.9 t -99.19 4.56 46.8 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.651 -1.281 . . . . 1.74 111.422 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.599 ' CG ' ' HB3' ' A' ' 69' ' ' ASP . 4.2 m170 -95.63 -18.25 20.69 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.419 -1.425 . . . . 2.8199999999999998 109.56 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.55 ' O ' HG11 ' A' ' 76' ' ' VAL . 5.4 m-85 -97.85 -26.69 14.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.346 -0.846 . . . . 2.5299999999999998 108.884 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.758 ' CG2' ' CZ ' ' A' ' 86' ' ' TYR . 15.4 m -147.48 -139.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.811 -0.811 . . . . 4.0899999999999999 108.811 -178.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.523 ' N ' ' CG2' ' A' ' 76' ' ' VAL . 15.0 mmmt -93.03 162.74 13.92 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.141 -1.429 . . . . 4.9299999999999997 107.141 177.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . 0.521 ' N ' ' CD ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -83.16 -51.3 0.67 Allowed Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 120.469 -1.394 . . . . 2.0899999999999999 109.949 -179.829 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.606 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 29.1 Cg_endo -76.77 120.7 5.6 Favored 'Trans proline' 0 C--N 1.302 -1.918 0 N-CA-C 108.447 -1.405 . . . . 1.26 108.447 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.623 ' CD1' ' CE1' ' A' ' 86' ' ' TYR . 0.3 OUTLIER -98.19 -67.38 0.85 Allowed 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.918 -1.142 . . . . 2.1899999999999999 107.918 -178.958 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.745 ' HB ' ' HA ' ' A' ' 46' ' ' ASN . 1.4 m 41.26 -167.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 C-N-CA 120.353 -0.539 . . . . 0.73999999999999999 109.872 177.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.629 ' N ' ' O ' ' A' ' 45' ' ' GLN . 0.6 OUTLIER -99.96 42.23 1.12 Allowed 'General case' 0 C--N 1.293 -1.881 0 O-C-N 120.529 -1.357 . . . . 4.6500000000000004 110.195 -177.4 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -148.79 44.78 0.74 Allowed Glycine 0 C--N 1.288 -2.12 0 N-CA-C 109.152 -1.579 . . . . 0.64000000000000001 109.152 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -152.47 162.33 41.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.057 -1.26 . . . . 4.8899999999999997 110.259 -179.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -117.26 141.63 48.06 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.099 -1.074 . . . . 5.2000000000000002 108.099 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.801 ' CD2' ' CE2' ' A' ' 41' ' ' PHE . 0.2 OUTLIER -108.33 -173.55 2.31 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.908 -1.12 . . . . 4.5999999999999996 112.27 -177.542 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.616 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 2.9 t70 159.52 74.45 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.28 0 CA-C-O 121.826 0.822 . . . . 2.5699999999999998 109.54 178.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.478 ' O ' HG12 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -106.92 137.49 37.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 107.581 -1.266 . . . . 3.3799999999999999 107.581 179.37 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.57 ' O ' ' CD1' ' A' ' 90' ' ' TYR . 8.6 mttt -142.88 -166.42 2.29 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.613 -1.304 . . . . 2.0800000000000001 111.57 -178.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.593 ' CZ ' HG22 ' A' ' 54' ' ' ILE . 77.3 m-85 -155.86 77.83 0.97 Allowed 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 108.62 -0.881 . . . . 1.3200000000000001 108.62 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.47 ' O ' ' O ' ' A' ' 90' ' ' TYR . 12.4 m -45.58 171.17 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.365 -0.834 . . . . 3.9199999999999999 109.533 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.613 ' CZ2' ' HG ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -150.34 107.99 3.67 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 118.97 -1.092 . . . . 4.0300000000000002 111.535 -179.311 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.423 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 0.7 OUTLIER -72.8 98.93 2.52 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 106.23 -1.767 . . . . 3.3199999999999998 106.23 177.042 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.596 ' CG1' ' CD1' ' A' ' 97' ' ' ILE . 69.6 t -109.74 95.56 20.55 Favored Pre-proline 0 C--N 1.301 -1.504 0 C-N-CA 119.037 -1.065 . . . . 2.0299999999999998 113.159 -176.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.592 ' HD2' ' CD1' ' A' ' 97' ' ' ILE . 31.1 Cg_endo -75.21 -92.86 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.833 2.356 . . . . 1.0900000000000001 108.441 175.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.524 ' O ' ' HB3' ' A' ' 31' ' ' ARG . 1.3 mmtp -121.06 -53.12 2.06 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 105.223 -2.14 . . . . 5.2400000000000002 105.223 176.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.672 ' HB ' ' HD3' ' A' ' 31' ' ' ARG . 1.6 mp 61.35 28.8 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 112.632 0.605 . . . . 1.0600000000000001 112.632 175.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.586 ' O ' ' HG3' ' A' ' 31' ' ' ARG . . . 58.64 160.52 0.09 OUTLIER Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 120.949 -1.095 . . . . 2.79 111.011 177.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.627 ' O ' ' HA ' ' A' ' 128' ' ' ARG . 46.2 Cg_endo -84.69 4.99 6.52 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 124.087 3.191 . . . . 2.79 110.801 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.58 ' HD3' ' CB ' ' A' ' 128' ' ' ARG . 4.6 mmmt -161.78 139.27 8.74 Favored 'General case' 0 C--N 1.283 -2.285 0 C-N-CA 119.332 -0.947 . . . . 3.02 110.647 -177.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.579 ' CB ' ' CD1' ' A' ' 127' ' ' ILE . 32.3 t -109.06 2.59 21.28 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.417 -0.802 . . . . 2.1899999999999999 109.043 178.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.529 ' O ' ' CB ' ' A' ' 103' ' ' ASN . 72.9 mt-10 64.54 2.05 1.5 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.557 -0.715 . . . . 5.54 110.144 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.529 ' CB ' ' O ' ' A' ' 102' ' ' GLU . 0.9 OUTLIER 163.94 152.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.02 -1.05 . . . . 3.1499999999999999 109.919 179.908 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.462 ' CG2' ' C ' ' A' ' 103' ' ' ASN . 0.3 OUTLIER -153.78 168.52 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.686 -0.857 . . . . 1.8400000000000001 108.686 179.52 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.1 t -161.81 131.13 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.946 -1.097 . . . . 1.72 109.66 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.549 ' HB ' ' CB ' ' A' ' 122' ' ' ALA . 3.4 t -132.24 124.98 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.24 -0.913 . . . . 1.74 109.287 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.535 ' O ' ' CG2' ' A' ' 108' ' ' VAL . 1.9 m -147.46 156.36 42.79 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.378 -0.826 . . . . 0.79000000000000004 108.838 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.562 ' CG1' ' N ' ' A' ' 109' ' ' LYS . 7.5 t -165.9 162.76 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.146 -0.971 . . . . 0.63 109.773 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.562 ' N ' ' CG1' ' A' ' 108' ' ' VAL . 0.3 OUTLIER 174.95 139.02 0.05 OUTLIER 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.419 -0.8 . . . . 0.73999999999999999 109.527 179.302 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.509 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 7.7 tp -126.57 129.28 48.26 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.289 -1.374 . . . . 1.6000000000000001 107.289 178.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 12.5 mt -125.03 128.18 72.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 121.189 -0.945 . . . . 1.04 111.283 -177.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -103.51 -114.16 3.9 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 107.443 -2.263 . . . . 1.1899999999999999 107.443 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -137.64 4.35 2.58 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.138 -1.431 . . . . 1.6200000000000001 107.138 177.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.446 ' ND2' ' N ' ' A' ' 114' ' ' ASN . 0.7 OUTLIER -124.03 13.92 9.12 Favored 'General case' 0 C--N 1.308 -1.238 0 O-C-N 121.545 -0.722 . . . . 1.29 109.402 -179.688 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 132.77 -158.97 23.32 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.653 -1.379 . . . . 1.23 109.653 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -99.37 117.04 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.296 -1.12 . . . . 0.57999999999999996 109.394 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.601 HD23 ' CB ' ' A' ' 80' ' ' LEU . 1.3 mt -61.63 -41.49 97.56 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.606 -0.684 . . . . 1.4199999999999999 110.875 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.517 ' HA ' ' CA ' ' A' ' 9' ' ' ALA . . . -168.51 136.16 2.08 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.114 -0.991 . . . . 1.6599999999999999 110.235 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . 0.548 ' SG ' ' N ' ' A' ' 8' ' ' CYS . 0.5 OUTLIER -137.32 177.72 7.65 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.533 -0.729 . . . . 1.6399999999999999 109.452 179.852 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.483 ' N ' ' SG ' ' A' ' 119' ' ' CYS . . . -173.95 123.49 0.33 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.238 -0.914 . . . . 0.54000000000000004 108.804 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.494 HD12 ' SG ' ' A' ' 119' ' ' CYS . 0.0 OUTLIER -127.48 140.87 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.055 -1.028 . . . . 3.5 111.429 -178.633 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.549 ' CB ' ' HB ' ' A' ' 106' ' ' VAL . . . -119.37 136.52 54.24 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.771 -1.196 . . . . 1.6100000000000001 107.771 177.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.412 ' O ' ' O ' ' A' ' 124' ' ' HIS . 17.7 m -89.62 94.69 9.95 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.813 -1.18 . . . . 1.8899999999999999 110.695 -178.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . 0.412 ' O ' ' O ' ' A' ' 123' ' ' THR . 1.6 t60 54.26 166.04 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.693 0.758 . . . . 4.5800000000000001 110.991 178.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -156.05 170.22 33.75 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 108.348 -1.901 . . . . 2.1099999999999999 108.348 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.496 ' HB2' HG13 ' A' ' 28' ' ' ILE . 0.4 OUTLIER -150.65 81.37 1.34 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.766 -1.432 . . . . 2.2999999999999998 109.806 -179.932 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.661 ' O ' ' HB3' ' A' ' 128' ' ' ARG . 3.3 mp -41.63 138.07 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.65 -0.656 . . . . 1.1499999999999999 110.573 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.661 ' HB3' ' O ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER 167.4 -165.58 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 122.274 1.035 . . . . 2.5 111.266 177.76 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.615 ' N ' ' CG ' ' A' ' 128' ' ' ARG . 3.5 m-20 . . . . . 0 C--N 1.299 -1.604 0 CA-C-O 117.982 -1.009 . . . . 6.8700000000000001 109.703 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . 0.462 ' O ' ' HB3' ' A' ' 17' ' ' MET . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 121.358 0.599 . . . . 4.6399999999999997 109.728 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.519 ' O ' ' C ' ' A' ' 3' ' ' VAL . 1.3 pt20 -105.33 34.78 3.09 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.316 -0.994 . . . . 3.6899999999999999 108.316 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.537 ' CG1' ' HA ' ' A' ' 22' ' ' HIS . 0.6 OUTLIER -28.51 123.51 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 CA-C-O 121.487 0.66 . . . . 2.1099999999999999 110.239 -179.672 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -65.23 154.08 39.14 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.451 -0.781 . . . . 3.6499999999999999 110.408 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -154.88 170.55 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.446 -0.946 . . . . 2.25 108.446 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.413 ' O ' HD13 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -77.24 92.77 3.89 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.889 -1.132 . . . . 7.2199999999999998 109.499 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.448 ' HA ' ' O ' ' A' ' 119' ' ' CYS . 0.7 OUTLIER -88.13 -177.7 5.78 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.284 -0.885 . . . . 2.9700000000000002 109.134 179.806 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.492 ' O ' ' C ' ' A' ' 9' ' ' ALA . 37.4 m -151.04 -29.55 0.19 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.198 -0.939 . . . . 2.29 110.794 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.537 ' CA ' ' HA ' ' A' ' 118' ' ' ALA . . . -32.8 -77.23 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.425 -0.797 . . . . 1.3 110.938 -179.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.468 ' O ' ' HB3' ' A' ' 11' ' ' ASN . 0.9 OUTLIER 175.33 -77.33 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.415 -0.803 . . . . 3.1899999999999999 109.265 -178.747 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.468 ' HB3' ' O ' ' A' ' 10' ' ' ASN . 17.8 p-10 173.56 36.28 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.523 -0.918 . . . . 4.04 108.523 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.443 ' O ' ' C ' ' A' ' 13' ' ' ILE . 0.3 OUTLIER -129.18 -4.77 4.94 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.386 -0.821 . . . . 2.2999999999999998 109.78 -179.507 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.542 ' CG2' ' O ' ' A' ' 40' ' ' LEU . 18.5 mt -43.97 148.48 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.221 -0.924 . . . . 1.03 109.091 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.405 ' HE2' ' OD2' ' A' ' 42' ' ' ASP . 2.0 mmtt -96.86 -17.7 20.01 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.921 -0.77 . . . . 3.6699999999999999 108.921 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.525 ' CB ' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -170.03 100.89 0.29 Allowed 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 119.211 -0.995 . . . . 2.7799999999999998 110.404 -178.164 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.49 ' O ' ' HG3' ' A' ' 17' ' ' MET . 1.4 p -124.75 97.09 4.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 107.897 -1.149 . . . . 1.95 107.897 179.168 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.491 ' HG2' ' HB3' ' A' ' 2' ' ' GLN . 2.4 mpt? -150.77 155.45 39.29 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.127 -0.983 . . . . 2.52 110.793 -178.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.502 ' HB ' HG23 ' A' ' 3' ' ' VAL . 2.1 t -112.06 128.9 68.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 106.982 -1.488 . . . . 2.5099999999999998 106.982 178.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.526 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -87.75 89.29 7.94 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.852 -1.155 . . . . 2.6699999999999999 111.191 -177.848 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.509 ' O ' ' CB ' ' A' ' 21' ' ' CYS . . . 90.6 112.41 1.59 Allowed Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.816 -1.183 . . . . 1.28 110.879 178.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.534 ' HA ' ' CG2' ' A' ' 29' ' ' ILE . 0.0 OUTLIER 159.12 -50.37 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.445 -1.032 . . . . 0.80000000000000004 109.436 179.002 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.56 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 2.3 m-70 85.19 118.72 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 109.267 -0.642 . . . . 6.3399999999999999 109.267 -178.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 24' ' ' SER . . . -95.74 -176.91 36.85 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 109.752 -1.339 . . . . 1.02 109.752 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.496 ' O ' ' O ' ' A' ' 25' ' ' ASP . 15.0 m 60.19 -89.41 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.236 -1.155 . . . . 1.98 109.414 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.616 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.2 OUTLIER -50.68 -176.56 0.02 OUTLIER Pre-proline 0 C--N 1.304 -1.37 0 N-CA-C 108.149 -1.056 . . . . 1.5800000000000001 108.149 179.244 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.616 ' HD2' ' CB ' ' A' ' 25' ' ' ASP . 28.4 Cg_endo -70.24 82.9 0.81 Allowed 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 121.889 1.726 . . . . 1.75 109.29 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.56 ' HA ' ' O ' ' A' ' 22' ' ' HIS . 2.3 t -31.69 89.54 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 115.297 -0.865 . . . . 1.28 112.415 -178.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.486 ' O ' ' O ' ' A' ' 21' ' ' CYS . 28.7 mm -90.6 132.37 35.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 104.783 -2.303 . . . . 1.9299999999999999 104.783 175.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.534 ' CG2' ' HA ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -109.52 179.07 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.291 0 C-N-CA 118.666 -1.213 . . . . 0.91000000000000003 111.319 -176.86 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.581 ' N ' ' CD2' ' A' ' 30' ' ' HIS . 2.3 m-70 -128.08 154.34 45.81 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 119.767 -0.773 . . . . 0.66000000000000003 110.881 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.545 ' CB ' ' O ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -100.54 155.54 17.79 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.886 -1.153 . . . . 6.1299999999999999 107.886 178.404 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.441 ' C ' HG13 ' A' ' 94' ' ' VAL . . . 90.22 0.79 76.52 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.84 -1.304 . . . . 0.98999999999999999 109.84 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.545 ' O ' ' CB ' ' A' ' 94' ' ' VAL . 2.1 mtmm -129.66 145.7 58.07 Favored Pre-proline 0 N--CA 1.493 1.71 0 N-CA-C 107.564 -1.273 . . . . 2.46 107.564 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -71.35 82.71 1.07 Allowed 'Trans proline' 0 C--N 1.303 -1.846 0 C-N-CA 122.354 2.036 . . . . 1.1799999999999999 112.152 -177.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.526 ' HA ' ' O ' ' A' ' 19' ' ' ASP . 12.3 t80 -52.01 114.13 1.22 Allowed 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 107.352 -1.351 . . . . 2.8599999999999999 107.352 178.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.485 ' OG1' ' HA ' ' A' ' 91' ' ' THR . 7.4 m -132.53 88.8 2.57 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 118.892 -1.123 . . . . 2.6000000000000001 111.3 -178.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 37' ' ' LEU . 0.8 OUTLIER -80.56 126.48 31.3 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.236 -1.394 . . . . 2.6000000000000001 107.236 177.975 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.507 ' O ' ' HB1' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -140.22 -163.5 1.53 Allowed 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.578 -1.327 . . . . 3.2000000000000002 110.728 -178.274 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.507 ' HB1' ' O ' ' A' ' 38' ' ' GLU . . . 170.02 101.65 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.886 -1.153 . . . . 1.5600000000000001 107.886 179.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.595 ' HG ' ' CB ' ' A' ' 87' ' ' ASP . 1.5 mp -93.29 173.17 7.85 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.295 -0.878 . . . . 1.02 109.818 -178.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.636 ' CE1' ' CE2' ' A' ' 86' ' ' TYR . 10.6 p90 175.05 139.9 0.05 OUTLIER 'General case' 0 C--N 1.305 -1.333 0 O-C-N 120.955 -1.09 . . . . 0.62 109.298 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.514 ' O ' ' C ' ' A' ' 43' ' ' ALA . 3.9 m-20 -86.28 108.49 18.42 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 107.334 -1.358 . . . . 3.6499999999999999 107.334 178.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.584 ' CB ' ' O ' ' A' ' 81' ' ' VAL . . . -32.94 127.9 0.28 Allowed 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.727 -0.669 . . . . 0.35999999999999999 109.602 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -122.58 1.65 9.51 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.221 -0.925 . . . . 1.52 110.221 -178.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.653 ' O ' ' N ' ' A' ' 82' ' ' LYS . 1.9 pt20 -93.53 -142.17 0.22 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.259 -0.9 . . . . 0.72999999999999998 108.657 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.744 ' HA ' ' HB ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -154.31 66.66 0.71 Allowed 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.331 -0.856 . . . . 1.0900000000000001 109.084 178.266 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.555 ' O ' HG11 ' A' ' 81' ' ' VAL . 8.8 t -140.73 126.22 18.89 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.143 -1.598 . . . . 0.96999999999999997 112.081 -177.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.683 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -72.19 -2.11 17.55 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.749 -1.219 . . . . 1.4199999999999999 110.099 178.463 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.4 p -115.98 -175.44 2.73 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.906 -1.121 . . . . 2.5600000000000001 111.546 -178.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.582 ' CB ' ' CB ' ' A' ' 72' ' ' ALA . . . -153.54 170.39 20.91 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.641 -0.874 . . . . 2.7000000000000002 108.641 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.503 ' O ' ' O ' ' A' ' 52' ' ' ILE . 0.4 OUTLIER -152.53 28.27 0.56 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.775 -1.203 . . . . 3.1600000000000001 109.26 179.892 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.583 ' CG2' ' HB3' ' A' ' 72' ' ' ALA . 20.5 tt -29.12 155.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.285 -2.23 0 CA-C-O 122.02 0.914 . . . . 2.8999999999999999 112.206 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.456 ' O ' ' HB ' ' A' ' 54' ' ' ILE . 4.5 tt0 -117.06 -69.92 0.82 Allowed 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.005 -1.109 . . . . 3.1299999999999999 108.005 178.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.663 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 0.3 OUTLIER 59.25 150.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.412 -0.805 . . . . 2.4100000000000001 111.065 178.105 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.663 ' HG3' ' O ' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -178.23 94.08 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.976 -0.75 . . . . 2.77 108.976 178.373 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.443 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . . . -120.43 160.76 22.45 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.915 -1.115 . . . . 2.3599999999999999 109.221 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.466 ' OG ' ' HA ' ' A' ' 104' ' ' VAL . 0.1 OUTLIER -130.19 123.89 31.31 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.97 -1.081 . . . . 2.0499999999999998 109.789 -179.754 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.639 ' CD1' ' CZ2' ' A' ' 92' ' ' TRP . 0.1 OUTLIER -102.63 -147.99 0.38 Allowed 'General case' 0 N--CA 1.484 1.226 0 O-C-N 121.089 -1.007 . . . . 2.77 108.561 179.898 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.544 ' N ' HD21 ' A' ' 58' ' ' LEU . 24.2 t0 -94.11 81.62 4.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.067 -1.021 . . . . 3.3199999999999998 109.084 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.5 1.63 90.19 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 108.936 -1.665 . . . . 4.1699999999999999 108.936 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.413 ' O ' ' C ' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -115.25 57.1 0.73 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.331 -1.099 . . . . 3.3900000000000001 108.566 179.606 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 61' ' ' LEU . 0.9 OUTLIER -40.79 115.9 0.64 Allowed 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 121.353 0.597 . . . . 3.3599999999999999 110.724 -179.291 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.559 ' O ' ' CG2' ' A' ' 63' ' ' ILE . 0.5 OUTLIER -76.4 -3.11 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-O 122.125 0.964 . . . . 2.6099999999999999 108.673 177.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.501 ' C ' ' O ' ' A' ' 63' ' ' ILE . 29.7 m-20 -25.6 134.56 0.02 OUTLIER 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 115.199 -0.91 . . . . 3.7799999999999998 111.649 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.526 HG23 ' CG2' ' A' ' 54' ' ' ILE . 93.6 t -113.67 92.91 26.0 Favored Pre-proline 0 C--N 1.302 -1.476 0 N-CA-C 108.373 -0.973 . . . . 1.8999999999999999 108.373 179.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.409 ' HD3' ' O ' ' A' ' 64' ' ' ASP . 36.4 Cg_endo -75.52 -94.84 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.535 2.157 . . . . 1.48 110.528 -178.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 68' ' ' ILE . . . -134.2 48.72 0.93 Allowed Glycine 0 N--CA 1.488 2.121 0 N-CA-C 110.108 -1.197 . . . . 3.1899999999999999 110.108 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.429 ' O ' ' O ' ' A' ' 67' ' ' GLY . 13.5 mm -58.28 -104.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.148 -1.207 . . . . 2.1899999999999999 108.63 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.475 ' OD2' ' HB2' ' A' ' 74' ' ' HIS . 0.4 OUTLIER -79.65 133.75 36.41 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.466 -1.396 . . . . 5.2400000000000002 108.043 178.622 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.8 t -67.6 -13.84 62.42 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.254 -0.904 . . . . 6.0199999999999996 111.864 -177.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.521 ' O ' ' N ' ' A' ' 73' ' ' CYS . 4.9 m-20 -138.28 49.42 1.92 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.328 -1.483 . . . . 1.04 111.803 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.583 ' HB3' ' CG2' ' A' ' 52' ' ' ILE . . . 40.67 19.48 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.843 0 O-C-N 121.116 -0.99 . . . . 1.3899999999999999 112.879 176.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.521 ' N ' ' O ' ' A' ' 71' ' ' ASN . 80.8 m -68.45 -59.88 2.84 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 119.845 -1.784 . . . . 2.96 110.256 -179.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.475 ' HB2' ' OD2' ' A' ' 69' ' ' ASP . 11.9 t-160 -53.06 -27.25 19.08 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.321 -0.862 . . . . 3.2000000000000002 111.025 -178.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.545 ' O ' ' CD1' ' A' ' 88' ' ' ILE . 31.0 m-85 -83.95 -25.85 29.74 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.039 -1.038 . . . . 1.9299999999999999 110.83 -179.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.763 ' HB ' ' CE1' ' A' ' 86' ' ' TYR . 0.2 OUTLIER -158.19 171.87 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 120.749 -1.22 . . . . 0.59999999999999998 111.041 -177.961 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.658 ' N ' ' CG2' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -59.29 94.06 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 105.709 -1.96 . . . . 3.9100000000000001 105.709 176.148 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . 0.516 ' SG ' ' O ' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -37.02 -51.85 2.11 Favored Pre-proline 0 C--N 1.297 -1.683 0 O-C-N 121.67 -0.644 . . . . 3.27 111.565 -177.182 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.683 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 29.6 Cg_endo -73.4 103.12 1.57 Allowed 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 120.886 1.058 . . . . 0.91000000000000003 109.544 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.574 HD22 ' CD2' ' A' ' 86' ' ' TYR . 0.5 OUTLIER -97.85 -62.64 1.22 Allowed 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.99 -0.744 . . . . 3.8500000000000001 108.99 -178.812 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.744 ' HB ' ' HA ' ' A' ' 46' ' ' ASN . 1.5 m 40.16 -166.64 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-N 116.176 -0.465 . . . . 0.89000000000000001 109.846 178.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.653 ' N ' ' O ' ' A' ' 45' ' ' GLN . 0.0 OUTLIER -104.91 42.22 1.24 Allowed 'General case' 0 C--N 1.289 -2.036 0 O-C-N 120.302 -1.499 . . . . 2.5899999999999999 110.126 -177.089 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -146.92 31.73 1.45 Allowed Glycine 0 C--N 1.288 -2.115 0 N-CA-C 109.439 -1.464 . . . . 0.68999999999999995 109.439 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -153.46 132.12 12.27 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 120.89 -1.359 . . . . 3.7799999999999998 110.554 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.488 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 3.6 pt20 -104.22 132.99 49.88 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 106.447 -1.686 . . . . 4.21 106.447 177.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.763 ' CE1' ' HB ' ' A' ' 76' ' ' VAL . 0.1 OUTLIER -152.09 169.15 23.09 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 118.241 -1.383 . . . . 0.60999999999999999 109.709 -178.377 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.595 ' CB ' ' HG ' ' A' ' 40' ' ' LEU . 6.9 p-10 -134.0 91.86 2.87 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.71 -1.243 . . . . 0.5 113.669 -175.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.545 ' CD1' ' O ' ' A' ' 75' ' ' PHE . 4.4 tp -57.84 -172.3 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 106.333 -1.729 . . . . 1.76 106.333 175.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.577 ' O ' ' CD2' ' A' ' 90' ' ' TYR . 12.7 mttt 167.03 174.37 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.393 -1.442 . . . . 2.77 112.049 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.577 ' CD2' ' O ' ' A' ' 89' ' ' LYS . 82.5 m-85 -158.86 44.97 0.28 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.111 -1.07 . . . . 1.6299999999999999 108.111 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.485 ' HA ' ' OG1' ' A' ' 36' ' ' THR . 74.4 p -51.94 -168.96 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.771 -0.581 . . . . 3.6099999999999999 110.19 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.639 ' CZ2' ' CD1' ' A' ' 58' ' ' LEU . 1.4 t90 176.55 90.73 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.303 0 O-C-N 121.091 -1.006 . . . . 5.5499999999999998 110.683 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.417 ' C ' ' O ' ' A' ' 92' ' ' TRP . 20.5 t-20 -49.47 98.53 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 106.463 -1.68 . . . . 5.8700000000000001 106.463 178.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.564 HG11 ' CD1' ' A' ' 97' ' ' ILE . 1.0 OUTLIER -79.73 125.36 82.52 Favored Pre-proline 0 C--N 1.298 -1.635 0 O-C-N 121.343 -0.848 . . . . 1.3600000000000001 112.297 -176.614 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.519 ' HD2' ' CD1' ' A' ' 97' ' ' ILE . 34.3 Cg_endo -82.62 -84.68 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 123.347 2.698 . . . . 1.7 108.853 176.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.545 ' O ' ' CB ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -138.05 -51.17 0.6 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 106.155 -1.794 . . . . 1.7 106.155 178.241 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.564 ' CD1' HG11 ' A' ' 94' ' ' VAL . 1.4 mp 62.81 5.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.756 -0.59 . . . . 1.8799999999999999 111.956 176.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.563 ' CB ' ' HD2' ' A' ' 99' ' ' PRO . . . 51.87 173.63 0.03 OUTLIER Pre-proline 0 C--N 1.305 -1.346 0 O-C-N 120.778 -1.201 . . . . 2.04 110.176 179.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.563 ' HD2' ' CB ' ' A' ' 98' ' ' ALA . 50.1 Cg_endo -82.34 149.25 14.94 Favored 'Trans proline' 0 C--N 1.301 -1.928 0 C-N-CA 123.658 2.905 . . . . 1.8 109.744 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.623 ' HD3' ' CB ' ' A' ' 128' ' ' ARG . 1.1 mmmp? 55.79 114.56 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.033 0 C-N-CA 119.454 -0.899 . . . . 2.7799999999999998 111.063 176.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.516 ' HB2' ' CD1' ' A' ' 127' ' ' ILE . 3.2 m -93.87 166.23 12.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.16 -0.962 . . . . 2.5 109.149 179.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.415 ' O ' ' CB ' ' A' ' 103' ' ' ASN . 0.2 OUTLIER -53.59 -19.08 3.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.278 -0.889 . . . . 2.6200000000000001 109.139 179.603 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.459 ' O ' ' OG ' ' A' ' 57' ' ' SER . 0.5 OUTLIER 168.67 154.06 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.554 -0.906 . . . . 1.5800000000000001 108.554 -179.996 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.532 HG22 ' CD1' ' A' ' 127' ' ' ILE . 0.1 OUTLIER -147.05 134.67 14.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 120.903 -1.123 . . . . 1.25 110.402 -179.649 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.482 ' CG2' ' C ' ' A' ' 104' ' ' VAL . 0.2 OUTLIER -155.01 145.47 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 107.973 -1.121 . . . . 2.9500000000000002 107.973 179.629 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.432 ' HB ' ' CB ' ' A' ' 122' ' ' ALA . 71.1 t -129.01 128.96 67.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 120.641 -1.287 . . . . 1.4299999999999999 110.401 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.49 ' C ' ' CG2' ' A' ' 108' ' ' VAL . 0.3 OUTLIER -150.43 140.56 22.11 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.19 -1.041 . . . . 1.1000000000000001 108.19 179.305 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.547 ' CG1' HD11 ' A' ' 54' ' ' ILE . 2.4 t -157.16 156.75 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.748 -1.22 . . . . 2.2999999999999998 110.463 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 119' ' ' CYS . 0.1 OUTLIER 177.96 119.42 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.696 -0.853 . . . . 2.4900000000000002 108.696 178.961 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.519 ' HB3' ' HB2' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -102.14 117.67 35.28 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 109.146 -0.686 . . . . 4.2300000000000004 109.146 -179.866 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.481 ' N ' HD11 ' A' ' 110' ' ' LEU . 24.1 mt -110.34 139.78 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.333 -0.854 . . . . 1.1799999999999999 110.331 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -108.39 -111.97 3.53 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 108.672 -1.771 . . . . 0.58999999999999997 108.672 178.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.423 ' HB2' ' HB ' ' A' ' 47' ' ' THR . 2.3 m-20 -139.2 4.46 2.23 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.722 -1.214 . . . . 3.2599999999999998 107.722 178.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.402 ' ND2' ' HB2' ' A' ' 45' ' ' GLN . 2.0 m-80 -118.49 -35.65 3.7 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.592 0.71 . . . . 0.89000000000000001 109.36 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -173.43 -141.56 3.56 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.411 -1.476 . . . . 0.58999999999999997 109.411 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -109.58 107.6 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.19 -1.183 . . . . 0.80000000000000004 109.9 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.566 HD23 ' CB ' ' A' ' 80' ' ' LEU . 1.1 mt -49.66 -49.7 46.3 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.252 -0.905 . . . . 1.1200000000000001 109.113 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.537 ' HA ' ' CA ' ' A' ' 9' ' ' ALA . . . -161.98 -167.47 1.67 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.403 -0.811 . . . . 1.45 109.247 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 109' ' ' LYS . 0.1 OUTLIER 172.91 170.59 0.13 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.257 -0.902 . . . . 1.0900000000000001 109.605 179.781 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.416 ' N ' ' SG ' ' A' ' 119' ' ' CYS . . . -175.44 127.18 0.25 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.836 -0.801 . . . . 1.48 108.836 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.413 HD13 ' O ' ' A' ' 6' ' ' LYS . 2.5 mp -133.46 147.29 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.158 -0.964 . . . . 0.79000000000000004 110.787 -179.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.432 ' CB ' ' HB ' ' A' ' 106' ' ' VAL . . . -112.72 -159.58 0.69 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.414 -0.803 . . . . 3.0299999999999998 108.991 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.452 ' O ' ' O ' ' A' ' 124' ' ' HIS . 0.2 OUTLIER -161.66 115.49 1.91 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.933 -1.104 . . . . 2.3500000000000001 110.495 -179.837 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . 0.539 ' N ' ' CD2' ' A' ' 124' ' ' HIS . 0.2 OUTLIER 57.67 118.4 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.387 -0.82 . . . . 4.54 110.562 178.882 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 27' ' ' CYS . . . -129.46 167.88 21.22 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 108.975 -1.65 . . . . 2.0699999999999998 108.975 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -172.25 86.01 0.07 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.042 -1.269 . . . . 3.7599999999999998 109.984 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.643 ' O ' ' CB ' ' A' ' 128' ' ' ARG . 2.4 mp -46.35 138.7 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.352 -0.843 . . . . 1.1899999999999999 109.822 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.643 ' CB ' ' O ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER 147.07 -93.88 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.859 -0.793 . . . . 4.8499999999999996 108.859 179.003 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.507 ' N ' ' HG2' ' A' ' 128' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.964 -1.017 . . . . 4.0800000000000001 109.457 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.2 t0 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.328 0.585 . . . . 5.8099999999999996 109.508 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.459 ' O ' ' O ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -122.46 23.18 9.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.193 -0.942 . . . . 3.8799999999999999 108.679 179.406 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.577 ' CG1' ' HA ' ' A' ' 22' ' ' HIS . 0.2 OUTLIER 38.71 -159.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-O 121.188 0.518 . . . . 2.3500000000000001 109.908 179.376 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -141.28 32.86 1.7 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.093 -1.004 . . . . 1.4399999999999999 109.48 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.1 m -53.16 136.85 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.423 -0.798 . . . . 0.91000000000000003 109.359 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -67.5 94.98 0.44 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.21 -0.931 . . . . 4.7300000000000004 109.704 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.527 ' OD2' ' CD1' ' A' ' 13' ' ' ILE . 0.2 OUTLIER -93.25 -176.16 4.05 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.112 -0.992 . . . . 4.4900000000000002 109.037 179.5 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 21.6 p -176.96 41.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.001 -1.062 . . . . 2.48 109.762 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.547 ' CB ' HG13 ' A' ' 13' ' ' ILE . . . -77.13 -72.43 0.35 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.37 -0.831 . . . . 0.67000000000000004 109.244 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.451 ' O ' ' CB ' ' A' ' 11' ' ' ASN . 0.9 OUTLIER -157.18 25.02 0.31 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.456 -0.777 . . . . 3.3999999999999999 109.561 -179.778 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.451 ' CB ' ' O ' ' A' ' 10' ' ' ASN . 0.5 OUTLIER 72.14 22.51 3.63 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.306 -0.871 . . . . 3.7000000000000002 109.485 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.49 ' O ' ' HB ' ' A' ' 13' ' ' ILE . 0.6 OUTLIER -145.04 -83.52 0.14 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.849 -0.797 . . . . 3.7799999999999998 108.849 179.834 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.574 ' O ' ' HB2' ' A' ' 14' ' ' LYS . 0.4 OUTLIER 71.44 -6.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.509 -0.744 . . . . 3.6600000000000001 111.486 178.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.574 ' HB2' ' O ' ' A' ' 13' ' ' ILE . 1.7 mtpt 68.21 -21.79 0.13 Allowed 'General case' 0 C--N 1.293 -1.864 0 O-C-N 121.504 -0.747 . . . . 5.8899999999999997 111.328 179.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.494 ' CB ' ' O ' ' A' ' 14' ' ' LYS . 0.1 OUTLIER 170.6 126.41 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 O-C-N 120.59 -1.319 . . . . 2.0 109.566 -177.581 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.491 ' C ' ' HG3' ' A' ' 17' ' ' MET . 6.4 p -140.96 114.64 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.128 -0.983 . . . . 1.28 108.845 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.491 ' HG3' ' C ' ' A' ' 16' ' ' VAL . 1.8 mtt -153.47 168.49 25.93 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.063 -1.055 . . . . 1.9099999999999999 110.63 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.462 ' HB ' HG23 ' A' ' 3' ' ' VAL . 16.5 t -129.29 177.66 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 107.388 -1.338 . . . . 2.04 107.388 178.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.425 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 3.6 t0 -117.54 66.44 0.74 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.597 -1.314 . . . . 2.1099999999999999 112.019 -178.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.49 ' O ' ' O ' ' A' ' 21' ' ' CYS . . . 120.53 -26.77 6.83 Favored Glycine 0 N--CA 1.493 2.497 0 C-N-CA 119.063 -1.541 . . . . 3.1299999999999999 112.39 177.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.57 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 3.9 t -60.21 -118.6 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.484 -1.597 . . . . 2.8399999999999999 109.572 -178.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.577 ' HA ' ' CG1' ' A' ' 3' ' ' VAL . 2.7 m-70 155.48 123.27 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.771 -1.206 . . . . 2.52 108.836 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.464 ' N ' HG13 ' A' ' 3' ' ' VAL . . . -75.67 155.24 46.48 Favored Glycine 0 N--CA 1.494 2.519 0 O-C-N 121.027 -1.046 . . . . 1.0600000000000001 110.718 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.451 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 5.4 m 70.22 155.87 0.14 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.356 -1.085 . . . . 2.6200000000000001 108.887 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.593 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.1 OUTLIER 57.9 175.36 0.04 OUTLIER Pre-proline 0 C--N 1.304 -1.378 0 N-CA-C 107.678 -1.23 . . . . 5.4199999999999999 107.678 -179.824 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.593 ' HD2' ' CB ' ' A' ' 25' ' ' ASP . 25.3 Cg_endo -67.31 85.06 0.35 Allowed 'Trans proline' 0 C--N 1.295 -2.281 0 C-N-CA 122.037 1.825 . . . . 1.53 109.763 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.479 ' C ' ' O ' ' A' ' 26' ' ' PRO . 3.9 t -23.62 86.45 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.973 0 CA-C-N 115.332 -0.849 . . . . 1.8200000000000001 111.808 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.502 ' N ' ' O ' ' A' ' 26' ' ' PRO . 29.3 mm -77.97 143.43 12.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 C-N-CA 118.649 -1.22 . . . . 0.88 107.968 178.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.553 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 0.2 OUTLIER -129.67 -177.53 2.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 O-C-N 120.981 -1.074 . . . . 1.3100000000000001 112.142 -177.194 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 36.5 m-70 -114.51 166.57 11.57 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.415 0.626 . . . . 2.1899999999999999 110.496 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.606 ' CD ' ' O ' ' A' ' 98' ' ' ALA . 0.1 OUTLIER -122.13 10.54 10.05 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.732 0.777 . . . . 12.470000000000001 108.966 178.863 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' A' ' 95' ' ' PRO . . . -116.93 -5.88 14.81 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.649 -1.381 . . . . 3.0299999999999998 109.649 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.566 ' C ' ' HB ' ' A' ' 94' ' ' VAL . 6.9 mtpt -116.78 147.04 39.1 Favored Pre-proline 0 C--N 1.303 -1.441 0 N-CA-C 106.977 -1.49 . . . . 3.9100000000000001 106.977 178.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.552 ' O ' ' N ' ' A' ' 36' ' ' THR . 28.3 Cg_endo -66.65 102.98 0.65 Allowed 'Trans proline' 0 C--N 1.299 -2.039 0 C-N-CA 122.178 1.919 . . . . 1.25 111.919 -177.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.525 ' O ' ' HA ' ' A' ' 91' ' ' THR . 49.4 t80 -41.65 94.66 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.822 -1.177 . . . . 4.2000000000000002 107.822 178.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.552 ' N ' ' O ' ' A' ' 34' ' ' PRO . 19.3 m -114.51 78.11 1.12 Allowed 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.529 -0.868 . . . . 2.3900000000000001 110.548 -178.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.503 ' C ' ' CD1' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -77.46 131.25 37.87 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 106.294 -1.743 . . . . 2.3199999999999998 106.294 177.91 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.488 ' O ' ' HB1' ' A' ' 39' ' ' ALA . 3.8 mt-10 -142.83 178.82 7.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.683 -1.261 . . . . 2.9399999999999999 111.149 -177.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.488 ' HB1' ' O ' ' A' ' 38' ' ' GLU . . . 171.67 95.94 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.298 -1.371 . . . . 0.68999999999999995 107.298 178.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.589 ' HG ' ' CB ' ' A' ' 87' ' ' ASP . 0.0 OUTLIER -90.38 174.13 7.73 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.464 -0.773 . . . . 1.95 109.652 -178.418 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.656 ' CE1' ' CE2' ' A' ' 86' ' ' TYR . 20.8 p90 173.01 141.7 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.776 -1.202 . . . . 0.47999999999999998 110.184 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.508 ' O ' ' C ' ' A' ' 43' ' ' ALA . 9.1 p-10 -90.87 112.86 24.87 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 107.445 -1.317 . . . . 4.1100000000000003 107.445 178.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.573 ' HB3' ' HB3' ' A' ' 80' ' ' LEU . . . -33.31 123.89 0.4 Allowed 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 115.613 -0.721 . . . . 0.44 110.012 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -120.08 3.88 10.92 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.497 -0.752 . . . . 3.6600000000000001 110.822 -177.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.663 ' O ' ' N ' ' A' ' 82' ' ' LYS . 2.0 pt20 -97.69 -142.77 0.3 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.186 -0.946 . . . . 0.67000000000000004 108.598 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.722 ' HA ' ' HB ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -153.16 68.17 0.8 Allowed 'General case' 0 C--N 1.295 -1.781 0 O-C-N 121.285 -0.884 . . . . 0.40000000000000002 108.631 178.551 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.525 ' O ' ' CG2' ' A' ' 47' ' ' THR . 9.1 t -145.67 111.38 5.5 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.01 -1.681 . . . . 1.2 112.042 -177.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.649 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -59.69 -23.04 62.8 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.348 -1.353 . . . . 4.4400000000000004 107.348 177.152 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.1 p -82.86 -165.09 0.97 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.856 -0.528 . . . . 1.51 109.6 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.591 ' O ' ' CA ' ' A' ' 71' ' ' ASN . . . 178.14 155.5 0.37 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.277 -0.889 . . . . 0.5 109.128 -179.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 111' ' ' ILE . 19.7 mtmt -127.75 171.13 12.0 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.061 -1.459 . . . . 1.6799999999999999 107.061 178.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.542 HG12 ' CG1' ' A' ' 65' ' ' VAL . 3.0 tt -158.65 156.43 3.88 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 C-N-CA 118.221 -1.392 . . . . 0.92000000000000004 110.949 -179.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.524 ' O ' ' NZ ' ' A' ' 55' ' ' LYS . 4.1 tp10 -159.71 48.93 0.3 Allowed 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.267 -1.382 . . . . 3.6200000000000001 107.267 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.665 ' O ' ' HB ' ' A' ' 65' ' ' VAL . 1.3 mt -85.7 136.92 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 CA-C-O 122.354 1.074 . . . . 3.0699999999999998 111.201 -178.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.554 ' HG3' ' O ' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -144.01 98.05 3.16 Favored 'General case' 0 C--N 1.282 -2.365 0 O-C-N 121.0 -1.062 . . . . 1.7 109.972 178.972 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.508 ' O ' ' N ' ' A' ' 63' ' ' ILE . . . -107.35 132.5 53.07 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 107.814 -1.18 . . . . 1.8899999999999999 107.814 178.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' ' 62' ' ' GLU . 58.6 m -117.66 113.66 22.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.819 -1.176 . . . . 2.48 110.598 -178.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.45 ' O ' ' C ' ' A' ' 59' ' ' ASP . 0.2 OUTLIER -94.63 176.99 6.07 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.153 -1.054 . . . . 5.7199999999999998 108.153 178.909 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.483 ' HB2' ' HB2' ' A' ' 101' ' ' SER . 0.0 OUTLIER -44.12 -60.74 1.74 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.922 -1.111 . . . . 3.3399999999999999 109.235 -179.752 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.435 ' N ' ' CG ' ' A' ' 59' ' ' ASP . . . -129.27 10.24 6.19 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.517 -1.433 . . . . 2.3399999999999999 109.517 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.576 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 2.9 mm? -110.11 47.06 0.98 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.06 -1.259 . . . . 4.04 107.851 178.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 1.4 mt-10 -42.67 87.77 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 115.61 -0.723 . . . . 2.2999999999999998 110.929 -179.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.54 ' N ' ' O ' ' A' ' 61' ' ' LEU . 6.8 mt -62.93 164.9 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 N-CA-C 106.696 -1.594 . . . . 0.59999999999999998 106.696 177.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.497 ' O ' HG21 ' A' ' 65' ' ' VAL . 1.7 t0 -168.26 153.29 6.53 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.614 -1.304 . . . . 2.0099999999999998 110.186 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.665 ' HB ' ' O ' ' A' ' 54' ' ' ILE . 23.7 t -150.89 62.79 5.4 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.636 -0.665 . . . . 0.53000000000000003 110.04 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.592 ' HD3' ' N ' ' A' ' 65' ' ' VAL . 37.7 Cg_endo -84.96 95.45 0.66 Allowed 'Trans proline' 0 C--N 1.301 -1.938 0 C-N-CA 123.296 2.664 . . . . 1.1599999999999999 110.979 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.478 ' C ' ' O ' ' A' ' 66' ' ' PRO . . . 38.31 57.9 1.72 Allowed Glycine 0 N--CA 1.495 2.61 0 N-CA-C 109.621 -1.392 . . . . 2.9199999999999999 109.621 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.456 HG21 ' N ' ' A' ' 69' ' ' ASP . 22.7 mm -84.32 -94.04 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.278 -1.131 . . . . 3.52 109.948 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.483 ' OD2' ' HA ' ' A' ' 72' ' ' ALA . 35.5 p30 -51.64 166.06 0.15 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.175 -0.953 . . . . 1.5 110.038 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -69.27 -20.02 63.92 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.363 -0.836 . . . . 2.9199999999999999 109.607 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.591 ' CA ' ' O ' ' A' ' 50' ' ' ALA . 6.6 m-20 -175.57 73.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.785 -1.197 . . . . 0.88 111.307 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.552 ' CB ' ' HB2' ' A' ' 50' ' ' ALA . . . 40.33 26.89 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.562 -0.711 . . . . 0.94999999999999996 111.478 176.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.526 ' HB3' ' HB2' ' A' ' 78' ' ' CYS . 4.0 m -88.41 -49.25 7.05 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.909 -1.119 . . . . 3.0899999999999999 110.046 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.45 ' HB2' ' HB3' ' A' ' 69' ' ' ASP . 0.2 OUTLIER -59.17 -7.14 1.07 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.348 -0.845 . . . . 2.0099999999999998 111.957 -178.044 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.536 ' O ' ' CD1' ' A' ' 88' ' ' ILE . 83.8 m-85 -115.62 -10.12 11.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.489 -1.382 . . . . 0.5 110.644 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.724 ' CG2' ' CZ ' ' A' ' 86' ' ' TYR . 0.2 OUTLIER -164.51 175.91 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.871 -1.143 . . . . 0.48999999999999999 110.153 -178.483 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.664 ' N ' ' CG2' ' A' ' 76' ' ' VAL . 11.8 mmmt -61.55 93.15 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 106.226 -1.768 . . . . 3.5699999999999998 106.226 176.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . 0.526 ' HB2' ' HB3' ' A' ' 73' ' ' CYS . 4.1 t -37.91 -50.37 3.04 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.359 -0.838 . . . . 3.5299999999999998 111.79 -177.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.649 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 30.6 Cg_endo -74.71 108.27 2.66 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 N-CA-C 108.674 -1.318 . . . . 0.57999999999999996 108.674 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.573 ' HB3' ' HB3' ' A' ' 43' ' ' ALA . 0.6 OUTLIER -103.28 -66.71 0.92 Allowed 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 108.378 -0.971 . . . . 3.79 108.378 -178.701 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.722 ' HB ' ' HA ' ' A' ' 46' ' ' ASN . 1.4 m 41.45 -167.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 109.221 -0.659 . . . . 0.40999999999999998 109.221 178.048 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.663 ' N ' ' O ' ' A' ' 45' ' ' GLN . 0.0 OUTLIER -101.82 42.71 1.11 Allowed 'General case' 0 C--N 1.284 -2.267 0 O-C-N 120.261 -1.524 . . . . 4.4000000000000004 109.704 -176.98 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -146.62 37.3 1.21 Allowed Glycine 0 C--N 1.287 -2.143 0 N-CA-C 108.712 -1.755 . . . . 0.5 108.712 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 35.3 tp60 -152.52 143.44 22.99 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 121.157 -1.202 . . . . 3.5800000000000001 110.78 -179.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -117.59 134.5 54.81 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 105.596 -2.002 . . . . 3.1400000000000001 105.596 177.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.724 ' CZ ' ' CG2' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -163.4 163.58 24.95 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 117.514 -1.675 . . . . 0.59999999999999998 109.95 -177.42 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.594 ' N ' ' CD1' ' A' ' 86' ' ' TYR . 12.7 p-10 -133.14 102.29 5.53 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.852 -1.155 . . . . 0.58999999999999997 112.968 -176.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.536 ' CD1' ' O ' ' A' ' 75' ' ' PHE . 3.0 tp -70.26 -175.9 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 107.423 -1.325 . . . . 2.4700000000000002 107.423 176.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.544 ' O ' ' CD2' ' A' ' 90' ' ' TYR . 3.1 mttt 174.13 173.65 0.18 Allowed 'General case' 0 N--CA 1.5 2.07 0 O-C-N 120.852 -1.155 . . . . 1.1799999999999999 110.83 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.544 ' CD2' ' O ' ' A' ' 89' ' ' LYS . 5.8 m-85 -172.43 60.56 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 106.908 -1.516 . . . . 2.4100000000000001 106.908 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.529 ' HA ' ' HA ' ' A' ' 36' ' ' THR . 0.3 OUTLIER -90.25 -169.19 2.33 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.518 -0.739 . . . . 3.7200000000000002 111.667 -177.306 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.544 ' CH2' ' HB3' ' A' ' 61' ' ' LEU . 0.2 OUTLIER -171.2 151.63 3.21 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.581 -0.699 . . . . 8.2400000000000002 110.323 -178.973 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -81.89 142.73 32.23 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.908 -1.145 . . . . 3.3300000000000001 107.908 178.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.566 ' HB ' ' C ' ' A' ' 33' ' ' LYS . 51.5 t -147.89 112.97 3.92 Favored Pre-proline 0 C--N 1.305 -1.335 0 O-C-N 120.805 -1.185 . . . . 2.1800000000000002 111.667 -177.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.612 ' HD2' ' CD1' ' A' ' 97' ' ' ILE . 29.9 Cg_endo -74.56 -67.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 123.259 2.639 . . . . 3.8900000000000001 111.513 178.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.595 ' O ' ' HB3' ' A' ' 31' ' ' ARG . 0.4 OUTLIER -162.44 -33.65 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 107.368 -1.345 . . . . 6.6299999999999999 107.368 -179.826 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.612 ' CD1' ' HD2' ' A' ' 95' ' ' PRO . 1.4 mt 34.48 24.37 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 114.02 1.118 . . . . 2.8500000000000001 114.02 176.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.62 ' CB ' ' CD ' ' A' ' 99' ' ' PRO . . . 61.28 -177.2 0.03 OUTLIER Pre-proline 0 C--N 1.301 -1.513 0 O-C-N 120.279 -1.513 . . . . 1.5700000000000001 109.926 178.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.62 ' CD ' ' CB ' ' A' ' 98' ' ' ALA . 46.8 Cg_endo -86.53 151.23 8.97 Favored 'Trans proline' 0 C--N 1.302 -1.896 0 C-N-CA 123.645 2.896 . . . . 0.93000000000000005 111.052 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.512 ' HB2' ' O ' ' A' ' 99' ' ' PRO . 2.0 mptm? 64.08 142.91 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.965 0.888 . . . . 4.0700000000000003 112.419 175.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.497 ' O ' ' CB ' ' A' ' 102' ' ' GLU . 2.9 p -111.15 12.31 21.89 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.918 -0.771 . . . . 3.5 108.918 179.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.549 ' O ' ' CB ' ' A' ' 103' ' ' ASN . 0.8 OUTLIER 76.66 -5.98 2.09 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.603 -0.685 . . . . 3.1000000000000001 109.342 -179.425 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.549 ' CB ' ' O ' ' A' ' 102' ' ' GLU . 3.6 t-20 159.19 146.04 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.453 -0.78 . . . . 3.0899999999999999 109.45 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.541 HG22 ' CD1' ' A' ' 127' ' ' ILE . 0.1 OUTLIER -157.55 -174.3 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.255 -0.903 . . . . 0.65000000000000002 110.065 -179.76 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.525 ' CB ' ' O ' ' A' ' 104' ' ' VAL . 1.2 t 159.27 125.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.2 -1.037 . . . . 1.1200000000000001 108.2 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.499 ' O ' ' CG1' ' A' ' 106' ' ' VAL . 2.1 t -125.13 97.39 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 120.833 -1.167 . . . . 1.5900000000000001 110.555 -178.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.49 ' HB ' ' HE3' ' A' ' 55' ' ' LYS . 25.6 m -116.52 143.61 45.37 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.504 -1.295 . . . . 1.3100000000000001 107.504 178.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.549 ' CG1' HD12 ' A' ' 54' ' ' ILE . 88.0 t -151.15 152.89 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.59 -1.319 . . . . 1.55 110.585 -178.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -173.62 118.05 0.27 Allowed 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.798 0.809 . . . . 1.3100000000000001 109.472 178.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.562 ' HB3' ' HB2' ' A' ' 117' ' ' LEU . 9.8 tp -106.26 121.8 44.93 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 106.777 -1.564 . . . . 1.6299999999999999 106.777 178.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.507 ' O ' ' HB2' ' A' ' 51' ' ' LYS . 4.0 mt -121.11 117.49 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.25 -0.906 . . . . 1.5600000000000001 112.296 -176.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -86.23 -112.37 0.83 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 107.806 -2.117 . . . . 0.75 107.806 176.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -141.1 -0.1 1.49 Allowed 'General case' 0 C--N 1.307 -1.268 0 O-C-N 120.928 -1.337 . . . . 1.51 108.123 178.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.463 ' ND2' ' N ' ' A' ' 114' ' ' ASN . 0.2 OUTLIER -120.98 -5.59 9.56 Favored 'General case' 0 C--N 1.313 -0.985 0 O-C-N 121.163 -0.961 . . . . 1.1699999999999999 109.955 -179.923 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 160.56 164.47 15.6 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 109.641 -1.383 . . . . 1.3999999999999999 109.641 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.452 ' O ' HG11 ' A' ' 116' ' ' VAL . 2.1 p -70.62 110.54 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.112 -1.228 . . . . 1.26 109.455 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.562 ' HB2' ' HB3' ' A' ' 110' ' ' LEU . 1.3 mt -48.52 -51.46 27.28 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.465 -0.772 . . . . 1.5600000000000001 110.156 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -168.97 135.49 1.76 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.223 -0.923 . . . . 2.1899999999999999 109.597 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 22.0 p -126.13 -162.31 1.12 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.916 -1.115 . . . . 1.8899999999999999 110.637 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 171.24 124.86 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.38 -0.97 . . . . 0.48999999999999999 108.38 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.2 mp -133.69 126.62 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 120.976 -1.078 . . . . 2.1000000000000001 110.798 -178.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.479 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . . . -111.43 82.16 1.56 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.208 -1.034 . . . . 1.1799999999999999 108.208 178.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.54 ' CG2' ' O ' ' A' ' 123' ' ' THR . 0.5 OUTLIER -33.52 125.04 0.42 Allowed 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.563 0.697 . . . . 3.7400000000000002 110.666 -179.083 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . 0.475 ' O ' ' O ' ' A' ' 123' ' ' THR . 8.1 m170 54.41 163.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.555 -0.716 . . . . 3.6299999999999999 109.786 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -153.88 129.72 2.73 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.401 -1.48 . . . . 1.6599999999999999 109.401 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 28' ' ' ILE . 5.7 mtmt -153.23 119.17 5.39 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.328 -1.101 . . . . 3.0299999999999998 108.536 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.552 HG22 ' CG ' ' A' ' 31' ' ' ARG . 1.5 mp -94.12 160.67 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.234 -0.916 . . . . 1.78 110.506 -178.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.522 ' C ' ' HA ' ' A' ' 99' ' ' PRO . 1.4 mtm180 -150.8 -174.72 4.87 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 109.016 -0.735 . . . . 4.1799999999999997 109.016 178.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.523 ' N ' ' HB3' ' A' ' 99' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 117.917 -1.04 . . . . 7.7800000000000002 109.708 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . 0.491 ' O ' ' HG3' ' A' ' 2' ' ' GLN . 14.5 m-20 . . . . . 0 N--CA 1.492 1.644 0 N-CA-C 109.6 -0.518 . . . . 4.3600000000000003 109.6 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.493 ' O ' ' C ' ' A' ' 3' ' ' VAL . 4.4 pt20 37.41 31.93 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.691 -0.485 . . . . 3.1899999999999999 109.691 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.553 HG13 ' N ' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -33.74 144.95 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-O 121.367 0.603 . . . . 2.27 110.402 -179.562 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.489 ' O ' ' N ' ' A' ' 24' ' ' SER . 5.3 t70 -89.64 148.83 23.09 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.419 -0.801 . . . . 2.4700000000000002 109.437 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.465 HG11 ' O ' ' A' ' 4' ' ' ASP . 0.0 OUTLIER -156.08 167.24 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.353 -0.842 . . . . 2.0699999999999998 108.988 179.961 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.544 ' N ' ' HD3' ' A' ' 6' ' ' LYS . 1.4 mptt -80.02 76.92 6.74 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.073 -1.084 . . . . 4.3799999999999999 108.073 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.511 ' HB2' ' O ' ' A' ' 119' ' ' CYS . 51.6 p30 -94.35 168.38 10.93 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.832 0.825 . . . . 0.91000000000000003 110.436 -178.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.54 ' N ' ' SG ' ' A' ' 119' ' ' CYS . 29.2 m -113.17 -36.1 5.16 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.031 -1.47 . . . . 3.2599999999999998 107.031 178.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.559 ' O ' ' CB ' ' A' ' 10' ' ' ASN . . . -64.14 -144.84 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.358 -0.979 . . . . 5.0199999999999996 108.358 177.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.559 ' CB ' ' O ' ' A' ' 9' ' ' ALA . 0.1 OUTLIER 80.45 -42.92 0.22 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 120.506 -0.477 . . . . 10.369999999999999 110.874 177.372 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -63.38 -17.73 62.94 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.957 -1.089 . . . . 5.1299999999999999 108.23 178.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.418 ' HG2' ' HB3' ' A' ' 44' ' ' ASN . 13.1 tp10 -132.37 -28.78 1.64 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.673 -0.642 . . . . 4.3099999999999996 109.575 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.698 HG12 ' HB3' ' A' ' 41' ' ' PHE . 10.4 mt -48.43 154.7 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.09 -1.006 . . . . 2.0600000000000001 109.825 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.444 ' N ' ' CG2' ' A' ' 13' ' ' ILE . 0.0 OUTLIER -110.91 -23.21 11.11 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.784 -0.821 . . . . 1.1899999999999999 108.784 179.776 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -156.99 122.07 4.57 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 119.202 -0.999 . . . . 3.1499999999999999 109.657 -178.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.472 ' O ' ' HG3' ' A' ' 17' ' ' MET . 4.5 p -155.3 104.65 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.074 -1.016 . . . . 1.49 109.412 -179.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.472 ' HG3' ' O ' ' A' ' 16' ' ' VAL . 3.0 mpp? -150.42 152.74 34.78 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.202 -0.936 . . . . 1.6000000000000001 110.493 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.614 HG13 ' CZ ' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -121.4 106.04 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 108.087 -1.079 . . . . 1.04 108.087 178.535 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.431 ' HB3' ' O ' ' A' ' 34' ' ' PRO . 1.2 t0 -52.49 86.92 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.644 -0.66 . . . . 1.8700000000000001 110.928 -178.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.534 ' O ' ' HB3' ' A' ' 21' ' ' CYS . . . 98.46 -169.96 24.04 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 120.035 -1.078 . . . . 2.0099999999999998 110.928 178.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.597 ' HA ' ' HA ' ' A' ' 29' ' ' ILE . 36.2 t 86.14 -25.52 0.11 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 122.268 -0.548 . . . . 1.53 110.193 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.581 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 0.3 OUTLIER 42.2 83.99 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.858 -1.151 . . . . 2.6000000000000001 108.973 -179.192 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.497 ' O ' ' CB ' ' A' ' 24' ' ' SER . . . -83.39 -144.56 5.77 Favored Glycine 0 N--CA 1.498 2.811 0 O-C-N 121.489 -0.757 . . . . 1.8400000000000001 112.327 -178.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.497 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 0.1 OUTLIER 78.46 -79.38 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 107.45 -1.315 . . . . 1.3999999999999999 107.45 -177.818 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.668 ' HB2' ' CD ' ' A' ' 26' ' ' PRO . 7.3 p30 -84.87 -149.4 0.0 OUTLIER Pre-proline 0 C--N 1.298 -1.67 0 N-CA-C 105.263 -2.125 . . . . 2.3900000000000001 105.263 177.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.668 ' CD ' ' HB2' ' A' ' 25' ' ' ASP . 25.9 Cg_endo -70.07 102.36 1.07 Allowed 'Trans proline' 0 C--N 1.32 -0.969 0 CA-C-N 121.168 1.453 . . . . 1.6699999999999999 108.601 179.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.581 ' HA ' ' O ' ' A' ' 22' ' ' HIS . 3.2 t -54.72 81.23 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 115.42 -0.809 . . . . 1.6299999999999999 113.07 -176.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.534 ' O ' ' O ' ' A' ' 21' ' ' CYS . 0.6 OUTLIER -83.09 145.29 8.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 106.863 -1.532 . . . . 3.0 106.863 176.475 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.597 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -113.35 -175.95 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 O-C-N 120.756 -1.215 . . . . 1.1100000000000001 111.827 -176.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 34.5 m-70 -127.04 107.25 9.88 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 119.952 -0.699 . . . . 2.2599999999999998 111.269 -178.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.553 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -53.86 149.1 9.22 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.492 -0.755 . . . . 4.3499999999999996 109.038 178.353 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.506 ' HA2' ' O ' ' A' ' 95' ' ' PRO . . . 92.06 -1.97 74.78 Favored Glycine 0 N--CA 1.493 2.478 0 C-N-CA 119.814 -1.184 . . . . 2.1699999999999999 110.61 178.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.569 ' O ' HG13 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -124.12 139.97 33.83 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 120.963 -1.316 . . . . 3.0499999999999998 109.479 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.431 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 27.0 Cg_endo -64.93 134.72 41.21 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.398 2.065 . . . . 2.8199999999999998 110.935 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.614 ' CZ ' HG13 ' A' ' 18' ' ' VAL . 5.1 t80 -114.41 60.72 0.67 Allowed 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.466 -0.568 . . . . 1.3300000000000001 109.466 -178.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.423 ' O ' ' O ' ' A' ' 37' ' ' LEU . 81.5 m -73.08 81.97 1.26 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.303 -0.873 . . . . 2.52 109.09 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.52 ' O ' ' CG ' ' A' ' 38' ' ' GLU . 3.0 mp -52.7 -178.21 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.189 -0.945 . . . . 6.3399999999999999 108.653 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.546 ' CG ' ' HG2' ' A' ' 89' ' ' LYS . 0.1 OUTLIER 166.73 158.56 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.916 -1.115 . . . . 2.7000000000000002 109.795 -179.602 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.484 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . 171.81 83.41 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.697 0.76 . . . . 1.29 109.506 178.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.607 ' HG ' ' HA ' ' A' ' 87' ' ' ASP . 0.6 OUTLIER -82.12 165.05 20.89 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 108.269 -1.011 . . . . 2.4900000000000002 108.269 179.031 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.763 ' CZ ' ' CD2' ' A' ' 86' ' ' TYR . 0.4 OUTLIER -156.79 164.85 37.63 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.323 -1.362 . . . . 1.3300000000000001 107.323 176.285 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.411 ' O ' ' C ' ' A' ' 43' ' ' ALA . 1.0 OUTLIER -116.85 116.38 27.34 Favored 'General case' 0 C--N 1.29 -2.013 0 C-N-CA 119.309 -0.957 . . . . 2.4900000000000002 108.584 -179.8 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.568 ' CB ' ' O ' ' A' ' 81' ' ' VAL . . . -46.81 119.59 2.57 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 107.386 -1.339 . . . . 0.47999999999999998 107.386 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.437 ' C ' ' HB3' ' A' ' 82' ' ' LYS . 0.1 OUTLIER -130.63 19.38 5.16 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.699 0.761 . . . . 3.3199999999999998 108.999 -178.15 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.635 ' OE1' ' HB2' ' A' ' 80' ' ' LEU . 3.0 pt20 -109.37 -139.41 0.38 Allowed 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.512 -0.742 . . . . 0.91000000000000003 110.408 -178.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.57 ' N ' ' HA ' ' A' ' 81' ' ' VAL . 3.4 m120 -158.55 53.43 0.43 Allowed 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.531 -0.914 . . . . 5.2800000000000002 108.531 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.599 ' N ' ' CG2' ' A' ' 81' ' ' VAL . 10.4 t -134.78 127.47 30.95 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.386 -1.446 . . . . 2.8700000000000001 110.555 -178.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.626 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -70.71 -20.15 62.69 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.012 -1.055 . . . . 5.8499999999999996 108.934 178.744 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.451 ' OG1' ' OG1' ' A' ' 47' ' ' THR . 24.7 p -73.79 178.81 4.59 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.922 0.868 . . . . 3.4199999999999999 111.077 -178.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.562 ' O ' ' CA ' ' A' ' 71' ' ' ASN . . . 177.52 131.06 0.06 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.258 -1.386 . . . . 1.6000000000000001 107.258 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.522 ' O ' ' C ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -136.11 48.55 2.16 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 120.104 -1.623 . . . . 3.0800000000000001 109.91 -178.628 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.522 ' C ' ' O ' ' A' ' 51' ' ' LYS . 2.0 tt -28.29 146.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.178 0 CA-C-N 115.451 -0.795 . . . . 3.2400000000000002 110.361 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.439 ' C ' ' HE2' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -137.95 82.96 1.95 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.301 -0.874 . . . . 3.0899999999999999 109.474 -179.818 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.693 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 0.5 OUTLIER -108.57 141.51 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.293 -0.879 . . . . 0.87 109.278 179.651 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.693 ' HG3' ' O ' ' A' ' 54' ' ' ILE . 0.2 OUTLIER -152.4 90.18 1.48 Allowed 'General case' 0 C--N 1.285 -2.204 0 O-C-N 121.348 -0.845 . . . . 1.6599999999999999 109.175 178.462 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.483 ' CB ' ' HB ' ' A' ' 63' ' ' ILE . . . -109.36 145.21 36.44 Favored 'General case' 0 C--N 1.292 -1.897 0 O-C-N 121.512 -0.743 . . . . 0.69999999999999996 109.551 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.476 ' O ' ' CG1' ' A' ' 104' ' ' VAL . 30.3 m -128.12 137.13 51.99 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.972 -1.08 . . . . 3.0099999999999998 109.142 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.574 ' HB3' ' CB ' ' A' ' 61' ' ' LEU . 0.2 OUTLIER -135.39 158.33 44.64 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.28 -0.887 . . . . 2.6499999999999999 109.198 -179.604 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.432 ' HB2' ' HB2' ' A' ' 101' ' ' SER . 18.1 t70 -48.86 -63.89 0.96 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.274 -0.892 . . . . 3.2400000000000002 108.608 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -108.17 24.89 21.85 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 108.862 -1.695 . . . . 1.23 108.862 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.574 ' CB ' ' HB3' ' A' ' 58' ' ' LEU . 0.4 OUTLIER -146.33 66.48 1.19 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.269 -1.136 . . . . 4.5599999999999996 109.118 -179.709 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.09 82.44 0.51 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.469 -0.769 . . . . 2.1800000000000002 109.985 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.483 ' HB ' ' CB ' ' A' ' 56' ' ' ALA . 8.5 mt -66.85 169.44 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 120.866 -1.146 . . . . 0.89000000000000001 108.091 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.443 ' O ' HG21 ' A' ' 65' ' ' VAL . 0.5 OUTLIER 175.9 145.75 0.08 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.018 -1.052 . . . . 1.0600000000000001 109.469 -179.791 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.63 ' HB ' ' O ' ' A' ' 54' ' ' ILE . 14.5 t -144.39 63.93 11.59 Favored Pre-proline 0 N--CA 1.488 1.425 0 O-C-N 121.318 -0.864 . . . . 1.25 110.01 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.538 ' HD3' ' N ' ' A' ' 65' ' ' VAL . 36.4 Cg_endo -79.34 94.61 1.05 Allowed 'Trans proline' 0 C--N 1.298 -2.105 0 C-N-CA 122.918 2.412 . . . . 2.0299999999999998 110.328 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.466 ' C ' ' O ' ' A' ' 66' ' ' PRO . . . 36.45 46.96 1.11 Allowed Glycine 0 N--CA 1.496 2.688 0 N-CA-C 110.119 -1.192 . . . . 2.2400000000000002 110.119 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.502 ' CG2' ' N ' ' A' ' 69' ' ' ASP . 1.9 mm -63.5 -75.05 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.245 -1.15 . . . . 2.54 109.721 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.586 ' HB3' ' CG ' ' A' ' 74' ' ' HIS . 6.4 p-10 -77.96 162.81 26.5 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.113 -0.992 . . . . 1.8200000000000001 109.369 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.536 ' O ' ' ND2' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -57.11 -55.57 33.0 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.435 -0.791 . . . . 3.0899999999999999 110.318 -179.449 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.562 ' CA ' ' O ' ' A' ' 50' ' ' ALA . 2.7 m120 -147.45 87.69 1.66 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.913 -1.117 . . . . 3.0600000000000001 111.488 -178.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.551 ' N ' ' OD2' ' A' ' 69' ' ' ASP . . . 37.2 26.77 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.895 -0.503 . . . . 0.48999999999999999 111.986 176.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.525 ' N ' ' O ' ' A' ' 71' ' ' ASN . 4.3 t -99.46 0.73 43.16 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 120.88 -1.137 . . . . 1.1399999999999999 111.23 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.586 ' CG ' ' HB3' ' A' ' 69' ' ' ASP . 0.3 OUTLIER -90.7 -29.54 17.64 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.757 -1.214 . . . . 3.1600000000000001 109.687 179.811 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.505 ' O ' ' HB ' ' A' ' 76' ' ' VAL . 13.5 m-85 -103.6 14.07 31.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.362 -0.836 . . . . 2.0499999999999998 109.29 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.752 ' CG1' ' CZ ' ' A' ' 86' ' ' TYR . 5.4 p 178.27 -142.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-O 121.787 0.804 . . . . 3.3500000000000001 109.512 -177.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.566 ' H ' ' CG2' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -99.03 158.69 15.48 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 106.304 -1.739 . . . . 4.7400000000000002 106.304 177.049 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . 0.562 ' N ' ' CD ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -81.96 -48.62 0.94 Allowed Pre-proline 0 N--CA 1.493 1.694 0 C-N-CA 118.054 -1.458 . . . . 2.5800000000000001 109.544 179.866 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.626 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 32.0 Cg_endo -77.2 114.92 3.87 Favored 'Trans proline' 0 C--N 1.302 -1.904 0 N-CA-C 107.498 -1.77 . . . . 2.5 107.498 178.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.635 ' HB2' ' OE1' ' A' ' 45' ' ' GLN . 0.1 OUTLIER -85.96 -69.19 0.68 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 106.588 -1.634 . . . . 1.52 106.588 -179.11 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.599 ' CG2' ' N ' ' A' ' 47' ' ' THR 0.256 48.4 t 50.06 -174.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 C-N-CA 118.276 -1.37 . . . . 4.0700000000000003 109.262 175.488 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.556 ' HA ' ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -104.56 47.32 0.88 Allowed 'General case' 0 C--N 1.293 -1.884 0 O-C-N 121.143 -0.973 . . . . 3.4500000000000002 110.008 -179.381 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -137.43 11.19 3.78 Favored Glycine 0 N--CA 1.491 2.309 0 C-N-CA 118.734 -1.698 . . . . 0.53000000000000003 113.059 -178.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.482 ' NE2' ' O ' ' A' ' 79' ' ' PRO . 1.2 pt20 -148.92 171.05 16.95 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 120.452 2.126 . . . . 6.1900000000000004 111.334 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -108.02 142.1 38.68 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.775 0.798 . . . . 5.9699999999999998 110.956 -178.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.763 ' CD2' ' CZ ' ' A' ' 41' ' ' PHE . 0.4 OUTLIER -99.62 173.18 6.85 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.069 0.462 . . . . 3.8900000000000001 110.576 -179.61 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.607 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 9.9 p-10 176.83 83.64 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.464 -0.773 . . . . 3.4700000000000002 110.918 178.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.537 HG12 ' N ' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -127.87 146.06 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 107.313 -1.366 . . . . 3.5899999999999999 107.313 178.409 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.546 ' HG2' ' CG ' ' A' ' 38' ' ' GLU . 1.7 mtmt -147.62 -169.37 3.3 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.955 -1.091 . . . . 3.96 111.797 -177.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.587 ' CZ ' HG22 ' A' ' 54' ' ' ILE . 67.4 m-85 -156.7 126.64 6.36 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 107.728 -1.212 . . . . 1.1899999999999999 107.728 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.31 156.67 30.81 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.587 -1.32 . . . . 4.0099999999999998 110.842 -178.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.531 ' C ' ' CD1' ' A' ' 92' ' ' TRP . 3.3 t90 -143.19 109.97 5.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.548 -0.72 . . . . 6.3099999999999996 109.168 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -61.08 120.13 9.68 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.685 -1.228 . . . . 4.7300000000000004 107.685 178.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.603 ' CG1' ' CD1' ' A' ' 97' ' ' ILE . 18.4 t -114.68 95.94 42.34 Favored Pre-proline 0 N--CA 1.489 1.499 0 C-N-CA 119.028 -1.069 . . . . 2.6299999999999999 111.573 -178.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.52 ' HD2' ' CD1' ' A' ' 97' ' ' ILE . 31.0 Cg_endo -75.88 -79.52 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.939 2.426 . . . . 3.1699999999999999 109.269 177.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.553 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 5.5 tptt -137.52 -59.63 0.67 Allowed 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 104.662 -2.347 . . . . 4.71 104.662 177.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.603 ' CD1' ' CG1' ' A' ' 94' ' ' VAL . 1.2 mp 66.59 5.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 O-C-N 121.679 -0.638 . . . . 2.1000000000000001 112.711 174.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.618 ' CB ' ' HD2' ' A' ' 99' ' ' PRO . . . 54.86 177.96 0.03 OUTLIER Pre-proline 0 C--N 1.302 -1.459 0 O-C-N 120.408 -1.433 . . . . 1.53 109.256 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.618 ' HD2' ' CB ' ' A' ' 98' ' ' ALA . 46.4 Cg_endo -80.5 155.46 21.48 Favored 'Trans proline' 0 C--N 1.3 -1.984 0 C-N-CA 123.525 2.816 . . . . 1.5 110.345 -179.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.622 ' HD3' ' CB ' ' A' ' 128' ' ' ARG . 1.4 mmmp? 56.91 149.47 0.01 OUTLIER 'General case' 0 C--N 1.29 -1.987 0 CA-C-O 122.157 0.98 . . . . 3.77 112.184 176.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.517 ' OG ' HG23 ' A' ' 104' ' ' VAL . 78.0 p -129.68 164.72 23.32 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.118 -0.697 . . . . 2.3100000000000001 109.118 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.556 ' O ' ' CB ' ' A' ' 103' ' ' ASN . 4.3 mt-10 -51.04 -22.22 2.25 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.147 -0.971 . . . . 2.9700000000000002 109.023 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.556 ' CB ' ' O ' ' A' ' 102' ' ' GLU . 0.3 OUTLIER 157.1 157.02 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.563 -0.903 . . . . 3.2000000000000002 108.563 -179.713 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.522 HG22 ' CD1' ' A' ' 127' ' ' ILE . 0.2 OUTLIER -152.07 174.58 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.05 -1.031 . . . . 0.91000000000000003 109.611 -179.919 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 56' ' ' ALA . 1.2 t 164.57 130.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 108.06 -1.089 . . . . 1.3799999999999999 108.06 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 3.6 t -128.56 102.98 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.899 -1.125 . . . . 1.77 110.562 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.431 ' C ' HG21 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -108.64 147.45 31.85 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.366 -0.975 . . . . 1.52 108.366 178.905 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.478 HG11 ' CD1' ' A' ' 54' ' ' ILE . 1.5 t -151.69 153.32 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.696 -1.252 . . . . 3.4300000000000002 110.546 -179.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 119' ' ' CYS . 0.4 OUTLIER 172.48 116.15 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.503 -0.748 . . . . 2.5800000000000001 110.334 178.796 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.541 ' CD2' HD13 ' A' ' 80' ' ' LEU . 32.7 tp -104.04 127.89 51.61 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.684 -1.228 . . . . 3.1600000000000001 107.684 177.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.487 ' O ' ' HG3' ' A' ' 51' ' ' LYS . 10.3 mt -125.88 136.83 59.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 O-C-N 121.277 -0.89 . . . . 1.3100000000000001 110.431 -178.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -100.07 -109.86 3.13 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 108.099 -2.0 . . . . 1.4299999999999999 108.099 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -145.34 11.91 1.34 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.353 -1.351 . . . . 3.1400000000000001 107.353 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.419 ' OD1' ' NE2' ' A' ' 45' ' ' GLN . 1.3 p30 -127.53 -33.17 2.35 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.547 0.689 . . . . 4.1500000000000004 109.483 -178.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -179.91 156.61 18.45 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.107 -1.597 . . . . 1.6899999999999999 109.107 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -57.02 112.54 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.147 -1.208 . . . . 1.3799999999999999 109.918 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.551 ' CD2' HD11 ' A' ' 80' ' ' LEU . 2.9 mt -55.54 -68.02 0.23 Allowed 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.608 -0.886 . . . . 2.0499999999999998 108.608 179.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.548 ' O ' ' HB3' ' A' ' 119' ' ' CYS . . . -130.39 -177.98 4.56 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.296 -1.002 . . . . 0.79000000000000004 108.296 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . 0.548 ' HB3' ' O ' ' A' ' 118' ' ' ALA . 0.1 OUTLIER 169.15 155.8 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.08 -1.013 . . . . 1.1200000000000001 110.145 179.777 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.467 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . . . -176.88 129.68 0.18 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.314 -0.866 . . . . 1.6399999999999999 109.416 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.3 mt -122.73 131.72 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.138 -0.977 . . . . 1.29 109.886 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -85.79 -35.81 20.48 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.337 -0.986 . . . . 2.2599999999999998 108.337 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.408 ' O ' ' O ' ' A' ' 124' ' ' HIS . 2.4 m 64.77 121.41 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.61 -0.681 . . . . 2.9700000000000002 110.372 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . 0.408 ' O ' ' O ' ' A' ' 123' ' ' THR . 3.9 m170 48.02 98.03 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.543 -0.723 . . . . 3.3199999999999998 110.771 178.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.465 ' O ' ' HB ' ' A' ' 104' ' ' VAL . . . -116.83 119.38 4.46 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 108.294 -1.922 . . . . 1.75 108.294 178.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -137.27 140.02 41.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.949 -1.324 . . . . 3.5099999999999998 110.587 -178.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.685 ' O ' ' CB ' ' A' ' 128' ' ' ARG . 2.2 mp -83.16 149.53 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 108.292 -1.003 . . . . 1.54 108.292 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.685 ' CB ' ' O ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER 137.22 -82.11 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 108.96 -0.755 . . . . 4.5899999999999999 108.96 179.355 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.442 ' N ' ' CD ' ' A' ' 128' ' ' ARG . 13.1 t70 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 117.948 -1.025 . . . . 4.5 109.382 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . 0.526 ' C ' ' CG ' ' A' ' 2' ' ' GLN . 5.2 m-20 . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.31 -0.626 . . . . 4.4199999999999999 109.31 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.56 ' HA ' ' CG ' ' A' ' 17' ' ' MET . 0.8 OUTLIER 37.35 30.07 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.647 -0.658 . . . . 4.54 110.589 179.166 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.515 HG23 ' HB ' ' A' ' 18' ' ' VAL . 28.8 m -44.46 122.17 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.28 -0.887 . . . . 2.9700000000000002 108.815 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.489 ' O ' ' HA3' ' A' ' 23' ' ' GLY . 8.3 t70 -55.39 134.61 50.39 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.449 -0.782 . . . . 2.1699999999999999 110.586 -179.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.3 171.16 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 108.224 -1.028 . . . . 1.22 108.224 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 120' ' ' ALA . 27.4 mtpt -105.33 101.47 11.0 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.787 -1.196 . . . . 3.96 110.007 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.483 ' HA ' ' O ' ' A' ' 119' ' ' CYS . 65.1 m-20 -97.19 170.69 8.93 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.472 -0.768 . . . . 4.04 109.362 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.515 ' N ' ' SG ' ' A' ' 119' ' ' CYS . 3.8 m -138.69 4.64 2.36 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.34 -0.85 . . . . 1.49 109.639 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.531 ' CB ' ' HA ' ' A' ' 118' ' ' ALA . . . -47.09 -62.73 1.28 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.07 -1.019 . . . . 0.70999999999999996 109.586 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.444 ' OD1' ' OD1' ' A' ' 11' ' ' ASN . 1.1 t-20 178.83 -81.85 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.919 -0.712 . . . . 4.7800000000000002 109.301 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.444 ' OD1' ' OD1' ' A' ' 10' ' ' ASN . 14.3 p-10 -164.45 42.26 0.09 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.55 -0.719 . . . . 4.3499999999999996 109.214 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.506 ' O ' ' HB ' ' A' ' 13' ' ' ILE . 0.7 OUTLIER -163.68 -81.94 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.231 -0.918 . . . . 3.7799999999999998 109.566 -179.819 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.526 ' CG2' ' O ' ' A' ' 15' ' ' LYS . 0.1 OUTLIER 74.22 -2.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 CA-C-O 121.784 0.802 . . . . 3.79 110.257 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.524 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 15.1 mttm 65.99 -19.21 0.1 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.043 -1.036 . . . . 2.77 111.771 178.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.526 ' O ' ' CG2' ' A' ' 13' ' ' ILE . 0.0 OUTLIER 166.14 151.24 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.399 0 O-C-N 120.685 -1.26 . . . . 1.6499999999999999 109.029 -178.073 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.557 ' CG1' ' O ' ' A' ' 16' ' ' VAL . 12.6 p -169.46 100.8 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.129 -0.982 . . . . 1.3799999999999999 109.019 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.56 ' CG ' ' HA ' ' A' ' 2' ' ' GLN . 2.1 mpp? -151.19 150.16 30.28 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.589 -0.845 . . . . 1.8899999999999999 110.196 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.633 ' CG1' ' CE1' ' A' ' 35' ' ' PHE . 19.2 t -117.0 160.24 16.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 107.794 -1.188 . . . . 2.4100000000000001 107.794 178.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.569 ' CB ' ' O ' ' A' ' 34' ' ' PRO . 16.3 m-20 -94.91 36.17 1.21 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.835 -1.166 . . . . 1.6899999999999999 110.021 -179.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.547 ' O ' ' CB ' ' A' ' 21' ' ' CYS . . . 130.45 128.9 3.04 Favored Glycine 0 N--CA 1.487 2.079 0 C-N-CA 119.523 -1.322 . . . . 1.77 110.131 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.587 ' HB2' HG22 ' A' ' 29' ' ' ILE . 0.0 OUTLIER 154.67 -36.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.538 -0.912 . . . . 0.91000000000000003 108.538 179.132 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.583 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 7.2 t-160 66.44 116.27 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.181 -1.044 . . . . 5.3099999999999996 108.181 -178.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.537 ' O ' ' CB ' ' A' ' 24' ' ' SER . . . -103.67 176.2 23.9 Favored Glycine 0 N--CA 1.496 2.657 0 C-N-CA 119.064 -1.541 . . . . 1.1000000000000001 110.392 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.537 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 1.3 t 84.75 -69.4 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.677 -0.896 . . . . 1.02 110.164 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.692 ' CB ' ' CD ' ' A' ' 26' ' ' PRO . 0.8 OUTLIER -83.57 -157.2 0.01 OUTLIER Pre-proline 0 C--N 1.304 -1.388 0 N-CA-C 108.274 -1.01 . . . . 4.4900000000000002 108.274 -179.779 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.692 ' CD ' ' CB ' ' A' ' 25' ' ' ASP . 28.4 Cg_endo -74.38 89.53 1.07 Allowed 'Trans proline' 0 C--N 1.324 -0.76 0 N-CA-C 108.483 -1.391 . . . . 0.72999999999999998 108.483 179.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.583 ' HA ' ' O ' ' A' ' 22' ' ' HIS . 1.6 t -38.4 95.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 113.244 0.831 . . . . 0.88 113.244 -177.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.493 ' O ' ' O ' ' A' ' 21' ' ' CYS . 24.1 mm -89.9 141.29 14.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 104.784 -2.302 . . . . 0.91000000000000003 104.784 174.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.587 HG22 ' HB2' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -119.45 179.94 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 O-C-N 120.215 -1.553 . . . . 1.23 112.886 -176.086 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.511 ' NE2' ' OD2' ' A' ' 129' ' ' ASP . 14.3 m170 -117.55 157.18 26.79 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.787 0.803 . . . . 4.2699999999999996 110.828 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.564 ' HD3' ' CA ' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -115.43 154.55 29.06 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 107.76 -1.2 . . . . 1.9299999999999999 107.76 178.285 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.475 ' C ' HG13 ' A' ' 94' ' ' VAL . . . 89.51 -1.01 81.3 Favored Glycine 0 N--CA 1.495 2.602 0 C-N-CA 119.582 -1.294 . . . . 0.44 110.073 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.566 ' O ' ' CG2' ' A' ' 94' ' ' VAL . 12.6 mtmt -128.65 146.72 61.28 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.257 -1.143 . . . . 2.3599999999999999 108.284 179.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.569 ' O ' ' CB ' ' A' ' 19' ' ' ASP . 28.9 Cg_endo -66.26 109.89 1.66 Allowed 'Trans proline' 0 C--N 1.303 -1.855 0 C-N-CA 122.487 2.125 . . . . 0.62 110.199 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.633 ' CE1' ' CG1' ' A' ' 18' ' ' VAL . 47.5 t80 -81.11 70.3 7.91 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.414 0.626 . . . . 1.8500000000000001 109.602 -179.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.48 HG23 ' OE2' ' A' ' 38' ' ' GLU . 32.9 m -90.91 76.69 6.25 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.439 -0.788 . . . . 1.1799999999999999 109.816 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 37' ' ' LEU . 1.6 pp -68.48 141.79 55.5 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.611 -1.255 . . . . 1.3300000000000001 107.611 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.527 ' O ' ' CB ' ' A' ' 39' ' ' ALA . 14.2 mt-10 -142.21 -160.17 1.06 Allowed 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.82 -1.175 . . . . 1.04 110.995 -178.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.527 ' CB ' ' O ' ' A' ' 38' ' ' GLU . . . 156.35 96.44 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.153 -1.425 . . . . 0.58999999999999997 107.153 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.663 ' HG ' ' CB ' ' A' ' 87' ' ' ASP . 0.3 OUTLIER -91.4 -176.88 4.68 Favored 'General case' 0 C--N 1.294 -1.82 0 O-C-N 121.546 -0.721 . . . . 0.85999999999999999 110.371 -177.813 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.654 ' CE1' ' CE2' ' A' ' 86' ' ' TYR . 12.0 p90 175.37 147.74 0.09 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.393 -0.817 . . . . 0.44 109.147 177.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.465 ' O ' ' OD1' ' A' ' 44' ' ' ASN . 0.6 OUTLIER -98.72 112.41 24.49 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.441 -0.948 . . . . 4.3600000000000003 108.441 179.747 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.606 ' HB3' ' HB3' ' A' ' 80' ' ' LEU . . . -36.78 125.32 0.88 Allowed 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 115.932 -0.576 . . . . 0.45000000000000001 110.245 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.465 ' OD1' ' O ' ' A' ' 42' ' ' ASP . 1.7 m-80 -125.77 38.98 4.05 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.23 -0.919 . . . . 1.3999999999999999 109.417 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.634 ' OE1' ' HB2' ' A' ' 80' ' ' LEU . 3.4 pt20 -128.1 -129.72 0.22 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.417 -0.802 . . . . 1.1399999999999999 110.327 -178.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.628 ' N ' ' HA ' ' A' ' 81' ' ' VAL . 0.8 OUTLIER -169.78 54.61 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.644 -0.873 . . . . 6.3799999999999999 108.644 179.469 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.583 ' N ' HG21 ' A' ' 81' ' ' VAL . 10.1 t -133.68 138.21 45.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.809 -1.182 . . . . 2.2200000000000002 110.57 -178.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.691 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 0.6 OUTLIER -83.91 -11.55 56.74 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 120.897 -1.127 . . . . 4.3799999999999999 108.251 177.625 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.447 ' O ' ' HB1' ' A' ' 50' ' ' ALA . 2.6 p -95.67 -155.87 0.49 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.394 -0.816 . . . . 1.02 109.449 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.58 ' O ' ' CA ' ' A' ' 71' ' ' ASN . . . 177.64 154.14 0.29 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.389 -0.819 . . . . 0.62 109.963 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.537 ' O ' ' CB ' ' A' ' 72' ' ' ALA . 19.9 mtpt -115.92 -175.38 2.72 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 106.385 -1.709 . . . . 3.3399999999999999 106.385 177.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.545 HG13 HD11 ' A' ' 54' ' ' ILE . 3.1 tt -164.87 158.67 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 C-N-CA 117.692 -1.603 . . . . 1.1200000000000001 111.343 -179.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.451 ' O ' ' HE2' ' A' ' 55' ' ' LYS . 0.8 OUTLIER -157.89 48.79 0.4 Allowed 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.35 -0.982 . . . . 2.0 108.35 179.845 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.653 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 0.4 OUTLIER -83.02 155.48 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.665 -0.647 . . . . 1.1699999999999999 109.492 -179.533 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.653 ' HG3' ' O ' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -170.79 100.69 0.23 Allowed 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.109 -0.7 . . . . 2.7200000000000002 109.109 178.577 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.472 ' O ' ' HB ' ' A' ' 63' ' ' ILE . . . -126.66 124.04 38.95 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.363 -0.836 . . . . 1.05 110.02 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -108.76 128.28 54.74 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.187 -0.946 . . . . 3.02 109.241 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.681 ' HB2' ' CZ2' ' A' ' 92' ' ' TRP . 1.8 tm? -122.94 154.64 38.11 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.132 -0.98 . . . . 2.0099999999999998 109.078 -179.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.463 ' HB2' ' OG ' ' A' ' 101' ' ' SER . 0.4 OUTLIER -47.27 -59.31 3.26 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.262 -0.899 . . . . 4.0700000000000003 110.262 -179.205 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -104.07 24.02 30.48 Favored Glycine 0 N--CA 1.493 2.444 0 C-N-CA 119.731 -1.223 . . . . 1.5 110.46 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.426 ' O ' ' HB3' ' A' ' 58' ' ' LEU . 0.5 OUTLIER -164.51 87.69 0.48 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.024 -1.28 . . . . 4.25 109.327 179.666 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.426 ' O ' ' C ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -79.09 70.88 5.52 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.732 -0.605 . . . . 2.8500000000000001 110.301 -179.666 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.625 HD13 ' CH2' ' A' ' 92' ' ' TRP . 6.0 mt -48.1 160.62 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 107.115 -1.439 . . . . 0.72999999999999998 107.115 178.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -170.4 142.77 2.2 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.867 -1.146 . . . . 2.6899999999999999 109.215 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.57 ' HB ' ' O ' ' A' ' 54' ' ' ILE . 11.7 t -132.82 69.42 79.24 Favored Pre-proline 0 C--N 1.298 -1.647 0 O-C-N 121.353 -0.842 . . . . 0.95999999999999996 109.223 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.412 ' HD3' ' N ' ' A' ' 65' ' ' VAL . 34.8 Cg_endo -76.37 -2.08 12.23 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 122.994 2.462 . . . . 1.0 110.625 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 136.44 42.22 0.11 Allowed Glycine 0 N--CA 1.489 2.199 0 C-N-CA 119.864 -1.16 . . . . 1.0900000000000001 110.308 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.463 HG23 ' CE1' ' A' ' 75' ' ' PHE . 35.4 mm -52.92 -77.32 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 O-C-N 120.964 -1.315 . . . . 2.1800000000000002 108.875 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -87.77 160.13 18.17 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.062 -1.024 . . . . 4.5999999999999996 108.866 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.432 ' O ' ' CG ' ' A' ' 71' ' ' ASN . 13.8 t -78.51 -12.23 60.0 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.242 -0.911 . . . . 6.3099999999999996 109.968 -179.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.58 ' CA ' ' O ' ' A' ' 50' ' ' ALA . 5.7 m120 -164.31 77.0 0.34 Allowed 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 118.661 -1.216 . . . . 4.5499999999999998 112.324 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.537 ' CB ' ' O ' ' A' ' 51' ' ' LYS . . . 22.34 46.01 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 121.492 0.663 . . . . 0.93000000000000005 112.032 175.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.543 ' N ' ' O ' ' A' ' 71' ' ' ASN . 6.1 t -106.6 -42.12 5.07 Favored 'General case' 0 C--N 1.285 -2.219 0 O-C-N 121.346 -0.846 . . . . 0.95999999999999996 110.531 -178.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 4.6 m170 -78.46 -1.2 32.52 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.993 -1.067 . . . . 4.2699999999999996 109.79 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.499 ' O ' HD13 ' A' ' 88' ' ' ILE . 57.9 m-85 -110.47 -14.7 14.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.233 -0.917 . . . . 0.59999999999999998 109.898 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.785 ' HB ' ' CE1' ' A' ' 86' ' ' TYR . 0.2 OUTLIER -157.39 175.28 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 120.81 -1.181 . . . . 0.55000000000000004 110.731 -177.316 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.647 ' N ' ' CG2' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -57.73 93.3 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 105.373 -2.084 . . . . 3.0699999999999998 105.373 176.758 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . 0.544 ' HB2' ' HD3' ' A' ' 79' ' ' PRO . 2.7 m -34.57 -51.51 1.03 Allowed Pre-proline 0 N--CA 1.5 2.033 0 O-C-N 121.628 -0.67 . . . . 1.04 112.021 -176.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.691 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 32.1 Cg_endo -79.1 108.79 2.43 Favored 'Trans proline' 0 C--N 1.303 -1.842 0 N-CA-C 109.401 -1.038 . . . . 0.57999999999999996 109.401 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.634 ' HB2' ' OE1' ' A' ' 45' ' ' GLN . 0.1 OUTLIER -92.26 -65.47 1.0 Allowed 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.518 -1.29 . . . . 0.46000000000000002 107.518 -179.86 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.628 ' HA ' ' N ' ' A' ' 46' ' ' ASN . 14.0 t 54.84 -178.26 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 C-N-CA 119.29 -0.964 . . . . 4.2999999999999998 109.134 177.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.532 ' N ' ' CG1' ' A' ' 81' ' ' VAL . 13.0 ptmt -102.2 37.01 1.96 Allowed 'General case' 0 C--N 1.296 -1.759 0 O-C-N 120.467 -1.395 . . . . 3.1699999999999999 110.206 -178.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -145.65 37.22 1.29 Allowed Glycine 0 C--N 1.288 -2.105 0 N-CA-C 108.664 -1.774 . . . . 1.3 108.664 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -146.58 142.62 28.17 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 121.23 -1.159 . . . . 3.2599999999999998 110.627 -178.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.457 ' O ' ' CG ' ' A' ' 85' ' ' GLN . 11.2 pt20 -115.88 130.69 56.94 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 105.977 -1.86 . . . . 3.6699999999999999 105.977 177.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.785 ' CE1' ' HB ' ' A' ' 76' ' ' VAL . 0.1 OUTLIER -152.71 156.91 40.08 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 117.74 -1.584 . . . . 1.6599999999999999 109.968 -177.641 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.663 ' CB ' ' HG ' ' A' ' 40' ' ' LEU . 7.2 p-10 -127.89 96.95 4.65 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 113.915 1.08 . . . . 0.47999999999999998 113.915 -175.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.539 ' O ' ' CB ' ' A' ' 89' ' ' LYS . 6.2 tp -62.99 -163.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 N-CA-C 106.362 -1.718 . . . . 1.3700000000000001 106.362 175.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.587 ' O ' ' CG ' ' A' ' 90' ' ' TYR . 1.0 OUTLIER 161.83 179.49 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.718 -1.239 . . . . 3.8300000000000001 111.519 179.74 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.587 ' CG ' ' O ' ' A' ' 89' ' ' LYS . 62.9 m-85 -162.81 61.14 0.2 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 107.027 -1.472 . . . . 0.58999999999999997 107.027 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.506 ' O ' ' O ' ' A' ' 90' ' ' TYR . 7.1 p -43.36 178.05 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.132 0 CA-C-O 121.402 0.62 . . . . 1.8999999999999999 111.382 -178.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.681 ' CZ2' ' HB2' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -173.82 116.35 0.24 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 118.71 -1.196 . . . . 4.2000000000000002 112.516 -179.345 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -84.31 126.81 33.54 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 105.729 -1.952 . . . . 2.46 105.729 176.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.566 ' CG2' ' O ' ' A' ' 33' ' ' LYS . 1.7 t -112.42 102.78 54.81 Favored Pre-proline 0 C--N 1.302 -1.481 0 O-C-N 120.626 -1.297 . . . . 0.96999999999999997 113.033 -176.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.613 ' HD2' ' CD1' ' A' ' 97' ' ' ILE . 31.8 Cg_endo -79.04 44.2 1.64 Allowed 'Trans proline' 0 C--N 1.314 -1.255 0 C-N-CA 123.088 2.525 . . . . 2.2999999999999998 110.905 176.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.55 ' O ' ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER 82.32 -70.03 0.06 Allowed 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 107.458 -1.312 . . . . 4.71 107.458 -178.48 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.613 ' CD1' ' HD2' ' A' ' 95' ' ' PRO . 2.7 mp 69.16 17.95 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 112.745 0.646 . . . . 1.24 112.745 176.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.595 ' CB ' ' HD2' ' A' ' 99' ' ' PRO . . . 49.06 177.65 0.01 OUTLIER Pre-proline 0 C--N 1.304 -1.377 0 O-C-N 120.774 -1.204 . . . . 0.58999999999999997 110.477 178.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.595 ' HD2' ' CB ' ' A' ' 98' ' ' ALA . 50.8 Cg_endo -85.17 165.09 11.25 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 123.746 2.964 . . . . 0.67000000000000004 110.044 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.627 ' HD3' ' CB ' ' A' ' 128' ' ' ARG . 3.8 mmmm 43.04 115.69 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 113.23 0.826 . . . . 3.3399999999999999 113.23 175.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.47 ' HB3' HD11 ' A' ' 127' ' ' ILE . 10.1 t -92.31 161.61 14.62 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.961 -1.087 . . . . 0.64000000000000001 108.242 177.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.473 ' O ' ' CB ' ' A' ' 103' ' ' ASN . 0.3 OUTLIER -61.93 -10.4 9.47 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.05 -1.031 . . . . 4.04 110.055 -179.77 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.501 ' OD1' ' N ' ' A' ' 103' ' ' ASN . 1.1 p30 167.27 158.63 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.058 -1.026 . . . . 5.9699999999999998 109.569 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.541 ' O ' ' CB ' ' A' ' 105' ' ' VAL . 0.1 OUTLIER -158.65 -178.48 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.107 -0.995 . . . . 0.76000000000000001 109.677 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.541 ' CB ' ' O ' ' A' ' 104' ' ' VAL . 0.9 OUTLIER 159.79 123.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 108.561 -0.903 . . . . 0.88 108.561 -179.758 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 2.4 t -118.99 144.6 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 120.883 -1.136 . . . . 1.29 110.197 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.465 ' O ' ' CB ' ' A' ' 108' ' ' VAL . 0.2 OUTLIER -159.16 175.67 13.17 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.263 -1.014 . . . . 1.3300000000000001 108.263 179.789 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.56 HG12 ' N ' ' A' ' 109' ' ' LYS . 1.1 t 171.33 169.0 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 120.721 -1.237 . . . . 1.5600000000000001 110.528 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.56 ' N ' HG12 ' A' ' 108' ' ' VAL . 11.2 ttpt 164.28 121.91 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.634 0.73 . . . . 1.5 109.091 178.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.512 ' CD2' HD13 ' A' ' 80' ' ' LEU . 7.7 tp -108.92 125.44 52.02 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.585 -1.265 . . . . 2.1899999999999999 107.585 178.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.513 ' HB ' ' HB2' ' A' ' 51' ' ' LYS . 4.0 mt -130.31 114.7 29.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.162 -0.961 . . . . 1.78 110.71 -178.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.409 ' HA2' ' HA ' ' A' ' 50' ' ' ALA . . . -70.84 -116.18 0.04 OUTLIER Glycine 0 N--CA 1.485 1.947 0 N-CA-C 107.75 -2.14 . . . . 0.46999999999999997 107.75 177.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -135.07 -0.56 2.75 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.023 -1.281 . . . . 2.4300000000000002 107.546 178.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -109.85 -24.81 10.65 Favored 'General case' 0 C--N 1.312 -1.057 0 O-C-N 121.35 -0.844 . . . . 0.95999999999999996 109.428 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -179.85 176.72 47.69 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.401 -1.479 . . . . 1.26 109.401 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.479 ' HA ' ' HA ' ' A' ' 111' ' ' ILE . 0.9 OUTLIER -81.38 106.61 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.195 -1.18 . . . . 0.62 109.834 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.524 HD23 ' HB3' ' A' ' 80' ' ' LEU . 4.0 mt -52.3 -54.61 29.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.419 -0.801 . . . . 0.56000000000000005 110.543 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.531 ' HA ' ' CB ' ' A' ' 9' ' ' ALA . . . -140.63 -170.9 3.11 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.061 -1.024 . . . . 0.46999999999999997 110.847 -178.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . 0.531 ' SG ' ' N ' ' A' ' 120' ' ' ALA . 0.0 OUTLIER 175.5 159.61 0.24 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.578 -0.701 . . . . 0.47999999999999998 109.563 -179.652 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.531 ' N ' ' SG ' ' A' ' 119' ' ' CYS . . . -176.91 126.96 0.16 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.274 -0.891 . . . . 0.82999999999999996 109.055 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 6.4 mt -129.37 132.24 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.175 -0.953 . . . . 1.3100000000000001 109.902 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.419 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -115.8 20.89 14.28 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.156 -0.965 . . . . 1.4299999999999999 108.759 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.419 ' OG1' ' O ' ' A' ' 122' ' ' ALA . 82.5 p 47.02 -160.7 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.413 -0.804 . . . . 4.1299999999999999 109.272 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . 0.558 ' CE1' ' HB3' ' A' ' 26' ' ' PRO . 42.2 p-80 -71.06 160.09 33.53 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.223 -0.923 . . . . 4.5899999999999999 109.115 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' A' ' 27' ' ' CYS . . . -120.24 -169.76 14.1 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.621 -1.392 . . . . 1.79 109.621 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.414 ' O ' ' C ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER 178.41 74.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.285 -1.127 . . . . 2.6099999999999999 109.574 179.736 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.662 ' O ' ' CB ' ' A' ' 128' ' ' ARG . 2.5 mp -39.41 157.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.6 -0.688 . . . . 1.05 110.463 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.662 ' CB ' ' O ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER 132.97 -87.19 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.142 0 CA-C-O 121.357 0.599 . . . . 4.2400000000000002 109.956 178.476 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.511 ' OD2' ' NE2' ' A' ' 30' ' ' HIS . 1.7 t0 . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 118.112 -0.946 . . . . 4.2699999999999996 109.693 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.501 0.667 . . . . 3.2000000000000002 109.574 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.559 ' HA ' ' CG ' ' A' ' 17' ' ' MET . 12.2 pt20 -133.92 41.89 2.97 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.498 -0.751 . . . . 3.3300000000000001 108.984 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.53 ' CG1' ' HA ' ' A' ' 22' ' ' HIS . 2.0 m -45.86 120.89 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 108.16 -1.052 . . . . 3.0299999999999998 108.16 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.476 ' O ' ' HA3' ' A' ' 23' ' ' GLY . 71.3 m-20 -94.41 127.84 40.56 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.379 -0.826 . . . . 5.3899999999999997 110.913 -178.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.408 ' HA ' ' CA ' ' A' ' 23' ' ' GLY . 0.1 OUTLIER -95.72 -170.67 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.013 -1.106 . . . . 1.96 108.013 178.655 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.81 94.62 9.19 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.83 -1.169 . . . . 2.8900000000000001 109.153 179.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.469 ' HA ' ' O ' ' A' ' 119' ' ' CYS . 1.6 m-20 -99.07 174.35 6.38 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.537 -0.727 . . . . 4.4400000000000004 109.286 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.514 ' N ' ' SG ' ' A' ' 119' ' ' CYS . 31.6 p -163.62 49.14 0.14 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.238 -0.913 . . . . 2.23 109.725 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.522 ' O ' ' CB ' ' A' ' 10' ' ' ASN . . . -83.3 -66.33 0.9 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.112 -0.993 . . . . 0.60999999999999999 109.859 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.522 ' CB ' ' O ' ' A' ' 9' ' ' ALA . 0.9 OUTLIER 164.34 42.33 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.46 -0.896 . . . . 1.6499999999999999 109.788 -178.779 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.2 m120 49.88 23.93 1.18 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.937 -1.102 . . . . 3.04 108.042 -179.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 13' ' ' ILE . 0.0 OUTLIER -105.76 -28.54 10.62 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.574 -0.704 . . . . 3.3799999999999999 109.234 -179.764 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.526 ' CG2' ' O ' ' A' ' 40' ' ' LEU . 11.9 mt -41.81 143.7 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 109.077 -0.712 . . . . 0.66000000000000003 109.077 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -105.02 -19.2 13.91 Favored 'General case' 0 C--N 1.295 -1.767 0 O-C-N 121.402 -0.811 . . . . 5.3499999999999996 108.998 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.35 104.98 1.46 Allowed 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 119.031 -1.067 . . . . 3.9500000000000002 110.363 -177.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.445 HG12 ' O ' ' A' ' 16' ' ' VAL . 2.6 p -120.87 95.82 3.81 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 107.075 -1.454 . . . . 1.8400000000000001 107.075 178.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.559 ' CG ' ' HA ' ' A' ' 2' ' ' GLN . 2.3 mpt? -144.7 145.57 31.78 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.63 -0.669 . . . . 3.27 109.751 -178.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.528 ' CG1' ' HA ' ' A' ' 37' ' ' LEU . 1.7 t -110.93 120.36 61.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 108.255 -1.017 . . . . 1.8700000000000001 108.255 179.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -41.93 -26.1 0.08 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.39 -0.819 . . . . 2.7599999999999998 109.714 -179.44 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -158.1 -148.42 5.14 Favored Glycine 0 N--CA 1.488 2.116 0 C-N-CA 119.615 -1.279 . . . . 2.6200000000000001 109.964 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.622 ' HA ' ' HA ' ' A' ' 29' ' ' ILE . 50.4 t 65.15 -111.47 0.24 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.629 -0.924 . . . . 2.3500000000000001 109.664 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.543 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 0.3 OUTLIER 155.2 139.7 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 106.621 -1.622 . . . . 2.3300000000000001 106.621 -178.723 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' A' ' 4' ' ' ASP . . . -107.99 157.59 15.29 Favored Glycine 0 C--N 1.288 -2.119 0 N-CA-C 109.409 -1.477 . . . . 1.51 109.409 -179.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.457 ' O ' ' CB ' ' A' ' 25' ' ' ASP . 0.2 OUTLIER 66.61 137.2 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.216 -1.167 . . . . 3.4399999999999999 108.279 -179.163 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.542 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.2 OUTLIER 66.48 177.29 0.05 OUTLIER Pre-proline 0 C--N 1.304 -1.385 0 O-C-N 120.455 -1.403 . . . . 5.5199999999999996 107.998 -179.815 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.542 ' HD2' ' CB ' ' A' ' 25' ' ' ASP . 30.7 Cg_endo -74.8 123.67 8.15 Favored 'Trans proline' 0 C--N 1.299 -2.055 0 C-N-CA 122.747 2.298 . . . . 2.1099999999999999 109.397 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.543 ' HB2' ' O ' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -97.08 113.94 25.55 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.291 -0.881 . . . . 1.75 111.491 -177.819 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.54 ' CD1' ' HG3' ' A' ' 126' ' ' LYS . 20.1 mm -86.77 83.72 2.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 107.147 -1.427 . . . . 1.97 107.147 176.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.622 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -50.08 -177.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 O-C-N 121.699 -0.626 . . . . 3.0800000000000001 109.977 -179.138 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 79.5 m-70 -134.2 160.44 37.84 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.507 -0.877 . . . . 1.6699999999999999 110.659 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.573 ' HD3' ' CA ' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -108.83 113.02 25.6 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.528 -0.732 . . . . 2.5099999999999998 109.399 179.626 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 134.42 0.2 3.75 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 110.206 -1.158 . . . . 1.2 110.206 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.556 ' O ' ' CB ' ' A' ' 94' ' ' VAL . 13.3 mttt -130.23 144.43 53.17 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 120.93 -1.335 . . . . 3.3399999999999999 110.184 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.507 ' HA ' HG22 ' A' ' 94' ' ' VAL . 29.6 Cg_endo -69.41 81.08 0.75 Allowed 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 123.166 2.577 . . . . 0.81000000000000005 111.19 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.468 ' CZ ' ' HB3' ' A' ' 37' ' ' LEU . 5.2 t80 -55.42 122.13 10.52 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 109.433 -0.581 . . . . 3.0899999999999999 109.433 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 37.5 m -134.04 85.44 2.2 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.075 -1.015 . . . . 1.9399999999999999 109.571 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.528 ' HA ' ' CG1' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -62.66 141.38 58.55 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.235 -0.915 . . . . 2.5 108.891 179.746 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.56 ' O ' ' CB ' ' A' ' 39' ' ' ALA . 87.2 mt-10 -139.17 -171.23 3.06 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.147 -0.971 . . . . 2.21 110.06 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.56 ' CB ' ' O ' ' A' ' 38' ' ' GLU . . . 155.13 70.7 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.906 -1.146 . . . . 1.3600000000000001 107.906 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.619 ' HG ' ' CB ' ' A' ' 87' ' ' ASP . 0.8 OUTLIER -71.98 171.73 11.3 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 115.912 -0.585 . . . . 0.87 110.162 -178.841 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.669 ' CE2' ' CE2' ' A' ' 86' ' ' TYR . 5.5 p90 -176.01 148.39 0.82 Allowed 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.583 -0.895 . . . . 0.40000000000000002 108.583 179.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.509 ' O ' ' C ' ' A' ' 43' ' ' ALA . 6.7 t70 -95.28 112.19 23.94 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 107.286 -1.375 . . . . 2.0899999999999999 107.286 178.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.557 ' CB ' ' O ' ' A' ' 81' ' ' VAL . . . -36.1 125.53 0.76 Allowed 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 115.61 -0.723 . . . . 0.66000000000000003 109.1 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -124.04 15.02 9.19 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.171 -0.956 . . . . 4.0800000000000001 110.33 -177.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.641 ' O ' ' N ' ' A' ' 82' ' ' LYS . 2.3 pt20 -105.56 -139.41 0.37 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.379 -0.971 . . . . 0.48999999999999999 108.379 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.726 ' HA ' ' HB ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -156.73 67.98 0.57 Allowed 'General case' 0 C--N 1.294 -1.845 0 O-C-N 121.08 -1.013 . . . . 1.3400000000000001 109.306 178.59 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.497 HG21 ' O ' ' A' ' 47' ' ' THR . 10.3 t -146.33 118.47 8.31 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.263 -1.523 . . . . 0.75 111.607 -178.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.635 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 0.6 OUTLIER -66.4 -10.6 45.3 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.66 -1.275 . . . . 3.46 107.847 177.262 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.478 ' O ' ' HB1' ' A' ' 50' ' ' ALA . 30.5 p -98.44 -161.3 0.86 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.335 -0.853 . . . . 1.3899999999999999 108.807 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.549 ' HB2' ' CB ' ' A' ' 72' ' ' ALA . . . 174.67 160.4 0.19 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.168 -0.958 . . . . 0.41999999999999998 109.863 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.542 ' O ' ' CB ' ' A' ' 72' ' ' ALA . 20.3 mtmt -123.14 169.04 11.64 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 107.227 -1.398 . . . . 1.3400000000000001 107.227 177.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.545 HD11 ' CD1' ' A' ' 75' ' ' PHE . 11.1 tt -148.19 144.74 18.89 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.239 0 C-N-CA 118.413 -1.315 . . . . 0.72999999999999998 110.558 -178.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.456 ' O ' ' CE ' ' A' ' 55' ' ' LYS . 6.1 mt-10 -139.84 56.42 1.64 Allowed 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 107.101 -1.444 . . . . 3.0699999999999998 107.101 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.679 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -87.62 151.91 3.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 O-C-N 121.312 -0.867 . . . . 1.73 110.096 -178.392 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.679 ' HG3' ' O ' ' A' ' 54' ' ' ILE . 0.1 OUTLIER -166.51 95.22 0.54 Allowed 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 109.053 -0.721 . . . . 1.6399999999999999 109.053 178.305 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.503 ' O ' ' O ' ' A' ' 63' ' ' ILE . . . -118.78 138.66 52.53 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.394 -0.816 . . . . 0.88 109.563 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.455 ' O ' ' CG1' ' A' ' 104' ' ' VAL . 1.6 t -124.4 124.8 43.14 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.925 -1.109 . . . . 1.53 110.125 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.585 HD22 ' CZ3' ' A' ' 92' ' ' TRP . 2.6 tm? -117.85 152.86 34.52 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.255 -1.017 . . . . 3.0899999999999999 108.255 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.506 ' N ' HD11 ' A' ' 58' ' ' LEU . 5.4 t0 -43.61 -66.06 0.42 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.061 -1.025 . . . . 2.1699999999999999 109.938 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.428 ' O ' ' CD1' ' A' ' 61' ' ' LEU . . . -101.09 20.18 48.63 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.058 -1.217 . . . . 0.95999999999999996 110.058 -179.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.469 HD13 ' HA ' ' A' ' 61' ' ' LEU . 1.9 tp -152.69 79.13 1.21 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.141 -1.211 . . . . 3.6400000000000001 108.935 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.445 ' O ' ' C ' ' A' ' 63' ' ' ILE . 0.5 OUTLIER -74.9 76.05 2.15 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 116.203 -0.453 . . . . 3.9100000000000001 110.869 -179.19 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.503 ' O ' ' O ' ' A' ' 56' ' ' ALA . 3.2 mt -49.08 162.81 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 106.54 -1.652 . . . . 1.0800000000000001 106.54 178.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.436 ' O ' HG21 ' A' ' 65' ' ' VAL . 0.5 OUTLIER -176.02 147.43 0.75 Allowed 'General case' 0 C--N 1.297 -1.707 0 O-C-N 120.424 -1.423 . . . . 0.90000000000000002 109.004 -179.828 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.553 ' N ' ' HD3' ' A' ' 66' ' ' PRO . 17.1 t -140.77 62.28 17.27 Favored Pre-proline 0 C--N 1.299 -1.598 0 C-N-CA 119.279 -0.969 . . . . 1.49 110.215 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.553 ' HD3' ' N ' ' A' ' 65' ' ' VAL . 36.2 Cg_endo -78.32 -5.05 14.76 Favored 'Trans proline' 0 C--N 1.301 -1.964 0 C-N-CA 122.82 2.347 . . . . 1.3700000000000001 109.094 178.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 68' ' ' ILE . . . -177.62 -110.25 0.27 Allowed Glycine 0 N--CA 1.487 2.073 0 N-CA-C 108.14 -1.984 . . . . 2.3500000000000001 108.14 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.509 HD11 HG22 ' A' ' 68' ' ' ILE . 0.0 OUTLIER 39.97 85.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.421 -1.046 . . . . 3.5 109.779 179.103 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 46.28 80.38 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.003 -1.061 . . . . 5.9900000000000002 108.856 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.37 50.17 1.95 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.361 -0.837 . . . . 8.7200000000000006 109.467 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.529 ' CA ' ' O ' ' A' ' 50' ' ' ALA . 8.6 m-20 -136.86 38.04 2.6 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.195 -0.941 . . . . 2.1499999999999999 109.935 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.553 ' HB3' ' CD1' ' A' ' 110' ' ' LEU . . . 37.92 29.18 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 121.419 0.628 . . . . 1.0700000000000001 110.466 177.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.499 ' N ' ' O ' ' A' ' 71' ' ' ASN . 9.8 t -105.2 -52.29 2.87 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.455 -0.778 . . . . 1.0900000000000001 110.003 -179.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -67.27 -16.91 64.56 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.957 -1.089 . . . . 1.47 109.706 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.548 ' O ' ' CD1' ' A' ' 88' ' ' ILE . 91.7 m-85 -101.05 -9.14 21.69 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.173 -0.954 . . . . 1.0 110.169 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.758 ' HB ' ' CE1' ' A' ' 86' ' ' TYR . 0.2 OUTLIER -165.66 173.98 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 120.591 -1.318 . . . . 0.57999999999999996 111.366 -177.298 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.64 ' N ' ' CG2' ' A' ' 76' ' ' VAL . 2.5 mmmt -56.23 92.3 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.119 -1.437 . . . . 2.1200000000000001 107.119 177.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . 0.513 ' HB2' ' HD3' ' A' ' 79' ' ' PRO . 0.4 OUTLIER -35.22 -52.53 1.22 Allowed Pre-proline 0 N--CA 1.502 2.15 0 CA-C-N 116.323 -0.399 . . . . 0.96999999999999997 110.955 -177.596 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.635 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 31.2 Cg_endo -76.59 109.52 2.88 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 121.115 1.21 . . . . 0.70999999999999996 109.269 179.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.58 HD22 ' CD2' ' A' ' 86' ' ' TYR . 0.5 OUTLIER -103.15 -63.51 1.17 Allowed 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 121.41 0.624 . . . . 3.8599999999999999 109.399 -178.519 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.726 ' HB ' ' HA ' ' A' ' 46' ' ' ASN . 1.3 m 40.18 -167.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 C-N-CA 120.56 -0.456 . . . . 0.65000000000000002 109.884 178.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.641 ' N ' ' O ' ' A' ' 45' ' ' GLN . 1.0 OUTLIER -104.38 41.96 1.25 Allowed 'General case' 0 C--N 1.289 -2.054 0 O-C-N 120.39 -1.444 . . . . 3.8300000000000001 110.411 -176.848 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -146.65 35.88 1.28 Allowed Glycine 0 C--N 1.287 -2.19 0 N-CA-C 108.583 -1.807 . . . . 1.01 108.583 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.531 ' NE2' ' HG3' ' A' ' 77' ' ' LYS . 12.6 tp60 -150.0 140.1 22.08 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 121.237 -1.155 . . . . 4.3099999999999996 110.578 -179.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.496 ' HG2' ' HB2' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -112.42 129.31 56.36 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 105.566 -2.013 . . . . 4.04 105.566 177.048 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.758 ' CE1' ' HB ' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -151.21 160.94 43.55 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 117.525 -1.67 . . . . 1.27 110.124 -177.371 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.619 ' CB ' ' HG ' ' A' ' 40' ' ' LEU . 1.8 m-20 -129.03 99.5 5.29 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.948 -1.095 . . . . 4.0800000000000001 113.456 -175.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.567 ' O ' ' CB ' ' A' ' 89' ' ' LYS . 3.8 tp -66.78 -163.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 106.839 -1.541 . . . . 2.21 106.839 176.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.592 ' O ' ' CG ' ' A' ' 90' ' ' TYR . 10.4 mttt 161.39 175.4 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.271 0 O-C-N 120.927 -1.108 . . . . 2.0899999999999999 111.071 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.592 ' CG ' ' O ' ' A' ' 89' ' ' LYS . 41.9 m-85 -165.37 103.11 0.73 Allowed 'General case' 0 N--CA 1.504 2.269 0 N-CA-C 108.154 -1.054 . . . . 0.75 108.154 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.03 179.18 5.16 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.282 -0.887 . . . . 4.1299999999999999 111.467 -177.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.585 ' CZ3' HD22 ' A' ' 58' ' ' LEU . 1.7 t90 -167.62 101.57 0.49 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.759 -0.588 . . . . 5.3300000000000001 109.472 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.507 ' O ' ' CD1' ' A' ' 92' ' ' TRP . 49.4 t-20 -47.47 123.33 5.58 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 106.842 -1.54 . . . . 1.98 106.842 178.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.611 ' CG1' ' CD1' ' A' ' 97' ' ' ILE . 58.2 t -116.21 90.5 29.28 Favored Pre-proline 0 C--N 1.3 -1.547 0 C-N-CA 118.568 -1.253 . . . . 2.4100000000000001 111.934 -177.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.501 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 33.7 Cg_endo -83.07 58.65 6.38 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 123.423 2.749 . . . . 2.7200000000000002 109.809 178.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.594 ' O ' ' HB ' ' A' ' 97' ' ' ILE . 0.1 OUTLIER 71.04 -80.37 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.386 -1.339 . . . . 4.6799999999999997 107.386 -177.843 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.611 ' CD1' ' CG1' ' A' ' 94' ' ' VAL . 2.6 mp 76.44 34.58 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.638 -0.664 . . . . 1.6899999999999999 112.24 177.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.553 ' CB ' ' HD2' ' A' ' 99' ' ' PRO . . . 53.32 171.4 0.04 OUTLIER Pre-proline 0 C--N 1.3 -1.578 0 O-C-N 120.98 -1.075 . . . . 0.65000000000000002 110.991 178.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.728 ' O ' ' CB ' ' A' ' 100' ' ' LYS . 61.4 Cg_endo -87.45 83.91 0.92 Allowed 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 123.951 3.101 . . . . 1.7 110.487 -178.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.728 ' CB ' ' O ' ' A' ' 99' ' ' PRO . 0.1 OUTLIER 116.25 121.14 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 118.896 0.771 . . . . 2.75 111.02 178.279 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.458 ' OG ' HD11 ' A' ' 127' ' ' ILE . 1.9 p -92.29 148.7 21.93 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.754 -1.202 . . . . 2.5299999999999998 107.754 177.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 101' ' ' SER . 0.0 OUTLIER -42.58 -26.47 0.12 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.947 -1.096 . . . . 4.3799999999999999 109.727 -179.231 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.478 ' C ' ' CG2' ' A' ' 104' ' ' VAL . 1.4 t-20 171.23 160.22 0.08 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.317 -0.864 . . . . 2.2200000000000002 109.246 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.478 ' CG2' ' C ' ' A' ' 103' ' ' ASN . 0.1 OUTLIER -155.99 140.38 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.157 -0.964 . . . . 1.1200000000000001 109.64 179.942 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.414 ' O ' HG11 ' A' ' 105' ' ' VAL . 0.5 OUTLIER -143.09 134.37 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.352 -0.843 . . . . 1.6100000000000001 109.179 179.873 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.41 ' HB ' ' HB1' ' A' ' 122' ' ' ALA . 49.5 t -126.04 125.03 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.033 -1.042 . . . . 1.1899999999999999 109.775 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.527 ' C ' ' CG2' ' A' ' 108' ' ' VAL . 74.6 m -147.18 136.11 22.26 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.881 -1.155 . . . . 1.0800000000000001 107.881 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.597 ' CG1' ' CD1' ' A' ' 54' ' ' ILE . 0.3 OUTLIER -157.19 162.18 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 120.419 -1.426 . . . . 2.8900000000000001 110.881 -179.284 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.523 ' CE ' ' HB ' ' A' ' 116' ' ' VAL . 2.4 tttt 175.19 118.6 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.726 0.774 . . . . 4.4100000000000001 110.215 178.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.568 ' HB3' ' HB2' ' A' ' 117' ' ' LEU . 4.6 tp -92.89 122.26 35.09 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.367 -1.346 . . . . 1.4099999999999999 107.367 178.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.506 ' HB ' ' HB2' ' A' ' 51' ' ' LYS . 5.7 mt -122.12 114.99 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.766 -1.209 . . . . 1.03 111.932 -177.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -80.01 -127.58 0.67 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 107.91 -2.076 . . . . 1.0700000000000001 107.91 177.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -135.2 -2.97 2.48 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.878 -1.366 . . . . 2.6699999999999999 107.881 178.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.401 ' CG ' ' ND2' ' A' ' 46' ' ' ASN . 1.2 m-80 -115.03 -7.54 12.51 Favored 'General case' 0 C--N 1.313 -0.991 0 O-C-N 121.24 -0.913 . . . . 1.3 110.082 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 163.91 139.85 2.73 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 110.015 -1.234 . . . . 2.1200000000000001 110.015 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.523 ' HB ' ' CE ' ' A' ' 109' ' ' LYS . 0.1 OUTLIER -52.29 119.42 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.36 -1.082 . . . . 1.1299999999999999 109.823 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.568 ' HB2' ' HB3' ' A' ' 110' ' ' LEU . 1.7 mt -62.73 -59.98 4.13 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.274 -0.891 . . . . 0.90000000000000002 109.329 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.519 ' HA ' ' HA ' ' A' ' 9' ' ' ALA . . . -158.23 -173.02 4.12 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.54 -0.725 . . . . 1.3899999999999999 109.274 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . 0.514 ' SG ' ' N ' ' A' ' 8' ' ' CYS . 13.5 p 176.96 170.16 0.52 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.343 -0.848 . . . . 2.1099999999999999 109.422 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -164.21 131.45 3.26 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.495 -0.753 . . . . 0.72999999999999998 109.057 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 2.7 mp -128.18 142.82 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.089 -1.007 . . . . 1.49 110.57 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.416 ' O ' ' C ' ' A' ' 123' ' ' THR . . . -138.19 64.41 1.5 Allowed 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.028 -1.101 . . . . 0.80000000000000004 108.028 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.484 ' O ' ' O ' ' A' ' 124' ' ' HIS . 0.4 OUTLIER -38.74 132.28 1.22 Allowed 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.681 0.753 . . . . 2.96 111.533 -178.472 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . 0.484 ' O ' ' O ' ' A' ' 123' ' ' THR . 1.4 m-70 47.74 173.0 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.866 0.841 . . . . 3.9900000000000002 111.495 178.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 167.49 141.83 3.28 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.39 -1.484 . . . . 0.78000000000000003 109.39 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.54 ' HG3' ' CD1' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -147.01 134.11 20.42 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.116 -1.226 . . . . 3.2799999999999998 109.343 179.683 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.574 ' CD1' HG13 ' A' ' 29' ' ' ILE . 0.8 OUTLIER -79.27 124.1 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.408 -0.808 . . . . 2.0600000000000001 111.172 -178.306 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.598 ' HB2' ' HG2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER 168.64 -89.78 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.887 -1.133 . . . . 2.96 109.491 177.172 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.446 ' N ' ' CG2' ' A' ' 28' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 118.013 -0.994 . . . . 3.6499999999999999 109.212 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.183 -0.673 . . . . 4.2999999999999998 109.183 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.539 ' HB3' ' CG ' ' A' ' 17' ' ' MET . 1.2 pt20 -100.6 -172.97 2.29 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.063 -1.023 . . . . 2.9399999999999999 109.508 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.595 ' CG1' ' HA ' ' A' ' 22' ' ' HIS . 5.5 m -128.92 -168.26 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.348 -0.845 . . . . 2.46 109.409 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -130.87 77.8 1.8 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.178 -0.951 . . . . 1.4399999999999999 109.305 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.8 m -100.6 150.78 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.162 -0.961 . . . . 1.6899999999999999 109.596 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.426 ' O ' HD11 ' A' ' 121' ' ' ILE . 12.8 mtpp -75.05 93.68 2.77 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.496 -0.752 . . . . 2.8799999999999999 109.701 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.407 ' HA ' ' O ' ' A' ' 119' ' ' CYS . 35.4 p-10 -82.81 176.08 9.59 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.197 -0.939 . . . . 2.2999999999999998 109.122 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.517 ' N ' ' SG ' ' A' ' 119' ' ' CYS . 7.8 m -138.59 9.09 2.64 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.124 -0.985 . . . . 1.3200000000000001 109.919 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.572 ' CA ' ' HA ' ' A' ' 118' ' ' ALA . . . -56.55 -43.99 80.48 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.932 -1.105 . . . . 0.88 109.035 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.51 ' CB ' ' O ' ' A' ' 9' ' ' ALA . 0.5 OUTLIER 163.61 -58.09 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.948 -0.76 . . . . 5.0099999999999998 108.948 -179.185 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.474 ' HB2' ' O ' ' A' ' 10' ' ' ASN . 1.9 t-20 174.46 38.0 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.921 -0.77 . . . . 4.3700000000000001 108.921 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.41 ' CG ' ' H ' ' A' ' 13' ' ' ILE . 2.2 pt-20 -171.56 -62.71 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.025 -1.047 . . . . 4.9100000000000001 110.859 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.545 HG13 ' CB ' ' A' ' 9' ' ' ALA . 0.1 OUTLIER 67.76 4.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.122 -0.987 . . . . 3.9100000000000001 110.155 -179.047 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.537 ' HB2' ' O ' ' A' ' 13' ' ' ILE . 0.0 OUTLIER 75.08 -31.95 0.22 Allowed 'General case' 0 C--N 1.293 -1.876 0 O-C-N 121.386 -0.821 . . . . 3.7200000000000002 111.036 178.747 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.532 ' CB ' ' O ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER 165.81 109.93 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 118.785 -1.166 . . . . 4.5899999999999999 110.569 -178.622 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.545 ' HB ' HG23 ' A' ' 13' ' ' ILE . 6.8 p -120.07 107.85 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.096 -1.002 . . . . 2.23 108.76 178.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.539 ' CG ' ' HB3' ' A' ' 2' ' ' GLN . 0.5 OUTLIER -145.83 146.91 31.33 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.366 -0.934 . . . . 2.0 110.332 -179.605 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.483 HG11 ' HA ' ' A' ' 37' ' ' LEU . 42.1 t -117.62 148.95 20.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 108.255 -1.017 . . . . 2.02 108.255 179.088 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.412 ' HB3' ' HA ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -81.17 71.2 8.14 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.069 -1.086 . . . . 1.0 108.069 179.446 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.542 ' O ' ' CB ' ' A' ' 21' ' ' CYS . . . 108.02 -167.85 13.56 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 109.157 -1.577 . . . . 1.76 109.157 -178.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.602 ' O ' ' O ' ' A' ' 28' ' ' ILE . 15.5 t 83.54 -57.71 0.14 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.782 -0.834 . . . . 1.6699999999999999 109.984 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.595 ' HA ' ' CG1' ' A' ' 3' ' ' VAL . 0.3 OUTLIER 58.14 107.39 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.561 -1.337 . . . . 5.6500000000000004 109.145 -178.799 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.573 ' O ' ' CB ' ' A' ' 24' ' ' SER . . . -92.54 -143.8 13.18 Favored Glycine 0 N--CA 1.497 2.737 0 O-C-N 121.163 -0.961 . . . . 1.71 111.236 -178.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.573 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 1.0 OUTLIER 86.09 -48.73 0.06 Allowed 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.38 -0.97 . . . . 2.3799999999999999 108.38 -178.823 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.701 ' CB ' ' CD ' ' A' ' 26' ' ' PRO . 5.2 m-20 -120.11 -149.86 0.01 OUTLIER Pre-proline 0 C--N 1.303 -1.426 0 N-CA-C 105.665 -1.976 . . . . 4.4500000000000002 105.665 178.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.701 ' CD ' ' CB ' ' A' ' 25' ' ' ASP . 30.9 Cg_endo -74.34 85.69 1.39 Allowed 'Trans proline' 0 C--O 1.208 -1.012 0 N-CA-C 107.169 -1.896 . . . . 0.56000000000000005 107.169 178.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.562 ' HA ' ' O ' ' A' ' 22' ' ' HIS . 4.1 t -34.51 80.17 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 113.697 0.999 . . . . 1.6899999999999999 113.697 -176.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.602 ' O ' ' O ' ' A' ' 21' ' ' CYS . 0.7 OUTLIER -71.68 144.51 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 N-CA-C 106.772 -1.566 . . . . 2.25 106.772 176.343 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.58 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 0.1 OUTLIER -122.99 -159.9 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 O-C-N 120.371 -1.456 . . . . 0.89000000000000001 112.706 -176.425 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 40.5 m-70 -131.07 166.55 20.82 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.657 0.742 . . . . 1.8500000000000001 110.418 -179.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.565 ' HD3' ' HA ' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -116.05 -167.15 1.22 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.617 -0.677 . . . . 3.5499999999999998 109.464 -179.98 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' A' ' 95' ' ' PRO . . . 42.74 27.96 0.6 Allowed Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.692 -0.963 . . . . 1.1200000000000001 110.692 179.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.587 ' O ' HG13 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -151.76 133.87 8.4 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 120.754 -1.439 . . . . 2.0099999999999998 109.493 179.789 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.507 ' HA ' HG22 ' A' ' 94' ' ' VAL . 28.8 Cg_endo -68.26 78.99 0.6 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.601 2.2 . . . . 1.8 111.325 -179.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.483 ' CD1' ' C ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -62.05 149.52 40.81 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.281 -1.007 . . . . 4.1500000000000004 108.281 178.944 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.477 ' OG1' ' HB ' ' A' ' 91' ' ' THR . 6.4 m -153.71 95.81 1.93 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.918 -1.114 . . . . 1.76 110.211 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.483 ' HA ' HG11 ' A' ' 18' ' ' VAL . 2.3 pp -61.1 142.28 56.8 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.818 -1.179 . . . . 1.3200000000000001 107.818 178.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.507 ' HG3' ' CG ' ' A' ' 89' ' ' LYS . 2.0 tt0 -136.04 131.6 35.14 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.995 -1.066 . . . . 3.9500000000000002 109.882 -179.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -141.28 90.58 2.32 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.765 -1.198 . . . . 1.4299999999999999 107.765 178.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.602 ' HG ' ' CB ' ' A' ' 87' ' ' ASP . 0.2 OUTLIER -83.07 -176.36 6.29 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 109.236 -0.653 . . . . 1.1699999999999999 109.236 -178.567 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.596 ' O ' ' CD1' ' A' ' 41' ' ' PHE . 6.2 p90 171.08 133.86 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.361 -1.348 . . . . 1.6399999999999999 107.361 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.562 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 0.0 OUTLIER -90.13 119.88 30.84 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 107.969 -1.122 . . . . 3.71 107.969 179.86 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.561 ' O ' ' HA ' ' A' ' 82' ' ' LYS . . . -38.79 112.44 0.24 Allowed 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 109.47 -0.567 . . . . 0.59999999999999998 109.47 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.501 ' CG ' ' O ' ' A' ' 42' ' ' ASP . 2.5 m-80 -122.14 45.75 2.27 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.479 -0.763 . . . . 1.8899999999999999 109.023 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.598 ' OE1' ' HB2' ' A' ' 80' ' ' LEU . 3.5 pt20 -133.5 -133.12 0.17 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.267 -0.896 . . . . 1.48 110.198 -178.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.626 ' N ' ' HA ' ' A' ' 81' ' ' VAL . 47.3 t30 -169.89 53.0 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.441 -0.787 . . . . 6.04 109.604 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.592 ' CG2' ' OE1' ' A' ' 45' ' ' GLN . 3.9 t -139.18 138.25 36.77 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.613 -1.304 . . . . 0.88 110.576 -178.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.605 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 1.2 mtmp? -78.84 -0.84 32.23 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.81 -1.181 . . . . 4.4800000000000004 108.478 177.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.446 ' O ' HG22 ' A' ' 47' ' ' THR . 72.5 p -107.55 165.9 11.07 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.262 -0.899 . . . . 0.94999999999999996 108.962 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.609 ' O ' ' HA ' ' A' ' 71' ' ' ASN . . . -144.21 148.21 34.65 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.402 -0.962 . . . . 1.46 108.402 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.508 ' HB2' ' HB ' ' A' ' 111' ' ' ILE . 56.6 mttt -118.03 -169.45 1.69 Allowed 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.17 -1.418 . . . . 2.8999999999999999 107.17 177.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.414 ' HB ' ' O ' ' A' ' 51' ' ' LYS . 5.5 tt -176.4 151.4 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 C-N-CA 118.731 -1.188 . . . . 1.27 110.179 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.49 ' O ' ' NZ ' ' A' ' 55' ' ' LYS . 0.4 OUTLIER -148.45 57.54 1.06 Allowed 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.583 -0.895 . . . . 2.8599999999999999 108.583 179.916 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.636 ' CD1' ' CE2' ' A' ' 90' ' ' TYR . 1.6 mm -73.58 160.39 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.486 -0.759 . . . . 3.8999999999999999 109.675 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.576 ' N ' ' CG2' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -173.14 81.57 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.252 0.548 . . . . 1.71 110.055 178.548 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.534 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . . . -122.16 155.42 35.82 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 108.78 -0.822 . . . . 2.8799999999999999 108.78 179.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.431 ' OG ' ' HA ' ' A' ' 104' ' ' VAL . 0.0 OUTLIER -129.7 136.56 49.83 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.035 -1.041 . . . . 1.3700000000000001 109.402 -179.609 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.572 HD22 ' CE3' ' A' ' 92' ' ' TRP . 0.0 OUTLIER -128.0 164.49 22.23 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.286 -0.884 . . . . 5.3600000000000003 109.202 -179.506 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.498 ' OD2' ' N ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -39.47 -68.03 0.19 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.38 -0.825 . . . . 4.2699999999999996 109.617 -179.796 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.498 ' N ' ' OD2' ' A' ' 59' ' ' ASP . . . -118.81 30.1 6.03 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.146 -1.582 . . . . 1.23 109.146 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.453 HD21 ' O ' ' A' ' 60' ' ' GLY . 0.2 OUTLIER -139.81 61.24 1.54 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.257 -1.143 . . . . 1.0600000000000001 110.049 -179.578 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.495 ' HG3' ' O ' ' A' ' 62' ' ' GLU . 0.3 OUTLIER -55.69 100.2 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.967 -1.083 . . . . 3.46 108.162 179.348 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.565 ' O ' ' CG2' ' A' ' 63' ' ' ILE . 2.9 mt -71.8 -2.68 3.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.364 -0.835 . . . . 2.8500000000000001 111.087 -178.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.507 ' C ' ' O ' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -30.97 137.65 0.04 OUTLIER 'General case' 0 C--N 1.285 -2.213 0 CA-C-O 121.532 0.682 . . . . 3.8999999999999999 110.009 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.585 HG23 ' HB ' ' A' ' 54' ' ' ILE . 70.1 t -126.01 90.26 50.62 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.396 -0.815 . . . . 1.8799999999999999 109.755 -178.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.89 -4.53 13.42 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.92 2.413 . . . . 1.45 110.757 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 68' ' ' ILE . . . 167.83 -92.09 0.1 Allowed Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.617 -1.393 . . . . 2.9900000000000002 109.617 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.482 ' O ' ' O ' ' A' ' 69' ' ' ASP . 1.2 mm 49.95 99.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.216 -1.167 . . . . 3.21 109.791 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.501 ' CG ' ' HB2' ' A' ' 74' ' ' HIS . 13.0 m-20 53.23 104.91 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.337 -0.852 . . . . 5.5 108.91 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -82.32 31.55 0.4 Allowed 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.383 -0.823 . . . . 5.9100000000000001 111.113 -178.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.609 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -154.16 40.16 0.47 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.449 -1.407 . . . . 4.7800000000000002 111.445 179.79 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.538 ' CB ' ' HB2' ' A' ' 50' ' ' ALA . . . 32.27 31.71 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.173 0.511 . . . . 0.66000000000000003 111.894 176.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.562 ' N ' ' O ' ' A' ' 71' ' ' ASN . 16.6 t -98.0 -21.34 16.87 Favored 'General case' 0 C--N 1.293 -1.857 0 O-C-N 121.142 -0.974 . . . . 0.90000000000000002 111.256 -178.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.501 ' HB2' ' CG ' ' A' ' 69' ' ' ASP . 11.4 t-160 -71.57 -25.89 62.39 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.898 -1.126 . . . . 2.0499999999999998 111.434 -178.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.518 ' HB2' HD13 ' A' ' 88' ' ' ILE . 8.2 m-85 -95.62 -29.47 14.31 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.533 -1.354 . . . . 2.5600000000000001 111.375 -178.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.707 ' CG2' ' CE2' ' A' ' 86' ' ' TYR . 3.3 m -148.37 -149.46 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.915 -1.116 . . . . 3.8199999999999998 111.259 -177.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.532 ' N ' ' CG2' ' A' ' 76' ' ' VAL . 0.1 OUTLIER -85.49 105.37 16.05 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.727 -0.842 . . . . 4.1900000000000004 108.727 179.445 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . 0.585 ' N ' ' HD2' ' A' ' 79' ' ' PRO . 0.1 OUTLIER -47.78 -44.62 58.02 Favored Pre-proline 0 N--CA 1.493 1.722 0 C-N-CA 118.277 -1.369 . . . . 1.1100000000000001 109.066 179.897 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.605 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 28.9 Cg_endo -72.78 104.1 1.69 Allowed 'Trans proline' 0 C--N 1.317 -1.125 0 N-CA-C 108.471 -1.396 . . . . 0.68999999999999995 108.471 177.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.624 HD21 ' CD2' ' A' ' 117' ' ' LEU . 0.2 OUTLIER -96.31 -64.49 1.05 Allowed 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 108.914 -0.773 . . . . 3.8599999999999999 108.914 -178.214 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.626 ' HA ' ' N ' ' A' ' 46' ' ' ASN . 24.5 t 53.54 177.68 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 C-N-CA 118.784 -1.166 . . . . 4.3499999999999996 108.748 177.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.561 ' HA ' ' O ' ' A' ' 43' ' ' ALA . 0.6 OUTLIER -96.52 31.01 2.38 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 120.797 -1.189 . . . . 3.4900000000000002 109.029 -179.315 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -132.49 27.4 3.56 Favored Glycine 0 C--N 1.289 -2.039 0 N-CA-C 108.14 -1.984 . . . . 0.95999999999999996 108.14 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.545 ' HG3' ' N ' ' A' ' 85' ' ' GLN . 9.0 tp-100 -142.39 159.55 42.0 Favored 'General case' 0 C--N 1.308 -1.229 0 O-C-N 121.486 -1.008 . . . . 1.7 108.37 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.562 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -154.53 137.28 15.27 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.452 -0.944 . . . . 3.0299999999999998 108.452 179.606 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.707 ' CE2' ' CG2' ' A' ' 76' ' ' VAL . 12.1 p90 -158.55 177.41 11.25 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 117.581 -1.648 . . . . 3.3399999999999999 111.386 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.602 ' CB ' ' HG ' ' A' ' 40' ' ' LEU . 8.9 p-10 -121.08 89.02 3.05 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 119.664 -0.815 . . . . 1.21 112.49 -177.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.58 ' CG2' ' N ' ' A' ' 89' ' ' LYS . 0.6 OUTLIER -59.05 -164.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 106.761 -1.57 . . . . 1.28 106.761 176.751 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.58 ' N ' ' CG2' ' A' ' 88' ' ' ILE . 0.2 OUTLIER 163.15 174.15 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.955 -1.091 . . . . 2.2599999999999998 110.725 179.286 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.636 ' CE2' ' CD1' ' A' ' 54' ' ' ILE . 13.6 m-85 -160.87 75.4 0.53 Allowed 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.524 -0.917 . . . . 1.0800000000000001 108.524 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.477 ' HB ' ' OG1' ' A' ' 36' ' ' THR . 1.6 p -74.36 -167.62 0.56 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.421 -0.799 . . . . 2.0499999999999998 110.151 -179.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.572 ' CE3' HD22 ' A' ' 58' ' ' LEU . 3.0 t90 -171.62 112.5 0.33 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.425 -0.797 . . . . 5.4500000000000002 110.065 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.534 ' O ' ' NE1' ' A' ' 92' ' ' TRP . 1.6 t30 -49.31 122.27 5.9 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 106.02 -1.845 . . . . 1.8600000000000001 106.02 177.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.622 ' CG1' ' CD1' ' A' ' 97' ' ' ILE . 60.6 t -123.28 101.51 37.85 Favored Pre-proline 0 C--N 1.301 -1.515 0 C-N-CA 117.888 -1.525 . . . . 2.5600000000000001 113.277 -176.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.57 ' HD2' ' CD1' ' A' ' 97' ' ' ILE . 31.4 Cg_endo -72.33 -149.36 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.806 2.338 . . . . 1.77 108.734 176.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -69.39 -49.48 54.97 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.443 -1.411 . . . . 4.04 108.098 178.514 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.622 ' CD1' ' CG1' ' A' ' 94' ' ' VAL . 2.8 mp 62.32 -2.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 113.227 0.825 . . . . 1.6399999999999999 113.227 177.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.593 ' CB ' ' HD2' ' A' ' 99' ' ' PRO . . . 57.53 178.31 0.04 OUTLIER Pre-proline 0 C--N 1.3 -1.568 0 O-C-N 119.942 -1.724 . . . . 0.38 108.49 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.593 ' HD2' ' CB ' ' A' ' 98' ' ' ALA . 52.9 Cg_endo -82.52 151.77 15.27 Favored 'Trans proline' 0 C--N 1.299 -2.06 0 C-N-CA 123.454 2.769 . . . . 0.56000000000000005 110.204 -178.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.611 ' CD ' ' O ' ' A' ' 127' ' ' ILE . 0.3 OUTLIER 55.02 115.27 0.01 OUTLIER 'General case' 0 C--N 1.288 -2.079 0 C-N-CA 119.403 -0.919 . . . . 3.3700000000000001 111.413 176.213 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.504 ' OG ' ' CD1' ' A' ' 127' ' ' ILE . 67.6 m -86.91 158.74 19.24 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.186 -0.946 . . . . 2.98 108.686 178.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.421 ' O ' ' HB2' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -50.29 -21.29 1.33 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.009 -1.057 . . . . 5.1699999999999999 109.582 -179.499 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.475 ' C ' ' CG2' ' A' ' 104' ' ' VAL . 15.4 t-20 -179.22 159.95 0.99 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.127 -0.983 . . . . 1.3 109.597 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.475 ' CG2' ' C ' ' A' ' 103' ' ' ASN . 0.9 OUTLIER -154.76 171.6 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.33 -0.856 . . . . 1.8700000000000001 110.003 179.793 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 56' ' ' ALA . 0.9 OUTLIER 170.61 147.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 108.019 -1.104 . . . . 1.3999999999999999 108.019 -179.863 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.455 ' HB ' ' HB1' ' A' ' 122' ' ' ALA . 1.5 t -143.56 137.42 25.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 120.331 -1.48 . . . . 1.96 110.29 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.5 ' O ' HG21 ' A' ' 108' ' ' VAL . 0.9 OUTLIER -167.88 148.98 5.24 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.159 -1.052 . . . . 1.46 108.159 179.691 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.512 HG12 HD12 ' A' ' 54' ' ' ILE . 2.7 t -157.19 163.6 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.848 -1.158 . . . . 1.8700000000000001 110.83 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.538 ' HG3' ' N ' ' A' ' 110' ' ' LEU . 0.3 OUTLIER -169.87 146.39 3.16 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.721 -0.844 . . . . 2.04 108.721 178.801 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.538 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 11.5 tp -139.03 126.45 21.64 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 106.774 -1.565 . . . . 1.8100000000000001 106.774 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.508 ' HB ' ' HB2' ' A' ' 51' ' ' LYS . 7.6 mt -134.24 120.02 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.214 -0.929 . . . . 1.3 111.586 -177.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.467 ' HA3' ' NE2' ' A' ' 45' ' ' GLN . . . -83.94 -108.37 0.57 Allowed Glycine 0 N--CA 1.486 2.016 0 N-CA-C 108.026 -2.03 . . . . 0.72999999999999998 108.026 177.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -145.62 7.87 1.13 Allowed 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.072 -1.252 . . . . 1.54 107.951 178.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.459 ' ND2' ' N ' ' A' ' 114' ' ' ASN . 0.5 OUTLIER -124.8 -17.35 5.9 Favored 'General case' 0 C--N 1.308 -1.196 0 O-C-N 121.466 -0.771 . . . . 1.48 109.922 -179.766 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 169.37 144.88 4.41 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.695 -1.362 . . . . 2.3500000000000001 109.695 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 111' ' ' ILE . 0.1 OUTLIER -53.35 111.16 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.174 -1.192 . . . . 1.1599999999999999 109.975 -179.644 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.624 ' CD2' HD21 ' A' ' 80' ' ' LEU . 10.7 mt -54.42 -51.66 64.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.633 -0.667 . . . . 2.5600000000000001 111.064 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.572 ' HA ' ' CA ' ' A' ' 9' ' ' ALA . . . -166.59 147.19 6.06 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.841 -1.162 . . . . 1.3300000000000001 111.269 -178.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . 0.525 ' SG ' ' N ' ' A' ' 120' ' ' ALA . 0.5 OUTLIER -139.89 178.31 7.34 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 109.026 -0.731 . . . . 1.6599999999999999 109.026 179.279 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.525 ' N ' ' SG ' ' A' ' 119' ' ' CYS . . . -179.12 125.93 0.09 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.097 -1.002 . . . . 1.0900000000000001 109.423 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.426 HD11 ' O ' ' A' ' 6' ' ' LYS . 1.0 OUTLIER -129.78 138.36 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.162 -0.961 . . . . 1.6000000000000001 109.799 -179.875 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.455 ' HB1' ' HB ' ' A' ' 106' ' ' VAL . . . -107.36 -23.27 12.28 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.213 -0.929 . . . . 2.77 109.321 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.453 ' O ' ' CB ' ' A' ' 124' ' ' HIS . 6.9 m 66.32 98.65 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.564 -0.71 . . . . 2.23 110.442 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . 0.453 ' CB ' ' O ' ' A' ' 123' ' ' THR . 0.0 OUTLIER 71.95 177.67 0.26 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.226 -0.921 . . . . 2.75 110.573 178.899 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -176.45 137.41 3.61 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.006 -1.638 . . . . 0.79000000000000004 109.006 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.495 ' O ' ' CG2' ' A' ' 28' ' ' ILE . 22.7 mtmt -144.0 95.94 2.81 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.959 -1.318 . . . . 4.5099999999999998 110.284 -179.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.611 ' O ' ' CD ' ' A' ' 100' ' ' LYS . 1.2 mp -58.32 143.44 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.151 -0.968 . . . . 1.25 109.41 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.59 ' CB ' ' O ' ' A' ' 127' ' ' ILE . 13.7 ttt-85 149.45 -94.68 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 108.557 -0.905 . . . . 3.1499999999999999 108.557 178.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.526 ' N ' ' HG2' ' A' ' 128' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.497 1.875 0 CA-C-O 117.984 -1.008 . . . . 4.5499999999999998 110.247 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.1 p30 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.418 0.628 . . . . 3.9500000000000002 109.713 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.522 ' HB3' ' HG2' ' A' ' 17' ' ' MET . 1.4 pt20 -117.4 -168.36 1.47 Allowed 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.369 -0.832 . . . . 2.1000000000000001 109.436 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.569 HG13 ' CA ' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -135.84 -173.4 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 108.53 -0.915 . . . . 1.3799999999999999 108.53 179.024 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.87 41.58 1.58 Allowed 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.203 -0.935 . . . . 1.01 109.057 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.9 m -54.02 161.9 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.372 -0.83 . . . . 1.22 109.408 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.47 ' O ' ' C ' ' A' ' 7' ' ' ASP . 11.2 mmtm -87.61 52.44 2.49 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.151 -0.968 . . . . 3.54 109.574 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.47 ' C ' ' O ' ' A' ' 6' ' ' LYS . 5.3 p30 -38.78 156.1 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 109.327 -0.62 . . . . 1.46 109.327 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -153.08 34.35 0.47 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.986 -1.072 . . . . 1.4199999999999999 110.531 -179.253 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.528 ' HB3' ' HA ' ' A' ' 118' ' ' ALA . . . -69.59 -174.05 0.66 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.592 -1.317 . . . . 2.1200000000000001 109.048 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.583 ' O ' ' CB ' ' A' ' 11' ' ' ASN . 0.7 OUTLIER -54.56 -53.33 55.96 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 108.342 -0.985 . . . . 2.9900000000000002 108.342 178.174 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.583 ' CB ' ' O ' ' A' ' 10' ' ' ASN . 12.3 p30 147.19 40.88 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.036 -1.098 . . . . 8.1400000000000006 108.036 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.456 ' HB2' ' OD2' ' A' ' 42' ' ' ASP . 7.2 mt-10 -147.33 8.3 0.91 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.178 -0.951 . . . . 2.6800000000000002 110.654 -178.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.514 ' HA ' ' HA ' ' A' ' 41' ' ' PHE . 36.1 mt -44.59 148.35 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.891 -1.13 . . . . 0.70999999999999996 108.798 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.467 ' N ' HG21 ' A' ' 13' ' ' ILE . 0.2 OUTLIER -97.82 -19.33 18.21 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.423 -0.798 . . . . 2.9100000000000001 109.462 -179.582 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.444 ' HB2' ' HE2' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -172.65 134.95 0.65 Allowed 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 118.725 -1.19 . . . . 1.29 110.631 -177.854 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.52 ' O ' ' CG1' ' A' ' 16' ' ' VAL . 0.9 OUTLIER -139.02 104.26 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 107.246 -1.39 . . . . 2.8599999999999999 107.246 179.158 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.522 ' HG2' ' HB3' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -149.46 140.73 23.15 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 118.901 -1.12 . . . . 1.99 111.234 -177.805 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.52 ' CG2' ' HA ' ' A' ' 37' ' ' LEU . 39.6 t -118.2 132.53 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 108.236 -1.024 . . . . 2.4399999999999999 108.236 178.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -76.84 79.65 3.43 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.193 -0.942 . . . . 1.6100000000000001 110.213 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.553 ' O ' ' CB ' ' A' ' 21' ' ' CYS . . . 87.9 121.98 1.72 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 110.014 -1.234 . . . . 0.75 110.014 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.553 ' CB ' ' O ' ' A' ' 20' ' ' GLY . 0.0 OUTLIER 157.24 -41.46 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.629 -0.924 . . . . 0.37 109.298 179.319 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.569 ' CA ' HG13 ' A' ' 3' ' ' VAL . 0.9 OUTLIER 80.73 122.69 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.293 -0.879 . . . . 1.47 110.248 -179.547 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.472 ' O ' ' HB3' ' A' ' 24' ' ' SER . . . -96.85 178.74 33.75 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.622 -1.391 . . . . 0.53000000000000003 109.622 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.505 ' O ' ' O ' ' A' ' 25' ' ' ASP . 27.7 t 63.63 -91.32 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.223 -1.163 . . . . 1.6799999999999999 110.217 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.618 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.1 OUTLIER -50.18 -175.33 0.01 OUTLIER Pre-proline 0 C--N 1.305 -1.369 0 N-CA-C 108.83 -0.804 . . . . 0.45000000000000001 108.83 179.681 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.618 ' HD2' ' CB ' ' A' ' 25' ' ' ASP . 28.4 Cg_endo -70.14 84.8 0.7 Allowed 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 121.462 1.442 . . . . 0.58999999999999997 108.552 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 22' ' ' HIS . 0.9 OUTLIER -28.54 95.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 115.325 -0.852 . . . . 0.28000000000000003 112.453 -178.039 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.534 ' O ' ' O ' ' A' ' 21' ' ' CYS . 23.3 mm -90.92 137.6 21.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 105.289 -2.115 . . . . 0.54000000000000004 105.289 175.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.539 ' CG2' ' HA ' ' A' ' 21' ' ' CYS . 0.2 OUTLIER -119.69 177.69 2.79 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 O-C-N 120.553 -1.342 . . . . 0.37 112.898 -175.556 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 51.2 m-70 -112.37 158.13 20.18 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.916 0.865 . . . . 1.5 110.817 -179.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.538 ' CB ' ' O ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -111.3 141.32 44.99 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.123 -1.066 . . . . 4.2599999999999998 108.123 178.408 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.446 ' HA2' ' O ' ' A' ' 95' ' ' PRO . . . 101.11 3.34 54.48 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.469 -1.452 . . . . 0.67000000000000004 109.469 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.599 ' N ' HG13 ' A' ' 94' ' ' VAL . 1.9 mtmt -133.87 144.51 52.04 Favored Pre-proline 0 C--N 1.305 -1.355 0 O-C-N 121.42 -1.047 . . . . 0.69999999999999996 108.328 179.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.411 ' HA ' ' HB ' ' A' ' 94' ' ' VAL . 28.5 Cg_endo -69.62 81.4 0.79 Allowed 'Trans proline' 0 C--N 1.301 -1.944 0 C-N-CA 122.346 2.031 . . . . 0.90000000000000002 111.175 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.585 ' O ' ' CD1' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -59.58 122.84 15.07 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.998 -1.112 . . . . 3.29 107.998 178.974 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.51 ' CG2' ' HA ' ' A' ' 91' ' ' THR . 88.0 m -141.19 91.83 2.43 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.11 -0.994 . . . . 1.8400000000000001 110.226 -178.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.52 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 1.2 pp -64.26 137.78 58.1 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.294 -0.879 . . . . 1.22 108.714 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.531 ' HG2' ' CG ' ' A' ' 89' ' ' LYS . 4.3 mt-10 -128.0 168.17 15.66 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.134 -0.979 . . . . 1.95 109.731 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.488 ' HB1' ' O ' ' A' ' 38' ' ' GLU . . . 176.83 74.01 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.984 0.897 . . . . 0.88 109.407 178.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.568 ' N ' HD11 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -67.76 169.98 8.72 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 109.529 -0.545 . . . . 0.70999999999999996 109.529 179.931 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.748 ' CE2' ' CD2' ' A' ' 86' ' ' TYR . 1.4 p90 -165.85 162.42 18.36 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.156 -0.965 . . . . 0.70999999999999996 108.674 177.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.456 ' OD2' ' HB2' ' A' ' 12' ' ' GLU . 4.3 p30 -120.03 115.93 24.72 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 122.037 0.923 . . . . 4.9500000000000002 109.022 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.58 ' CB ' ' O ' ' A' ' 81' ' ' VAL . . . -42.2 115.43 0.68 Allowed 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 108.854 -0.795 . . . . 0.37 108.854 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.4 ' OD1' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -124.31 -0.87 8.2 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.364 -0.835 . . . . 1.0 109.968 -178.608 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.616 ' O ' ' N ' ' A' ' 82' ' ' LYS . 2.5 pt20 -92.59 -142.63 0.21 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.384 -0.822 . . . . 0.72999999999999998 109.017 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.73 ' HA ' ' HB ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -155.62 71.41 0.76 Allowed 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.174 -0.954 . . . . 0.71999999999999997 109.561 179.002 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.51 ' O ' HG11 ' A' ' 81' ' ' VAL . 4.8 t -150.15 121.6 7.93 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 119.959 -1.713 . . . . 0.93000000000000005 111.123 -178.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.602 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 7.0 mtmt -68.63 -7.55 34.08 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.785 -1.197 . . . . 3.7200000000000002 109.186 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.438 ' OG1' ' OG1' ' A' ' 47' ' ' THR . 0.0 OUTLIER -87.85 158.88 18.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.176 -0.952 . . . . 1.95 109.492 -179.812 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.622 ' O ' ' CA ' ' A' ' 71' ' ' ASN . . . -151.66 135.08 16.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.369 -0.832 . . . . 1.02 108.882 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.578 ' O ' ' CB ' ' A' ' 72' ' ' ALA . 0.1 OUTLIER -117.64 -158.99 0.73 Allowed 'General case' 0 C--N 1.298 -1.662 0 O-C-N 120.564 -1.335 . . . . 3.1400000000000001 108.028 178.475 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.474 ' HB ' ' O ' ' A' ' 51' ' ' LYS . 1.5 tt -177.93 161.74 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 C-N-CA 118.647 -1.221 . . . . 0.90000000000000002 110.481 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.535 ' O ' ' CE ' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -160.33 40.0 0.17 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.804 -0.813 . . . . 0.54000000000000004 108.804 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.605 HG22 ' CZ ' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -72.77 148.01 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.138 -0.976 . . . . 0.40999999999999998 109.801 -179.656 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.597 ' HG3' ' O ' ' A' ' 54' ' ' ILE . 0.3 OUTLIER -163.19 94.62 0.82 Allowed 'General case' 0 C--N 1.287 -2.121 0 O-C-N 121.282 -0.886 . . . . 2.3100000000000001 109.005 178.515 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.511 ' O ' HG13 ' A' ' 63' ' ' ILE . . . -119.77 120.01 35.28 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 119.639 -0.824 . . . . 1.76 110.584 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.461 ' O ' HG11 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -101.47 124.62 47.44 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.012 -1.107 . . . . 1.23 108.012 178.572 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.59 HD22 ' CE3' ' A' ' 92' ' ' TRP . 0.0 OUTLIER -119.87 169.1 10.46 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.844 -1.16 . . . . 5.2699999999999996 110.109 -178.517 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.477 ' HB2' ' CB ' ' A' ' 101' ' ' SER . 67.4 t0 -77.79 80.4 4.25 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.546 -0.909 . . . . 4.9100000000000001 108.546 179.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.08 1.41 41.77 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 108.537 -1.825 . . . . 1.47 108.537 -178.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.536 ' HG ' ' CD1' ' A' ' 92' ' ' TRP . 0.4 OUTLIER -136.64 59.53 1.69 Allowed 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.027 -1.101 . . . . 1.71 108.027 179.397 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -69.11 81.87 0.33 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.714 -0.616 . . . . 1.4299999999999999 110.229 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.511 HG13 ' O ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -82.98 125.61 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 118.445 -1.302 . . . . 2.8799999999999999 108.682 178.895 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.462 ' O ' HG21 ' A' ' 65' ' ' VAL . 1.4 m-20 -128.58 164.42 22.88 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.699 -0.852 . . . . 1.49 108.699 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.604 ' HB ' ' O ' ' A' ' 54' ' ' ILE . 43.3 t -143.4 68.7 17.32 Favored Pre-proline 0 C--N 1.3 -1.551 0 O-C-N 121.01 -1.056 . . . . 0.83999999999999997 110.114 -179.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.512 ' HD2' ' CG1' ' A' ' 68' ' ' ILE . 36.4 Cg_endo -80.72 95.94 0.99 Allowed 'Trans proline' 0 C--N 1.301 -1.938 0 C-N-CA 123.063 2.509 . . . . 2.6699999999999999 110.264 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.499 ' C ' ' O ' ' A' ' 66' ' ' PRO . . . 33.53 50.08 0.54 Allowed Glycine 0 N--CA 1.497 2.702 0 N-CA-C 109.85 -1.3 . . . . 1.95 109.85 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.512 ' CG1' ' HD2' ' A' ' 66' ' ' PRO . 5.8 mt -76.08 -76.7 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.376 -1.073 . . . . 1.6799999999999999 109.842 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.568 ' HB3' ' HB2' ' A' ' 74' ' ' HIS . 15.1 p30 -59.26 157.62 10.46 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.329 -0.857 . . . . 1.27 109.262 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.464 ' O ' ' CG ' ' A' ' 71' ' ' ASN . 20.0 p -77.4 -20.2 54.99 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.843 -1.169 . . . . 1.76 107.843 178.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.622 ' CA ' ' O ' ' A' ' 50' ' ' ALA . 3.3 m120 -173.96 73.93 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.369 0.604 . . . . 3.6800000000000002 109.661 179.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.578 ' CB ' ' O ' ' A' ' 51' ' ' LYS . . . 38.85 26.59 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.547 -0.72 . . . . 0.73999999999999999 111.56 177.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.517 ' SG ' ' N ' ' A' ' 78' ' ' CYS . 2.4 t -100.85 -17.77 16.71 Favored 'General case' 0 C--N 1.29 -2.013 0 O-C-N 121.151 -0.968 . . . . 1.3600000000000001 110.433 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.568 ' HB2' ' HB3' ' A' ' 69' ' ' ASP . 3.1 t-80 -61.23 -28.97 69.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.801 -1.187 . . . . 2.9900000000000002 109.829 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -99.74 -54.83 2.81 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.696 -1.253 . . . . 2.6800000000000002 110.319 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.706 ' CG2' ' CZ ' ' A' ' 86' ' ' TYR . 8.3 m -108.67 -145.52 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 CA-C-O 121.775 0.798 . . . . 3.9100000000000001 109.186 -178.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.527 ' N ' ' CG2' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -93.1 167.68 11.62 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.124 -1.436 . . . . 4.5 107.124 177.629 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . 0.59 ' N ' ' CD ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -91.36 -43.76 0.38 Allowed Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 120.476 -1.39 . . . . 1.77 110.469 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.602 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 31.0 Cg_endo -78.65 117.02 3.89 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 121.211 1.274 . . . . 1.1100000000000001 109.385 178.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.637 HD12 ' CZ ' ' A' ' 86' ' ' TYR . 0.1 OUTLIER -97.11 -68.12 0.81 Allowed 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.375 -0.972 . . . . 1.4199999999999999 108.375 -179.074 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.73 ' HB ' ' HA ' ' A' ' 46' ' ' ASN . 1.1 m 40.9 -168.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 116.051 -0.522 . . . . 0.58999999999999997 109.812 178.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.616 ' N ' ' O ' ' A' ' 45' ' ' GLN . 0.0 OUTLIER -99.22 41.13 1.16 Allowed 'General case' 0 C--N 1.295 -1.803 0 O-C-N 120.378 -1.451 . . . . 1.78 109.972 -177.649 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -143.94 39.73 1.24 Allowed Glycine 0 C--N 1.293 -1.812 0 N-CA-C 109.95 -1.26 . . . . 0.76000000000000001 109.95 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.443 ' NE2' ' HA ' ' A' ' 84' ' ' GLN . 7.8 tp-100 -158.88 154.12 25.5 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.93 -1.335 . . . . 2.2999999999999998 110.001 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -111.85 160.44 17.37 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.65 -0.87 . . . . 3.1200000000000001 108.65 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.748 ' CD2' ' CE2' ' A' ' 41' ' ' PHE . 0.9 OUTLIER -127.45 -170.25 2.19 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.798 -1.189 . . . . 4.3899999999999997 110.546 -179.005 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.53 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 3.2 p30 174.68 39.12 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.65 -0.87 . . . . 1.97 108.65 178.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.534 ' O ' ' CB ' ' A' ' 89' ' ' LYS . 0.4 OUTLIER -53.01 -170.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.867 -0.79 . . . . 1.5700000000000001 108.867 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.596 ' O ' ' CG ' ' A' ' 90' ' ' TYR . 0.2 OUTLIER 165.81 -179.32 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 119.07 -1.052 . . . . 2.1699999999999999 110.442 -179.323 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.605 ' CZ ' HG22 ' A' ' 54' ' ' ILE . 31.1 m-85 -167.35 93.62 0.43 Allowed 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.122 -1.066 . . . . 1.0600000000000001 108.122 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.51 ' HA ' ' CG2' ' A' ' 36' ' ' THR . 0.6 OUTLIER -87.17 -162.86 0.84 Allowed 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.773 0.797 . . . . 1.8200000000000001 110.959 -178.183 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.59 ' CE3' HD22 ' A' ' 58' ' ' LEU . 7.1 t90 -175.18 90.48 0.05 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.531 -0.731 . . . . 5.2599999999999998 109.599 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.461 ' C ' ' O ' ' A' ' 92' ' ' TRP . 3.1 t-20 -45.48 108.76 0.14 Allowed 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 106.8 -1.555 . . . . 1.9199999999999999 106.8 178.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.599 HG13 ' N ' ' A' ' 33' ' ' LYS . 2.4 t -104.58 116.21 61.47 Favored Pre-proline 0 C--N 1.301 -1.508 0 C-N-CA 118.854 -1.139 . . . . 0.94999999999999996 113.128 -176.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.539 ' HD2' ' CD1' ' A' ' 97' ' ' ILE . 33.4 Cg_endo -81.08 -86.12 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 123.206 2.604 . . . . 0.56000000000000005 108.538 176.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.538 ' O ' ' CB ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -135.7 -56.14 0.78 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 105.679 -1.971 . . . . 3.1099999999999999 105.679 177.766 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.591 ' CD1' HG11 ' A' ' 94' ' ' VAL . 1.5 mp 67.91 7.32 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 113.203 0.816 . . . . 0.80000000000000004 113.203 175.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.593 ' CB ' ' HD2' ' A' ' 99' ' ' PRO . . . 52.96 177.87 0.03 OUTLIER Pre-proline 0 C--N 1.302 -1.482 0 O-C-N 120.241 -1.537 . . . . 0.65000000000000002 109.626 179.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.593 ' HD2' ' CB ' ' A' ' 98' ' ' ALA . 51.8 Cg_endo -83.59 152.78 13.46 Favored 'Trans proline' 0 C--N 1.303 -1.867 0 C-N-CA 123.751 2.968 . . . . 0.90000000000000002 110.086 -179.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.638 ' HD3' ' CB ' ' A' ' 128' ' ' ARG . 1.7 mmmp? 55.98 127.35 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.97 0 C-N-CA 119.683 -0.807 . . . . 1.3200000000000001 111.674 176.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.477 ' CB ' ' HB2' ' A' ' 59' ' ' ASP . 12.3 t -97.67 154.6 17.46 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.196 -0.94 . . . . 1.02 108.595 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.438 ' O ' ' CB ' ' A' ' 103' ' ' ASN . 76.1 mt-10 -48.85 -22.45 0.83 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.118 -0.989 . . . . 1.7 109.624 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.438 ' CB ' ' O ' ' A' ' 102' ' ' GLU . 0.4 OUTLIER 165.02 152.0 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.036 -1.098 . . . . 3.2999999999999998 108.036 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.461 HG11 ' O ' ' A' ' 57' ' ' SER . 0.1 OUTLIER -142.76 153.76 17.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 120.814 -1.179 . . . . 0.93000000000000005 110.949 -178.944 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.427 ' CG2' ' O ' ' A' ' 104' ' ' VAL . 25.4 t -157.64 104.04 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 107.561 -1.274 . . . . 1.95 107.561 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.45 ' HB ' ' CB ' ' A' ' 122' ' ' ALA . 15.7 t -103.55 111.06 31.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 120.988 -1.07 . . . . 0.92000000000000004 109.484 -178.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.431 ' HB ' ' HE2' ' A' ' 55' ' ' LYS . 0.2 OUTLIER -129.98 175.27 9.02 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 120.877 -1.139 . . . . 1.21 108.269 179.269 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.557 ' CG1' ' N ' ' A' ' 109' ' ' LYS . 1.2 t 175.07 168.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 C-N-CA 118.835 -1.146 . . . . 0.95999999999999996 110.318 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.557 ' N ' ' CG1' ' A' ' 108' ' ' VAL . 1.1 ttpt 162.94 134.63 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.838 0.828 . . . . 1.9299999999999999 109.67 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.633 HD21 ' CE2' ' A' ' 41' ' ' PHE . 9.4 tp -113.22 130.04 56.34 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 106.873 -1.528 . . . . 1.4399999999999999 106.873 178.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.452 ' HB ' ' HB2' ' A' ' 51' ' ' LYS . 9.4 mt -127.25 120.12 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.154 -0.966 . . . . 0.93999999999999995 111.737 -177.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -92.4 -114.25 2.11 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 108.812 -1.715 . . . . 0.82999999999999996 108.812 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -138.21 1.94 2.26 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.044 -1.268 . . . . 1.6200000000000001 108.004 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -112.58 -39.31 4.38 Favored 'General case' 0 C--N 1.31 -1.129 0 O-C-N 121.415 -0.803 . . . . 0.75 109.048 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -177.38 155.38 17.65 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.07 -1.612 . . . . 1.54 109.07 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.533 ' CG2' ' O ' ' A' ' 118' ' ' ALA . 0.2 OUTLIER -50.18 111.88 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.167 -1.196 . . . . 1.5800000000000001 109.82 -179.647 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.544 ' CD2' HD13 ' A' ' 80' ' ' LEU . 1.4 mt -57.49 -62.89 1.46 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.294 -0.879 . . . . 0.85999999999999999 109.666 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.533 ' O ' ' CG2' ' A' ' 116' ' ' VAL . . . -123.97 -175.26 3.19 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.13 -0.981 . . . . 0.48999999999999999 110.083 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . 0.521 ' HA ' ' HA ' ' A' ' 109' ' ' LYS . 1.9 t 172.37 150.51 0.06 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.155 -0.966 . . . . 0.84999999999999998 110.15 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.445 ' C ' HG13 ' A' ' 121' ' ' ILE . . . -170.02 130.98 1.0 Allowed 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.79 -0.818 . . . . 1.0800000000000001 108.79 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.445 HG13 ' C ' ' A' ' 120' ' ' ALA . 2.8 mt -134.15 139.47 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.177 -0.952 . . . . 0.66000000000000003 110.075 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.45 ' CB ' ' HB ' ' A' ' 106' ' ' VAL . . . -106.77 -17.92 14.08 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.487 -0.931 . . . . 2.0800000000000001 108.487 179.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 58.51 89.08 0.06 Allowed 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 121.519 0.676 . . . . 2.5800000000000001 110.196 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 61.9 -160.93 0.3 Allowed 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.724 0.773 . . . . 4.6600000000000001 110.378 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 153.91 150.61 5.52 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.346 -1.902 . . . . 1.1100000000000001 108.346 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 69.0 mttt -140.38 96.56 3.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.95 -1.323 . . . . 2.2999999999999998 109.987 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.645 ' O ' ' CB ' ' A' ' 128' ' ' ARG . 2.1 mp -46.05 152.43 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.649 -0.657 . . . . 0.80000000000000004 109.843 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.645 ' CB ' ' O ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER 141.79 -77.3 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.692 0.758 . . . . 0.96999999999999997 109.132 178.823 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.557 ' N ' ' CD ' ' A' ' 128' ' ' ARG . 0.4 OUTLIER . . . . . 0 C--N 1.301 -1.533 0 CA-C-O 118.017 -0.992 . . . . 4.2300000000000004 109.63 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.478 ' O ' ' O ' ' A' ' 2' ' ' GLN . 65.7 m-20 . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.5 0.667 . . . . 4.8099999999999996 109.804 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.534 ' HA ' ' HB3' ' A' ' 17' ' ' MET . 93.6 mt-30 47.91 179.08 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 122.158 0.98 . . . . 3.8399999999999999 110.999 178.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.648 HG21 ' HA ' ' A' ' 22' ' ' HIS . 2.2 p -162.72 -149.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 108.642 -0.873 . . . . 5.2699999999999996 108.642 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.56 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 32.2 t0 -163.73 54.74 0.16 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.652 -1.28 . . . . 2.3700000000000001 110.222 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.4 m -89.12 152.39 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.031 -1.043 . . . . 1.6499999999999999 109.83 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.48 95.57 3.31 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.319 -0.863 . . . . 4.5800000000000001 109.238 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -89.88 173.97 7.95 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.358 -0.839 . . . . 1.47 109.582 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.487 ' N ' ' SG ' ' A' ' 119' ' ' CYS . 24.8 p -164.76 47.79 0.1 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.258 -0.901 . . . . 2.3999999999999999 109.696 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.554 ' O ' ' CB ' ' A' ' 10' ' ' ASN . . . -76.4 -67.31 0.7 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.304 -0.873 . . . . 0.57999999999999996 109.244 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.554 ' CB ' ' O ' ' A' ' 9' ' ' ALA . 0.7 OUTLIER 160.37 39.5 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.487 -0.931 . . . . 1.21 108.487 -178.285 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 54.4 t30 55.87 21.67 5.03 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.316 -0.994 . . . . 2.04 108.316 -178.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -104.48 -22.18 13.34 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.21 -0.663 . . . . 3.46 109.21 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.541 ' CG2' ' O ' ' A' ' 40' ' ' LEU . 3.8 mt -52.03 143.16 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.073 -1.017 . . . . 1.1299999999999999 108.925 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.428 ' N ' HG21 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -104.89 -22.7 13.11 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.351 -0.843 . . . . 3.2799999999999998 109.223 179.724 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -168.75 108.95 0.49 Allowed 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 118.426 -1.31 . . . . 3.2799999999999998 111.595 -178.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.5 ' HA ' ' HA ' ' A' ' 39' ' ' ALA . 3.2 p -118.12 94.09 2.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 N-CA-C 106.819 -1.549 . . . . 1.03 106.819 177.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.534 ' HB3' ' HA ' ' A' ' 2' ' ' GLN . 7.0 mmt -134.87 118.32 16.83 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.487 -0.885 . . . . 2.6299999999999999 111.356 -177.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.459 HG22 HG13 ' A' ' 3' ' ' VAL . 11.2 t -85.86 126.25 40.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 107.171 -1.418 . . . . 2.0899999999999999 107.171 177.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.564 ' HB3' ' CB ' ' A' ' 35' ' ' PHE . 2.0 t0 -45.8 -22.17 0.17 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.071 -1.018 . . . . 2.3500000000000001 110.396 -178.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.565 ' O ' ' CB ' ' A' ' 21' ' ' CYS . . . -177.82 135.32 2.68 Favored Glycine 0 N--CA 1.49 2.299 0 C-N-CA 118.947 -1.597 . . . . 3.0600000000000001 110.857 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.578 ' HA ' ' CG2' ' A' ' 29' ' ' ILE . 0.0 OUTLIER 153.12 -37.0 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.881 -0.776 . . . . 1.1399999999999999 109.614 178.671 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.648 ' HA ' HG21 ' A' ' 3' ' ' VAL . 42.6 t-80 53.76 102.85 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.78 -1.2 . . . . 4.3600000000000003 109.362 -179.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.523 ' O ' ' CB ' ' A' ' 24' ' ' SER . . . -90.03 -147.18 16.73 Favored Glycine 0 N--CA 1.499 2.867 0 O-C-N 121.044 -1.035 . . . . 1.8400000000000001 111.407 -178.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.525 ' N ' ' O ' ' A' ' 4' ' ' ASP . 0.1 OUTLIER 80.92 -77.9 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.626 -0.926 . . . . 1.26 108.667 -178.986 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.656 ' HB2' ' CD ' ' A' ' 26' ' ' PRO . 7.4 p30 -86.17 -152.84 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.51 0 N-CA-C 105.727 -1.953 . . . . 1.8400000000000001 105.727 178.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.656 ' CD ' ' HB2' ' A' ' 25' ' ' ASP . 28.7 Cg_endo -72.99 91.72 0.82 Allowed 'Trans proline' 0 C--N 1.319 -1.016 0 N-CA-C 108.395 -1.425 . . . . 0.48999999999999999 108.395 179.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.632 ' HA ' ' O ' ' A' ' 22' ' ' HIS . 0.3 OUTLIER -34.36 101.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.559 0.695 . . . . 0.40999999999999998 112.036 -177.202 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.528 ' O ' ' O ' ' A' ' 21' ' ' CYS . 28.4 mm -97.05 135.82 29.91 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 106.829 -1.545 . . . . 0.60999999999999999 106.829 176.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.578 ' CG2' ' HA ' ' A' ' 21' ' ' CYS . 0.5 OUTLIER -122.87 -166.77 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 O-C-N 121.005 -1.06 . . . . 1.52 111.676 -177.468 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.61 ' N ' ' CD2' ' A' ' 30' ' ' HIS . 0.0 OUTLIER -123.77 168.67 12.41 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 115.863 -0.608 . . . . 3.1099999999999999 109.446 179.628 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.534 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -115.6 -163.96 0.92 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.089 -1.007 . . . . 2.0 109.453 179.43 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 31' ' ' ARG . . . 39.19 44.62 2.17 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.902 -1.279 . . . . 1.5700000000000001 109.902 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.474 ' C ' ' HB ' ' A' ' 94' ' ' VAL . 0.1 OUTLIER -172.08 109.7 0.37 Allowed Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.153 -1.204 . . . . 3.1200000000000001 109.577 -179.742 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.557 ' HA ' ' HB ' ' A' ' 94' ' ' VAL . 29.3 Cg_endo -70.37 115.5 4.21 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.821 2.348 . . . . 4.0599999999999996 110.949 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.564 ' CB ' ' HB3' ' A' ' 19' ' ' ASP . 22.5 m-85 -100.13 -157.41 0.6 Allowed 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.773 -0.825 . . . . 9.1500000000000004 108.773 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.533 ' O ' ' HG3' ' A' ' 38' ' ' GLU . 1.8 m -175.63 102.22 0.07 Allowed 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.368 -0.833 . . . . 1.4399999999999999 108.768 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.416 ' O ' ' CG ' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -52.2 153.25 2.88 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.235 -1.024 . . . . 4.9199999999999999 108.235 179.8 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.533 ' HG3' ' O ' ' A' ' 36' ' ' THR . 63.0 mt-10 -154.38 166.75 32.24 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.791 -1.193 . . . . 0.69999999999999996 110.96 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.5 ' HA ' ' HA ' ' A' ' 16' ' ' VAL . . . 168.18 96.6 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.58 -0.896 . . . . 0.55000000000000004 108.58 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.57 ' HG ' ' HA ' ' A' ' 87' ' ' ASP . 0.5 OUTLIER -90.12 154.82 19.49 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.394 -0.595 . . . . 1.3500000000000001 109.394 -179.517 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.762 ' CE2' ' CD2' ' A' ' 86' ' ' TYR . 0.2 OUTLIER -152.52 169.87 21.56 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.056 -1.027 . . . . 0.78000000000000003 109.349 178.41 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.463 ' OD2' ' OE1' ' A' ' 85' ' ' GLN . 6.7 t0 -119.46 112.45 19.41 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 122.195 0.998 . . . . 1.5 109.206 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.56 ' CB ' ' O ' ' A' ' 81' ' ' VAL . . . -42.28 116.39 0.83 Allowed 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 115.431 -0.804 . . . . 0.73999999999999999 109.198 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.473 ' O ' ' HB3' ' A' ' 82' ' ' LYS . 11.3 p30 -126.17 -0.1 7.11 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.243 -0.911 . . . . 4.4000000000000004 109.731 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.595 ' O ' ' N ' ' A' ' 82' ' ' LYS . 3.1 pt20 -90.68 -137.61 0.14 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.413 -0.805 . . . . 0.68999999999999995 109.01 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.762 ' HA ' ' HB ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -159.23 68.87 0.44 Allowed 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 119.59 -0.844 . . . . 1.8 109.637 179.215 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.522 ' CG2' ' OE1' ' A' ' 45' ' ' GLN . 3.5 t -145.25 120.01 9.88 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.045 -1.659 . . . . 1.3700000000000001 110.764 -178.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.622 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 0.2 OUTLIER -68.74 -5.53 21.09 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.841 -1.162 . . . . 2.54 109.075 178.553 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.0 p -98.79 -177.6 3.7 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.058 -1.026 . . . . 1.6599999999999999 109.893 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.552 ' O ' ' CA ' ' A' ' 71' ' ' ASN . . . -163.94 145.62 9.01 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.442 -0.948 . . . . 0.64000000000000001 108.442 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 16.6 mtmt -138.36 91.97 2.6 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 122.964 1.364 . . . . 3.1000000000000001 109.506 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.487 HG13 HD12 ' A' ' 54' ' ' ILE . 1.2 tt -67.98 158.15 5.85 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.474 0 CA-C-N 114.063 -1.426 . . . . 2.73 110.086 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -150.93 49.16 0.85 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.33 -0.857 . . . . 2.27 109.127 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.61 ' CG1' ' CE2' ' A' ' 90' ' ' TYR . 0.2 OUTLIER -75.64 159.49 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.42 -0.8 . . . . 0.93999999999999995 108.925 -179.869 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.549 ' HD3' ' O ' ' A' ' 54' ' ' ILE . 0.4 OUTLIER -166.13 29.71 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.178 -1.009 . . . . 2.29 110.774 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.563 ' CB ' HG22 ' A' ' 63' ' ' ILE . . . -66.7 159.04 28.63 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 108.809 -0.811 . . . . 2.8900000000000001 108.809 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.15 130.08 24.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.032 -1.043 . . . . 1.23 109.736 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.569 ' CD1' ' N ' ' A' ' 59' ' ' ASP . 2.5 tm? -119.91 154.92 33.69 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.212 -0.93 . . . . 1.71 108.78 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.569 ' N ' ' CD1' ' A' ' 58' ' ' LEU . 5.6 t70 -76.93 79.24 3.49 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 107.818 -1.179 . . . . 3.9100000000000001 107.818 178.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.432 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 125.8 -5.83 7.92 Favored Glycine 0 N--CA 1.485 1.91 0 N-CA-C 108.787 -1.725 . . . . 2.2000000000000002 108.787 -178.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.471 ' O ' ' N ' ' A' ' 63' ' ' ILE . 0.4 OUTLIER -141.86 53.48 1.49 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.238 -1.154 . . . . 1.4199999999999999 109.263 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 61' ' ' LEU . 36.1 mm-40 -41.18 97.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.544 -0.722 . . . . 3.0699999999999998 109.625 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.563 HG22 ' CB ' ' A' ' 56' ' ' ALA . 0.3 OUTLIER -75.09 -2.93 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 CA-C-O 121.952 0.882 . . . . 3.1299999999999999 110.133 -179.986 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.462 ' C ' ' O ' ' A' ' 63' ' ' ILE . 0.6 OUTLIER -40.03 140.13 0.61 Allowed 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 108.925 -0.768 . . . . 3.2999999999999998 108.925 179.317 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.53 HG23 ' HB ' ' A' ' 54' ' ' ILE . 98.8 t -123.0 86.2 50.92 Favored Pre-proline 0 C--N 1.301 -1.533 0 O-C-N 121.168 -0.957 . . . . 1.96 110.556 -178.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.465 ' O ' ' C ' ' A' ' 67' ' ' GLY . 35.7 Cg_endo -79.29 89.34 1.36 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.791 2.327 . . . . 3.7200000000000002 110.422 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.465 ' C ' ' O ' ' A' ' 66' ' ' PRO . . . 37.14 68.94 0.31 Allowed Glycine 0 N--CA 1.495 2.585 0 N-CA-C 110.117 -1.193 . . . . 1.3300000000000001 110.117 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 21.2 mt -83.94 -78.03 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.13 -1.217 . . . . 3.1099999999999999 109.613 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.469 ' OD2' ' CE1' ' A' ' 75' ' ' PHE . 5.2 p30 -78.47 130.58 36.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.212 -0.93 . . . . 2.4500000000000002 109.233 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.516 ' O ' ' ND2' ' A' ' 71' ' ' ASN . 13.7 t -51.58 -23.02 3.72 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.09 -1.006 . . . . 3.79 109.715 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.552 ' CA ' ' O ' ' A' ' 50' ' ' ALA . 23.3 m-80 -168.32 76.05 0.12 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.953 -1.092 . . . . 1.73 111.225 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.455 ' CB ' ' HB2' ' A' ' 50' ' ' ALA . . . 32.02 33.75 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.283 0.563 . . . . 0.81999999999999995 111.921 176.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.535 ' N ' ' O ' ' A' ' 71' ' ' ASN . 31.0 t -109.79 21.64 16.66 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 121.179 -0.95 . . . . 1.1599999999999999 110.393 -179.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 17.6 t-160 -121.64 -18.26 7.22 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.374 -1.454 . . . . 2.8599999999999999 109.45 178.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.526 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 7.3 m-85 -104.67 -15.09 15.37 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -0.887 . . . . 2.8100000000000001 108.695 179.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.651 ' CG2' ' CE2' ' A' ' 86' ' ' TYR . 18.2 m -150.73 -153.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 N-CA-C 107.097 -1.445 . . . . 3.8500000000000001 107.097 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.483 ' O ' HG22 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -81.65 -177.65 6.63 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 106.287 -1.745 . . . . 4.0 106.287 176.325 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . 0.49 ' HB2' ' HD3' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -109.1 -51.87 0.07 OUTLIER Pre-proline 0 C--N 1.293 -1.86 0 O-C-N 120.64 -1.287 . . . . 2.0800000000000001 110.796 -179.559 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.622 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 29.6 Cg_endo -77.83 111.6 3.14 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 N-CA-C 108.506 -1.382 . . . . 1.0800000000000001 108.506 178.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.643 ' CD2' ' CE1' ' A' ' 86' ' ' TYR . 0.6 OUTLIER -93.6 -67.54 0.85 Allowed 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.622 -0.673 . . . . 3.9700000000000002 109.363 -178.1 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.762 ' HB ' ' HA ' ' A' ' 46' ' ' ASN . 1.4 m 40.8 -167.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 C-N-CA 120.46 -0.496 . . . . 0.63 110.072 177.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.595 ' N ' ' O ' ' A' ' 45' ' ' GLN . 0.0 OUTLIER -98.47 41.62 1.13 Allowed 'General case' 0 C--N 1.292 -1.91 0 O-C-N 120.629 -1.294 . . . . 1.6299999999999999 109.81 -177.45 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -150.68 46.4 0.62 Allowed Glycine 0 C--N 1.288 -2.123 0 N-CA-C 108.863 -1.695 . . . . 0.98999999999999999 108.863 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.5 ' OE1' ' O ' ' A' ' 85' ' ' GLN . 3.0 tp-100 -159.4 150.07 19.46 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.132 -1.217 . . . . 1.96 110.18 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.5 ' O ' ' OE1' ' A' ' 84' ' ' GLN . 0.0 OUTLIER -104.25 157.37 17.18 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.569 -1.271 . . . . 2.8599999999999999 107.569 178.412 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.762 ' CD2' ' CE2' ' A' ' 41' ' ' PHE . 0.4 OUTLIER -125.64 -167.65 1.72 Allowed 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.313 -1.492 . . . . 4.6799999999999997 111.592 -178.928 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.57 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER 170.98 38.44 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.409 -0.814 . . . . 3.2000000000000002 109.088 179.342 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.566 ' CD1' HG12 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -49.52 -178.01 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 108.256 -1.016 . . . . 1.0600000000000001 108.256 179.129 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.554 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 1.2 mtmt 170.5 164.56 0.07 Allowed 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 119.069 -1.052 . . . . 1.99 109.957 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.61 ' CE2' ' CG1' ' A' ' 54' ' ' ILE . 17.0 m-85 -150.58 91.21 1.71 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.467 -0.771 . . . . 1.1100000000000001 109.246 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.476 ' O ' ' O ' ' A' ' 90' ' ' TYR . 1.4 t -44.71 171.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.7 -0.625 . . . . 4.1200000000000001 109.612 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.476 ' O ' HG21 ' A' ' 94' ' ' VAL . 0.3 OUTLIER -146.36 92.53 2.19 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.147 -0.971 . . . . 4.8399999999999999 110.131 -179.938 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -65.43 112.43 3.54 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.126 -1.435 . . . . 4.5300000000000002 107.126 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.595 ' CG1' ' CD1' ' A' ' 97' ' ' ILE . 59.5 t -125.05 93.94 44.74 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 120.917 -1.115 . . . . 3.2200000000000002 112.451 -177.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.587 ' HD2' ' CD1' ' A' ' 97' ' ' ILE . 33.3 Cg_endo -73.65 -151.42 0.03 OUTLIER 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 122.105 1.87 . . . . 3.3199999999999998 108.26 176.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.534 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 2.7 mmtt -67.54 -32.61 73.51 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.215 -1.553 . . . . 3.6600000000000001 109.184 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.595 ' CD1' ' CG1' ' A' ' 94' ' ' VAL . 4.0 mt 42.39 15.87 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.125 -0.984 . . . . 2.2599999999999998 112.354 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.59 ' CB ' ' HD2' ' A' ' 99' ' ' PRO . . . 50.65 173.37 0.03 OUTLIER Pre-proline 0 C--N 1.307 -1.242 0 O-C-N 120.292 -1.505 . . . . 1.8300000000000001 109.93 179.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.708 ' O ' ' HB2' ' A' ' 100' ' ' LYS . 57.4 Cg_endo -81.66 76.29 4.43 Favored 'Trans proline' 0 C--N 1.296 -2.208 0 C-N-CA 123.163 2.575 . . . . 2.6200000000000001 108.418 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.708 ' HB2' ' O ' ' A' ' 99' ' ' PRO . 4.6 mmmm 119.2 127.11 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 123.8 0.687 . . . . 3.6299999999999999 109.751 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.512 ' O ' ' HB2' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -87.38 11.49 14.38 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.271 -0.893 . . . . 1.51 109.392 179.638 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.562 ' O ' ' CB ' ' A' ' 103' ' ' ASN . 2.1 mp0 67.63 -0.42 1.94 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.656 -0.652 . . . . 6.0999999999999996 109.906 -179.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.562 ' CB ' ' O ' ' A' ' 102' ' ' GLU . 3.3 t30 160.91 143.23 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.275 -0.89 . . . . 2.6499999999999999 109.928 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.522 ' N ' ' OD1' ' A' ' 103' ' ' ASN . 0.1 OUTLIER -159.9 158.67 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.423 -0.798 . . . . 1.1299999999999999 109.295 -179.772 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.2 t -149.33 131.22 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.042 -1.036 . . . . 1.55 109.66 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.541 ' HB ' ' CB ' ' A' ' 122' ' ' ALA . 10.5 t -119.87 130.3 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.135 -0.978 . . . . 2.2200000000000002 109.62 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.518 ' O ' ' CG2' ' A' ' 108' ' ' VAL . 0.3 OUTLIER -154.34 140.19 18.16 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.529 -0.915 . . . . 1.8799999999999999 108.529 179.711 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.541 HG12 ' CD1' ' A' ' 54' ' ' ILE . 34.7 t -158.49 151.14 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.872 -1.143 . . . . 2.0499999999999998 110.266 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 119' ' ' CYS . 6.7 ttpt -172.46 134.5 0.67 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.222 -0.924 . . . . 1.8400000000000001 110.284 178.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.59 HD21 ' CE2' ' A' ' 41' ' ' PHE . 9.8 tp -111.15 132.65 54.13 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 106.833 -1.543 . . . . 1.52 106.833 177.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.45 ' HB ' ' HB2' ' A' ' 51' ' ' LYS . 8.4 mt -133.71 113.78 19.04 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 O-C-N 121.128 -0.983 . . . . 1.3100000000000001 110.972 -177.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -76.88 -110.76 0.14 Allowed Glycine 0 N--CA 1.486 1.993 0 N-CA-C 107.944 -2.062 . . . . 0.65000000000000002 107.944 178.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -142.48 9.39 1.82 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.531 -1.285 . . . . 1.6299999999999999 107.531 178.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.498 ' OD1' ' NE2' ' A' ' 45' ' ' GLN . 0.3 OUTLIER -123.88 -31.86 3.35 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.693 0.759 . . . . 3.8999999999999999 109.362 -178.997 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -171.37 -142.87 3.81 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 108.708 -1.757 . . . . 0.76000000000000001 108.708 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.474 HG22 ' O ' ' A' ' 110' ' ' LEU . 2.4 p -114.87 131.83 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.087 -1.243 . . . . 1.1699999999999999 109.121 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.58 ' CD2' HD21 ' A' ' 80' ' ' LEU . 4.0 mt -78.85 -49.42 12.95 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.435 -0.791 . . . . 1.8100000000000001 109.78 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.509 ' HA ' ' HB3' ' A' ' 9' ' ' ALA . . . -161.4 130.61 4.61 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.302 -0.874 . . . . 2.0899999999999999 109.688 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 109' ' ' LYS . 16.4 p -129.19 -172.11 2.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.207 -0.933 . . . . 1.97 110.01 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 175.18 127.06 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.34 -0.85 . . . . 1.5700000000000001 109.206 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.2 mp -127.66 139.78 50.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.183 -0.948 . . . . 0.85999999999999999 110.385 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.541 ' CB ' ' HB ' ' A' ' 106' ' ' VAL . . . -144.71 33.32 1.15 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.061 -1.089 . . . . 1.0900000000000001 108.061 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.49 ' O ' ' O ' ' A' ' 122' ' ' ALA . 3.2 m -40.5 168.02 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.536 0.684 . . . . 5.0099999999999998 110.662 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 59.26 66.94 0.96 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.513 -0.742 . . . . 2.0 109.457 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.464 ' O ' HG21 ' A' ' 104' ' ' VAL . . . -94.86 147.2 18.51 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.313 -1.515 . . . . 1.27 109.313 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.507 ' HB3' ' HE3' ' A' ' 100' ' ' LYS . 7.6 mtmt -153.9 121.58 5.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.427 -1.043 . . . . 4.0999999999999996 108.509 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.545 ' O ' ' CD ' ' A' ' 100' ' ' LYS . 1.6 mp -90.37 118.39 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.11 -0.994 . . . . 1.26 112.102 -177.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.59 ' HB2' ' HG2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER 176.14 -62.22 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.771 -1.206 . . . . 3.8100000000000001 109.302 177.595 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.536 ' N ' ' HD3' ' A' ' 128' ' ' ARG . 6.9 t70 . . . . . 0 N--CA 1.494 1.74 0 CA-C-O 117.953 -1.023 . . . . 4.5599999999999996 109.339 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.484 ' O ' ' HB3' ' A' ' 17' ' ' MET . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.524 0.678 . . . . 5.04 109.643 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.5 ' HA ' ' HB3' ' A' ' 17' ' ' MET . 31.1 mt-30 -94.77 178.77 5.47 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.901 0.858 . . . . 4.2400000000000002 110.169 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.536 ' CG2' ' CG2' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -133.58 -169.2 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.035 -1.098 . . . . 2.29 108.035 179.494 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -117.88 52.76 0.98 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.909 -1.119 . . . . 1.0800000000000001 109.017 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 26.9 m -73.33 159.34 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.414 -0.804 . . . . 1.23 110.143 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.14 74.49 9.59 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.448 -0.782 . . . . 5.3499999999999996 109.278 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.505 ' OD1' ' N ' ' A' ' 8' ' ' CYS . 0.7 OUTLIER -75.22 -170.03 1.08 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.257 -0.902 . . . . 1.8600000000000001 109.55 -179.866 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.505 ' N ' ' OD1' ' A' ' 7' ' ' ASP . 16.6 p 179.25 33.76 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.112 -0.993 . . . . 2.3799999999999999 109.58 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.533 ' HB3' ' HA ' ' A' ' 118' ' ' ALA . . . -62.88 -58.66 6.62 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.296 -0.877 . . . . 0.76000000000000001 109.607 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.503 ' CB ' ' O ' ' A' ' 9' ' ' ALA . 1.7 m-80 166.59 36.73 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.612 -0.835 . . . . 4.7800000000000002 109.398 -178.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.8 t30 51.19 34.39 11.2 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.14 -0.975 . . . . 2.5899999999999999 108.716 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.483 ' HG2' ' OD1' ' A' ' 44' ' ' ASN . 6.6 tp10 -128.73 -21.85 3.35 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.366 -0.834 . . . . 4.5199999999999996 110.034 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.472 ' CG2' ' O ' ' A' ' 40' ' ' LEU . 5.9 mt -42.51 139.25 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.146 -0.971 . . . . 1.1799999999999999 108.931 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.446 ' HD2' ' OD1' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -100.59 -31.38 11.27 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-O 121.956 0.884 . . . . 2.1200000000000001 108.813 -179.783 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.08 120.09 12.07 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 119.909 -0.716 . . . . 2.7200000000000002 109.667 -178.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.468 ' C ' ' HG2' ' A' ' 17' ' ' MET . 11.3 p -136.82 118.12 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.272 -0.892 . . . . 1.4199999999999999 108.845 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.5 ' HB3' ' HA ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -156.05 173.41 16.84 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.426 -0.796 . . . . 6.1399999999999997 109.606 -179.258 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.55 ' HB ' ' HB3' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -132.55 9.54 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 O-C-N 121.085 -1.009 . . . . 3.9100000000000001 108.975 178.34 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.537 ' CB ' ' HA ' ' A' ' 35' ' ' PHE . 7.9 t70 77.55 58.54 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 112.551 0.575 . . . . 3.1000000000000001 112.551 178.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 29' ' ' ILE . . . 70.67 31.42 67.75 Favored Glycine 0 N--CA 1.499 2.876 0 O-C-N 120.777 -1.202 . . . . 2.6899999999999999 111.811 177.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.573 ' HA ' ' CG2' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -92.96 -19.44 21.6 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.889 -1.359 . . . . 2.6899999999999999 108.247 178.839 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.591 ' N ' ' CD2' ' A' ' 22' ' ' HIS . 4.2 m170 67.65 109.69 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.515 -0.741 . . . . 5.8700000000000001 109.447 -179.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 24' ' ' SER . . . -80.88 178.18 54.11 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 110.175 -1.17 . . . . 0.82999999999999996 110.175 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.468 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 41.0 t 62.3 151.73 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.351 -1.088 . . . . 2.6800000000000002 108.509 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.593 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.2 OUTLIER 59.6 179.92 0.04 OUTLIER Pre-proline 0 C--N 1.306 -1.302 0 N-CA-C 107.336 -1.357 . . . . 5.4900000000000002 107.336 -179.644 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.593 ' HD2' ' CB ' ' A' ' 25' ' ' ASP . 26.8 Cg_endo -70.78 83.74 0.86 Allowed 'Trans proline' 0 C--N 1.296 -2.228 0 C-N-CA 121.94 1.76 . . . . 1.0800000000000001 108.404 178.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.452 ' O ' ' HA2' ' A' ' 125' ' ' GLY . 0.0 OUTLIER -33.37 115.54 0.22 Allowed 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 115.422 -0.808 . . . . 0.71999999999999997 111.982 -178.009 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.522 ' O ' ' O ' ' A' ' 21' ' ' CYS . 25.2 mm -107.72 139.56 29.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 107.46 -1.311 . . . . 0.82999999999999996 107.46 176.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.573 ' CG2' ' HA ' ' A' ' 21' ' ' CYS . 0.7 OUTLIER -122.55 -175.57 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 O-C-N 120.981 -1.074 . . . . 1.1599999999999999 111.572 -177.442 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.508 ' O ' ' CE1' ' A' ' 35' ' ' PHE . 98.1 m-70 -111.92 -171.55 1.87 Allowed 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.528 0.68 . . . . 2.3399999999999999 110.366 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.564 ' CD ' ' O ' ' A' ' 98' ' ' ALA . 0.1 OUTLIER -130.39 -160.8 1.07 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.515 -0.74 . . . . 3.79 109.103 179.51 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.48 ' O ' ' HG3' ' A' ' 33' ' ' LYS . . . 40.23 34.86 0.66 Allowed Glycine 0 N--CA 1.495 2.581 0 N-CA-C 110.08 -1.208 . . . . 0.76000000000000001 110.08 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.692 ' O ' HG13 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -167.96 129.02 1.16 Allowed Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.277 -1.131 . . . . 5.2599999999999998 108.999 -179.921 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.485 ' HA ' ' HB ' ' A' ' 94' ' ' VAL . 20.3 Cg_endo -58.74 129.43 32.23 Favored 'Trans proline' 0 C--N 1.302 -1.883 0 C-N-CA 121.603 1.535 . . . . 2.21 109.869 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.592 ' HB2' ' CD1' ' A' ' 92' ' ' TRP . 19.9 m-85 -79.36 40.95 0.45 Allowed 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 116.234 -0.439 . . . . 8.5099999999999998 110.611 -178.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.482 ' C ' ' O ' ' A' ' 35' ' ' PHE . 24.4 m -35.01 91.45 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.534 -0.729 . . . . 2.1899999999999999 110.585 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -89.9 122.49 32.99 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.941 -1.133 . . . . 1.1399999999999999 107.941 179.264 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.538 ' HG2' ' HG2' ' A' ' 89' ' ' LYS . 55.9 mt-10 -121.29 177.57 5.12 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 120.818 -1.176 . . . . 1.0 111.092 -178.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.518 ' O ' ' CD1' ' A' ' 41' ' ' PHE . . . 177.05 63.96 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 106.683 -1.599 . . . . 0.98999999999999999 106.683 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.622 ' HG ' ' CB ' ' A' ' 87' ' ' ASP . 0.6 OUTLIER -69.83 168.24 15.55 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 115.337 -0.847 . . . . 0.95999999999999996 110.31 -178.281 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.658 ' CE2' ' CE2' ' A' ' 86' ' ' TYR . 6.3 p90 -178.73 146.97 0.36 Allowed 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.299 -0.875 . . . . 0.44 109.229 179.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.589 ' O ' ' C ' ' A' ' 43' ' ' ALA . 0.4 OUTLIER -94.44 98.22 10.72 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 106.314 -1.735 . . . . 4.8700000000000001 106.314 177.664 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.589 ' C ' ' O ' ' A' ' 42' ' ' ASP . . . -17.83 122.38 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 115.38 -0.827 . . . . 1.21 110.722 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.483 ' OD1' ' HG2' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -118.97 30.74 7.01 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.317 -0.865 . . . . 2.3799999999999999 111.017 -177.866 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.666 ' O ' ' N ' ' A' ' 82' ' ' LYS . 2.0 pt20 -126.59 -142.15 0.28 Allowed 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.988 -1.115 . . . . 0.59999999999999998 107.988 179.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.729 ' HA ' ' HB ' ' A' ' 81' ' ' VAL . 0.1 OUTLIER -154.04 68.31 0.75 Allowed 'General case' 0 C--N 1.292 -1.917 0 O-C-N 121.058 -1.026 . . . . 3.6499999999999999 108.675 177.889 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.528 ' O ' ' CG2' ' A' ' 47' ' ' THR . 10.7 t -145.69 120.89 10.17 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 120.101 -1.624 . . . . 0.69999999999999996 111.96 -177.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.649 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -67.59 -25.63 65.87 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.608 -1.307 . . . . 3.8999999999999999 107.812 177.336 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.481 ' O ' ' HB1' ' A' ' 50' ' ' ALA . 66.0 p -82.63 -163.57 0.72 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.695 -0.628 . . . . 1.8799999999999999 109.373 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.588 ' O ' ' CA ' ' A' ' 71' ' ' ASN . . . 175.63 160.46 0.26 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.284 -0.885 . . . . 0.5 109.817 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.542 ' O ' ' CB ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -126.66 -160.14 0.97 Allowed 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 106.516 -1.661 . . . . 4.1500000000000004 106.516 177.581 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.467 ' HB ' ' O ' ' A' ' 51' ' ' LYS . 20.6 tt -177.56 164.41 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 C-N-CA 117.914 -1.515 . . . . 0.97999999999999998 111.641 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.513 ' O ' ' HE2' ' A' ' 55' ' ' LYS . 2.3 mt-10 -165.46 59.28 0.12 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.124 -1.065 . . . . 0.93999999999999995 108.124 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.68 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 0.4 OUTLIER -96.99 139.77 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.352 -0.842 . . . . 0.59999999999999998 109.997 -179.462 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.68 ' HG3' ' O ' ' A' ' 54' ' ' ILE . 1.9 mtmt -150.96 93.38 1.93 Allowed 'General case' 0 C--N 1.284 -2.274 0 C-N-CA 119.833 -0.747 . . . . 1.6899999999999999 109.781 178.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.497 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . . . -110.35 150.4 28.83 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 108.022 -1.103 . . . . 1.8200000000000001 108.022 178.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.48 ' HA ' ' HA ' ' A' ' 62' ' ' GLU . 0.8 OUTLIER -131.03 122.81 27.45 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.774 -1.204 . . . . 1.5600000000000001 111.392 -178.622 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.483 ' CD1' ' N ' ' A' ' 59' ' ' ASP . 2.0 tm? -110.37 158.23 18.67 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.034 -1.099 . . . . 2.3799999999999999 108.034 178.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.483 ' N ' ' CD1' ' A' ' 58' ' ' LEU . 23.4 t0 -40.89 -72.25 0.07 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.155 -0.966 . . . . 3.23 109.792 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -106.29 30.39 9.66 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.496 -1.442 . . . . 1.04 109.496 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.459 ' HB3' ' HB3' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -150.28 60.53 0.97 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.347 -1.09 . . . . 1.3700000000000001 108.996 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.48 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 0.1 OUTLIER -63.42 86.82 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.661 -0.649 . . . . 3.3999999999999999 110.653 -179.31 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.497 ' HB ' ' HB2' ' A' ' 56' ' ' ALA . 2.0 mt -54.69 160.96 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 107.442 -1.318 . . . . 0.91000000000000003 107.442 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.476 ' O ' HG21 ' A' ' 65' ' ' VAL . 17.8 t0 -168.42 146.95 4.29 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.678 -1.264 . . . . 2.6000000000000001 110.097 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.627 ' HB ' ' O ' ' A' ' 54' ' ' ILE . 4.9 t -149.0 74.83 9.99 Favored Pre-proline 0 N--CA 1.488 1.44 0 O-C-N 121.631 -0.668 . . . . 0.77000000000000002 109.285 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -80.33 -7.59 13.92 Favored 'Trans proline' 0 C--N 1.302 -1.886 0 C-N-CA 123.028 2.486 . . . . 1.05 110.465 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 135.39 56.12 0.06 OUTLIER Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.464 -1.454 . . . . 0.88 109.464 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 21.0 mt -81.46 -59.48 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.273 -1.133 . . . . 2.3900000000000001 109.729 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.483 ' OD1' ' O ' ' A' ' 69' ' ' ASP . 8.9 p30 -66.75 142.74 57.28 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.117 -0.989 . . . . 1.6499999999999999 109.228 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.416 ' O ' ' CG ' ' A' ' 71' ' ' ASN . 5.8 t -67.69 -10.27 50.91 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.084 -1.01 . . . . 3.8399999999999999 108.848 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.588 ' CA ' ' O ' ' A' ' 50' ' ' ALA . 7.4 m-20 178.02 66.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.918 . . . . 0.35999999999999999 110.347 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.542 ' CB ' ' O ' ' A' ' 51' ' ' LYS . . . 39.77 27.54 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 121.456 0.646 . . . . 0.34999999999999998 110.674 177.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.478 ' N ' ' O ' ' A' ' 71' ' ' ASN . 6.7 t -102.76 -22.34 13.93 Favored 'General case' 0 C--N 1.293 -1.885 0 O-C-N 121.447 -0.783 . . . . 0.64000000000000001 109.88 -179.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.469 ' HB2' ' HB3' ' A' ' 69' ' ' ASP . 0.4 OUTLIER -84.93 5.87 27.29 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.228 -0.92 . . . . 5.0999999999999996 109.783 -179.881 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.466 ' C ' ' CG1' ' A' ' 76' ' ' VAL . 76.5 m-85 -135.37 0.79 2.83 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.044 -1.035 . . . . 1.03 110.841 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.751 ' HB ' ' CE1' ' A' ' 86' ' ' TYR . 0.2 OUTLIER -167.92 173.66 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.362 -1.461 . . . . 0.84999999999999998 111.139 -178.094 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.618 ' N ' ' CG2' ' A' ' 76' ' ' VAL . 0.1 OUTLIER -55.03 94.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 106.264 -1.754 . . . . 4.8700000000000001 106.264 177.447 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . 0.598 ' HB2' ' HD3' ' A' ' 79' ' ' PRO . 2.4 m -33.47 -53.27 0.75 Allowed Pre-proline 0 N--CA 1.504 2.236 0 O-C-N 121.789 -0.569 . . . . 1.3600000000000001 112.382 -176.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.649 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 33.9 Cg_endo -79.75 113.08 3.0 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 120.93 1.086 . . . . 1.02 110.193 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.621 ' CB ' HD23 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -97.37 -65.7 0.95 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.229 -0.919 . . . . 0.73999999999999999 108.58 -179.59 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.729 ' HB ' ' HA ' ' A' ' 46' ' ' ASN . 1.3 m 41.38 -168.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 C-N-CA 120.32 -0.552 . . . . 0.88 109.701 178.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.666 ' N ' ' O ' ' A' ' 45' ' ' GLN . 0.0 OUTLIER -102.53 42.38 1.15 Allowed 'General case' 0 C--N 1.29 -1.982 0 O-C-N 120.133 -1.604 . . . . 1.76 110.999 -175.98 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.492 ' O ' ' OE1' ' A' ' 84' ' ' GLN . . . -151.83 31.73 0.9 Allowed Glycine 0 C--N 1.285 -2.264 0 N-CA-C 108.995 -1.642 . . . . 1.6499999999999999 108.995 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.492 ' OE1' ' O ' ' A' ' 83' ' ' GLY . 0.2 OUTLIER -137.3 121.69 18.23 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.284 -1.127 . . . . 3.96 110.726 -179.018 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -97.01 125.56 41.52 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 105.435 -2.061 . . . . 3.1299999999999999 105.435 176.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.751 ' CE1' ' HB ' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -153.51 161.08 42.59 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 117.657 -1.617 . . . . 1.01 109.759 -177.445 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.622 ' CB ' ' HG ' ' A' ' 40' ' ' LEU . 3.1 p-10 -129.23 101.09 5.85 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.97 -1.081 . . . . 0.83999999999999997 113.285 -175.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.554 ' CD1' HG13 ' A' ' 76' ' ' VAL . 3.2 tp -69.17 -160.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 107.722 -1.214 . . . . 1.28 107.722 176.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.551 ' CB ' ' O ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER 159.75 170.14 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.196 -0.94 . . . . 2.6600000000000001 109.993 179.689 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.556 ' CE2' HG22 ' A' ' 54' ' ' ILE . 10.0 m-85 -162.48 67.83 0.24 Allowed 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.944 -0.762 . . . . 1.55 108.944 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.54 ' C ' ' CD1' ' A' ' 92' ' ' TRP . 3.0 t -56.39 176.19 0.09 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.474 -0.766 . . . . 3.2999999999999998 109.94 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.667 ' N ' ' CD1' ' A' ' 92' ' ' TRP . 0.0 OUTLIER -142.36 147.79 36.85 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.229 -0.919 . . . . 7.1399999999999997 109.914 -179.377 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.506 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 25.3 m-20 -74.93 94.64 2.85 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 104.338 -2.468 . . . . 6.2999999999999998 104.338 175.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.692 HG13 ' O ' ' A' ' 33' ' ' LYS . 60.8 t -106.3 96.04 12.72 Favored Pre-proline 0 N--CA 1.488 1.466 0 C-N-CA 118.817 -1.153 . . . . 2.5 113.777 -175.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.61 ' HD2' ' CD1' ' A' ' 97' ' ' ILE . 35.2 Cg_endo -77.42 -150.11 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.538 2.158 . . . . 2.6400000000000001 107.319 174.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.553 ' O ' ' CB ' ' A' ' 31' ' ' ARG . 0.7 OUTLIER -72.12 -25.23 61.65 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.426 -1.421 . . . . 3.7400000000000002 108.561 178.485 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.616 ' CD1' ' CG1' ' A' ' 94' ' ' VAL . 4.0 mt 43.25 14.49 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.505 -0.747 . . . . 1.95 112.842 179.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.641 ' CB ' ' HD2' ' A' ' 99' ' ' PRO . . . 52.64 175.38 0.03 OUTLIER Pre-proline 0 C--N 1.304 -1.403 0 O-C-N 119.769 -1.832 . . . . 1.5 109.226 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.641 ' HD2' ' CB ' ' A' ' 98' ' ' ALA . 37.3 Cg_endo -73.1 -7.17 20.21 Favored 'Trans proline' 0 C--N 1.299 -2.055 0 C-N-CA 123.293 2.662 . . . . 4.0599999999999996 110.995 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.643 ' HD3' ' CB ' ' A' ' 128' ' ' ARG . 1.1 mmmt -149.73 126.58 11.12 Favored 'General case' 0 C--N 1.276 -2.623 0 C-N-CA 119.462 -0.895 . . . . 2.1600000000000001 109.859 -178.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.458 ' HB3' HD11 ' A' ' 127' ' ' ILE . 4.3 t -89.3 159.09 17.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.187 -0.945 . . . . 1.3300000000000001 109.642 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.63 -10.65 48.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.444 -0.785 . . . . 1.3999999999999999 110.362 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.507 ' C ' ' CG2' ' A' ' 104' ' ' VAL . 0.1 OUTLIER 175.1 146.05 0.07 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.814 -1.178 . . . . 3.5099999999999998 110.177 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.507 ' CG2' ' C ' ' A' ' 103' ' ' ASN . 0.2 OUTLIER -156.68 168.36 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.556 -0.715 . . . . 1.0700000000000001 109.804 -179.781 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.505 ' CB ' ' O ' ' A' ' 104' ' ' VAL . 0.9 OUTLIER 161.87 125.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.261 -1.015 . . . . 1.8600000000000001 108.261 -179.934 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 42.6 t -119.53 96.4 4.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 120.986 -1.071 . . . . 1.75 110.664 -179.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.51 ' O ' ' CG2' ' A' ' 108' ' ' VAL . 7.4 m -105.43 150.56 25.16 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.246 -1.39 . . . . 1.26 107.246 178.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.538 HG13 ' N ' ' A' ' 109' ' ' LYS . 75.6 t -157.84 160.76 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 C-N-CA 118.281 -1.368 . . . . 1.6799999999999999 111.545 -178.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.538 ' N ' HG13 ' A' ' 108' ' ' VAL . 1.8 ttpt 177.54 126.39 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.524 -0.917 . . . . 1.48 108.524 178.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.476 ' HB3' ' HB2' ' A' ' 117' ' ' LEU . 11.5 tp -118.35 127.6 53.84 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 107.275 -1.38 . . . . 1.5700000000000001 107.275 178.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.505 ' O ' ' CG ' ' A' ' 51' ' ' LYS . 1.7 mt -124.97 116.93 48.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 O-C-N 121.262 -0.899 . . . . 1.76 111.503 -177.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.453 ' HA2' ' HA ' ' A' ' 50' ' ' ALA . . . -86.1 -110.1 0.78 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.122 -1.991 . . . . 0.39000000000000001 108.122 177.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.407 ' O ' ' CG ' ' A' ' 113' ' ' ASP . 7.4 t70 -136.54 1.71 2.63 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.066 -1.255 . . . . 2.1099999999999999 107.71 178.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.441 ' ND2' ' N ' ' A' ' 114' ' ' ASN . 0.6 OUTLIER -116.1 -20.42 9.88 Favored 'General case' 0 C--N 1.31 -1.139 0 O-C-N 121.491 -0.756 . . . . 0.66000000000000003 109.601 -179.614 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 169.76 -161.32 34.63 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.35 -1.5 . . . . 0.52000000000000002 109.35 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.486 ' O ' HG11 ' A' ' 116' ' ' VAL . 2.5 p -90.8 105.34 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.101 -1.235 . . . . 1.78 109.517 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.621 HD23 ' CB ' ' A' ' 80' ' ' LEU . 1.4 mt -49.58 -53.23 25.02 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.219 -0.926 . . . . 1.1899999999999999 110.8 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.533 ' HA ' ' HB3' ' A' ' 9' ' ' ALA . . . -158.24 129.08 6.33 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.219 -0.926 . . . . 2.1299999999999999 110.245 -178.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . 0.435 ' HB3' HG23 ' A' ' 116' ' ' VAL . 10.2 p -134.29 169.2 17.56 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.484 -0.76 . . . . 2.1299999999999999 109.439 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.443 ' O ' HG13 ' A' ' 121' ' ' ILE . . . -173.31 138.75 0.73 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.375 -0.828 . . . . 0.81999999999999995 109.0 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 120' ' ' ALA . 2.7 mp -139.44 132.45 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.975 -1.078 . . . . 1.4099999999999999 110.437 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.466 ' O ' ' C ' ' A' ' 123' ' ' THR . . . -114.74 93.5 4.35 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.994 -1.113 . . . . 1.54 107.994 179.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.466 ' C ' ' O ' ' A' ' 122' ' ' ALA . 98.6 m -33.47 99.2 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.489 0.661 . . . . 1.97 110.835 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.443 ' HA ' HG21 ' A' ' 105' ' ' VAL . 0.1 OUTLIER 53.92 176.32 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.627 -0.671 . . . . 4.21 110.111 179.704 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.488 ' O ' ' HB ' ' A' ' 104' ' ' VAL . . . -160.31 119.35 0.88 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.546 -1.422 . . . . 0.79000000000000004 109.546 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -128.61 104.72 7.83 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.14 -1.212 . . . . 3.9199999999999999 109.461 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.614 ' O ' ' CB ' ' A' ' 128' ' ' ARG . 2.8 mp -54.77 157.26 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.249 -0.907 . . . . 1.6299999999999999 109.28 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.643 ' CB ' ' HD3' ' A' ' 100' ' ' LYS . 0.0 OUTLIER 134.66 -86.2 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.446 0 N-CA-C 108.266 -1.013 . . . . 4.6299999999999999 108.266 179.37 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.477 ' N ' ' CG ' ' A' ' 128' ' ' ARG . 1.7 t0 . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 118.077 -0.963 . . . . 2.6499999999999999 109.543 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 1' ' ' ASP . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.484 0.659 . . . . 4.0 109.817 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.571 ' HA ' ' HB3' ' A' ' 17' ' ' MET . 66.7 mt-30 53.99 -179.31 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.888 0.852 . . . . 3.8500000000000001 110.887 178.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.586 ' CG1' ' N ' ' A' ' 4' ' ' ASP . 0.8 OUTLIER -170.94 -155.26 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 108.78 -0.822 . . . . 4.5800000000000001 108.78 179.85 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.586 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 17.7 m-20 -146.58 114.95 6.69 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.9 -1.125 . . . . 3.1200000000000001 110.245 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.7 m -142.21 146.42 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 120.965 -1.085 . . . . 1.22 109.792 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.477 ' O ' HG12 ' A' ' 121' ' ' ILE . 8.5 mmtt -69.59 105.3 2.62 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.319 -0.863 . . . . 4.6399999999999997 109.877 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.442 ' HA ' ' O ' ' A' ' 119' ' ' CYS . 0.8 OUTLIER -95.91 167.42 11.26 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.145 -0.972 . . . . 3.4399999999999999 108.641 179.335 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.548 ' N ' ' SG ' ' A' ' 119' ' ' CYS . 6.3 m -140.07 7.98 2.26 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.052 -1.03 . . . . 1.4099999999999999 109.755 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.517 ' CA ' ' HA ' ' A' ' 118' ' ' ALA . . . -49.62 -75.34 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.163 -0.961 . . . . 1.24 109.587 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.449 ' CB ' ' O ' ' A' ' 9' ' ' ALA . 0.9 OUTLIER 167.34 37.29 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.885 -0.783 . . . . 1.95 108.885 -178.478 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 58.41 26.27 13.93 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.908 -1.145 . . . . 3.27 107.908 -178.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.484 ' O ' ' C ' ' A' ' 13' ' ' ILE . 0.3 OUTLIER -116.98 -21.72 8.79 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.507 -0.746 . . . . 2.5899999999999999 110.414 -179.16 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.484 ' C ' ' O ' ' A' ' 12' ' ' GLU . 5.7 mt -43.09 139.87 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 108.144 -1.058 . . . . 1.52 108.144 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.41 ' N ' HG21 ' A' ' 13' ' ' ILE . 0.4 OUTLIER -94.27 -25.59 16.97 Favored 'General case' 0 C--N 1.292 -1.931 0 O-C-N 121.513 -0.742 . . . . 3.7799999999999998 109.585 -178.739 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.438 ' HG2' ' HE1' ' A' ' 17' ' ' MET . 3.7 mtmt -167.48 105.51 0.54 Allowed 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 118.006 -1.478 . . . . 1.8500000000000001 111.981 -178.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.483 ' HA ' ' HA ' ' A' ' 39' ' ' ALA . 2.2 p -116.97 94.72 3.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 N-CA-C 106.152 -1.795 . . . . 1.3999999999999999 106.152 177.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.571 ' HB3' ' HA ' ' A' ' 2' ' ' GLN . 12.3 mmt -132.46 142.51 49.27 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.558 -0.713 . . . . 3.6899999999999999 111.392 -176.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.479 HG23 ' CD2' ' A' ' 37' ' ' LEU . 16.7 t -110.84 141.02 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 107.935 -1.135 . . . . 2.52 107.935 178.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.477 ' HB3' ' HA ' ' A' ' 35' ' ' PHE . 7.4 t70 -62.95 -40.93 99.16 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.094 -1.004 . . . . 2.52 110.538 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.542 ' O ' ' CB ' ' A' ' 21' ' ' CYS . . . -156.01 139.82 6.84 Favored Glycine 0 N--CA 1.489 2.212 0 C-N-CA 119.351 -1.404 . . . . 3.1200000000000001 110.286 -179.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.545 ' HB2' HG22 ' A' ' 29' ' ' ILE . 0.0 OUTLIER 155.01 -56.76 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.572 -0.958 . . . . 0.84999999999999998 108.812 179.288 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.534 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 1.6 t60 80.66 120.57 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 107.689 -1.226 . . . . 4.7800000000000002 107.689 -177.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.539 ' HA3' ' O ' ' A' ' 4' ' ' ASP . . . -106.26 -166.88 22.97 Favored Glycine 0 N--CA 1.493 2.481 0 C-N-CA 119.25 -1.453 . . . . 1.1799999999999999 111.341 -178.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.423 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 0.5 OUTLIER 69.86 -87.9 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.499 -1.0 . . . . 1.1799999999999999 108.602 -179.241 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.618 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 3.0 p-10 -63.66 -163.61 0.01 OUTLIER Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 107.14 -1.43 . . . . 1.3500000000000001 107.14 178.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.618 ' HD2' ' CB ' ' A' ' 25' ' ' ASP . 29.6 Cg_endo -72.32 106.09 1.99 Allowed 'Trans proline' 0 C--N 1.313 -1.323 0 N-CA-C 108.545 -1.367 . . . . 1.79 108.545 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.534 ' HB2' ' O ' ' A' ' 22' ' ' HIS . 1.3 t -62.44 92.47 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.756 -0.59 . . . . 1.1000000000000001 112.579 -176.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.499 HG21 ' N ' ' A' ' 29' ' ' ILE . 1.7 mp -91.1 135.0 27.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 105.182 -2.155 . . . . 3.3300000000000001 105.182 174.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.545 HG22 ' HB2' ' A' ' 21' ' ' CYS . 0.1 OUTLIER -108.82 173.79 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.196 0 O-C-N 120.666 -1.272 . . . . 0.92000000000000004 111.147 -177.476 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.429 ' O ' ' CZ ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -102.43 132.51 48.4 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 122.2 1.0 . . . . 3.7000000000000002 111.708 -178.467 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.672 ' HD3' ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -99.21 109.9 22.51 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 115.634 -0.712 . . . . 9.9399999999999995 109.265 179.21 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.511 ' HA2' ' O ' ' A' ' 95' ' ' PRO . . . 136.18 0.71 3.02 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.556 -1.307 . . . . 1.28 110.336 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.494 ' O ' HG13 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -139.32 139.07 21.72 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 120.868 -1.372 . . . . 4.2599999999999998 109.631 179.891 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.465 ' HA ' ' HB ' ' A' ' 94' ' ' VAL . 30.5 Cg_endo -70.99 123.32 9.59 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.713 2.275 . . . . 2.7599999999999998 110.224 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.477 ' HA ' ' HB3' ' A' ' 19' ' ' ASP . 19.6 m-30 -103.91 -164.65 1.08 Allowed 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.777 0.799 . . . . 8.7200000000000006 110.32 -178.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.513 ' O ' ' HG3' ' A' ' 38' ' ' GLU . 1.3 m -179.84 90.36 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.679 -0.86 . . . . 1.73 108.679 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.479 ' CD2' HG23 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -57.35 152.7 13.71 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.086 -1.009 . . . . 4.6299999999999999 108.438 179.729 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.513 ' HG3' ' O ' ' A' ' 36' ' ' THR . 72.8 mt-10 -154.13 176.6 12.05 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.89 -1.131 . . . . 0.54000000000000004 111.015 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.483 ' HA ' ' HA ' ' A' ' 16' ' ' VAL . . . 168.71 85.89 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.252 -1.388 . . . . 0.65000000000000002 107.252 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.616 ' HG ' ' HA ' ' A' ' 87' ' ' ASP . 4.3 mp -88.22 144.52 26.4 Favored 'General case' 0 C--N 1.291 -1.97 0 O-C-N 121.85 -0.531 . . . . 1.8700000000000001 110.095 -178.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.801 ' CE2' ' CD2' ' A' ' 86' ' ' TYR . 0.1 OUTLIER -136.2 174.69 10.34 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.942 -1.099 . . . . 1.0900000000000001 108.26 176.841 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.495 ' O ' ' C ' ' A' ' 43' ' ' ALA . 0.2 OUTLIER -126.24 102.24 7.1 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 106.651 -1.611 . . . . 2.7599999999999998 106.651 178.582 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.569 ' CB ' ' O ' ' A' ' 81' ' ' VAL . . . -34.79 117.59 0.38 Allowed 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 115.548 -0.751 . . . . 0.46000000000000002 109.33 -179.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.468 ' O ' ' HB3' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -126.8 0.15 6.69 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.36 0.6 . . . . 0.79000000000000004 109.68 -178.473 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.629 ' O ' ' N ' ' A' ' 82' ' ' LYS . 3.3 pt20 -90.86 -141.64 0.17 Allowed 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.405 -0.961 . . . . 1.0 108.405 179.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.745 ' HA ' ' HB ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -156.86 71.76 0.69 Allowed 'General case' 0 C--N 1.293 -1.848 0 O-C-N 120.962 -1.086 . . . . 0.90000000000000002 109.641 178.94 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.53 ' CG2' ' OE1' ' A' ' 45' ' ' GLN . 7.5 t -150.33 122.19 8.15 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.17 -1.581 . . . . 1.48 111.003 -178.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.606 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 1.7 mtpt -69.17 -17.97 63.87 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.89 -1.131 . . . . 3.98 109.131 178.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.474 ' OG1' ' OG1' ' A' ' 47' ' ' THR . 1.1 p -76.32 176.41 8.18 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.16 -0.963 . . . . 1.6200000000000001 109.719 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.543 ' O ' ' CA ' ' A' ' 71' ' ' ASN . . . -176.23 136.89 0.29 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.242 -0.911 . . . . 0.78000000000000003 109.962 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.542 ' O ' ' CB ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -121.1 -156.26 0.67 Allowed 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.723 -1.214 . . . . 3.1400000000000001 107.723 178.393 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.452 ' CG1' HD11 ' A' ' 54' ' ' ILE . 17.3 tt -175.31 165.59 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 C-N-CA 118.616 -1.234 . . . . 1.02 111.293 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.44 ' C ' HD13 ' A' ' 54' ' ' ILE . 0.4 OUTLIER -168.09 68.94 0.08 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.718 -0.845 . . . . 3.1800000000000002 108.718 179.778 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.61 ' N ' ' CD1' ' A' ' 54' ' ' ILE . 0.7 OUTLIER -109.17 149.76 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.308 -0.87 . . . . 0.68000000000000005 110.066 -178.967 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.606 ' HG3' ' O ' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -164.98 100.73 0.76 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.331 -0.856 . . . . 2.3199999999999998 109.602 178.16 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.44 ' O ' ' O ' ' A' ' 63' ' ' ILE . . . -106.74 147.9 29.07 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.114 -0.991 . . . . 1.76 108.375 178.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.517 ' HA ' ' HA ' ' A' ' 62' ' ' GLU . 37.2 t -132.5 129.12 38.73 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.868 -1.145 . . . . 2.1299999999999999 110.315 -179.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.613 ' HG ' ' CZ2' ' A' ' 92' ' ' TRP . 0.1 OUTLIER -114.15 -152.13 0.5 Allowed 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.081 -1.081 . . . . 3.9100000000000001 108.081 179.42 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.569 ' HB3' ' CG2' ' A' ' 97' ' ' ILE . 48.4 t0 -106.72 87.73 2.59 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.71 -1.244 . . . . 4.1500000000000004 108.403 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.71 -6.93 62.94 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 108.326 -1.91 . . . . 2.5600000000000001 108.326 -178.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -128.02 49.66 2.13 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 107.581 -1.266 . . . . 2.1899999999999999 107.581 179.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.528 ' O ' ' CG ' ' A' ' 62' ' ' GLU . 1.8 tt0 -59.65 91.24 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.862 -0.524 . . . . 4.3700000000000001 109.967 -179.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.488 HD12 HG22 ' A' ' 63' ' ' ILE . 8.3 mt -55.98 159.85 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 C-N-CA 118.773 -1.171 . . . . 1.46 107.952 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.465 ' O ' HG21 ' A' ' 65' ' ' VAL . 40.2 p-10 -156.27 162.92 40.08 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.174 -0.954 . . . . 5.1200000000000001 110.202 -179.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.608 ' HB ' ' O ' ' A' ' 54' ' ' ILE . 35.4 t -146.92 66.37 10.42 Favored Pre-proline 0 C--N 1.303 -1.442 0 O-C-N 121.499 -0.751 . . . . 1.77 109.11 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.523 ' O ' ' C ' ' A' ' 67' ' ' GLY . 37.3 Cg_endo -80.25 102.72 1.46 Allowed 'Trans proline' 0 C--N 1.3 -1.979 0 C-N-CA 123.329 2.686 . . . . 4.4699999999999998 111.34 -179.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.523 ' C ' ' O ' ' A' ' 66' ' ' PRO . . . 22.99 51.8 0.02 OUTLIER Glycine 0 N--CA 1.5 2.914 0 N-CA-C 111.511 -0.635 . . . . 1.1499999999999999 111.511 179.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.415 ' N ' ' O ' ' A' ' 66' ' ' PRO . 6.6 mt -60.73 -81.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.072 -1.252 . . . . 3.6000000000000001 109.442 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.599 ' HB3' ' CG ' ' A' ' 74' ' ' HIS . 52.3 p30 -68.69 -167.62 0.1 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.342 -0.849 . . . . 2.25 109.957 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.462 ' O ' ' OD1' ' A' ' 71' ' ' ASN . 1.1 p -111.11 5.1 19.88 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.982 -0.747 . . . . 1.3999999999999999 108.982 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.543 ' CA ' ' O ' ' A' ' 50' ' ' ALA . 2.2 m-20 172.95 69.1 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.177 -0.952 . . . . 2.0299999999999998 110.972 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.542 ' CB ' ' O ' ' A' ' 51' ' ' LYS . . . 38.75 23.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 112.627 0.602 . . . . 0.45000000000000001 112.627 177.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.508 ' N ' ' O ' ' A' ' 71' ' ' ASN . 22.9 t -99.19 4.56 46.8 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.651 -1.281 . . . . 1.74 111.422 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.599 ' CG ' ' HB3' ' A' ' 69' ' ' ASP . 4.2 m170 -95.63 -18.25 20.69 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.419 -1.425 . . . . 2.8199999999999998 109.56 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.55 ' O ' HG11 ' A' ' 76' ' ' VAL . 5.4 m-85 -97.85 -26.69 14.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.346 -0.846 . . . . 2.5299999999999998 108.884 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.758 ' CG2' ' CZ ' ' A' ' 86' ' ' TYR . 15.4 m -147.48 -139.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.811 -0.811 . . . . 4.0899999999999999 108.811 -178.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.523 ' N ' ' CG2' ' A' ' 76' ' ' VAL . 15.0 mmmt -93.03 162.74 13.92 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.141 -1.429 . . . . 4.9299999999999997 107.141 177.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . 0.521 ' N ' ' CD ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -83.16 -51.3 0.67 Allowed Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 120.469 -1.394 . . . . 2.0899999999999999 109.949 -179.829 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.606 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 29.1 Cg_endo -76.77 120.7 5.6 Favored 'Trans proline' 0 C--N 1.302 -1.918 0 N-CA-C 108.447 -1.405 . . . . 1.26 108.447 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.623 ' CD1' ' CE1' ' A' ' 86' ' ' TYR . 0.3 OUTLIER -98.19 -67.38 0.85 Allowed 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.918 -1.142 . . . . 2.1899999999999999 107.918 -178.958 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.745 ' HB ' ' HA ' ' A' ' 46' ' ' ASN . 1.4 m 41.26 -167.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 C-N-CA 120.353 -0.539 . . . . 0.73999999999999999 109.872 177.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.629 ' N ' ' O ' ' A' ' 45' ' ' GLN . 0.6 OUTLIER -99.96 42.23 1.12 Allowed 'General case' 0 C--N 1.293 -1.881 0 O-C-N 120.529 -1.357 . . . . 4.6500000000000004 110.195 -177.4 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -148.79 44.78 0.74 Allowed Glycine 0 C--N 1.288 -2.12 0 N-CA-C 109.152 -1.579 . . . . 0.64000000000000001 109.152 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -152.47 162.33 41.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.057 -1.26 . . . . 4.8899999999999997 110.259 -179.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -117.26 141.63 48.06 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.099 -1.074 . . . . 5.2000000000000002 108.099 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.801 ' CD2' ' CE2' ' A' ' 41' ' ' PHE . 0.2 OUTLIER -108.33 -173.55 2.31 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.908 -1.12 . . . . 4.5999999999999996 112.27 -177.542 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.616 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 2.9 t70 159.52 74.45 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.28 0 CA-C-O 121.826 0.822 . . . . 2.5699999999999998 109.54 178.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.478 ' O ' HG12 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -106.92 137.49 37.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 107.581 -1.266 . . . . 3.3799999999999999 107.581 179.37 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.57 ' O ' ' CD1' ' A' ' 90' ' ' TYR . 8.6 mttt -142.88 -166.42 2.29 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.613 -1.304 . . . . 2.0800000000000001 111.57 -178.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.593 ' CZ ' HG22 ' A' ' 54' ' ' ILE . 77.3 m-85 -155.86 77.83 0.97 Allowed 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 108.62 -0.881 . . . . 1.3200000000000001 108.62 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.47 ' O ' ' O ' ' A' ' 90' ' ' TYR . 12.4 m -45.58 171.17 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.365 -0.834 . . . . 3.9199999999999999 109.533 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.613 ' CZ2' ' HG ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -150.34 107.99 3.67 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 118.97 -1.092 . . . . 4.0300000000000002 111.535 -179.311 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.423 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 0.7 OUTLIER -72.8 98.93 2.52 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 106.23 -1.767 . . . . 3.3199999999999998 106.23 177.042 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.596 ' CG1' ' CD1' ' A' ' 97' ' ' ILE . 69.6 t -109.74 95.56 20.55 Favored Pre-proline 0 C--N 1.301 -1.504 0 C-N-CA 119.037 -1.065 . . . . 2.0299999999999998 113.159 -176.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.592 ' HD2' ' CD1' ' A' ' 97' ' ' ILE . 31.1 Cg_endo -75.21 -92.86 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.833 2.356 . . . . 1.0900000000000001 108.441 175.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.524 ' O ' ' HB3' ' A' ' 31' ' ' ARG . 1.3 mmtp -121.06 -53.12 2.06 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 105.223 -2.14 . . . . 5.2400000000000002 105.223 176.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.672 ' HB ' ' HD3' ' A' ' 31' ' ' ARG . 1.6 mp 61.35 28.8 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 112.632 0.605 . . . . 1.0600000000000001 112.632 175.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.586 ' O ' ' HG3' ' A' ' 31' ' ' ARG . . . 58.64 160.52 0.09 OUTLIER Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 120.949 -1.095 . . . . 2.79 111.011 177.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.627 ' O ' ' HA ' ' A' ' 128' ' ' ARG . 46.2 Cg_endo -84.69 4.99 6.52 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 124.087 3.191 . . . . 2.79 110.801 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.58 ' HD3' ' CB ' ' A' ' 128' ' ' ARG . 4.6 mmmt -161.78 139.27 8.74 Favored 'General case' 0 C--N 1.283 -2.285 0 C-N-CA 119.332 -0.947 . . . . 3.02 110.647 -177.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.579 ' CB ' ' CD1' ' A' ' 127' ' ' ILE . 32.3 t -109.06 2.59 21.28 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.417 -0.802 . . . . 2.1899999999999999 109.043 178.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.529 ' O ' ' CB ' ' A' ' 103' ' ' ASN . 72.9 mt-10 64.54 2.05 1.5 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.557 -0.715 . . . . 5.54 110.144 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.529 ' CB ' ' O ' ' A' ' 102' ' ' GLU . 0.9 OUTLIER 163.94 152.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.02 -1.05 . . . . 3.1499999999999999 109.919 179.908 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.462 ' CG2' ' C ' ' A' ' 103' ' ' ASN . 0.3 OUTLIER -153.78 168.52 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.686 -0.857 . . . . 1.8400000000000001 108.686 179.52 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.1 t -161.81 131.13 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.946 -1.097 . . . . 1.72 109.66 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.549 ' HB ' ' CB ' ' A' ' 122' ' ' ALA . 3.4 t -132.24 124.98 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.24 -0.913 . . . . 1.74 109.287 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.535 ' O ' ' CG2' ' A' ' 108' ' ' VAL . 1.9 m -147.46 156.36 42.79 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.378 -0.826 . . . . 0.79000000000000004 108.838 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.562 ' CG1' ' N ' ' A' ' 109' ' ' LYS . 7.5 t -165.9 162.76 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.146 -0.971 . . . . 0.63 109.773 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.562 ' N ' ' CG1' ' A' ' 108' ' ' VAL . 0.3 OUTLIER 174.95 139.02 0.05 OUTLIER 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.419 -0.8 . . . . 0.73999999999999999 109.527 179.302 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.509 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 7.7 tp -126.57 129.28 48.26 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.289 -1.374 . . . . 1.6000000000000001 107.289 178.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 12.5 mt -125.03 128.18 72.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 121.189 -0.945 . . . . 1.04 111.283 -177.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -103.51 -114.16 3.9 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 107.443 -2.263 . . . . 1.1899999999999999 107.443 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -137.64 4.35 2.58 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.138 -1.431 . . . . 1.6200000000000001 107.138 177.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.446 ' ND2' ' N ' ' A' ' 114' ' ' ASN . 0.7 OUTLIER -124.03 13.92 9.12 Favored 'General case' 0 C--N 1.308 -1.238 0 O-C-N 121.545 -0.722 . . . . 1.29 109.402 -179.688 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 132.77 -158.97 23.32 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.653 -1.379 . . . . 1.23 109.653 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -99.37 117.04 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.296 -1.12 . . . . 0.57999999999999996 109.394 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.601 HD23 ' CB ' ' A' ' 80' ' ' LEU . 1.3 mt -61.63 -41.49 97.56 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.606 -0.684 . . . . 1.4199999999999999 110.875 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.517 ' HA ' ' CA ' ' A' ' 9' ' ' ALA . . . -168.51 136.16 2.08 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.114 -0.991 . . . . 1.6599999999999999 110.235 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . 0.548 ' SG ' ' N ' ' A' ' 8' ' ' CYS . 0.5 OUTLIER -137.32 177.72 7.65 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.533 -0.729 . . . . 1.6399999999999999 109.452 179.852 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.483 ' N ' ' SG ' ' A' ' 119' ' ' CYS . . . -173.95 123.49 0.33 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.238 -0.914 . . . . 0.54000000000000004 108.804 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.494 HD12 ' SG ' ' A' ' 119' ' ' CYS . 0.0 OUTLIER -127.48 140.87 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.055 -1.028 . . . . 3.5 111.429 -178.633 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.549 ' CB ' ' HB ' ' A' ' 106' ' ' VAL . . . -119.37 136.52 54.24 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.771 -1.196 . . . . 1.6100000000000001 107.771 177.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.412 ' O ' ' O ' ' A' ' 124' ' ' HIS . 17.7 m -89.62 94.69 9.95 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.813 -1.18 . . . . 1.8899999999999999 110.695 -178.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.412 ' O ' ' O ' ' A' ' 123' ' ' THR . 1.6 t60 54.26 166.04 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.693 0.758 . . . . 4.5800000000000001 110.991 178.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -156.05 170.22 33.75 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 108.348 -1.901 . . . . 2.1099999999999999 108.348 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.496 ' HB2' HG13 ' A' ' 28' ' ' ILE . 0.4 OUTLIER -150.65 81.37 1.34 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.766 -1.432 . . . . 2.2999999999999998 109.806 -179.932 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.661 ' O ' ' HB3' ' A' ' 128' ' ' ARG . 3.3 mp -41.63 138.07 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.65 -0.656 . . . . 1.1499999999999999 110.573 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.661 ' HB3' ' O ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER 167.4 -165.58 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 122.274 1.035 . . . . 2.5 111.266 177.76 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.615 ' N ' ' CG ' ' A' ' 128' ' ' ARG . 3.5 m-20 . . . . . 0 C--N 1.299 -1.604 0 CA-C-O 117.982 -1.009 . . . . 6.8700000000000001 109.703 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.462 ' O ' ' HB3' ' A' ' 17' ' ' MET . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 121.358 0.599 . . . . 4.6399999999999997 109.728 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.519 ' O ' ' C ' ' A' ' 3' ' ' VAL . 1.3 pt20 -105.33 34.78 3.09 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.316 -0.994 . . . . 3.6899999999999999 108.316 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.537 ' CG1' ' HA ' ' A' ' 22' ' ' HIS . 0.6 OUTLIER -28.51 123.51 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 CA-C-O 121.487 0.66 . . . . 2.1099999999999999 110.239 -179.672 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -65.23 154.08 39.14 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.451 -0.781 . . . . 3.6499999999999999 110.408 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -154.88 170.55 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.446 -0.946 . . . . 2.25 108.446 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.413 ' O ' HD13 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -77.24 92.77 3.89 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.889 -1.132 . . . . 7.2199999999999998 109.499 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.448 ' HA ' ' O ' ' A' ' 119' ' ' CYS . 0.7 OUTLIER -88.13 -177.7 5.78 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.284 -0.885 . . . . 2.9700000000000002 109.134 179.806 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.492 ' O ' ' C ' ' A' ' 9' ' ' ALA . 37.4 m -151.04 -29.55 0.19 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.198 -0.939 . . . . 2.29 110.794 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.537 ' CA ' ' HA ' ' A' ' 118' ' ' ALA . . . -32.8 -77.23 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.425 -0.797 . . . . 1.3 110.938 -179.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.468 ' O ' ' HB3' ' A' ' 11' ' ' ASN . 0.9 OUTLIER 175.33 -77.33 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.415 -0.803 . . . . 3.1899999999999999 109.265 -178.747 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.468 ' HB3' ' O ' ' A' ' 10' ' ' ASN . 17.8 p-10 173.56 36.28 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.523 -0.918 . . . . 4.04 108.523 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.443 ' O ' ' C ' ' A' ' 13' ' ' ILE . 0.3 OUTLIER -129.18 -4.77 4.94 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.386 -0.821 . . . . 2.2999999999999998 109.78 -179.507 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.542 ' CG2' ' O ' ' A' ' 40' ' ' LEU . 18.5 mt -43.97 148.48 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.221 -0.924 . . . . 1.03 109.091 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.405 ' HE2' ' OD2' ' A' ' 42' ' ' ASP . 2.0 mmtt -96.86 -17.7 20.01 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.921 -0.77 . . . . 3.6699999999999999 108.921 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.525 ' CB ' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -170.03 100.89 0.29 Allowed 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 119.211 -0.995 . . . . 2.7799999999999998 110.404 -178.164 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.49 ' O ' ' HG3' ' A' ' 17' ' ' MET . 1.4 p -124.75 97.09 4.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 107.897 -1.149 . . . . 1.95 107.897 179.168 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.491 ' HG2' ' HB3' ' A' ' 2' ' ' GLN . 2.4 mpt? -150.77 155.45 39.29 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.127 -0.983 . . . . 2.52 110.793 -178.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.502 ' HB ' HG23 ' A' ' 3' ' ' VAL . 2.1 t -112.06 128.9 68.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 106.982 -1.488 . . . . 2.5099999999999998 106.982 178.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.526 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -87.75 89.29 7.94 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.852 -1.155 . . . . 2.6699999999999999 111.191 -177.848 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.509 ' O ' ' CB ' ' A' ' 21' ' ' CYS . . . 90.6 112.41 1.59 Allowed Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.816 -1.183 . . . . 1.28 110.879 178.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.534 ' HA ' ' CG2' ' A' ' 29' ' ' ILE . 0.0 OUTLIER 159.12 -50.37 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.445 -1.032 . . . . 0.80000000000000004 109.436 179.002 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.56 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 2.3 m-70 85.19 118.72 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 109.267 -0.642 . . . . 6.3399999999999999 109.267 -178.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 24' ' ' SER . . . -95.74 -176.91 36.85 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 109.752 -1.339 . . . . 1.02 109.752 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.496 ' O ' ' O ' ' A' ' 25' ' ' ASP . 15.0 m 60.19 -89.41 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.236 -1.155 . . . . 1.98 109.414 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.616 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.2 OUTLIER -50.68 -176.56 0.02 OUTLIER Pre-proline 0 C--N 1.304 -1.37 0 N-CA-C 108.149 -1.056 . . . . 1.5800000000000001 108.149 179.244 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.616 ' HD2' ' CB ' ' A' ' 25' ' ' ASP . 28.4 Cg_endo -70.24 82.9 0.81 Allowed 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 121.889 1.726 . . . . 1.75 109.29 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.56 ' HA ' ' O ' ' A' ' 22' ' ' HIS . 2.3 t -31.69 89.54 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 115.297 -0.865 . . . . 1.28 112.415 -178.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.486 ' O ' ' O ' ' A' ' 21' ' ' CYS . 28.7 mm -90.6 132.37 35.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 104.783 -2.303 . . . . 1.9299999999999999 104.783 175.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.534 ' CG2' ' HA ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -109.52 179.07 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.291 0 C-N-CA 118.666 -1.213 . . . . 0.91000000000000003 111.319 -176.86 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.581 ' N ' ' CD2' ' A' ' 30' ' ' HIS . 2.3 m-70 -128.08 154.34 45.81 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 119.767 -0.773 . . . . 0.66000000000000003 110.881 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.545 ' CB ' ' O ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -100.54 155.54 17.79 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.886 -1.153 . . . . 6.1299999999999999 107.886 178.404 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.441 ' C ' HG13 ' A' ' 94' ' ' VAL . . . 90.22 0.79 76.52 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.84 -1.304 . . . . 0.98999999999999999 109.84 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.545 ' O ' ' CB ' ' A' ' 94' ' ' VAL . 2.1 mtmm -129.66 145.7 58.07 Favored Pre-proline 0 N--CA 1.493 1.71 0 N-CA-C 107.564 -1.273 . . . . 2.46 107.564 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -71.35 82.71 1.07 Allowed 'Trans proline' 0 C--N 1.303 -1.846 0 C-N-CA 122.354 2.036 . . . . 1.1799999999999999 112.152 -177.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.526 ' HA ' ' O ' ' A' ' 19' ' ' ASP . 12.3 t80 -52.01 114.13 1.22 Allowed 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 107.352 -1.351 . . . . 2.8599999999999999 107.352 178.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.485 ' OG1' ' HA ' ' A' ' 91' ' ' THR . 7.4 m -132.53 88.8 2.57 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 118.892 -1.123 . . . . 2.6000000000000001 111.3 -178.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 37' ' ' LEU . 0.8 OUTLIER -80.56 126.48 31.3 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.236 -1.394 . . . . 2.6000000000000001 107.236 177.975 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.507 ' O ' ' HB1' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -140.22 -163.5 1.53 Allowed 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.578 -1.327 . . . . 3.2000000000000002 110.728 -178.274 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.507 ' HB1' ' O ' ' A' ' 38' ' ' GLU . . . 170.02 101.65 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.886 -1.153 . . . . 1.5600000000000001 107.886 179.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.595 ' HG ' ' CB ' ' A' ' 87' ' ' ASP . 1.5 mp -93.29 173.17 7.85 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.295 -0.878 . . . . 1.02 109.818 -178.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.636 ' CE1' ' CE2' ' A' ' 86' ' ' TYR . 10.6 p90 175.05 139.9 0.05 OUTLIER 'General case' 0 C--N 1.305 -1.333 0 O-C-N 120.955 -1.09 . . . . 0.62 109.298 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.514 ' O ' ' C ' ' A' ' 43' ' ' ALA . 3.9 m-20 -86.28 108.49 18.42 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 107.334 -1.358 . . . . 3.6499999999999999 107.334 178.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.584 ' CB ' ' O ' ' A' ' 81' ' ' VAL . . . -32.94 127.9 0.28 Allowed 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.727 -0.669 . . . . 0.35999999999999999 109.602 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -122.58 1.65 9.51 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.221 -0.925 . . . . 1.52 110.221 -178.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.653 ' O ' ' N ' ' A' ' 82' ' ' LYS . 1.9 pt20 -93.53 -142.17 0.22 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.259 -0.9 . . . . 0.72999999999999998 108.657 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.744 ' HA ' ' HB ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -154.31 66.66 0.71 Allowed 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.331 -0.856 . . . . 1.0900000000000001 109.084 178.266 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.555 ' O ' HG11 ' A' ' 81' ' ' VAL . 8.8 t -140.73 126.22 18.89 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.143 -1.598 . . . . 0.96999999999999997 112.081 -177.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.683 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -72.19 -2.11 17.55 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.749 -1.219 . . . . 1.4199999999999999 110.099 178.463 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.4 p -115.98 -175.44 2.73 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.906 -1.121 . . . . 2.5600000000000001 111.546 -178.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.582 ' CB ' ' CB ' ' A' ' 72' ' ' ALA . . . -153.54 170.39 20.91 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.641 -0.874 . . . . 2.7000000000000002 108.641 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.503 ' O ' ' O ' ' A' ' 52' ' ' ILE . 0.4 OUTLIER -152.53 28.27 0.56 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.775 -1.203 . . . . 3.1600000000000001 109.26 179.892 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.583 ' CG2' ' HB3' ' A' ' 72' ' ' ALA . 20.5 tt -29.12 155.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.285 -2.23 0 CA-C-O 122.02 0.914 . . . . 2.8999999999999999 112.206 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.456 ' O ' ' HB ' ' A' ' 54' ' ' ILE . 4.5 tt0 -117.06 -69.92 0.82 Allowed 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.005 -1.109 . . . . 3.1299999999999999 108.005 178.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.663 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 0.3 OUTLIER 59.25 150.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.412 -0.805 . . . . 2.4100000000000001 111.065 178.105 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.663 ' HG3' ' O ' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -178.23 94.08 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.976 -0.75 . . . . 2.77 108.976 178.373 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.443 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . . . -120.43 160.76 22.45 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.915 -1.115 . . . . 2.3599999999999999 109.221 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.466 ' OG ' ' HA ' ' A' ' 104' ' ' VAL . 0.1 OUTLIER -130.19 123.89 31.31 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.97 -1.081 . . . . 2.0499999999999998 109.789 -179.754 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.639 ' CD1' ' CZ2' ' A' ' 92' ' ' TRP . 0.1 OUTLIER -102.63 -147.99 0.38 Allowed 'General case' 0 N--CA 1.484 1.226 0 O-C-N 121.089 -1.007 . . . . 2.77 108.561 179.898 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.544 ' N ' HD21 ' A' ' 58' ' ' LEU . 24.2 t0 -94.11 81.62 4.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.067 -1.021 . . . . 3.3199999999999998 109.084 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.5 1.63 90.19 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 108.936 -1.665 . . . . 4.1699999999999999 108.936 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.413 ' O ' ' C ' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -115.25 57.1 0.73 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.331 -1.099 . . . . 3.3900000000000001 108.566 179.606 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 61' ' ' LEU . 0.9 OUTLIER -40.79 115.9 0.64 Allowed 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 121.353 0.597 . . . . 3.3599999999999999 110.724 -179.291 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.559 ' O ' ' CG2' ' A' ' 63' ' ' ILE . 0.5 OUTLIER -76.4 -3.11 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-O 122.125 0.964 . . . . 2.6099999999999999 108.673 177.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.501 ' C ' ' O ' ' A' ' 63' ' ' ILE . 29.7 m-20 -25.6 134.56 0.02 OUTLIER 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 115.199 -0.91 . . . . 3.7799999999999998 111.649 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.526 HG23 ' CG2' ' A' ' 54' ' ' ILE . 93.6 t -113.67 92.91 26.0 Favored Pre-proline 0 C--N 1.302 -1.476 0 N-CA-C 108.373 -0.973 . . . . 1.8999999999999999 108.373 179.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.409 ' HD3' ' O ' ' A' ' 64' ' ' ASP . 36.4 Cg_endo -75.52 -94.84 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.535 2.157 . . . . 1.48 110.528 -178.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 68' ' ' ILE . . . -134.2 48.72 0.93 Allowed Glycine 0 N--CA 1.488 2.121 0 N-CA-C 110.108 -1.197 . . . . 3.1899999999999999 110.108 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.429 ' O ' ' O ' ' A' ' 67' ' ' GLY . 13.5 mm -58.28 -104.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.148 -1.207 . . . . 2.1899999999999999 108.63 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.475 ' OD2' ' HB2' ' A' ' 74' ' ' HIS . 0.4 OUTLIER -79.65 133.75 36.41 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.466 -1.396 . . . . 5.2400000000000002 108.043 178.622 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.8 t -67.6 -13.84 62.42 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.254 -0.904 . . . . 6.0199999999999996 111.864 -177.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.521 ' O ' ' N ' ' A' ' 73' ' ' CYS . 4.9 m-20 -138.28 49.42 1.92 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.328 -1.483 . . . . 1.04 111.803 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.583 ' HB3' ' CG2' ' A' ' 52' ' ' ILE . . . 40.67 19.48 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.843 0 O-C-N 121.116 -0.99 . . . . 1.3899999999999999 112.879 176.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.521 ' N ' ' O ' ' A' ' 71' ' ' ASN . 80.8 m -68.45 -59.88 2.84 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 119.845 -1.784 . . . . 2.96 110.256 -179.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.475 ' HB2' ' OD2' ' A' ' 69' ' ' ASP . 11.9 t-160 -53.06 -27.25 19.08 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.321 -0.862 . . . . 3.2000000000000002 111.025 -178.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.545 ' O ' ' CD1' ' A' ' 88' ' ' ILE . 31.0 m-85 -83.95 -25.85 29.74 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.039 -1.038 . . . . 1.9299999999999999 110.83 -179.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.763 ' HB ' ' CE1' ' A' ' 86' ' ' TYR . 0.2 OUTLIER -158.19 171.87 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 120.749 -1.22 . . . . 0.59999999999999998 111.041 -177.961 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.658 ' N ' ' CG2' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -59.29 94.06 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 105.709 -1.96 . . . . 3.9100000000000001 105.709 176.148 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . 0.516 ' SG ' ' O ' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -37.02 -51.85 2.11 Favored Pre-proline 0 C--N 1.297 -1.683 0 O-C-N 121.67 -0.644 . . . . 3.27 111.565 -177.182 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.683 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 29.6 Cg_endo -73.4 103.12 1.57 Allowed 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 120.886 1.058 . . . . 0.91000000000000003 109.544 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.574 HD22 ' CD2' ' A' ' 86' ' ' TYR . 0.5 OUTLIER -97.85 -62.64 1.22 Allowed 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.99 -0.744 . . . . 3.8500000000000001 108.99 -178.812 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.744 ' HB ' ' HA ' ' A' ' 46' ' ' ASN . 1.5 m 40.16 -166.64 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-N 116.176 -0.465 . . . . 0.89000000000000001 109.846 178.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.653 ' N ' ' O ' ' A' ' 45' ' ' GLN . 0.0 OUTLIER -104.91 42.22 1.24 Allowed 'General case' 0 C--N 1.289 -2.036 0 O-C-N 120.302 -1.499 . . . . 2.5899999999999999 110.126 -177.089 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -146.92 31.73 1.45 Allowed Glycine 0 C--N 1.288 -2.115 0 N-CA-C 109.439 -1.464 . . . . 0.68999999999999995 109.439 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -153.46 132.12 12.27 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 120.89 -1.359 . . . . 3.7799999999999998 110.554 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.488 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 3.6 pt20 -104.22 132.99 49.88 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 106.447 -1.686 . . . . 4.21 106.447 177.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.763 ' CE1' ' HB ' ' A' ' 76' ' ' VAL . 0.1 OUTLIER -152.09 169.15 23.09 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 118.241 -1.383 . . . . 0.60999999999999999 109.709 -178.377 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.595 ' CB ' ' HG ' ' A' ' 40' ' ' LEU . 6.9 p-10 -134.0 91.86 2.87 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.71 -1.243 . . . . 0.5 113.669 -175.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.545 ' CD1' ' O ' ' A' ' 75' ' ' PHE . 4.4 tp -57.84 -172.3 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 106.333 -1.729 . . . . 1.76 106.333 175.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.577 ' O ' ' CD2' ' A' ' 90' ' ' TYR . 12.7 mttt 167.03 174.37 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.393 -1.442 . . . . 2.77 112.049 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.577 ' CD2' ' O ' ' A' ' 89' ' ' LYS . 82.5 m-85 -158.86 44.97 0.28 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.111 -1.07 . . . . 1.6299999999999999 108.111 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.485 ' HA ' ' OG1' ' A' ' 36' ' ' THR . 74.4 p -51.94 -168.96 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.771 -0.581 . . . . 3.6099999999999999 110.19 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.639 ' CZ2' ' CD1' ' A' ' 58' ' ' LEU . 1.4 t90 176.55 90.73 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.303 0 O-C-N 121.091 -1.006 . . . . 5.5499999999999998 110.683 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.417 ' C ' ' O ' ' A' ' 92' ' ' TRP . 20.5 t-20 -49.47 98.53 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 106.463 -1.68 . . . . 5.8700000000000001 106.463 178.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.564 HG11 ' CD1' ' A' ' 97' ' ' ILE . 1.0 OUTLIER -79.73 125.36 82.52 Favored Pre-proline 0 C--N 1.298 -1.635 0 O-C-N 121.343 -0.848 . . . . 1.3600000000000001 112.297 -176.614 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.519 ' HD2' ' CD1' ' A' ' 97' ' ' ILE . 34.3 Cg_endo -82.62 -84.68 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 123.347 2.698 . . . . 1.7 108.853 176.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.545 ' O ' ' CB ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -138.05 -51.17 0.6 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 106.155 -1.794 . . . . 1.7 106.155 178.241 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.564 ' CD1' HG11 ' A' ' 94' ' ' VAL . 1.4 mp 62.81 5.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.756 -0.59 . . . . 1.8799999999999999 111.956 176.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.563 ' CB ' ' HD2' ' A' ' 99' ' ' PRO . . . 51.87 173.63 0.03 OUTLIER Pre-proline 0 C--N 1.305 -1.346 0 O-C-N 120.778 -1.201 . . . . 2.04 110.176 179.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.563 ' HD2' ' CB ' ' A' ' 98' ' ' ALA . 50.1 Cg_endo -82.34 149.25 14.94 Favored 'Trans proline' 0 C--N 1.301 -1.928 0 C-N-CA 123.658 2.905 . . . . 1.8 109.744 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.623 ' HD3' ' CB ' ' A' ' 128' ' ' ARG . 1.1 mmmp? 55.79 114.56 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.033 0 C-N-CA 119.454 -0.899 . . . . 2.7799999999999998 111.063 176.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.516 ' HB2' ' CD1' ' A' ' 127' ' ' ILE . 3.2 m -93.87 166.23 12.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.16 -0.962 . . . . 2.5 109.149 179.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.415 ' O ' ' CB ' ' A' ' 103' ' ' ASN . 0.2 OUTLIER -53.59 -19.08 3.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.278 -0.889 . . . . 2.6200000000000001 109.139 179.603 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.459 ' O ' ' OG ' ' A' ' 57' ' ' SER . 0.5 OUTLIER 168.67 154.06 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.554 -0.906 . . . . 1.5800000000000001 108.554 -179.996 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.532 HG22 ' CD1' ' A' ' 127' ' ' ILE . 0.1 OUTLIER -147.05 134.67 14.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 120.903 -1.123 . . . . 1.25 110.402 -179.649 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.482 ' CG2' ' C ' ' A' ' 104' ' ' VAL . 0.2 OUTLIER -155.01 145.47 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 107.973 -1.121 . . . . 2.9500000000000002 107.973 179.629 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.432 ' HB ' ' CB ' ' A' ' 122' ' ' ALA . 71.1 t -129.01 128.96 67.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 120.641 -1.287 . . . . 1.4299999999999999 110.401 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.49 ' C ' ' CG2' ' A' ' 108' ' ' VAL . 0.3 OUTLIER -150.43 140.56 22.11 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.19 -1.041 . . . . 1.1000000000000001 108.19 179.305 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.547 ' CG1' HD11 ' A' ' 54' ' ' ILE . 2.4 t -157.16 156.75 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.748 -1.22 . . . . 2.2999999999999998 110.463 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 119' ' ' CYS . 0.1 OUTLIER 177.96 119.42 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.696 -0.853 . . . . 2.4900000000000002 108.696 178.961 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.519 ' HB3' ' HB2' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -102.14 117.67 35.28 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 109.146 -0.686 . . . . 4.2300000000000004 109.146 -179.866 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.481 ' N ' HD11 ' A' ' 110' ' ' LEU . 24.1 mt -110.34 139.78 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.333 -0.854 . . . . 1.1799999999999999 110.331 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -108.39 -111.97 3.53 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 108.672 -1.771 . . . . 0.58999999999999997 108.672 178.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.423 ' HB2' ' HB ' ' A' ' 47' ' ' THR . 2.3 m-20 -139.2 4.46 2.23 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.722 -1.214 . . . . 3.2599999999999998 107.722 178.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.402 ' ND2' ' HB2' ' A' ' 45' ' ' GLN . 2.0 m-80 -118.49 -35.65 3.7 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.592 0.71 . . . . 0.89000000000000001 109.36 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -173.43 -141.56 3.56 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.411 -1.476 . . . . 0.58999999999999997 109.411 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -109.58 107.6 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.19 -1.183 . . . . 0.80000000000000004 109.9 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.566 HD23 ' CB ' ' A' ' 80' ' ' LEU . 1.1 mt -49.66 -49.7 46.3 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.252 -0.905 . . . . 1.1200000000000001 109.113 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.537 ' HA ' ' CA ' ' A' ' 9' ' ' ALA . . . -161.98 -167.47 1.67 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.403 -0.811 . . . . 1.45 109.247 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 109' ' ' LYS . 0.1 OUTLIER 172.91 170.59 0.13 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.257 -0.902 . . . . 1.0900000000000001 109.605 179.781 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.416 ' N ' ' SG ' ' A' ' 119' ' ' CYS . . . -175.44 127.18 0.25 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.836 -0.801 . . . . 1.48 108.836 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.413 HD13 ' O ' ' A' ' 6' ' ' LYS . 2.5 mp -133.46 147.29 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.158 -0.964 . . . . 0.79000000000000004 110.787 -179.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.432 ' CB ' ' HB ' ' A' ' 106' ' ' VAL . . . -112.72 -159.58 0.69 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.414 -0.803 . . . . 3.0299999999999998 108.991 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.452 ' O ' ' O ' ' A' ' 124' ' ' HIS . 0.2 OUTLIER -161.66 115.49 1.91 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.933 -1.104 . . . . 2.3500000000000001 110.495 -179.837 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.539 ' N ' ' CD2' ' A' ' 124' ' ' HIS . 0.2 OUTLIER 57.67 118.4 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.387 -0.82 . . . . 4.54 110.562 178.882 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 27' ' ' CYS . . . -129.46 167.88 21.22 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 108.975 -1.65 . . . . 2.0699999999999998 108.975 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -172.25 86.01 0.07 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.042 -1.269 . . . . 3.7599999999999998 109.984 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.643 ' O ' ' CB ' ' A' ' 128' ' ' ARG . 2.4 mp -46.35 138.7 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.352 -0.843 . . . . 1.1899999999999999 109.822 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.643 ' CB ' ' O ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER 147.07 -93.88 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.859 -0.793 . . . . 4.8499999999999996 108.859 179.003 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.507 ' N ' ' HG2' ' A' ' 128' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.964 -1.017 . . . . 4.0800000000000001 109.457 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.2 t0 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.328 0.585 . . . . 5.8099999999999996 109.508 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.459 ' O ' ' O ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -122.46 23.18 9.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.193 -0.942 . . . . 3.8799999999999999 108.679 179.406 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.577 ' CG1' ' HA ' ' A' ' 22' ' ' HIS . 0.2 OUTLIER 38.71 -159.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-O 121.188 0.518 . . . . 2.3500000000000001 109.908 179.376 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -141.28 32.86 1.7 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.093 -1.004 . . . . 1.4399999999999999 109.48 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.1 m -53.16 136.85 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.423 -0.798 . . . . 0.91000000000000003 109.359 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -67.5 94.98 0.44 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.21 -0.931 . . . . 4.7300000000000004 109.704 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.527 ' OD2' ' CD1' ' A' ' 13' ' ' ILE . 0.2 OUTLIER -93.25 -176.16 4.05 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.112 -0.992 . . . . 4.4900000000000002 109.037 179.5 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 21.6 p -176.96 41.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.001 -1.062 . . . . 2.48 109.762 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.547 ' CB ' HG13 ' A' ' 13' ' ' ILE . . . -77.13 -72.43 0.35 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.37 -0.831 . . . . 0.67000000000000004 109.244 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.451 ' O ' ' CB ' ' A' ' 11' ' ' ASN . 0.9 OUTLIER -157.18 25.02 0.31 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.456 -0.777 . . . . 3.3999999999999999 109.561 -179.778 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.451 ' CB ' ' O ' ' A' ' 10' ' ' ASN . 0.5 OUTLIER 72.14 22.51 3.63 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.306 -0.871 . . . . 3.7000000000000002 109.485 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.49 ' O ' ' HB ' ' A' ' 13' ' ' ILE . 0.6 OUTLIER -145.04 -83.52 0.14 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.849 -0.797 . . . . 3.7799999999999998 108.849 179.834 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.574 ' O ' ' HB2' ' A' ' 14' ' ' LYS . 0.4 OUTLIER 71.44 -6.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.509 -0.744 . . . . 3.6600000000000001 111.486 178.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.574 ' HB2' ' O ' ' A' ' 13' ' ' ILE . 1.7 mtpt 68.21 -21.79 0.13 Allowed 'General case' 0 C--N 1.293 -1.864 0 O-C-N 121.504 -0.747 . . . . 5.8899999999999997 111.328 179.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.494 ' CB ' ' O ' ' A' ' 14' ' ' LYS . 0.1 OUTLIER 170.6 126.41 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 O-C-N 120.59 -1.319 . . . . 2.0 109.566 -177.581 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.491 ' C ' ' HG3' ' A' ' 17' ' ' MET . 6.4 p -140.96 114.64 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.128 -0.983 . . . . 1.28 108.845 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.491 ' HG3' ' C ' ' A' ' 16' ' ' VAL . 1.8 mtt -153.47 168.49 25.93 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.063 -1.055 . . . . 1.9099999999999999 110.63 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.462 ' HB ' HG23 ' A' ' 3' ' ' VAL . 16.5 t -129.29 177.66 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 107.388 -1.338 . . . . 2.04 107.388 178.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.425 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 3.6 t0 -117.54 66.44 0.74 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.597 -1.314 . . . . 2.1099999999999999 112.019 -178.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.49 ' O ' ' O ' ' A' ' 21' ' ' CYS . . . 120.53 -26.77 6.83 Favored Glycine 0 N--CA 1.493 2.497 0 C-N-CA 119.063 -1.541 . . . . 3.1299999999999999 112.39 177.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.57 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 3.9 t -60.21 -118.6 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.484 -1.597 . . . . 2.8399999999999999 109.572 -178.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.577 ' HA ' ' CG1' ' A' ' 3' ' ' VAL . 2.7 m-70 155.48 123.27 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.771 -1.206 . . . . 2.52 108.836 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.464 ' N ' HG13 ' A' ' 3' ' ' VAL . . . -75.67 155.24 46.48 Favored Glycine 0 N--CA 1.494 2.519 0 O-C-N 121.027 -1.046 . . . . 1.0600000000000001 110.718 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.451 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 5.4 m 70.22 155.87 0.14 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.356 -1.085 . . . . 2.6200000000000001 108.887 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.593 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.1 OUTLIER 57.9 175.36 0.04 OUTLIER Pre-proline 0 C--N 1.304 -1.378 0 N-CA-C 107.678 -1.23 . . . . 5.4199999999999999 107.678 -179.824 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.593 ' HD2' ' CB ' ' A' ' 25' ' ' ASP . 25.3 Cg_endo -67.31 85.06 0.35 Allowed 'Trans proline' 0 C--N 1.295 -2.281 0 C-N-CA 122.037 1.825 . . . . 1.53 109.763 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.479 ' C ' ' O ' ' A' ' 26' ' ' PRO . 3.9 t -23.62 86.45 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.973 0 CA-C-N 115.332 -0.849 . . . . 1.8200000000000001 111.808 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.502 ' N ' ' O ' ' A' ' 26' ' ' PRO . 29.3 mm -77.97 143.43 12.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 C-N-CA 118.649 -1.22 . . . . 0.88 107.968 178.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.553 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 0.2 OUTLIER -129.67 -177.53 2.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 O-C-N 120.981 -1.074 . . . . 1.3100000000000001 112.142 -177.194 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 36.5 m-70 -114.51 166.57 11.57 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.415 0.626 . . . . 2.1899999999999999 110.496 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.606 ' CD ' ' O ' ' A' ' 98' ' ' ALA . 0.1 OUTLIER -122.13 10.54 10.05 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.732 0.777 . . . . 12.470000000000001 108.966 178.863 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' A' ' 95' ' ' PRO . . . -116.93 -5.88 14.81 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.649 -1.381 . . . . 3.0299999999999998 109.649 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.566 ' C ' ' HB ' ' A' ' 94' ' ' VAL . 6.9 mtpt -116.78 147.04 39.1 Favored Pre-proline 0 C--N 1.303 -1.441 0 N-CA-C 106.977 -1.49 . . . . 3.9100000000000001 106.977 178.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.552 ' O ' ' N ' ' A' ' 36' ' ' THR . 28.3 Cg_endo -66.65 102.98 0.65 Allowed 'Trans proline' 0 C--N 1.299 -2.039 0 C-N-CA 122.178 1.919 . . . . 1.25 111.919 -177.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.525 ' O ' ' HA ' ' A' ' 91' ' ' THR . 49.4 t80 -41.65 94.66 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.822 -1.177 . . . . 4.2000000000000002 107.822 178.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.552 ' N ' ' O ' ' A' ' 34' ' ' PRO . 19.3 m -114.51 78.11 1.12 Allowed 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.529 -0.868 . . . . 2.3900000000000001 110.548 -178.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.503 ' C ' ' CD1' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -77.46 131.25 37.87 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 106.294 -1.743 . . . . 2.3199999999999998 106.294 177.91 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.488 ' O ' ' HB1' ' A' ' 39' ' ' ALA . 3.8 mt-10 -142.83 178.82 7.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.683 -1.261 . . . . 2.9399999999999999 111.149 -177.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.488 ' HB1' ' O ' ' A' ' 38' ' ' GLU . . . 171.67 95.94 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.298 -1.371 . . . . 0.68999999999999995 107.298 178.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.589 ' HG ' ' CB ' ' A' ' 87' ' ' ASP . 0.0 OUTLIER -90.38 174.13 7.73 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.464 -0.773 . . . . 1.95 109.652 -178.418 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.656 ' CE1' ' CE2' ' A' ' 86' ' ' TYR . 20.8 p90 173.01 141.7 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.776 -1.202 . . . . 0.47999999999999998 110.184 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.508 ' O ' ' C ' ' A' ' 43' ' ' ALA . 9.1 p-10 -90.87 112.86 24.87 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 107.445 -1.317 . . . . 4.1100000000000003 107.445 178.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.573 ' HB3' ' HB3' ' A' ' 80' ' ' LEU . . . -33.31 123.89 0.4 Allowed 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 115.613 -0.721 . . . . 0.44 110.012 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -120.08 3.88 10.92 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.497 -0.752 . . . . 3.6600000000000001 110.822 -177.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.663 ' O ' ' N ' ' A' ' 82' ' ' LYS . 2.0 pt20 -97.69 -142.77 0.3 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.186 -0.946 . . . . 0.67000000000000004 108.598 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.722 ' HA ' ' HB ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -153.16 68.17 0.8 Allowed 'General case' 0 C--N 1.295 -1.781 0 O-C-N 121.285 -0.884 . . . . 0.40000000000000002 108.631 178.551 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.525 ' O ' ' CG2' ' A' ' 47' ' ' THR . 9.1 t -145.67 111.38 5.5 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.01 -1.681 . . . . 1.2 112.042 -177.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.649 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -59.69 -23.04 62.8 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.348 -1.353 . . . . 4.4400000000000004 107.348 177.152 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.1 p -82.86 -165.09 0.97 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.856 -0.528 . . . . 1.51 109.6 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.591 ' O ' ' CA ' ' A' ' 71' ' ' ASN . . . 178.14 155.5 0.37 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.277 -0.889 . . . . 0.5 109.128 -179.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 111' ' ' ILE . 19.7 mtmt -127.75 171.13 12.0 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.061 -1.459 . . . . 1.6799999999999999 107.061 178.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.542 HG12 ' CG1' ' A' ' 65' ' ' VAL . 3.0 tt -158.65 156.43 3.88 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 C-N-CA 118.221 -1.392 . . . . 0.92000000000000004 110.949 -179.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.524 ' O ' ' NZ ' ' A' ' 55' ' ' LYS . 4.1 tp10 -159.71 48.93 0.3 Allowed 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.267 -1.382 . . . . 3.6200000000000001 107.267 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.665 ' O ' ' HB ' ' A' ' 65' ' ' VAL . 1.3 mt -85.7 136.92 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 CA-C-O 122.354 1.074 . . . . 3.0699999999999998 111.201 -178.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.554 ' HG3' ' O ' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -144.01 98.05 3.16 Favored 'General case' 0 C--N 1.282 -2.365 0 O-C-N 121.0 -1.062 . . . . 1.7 109.972 178.972 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.508 ' O ' ' N ' ' A' ' 63' ' ' ILE . . . -107.35 132.5 53.07 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 107.814 -1.18 . . . . 1.8899999999999999 107.814 178.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' ' 62' ' ' GLU . 58.6 m -117.66 113.66 22.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.819 -1.176 . . . . 2.48 110.598 -178.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.45 ' O ' ' C ' ' A' ' 59' ' ' ASP . 0.2 OUTLIER -94.63 176.99 6.07 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.153 -1.054 . . . . 5.7199999999999998 108.153 178.909 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.483 ' HB2' ' HB2' ' A' ' 101' ' ' SER . 0.0 OUTLIER -44.12 -60.74 1.74 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.922 -1.111 . . . . 3.3399999999999999 109.235 -179.752 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.435 ' N ' ' CG ' ' A' ' 59' ' ' ASP . . . -129.27 10.24 6.19 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.517 -1.433 . . . . 2.3399999999999999 109.517 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.576 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 2.9 mm? -110.11 47.06 0.98 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.06 -1.259 . . . . 4.04 107.851 178.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 1.4 mt-10 -42.67 87.77 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 115.61 -0.723 . . . . 2.2999999999999998 110.929 -179.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.54 ' N ' ' O ' ' A' ' 61' ' ' LEU . 6.8 mt -62.93 164.9 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 N-CA-C 106.696 -1.594 . . . . 0.59999999999999998 106.696 177.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.497 ' O ' HG21 ' A' ' 65' ' ' VAL . 1.7 t0 -168.26 153.29 6.53 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.614 -1.304 . . . . 2.0099999999999998 110.186 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.665 ' HB ' ' O ' ' A' ' 54' ' ' ILE . 23.7 t -150.89 62.79 5.4 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.636 -0.665 . . . . 0.53000000000000003 110.04 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.592 ' HD3' ' N ' ' A' ' 65' ' ' VAL . 37.7 Cg_endo -84.96 95.45 0.66 Allowed 'Trans proline' 0 C--N 1.301 -1.938 0 C-N-CA 123.296 2.664 . . . . 1.1599999999999999 110.979 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.478 ' C ' ' O ' ' A' ' 66' ' ' PRO . . . 38.31 57.9 1.72 Allowed Glycine 0 N--CA 1.495 2.61 0 N-CA-C 109.621 -1.392 . . . . 2.9199999999999999 109.621 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.456 HG21 ' N ' ' A' ' 69' ' ' ASP . 22.7 mm -84.32 -94.04 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.278 -1.131 . . . . 3.52 109.948 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.483 ' OD2' ' HA ' ' A' ' 72' ' ' ALA . 35.5 p30 -51.64 166.06 0.15 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.175 -0.953 . . . . 1.5 110.038 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -69.27 -20.02 63.92 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.363 -0.836 . . . . 2.9199999999999999 109.607 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.591 ' CA ' ' O ' ' A' ' 50' ' ' ALA . 6.6 m-20 -175.57 73.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.785 -1.197 . . . . 0.88 111.307 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.552 ' CB ' ' HB2' ' A' ' 50' ' ' ALA . . . 40.33 26.89 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.562 -0.711 . . . . 0.94999999999999996 111.478 176.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.526 ' HB3' ' HB2' ' A' ' 78' ' ' CYS . 4.0 m -88.41 -49.25 7.05 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.909 -1.119 . . . . 3.0899999999999999 110.046 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.45 ' HB2' ' HB3' ' A' ' 69' ' ' ASP . 0.2 OUTLIER -59.17 -7.14 1.07 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.348 -0.845 . . . . 2.0099999999999998 111.957 -178.044 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.536 ' O ' ' CD1' ' A' ' 88' ' ' ILE . 83.8 m-85 -115.62 -10.12 11.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.489 -1.382 . . . . 0.5 110.644 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.724 ' CG2' ' CZ ' ' A' ' 86' ' ' TYR . 0.2 OUTLIER -164.51 175.91 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.871 -1.143 . . . . 0.48999999999999999 110.153 -178.483 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.664 ' N ' ' CG2' ' A' ' 76' ' ' VAL . 11.8 mmmt -61.55 93.15 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 106.226 -1.768 . . . . 3.5699999999999998 106.226 176.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . 0.526 ' HB2' ' HB3' ' A' ' 73' ' ' CYS . 4.1 t -37.91 -50.37 3.04 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.359 -0.838 . . . . 3.5299999999999998 111.79 -177.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.649 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 30.6 Cg_endo -74.71 108.27 2.66 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 N-CA-C 108.674 -1.318 . . . . 0.57999999999999996 108.674 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.573 ' HB3' ' HB3' ' A' ' 43' ' ' ALA . 0.6 OUTLIER -103.28 -66.71 0.92 Allowed 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 108.378 -0.971 . . . . 3.79 108.378 -178.701 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.722 ' HB ' ' HA ' ' A' ' 46' ' ' ASN . 1.4 m 41.45 -167.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 109.221 -0.659 . . . . 0.40999999999999998 109.221 178.048 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.663 ' N ' ' O ' ' A' ' 45' ' ' GLN . 0.0 OUTLIER -101.82 42.71 1.11 Allowed 'General case' 0 C--N 1.284 -2.267 0 O-C-N 120.261 -1.524 . . . . 4.4000000000000004 109.704 -176.98 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -146.62 37.3 1.21 Allowed Glycine 0 C--N 1.287 -2.143 0 N-CA-C 108.712 -1.755 . . . . 0.5 108.712 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 35.3 tp60 -152.52 143.44 22.99 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 121.157 -1.202 . . . . 3.5800000000000001 110.78 -179.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -117.59 134.5 54.81 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 105.596 -2.002 . . . . 3.1400000000000001 105.596 177.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.724 ' CZ ' ' CG2' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -163.4 163.58 24.95 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 117.514 -1.675 . . . . 0.59999999999999998 109.95 -177.42 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.594 ' N ' ' CD1' ' A' ' 86' ' ' TYR . 12.7 p-10 -133.14 102.29 5.53 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.852 -1.155 . . . . 0.58999999999999997 112.968 -176.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.536 ' CD1' ' O ' ' A' ' 75' ' ' PHE . 3.0 tp -70.26 -175.9 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 107.423 -1.325 . . . . 2.4700000000000002 107.423 176.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.544 ' O ' ' CD2' ' A' ' 90' ' ' TYR . 3.1 mttt 174.13 173.65 0.18 Allowed 'General case' 0 N--CA 1.5 2.07 0 O-C-N 120.852 -1.155 . . . . 1.1799999999999999 110.83 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.544 ' CD2' ' O ' ' A' ' 89' ' ' LYS . 5.8 m-85 -172.43 60.56 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 106.908 -1.516 . . . . 2.4100000000000001 106.908 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.529 ' HA ' ' HA ' ' A' ' 36' ' ' THR . 0.3 OUTLIER -90.25 -169.19 2.33 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.518 -0.739 . . . . 3.7200000000000002 111.667 -177.306 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.544 ' CH2' ' HB3' ' A' ' 61' ' ' LEU . 0.2 OUTLIER -171.2 151.63 3.21 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.581 -0.699 . . . . 8.2400000000000002 110.323 -178.973 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -81.89 142.73 32.23 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.908 -1.145 . . . . 3.3300000000000001 107.908 178.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.566 ' HB ' ' C ' ' A' ' 33' ' ' LYS . 51.5 t -147.89 112.97 3.92 Favored Pre-proline 0 C--N 1.305 -1.335 0 O-C-N 120.805 -1.185 . . . . 2.1800000000000002 111.667 -177.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.612 ' HD2' ' CD1' ' A' ' 97' ' ' ILE . 29.9 Cg_endo -74.56 -67.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 123.259 2.639 . . . . 3.8900000000000001 111.513 178.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.595 ' O ' ' HB3' ' A' ' 31' ' ' ARG . 0.4 OUTLIER -162.44 -33.65 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 107.368 -1.345 . . . . 6.6299999999999999 107.368 -179.826 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.612 ' CD1' ' HD2' ' A' ' 95' ' ' PRO . 1.4 mt 34.48 24.37 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 114.02 1.118 . . . . 2.8500000000000001 114.02 176.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.62 ' CB ' ' CD ' ' A' ' 99' ' ' PRO . . . 61.28 -177.2 0.03 OUTLIER Pre-proline 0 C--N 1.301 -1.513 0 O-C-N 120.279 -1.513 . . . . 1.5700000000000001 109.926 178.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.62 ' CD ' ' CB ' ' A' ' 98' ' ' ALA . 46.8 Cg_endo -86.53 151.23 8.97 Favored 'Trans proline' 0 C--N 1.302 -1.896 0 C-N-CA 123.645 2.896 . . . . 0.93000000000000005 111.052 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.512 ' HB2' ' O ' ' A' ' 99' ' ' PRO . 2.0 mptm? 64.08 142.91 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.965 0.888 . . . . 4.0700000000000003 112.419 175.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.497 ' O ' ' CB ' ' A' ' 102' ' ' GLU . 2.9 p -111.15 12.31 21.89 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.918 -0.771 . . . . 3.5 108.918 179.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.549 ' O ' ' CB ' ' A' ' 103' ' ' ASN . 0.8 OUTLIER 76.66 -5.98 2.09 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.603 -0.685 . . . . 3.1000000000000001 109.342 -179.425 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.549 ' CB ' ' O ' ' A' ' 102' ' ' GLU . 3.6 t-20 159.19 146.04 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.453 -0.78 . . . . 3.0899999999999999 109.45 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.541 HG22 ' CD1' ' A' ' 127' ' ' ILE . 0.1 OUTLIER -157.55 -174.3 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.255 -0.903 . . . . 0.65000000000000002 110.065 -179.76 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.525 ' CB ' ' O ' ' A' ' 104' ' ' VAL . 1.2 t 159.27 125.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.2 -1.037 . . . . 1.1200000000000001 108.2 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.499 ' O ' ' CG1' ' A' ' 106' ' ' VAL . 2.1 t -125.13 97.39 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 120.833 -1.167 . . . . 1.5900000000000001 110.555 -178.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.49 ' HB ' ' HE3' ' A' ' 55' ' ' LYS . 25.6 m -116.52 143.61 45.37 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.504 -1.295 . . . . 1.3100000000000001 107.504 178.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.549 ' CG1' HD12 ' A' ' 54' ' ' ILE . 88.0 t -151.15 152.89 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.59 -1.319 . . . . 1.55 110.585 -178.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -173.62 118.05 0.27 Allowed 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.798 0.809 . . . . 1.3100000000000001 109.472 178.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.562 ' HB3' ' HB2' ' A' ' 117' ' ' LEU . 9.8 tp -106.26 121.8 44.93 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 106.777 -1.564 . . . . 1.6299999999999999 106.777 178.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.507 ' O ' ' HB2' ' A' ' 51' ' ' LYS . 4.0 mt -121.11 117.49 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.25 -0.906 . . . . 1.5600000000000001 112.296 -176.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -86.23 -112.37 0.83 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 107.806 -2.117 . . . . 0.75 107.806 176.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -141.1 -0.1 1.49 Allowed 'General case' 0 C--N 1.307 -1.268 0 O-C-N 120.928 -1.337 . . . . 1.51 108.123 178.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.463 ' ND2' ' N ' ' A' ' 114' ' ' ASN . 0.2 OUTLIER -120.98 -5.59 9.56 Favored 'General case' 0 C--N 1.313 -0.985 0 O-C-N 121.163 -0.961 . . . . 1.1699999999999999 109.955 -179.923 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 160.56 164.47 15.6 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 109.641 -1.383 . . . . 1.3999999999999999 109.641 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.452 ' O ' HG11 ' A' ' 116' ' ' VAL . 2.1 p -70.62 110.54 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.112 -1.228 . . . . 1.26 109.455 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.562 ' HB2' ' HB3' ' A' ' 110' ' ' LEU . 1.3 mt -48.52 -51.46 27.28 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.465 -0.772 . . . . 1.5600000000000001 110.156 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -168.97 135.49 1.76 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.223 -0.923 . . . . 2.1899999999999999 109.597 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 22.0 p -126.13 -162.31 1.12 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.916 -1.115 . . . . 1.8899999999999999 110.637 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 171.24 124.86 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.38 -0.97 . . . . 0.48999999999999999 108.38 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.2 mp -133.69 126.62 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 120.976 -1.078 . . . . 2.1000000000000001 110.798 -178.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.479 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . . . -111.43 82.16 1.56 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.208 -1.034 . . . . 1.1799999999999999 108.208 178.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.54 ' CG2' ' O ' ' A' ' 123' ' ' THR . 0.5 OUTLIER -33.52 125.04 0.42 Allowed 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.563 0.697 . . . . 3.7400000000000002 110.666 -179.083 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.475 ' O ' ' O ' ' A' ' 123' ' ' THR . 8.1 m170 54.41 163.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.555 -0.716 . . . . 3.6299999999999999 109.786 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -153.88 129.72 2.73 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.401 -1.48 . . . . 1.6599999999999999 109.401 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 28' ' ' ILE . 5.7 mtmt -153.23 119.17 5.39 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.328 -1.101 . . . . 3.0299999999999998 108.536 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.552 HG22 ' CG ' ' A' ' 31' ' ' ARG . 1.5 mp -94.12 160.67 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.234 -0.916 . . . . 1.78 110.506 -178.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.522 ' C ' ' HA ' ' A' ' 99' ' ' PRO . 1.4 mtm180 -150.8 -174.72 4.87 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 109.016 -0.735 . . . . 4.1799999999999997 109.016 178.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.523 ' N ' ' HB3' ' A' ' 99' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 117.917 -1.04 . . . . 7.7800000000000002 109.708 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.491 ' O ' ' HG3' ' A' ' 2' ' ' GLN . 14.5 m-20 . . . . . 0 N--CA 1.492 1.644 0 N-CA-C 109.6 -0.518 . . . . 4.3600000000000003 109.6 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.493 ' O ' ' C ' ' A' ' 3' ' ' VAL . 4.4 pt20 37.41 31.93 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.691 -0.485 . . . . 3.1899999999999999 109.691 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.553 HG13 ' N ' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -33.74 144.95 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-O 121.367 0.603 . . . . 2.27 110.402 -179.562 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.489 ' O ' ' N ' ' A' ' 24' ' ' SER . 5.3 t70 -89.64 148.83 23.09 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.419 -0.801 . . . . 2.4700000000000002 109.437 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.465 HG11 ' O ' ' A' ' 4' ' ' ASP . 0.0 OUTLIER -156.08 167.24 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.353 -0.842 . . . . 2.0699999999999998 108.988 179.961 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.544 ' N ' ' HD3' ' A' ' 6' ' ' LYS . 1.4 mptt -80.02 76.92 6.74 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.073 -1.084 . . . . 4.3799999999999999 108.073 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.511 ' HB2' ' O ' ' A' ' 119' ' ' CYS . 51.6 p30 -94.35 168.38 10.93 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.832 0.825 . . . . 0.91000000000000003 110.436 -178.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.54 ' N ' ' SG ' ' A' ' 119' ' ' CYS . 29.2 m -113.17 -36.1 5.16 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.031 -1.47 . . . . 3.2599999999999998 107.031 178.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.559 ' O ' ' CB ' ' A' ' 10' ' ' ASN . . . -64.14 -144.84 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.358 -0.979 . . . . 5.0199999999999996 108.358 177.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.559 ' CB ' ' O ' ' A' ' 9' ' ' ALA . 0.1 OUTLIER 80.45 -42.92 0.22 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 120.506 -0.477 . . . . 10.369999999999999 110.874 177.372 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -63.38 -17.73 62.94 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.957 -1.089 . . . . 5.1299999999999999 108.23 178.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.418 ' HG2' ' HB3' ' A' ' 44' ' ' ASN . 13.1 tp10 -132.37 -28.78 1.64 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.673 -0.642 . . . . 4.3099999999999996 109.575 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.698 HG12 ' HB3' ' A' ' 41' ' ' PHE . 10.4 mt -48.43 154.7 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.09 -1.006 . . . . 2.0600000000000001 109.825 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.444 ' N ' ' CG2' ' A' ' 13' ' ' ILE . 0.0 OUTLIER -110.91 -23.21 11.11 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.784 -0.821 . . . . 1.1899999999999999 108.784 179.776 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -156.99 122.07 4.57 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 119.202 -0.999 . . . . 3.1499999999999999 109.657 -178.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.472 ' O ' ' HG3' ' A' ' 17' ' ' MET . 4.5 p -155.3 104.65 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.074 -1.016 . . . . 1.49 109.412 -179.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.472 ' HG3' ' O ' ' A' ' 16' ' ' VAL . 3.0 mpp? -150.42 152.74 34.78 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.202 -0.936 . . . . 1.6000000000000001 110.493 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.614 HG13 ' CZ ' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -121.4 106.04 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 108.087 -1.079 . . . . 1.04 108.087 178.535 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.431 ' HB3' ' O ' ' A' ' 34' ' ' PRO . 1.2 t0 -52.49 86.92 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.644 -0.66 . . . . 1.8700000000000001 110.928 -178.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.534 ' O ' ' HB3' ' A' ' 21' ' ' CYS . . . 98.46 -169.96 24.04 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 120.035 -1.078 . . . . 2.0099999999999998 110.928 178.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.597 ' HA ' ' HA ' ' A' ' 29' ' ' ILE . 36.2 t 86.14 -25.52 0.11 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 122.268 -0.548 . . . . 1.53 110.193 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.581 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 0.3 OUTLIER 42.2 83.99 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.858 -1.151 . . . . 2.6000000000000001 108.973 -179.192 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.497 ' O ' ' CB ' ' A' ' 24' ' ' SER . . . -83.39 -144.56 5.77 Favored Glycine 0 N--CA 1.498 2.811 0 O-C-N 121.489 -0.757 . . . . 1.8400000000000001 112.327 -178.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.497 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 0.1 OUTLIER 78.46 -79.38 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 107.45 -1.315 . . . . 1.3999999999999999 107.45 -177.818 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.668 ' HB2' ' CD ' ' A' ' 26' ' ' PRO . 7.3 p30 -84.87 -149.4 0.0 OUTLIER Pre-proline 0 C--N 1.298 -1.67 0 N-CA-C 105.263 -2.125 . . . . 2.3900000000000001 105.263 177.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.668 ' CD ' ' HB2' ' A' ' 25' ' ' ASP . 25.9 Cg_endo -70.07 102.36 1.07 Allowed 'Trans proline' 0 C--N 1.32 -0.969 0 CA-C-N 121.168 1.453 . . . . 1.6699999999999999 108.601 179.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.581 ' HA ' ' O ' ' A' ' 22' ' ' HIS . 3.2 t -54.72 81.23 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 115.42 -0.809 . . . . 1.6299999999999999 113.07 -176.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.534 ' O ' ' O ' ' A' ' 21' ' ' CYS . 0.6 OUTLIER -83.09 145.29 8.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 106.863 -1.532 . . . . 3.0 106.863 176.475 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.597 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -113.35 -175.95 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 O-C-N 120.756 -1.215 . . . . 1.1100000000000001 111.827 -176.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 34.5 m-70 -127.04 107.25 9.88 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 119.952 -0.699 . . . . 2.2599999999999998 111.269 -178.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.553 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -53.86 149.1 9.22 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.492 -0.755 . . . . 4.3499999999999996 109.038 178.353 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.506 ' HA2' ' O ' ' A' ' 95' ' ' PRO . . . 92.06 -1.97 74.78 Favored Glycine 0 N--CA 1.493 2.478 0 C-N-CA 119.814 -1.184 . . . . 2.1699999999999999 110.61 178.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.569 ' O ' HG13 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -124.12 139.97 33.83 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 120.963 -1.316 . . . . 3.0499999999999998 109.479 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.431 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 27.0 Cg_endo -64.93 134.72 41.21 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.398 2.065 . . . . 2.8199999999999998 110.935 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.614 ' CZ ' HG13 ' A' ' 18' ' ' VAL . 5.1 t80 -114.41 60.72 0.67 Allowed 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.466 -0.568 . . . . 1.3300000000000001 109.466 -178.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.423 ' O ' ' O ' ' A' ' 37' ' ' LEU . 81.5 m -73.08 81.97 1.26 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.303 -0.873 . . . . 2.52 109.09 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.52 ' O ' ' CG ' ' A' ' 38' ' ' GLU . 3.0 mp -52.7 -178.21 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.189 -0.945 . . . . 6.3399999999999999 108.653 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.546 ' CG ' ' HG2' ' A' ' 89' ' ' LYS . 0.1 OUTLIER 166.73 158.56 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.916 -1.115 . . . . 2.7000000000000002 109.795 -179.602 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.484 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . 171.81 83.41 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.697 0.76 . . . . 1.29 109.506 178.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.607 ' HG ' ' HA ' ' A' ' 87' ' ' ASP . 0.6 OUTLIER -82.12 165.05 20.89 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 108.269 -1.011 . . . . 2.4900000000000002 108.269 179.031 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.763 ' CZ ' ' CD2' ' A' ' 86' ' ' TYR . 0.4 OUTLIER -156.79 164.85 37.63 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.323 -1.362 . . . . 1.3300000000000001 107.323 176.285 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.411 ' O ' ' C ' ' A' ' 43' ' ' ALA . 1.0 OUTLIER -116.85 116.38 27.34 Favored 'General case' 0 C--N 1.29 -2.013 0 C-N-CA 119.309 -0.957 . . . . 2.4900000000000002 108.584 -179.8 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.568 ' CB ' ' O ' ' A' ' 81' ' ' VAL . . . -46.81 119.59 2.57 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 107.386 -1.339 . . . . 0.47999999999999998 107.386 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.437 ' C ' ' HB3' ' A' ' 82' ' ' LYS . 0.1 OUTLIER -130.63 19.38 5.16 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.699 0.761 . . . . 3.3199999999999998 108.999 -178.15 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.635 ' OE1' ' HB2' ' A' ' 80' ' ' LEU . 3.0 pt20 -109.37 -139.41 0.38 Allowed 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.512 -0.742 . . . . 0.91000000000000003 110.408 -178.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.57 ' N ' ' HA ' ' A' ' 81' ' ' VAL . 3.4 m120 -158.55 53.43 0.43 Allowed 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.531 -0.914 . . . . 5.2800000000000002 108.531 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.599 ' N ' ' CG2' ' A' ' 81' ' ' VAL . 10.4 t -134.78 127.47 30.95 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.386 -1.446 . . . . 2.8700000000000001 110.555 -178.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.626 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -70.71 -20.15 62.69 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.012 -1.055 . . . . 5.8499999999999996 108.934 178.744 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.451 ' OG1' ' OG1' ' A' ' 47' ' ' THR . 24.7 p -73.79 178.81 4.59 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.922 0.868 . . . . 3.4199999999999999 111.077 -178.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.562 ' O ' ' CA ' ' A' ' 71' ' ' ASN . . . 177.52 131.06 0.06 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.258 -1.386 . . . . 1.6000000000000001 107.258 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.522 ' O ' ' C ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -136.11 48.55 2.16 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 120.104 -1.623 . . . . 3.0800000000000001 109.91 -178.628 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.522 ' C ' ' O ' ' A' ' 51' ' ' LYS . 2.0 tt -28.29 146.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.178 0 CA-C-N 115.451 -0.795 . . . . 3.2400000000000002 110.361 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.439 ' C ' ' HE2' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -137.95 82.96 1.95 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.301 -0.874 . . . . 3.0899999999999999 109.474 -179.818 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.693 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 0.5 OUTLIER -108.57 141.51 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.293 -0.879 . . . . 0.87 109.278 179.651 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.693 ' HG3' ' O ' ' A' ' 54' ' ' ILE . 0.2 OUTLIER -152.4 90.18 1.48 Allowed 'General case' 0 C--N 1.285 -2.204 0 O-C-N 121.348 -0.845 . . . . 1.6599999999999999 109.175 178.462 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.483 ' CB ' ' HB ' ' A' ' 63' ' ' ILE . . . -109.36 145.21 36.44 Favored 'General case' 0 C--N 1.292 -1.897 0 O-C-N 121.512 -0.743 . . . . 0.69999999999999996 109.551 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.476 ' O ' ' CG1' ' A' ' 104' ' ' VAL . 30.3 m -128.12 137.13 51.99 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.972 -1.08 . . . . 3.0099999999999998 109.142 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.574 ' HB3' ' CB ' ' A' ' 61' ' ' LEU . 0.2 OUTLIER -135.39 158.33 44.64 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.28 -0.887 . . . . 2.6499999999999999 109.198 -179.604 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.432 ' HB2' ' HB2' ' A' ' 101' ' ' SER . 18.1 t70 -48.86 -63.89 0.96 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.274 -0.892 . . . . 3.2400000000000002 108.608 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -108.17 24.89 21.85 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 108.862 -1.695 . . . . 1.23 108.862 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.574 ' CB ' ' HB3' ' A' ' 58' ' ' LEU . 0.4 OUTLIER -146.33 66.48 1.19 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.269 -1.136 . . . . 4.5599999999999996 109.118 -179.709 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.09 82.44 0.51 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.469 -0.769 . . . . 2.1800000000000002 109.985 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.483 ' HB ' ' CB ' ' A' ' 56' ' ' ALA . 8.5 mt -66.85 169.44 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 120.866 -1.146 . . . . 0.89000000000000001 108.091 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.443 ' O ' HG21 ' A' ' 65' ' ' VAL . 0.5 OUTLIER 175.9 145.75 0.08 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.018 -1.052 . . . . 1.0600000000000001 109.469 -179.791 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.63 ' HB ' ' O ' ' A' ' 54' ' ' ILE . 14.5 t -144.39 63.93 11.59 Favored Pre-proline 0 N--CA 1.488 1.425 0 O-C-N 121.318 -0.864 . . . . 1.25 110.01 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.538 ' HD3' ' N ' ' A' ' 65' ' ' VAL . 36.4 Cg_endo -79.34 94.61 1.05 Allowed 'Trans proline' 0 C--N 1.298 -2.105 0 C-N-CA 122.918 2.412 . . . . 2.0299999999999998 110.328 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.466 ' C ' ' O ' ' A' ' 66' ' ' PRO . . . 36.45 46.96 1.11 Allowed Glycine 0 N--CA 1.496 2.688 0 N-CA-C 110.119 -1.192 . . . . 2.2400000000000002 110.119 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.502 ' CG2' ' N ' ' A' ' 69' ' ' ASP . 1.9 mm -63.5 -75.05 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.245 -1.15 . . . . 2.54 109.721 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.586 ' HB3' ' CG ' ' A' ' 74' ' ' HIS . 6.4 p-10 -77.96 162.81 26.5 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.113 -0.992 . . . . 1.8200000000000001 109.369 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.536 ' O ' ' ND2' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -57.11 -55.57 33.0 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.435 -0.791 . . . . 3.0899999999999999 110.318 -179.449 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.562 ' CA ' ' O ' ' A' ' 50' ' ' ALA . 2.7 m120 -147.45 87.69 1.66 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.913 -1.117 . . . . 3.0600000000000001 111.488 -178.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.551 ' N ' ' OD2' ' A' ' 69' ' ' ASP . . . 37.2 26.77 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.895 -0.503 . . . . 0.48999999999999999 111.986 176.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.525 ' N ' ' O ' ' A' ' 71' ' ' ASN . 4.3 t -99.46 0.73 43.16 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 120.88 -1.137 . . . . 1.1399999999999999 111.23 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.586 ' CG ' ' HB3' ' A' ' 69' ' ' ASP . 0.3 OUTLIER -90.7 -29.54 17.64 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.757 -1.214 . . . . 3.1600000000000001 109.687 179.811 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.505 ' O ' ' HB ' ' A' ' 76' ' ' VAL . 13.5 m-85 -103.6 14.07 31.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.362 -0.836 . . . . 2.0499999999999998 109.29 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.752 ' CG1' ' CZ ' ' A' ' 86' ' ' TYR . 5.4 p 178.27 -142.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-O 121.787 0.804 . . . . 3.3500000000000001 109.512 -177.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.566 ' H ' ' CG2' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -99.03 158.69 15.48 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 106.304 -1.739 . . . . 4.7400000000000002 106.304 177.049 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . 0.562 ' N ' ' CD ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -81.96 -48.62 0.94 Allowed Pre-proline 0 N--CA 1.493 1.694 0 C-N-CA 118.054 -1.458 . . . . 2.5800000000000001 109.544 179.866 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.626 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 32.0 Cg_endo -77.2 114.92 3.87 Favored 'Trans proline' 0 C--N 1.302 -1.904 0 N-CA-C 107.498 -1.77 . . . . 2.5 107.498 178.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.635 ' HB2' ' OE1' ' A' ' 45' ' ' GLN . 0.1 OUTLIER -85.96 -69.19 0.68 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 106.588 -1.634 . . . . 1.52 106.588 -179.11 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.599 ' CG2' ' N ' ' A' ' 47' ' ' THR 0.256 48.4 t 50.06 -174.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 C-N-CA 118.276 -1.37 . . . . 4.0700000000000003 109.262 175.488 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.556 ' HA ' ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -104.56 47.32 0.88 Allowed 'General case' 0 C--N 1.293 -1.884 0 O-C-N 121.143 -0.973 . . . . 3.4500000000000002 110.008 -179.381 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -137.43 11.19 3.78 Favored Glycine 0 N--CA 1.491 2.309 0 C-N-CA 118.734 -1.698 . . . . 0.53000000000000003 113.059 -178.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.482 ' NE2' ' O ' ' A' ' 79' ' ' PRO . 1.2 pt20 -148.92 171.05 16.95 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 120.452 2.126 . . . . 6.1900000000000004 111.334 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -108.02 142.1 38.68 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.775 0.798 . . . . 5.9699999999999998 110.956 -178.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.763 ' CD2' ' CZ ' ' A' ' 41' ' ' PHE . 0.4 OUTLIER -99.62 173.18 6.85 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.069 0.462 . . . . 3.8900000000000001 110.576 -179.61 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.607 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 9.9 p-10 176.83 83.64 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.464 -0.773 . . . . 3.4700000000000002 110.918 178.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.537 HG12 ' N ' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -127.87 146.06 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 107.313 -1.366 . . . . 3.5899999999999999 107.313 178.409 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.546 ' HG2' ' CG ' ' A' ' 38' ' ' GLU . 1.7 mtmt -147.62 -169.37 3.3 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.955 -1.091 . . . . 3.96 111.797 -177.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.587 ' CZ ' HG22 ' A' ' 54' ' ' ILE . 67.4 m-85 -156.7 126.64 6.36 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 107.728 -1.212 . . . . 1.1899999999999999 107.728 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.31 156.67 30.81 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.587 -1.32 . . . . 4.0099999999999998 110.842 -178.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.531 ' C ' ' CD1' ' A' ' 92' ' ' TRP . 3.3 t90 -143.19 109.97 5.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.548 -0.72 . . . . 6.3099999999999996 109.168 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -61.08 120.13 9.68 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.685 -1.228 . . . . 4.7300000000000004 107.685 178.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.603 ' CG1' ' CD1' ' A' ' 97' ' ' ILE . 18.4 t -114.68 95.94 42.34 Favored Pre-proline 0 N--CA 1.489 1.499 0 C-N-CA 119.028 -1.069 . . . . 2.6299999999999999 111.573 -178.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.52 ' HD2' ' CD1' ' A' ' 97' ' ' ILE . 31.0 Cg_endo -75.88 -79.52 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.939 2.426 . . . . 3.1699999999999999 109.269 177.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.553 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 5.5 tptt -137.52 -59.63 0.67 Allowed 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 104.662 -2.347 . . . . 4.71 104.662 177.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.603 ' CD1' ' CG1' ' A' ' 94' ' ' VAL . 1.2 mp 66.59 5.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 O-C-N 121.679 -0.638 . . . . 2.1000000000000001 112.711 174.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.618 ' CB ' ' HD2' ' A' ' 99' ' ' PRO . . . 54.86 177.96 0.03 OUTLIER Pre-proline 0 C--N 1.302 -1.459 0 O-C-N 120.408 -1.433 . . . . 1.53 109.256 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.618 ' HD2' ' CB ' ' A' ' 98' ' ' ALA . 46.4 Cg_endo -80.5 155.46 21.48 Favored 'Trans proline' 0 C--N 1.3 -1.984 0 C-N-CA 123.525 2.816 . . . . 1.5 110.345 -179.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.622 ' HD3' ' CB ' ' A' ' 128' ' ' ARG . 1.4 mmmp? 56.91 149.47 0.01 OUTLIER 'General case' 0 C--N 1.29 -1.987 0 CA-C-O 122.157 0.98 . . . . 3.77 112.184 176.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.517 ' OG ' HG23 ' A' ' 104' ' ' VAL . 78.0 p -129.68 164.72 23.32 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.118 -0.697 . . . . 2.3100000000000001 109.118 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.556 ' O ' ' CB ' ' A' ' 103' ' ' ASN . 4.3 mt-10 -51.04 -22.22 2.25 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.147 -0.971 . . . . 2.9700000000000002 109.023 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.556 ' CB ' ' O ' ' A' ' 102' ' ' GLU . 0.3 OUTLIER 157.1 157.02 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.563 -0.903 . . . . 3.2000000000000002 108.563 -179.713 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.522 HG22 ' CD1' ' A' ' 127' ' ' ILE . 0.2 OUTLIER -152.07 174.58 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.05 -1.031 . . . . 0.91000000000000003 109.611 -179.919 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 56' ' ' ALA . 1.2 t 164.57 130.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 108.06 -1.089 . . . . 1.3799999999999999 108.06 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 3.6 t -128.56 102.98 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.899 -1.125 . . . . 1.77 110.562 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.431 ' C ' HG21 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -108.64 147.45 31.85 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.366 -0.975 . . . . 1.52 108.366 178.905 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.478 HG11 ' CD1' ' A' ' 54' ' ' ILE . 1.5 t -151.69 153.32 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.696 -1.252 . . . . 3.4300000000000002 110.546 -179.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 119' ' ' CYS . 0.4 OUTLIER 172.48 116.15 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.503 -0.748 . . . . 2.5800000000000001 110.334 178.796 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.541 ' CD2' HD13 ' A' ' 80' ' ' LEU . 32.7 tp -104.04 127.89 51.61 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.684 -1.228 . . . . 3.1600000000000001 107.684 177.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.487 ' O ' ' HG3' ' A' ' 51' ' ' LYS . 10.3 mt -125.88 136.83 59.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 O-C-N 121.277 -0.89 . . . . 1.3100000000000001 110.431 -178.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -100.07 -109.86 3.13 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 108.099 -2.0 . . . . 1.4299999999999999 108.099 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -145.34 11.91 1.34 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.353 -1.351 . . . . 3.1400000000000001 107.353 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.419 ' OD1' ' NE2' ' A' ' 45' ' ' GLN . 1.3 p30 -127.53 -33.17 2.35 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.547 0.689 . . . . 4.1500000000000004 109.483 -178.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -179.91 156.61 18.45 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.107 -1.597 . . . . 1.6899999999999999 109.107 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -57.02 112.54 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.147 -1.208 . . . . 1.3799999999999999 109.918 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.551 ' CD2' HD11 ' A' ' 80' ' ' LEU . 2.9 mt -55.54 -68.02 0.23 Allowed 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.608 -0.886 . . . . 2.0499999999999998 108.608 179.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.548 ' O ' ' HB3' ' A' ' 119' ' ' CYS . . . -130.39 -177.98 4.56 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.296 -1.002 . . . . 0.79000000000000004 108.296 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . 0.548 ' HB3' ' O ' ' A' ' 118' ' ' ALA . 0.1 OUTLIER 169.15 155.8 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.08 -1.013 . . . . 1.1200000000000001 110.145 179.777 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.467 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . . . -176.88 129.68 0.18 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.314 -0.866 . . . . 1.6399999999999999 109.416 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.3 mt -122.73 131.72 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.138 -0.977 . . . . 1.29 109.886 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -85.79 -35.81 20.48 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.337 -0.986 . . . . 2.2599999999999998 108.337 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.408 ' O ' ' O ' ' A' ' 124' ' ' HIS . 2.4 m 64.77 121.41 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.61 -0.681 . . . . 2.9700000000000002 110.372 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.408 ' O ' ' O ' ' A' ' 123' ' ' THR . 3.9 m170 48.02 98.03 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.543 -0.723 . . . . 3.3199999999999998 110.771 178.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.465 ' O ' ' HB ' ' A' ' 104' ' ' VAL . . . -116.83 119.38 4.46 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 108.294 -1.922 . . . . 1.75 108.294 178.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -137.27 140.02 41.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.949 -1.324 . . . . 3.5099999999999998 110.587 -178.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.685 ' O ' ' CB ' ' A' ' 128' ' ' ARG . 2.2 mp -83.16 149.53 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 108.292 -1.003 . . . . 1.54 108.292 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.685 ' CB ' ' O ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER 137.22 -82.11 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 108.96 -0.755 . . . . 4.5899999999999999 108.96 179.355 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.442 ' N ' ' CD ' ' A' ' 128' ' ' ARG . 13.1 t70 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 117.948 -1.025 . . . . 4.5 109.382 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.526 ' C ' ' CG ' ' A' ' 2' ' ' GLN . 5.2 m-20 . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.31 -0.626 . . . . 4.4199999999999999 109.31 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.56 ' HA ' ' CG ' ' A' ' 17' ' ' MET . 0.8 OUTLIER 37.35 30.07 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.647 -0.658 . . . . 4.54 110.589 179.166 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.515 HG23 ' HB ' ' A' ' 18' ' ' VAL . 28.8 m -44.46 122.17 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.28 -0.887 . . . . 2.9700000000000002 108.815 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.489 ' O ' ' HA3' ' A' ' 23' ' ' GLY . 8.3 t70 -55.39 134.61 50.39 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.449 -0.782 . . . . 2.1699999999999999 110.586 -179.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.3 171.16 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 108.224 -1.028 . . . . 1.22 108.224 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 120' ' ' ALA . 27.4 mtpt -105.33 101.47 11.0 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.787 -1.196 . . . . 3.96 110.007 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.483 ' HA ' ' O ' ' A' ' 119' ' ' CYS . 65.1 m-20 -97.19 170.69 8.93 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.472 -0.768 . . . . 4.04 109.362 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.515 ' N ' ' SG ' ' A' ' 119' ' ' CYS . 3.8 m -138.69 4.64 2.36 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.34 -0.85 . . . . 1.49 109.639 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.531 ' CB ' ' HA ' ' A' ' 118' ' ' ALA . . . -47.09 -62.73 1.28 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.07 -1.019 . . . . 0.70999999999999996 109.586 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.444 ' OD1' ' OD1' ' A' ' 11' ' ' ASN . 1.1 t-20 178.83 -81.85 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.919 -0.712 . . . . 4.7800000000000002 109.301 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.444 ' OD1' ' OD1' ' A' ' 10' ' ' ASN . 14.3 p-10 -164.45 42.26 0.09 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.55 -0.719 . . . . 4.3499999999999996 109.214 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.506 ' O ' ' HB ' ' A' ' 13' ' ' ILE . 0.7 OUTLIER -163.68 -81.94 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.231 -0.918 . . . . 3.7799999999999998 109.566 -179.819 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.526 ' CG2' ' O ' ' A' ' 15' ' ' LYS . 0.1 OUTLIER 74.22 -2.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 CA-C-O 121.784 0.802 . . . . 3.79 110.257 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.524 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 15.1 mttm 65.99 -19.21 0.1 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.043 -1.036 . . . . 2.77 111.771 178.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.526 ' O ' ' CG2' ' A' ' 13' ' ' ILE . 0.0 OUTLIER 166.14 151.24 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.399 0 O-C-N 120.685 -1.26 . . . . 1.6499999999999999 109.029 -178.073 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.557 ' CG1' ' O ' ' A' ' 16' ' ' VAL . 12.6 p -169.46 100.8 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.129 -0.982 . . . . 1.3799999999999999 109.019 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.56 ' CG ' ' HA ' ' A' ' 2' ' ' GLN . 2.1 mpp? -151.19 150.16 30.28 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.589 -0.845 . . . . 1.8899999999999999 110.196 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.633 ' CG1' ' CE1' ' A' ' 35' ' ' PHE . 19.2 t -117.0 160.24 16.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 107.794 -1.188 . . . . 2.4100000000000001 107.794 178.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.569 ' CB ' ' O ' ' A' ' 34' ' ' PRO . 16.3 m-20 -94.91 36.17 1.21 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.835 -1.166 . . . . 1.6899999999999999 110.021 -179.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.547 ' O ' ' CB ' ' A' ' 21' ' ' CYS . . . 130.45 128.9 3.04 Favored Glycine 0 N--CA 1.487 2.079 0 C-N-CA 119.523 -1.322 . . . . 1.77 110.131 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.587 ' HB2' HG22 ' A' ' 29' ' ' ILE . 0.0 OUTLIER 154.67 -36.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.538 -0.912 . . . . 0.91000000000000003 108.538 179.132 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.583 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 7.2 t-160 66.44 116.27 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.181 -1.044 . . . . 5.3099999999999996 108.181 -178.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.537 ' O ' ' CB ' ' A' ' 24' ' ' SER . . . -103.67 176.2 23.9 Favored Glycine 0 N--CA 1.496 2.657 0 C-N-CA 119.064 -1.541 . . . . 1.1000000000000001 110.392 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.537 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 1.3 t 84.75 -69.4 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.677 -0.896 . . . . 1.02 110.164 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.692 ' CB ' ' CD ' ' A' ' 26' ' ' PRO . 0.8 OUTLIER -83.57 -157.2 0.01 OUTLIER Pre-proline 0 C--N 1.304 -1.388 0 N-CA-C 108.274 -1.01 . . . . 4.4900000000000002 108.274 -179.779 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.692 ' CD ' ' CB ' ' A' ' 25' ' ' ASP . 28.4 Cg_endo -74.38 89.53 1.07 Allowed 'Trans proline' 0 C--N 1.324 -0.76 0 N-CA-C 108.483 -1.391 . . . . 0.72999999999999998 108.483 179.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.583 ' HA ' ' O ' ' A' ' 22' ' ' HIS . 1.6 t -38.4 95.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 113.244 0.831 . . . . 0.88 113.244 -177.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.493 ' O ' ' O ' ' A' ' 21' ' ' CYS . 24.1 mm -89.9 141.29 14.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 104.784 -2.302 . . . . 0.91000000000000003 104.784 174.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.587 HG22 ' HB2' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -119.45 179.94 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 O-C-N 120.215 -1.553 . . . . 1.23 112.886 -176.086 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.511 ' NE2' ' OD2' ' A' ' 129' ' ' ASP . 14.3 m170 -117.55 157.18 26.79 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.787 0.803 . . . . 4.2699999999999996 110.828 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.564 ' HD3' ' CA ' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -115.43 154.55 29.06 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 107.76 -1.2 . . . . 1.9299999999999999 107.76 178.285 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.475 ' C ' HG13 ' A' ' 94' ' ' VAL . . . 89.51 -1.01 81.3 Favored Glycine 0 N--CA 1.495 2.602 0 C-N-CA 119.582 -1.294 . . . . 0.44 110.073 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.566 ' O ' ' CG2' ' A' ' 94' ' ' VAL . 12.6 mtmt -128.65 146.72 61.28 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.257 -1.143 . . . . 2.3599999999999999 108.284 179.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.569 ' O ' ' CB ' ' A' ' 19' ' ' ASP . 28.9 Cg_endo -66.26 109.89 1.66 Allowed 'Trans proline' 0 C--N 1.303 -1.855 0 C-N-CA 122.487 2.125 . . . . 0.62 110.199 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.633 ' CE1' ' CG1' ' A' ' 18' ' ' VAL . 47.5 t80 -81.11 70.3 7.91 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.414 0.626 . . . . 1.8500000000000001 109.602 -179.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.48 HG23 ' OE2' ' A' ' 38' ' ' GLU . 32.9 m -90.91 76.69 6.25 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.439 -0.788 . . . . 1.1799999999999999 109.816 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 37' ' ' LEU . 1.6 pp -68.48 141.79 55.5 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.611 -1.255 . . . . 1.3300000000000001 107.611 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.527 ' O ' ' CB ' ' A' ' 39' ' ' ALA . 14.2 mt-10 -142.21 -160.17 1.06 Allowed 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.82 -1.175 . . . . 1.04 110.995 -178.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.527 ' CB ' ' O ' ' A' ' 38' ' ' GLU . . . 156.35 96.44 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.153 -1.425 . . . . 0.58999999999999997 107.153 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.663 ' HG ' ' CB ' ' A' ' 87' ' ' ASP . 0.3 OUTLIER -91.4 -176.88 4.68 Favored 'General case' 0 C--N 1.294 -1.82 0 O-C-N 121.546 -0.721 . . . . 0.85999999999999999 110.371 -177.813 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.654 ' CE1' ' CE2' ' A' ' 86' ' ' TYR . 12.0 p90 175.37 147.74 0.09 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.393 -0.817 . . . . 0.44 109.147 177.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.465 ' O ' ' OD1' ' A' ' 44' ' ' ASN . 0.6 OUTLIER -98.72 112.41 24.49 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.441 -0.948 . . . . 4.3600000000000003 108.441 179.747 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.606 ' HB3' ' HB3' ' A' ' 80' ' ' LEU . . . -36.78 125.32 0.88 Allowed 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 115.932 -0.576 . . . . 0.45000000000000001 110.245 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.465 ' OD1' ' O ' ' A' ' 42' ' ' ASP . 1.7 m-80 -125.77 38.98 4.05 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.23 -0.919 . . . . 1.3999999999999999 109.417 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.634 ' OE1' ' HB2' ' A' ' 80' ' ' LEU . 3.4 pt20 -128.1 -129.72 0.22 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.417 -0.802 . . . . 1.1399999999999999 110.327 -178.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.628 ' N ' ' HA ' ' A' ' 81' ' ' VAL . 0.8 OUTLIER -169.78 54.61 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.644 -0.873 . . . . 6.3799999999999999 108.644 179.469 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.583 ' N ' HG21 ' A' ' 81' ' ' VAL . 10.1 t -133.68 138.21 45.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.809 -1.182 . . . . 2.2200000000000002 110.57 -178.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.691 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 0.6 OUTLIER -83.91 -11.55 56.74 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 120.897 -1.127 . . . . 4.3799999999999999 108.251 177.625 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.447 ' O ' ' HB1' ' A' ' 50' ' ' ALA . 2.6 p -95.67 -155.87 0.49 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.394 -0.816 . . . . 1.02 109.449 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.58 ' O ' ' CA ' ' A' ' 71' ' ' ASN . . . 177.64 154.14 0.29 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.389 -0.819 . . . . 0.62 109.963 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.537 ' O ' ' CB ' ' A' ' 72' ' ' ALA . 19.9 mtpt -115.92 -175.38 2.72 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 106.385 -1.709 . . . . 3.3399999999999999 106.385 177.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.545 HG13 HD11 ' A' ' 54' ' ' ILE . 3.1 tt -164.87 158.67 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 C-N-CA 117.692 -1.603 . . . . 1.1200000000000001 111.343 -179.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.451 ' O ' ' HE2' ' A' ' 55' ' ' LYS . 0.8 OUTLIER -157.89 48.79 0.4 Allowed 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.35 -0.982 . . . . 2.0 108.35 179.845 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.653 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 0.4 OUTLIER -83.02 155.48 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.665 -0.647 . . . . 1.1699999999999999 109.492 -179.533 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.653 ' HG3' ' O ' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -170.79 100.69 0.23 Allowed 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.109 -0.7 . . . . 2.7200000000000002 109.109 178.577 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.472 ' O ' ' HB ' ' A' ' 63' ' ' ILE . . . -126.66 124.04 38.95 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.363 -0.836 . . . . 1.05 110.02 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -108.76 128.28 54.74 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.187 -0.946 . . . . 3.02 109.241 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.681 ' HB2' ' CZ2' ' A' ' 92' ' ' TRP . 1.8 tm? -122.94 154.64 38.11 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.132 -0.98 . . . . 2.0099999999999998 109.078 -179.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.463 ' HB2' ' OG ' ' A' ' 101' ' ' SER . 0.4 OUTLIER -47.27 -59.31 3.26 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.262 -0.899 . . . . 4.0700000000000003 110.262 -179.205 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -104.07 24.02 30.48 Favored Glycine 0 N--CA 1.493 2.444 0 C-N-CA 119.731 -1.223 . . . . 1.5 110.46 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.426 ' O ' ' HB3' ' A' ' 58' ' ' LEU . 0.5 OUTLIER -164.51 87.69 0.48 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.024 -1.28 . . . . 4.25 109.327 179.666 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.426 ' O ' ' C ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -79.09 70.88 5.52 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.732 -0.605 . . . . 2.8500000000000001 110.301 -179.666 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.625 HD13 ' CH2' ' A' ' 92' ' ' TRP . 6.0 mt -48.1 160.62 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 107.115 -1.439 . . . . 0.72999999999999998 107.115 178.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -170.4 142.77 2.2 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.867 -1.146 . . . . 2.6899999999999999 109.215 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.57 ' HB ' ' O ' ' A' ' 54' ' ' ILE . 11.7 t -132.82 69.42 79.24 Favored Pre-proline 0 C--N 1.298 -1.647 0 O-C-N 121.353 -0.842 . . . . 0.95999999999999996 109.223 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.412 ' HD3' ' N ' ' A' ' 65' ' ' VAL . 34.8 Cg_endo -76.37 -2.08 12.23 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 122.994 2.462 . . . . 1.0 110.625 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 136.44 42.22 0.11 Allowed Glycine 0 N--CA 1.489 2.199 0 C-N-CA 119.864 -1.16 . . . . 1.0900000000000001 110.308 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.463 HG23 ' CE1' ' A' ' 75' ' ' PHE . 35.4 mm -52.92 -77.32 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 O-C-N 120.964 -1.315 . . . . 2.1800000000000002 108.875 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -87.77 160.13 18.17 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.062 -1.024 . . . . 4.5999999999999996 108.866 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.432 ' O ' ' CG ' ' A' ' 71' ' ' ASN . 13.8 t -78.51 -12.23 60.0 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.242 -0.911 . . . . 6.3099999999999996 109.968 -179.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.58 ' CA ' ' O ' ' A' ' 50' ' ' ALA . 5.7 m120 -164.31 77.0 0.34 Allowed 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 118.661 -1.216 . . . . 4.5499999999999998 112.324 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.537 ' CB ' ' O ' ' A' ' 51' ' ' LYS . . . 22.34 46.01 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 121.492 0.663 . . . . 0.93000000000000005 112.032 175.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.543 ' N ' ' O ' ' A' ' 71' ' ' ASN . 6.1 t -106.6 -42.12 5.07 Favored 'General case' 0 C--N 1.285 -2.219 0 O-C-N 121.346 -0.846 . . . . 0.95999999999999996 110.531 -178.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 4.6 m170 -78.46 -1.2 32.52 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.993 -1.067 . . . . 4.2699999999999996 109.79 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.499 ' O ' HD13 ' A' ' 88' ' ' ILE . 57.9 m-85 -110.47 -14.7 14.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.233 -0.917 . . . . 0.59999999999999998 109.898 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.785 ' HB ' ' CE1' ' A' ' 86' ' ' TYR . 0.2 OUTLIER -157.39 175.28 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 120.81 -1.181 . . . . 0.55000000000000004 110.731 -177.316 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.647 ' N ' ' CG2' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -57.73 93.3 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 105.373 -2.084 . . . . 3.0699999999999998 105.373 176.758 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . 0.544 ' HB2' ' HD3' ' A' ' 79' ' ' PRO . 2.7 m -34.57 -51.51 1.03 Allowed Pre-proline 0 N--CA 1.5 2.033 0 O-C-N 121.628 -0.67 . . . . 1.04 112.021 -176.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.691 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 32.1 Cg_endo -79.1 108.79 2.43 Favored 'Trans proline' 0 C--N 1.303 -1.842 0 N-CA-C 109.401 -1.038 . . . . 0.57999999999999996 109.401 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.634 ' HB2' ' OE1' ' A' ' 45' ' ' GLN . 0.1 OUTLIER -92.26 -65.47 1.0 Allowed 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.518 -1.29 . . . . 0.46000000000000002 107.518 -179.86 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.628 ' HA ' ' N ' ' A' ' 46' ' ' ASN . 14.0 t 54.84 -178.26 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 C-N-CA 119.29 -0.964 . . . . 4.2999999999999998 109.134 177.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.532 ' N ' ' CG1' ' A' ' 81' ' ' VAL . 13.0 ptmt -102.2 37.01 1.96 Allowed 'General case' 0 C--N 1.296 -1.759 0 O-C-N 120.467 -1.395 . . . . 3.1699999999999999 110.206 -178.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -145.65 37.22 1.29 Allowed Glycine 0 C--N 1.288 -2.105 0 N-CA-C 108.664 -1.774 . . . . 1.3 108.664 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -146.58 142.62 28.17 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 121.23 -1.159 . . . . 3.2599999999999998 110.627 -178.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.457 ' O ' ' CG ' ' A' ' 85' ' ' GLN . 11.2 pt20 -115.88 130.69 56.94 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 105.977 -1.86 . . . . 3.6699999999999999 105.977 177.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.785 ' CE1' ' HB ' ' A' ' 76' ' ' VAL . 0.1 OUTLIER -152.71 156.91 40.08 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 117.74 -1.584 . . . . 1.6599999999999999 109.968 -177.641 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.663 ' CB ' ' HG ' ' A' ' 40' ' ' LEU . 7.2 p-10 -127.89 96.95 4.65 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 113.915 1.08 . . . . 0.47999999999999998 113.915 -175.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.539 ' O ' ' CB ' ' A' ' 89' ' ' LYS . 6.2 tp -62.99 -163.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 N-CA-C 106.362 -1.718 . . . . 1.3700000000000001 106.362 175.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.587 ' O ' ' CG ' ' A' ' 90' ' ' TYR . 1.0 OUTLIER 161.83 179.49 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.718 -1.239 . . . . 3.8300000000000001 111.519 179.74 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.587 ' CG ' ' O ' ' A' ' 89' ' ' LYS . 62.9 m-85 -162.81 61.14 0.2 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 107.027 -1.472 . . . . 0.58999999999999997 107.027 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.506 ' O ' ' O ' ' A' ' 90' ' ' TYR . 7.1 p -43.36 178.05 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.132 0 CA-C-O 121.402 0.62 . . . . 1.8999999999999999 111.382 -178.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.681 ' CZ2' ' HB2' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -173.82 116.35 0.24 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 118.71 -1.196 . . . . 4.2000000000000002 112.516 -179.345 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -84.31 126.81 33.54 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 105.729 -1.952 . . . . 2.46 105.729 176.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.566 ' CG2' ' O ' ' A' ' 33' ' ' LYS . 1.7 t -112.42 102.78 54.81 Favored Pre-proline 0 C--N 1.302 -1.481 0 O-C-N 120.626 -1.297 . . . . 0.96999999999999997 113.033 -176.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.613 ' HD2' ' CD1' ' A' ' 97' ' ' ILE . 31.8 Cg_endo -79.04 44.2 1.64 Allowed 'Trans proline' 0 C--N 1.314 -1.255 0 C-N-CA 123.088 2.525 . . . . 2.2999999999999998 110.905 176.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.55 ' O ' ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER 82.32 -70.03 0.06 Allowed 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 107.458 -1.312 . . . . 4.71 107.458 -178.48 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.613 ' CD1' ' HD2' ' A' ' 95' ' ' PRO . 2.7 mp 69.16 17.95 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 112.745 0.646 . . . . 1.24 112.745 176.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.595 ' CB ' ' HD2' ' A' ' 99' ' ' PRO . . . 49.06 177.65 0.01 OUTLIER Pre-proline 0 C--N 1.304 -1.377 0 O-C-N 120.774 -1.204 . . . . 0.58999999999999997 110.477 178.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.595 ' HD2' ' CB ' ' A' ' 98' ' ' ALA . 50.8 Cg_endo -85.17 165.09 11.25 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 123.746 2.964 . . . . 0.67000000000000004 110.044 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.627 ' HD3' ' CB ' ' A' ' 128' ' ' ARG . 3.8 mmmm 43.04 115.69 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 113.23 0.826 . . . . 3.3399999999999999 113.23 175.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.47 ' HB3' HD11 ' A' ' 127' ' ' ILE . 10.1 t -92.31 161.61 14.62 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.961 -1.087 . . . . 0.64000000000000001 108.242 177.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.473 ' O ' ' CB ' ' A' ' 103' ' ' ASN . 0.3 OUTLIER -61.93 -10.4 9.47 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.05 -1.031 . . . . 4.04 110.055 -179.77 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.501 ' OD1' ' N ' ' A' ' 103' ' ' ASN . 1.1 p30 167.27 158.63 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.058 -1.026 . . . . 5.9699999999999998 109.569 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.541 ' O ' ' CB ' ' A' ' 105' ' ' VAL . 0.1 OUTLIER -158.65 -178.48 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.107 -0.995 . . . . 0.76000000000000001 109.677 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.541 ' CB ' ' O ' ' A' ' 104' ' ' VAL . 0.9 OUTLIER 159.79 123.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 108.561 -0.903 . . . . 0.88 108.561 -179.758 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 2.4 t -118.99 144.6 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 120.883 -1.136 . . . . 1.29 110.197 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.465 ' O ' ' CB ' ' A' ' 108' ' ' VAL . 0.2 OUTLIER -159.16 175.67 13.17 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.263 -1.014 . . . . 1.3300000000000001 108.263 179.789 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.56 HG12 ' N ' ' A' ' 109' ' ' LYS . 1.1 t 171.33 169.0 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 120.721 -1.237 . . . . 1.5600000000000001 110.528 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.56 ' N ' HG12 ' A' ' 108' ' ' VAL . 11.2 ttpt 164.28 121.91 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.634 0.73 . . . . 1.5 109.091 178.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.512 ' CD2' HD13 ' A' ' 80' ' ' LEU . 7.7 tp -108.92 125.44 52.02 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.585 -1.265 . . . . 2.1899999999999999 107.585 178.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.513 ' HB ' ' HB2' ' A' ' 51' ' ' LYS . 4.0 mt -130.31 114.7 29.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.162 -0.961 . . . . 1.78 110.71 -178.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.409 ' HA2' ' HA ' ' A' ' 50' ' ' ALA . . . -70.84 -116.18 0.04 OUTLIER Glycine 0 N--CA 1.485 1.947 0 N-CA-C 107.75 -2.14 . . . . 0.46999999999999997 107.75 177.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -135.07 -0.56 2.75 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.023 -1.281 . . . . 2.4300000000000002 107.546 178.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -109.85 -24.81 10.65 Favored 'General case' 0 C--N 1.312 -1.057 0 O-C-N 121.35 -0.844 . . . . 0.95999999999999996 109.428 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -179.85 176.72 47.69 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.401 -1.479 . . . . 1.26 109.401 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.479 ' HA ' ' HA ' ' A' ' 111' ' ' ILE . 0.9 OUTLIER -81.38 106.61 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.195 -1.18 . . . . 0.62 109.834 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.524 HD23 ' HB3' ' A' ' 80' ' ' LEU . 4.0 mt -52.3 -54.61 29.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.419 -0.801 . . . . 0.56000000000000005 110.543 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.531 ' HA ' ' CB ' ' A' ' 9' ' ' ALA . . . -140.63 -170.9 3.11 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.061 -1.024 . . . . 0.46999999999999997 110.847 -178.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . 0.531 ' SG ' ' N ' ' A' ' 120' ' ' ALA . 0.0 OUTLIER 175.5 159.61 0.24 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.578 -0.701 . . . . 0.47999999999999998 109.563 -179.652 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.531 ' N ' ' SG ' ' A' ' 119' ' ' CYS . . . -176.91 126.96 0.16 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.274 -0.891 . . . . 0.82999999999999996 109.055 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 6.4 mt -129.37 132.24 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.175 -0.953 . . . . 1.3100000000000001 109.902 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.419 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -115.8 20.89 14.28 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.156 -0.965 . . . . 1.4299999999999999 108.759 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.419 ' OG1' ' O ' ' A' ' 122' ' ' ALA . 82.5 p 47.02 -160.7 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.413 -0.804 . . . . 4.1299999999999999 109.272 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.558 ' CE1' ' HB3' ' A' ' 26' ' ' PRO . 42.2 p-80 -71.06 160.09 33.53 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.223 -0.923 . . . . 4.5899999999999999 109.115 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' A' ' 27' ' ' CYS . . . -120.24 -169.76 14.1 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.621 -1.392 . . . . 1.79 109.621 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.414 ' O ' ' C ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER 178.41 74.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.285 -1.127 . . . . 2.6099999999999999 109.574 179.736 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.662 ' O ' ' CB ' ' A' ' 128' ' ' ARG . 2.5 mp -39.41 157.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.6 -0.688 . . . . 1.05 110.463 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.662 ' CB ' ' O ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER 132.97 -87.19 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.142 0 CA-C-O 121.357 0.599 . . . . 4.2400000000000002 109.956 178.476 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.511 ' OD2' ' NE2' ' A' ' 30' ' ' HIS . 1.7 t0 . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 118.112 -0.946 . . . . 4.2699999999999996 109.693 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.501 0.667 . . . . 3.2000000000000002 109.574 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.559 ' HA ' ' CG ' ' A' ' 17' ' ' MET . 12.2 pt20 -133.92 41.89 2.97 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.498 -0.751 . . . . 3.3300000000000001 108.984 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.53 ' CG1' ' HA ' ' A' ' 22' ' ' HIS . 2.0 m -45.86 120.89 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 108.16 -1.052 . . . . 3.0299999999999998 108.16 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.476 ' O ' ' HA3' ' A' ' 23' ' ' GLY . 71.3 m-20 -94.41 127.84 40.56 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.379 -0.826 . . . . 5.3899999999999997 110.913 -178.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.408 ' HA ' ' CA ' ' A' ' 23' ' ' GLY . 0.1 OUTLIER -95.72 -170.67 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.013 -1.106 . . . . 1.96 108.013 178.655 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.81 94.62 9.19 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.83 -1.169 . . . . 2.8900000000000001 109.153 179.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.469 ' HA ' ' O ' ' A' ' 119' ' ' CYS . 1.6 m-20 -99.07 174.35 6.38 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.537 -0.727 . . . . 4.4400000000000004 109.286 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.514 ' N ' ' SG ' ' A' ' 119' ' ' CYS . 31.6 p -163.62 49.14 0.14 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.238 -0.913 . . . . 2.23 109.725 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.522 ' O ' ' CB ' ' A' ' 10' ' ' ASN . . . -83.3 -66.33 0.9 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.112 -0.993 . . . . 0.60999999999999999 109.859 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.522 ' CB ' ' O ' ' A' ' 9' ' ' ALA . 0.9 OUTLIER 164.34 42.33 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.46 -0.896 . . . . 1.6499999999999999 109.788 -178.779 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.2 m120 49.88 23.93 1.18 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.937 -1.102 . . . . 3.04 108.042 -179.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 13' ' ' ILE . 0.0 OUTLIER -105.76 -28.54 10.62 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.574 -0.704 . . . . 3.3799999999999999 109.234 -179.764 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.526 ' CG2' ' O ' ' A' ' 40' ' ' LEU . 11.9 mt -41.81 143.7 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 109.077 -0.712 . . . . 0.66000000000000003 109.077 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -105.02 -19.2 13.91 Favored 'General case' 0 C--N 1.295 -1.767 0 O-C-N 121.402 -0.811 . . . . 5.3499999999999996 108.998 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.35 104.98 1.46 Allowed 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 119.031 -1.067 . . . . 3.9500000000000002 110.363 -177.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.445 HG12 ' O ' ' A' ' 16' ' ' VAL . 2.6 p -120.87 95.82 3.81 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 107.075 -1.454 . . . . 1.8400000000000001 107.075 178.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.559 ' CG ' ' HA ' ' A' ' 2' ' ' GLN . 2.3 mpt? -144.7 145.57 31.78 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.63 -0.669 . . . . 3.27 109.751 -178.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.528 ' CG1' ' HA ' ' A' ' 37' ' ' LEU . 1.7 t -110.93 120.36 61.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 108.255 -1.017 . . . . 1.8700000000000001 108.255 179.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -41.93 -26.1 0.08 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.39 -0.819 . . . . 2.7599999999999998 109.714 -179.44 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -158.1 -148.42 5.14 Favored Glycine 0 N--CA 1.488 2.116 0 C-N-CA 119.615 -1.279 . . . . 2.6200000000000001 109.964 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.622 ' HA ' ' HA ' ' A' ' 29' ' ' ILE . 50.4 t 65.15 -111.47 0.24 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.629 -0.924 . . . . 2.3500000000000001 109.664 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.543 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 0.3 OUTLIER 155.2 139.7 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 106.621 -1.622 . . . . 2.3300000000000001 106.621 -178.723 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' A' ' 4' ' ' ASP . . . -107.99 157.59 15.29 Favored Glycine 0 C--N 1.288 -2.119 0 N-CA-C 109.409 -1.477 . . . . 1.51 109.409 -179.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.457 ' O ' ' CB ' ' A' ' 25' ' ' ASP . 0.2 OUTLIER 66.61 137.2 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.216 -1.167 . . . . 3.4399999999999999 108.279 -179.163 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.542 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.2 OUTLIER 66.48 177.29 0.05 OUTLIER Pre-proline 0 C--N 1.304 -1.385 0 O-C-N 120.455 -1.403 . . . . 5.5199999999999996 107.998 -179.815 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.542 ' HD2' ' CB ' ' A' ' 25' ' ' ASP . 30.7 Cg_endo -74.8 123.67 8.15 Favored 'Trans proline' 0 C--N 1.299 -2.055 0 C-N-CA 122.747 2.298 . . . . 2.1099999999999999 109.397 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.543 ' HB2' ' O ' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -97.08 113.94 25.55 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.291 -0.881 . . . . 1.75 111.491 -177.819 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.54 ' CD1' ' HG3' ' A' ' 126' ' ' LYS . 20.1 mm -86.77 83.72 2.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 107.147 -1.427 . . . . 1.97 107.147 176.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.622 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -50.08 -177.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 O-C-N 121.699 -0.626 . . . . 3.0800000000000001 109.977 -179.138 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 79.5 m-70 -134.2 160.44 37.84 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.507 -0.877 . . . . 1.6699999999999999 110.659 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.573 ' HD3' ' CA ' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -108.83 113.02 25.6 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.528 -0.732 . . . . 2.5099999999999998 109.399 179.626 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 134.42 0.2 3.75 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 110.206 -1.158 . . . . 1.2 110.206 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.556 ' O ' ' CB ' ' A' ' 94' ' ' VAL . 13.3 mttt -130.23 144.43 53.17 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 120.93 -1.335 . . . . 3.3399999999999999 110.184 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.507 ' HA ' HG22 ' A' ' 94' ' ' VAL . 29.6 Cg_endo -69.41 81.08 0.75 Allowed 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 123.166 2.577 . . . . 0.81000000000000005 111.19 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.468 ' CZ ' ' HB3' ' A' ' 37' ' ' LEU . 5.2 t80 -55.42 122.13 10.52 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 109.433 -0.581 . . . . 3.0899999999999999 109.433 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 37.5 m -134.04 85.44 2.2 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.075 -1.015 . . . . 1.9399999999999999 109.571 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.528 ' HA ' ' CG1' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -62.66 141.38 58.55 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.235 -0.915 . . . . 2.5 108.891 179.746 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.56 ' O ' ' CB ' ' A' ' 39' ' ' ALA . 87.2 mt-10 -139.17 -171.23 3.06 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.147 -0.971 . . . . 2.21 110.06 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.56 ' CB ' ' O ' ' A' ' 38' ' ' GLU . . . 155.13 70.7 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.906 -1.146 . . . . 1.3600000000000001 107.906 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.619 ' HG ' ' CB ' ' A' ' 87' ' ' ASP . 0.8 OUTLIER -71.98 171.73 11.3 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 115.912 -0.585 . . . . 0.87 110.162 -178.841 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.669 ' CE2' ' CE2' ' A' ' 86' ' ' TYR . 5.5 p90 -176.01 148.39 0.82 Allowed 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.583 -0.895 . . . . 0.40000000000000002 108.583 179.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.509 ' O ' ' C ' ' A' ' 43' ' ' ALA . 6.7 t70 -95.28 112.19 23.94 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 107.286 -1.375 . . . . 2.0899999999999999 107.286 178.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.557 ' CB ' ' O ' ' A' ' 81' ' ' VAL . . . -36.1 125.53 0.76 Allowed 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 115.61 -0.723 . . . . 0.66000000000000003 109.1 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -124.04 15.02 9.19 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.171 -0.956 . . . . 4.0800000000000001 110.33 -177.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.641 ' O ' ' N ' ' A' ' 82' ' ' LYS . 2.3 pt20 -105.56 -139.41 0.37 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.379 -0.971 . . . . 0.48999999999999999 108.379 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.726 ' HA ' ' HB ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -156.73 67.98 0.57 Allowed 'General case' 0 C--N 1.294 -1.845 0 O-C-N 121.08 -1.013 . . . . 1.3400000000000001 109.306 178.59 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.497 HG21 ' O ' ' A' ' 47' ' ' THR . 10.3 t -146.33 118.47 8.31 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.263 -1.523 . . . . 0.75 111.607 -178.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.635 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 0.6 OUTLIER -66.4 -10.6 45.3 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.66 -1.275 . . . . 3.46 107.847 177.262 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.478 ' O ' ' HB1' ' A' ' 50' ' ' ALA . 30.5 p -98.44 -161.3 0.86 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.335 -0.853 . . . . 1.3899999999999999 108.807 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.549 ' HB2' ' CB ' ' A' ' 72' ' ' ALA . . . 174.67 160.4 0.19 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.168 -0.958 . . . . 0.41999999999999998 109.863 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.542 ' O ' ' CB ' ' A' ' 72' ' ' ALA . 20.3 mtmt -123.14 169.04 11.64 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 107.227 -1.398 . . . . 1.3400000000000001 107.227 177.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.545 HD11 ' CD1' ' A' ' 75' ' ' PHE . 11.1 tt -148.19 144.74 18.89 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.239 0 C-N-CA 118.413 -1.315 . . . . 0.72999999999999998 110.558 -178.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.456 ' O ' ' CE ' ' A' ' 55' ' ' LYS . 6.1 mt-10 -139.84 56.42 1.64 Allowed 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 107.101 -1.444 . . . . 3.0699999999999998 107.101 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.679 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -87.62 151.91 3.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 O-C-N 121.312 -0.867 . . . . 1.73 110.096 -178.392 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.679 ' HG3' ' O ' ' A' ' 54' ' ' ILE . 0.1 OUTLIER -166.51 95.22 0.54 Allowed 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 109.053 -0.721 . . . . 1.6399999999999999 109.053 178.305 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.503 ' O ' ' O ' ' A' ' 63' ' ' ILE . . . -118.78 138.66 52.53 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.394 -0.816 . . . . 0.88 109.563 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.455 ' O ' ' CG1' ' A' ' 104' ' ' VAL . 1.6 t -124.4 124.8 43.14 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.925 -1.109 . . . . 1.53 110.125 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.585 HD22 ' CZ3' ' A' ' 92' ' ' TRP . 2.6 tm? -117.85 152.86 34.52 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.255 -1.017 . . . . 3.0899999999999999 108.255 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.506 ' N ' HD11 ' A' ' 58' ' ' LEU . 5.4 t0 -43.61 -66.06 0.42 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.061 -1.025 . . . . 2.1699999999999999 109.938 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.428 ' O ' ' CD1' ' A' ' 61' ' ' LEU . . . -101.09 20.18 48.63 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.058 -1.217 . . . . 0.95999999999999996 110.058 -179.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.469 HD13 ' HA ' ' A' ' 61' ' ' LEU . 1.9 tp -152.69 79.13 1.21 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.141 -1.211 . . . . 3.6400000000000001 108.935 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.445 ' O ' ' C ' ' A' ' 63' ' ' ILE . 0.5 OUTLIER -74.9 76.05 2.15 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 116.203 -0.453 . . . . 3.9100000000000001 110.869 -179.19 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.503 ' O ' ' O ' ' A' ' 56' ' ' ALA . 3.2 mt -49.08 162.81 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 106.54 -1.652 . . . . 1.0800000000000001 106.54 178.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.436 ' O ' HG21 ' A' ' 65' ' ' VAL . 0.5 OUTLIER -176.02 147.43 0.75 Allowed 'General case' 0 C--N 1.297 -1.707 0 O-C-N 120.424 -1.423 . . . . 0.90000000000000002 109.004 -179.828 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.553 ' N ' ' HD3' ' A' ' 66' ' ' PRO . 17.1 t -140.77 62.28 17.27 Favored Pre-proline 0 C--N 1.299 -1.598 0 C-N-CA 119.279 -0.969 . . . . 1.49 110.215 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.553 ' HD3' ' N ' ' A' ' 65' ' ' VAL . 36.2 Cg_endo -78.32 -5.05 14.76 Favored 'Trans proline' 0 C--N 1.301 -1.964 0 C-N-CA 122.82 2.347 . . . . 1.3700000000000001 109.094 178.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 68' ' ' ILE . . . -177.62 -110.25 0.27 Allowed Glycine 0 N--CA 1.487 2.073 0 N-CA-C 108.14 -1.984 . . . . 2.3500000000000001 108.14 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.509 HD11 HG22 ' A' ' 68' ' ' ILE . 0.0 OUTLIER 39.97 85.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.421 -1.046 . . . . 3.5 109.779 179.103 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 46.28 80.38 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.003 -1.061 . . . . 5.9900000000000002 108.856 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.37 50.17 1.95 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.361 -0.837 . . . . 8.7200000000000006 109.467 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.529 ' CA ' ' O ' ' A' ' 50' ' ' ALA . 8.6 m-20 -136.86 38.04 2.6 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.195 -0.941 . . . . 2.1499999999999999 109.935 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.553 ' HB3' ' CD1' ' A' ' 110' ' ' LEU . . . 37.92 29.18 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 121.419 0.628 . . . . 1.0700000000000001 110.466 177.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.499 ' N ' ' O ' ' A' ' 71' ' ' ASN . 9.8 t -105.2 -52.29 2.87 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.455 -0.778 . . . . 1.0900000000000001 110.003 -179.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -67.27 -16.91 64.56 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.957 -1.089 . . . . 1.47 109.706 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.548 ' O ' ' CD1' ' A' ' 88' ' ' ILE . 91.7 m-85 -101.05 -9.14 21.69 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.173 -0.954 . . . . 1.0 110.169 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.758 ' HB ' ' CE1' ' A' ' 86' ' ' TYR . 0.2 OUTLIER -165.66 173.98 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 120.591 -1.318 . . . . 0.57999999999999996 111.366 -177.298 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.64 ' N ' ' CG2' ' A' ' 76' ' ' VAL . 2.5 mmmt -56.23 92.3 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.119 -1.437 . . . . 2.1200000000000001 107.119 177.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . 0.513 ' HB2' ' HD3' ' A' ' 79' ' ' PRO . 0.4 OUTLIER -35.22 -52.53 1.22 Allowed Pre-proline 0 N--CA 1.502 2.15 0 CA-C-N 116.323 -0.399 . . . . 0.96999999999999997 110.955 -177.596 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.635 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 31.2 Cg_endo -76.59 109.52 2.88 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 121.115 1.21 . . . . 0.70999999999999996 109.269 179.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.58 HD22 ' CD2' ' A' ' 86' ' ' TYR . 0.5 OUTLIER -103.15 -63.51 1.17 Allowed 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 121.41 0.624 . . . . 3.8599999999999999 109.399 -178.519 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.726 ' HB ' ' HA ' ' A' ' 46' ' ' ASN . 1.3 m 40.18 -167.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 C-N-CA 120.56 -0.456 . . . . 0.65000000000000002 109.884 178.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.641 ' N ' ' O ' ' A' ' 45' ' ' GLN . 1.0 OUTLIER -104.38 41.96 1.25 Allowed 'General case' 0 C--N 1.289 -2.054 0 O-C-N 120.39 -1.444 . . . . 3.8300000000000001 110.411 -176.848 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -146.65 35.88 1.28 Allowed Glycine 0 C--N 1.287 -2.19 0 N-CA-C 108.583 -1.807 . . . . 1.01 108.583 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.531 ' NE2' ' HG3' ' A' ' 77' ' ' LYS . 12.6 tp60 -150.0 140.1 22.08 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 121.237 -1.155 . . . . 4.3099999999999996 110.578 -179.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.496 ' HG2' ' HB2' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -112.42 129.31 56.36 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 105.566 -2.013 . . . . 4.04 105.566 177.048 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.758 ' CE1' ' HB ' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -151.21 160.94 43.55 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 117.525 -1.67 . . . . 1.27 110.124 -177.371 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.619 ' CB ' ' HG ' ' A' ' 40' ' ' LEU . 1.8 m-20 -129.03 99.5 5.29 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.948 -1.095 . . . . 4.0800000000000001 113.456 -175.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.567 ' O ' ' CB ' ' A' ' 89' ' ' LYS . 3.8 tp -66.78 -163.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 106.839 -1.541 . . . . 2.21 106.839 176.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.592 ' O ' ' CG ' ' A' ' 90' ' ' TYR . 10.4 mttt 161.39 175.4 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.271 0 O-C-N 120.927 -1.108 . . . . 2.0899999999999999 111.071 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.592 ' CG ' ' O ' ' A' ' 89' ' ' LYS . 41.9 m-85 -165.37 103.11 0.73 Allowed 'General case' 0 N--CA 1.504 2.269 0 N-CA-C 108.154 -1.054 . . . . 0.75 108.154 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.03 179.18 5.16 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.282 -0.887 . . . . 4.1299999999999999 111.467 -177.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.585 ' CZ3' HD22 ' A' ' 58' ' ' LEU . 1.7 t90 -167.62 101.57 0.49 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.759 -0.588 . . . . 5.3300000000000001 109.472 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.507 ' O ' ' CD1' ' A' ' 92' ' ' TRP . 49.4 t-20 -47.47 123.33 5.58 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 106.842 -1.54 . . . . 1.98 106.842 178.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.611 ' CG1' ' CD1' ' A' ' 97' ' ' ILE . 58.2 t -116.21 90.5 29.28 Favored Pre-proline 0 C--N 1.3 -1.547 0 C-N-CA 118.568 -1.253 . . . . 2.4100000000000001 111.934 -177.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.501 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 33.7 Cg_endo -83.07 58.65 6.38 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 123.423 2.749 . . . . 2.7200000000000002 109.809 178.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.594 ' O ' ' HB ' ' A' ' 97' ' ' ILE . 0.1 OUTLIER 71.04 -80.37 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.386 -1.339 . . . . 4.6799999999999997 107.386 -177.843 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.611 ' CD1' ' CG1' ' A' ' 94' ' ' VAL . 2.6 mp 76.44 34.58 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.638 -0.664 . . . . 1.6899999999999999 112.24 177.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.553 ' CB ' ' HD2' ' A' ' 99' ' ' PRO . . . 53.32 171.4 0.04 OUTLIER Pre-proline 0 C--N 1.3 -1.578 0 O-C-N 120.98 -1.075 . . . . 0.65000000000000002 110.991 178.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.728 ' O ' ' CB ' ' A' ' 100' ' ' LYS . 61.4 Cg_endo -87.45 83.91 0.92 Allowed 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 123.951 3.101 . . . . 1.7 110.487 -178.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.728 ' CB ' ' O ' ' A' ' 99' ' ' PRO . 0.1 OUTLIER 116.25 121.14 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 118.896 0.771 . . . . 2.75 111.02 178.279 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.458 ' OG ' HD11 ' A' ' 127' ' ' ILE . 1.9 p -92.29 148.7 21.93 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.754 -1.202 . . . . 2.5299999999999998 107.754 177.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 101' ' ' SER . 0.0 OUTLIER -42.58 -26.47 0.12 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.947 -1.096 . . . . 4.3799999999999999 109.727 -179.231 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.478 ' C ' ' CG2' ' A' ' 104' ' ' VAL . 1.4 t-20 171.23 160.22 0.08 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.317 -0.864 . . . . 2.2200000000000002 109.246 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.478 ' CG2' ' C ' ' A' ' 103' ' ' ASN . 0.1 OUTLIER -155.99 140.38 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.157 -0.964 . . . . 1.1200000000000001 109.64 179.942 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.414 ' O ' HG11 ' A' ' 105' ' ' VAL . 0.5 OUTLIER -143.09 134.37 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.352 -0.843 . . . . 1.6100000000000001 109.179 179.873 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.41 ' HB ' ' HB1' ' A' ' 122' ' ' ALA . 49.5 t -126.04 125.03 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.033 -1.042 . . . . 1.1899999999999999 109.775 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.527 ' C ' ' CG2' ' A' ' 108' ' ' VAL . 74.6 m -147.18 136.11 22.26 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.881 -1.155 . . . . 1.0800000000000001 107.881 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.597 ' CG1' ' CD1' ' A' ' 54' ' ' ILE . 0.3 OUTLIER -157.19 162.18 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 120.419 -1.426 . . . . 2.8900000000000001 110.881 -179.284 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.523 ' CE ' ' HB ' ' A' ' 116' ' ' VAL . 2.4 tttt 175.19 118.6 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.726 0.774 . . . . 4.4100000000000001 110.215 178.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.568 ' HB3' ' HB2' ' A' ' 117' ' ' LEU . 4.6 tp -92.89 122.26 35.09 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.367 -1.346 . . . . 1.4099999999999999 107.367 178.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.506 ' HB ' ' HB2' ' A' ' 51' ' ' LYS . 5.7 mt -122.12 114.99 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.766 -1.209 . . . . 1.03 111.932 -177.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -80.01 -127.58 0.67 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 107.91 -2.076 . . . . 1.0700000000000001 107.91 177.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -135.2 -2.97 2.48 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.878 -1.366 . . . . 2.6699999999999999 107.881 178.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.401 ' CG ' ' ND2' ' A' ' 46' ' ' ASN . 1.2 m-80 -115.03 -7.54 12.51 Favored 'General case' 0 C--N 1.313 -0.991 0 O-C-N 121.24 -0.913 . . . . 1.3 110.082 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 163.91 139.85 2.73 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 110.015 -1.234 . . . . 2.1200000000000001 110.015 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.523 ' HB ' ' CE ' ' A' ' 109' ' ' LYS . 0.1 OUTLIER -52.29 119.42 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.36 -1.082 . . . . 1.1299999999999999 109.823 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.568 ' HB2' ' HB3' ' A' ' 110' ' ' LEU . 1.7 mt -62.73 -59.98 4.13 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.274 -0.891 . . . . 0.90000000000000002 109.329 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.519 ' HA ' ' HA ' ' A' ' 9' ' ' ALA . . . -158.23 -173.02 4.12 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.54 -0.725 . . . . 1.3899999999999999 109.274 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . 0.514 ' SG ' ' N ' ' A' ' 8' ' ' CYS . 13.5 p 176.96 170.16 0.52 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.343 -0.848 . . . . 2.1099999999999999 109.422 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -164.21 131.45 3.26 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.495 -0.753 . . . . 0.72999999999999998 109.057 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 2.7 mp -128.18 142.82 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.089 -1.007 . . . . 1.49 110.57 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.416 ' O ' ' C ' ' A' ' 123' ' ' THR . . . -138.19 64.41 1.5 Allowed 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.028 -1.101 . . . . 0.80000000000000004 108.028 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.484 ' O ' ' O ' ' A' ' 124' ' ' HIS . 0.4 OUTLIER -38.74 132.28 1.22 Allowed 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.681 0.753 . . . . 2.96 111.533 -178.472 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.484 ' O ' ' O ' ' A' ' 123' ' ' THR . 1.4 m-70 47.74 173.0 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.866 0.841 . . . . 3.9900000000000002 111.495 178.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 167.49 141.83 3.28 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.39 -1.484 . . . . 0.78000000000000003 109.39 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.54 ' HG3' ' CD1' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -147.01 134.11 20.42 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.116 -1.226 . . . . 3.2799999999999998 109.343 179.683 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.574 ' CD1' HG13 ' A' ' 29' ' ' ILE . 0.8 OUTLIER -79.27 124.1 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.408 -0.808 . . . . 2.0600000000000001 111.172 -178.306 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.598 ' HB2' ' HG2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER 168.64 -89.78 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.887 -1.133 . . . . 2.96 109.491 177.172 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.446 ' N ' ' CG2' ' A' ' 28' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 118.013 -0.994 . . . . 3.6499999999999999 109.212 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.183 -0.673 . . . . 4.2999999999999998 109.183 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.539 ' HB3' ' CG ' ' A' ' 17' ' ' MET . 1.2 pt20 -100.6 -172.97 2.29 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.063 -1.023 . . . . 2.9399999999999999 109.508 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.595 ' CG1' ' HA ' ' A' ' 22' ' ' HIS . 5.5 m -128.92 -168.26 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.348 -0.845 . . . . 2.46 109.409 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -130.87 77.8 1.8 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.178 -0.951 . . . . 1.4399999999999999 109.305 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.8 m -100.6 150.78 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.162 -0.961 . . . . 1.6899999999999999 109.596 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.426 ' O ' HD11 ' A' ' 121' ' ' ILE . 12.8 mtpp -75.05 93.68 2.77 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.496 -0.752 . . . . 2.8799999999999999 109.701 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.407 ' HA ' ' O ' ' A' ' 119' ' ' CYS . 35.4 p-10 -82.81 176.08 9.59 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.197 -0.939 . . . . 2.2999999999999998 109.122 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.517 ' N ' ' SG ' ' A' ' 119' ' ' CYS . 7.8 m -138.59 9.09 2.64 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.124 -0.985 . . . . 1.3200000000000001 109.919 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.572 ' CA ' ' HA ' ' A' ' 118' ' ' ALA . . . -56.55 -43.99 80.48 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.932 -1.105 . . . . 0.88 109.035 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.51 ' CB ' ' O ' ' A' ' 9' ' ' ALA . 0.5 OUTLIER 163.61 -58.09 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.948 -0.76 . . . . 5.0099999999999998 108.948 -179.185 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.474 ' HB2' ' O ' ' A' ' 10' ' ' ASN . 1.9 t-20 174.46 38.0 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.921 -0.77 . . . . 4.3700000000000001 108.921 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.41 ' CG ' ' H ' ' A' ' 13' ' ' ILE . 2.2 pt-20 -171.56 -62.71 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.025 -1.047 . . . . 4.9100000000000001 110.859 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.545 HG13 ' CB ' ' A' ' 9' ' ' ALA . 0.1 OUTLIER 67.76 4.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.122 -0.987 . . . . 3.9100000000000001 110.155 -179.047 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.537 ' HB2' ' O ' ' A' ' 13' ' ' ILE . 0.0 OUTLIER 75.08 -31.95 0.22 Allowed 'General case' 0 C--N 1.293 -1.876 0 O-C-N 121.386 -0.821 . . . . 3.7200000000000002 111.036 178.747 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.532 ' CB ' ' O ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER 165.81 109.93 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 118.785 -1.166 . . . . 4.5899999999999999 110.569 -178.622 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.545 ' HB ' HG23 ' A' ' 13' ' ' ILE . 6.8 p -120.07 107.85 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.096 -1.002 . . . . 2.23 108.76 178.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.539 ' CG ' ' HB3' ' A' ' 2' ' ' GLN . 0.5 OUTLIER -145.83 146.91 31.33 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.366 -0.934 . . . . 2.0 110.332 -179.605 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.483 HG11 ' HA ' ' A' ' 37' ' ' LEU . 42.1 t -117.62 148.95 20.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 108.255 -1.017 . . . . 2.02 108.255 179.088 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.412 ' HB3' ' HA ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -81.17 71.2 8.14 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.069 -1.086 . . . . 1.0 108.069 179.446 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.542 ' O ' ' CB ' ' A' ' 21' ' ' CYS . . . 108.02 -167.85 13.56 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 109.157 -1.577 . . . . 1.76 109.157 -178.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.602 ' O ' ' O ' ' A' ' 28' ' ' ILE . 15.5 t 83.54 -57.71 0.14 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.782 -0.834 . . . . 1.6699999999999999 109.984 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.595 ' HA ' ' CG1' ' A' ' 3' ' ' VAL . 0.3 OUTLIER 58.14 107.39 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.561 -1.337 . . . . 5.6500000000000004 109.145 -178.799 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.573 ' O ' ' CB ' ' A' ' 24' ' ' SER . . . -92.54 -143.8 13.18 Favored Glycine 0 N--CA 1.497 2.737 0 O-C-N 121.163 -0.961 . . . . 1.71 111.236 -178.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.573 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 1.0 OUTLIER 86.09 -48.73 0.06 Allowed 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.38 -0.97 . . . . 2.3799999999999999 108.38 -178.823 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.701 ' CB ' ' CD ' ' A' ' 26' ' ' PRO . 5.2 m-20 -120.11 -149.86 0.01 OUTLIER Pre-proline 0 C--N 1.303 -1.426 0 N-CA-C 105.665 -1.976 . . . . 4.4500000000000002 105.665 178.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.701 ' CD ' ' CB ' ' A' ' 25' ' ' ASP . 30.9 Cg_endo -74.34 85.69 1.39 Allowed 'Trans proline' 0 C--O 1.208 -1.012 0 N-CA-C 107.169 -1.896 . . . . 0.56000000000000005 107.169 178.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.562 ' HA ' ' O ' ' A' ' 22' ' ' HIS . 4.1 t -34.51 80.17 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 113.697 0.999 . . . . 1.6899999999999999 113.697 -176.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.602 ' O ' ' O ' ' A' ' 21' ' ' CYS . 0.7 OUTLIER -71.68 144.51 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 N-CA-C 106.772 -1.566 . . . . 2.25 106.772 176.343 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.58 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 0.1 OUTLIER -122.99 -159.9 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 O-C-N 120.371 -1.456 . . . . 0.89000000000000001 112.706 -176.425 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 40.5 m-70 -131.07 166.55 20.82 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.657 0.742 . . . . 1.8500000000000001 110.418 -179.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.565 ' HD3' ' HA ' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -116.05 -167.15 1.22 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.617 -0.677 . . . . 3.5499999999999998 109.464 -179.98 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' A' ' 95' ' ' PRO . . . 42.74 27.96 0.6 Allowed Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.692 -0.963 . . . . 1.1200000000000001 110.692 179.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.587 ' O ' HG13 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -151.76 133.87 8.4 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 120.754 -1.439 . . . . 2.0099999999999998 109.493 179.789 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.507 ' HA ' HG22 ' A' ' 94' ' ' VAL . 28.8 Cg_endo -68.26 78.99 0.6 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.601 2.2 . . . . 1.8 111.325 -179.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.483 ' CD1' ' C ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -62.05 149.52 40.81 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.281 -1.007 . . . . 4.1500000000000004 108.281 178.944 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.477 ' OG1' ' HB ' ' A' ' 91' ' ' THR . 6.4 m -153.71 95.81 1.93 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.918 -1.114 . . . . 1.76 110.211 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.483 ' HA ' HG11 ' A' ' 18' ' ' VAL . 2.3 pp -61.1 142.28 56.8 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.818 -1.179 . . . . 1.3200000000000001 107.818 178.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.507 ' HG3' ' CG ' ' A' ' 89' ' ' LYS . 2.0 tt0 -136.04 131.6 35.14 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.995 -1.066 . . . . 3.9500000000000002 109.882 -179.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -141.28 90.58 2.32 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.765 -1.198 . . . . 1.4299999999999999 107.765 178.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.602 ' HG ' ' CB ' ' A' ' 87' ' ' ASP . 0.2 OUTLIER -83.07 -176.36 6.29 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 109.236 -0.653 . . . . 1.1699999999999999 109.236 -178.567 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.596 ' O ' ' CD1' ' A' ' 41' ' ' PHE . 6.2 p90 171.08 133.86 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.361 -1.348 . . . . 1.6399999999999999 107.361 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.562 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 0.0 OUTLIER -90.13 119.88 30.84 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 107.969 -1.122 . . . . 3.71 107.969 179.86 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.561 ' O ' ' HA ' ' A' ' 82' ' ' LYS . . . -38.79 112.44 0.24 Allowed 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 109.47 -0.567 . . . . 0.59999999999999998 109.47 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.501 ' CG ' ' O ' ' A' ' 42' ' ' ASP . 2.5 m-80 -122.14 45.75 2.27 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.479 -0.763 . . . . 1.8899999999999999 109.023 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.598 ' OE1' ' HB2' ' A' ' 80' ' ' LEU . 3.5 pt20 -133.5 -133.12 0.17 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.267 -0.896 . . . . 1.48 110.198 -178.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.626 ' N ' ' HA ' ' A' ' 81' ' ' VAL . 47.3 t30 -169.89 53.0 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.441 -0.787 . . . . 6.04 109.604 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.592 ' CG2' ' OE1' ' A' ' 45' ' ' GLN . 3.9 t -139.18 138.25 36.77 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.613 -1.304 . . . . 0.88 110.576 -178.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.605 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 1.2 mtmp? -78.84 -0.84 32.23 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.81 -1.181 . . . . 4.4800000000000004 108.478 177.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.446 ' O ' HG22 ' A' ' 47' ' ' THR . 72.5 p -107.55 165.9 11.07 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.262 -0.899 . . . . 0.94999999999999996 108.962 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.609 ' O ' ' HA ' ' A' ' 71' ' ' ASN . . . -144.21 148.21 34.65 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.402 -0.962 . . . . 1.46 108.402 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.508 ' HB2' ' HB ' ' A' ' 111' ' ' ILE . 56.6 mttt -118.03 -169.45 1.69 Allowed 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.17 -1.418 . . . . 2.8999999999999999 107.17 177.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.414 ' HB ' ' O ' ' A' ' 51' ' ' LYS . 5.5 tt -176.4 151.4 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 C-N-CA 118.731 -1.188 . . . . 1.27 110.179 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.49 ' O ' ' NZ ' ' A' ' 55' ' ' LYS . 0.4 OUTLIER -148.45 57.54 1.06 Allowed 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.583 -0.895 . . . . 2.8599999999999999 108.583 179.916 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.636 ' CD1' ' CE2' ' A' ' 90' ' ' TYR . 1.6 mm -73.58 160.39 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.486 -0.759 . . . . 3.8999999999999999 109.675 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.576 ' N ' ' CG2' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -173.14 81.57 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.252 0.548 . . . . 1.71 110.055 178.548 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.534 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . . . -122.16 155.42 35.82 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 108.78 -0.822 . . . . 2.8799999999999999 108.78 179.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.431 ' OG ' ' HA ' ' A' ' 104' ' ' VAL . 0.0 OUTLIER -129.7 136.56 49.83 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.035 -1.041 . . . . 1.3700000000000001 109.402 -179.609 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.572 HD22 ' CE3' ' A' ' 92' ' ' TRP . 0.0 OUTLIER -128.0 164.49 22.23 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.286 -0.884 . . . . 5.3600000000000003 109.202 -179.506 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.498 ' OD2' ' N ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -39.47 -68.03 0.19 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.38 -0.825 . . . . 4.2699999999999996 109.617 -179.796 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.498 ' N ' ' OD2' ' A' ' 59' ' ' ASP . . . -118.81 30.1 6.03 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.146 -1.582 . . . . 1.23 109.146 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.453 HD21 ' O ' ' A' ' 60' ' ' GLY . 0.2 OUTLIER -139.81 61.24 1.54 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.257 -1.143 . . . . 1.0600000000000001 110.049 -179.578 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.495 ' HG3' ' O ' ' A' ' 62' ' ' GLU . 0.3 OUTLIER -55.69 100.2 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.967 -1.083 . . . . 3.46 108.162 179.348 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.565 ' O ' ' CG2' ' A' ' 63' ' ' ILE . 2.9 mt -71.8 -2.68 3.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.364 -0.835 . . . . 2.8500000000000001 111.087 -178.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.507 ' C ' ' O ' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -30.97 137.65 0.04 OUTLIER 'General case' 0 C--N 1.285 -2.213 0 CA-C-O 121.532 0.682 . . . . 3.8999999999999999 110.009 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.585 HG23 ' HB ' ' A' ' 54' ' ' ILE . 70.1 t -126.01 90.26 50.62 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.396 -0.815 . . . . 1.8799999999999999 109.755 -178.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.89 -4.53 13.42 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.92 2.413 . . . . 1.45 110.757 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 68' ' ' ILE . . . 167.83 -92.09 0.1 Allowed Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.617 -1.393 . . . . 2.9900000000000002 109.617 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.482 ' O ' ' O ' ' A' ' 69' ' ' ASP . 1.2 mm 49.95 99.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.216 -1.167 . . . . 3.21 109.791 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.501 ' CG ' ' HB2' ' A' ' 74' ' ' HIS . 13.0 m-20 53.23 104.91 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.337 -0.852 . . . . 5.5 108.91 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -82.32 31.55 0.4 Allowed 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.383 -0.823 . . . . 5.9100000000000001 111.113 -178.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.609 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -154.16 40.16 0.47 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.449 -1.407 . . . . 4.7800000000000002 111.445 179.79 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.538 ' CB ' ' HB2' ' A' ' 50' ' ' ALA . . . 32.27 31.71 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.173 0.511 . . . . 0.66000000000000003 111.894 176.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.562 ' N ' ' O ' ' A' ' 71' ' ' ASN . 16.6 t -98.0 -21.34 16.87 Favored 'General case' 0 C--N 1.293 -1.857 0 O-C-N 121.142 -0.974 . . . . 0.90000000000000002 111.256 -178.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.501 ' HB2' ' CG ' ' A' ' 69' ' ' ASP . 11.4 t-160 -71.57 -25.89 62.39 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.898 -1.126 . . . . 2.0499999999999998 111.434 -178.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.518 ' HB2' HD13 ' A' ' 88' ' ' ILE . 8.2 m-85 -95.62 -29.47 14.31 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.533 -1.354 . . . . 2.5600000000000001 111.375 -178.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.707 ' CG2' ' CE2' ' A' ' 86' ' ' TYR . 3.3 m -148.37 -149.46 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.915 -1.116 . . . . 3.8199999999999998 111.259 -177.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.532 ' N ' ' CG2' ' A' ' 76' ' ' VAL . 0.1 OUTLIER -85.49 105.37 16.05 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.727 -0.842 . . . . 4.1900000000000004 108.727 179.445 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . 0.585 ' N ' ' HD2' ' A' ' 79' ' ' PRO . 0.1 OUTLIER -47.78 -44.62 58.02 Favored Pre-proline 0 N--CA 1.493 1.722 0 C-N-CA 118.277 -1.369 . . . . 1.1100000000000001 109.066 179.897 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.605 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 28.9 Cg_endo -72.78 104.1 1.69 Allowed 'Trans proline' 0 C--N 1.317 -1.125 0 N-CA-C 108.471 -1.396 . . . . 0.68999999999999995 108.471 177.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.624 HD21 ' CD2' ' A' ' 117' ' ' LEU . 0.2 OUTLIER -96.31 -64.49 1.05 Allowed 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 108.914 -0.773 . . . . 3.8599999999999999 108.914 -178.214 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.626 ' HA ' ' N ' ' A' ' 46' ' ' ASN . 24.5 t 53.54 177.68 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 C-N-CA 118.784 -1.166 . . . . 4.3499999999999996 108.748 177.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.561 ' HA ' ' O ' ' A' ' 43' ' ' ALA . 0.6 OUTLIER -96.52 31.01 2.38 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 120.797 -1.189 . . . . 3.4900000000000002 109.029 -179.315 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -132.49 27.4 3.56 Favored Glycine 0 C--N 1.289 -2.039 0 N-CA-C 108.14 -1.984 . . . . 0.95999999999999996 108.14 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.545 ' HG3' ' N ' ' A' ' 85' ' ' GLN . 9.0 tp-100 -142.39 159.55 42.0 Favored 'General case' 0 C--N 1.308 -1.229 0 O-C-N 121.486 -1.008 . . . . 1.7 108.37 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.562 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -154.53 137.28 15.27 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.452 -0.944 . . . . 3.0299999999999998 108.452 179.606 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.707 ' CE2' ' CG2' ' A' ' 76' ' ' VAL . 12.1 p90 -158.55 177.41 11.25 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 117.581 -1.648 . . . . 3.3399999999999999 111.386 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.602 ' CB ' ' HG ' ' A' ' 40' ' ' LEU . 8.9 p-10 -121.08 89.02 3.05 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 119.664 -0.815 . . . . 1.21 112.49 -177.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.58 ' CG2' ' N ' ' A' ' 89' ' ' LYS . 0.6 OUTLIER -59.05 -164.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 106.761 -1.57 . . . . 1.28 106.761 176.751 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.58 ' N ' ' CG2' ' A' ' 88' ' ' ILE . 0.2 OUTLIER 163.15 174.15 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.955 -1.091 . . . . 2.2599999999999998 110.725 179.286 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.636 ' CE2' ' CD1' ' A' ' 54' ' ' ILE . 13.6 m-85 -160.87 75.4 0.53 Allowed 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.524 -0.917 . . . . 1.0800000000000001 108.524 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.477 ' HB ' ' OG1' ' A' ' 36' ' ' THR . 1.6 p -74.36 -167.62 0.56 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.421 -0.799 . . . . 2.0499999999999998 110.151 -179.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.572 ' CE3' HD22 ' A' ' 58' ' ' LEU . 3.0 t90 -171.62 112.5 0.33 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.425 -0.797 . . . . 5.4500000000000002 110.065 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.534 ' O ' ' NE1' ' A' ' 92' ' ' TRP . 1.6 t30 -49.31 122.27 5.9 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 106.02 -1.845 . . . . 1.8600000000000001 106.02 177.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.622 ' CG1' ' CD1' ' A' ' 97' ' ' ILE . 60.6 t -123.28 101.51 37.85 Favored Pre-proline 0 C--N 1.301 -1.515 0 C-N-CA 117.888 -1.525 . . . . 2.5600000000000001 113.277 -176.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.57 ' HD2' ' CD1' ' A' ' 97' ' ' ILE . 31.4 Cg_endo -72.33 -149.36 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.806 2.338 . . . . 1.77 108.734 176.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -69.39 -49.48 54.97 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.443 -1.411 . . . . 4.04 108.098 178.514 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.622 ' CD1' ' CG1' ' A' ' 94' ' ' VAL . 2.8 mp 62.32 -2.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 113.227 0.825 . . . . 1.6399999999999999 113.227 177.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.593 ' CB ' ' HD2' ' A' ' 99' ' ' PRO . . . 57.53 178.31 0.04 OUTLIER Pre-proline 0 C--N 1.3 -1.568 0 O-C-N 119.942 -1.724 . . . . 0.38 108.49 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.593 ' HD2' ' CB ' ' A' ' 98' ' ' ALA . 52.9 Cg_endo -82.52 151.77 15.27 Favored 'Trans proline' 0 C--N 1.299 -2.06 0 C-N-CA 123.454 2.769 . . . . 0.56000000000000005 110.204 -178.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.611 ' CD ' ' O ' ' A' ' 127' ' ' ILE . 0.3 OUTLIER 55.02 115.27 0.01 OUTLIER 'General case' 0 C--N 1.288 -2.079 0 C-N-CA 119.403 -0.919 . . . . 3.3700000000000001 111.413 176.213 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.504 ' OG ' ' CD1' ' A' ' 127' ' ' ILE . 67.6 m -86.91 158.74 19.24 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.186 -0.946 . . . . 2.98 108.686 178.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.421 ' O ' ' HB2' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -50.29 -21.29 1.33 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.009 -1.057 . . . . 5.1699999999999999 109.582 -179.499 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.475 ' C ' ' CG2' ' A' ' 104' ' ' VAL . 15.4 t-20 -179.22 159.95 0.99 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.127 -0.983 . . . . 1.3 109.597 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.475 ' CG2' ' C ' ' A' ' 103' ' ' ASN . 0.9 OUTLIER -154.76 171.6 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.33 -0.856 . . . . 1.8700000000000001 110.003 179.793 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 56' ' ' ALA . 0.9 OUTLIER 170.61 147.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 108.019 -1.104 . . . . 1.3999999999999999 108.019 -179.863 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.455 ' HB ' ' HB1' ' A' ' 122' ' ' ALA . 1.5 t -143.56 137.42 25.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 120.331 -1.48 . . . . 1.96 110.29 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.5 ' O ' HG21 ' A' ' 108' ' ' VAL . 0.9 OUTLIER -167.88 148.98 5.24 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.159 -1.052 . . . . 1.46 108.159 179.691 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.512 HG12 HD12 ' A' ' 54' ' ' ILE . 2.7 t -157.19 163.6 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.848 -1.158 . . . . 1.8700000000000001 110.83 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.538 ' HG3' ' N ' ' A' ' 110' ' ' LEU . 0.3 OUTLIER -169.87 146.39 3.16 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.721 -0.844 . . . . 2.04 108.721 178.801 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.538 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 11.5 tp -139.03 126.45 21.64 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 106.774 -1.565 . . . . 1.8100000000000001 106.774 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.508 ' HB ' ' HB2' ' A' ' 51' ' ' LYS . 7.6 mt -134.24 120.02 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.214 -0.929 . . . . 1.3 111.586 -177.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.467 ' HA3' ' NE2' ' A' ' 45' ' ' GLN . . . -83.94 -108.37 0.57 Allowed Glycine 0 N--CA 1.486 2.016 0 N-CA-C 108.026 -2.03 . . . . 0.72999999999999998 108.026 177.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -145.62 7.87 1.13 Allowed 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.072 -1.252 . . . . 1.54 107.951 178.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.459 ' ND2' ' N ' ' A' ' 114' ' ' ASN . 0.5 OUTLIER -124.8 -17.35 5.9 Favored 'General case' 0 C--N 1.308 -1.196 0 O-C-N 121.466 -0.771 . . . . 1.48 109.922 -179.766 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 169.37 144.88 4.41 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.695 -1.362 . . . . 2.3500000000000001 109.695 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 111' ' ' ILE . 0.1 OUTLIER -53.35 111.16 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.174 -1.192 . . . . 1.1599999999999999 109.975 -179.644 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.624 ' CD2' HD21 ' A' ' 80' ' ' LEU . 10.7 mt -54.42 -51.66 64.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.633 -0.667 . . . . 2.5600000000000001 111.064 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.572 ' HA ' ' CA ' ' A' ' 9' ' ' ALA . . . -166.59 147.19 6.06 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.841 -1.162 . . . . 1.3300000000000001 111.269 -178.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . 0.525 ' SG ' ' N ' ' A' ' 120' ' ' ALA . 0.5 OUTLIER -139.89 178.31 7.34 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 109.026 -0.731 . . . . 1.6599999999999999 109.026 179.279 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.525 ' N ' ' SG ' ' A' ' 119' ' ' CYS . . . -179.12 125.93 0.09 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.097 -1.002 . . . . 1.0900000000000001 109.423 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.426 HD11 ' O ' ' A' ' 6' ' ' LYS . 1.0 OUTLIER -129.78 138.36 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.162 -0.961 . . . . 1.6000000000000001 109.799 -179.875 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.455 ' HB1' ' HB ' ' A' ' 106' ' ' VAL . . . -107.36 -23.27 12.28 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.213 -0.929 . . . . 2.77 109.321 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.453 ' O ' ' CB ' ' A' ' 124' ' ' HIS . 6.9 m 66.32 98.65 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.564 -0.71 . . . . 2.23 110.442 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.453 ' CB ' ' O ' ' A' ' 123' ' ' THR . 0.0 OUTLIER 71.95 177.67 0.26 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.226 -0.921 . . . . 2.75 110.573 178.899 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -176.45 137.41 3.61 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.006 -1.638 . . . . 0.79000000000000004 109.006 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.495 ' O ' ' CG2' ' A' ' 28' ' ' ILE . 22.7 mtmt -144.0 95.94 2.81 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.959 -1.318 . . . . 4.5099999999999998 110.284 -179.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.611 ' O ' ' CD ' ' A' ' 100' ' ' LYS . 1.2 mp -58.32 143.44 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.151 -0.968 . . . . 1.25 109.41 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.59 ' CB ' ' O ' ' A' ' 127' ' ' ILE . 13.7 ttt-85 149.45 -94.68 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 108.557 -0.905 . . . . 3.1499999999999999 108.557 178.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.526 ' N ' ' HG2' ' A' ' 128' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.497 1.875 0 CA-C-O 117.984 -1.008 . . . . 4.5499999999999998 110.247 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.1 p30 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.418 0.628 . . . . 3.95 109.713 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.522 ' HB3' ' HG2' ' A' ' 17' ' ' MET . 1.4 pt20 -117.4 -168.36 1.47 Allowed 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.369 -0.832 . . . . 1.78 109.436 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.614 HG12 ' HA ' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -135.84 -173.4 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 108.53 -0.915 . . . . 0.7 108.53 179.024 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.87 41.58 1.58 Allowed 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.203 -0.935 . . . . 1.01 109.057 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.9 m -54.02 161.9 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.372 -0.83 . . . . 1.22 109.408 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.47 ' O ' ' C ' ' A' ' 7' ' ' ASP . 11.2 mmtm -87.61 52.44 2.49 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.151 -0.968 . . . . 2.67 109.574 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.47 ' C ' ' O ' ' A' ' 6' ' ' LYS . 5.3 p30 -38.78 156.1 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 109.327 -0.62 . . . . 1.46 109.327 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -153.08 34.35 0.47 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.986 -1.072 . . . . 1.22 110.531 -179.253 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.542 ' HA ' ' HA ' ' A' ' 118' ' ' ALA . . . -69.59 -174.05 0.66 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.592 -1.317 . . . . 2.12 109.048 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.583 ' O ' ' CB ' ' A' ' 11' ' ' ASN . 0.7 OUTLIER -54.56 -53.33 55.96 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 108.342 -0.985 . . . . 2.81 108.342 178.174 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.583 ' CB ' ' O ' ' A' ' 10' ' ' ASN . 12.3 p30 147.19 40.88 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.036 -1.098 . . . . 6.47 108.036 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.479 ' HB2' ' OD2' ' A' ' 42' ' ' ASP . 7.2 mt-10 -147.33 8.3 0.91 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.178 -0.951 . . . . 2.68 110.654 -178.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 1.009 HG23 ' O ' ' A' ' 40' ' ' LEU . 36.1 mt -44.59 148.35 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.891 -1.13 . . . . 0.29 108.798 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.82 -19.33 18.21 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.423 -0.798 . . . . 2.46 109.462 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.611 ' H ' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -172.65 134.95 0.65 Allowed 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 118.725 -1.19 . . . . 1.02 110.631 -177.854 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.753 ' O ' HG12 ' A' ' 16' ' ' VAL . 0.9 OUTLIER -139.02 104.26 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 107.246 -1.39 . . . . 2.1 107.246 179.158 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.522 ' HG2' ' HB3' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -149.46 140.73 23.15 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 118.901 -1.12 . . . . 1.64 111.234 -177.805 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.876 HG22 ' HA ' ' A' ' 37' ' ' LEU . 39.6 t -118.2 132.53 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 108.236 -1.024 . . . . 1.31 108.236 178.407 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -76.84 79.65 3.43 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.193 -0.942 . . . . 1.61 110.213 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.553 ' O ' ' CB ' ' A' ' 21' ' ' CYS . . . 87.9 121.98 1.72 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 110.014 -1.234 . . . . 0.59 110.014 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.851 ' CA ' HG23 ' A' ' 29' ' ' ILE . 0.0 OUTLIER 157.24 -41.46 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.629 -0.924 . . . . 0.37 109.298 179.319 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.614 ' HA ' HG12 ' A' ' 3' ' ' VAL . 0.9 OUTLIER 80.73 122.69 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.293 -0.879 . . . . 1.1 110.248 -179.547 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.467 ' O ' ' HB3' ' A' ' 24' ' ' SER . . . -96.85 178.74 33.75 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.622 -1.391 . . . . 0.44 109.622 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.505 ' O ' ' O ' ' A' ' 25' ' ' ASP . 27.7 t 63.63 -91.32 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.223 -1.163 . . . . 1.45 110.217 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.638 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.1 OUTLIER -50.18 -175.33 0.01 OUTLIER Pre-proline 0 C--N 1.305 -1.369 0 N-CA-C 108.83 -0.804 . . . . 0.4 108.83 179.681 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.638 ' HD2' ' CB ' ' A' ' 25' ' ' ASP . 28.4 Cg_endo -70.14 84.8 0.7 Allowed 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 121.462 1.442 . . . . 0.47 108.552 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.488 ' SG ' ' O ' ' A' ' 27' ' ' CYS . 0.9 OUTLIER -28.54 95.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 115.325 -0.852 . . . . 0.23 112.453 -178.039 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.617 HG23 ' O ' ' A' ' 126' ' ' LYS . 23.3 mm -90.92 137.6 21.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 105.289 -2.115 . . . . 0.26 105.289 175.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.851 HG23 ' CA ' ' A' ' 21' ' ' CYS . 0.2 OUTLIER -119.69 177.69 2.79 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 O-C-N 120.553 -1.342 . . . . 0.29 112.898 -175.556 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 51.2 m-70 -112.37 158.13 20.18 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.916 0.865 . . . . 1.09 110.817 -179.009 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.545 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -111.3 141.32 44.99 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.123 -1.066 . . . . 2.95 108.123 178.408 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' A' ' 95' ' ' PRO . . . 101.11 3.34 54.48 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.469 -1.452 . . . . 0.67 109.469 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.715 ' N ' HG11 ' A' ' 94' ' ' VAL . 1.9 mtmt -133.87 144.51 52.04 Favored Pre-proline 0 C--N 1.305 -1.355 0 O-C-N 121.42 -1.047 . . . . 0.49 108.328 179.038 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -69.62 81.4 0.79 Allowed 'Trans proline' 0 C--N 1.301 -1.944 0 C-N-CA 122.346 2.031 . . . . 0.9 111.175 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.585 ' CD1' ' O ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -59.58 122.84 15.07 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.998 -1.112 . . . . 2.54 107.998 178.974 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.756 HG23 ' HA ' ' A' ' 91' ' ' THR . 88.0 m -141.19 91.83 2.43 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.11 -0.994 . . . . 1.24 110.226 -178.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.876 ' HA ' HG22 ' A' ' 18' ' ' VAL . 1.2 pp -64.26 137.78 58.1 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.294 -0.879 . . . . 1.02 108.714 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.559 ' HG2' ' CG ' ' A' ' 89' ' ' LYS . 4.3 mt-10 -128.0 168.17 15.66 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.134 -0.979 . . . . 1.95 109.731 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.437 ' HB2' ' O ' ' A' ' 38' ' ' GLU . . . 176.83 74.01 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.984 0.897 . . . . 0.88 109.407 178.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 1.009 ' O ' HG23 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -67.76 169.98 8.72 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 109.529 -0.545 . . . . 0.35 109.529 179.931 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.748 ' CE2' ' CD2' ' A' ' 86' ' ' TYR . 1.4 p90 -165.85 162.42 18.36 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.156 -0.965 . . . . 0.64 108.674 177.481 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.479 ' OD2' ' HB2' ' A' ' 12' ' ' GLU . 4.3 p30 -120.03 115.93 24.72 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 122.037 0.923 . . . . 4.95 109.022 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.907 ' HB1' ' O ' ' A' ' 81' ' ' VAL . . . -42.2 115.43 0.68 Allowed 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 108.854 -0.795 . . . . 0.31 108.854 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.4 ' OD1' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -124.31 -0.87 8.2 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.364 -0.835 . . . . 0.8 109.968 -178.608 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.79 ' OE1' HD21 ' A' ' 117' ' ' LEU . 2.5 pt20 -92.59 -142.63 0.21 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.384 -0.822 . . . . 0.69 109.017 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.792 ' HA ' ' HB ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -155.62 71.41 0.76 Allowed 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.174 -0.954 . . . . 0.7 109.561 179.002 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.639 HG23 ' O ' ' A' ' 47' ' ' THR . 4.8 t -150.15 121.6 7.93 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 119.959 -1.713 . . . . 0.93 111.123 -178.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.608 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 7.0 mtmt -68.63 -7.55 34.08 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.785 -1.197 . . . . 2.05 109.186 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.85 158.88 18.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.176 -0.952 . . . . 1.6 109.492 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.796 ' HB1' ' HB3' ' A' ' 72' ' ' ALA . . . -151.66 135.08 16.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.369 -0.832 . . . . 0.38 108.882 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 1.083 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 0.1 OUTLIER -117.64 -158.99 0.73 Allowed 'General case' 0 C--N 1.298 -1.662 0 O-C-N 120.564 -1.335 . . . . 1.78 108.028 178.475 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.485 HG13 HD13 ' A' ' 54' ' ' ILE . 1.5 tt -177.93 161.74 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 C-N-CA 118.647 -1.221 . . . . 0.58 110.481 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.535 ' O ' ' CE ' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -160.33 40.0 0.17 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.804 -0.813 . . . . 0.54 108.804 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.95 ' HB ' HG21 ' A' ' 65' ' ' VAL . 0.3 OUTLIER -72.77 148.01 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.138 -0.976 . . . . 0.38 109.801 -179.656 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.595 ' HG3' ' O ' ' A' ' 54' ' ' ILE . 0.3 OUTLIER -163.19 94.62 0.82 Allowed 'General case' 0 C--N 1.287 -2.121 0 O-C-N 121.282 -0.886 . . . . 1.17 109.005 178.515 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.525 ' O ' HG13 ' A' ' 63' ' ' ILE . . . -119.77 120.01 35.28 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 119.639 -0.824 . . . . 0.67 110.584 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.47 124.62 47.44 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.012 -1.107 . . . . 0.68 108.012 178.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.577 HD21 ' CD1' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.87 169.1 10.46 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.844 -1.16 . . . . 4.25 110.109 -178.517 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.482 ' HB2' ' CB ' ' A' ' 101' ' ' SER . 67.4 t0 -77.79 80.4 4.25 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.546 -0.909 . . . . 4.91 108.546 179.371 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.601 ' O ' HD22 ' A' ' 61' ' ' LEU . . . 105.08 1.41 41.77 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 108.537 -1.825 . . . . 1.08 108.537 -178.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.601 HD22 ' O ' ' A' ' 60' ' ' GLY . 0.4 OUTLIER -136.64 59.53 1.69 Allowed 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.027 -1.101 . . . . 1.46 108.027 179.397 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -69.11 81.87 0.33 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.714 -0.616 . . . . 1.05 110.229 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.525 HG13 ' O ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -82.98 125.61 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 118.445 -1.302 . . . . 2.08 108.682 178.895 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -128.58 164.42 22.88 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.699 -0.852 . . . . 1.49 108.699 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.95 HG21 ' HB ' ' A' ' 54' ' ' ILE . 43.3 t -143.4 68.7 17.32 Favored Pre-proline 0 C--N 1.3 -1.551 0 O-C-N 121.01 -1.056 . . . . 0.77 110.114 -179.104 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.501 ' HD2' ' CG1' ' A' ' 68' ' ' ILE . 36.4 Cg_endo -80.72 95.94 0.99 Allowed 'Trans proline' 0 C--N 1.301 -1.938 0 C-N-CA 123.063 2.509 . . . . 2.67 110.264 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.499 ' C ' ' O ' ' A' ' 66' ' ' PRO . . . 33.53 50.08 0.54 Allowed Glycine 0 N--CA 1.497 2.702 0 N-CA-C 109.85 -1.3 . . . . 0.75 109.85 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.501 ' CG1' ' HD2' ' A' ' 66' ' ' PRO . 5.8 mt -76.08 -76.7 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.376 -1.073 . . . . 1.24 109.842 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.63 ' HB3' ' HB2' ' A' ' 74' ' ' HIS . 15.1 p30 -59.26 157.62 10.46 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.329 -0.857 . . . . 1.27 109.262 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.464 ' O ' ' CG ' ' A' ' 71' ' ' ASN . 20.0 p -77.4 -20.2 54.99 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.843 -1.169 . . . . 0.89 107.843 178.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.712 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 47.8 m-20 -173.96 73.93 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.369 0.604 . . . . 2.5 109.661 179.267 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 1.083 ' HB2' ' O ' ' A' ' 51' ' ' LYS . . . 38.85 26.59 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.547 -0.72 . . . . 0.74 111.56 177.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.517 ' SG ' ' N ' ' A' ' 78' ' ' CYS . 2.4 t -100.85 -17.77 16.71 Favored 'General case' 0 C--N 1.29 -2.013 0 O-C-N 121.151 -0.968 . . . . 1.36 110.433 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.63 ' HB2' ' HB3' ' A' ' 69' ' ' ASP . 3.1 t-80 -61.23 -28.97 69.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.801 -1.187 . . . . 2.07 109.829 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -99.74 -54.83 2.81 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.696 -1.253 . . . . 2.36 110.319 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 1.173 HG21 ' CZ ' ' A' ' 86' ' ' TYR . 8.3 m -108.67 -145.52 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 CA-C-O 121.775 0.798 . . . . 2.82 109.186 -178.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.769 ' N ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -93.1 167.68 11.62 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.124 -1.436 . . . . 2.86 107.124 177.629 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 78' ' ' CYS . . . . . 0.735 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -91.36 -43.76 0.38 Allowed Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 120.476 -1.39 . . . . 1.1 110.469 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.608 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 31.0 Cg_endo -78.65 117.02 3.89 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 121.211 1.274 . . . . 0.99 109.385 178.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.997 HD12 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -97.11 -68.12 0.81 Allowed 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.375 -0.972 . . . . 0.73 108.375 -179.074 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.907 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 1.1 m 40.9 -168.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 116.051 -0.522 . . . . 0.47 109.812 178.284 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.722 ' H ' HG23 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -99.22 41.13 1.16 Allowed 'General case' 0 C--N 1.295 -1.803 0 O-C-N 120.378 -1.451 . . . . 0.93 109.972 -177.649 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -143.94 39.73 1.24 Allowed Glycine 0 C--N 1.293 -1.812 0 N-CA-C 109.95 -1.26 . . . . 0.76 109.95 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 50.3 tp60 -158.88 154.12 25.5 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.93 -1.335 . . . . 1.5 110.001 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -111.85 160.44 17.37 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.65 -0.87 . . . . 2.38 108.65 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 1.173 ' CZ ' HG21 ' A' ' 76' ' ' VAL . 0.9 OUTLIER -127.45 -170.25 2.19 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.798 -1.189 . . . . 3.4 110.546 -179.005 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.572 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 3.2 p30 174.68 39.12 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.65 -0.87 . . . . 1.61 108.65 178.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.754 HD12 HG13 ' A' ' 76' ' ' VAL . 0.4 OUTLIER -53.01 -170.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.867 -0.79 . . . . 0.82 108.867 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.68 ' N ' HG23 ' A' ' 88' ' ' ILE . 0.2 OUTLIER 165.81 -179.32 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 119.07 -1.052 . . . . 1.3 110.442 -179.323 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.667 ' CZ ' HG21 ' A' ' 54' ' ' ILE . 31.1 m-85 -167.35 93.62 0.43 Allowed 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.122 -1.066 . . . . 1.06 108.122 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.756 ' HA ' HG23 ' A' ' 36' ' ' THR . 0.6 OUTLIER -87.17 -162.86 0.84 Allowed 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.773 0.797 . . . . 1.75 110.959 -178.183 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.566 ' CE3' HD21 ' A' ' 58' ' ' LEU . 7.1 t90 -175.18 90.48 0.05 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.531 -0.731 . . . . 4.32 109.599 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.461 ' C ' ' O ' ' A' ' 92' ' ' TRP . 3.1 t-20 -45.48 108.76 0.14 Allowed 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 106.8 -1.555 . . . . 1.29 106.8 178.322 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.873 HG13 ' CD1' ' A' ' 97' ' ' ILE . 2.4 t -104.58 116.21 61.47 Favored Pre-proline 0 C--N 1.301 -1.508 0 C-N-CA 118.854 -1.139 . . . . 0.57 113.128 -176.024 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.773 ' HD2' HD11 ' A' ' 97' ' ' ILE . 33.4 Cg_endo -81.08 -86.12 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 123.206 2.604 . . . . 0.49 108.538 176.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.545 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -135.7 -56.14 0.78 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 105.679 -1.971 . . . . 2.36 105.679 177.766 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.873 ' CD1' HG13 ' A' ' 94' ' ' VAL . 1.5 mp 67.91 7.32 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 113.203 0.816 . . . . 0.53 113.203 175.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 1.016 ' HB1' ' HD2' ' A' ' 99' ' ' PRO . . . 52.96 177.87 0.03 OUTLIER Pre-proline 0 C--N 1.302 -1.482 0 O-C-N 120.241 -1.537 . . . . 0.6 109.626 179.01 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 1.016 ' HD2' ' HB1' ' A' ' 98' ' ' ALA . 51.8 Cg_endo -83.59 152.78 13.46 Favored 'Trans proline' 0 C--N 1.303 -1.867 0 C-N-CA 123.751 2.968 . . . . 0.81 110.086 -179.238 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.646 ' HD3' ' CB ' ' A' ' 128' ' ' ARG . 1.7 mmmp? 55.98 127.35 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.97 0 C-N-CA 119.683 -0.807 . . . . 0.9 111.674 176.062 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.908 ' CB ' HD13 ' A' ' 127' ' ' ILE . 12.3 t -97.67 154.6 17.46 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.196 -0.94 . . . . 0.97 108.595 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.438 ' O ' ' CB ' ' A' ' 103' ' ' ASN . 76.1 mt-10 -48.85 -22.45 0.83 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.118 -0.989 . . . . 1.31 109.624 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.438 ' CB ' ' O ' ' A' ' 102' ' ' GLU . 0.4 OUTLIER 165.02 152.0 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.036 -1.098 . . . . 3.17 108.036 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.466 ' C ' HG23 ' A' ' 105' ' ' VAL . 0.1 OUTLIER -142.76 153.76 17.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 120.814 -1.179 . . . . 0.83 110.949 -178.944 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.466 HG23 ' C ' ' A' ' 104' ' ' VAL . 25.4 t -157.64 104.04 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 107.561 -1.274 . . . . 1.4 107.561 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.704 ' HB ' ' HB3' ' A' ' 122' ' ' ALA . 15.7 t -103.55 111.06 31.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 120.988 -1.07 . . . . 0.92 109.484 -178.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.587 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -129.98 175.27 9.02 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 120.877 -1.139 . . . . 1.21 108.269 179.269 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.797 HG22 ' CD1' ' A' ' 54' ' ' ILE . 1.2 t 175.07 168.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 C-N-CA 118.835 -1.146 . . . . 0.58 110.318 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.633 ' N ' HG13 ' A' ' 108' ' ' VAL . 1.1 ttpt 162.94 134.63 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.838 0.828 . . . . 1.36 109.67 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.561 ' HB3' ' HB2' ' A' ' 117' ' ' LEU . 9.4 tp -113.22 130.04 56.34 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 106.873 -1.528 . . . . 0.59 106.873 178.052 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.464 ' HB ' ' HB2' ' A' ' 51' ' ' LYS . 9.4 mt -127.25 120.12 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.154 -0.966 . . . . 0.68 111.737 -177.24 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.414 ' HA3' HG21 ' A' ' 47' ' ' THR . . . -92.4 -114.25 2.11 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 108.812 -1.715 . . . . 0.83 108.812 178.178 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -138.21 1.94 2.26 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.044 -1.268 . . . . 1.09 108.004 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -112.58 -39.31 4.38 Favored 'General case' 0 C--N 1.31 -1.129 0 O-C-N 121.415 -0.803 . . . . 0.75 109.048 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -177.38 155.38 17.65 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.07 -1.612 . . . . 1.54 109.07 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.533 ' CG2' ' O ' ' A' ' 118' ' ' ALA . 0.2 OUTLIER -50.18 111.88 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.167 -1.196 . . . . 0.7 109.82 -179.647 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.997 HD22 HD12 ' A' ' 80' ' ' LEU . 1.4 mt -57.49 -62.89 1.46 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.294 -0.879 . . . . 0.72 109.666 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.542 ' HA ' ' HA ' ' A' ' 9' ' ' ALA . . . -123.97 -175.26 3.19 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.13 -0.981 . . . . 0.22 110.083 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 0.542 ' HA ' ' HA ' ' A' ' 109' ' ' LYS . 1.9 t 172.37 150.51 0.06 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.155 -0.966 . . . . 0.85 110.15 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.444 ' C ' HG13 ' A' ' 121' ' ' ILE . . . -170.02 130.98 1.0 Allowed 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.79 -0.818 . . . . 0.58 108.79 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.444 HG13 ' C ' ' A' ' 120' ' ' ALA . 2.8 mt -134.15 139.47 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.177 -0.952 . . . . 0.46 110.075 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.704 ' HB3' ' HB ' ' A' ' 106' ' ' VAL . . . -106.77 -17.92 14.08 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.487 -0.931 . . . . 2.08 108.487 179.218 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.415 HG22 ' CE1' ' A' ' 124' ' ' HIS . 0.3 OUTLIER 58.51 89.08 0.06 Allowed 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 121.519 0.676 . . . . 1.43 110.196 179.718 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 124' ' ' HIS . . . . . 0.415 ' CE1' HG22 ' A' ' 123' ' ' THR . 7.4 m80 61.9 -160.93 0.3 Allowed 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.724 0.773 . . . . 3.56 110.378 179.143 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 153.91 150.61 5.52 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.346 -1.902 . . . . 1.11 108.346 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.617 ' O ' HG23 ' A' ' 28' ' ' ILE . 69.0 mttt -140.38 96.56 3.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.95 -1.323 . . . . 1.78 109.987 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.908 HD13 ' CB ' ' A' ' 101' ' ' SER . 2.1 mp -46.05 152.43 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.649 -0.657 . . . . 0.37 109.843 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.646 ' CB ' ' HD3' ' A' ' 100' ' ' LYS . 0.0 OUTLIER 141.79 -77.3 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.692 0.758 . . . . 0.58 109.132 178.823 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.587 ' CB ' HG21 ' A' ' 28' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--N 1.301 -1.533 0 CA-C-O 118.017 -0.992 . . . . 3.57 109.63 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 1' ' ' ASP . . . . . 0.478 ' O ' ' O ' ' A' ' 2' ' ' GLN . 65.7 m-20 . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.5 0.667 . . . . 4.81 109.804 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.549 ' HA ' ' HB3' ' A' ' 17' ' ' MET . 93.6 mt-30 47.91 179.08 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 122.158 0.98 . . . . 3.84 110.999 178.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.839 HG13 ' N ' ' A' ' 4' ' ' ASP . 2.2 p -162.72 -149.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 108.642 -0.873 . . . . 4.17 108.642 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.839 ' N ' HG13 ' A' ' 3' ' ' VAL . 32.2 t0 -163.73 54.74 0.16 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.652 -1.28 . . . . 2.24 110.222 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.621 HG12 ' HB2' ' A' ' 122' ' ' ALA . 19.4 m -89.12 152.39 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.031 -1.043 . . . . 0.9 109.83 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.48 95.57 3.31 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.319 -0.863 . . . . 2.79 109.238 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -89.88 173.97 7.95 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.358 -0.839 . . . . 1.47 109.582 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.487 ' N ' ' SG ' ' A' ' 119' ' ' CYS . 24.8 p -164.76 47.79 0.1 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.258 -0.901 . . . . 2.03 109.696 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.591 ' HB1' ' O ' ' A' ' 117' ' ' LEU . . . -76.4 -67.31 0.7 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.304 -0.873 . . . . 0.38 109.244 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.554 ' CB ' ' O ' ' A' ' 9' ' ' ALA . 0.7 OUTLIER 160.37 39.5 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.487 -0.931 . . . . 0.98 108.487 -178.285 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 54.4 t30 55.87 21.67 5.03 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.316 -0.994 . . . . 1.75 108.316 -178.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -104.48 -22.18 13.34 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.21 -0.663 . . . . 2.02 109.21 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.917 HG23 ' O ' ' A' ' 40' ' ' LEU . 3.8 mt -52.03 143.16 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.073 -1.017 . . . . 0.59 108.925 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.89 -22.7 13.11 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.351 -0.843 . . . . 1.91 109.223 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -168.75 108.95 0.49 Allowed 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 118.426 -1.31 . . . . 1.81 111.595 -178.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.622 ' O ' HG13 ' A' ' 16' ' ' VAL . 3.2 p -118.12 94.09 2.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 N-CA-C 106.819 -1.549 . . . . 0.78 106.819 177.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.549 ' HB3' ' HA ' ' A' ' 2' ' ' GLN . 7.0 mmt -134.87 118.32 16.83 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.487 -0.885 . . . . 2.63 111.356 -177.61 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.535 HG23 HG11 ' A' ' 3' ' ' VAL . 11.2 t -85.86 126.25 40.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 107.171 -1.418 . . . . 1.36 107.171 177.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.592 ' HB3' ' CB ' ' A' ' 35' ' ' PHE . 2.0 t0 -45.8 -22.17 0.17 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.071 -1.018 . . . . 2.35 110.396 -178.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.61 ' C ' HG23 ' A' ' 29' ' ' ILE . . . -177.82 135.32 2.68 Favored Glycine 0 N--CA 1.49 2.299 0 C-N-CA 118.947 -1.597 . . . . 1.76 110.857 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.972 ' CA ' HG23 ' A' ' 29' ' ' ILE . 0.0 OUTLIER 153.12 -37.0 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.881 -0.776 . . . . 0.91 109.614 178.671 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.636 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 42.6 t-80 53.76 102.85 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.78 -1.2 . . . . 3.46 109.362 -179.27 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.705 ' H ' HG22 ' A' ' 3' ' ' VAL . . . -90.03 -147.18 16.73 Favored Glycine 0 N--CA 1.499 2.867 0 O-C-N 121.044 -1.035 . . . . 1.03 111.407 -178.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.525 ' N ' ' O ' ' A' ' 4' ' ' ASP . 0.1 OUTLIER 80.92 -77.9 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.626 -0.926 . . . . 1.08 108.667 -178.986 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.676 ' HB2' ' CD ' ' A' ' 26' ' ' PRO . 7.4 p30 -86.17 -152.84 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.51 0 N-CA-C 105.727 -1.953 . . . . 1.84 105.727 178.289 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.676 ' CD ' ' HB2' ' A' ' 25' ' ' ASP . 28.7 Cg_endo -72.99 91.72 0.82 Allowed 'Trans proline' 0 C--N 1.319 -1.016 0 N-CA-C 108.395 -1.425 . . . . 0.43 108.395 179.14 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.636 ' HA ' ' O ' ' A' ' 22' ' ' HIS . 0.3 OUTLIER -34.36 101.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.559 0.695 . . . . 0.3 112.036 -177.202 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.756 HG21 ' HB3' ' A' ' 129' ' ' ASP . 28.4 mm -97.05 135.82 29.91 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 106.829 -1.545 . . . . 0.47 106.829 176.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.972 HG23 ' CA ' ' A' ' 21' ' ' CYS . 0.5 OUTLIER -122.87 -166.77 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 O-C-N 121.005 -1.06 . . . . 0.76 111.676 -177.468 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.577 ' H ' HG22 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -123.77 168.67 12.41 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 115.863 -0.608 . . . . 2.94 109.446 179.628 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.565 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -115.6 -163.96 0.92 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.089 -1.007 . . . . 1.56 109.453 179.43 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 31' ' ' ARG . . . 39.19 44.62 2.17 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.902 -1.279 . . . . 1.43 109.902 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.483 ' C ' ' HB ' ' A' ' 94' ' ' VAL . 0.1 OUTLIER -172.08 109.7 0.37 Allowed Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.153 -1.204 . . . . 2.37 109.577 -179.742 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.538 ' HA ' ' HB ' ' A' ' 94' ' ' VAL . 29.3 Cg_endo -70.37 115.5 4.21 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.821 2.348 . . . . 3.46 110.949 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.592 ' CB ' ' HB3' ' A' ' 19' ' ' ASP . 22.5 m-85 -100.13 -157.41 0.6 Allowed 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.773 -0.825 . . . . 7.48 108.773 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.551 ' O ' ' HG3' ' A' ' 38' ' ' GLU . 1.8 m -175.63 102.22 0.07 Allowed 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.368 -0.833 . . . . 0.78 108.768 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.468 ' HA ' HG13 ' A' ' 18' ' ' VAL . 0.2 OUTLIER -52.2 153.25 2.88 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.235 -1.024 . . . . 3.48 108.235 179.8 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.575 ' O ' ' HB2' ' A' ' 39' ' ' ALA . 63.0 mt-10 -154.38 166.75 32.24 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.791 -1.193 . . . . 0.64 110.96 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.575 ' HB2' ' O ' ' A' ' 38' ' ' GLU . . . 168.18 96.6 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.58 -0.896 . . . . 0.45 108.58 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.917 ' O ' HG23 ' A' ' 13' ' ' ILE . 0.5 OUTLIER -90.12 154.82 19.49 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.394 -0.595 . . . . 0.9 109.394 -179.517 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.762 ' CE2' ' CD2' ' A' ' 86' ' ' TYR . 0.2 OUTLIER -152.52 169.87 21.56 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.056 -1.027 . . . . 0.78 109.349 178.41 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.613 ' OD2' ' NE2' ' A' ' 85' ' ' GLN . 6.7 t0 -119.46 112.45 19.41 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 122.195 0.998 . . . . 1.5 109.206 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.884 ' HB1' ' O ' ' A' ' 81' ' ' VAL . . . -42.28 116.39 0.83 Allowed 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 115.431 -0.804 . . . . 0.73 109.198 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.491 ' O ' ' HB3' ' A' ' 82' ' ' LYS . 11.3 p30 -126.17 -0.1 7.11 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.243 -0.911 . . . . 4.4 109.731 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.89 ' CD ' HD21 ' A' ' 117' ' ' LEU . 3.1 pt20 -90.68 -137.61 0.14 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.413 -0.805 . . . . 0.69 109.01 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.858 ' HA ' ' HB ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -159.23 68.87 0.44 Allowed 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 119.59 -0.844 . . . . 1.6 109.637 179.215 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.71 HG21 ' HA3' ' A' ' 112' ' ' GLY . 3.5 t -145.25 120.01 9.88 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.045 -1.659 . . . . 0.56 110.764 -178.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.638 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 0.2 OUTLIER -68.74 -5.53 21.09 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.841 -1.162 . . . . 1.92 109.075 178.553 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.0 p -98.79 -177.6 3.7 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.058 -1.026 . . . . 1.14 109.893 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.922 ' HB1' ' HB3' ' A' ' 72' ' ' ALA . . . -163.94 145.62 9.01 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.442 -0.948 . . . . 0.55 108.442 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.656 ' HG2' HD21 ' A' ' 71' ' ' ASN . 16.6 mtmt -138.36 91.97 2.6 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 122.964 1.364 . . . . 2.27 109.506 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.674 ' HA ' HD12 ' A' ' 110' ' ' LEU . 1.2 tt -67.98 158.15 5.85 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.474 0 CA-C-N 114.063 -1.426 . . . . 1.47 110.086 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -150.93 49.16 0.85 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.33 -0.857 . . . . 2.0 109.127 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.958 ' HB ' HG21 ' A' ' 65' ' ' VAL . 0.2 OUTLIER -75.64 159.49 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.42 -0.8 . . . . 0.77 108.925 -179.869 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.555 ' HD3' ' O ' ' A' ' 54' ' ' ILE . 0.4 OUTLIER -166.13 29.71 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.178 -1.009 . . . . 1.46 110.774 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 1.029 ' HB3' HG21 ' A' ' 63' ' ' ILE . . . -66.7 159.04 28.63 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 108.809 -0.811 . . . . 1.27 108.809 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.15 130.08 24.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.032 -1.043 . . . . 0.87 109.736 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 1.066 HD13 ' N ' ' A' ' 59' ' ' ASP . 2.5 tm? -119.91 154.92 33.69 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.212 -0.93 . . . . 1.35 108.78 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 1.066 ' N ' HD13 ' A' ' 58' ' ' LEU . 5.6 t70 -76.93 79.24 3.49 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 107.818 -1.179 . . . . 3.91 107.818 178.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.703 ' O ' HD22 ' A' ' 61' ' ' LEU . . . 125.8 -5.83 7.92 Favored Glycine 0 N--CA 1.485 1.91 0 N-CA-C 108.787 -1.725 . . . . 0.9 108.787 -178.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.703 HD22 ' O ' ' A' ' 60' ' ' GLY . 0.4 OUTLIER -141.86 53.48 1.49 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.238 -1.154 . . . . 1.42 109.263 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 61' ' ' LEU . 36.1 mm-40 -41.18 97.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.544 -0.722 . . . . 3.07 109.625 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 1.029 HG21 ' HB3' ' A' ' 56' ' ' ALA . 0.3 OUTLIER -75.09 -2.93 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 CA-C-O 121.952 0.882 . . . . 2.88 110.133 -179.986 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.462 ' C ' ' O ' ' A' ' 63' ' ' ILE . 0.6 OUTLIER -40.03 140.13 0.61 Allowed 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 108.925 -0.768 . . . . 1.83 108.925 179.317 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.958 HG21 ' HB ' ' A' ' 54' ' ' ILE . 98.8 t -123.0 86.2 50.92 Favored Pre-proline 0 C--N 1.301 -1.533 0 O-C-N 121.168 -0.957 . . . . 1.44 110.556 -178.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.465 ' O ' ' C ' ' A' ' 67' ' ' GLY . 35.7 Cg_endo -79.29 89.34 1.36 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.791 2.327 . . . . 3.72 110.422 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.465 ' C ' ' O ' ' A' ' 66' ' ' PRO . . . 37.14 68.94 0.31 Allowed Glycine 0 N--CA 1.495 2.585 0 N-CA-C 110.117 -1.193 . . . . 1.33 110.117 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 21.2 mt -83.94 -78.03 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.13 -1.217 . . . . 2.45 109.613 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.469 ' OD2' ' CE1' ' A' ' 75' ' ' PHE . 5.2 p30 -78.47 130.58 36.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.212 -0.93 . . . . 2.45 109.233 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.436 ' O ' ' CG ' ' A' ' 71' ' ' ASN . 13.7 t -51.58 -23.02 3.72 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.09 -1.006 . . . . 2.82 109.715 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.656 HD21 ' HG2' ' A' ' 51' ' ' LYS . 6.9 m120 -168.32 76.05 0.12 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.953 -1.092 . . . . 1.32 111.225 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.922 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . . . 32.02 33.75 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.283 0.563 . . . . 0.8 111.921 176.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.535 ' N ' ' O ' ' A' ' 71' ' ' ASN . 31.0 t -109.79 21.64 16.66 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 121.179 -0.95 . . . . 1.0 110.393 -179.003 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 17.6 t-160 -121.64 -18.26 7.22 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.374 -1.454 . . . . 2.83 109.45 178.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' A' ' 75' ' ' PHE . 7.3 m-85 -104.67 -15.09 15.37 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -0.887 . . . . 2.49 108.695 179.03 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 1.076 HG21 ' CE2' ' A' ' 86' ' ' TYR . 18.2 m -150.73 -153.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 N-CA-C 107.097 -1.445 . . . . 3.17 107.097 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.843 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -81.65 -177.65 6.63 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 106.287 -1.745 . . . . 2.36 106.287 176.325 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' CYS . . . . . 0.588 ' H ' ' HD2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -109.1 -51.87 0.07 OUTLIER Pre-proline 0 C--N 1.293 -1.86 0 O-C-N 120.64 -1.287 . . . . 0.88 110.796 -179.559 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.638 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 29.6 Cg_endo -77.83 111.6 3.14 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 N-CA-C 108.506 -1.382 . . . . 0.85 108.506 178.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.984 HD22 HD13 ' A' ' 117' ' ' LEU . 0.6 OUTLIER -93.6 -67.54 0.85 Allowed 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.622 -0.673 . . . . 2.63 109.363 -178.1 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.884 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 1.4 m 40.8 -167.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 C-N-CA 120.46 -0.496 . . . . 0.6 110.072 177.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.734 ' H ' HG23 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -98.47 41.62 1.13 Allowed 'General case' 0 C--N 1.292 -1.91 0 O-C-N 120.629 -1.294 . . . . 0.76 109.81 -177.45 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -150.68 46.4 0.62 Allowed Glycine 0 C--N 1.288 -2.123 0 N-CA-C 108.863 -1.695 . . . . 0.99 108.863 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.495 ' NE2' ' O ' ' A' ' 85' ' ' GLN . 31.4 tp60 -159.4 150.07 19.46 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.132 -1.217 . . . . 1.96 110.18 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.613 ' NE2' ' OD2' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -104.25 157.37 17.18 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.569 -1.271 . . . . 2.43 107.569 178.412 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 1.076 ' CE2' HG21 ' A' ' 76' ' ' VAL . 0.4 OUTLIER -125.64 -167.65 1.72 Allowed 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.313 -1.492 . . . . 3.95 111.592 -178.928 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.616 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER 170.98 38.44 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.409 -0.814 . . . . 3.04 109.088 179.342 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.7 HD12 ' CG1' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -49.52 -178.01 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 108.256 -1.016 . . . . 0.64 108.256 179.129 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.57 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 1.2 mtmt 170.5 164.56 0.07 Allowed 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 119.069 -1.052 . . . . 0.83 109.957 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.616 ' CE2' HG12 ' A' ' 54' ' ' ILE . 17.0 m-85 -150.58 91.21 1.71 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.467 -0.771 . . . . 0.87 109.246 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.476 ' O ' ' O ' ' A' ' 90' ' ' TYR . 1.4 t -44.71 171.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.7 -0.625 . . . . 3.34 109.612 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.586 ' O ' HG23 ' A' ' 94' ' ' VAL . 0.3 OUTLIER -146.36 92.53 2.19 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.147 -0.971 . . . . 3.8 110.131 -179.938 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -65.43 112.43 3.54 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.126 -1.435 . . . . 4.53 107.126 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.849 HG13 ' CD1' ' A' ' 97' ' ' ILE . 59.5 t -125.05 93.94 44.74 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 120.917 -1.115 . . . . 2.48 112.451 -177.17 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.908 ' HD2' HD11 ' A' ' 97' ' ' ILE . 33.3 Cg_endo -73.65 -151.42 0.03 OUTLIER 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 122.105 1.87 . . . . 3.32 108.26 176.432 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.565 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 2.7 mmtt -67.54 -32.61 73.51 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.215 -1.553 . . . . 2.44 109.184 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.908 HD11 ' HD2' ' A' ' 95' ' ' PRO . 4.0 mt 42.39 15.87 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.125 -0.984 . . . . 1.77 112.354 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.982 ' HB1' ' HD2' ' A' ' 99' ' ' PRO . . . 50.65 173.37 0.03 OUTLIER Pre-proline 0 C--N 1.307 -1.242 0 O-C-N 120.292 -1.505 . . . . 1.6 109.93 179.236 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.982 ' HD2' ' HB1' ' A' ' 98' ' ' ALA . 57.4 Cg_endo -81.66 76.29 4.43 Favored 'Trans proline' 0 C--N 1.296 -2.208 0 C-N-CA 123.163 2.575 . . . . 2.62 108.418 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.698 ' CB ' ' O ' ' A' ' 99' ' ' PRO . 4.6 mmmm 119.2 127.11 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 123.8 0.687 . . . . 2.54 109.751 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.507 ' O ' ' HB2' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -87.38 11.49 14.38 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.271 -0.893 . . . . 1.51 109.392 179.638 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.562 ' O ' ' CB ' ' A' ' 103' ' ' ASN . 2.1 mp0 67.63 -0.42 1.94 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.656 -0.652 . . . . 6.1 109.906 -179.24 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.562 ' CB ' ' O ' ' A' ' 102' ' ' GLU . 3.3 t30 160.91 143.23 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.275 -0.89 . . . . 2.28 109.928 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 125' ' ' GLY . 0.1 OUTLIER -159.9 158.67 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.423 -0.798 . . . . 1.05 109.295 -179.772 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.435 ' O ' HG12 ' A' ' 105' ' ' VAL . 1.2 t -149.33 131.22 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.042 -1.036 . . . . 0.58 109.66 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.857 ' HB ' ' HB3' ' A' ' 122' ' ' ALA . 10.5 t -119.87 130.3 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.135 -0.978 . . . . 1.28 109.62 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.542 ' HB ' ' HB2' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -154.34 140.19 18.16 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.529 -0.915 . . . . 1.08 108.529 179.711 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.955 HG13 ' CD1' ' A' ' 54' ' ' ILE . 34.7 t -158.49 151.14 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.872 -1.143 . . . . 1.26 110.266 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.538 ' HA ' ' HA ' ' A' ' 119' ' ' CYS . 6.7 ttpt -172.46 134.5 0.67 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.222 -0.924 . . . . 1.25 110.284 178.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.691 ' O ' HG23 ' A' ' 116' ' ' VAL . 9.8 tp -111.15 132.65 54.13 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 106.833 -1.543 . . . . 0.62 106.833 177.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.468 ' HB ' ' HB2' ' A' ' 51' ' ' LYS . 8.4 mt -133.71 113.78 19.04 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 O-C-N 121.128 -0.983 . . . . 0.63 110.972 -177.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.71 ' HA3' HG21 ' A' ' 47' ' ' THR . . . -76.88 -110.76 0.14 Allowed Glycine 0 N--CA 1.486 1.993 0 N-CA-C 107.944 -2.062 . . . . 0.65 107.944 178.203 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -142.48 9.39 1.82 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.531 -1.285 . . . . 1.63 107.531 178.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.507 ' OD1' ' HB2' ' A' ' 45' ' ' GLN . 0.3 OUTLIER -123.88 -31.86 3.35 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.693 0.759 . . . . 3.9 109.362 -178.997 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -171.37 -142.87 3.81 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 108.708 -1.757 . . . . 0.76 108.708 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 110' ' ' LEU . 2.4 p -114.87 131.83 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.087 -1.243 . . . . 0.74 109.121 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.984 HD13 HD22 ' A' ' 80' ' ' LEU . 4.0 mt -78.85 -49.42 12.95 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.435 -0.791 . . . . 0.38 109.78 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.446 ' HA ' ' HB2' ' A' ' 9' ' ' ALA . . . -161.4 130.61 4.61 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.302 -0.874 . . . . 2.06 109.688 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 0.538 ' HA ' ' HA ' ' A' ' 109' ' ' LYS . 16.4 p -129.19 -172.11 2.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.207 -0.933 . . . . 0.93 110.01 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.491 ' HB2' ' O ' ' A' ' 119' ' ' CYS . . . 175.18 127.06 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.34 -0.85 . . . . 0.26 109.206 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.451 ' N ' HD12 ' A' ' 121' ' ' ILE . 5.2 mp -127.66 139.78 50.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.183 -0.948 . . . . 0.41 110.385 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.857 ' HB3' ' HB ' ' A' ' 106' ' ' VAL . . . -144.71 33.32 1.15 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.061 -1.089 . . . . 1.06 108.061 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.49 ' O ' ' O ' ' A' ' 122' ' ' ALA . 3.2 m -40.5 168.02 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.536 0.684 . . . . 4.52 110.662 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' HIS . . . . . 0.462 ' H ' HG22 ' A' ' 123' ' ' THR . 0.2 OUTLIER 59.26 66.94 0.96 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.513 -0.742 . . . . 1.66 109.457 179.768 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.618 ' O ' HG23 ' A' ' 104' ' ' VAL . . . -94.86 147.2 18.51 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.313 -1.515 . . . . 1.06 109.313 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.516 ' CG ' ' HE3' ' A' ' 100' ' ' LYS . 7.6 mtmt -153.9 121.58 5.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.427 -1.043 . . . . 2.73 108.509 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.545 ' O ' ' CD ' ' A' ' 100' ' ' LYS . 1.6 mp -90.37 118.39 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.11 -0.994 . . . . 1.05 112.102 -177.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.628 ' HB2' ' HG2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER 176.14 -62.22 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.771 -1.206 . . . . 3.02 109.302 177.595 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.756 ' HB3' HG21 ' A' ' 28' ' ' ILE . 6.9 t70 . . . . . 0 N--CA 1.494 1.74 0 CA-C-O 117.953 -1.023 . . . . 4.09 109.339 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' ASP . . . . . 0.503 ' O ' ' HB3' ' A' ' 17' ' ' MET . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.524 0.678 . . . . 5.04 109.643 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.515 ' HA ' ' HB3' ' A' ' 17' ' ' MET . 31.1 mt-30 -94.77 178.77 5.47 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.901 0.858 . . . . 4.24 110.169 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.977 HG21 ' CG2' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -133.58 -169.2 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.035 -1.098 . . . . 1.38 108.035 179.494 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -117.88 52.76 0.98 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.909 -1.119 . . . . 1.08 109.017 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 26.9 m -73.33 159.34 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.414 -0.804 . . . . 1.07 110.143 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.14 74.49 9.59 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.448 -0.782 . . . . 3.85 109.278 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.505 ' OD1' ' N ' ' A' ' 8' ' ' CYS . 0.7 OUTLIER -75.22 -170.03 1.08 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.257 -0.902 . . . . 1.86 109.55 -179.866 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.505 ' N ' ' OD1' ' A' ' 7' ' ' ASP . 16.6 p 179.25 33.76 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.112 -0.993 . . . . 2.24 109.58 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.615 ' HB1' ' O ' ' A' ' 117' ' ' LEU . . . -62.88 -58.66 6.62 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.296 -0.877 . . . . 0.68 109.607 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.503 ' CB ' ' O ' ' A' ' 9' ' ' ALA . 0.3 OUTLIER 166.59 36.73 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.612 -0.835 . . . . 3.19 109.398 -178.943 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.8 t30 51.19 34.39 11.2 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.14 -0.975 . . . . 1.69 108.716 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.485 ' HG2' ' OD1' ' A' ' 44' ' ' ASN . 6.6 tp10 -128.73 -21.85 3.35 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.366 -0.834 . . . . 3.25 110.034 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.96 HG23 ' O ' ' A' ' 40' ' ' LEU . 5.9 mt -42.51 139.25 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.146 -0.971 . . . . 0.97 108.931 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.438 ' HD2' ' OD1' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -100.59 -31.38 11.27 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-O 121.956 0.884 . . . . 1.67 108.813 -179.783 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.08 120.09 12.07 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 119.909 -0.716 . . . . 2.13 109.667 -178.065 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.632 ' O ' HG13 ' A' ' 16' ' ' VAL . 11.3 p -136.82 118.12 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.272 -0.892 . . . . 1.15 108.845 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.515 ' HB3' ' HA ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -156.05 173.41 16.84 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.426 -0.796 . . . . 5.09 109.606 -179.258 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.977 ' CG2' HG21 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -132.55 9.54 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 O-C-N 121.085 -1.009 . . . . 3.91 108.975 178.34 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.556 ' CB ' ' HA ' ' A' ' 35' ' ' PHE . 7.9 t70 77.55 58.54 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 112.551 0.575 . . . . 3.1 112.551 178.095 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' A' ' 29' ' ' ILE . . . 70.67 31.42 67.75 Favored Glycine 0 N--CA 1.499 2.876 0 O-C-N 120.777 -1.202 . . . . 2.69 111.811 177.276 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.852 ' HA ' HG23 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -92.96 -19.44 21.6 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.889 -1.359 . . . . 1.21 108.247 178.839 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.792 ' HA ' HG12 ' A' ' 3' ' ' VAL . 1.2 m-70 67.65 109.69 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.515 -0.741 . . . . 4.38 109.447 -179.094 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.46 ' O ' ' HB3' ' A' ' 24' ' ' SER . . . -80.88 178.18 54.11 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 110.175 -1.17 . . . . 0.47 110.175 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.46 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 41.0 t 62.3 151.73 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.351 -1.088 . . . . 2.68 108.509 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.61 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.2 OUTLIER 59.6 179.92 0.04 OUTLIER Pre-proline 0 C--N 1.306 -1.302 0 N-CA-C 107.336 -1.357 . . . . 5.49 107.336 -179.644 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.61 ' HD2' ' CB ' ' A' ' 25' ' ' ASP . 26.8 Cg_endo -70.78 83.74 0.86 Allowed 'Trans proline' 0 C--N 1.296 -2.228 0 C-N-CA 121.94 1.76 . . . . 0.92 108.404 178.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.462 ' O ' ' HA2' ' A' ' 125' ' ' GLY . 0.0 OUTLIER -33.37 115.54 0.22 Allowed 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 115.422 -0.808 . . . . 0.63 111.982 -178.009 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.803 HG23 ' O ' ' A' ' 126' ' ' LYS . 25.2 mm -107.72 139.56 29.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 107.46 -1.311 . . . . 0.58 107.46 176.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.852 HG23 ' HA ' ' A' ' 21' ' ' CYS . 0.7 OUTLIER -122.55 -175.57 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 O-C-N 120.981 -1.074 . . . . 0.9 111.572 -177.442 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.508 ' O ' ' CE1' ' A' ' 35' ' ' PHE . 98.1 m-70 -111.92 -171.55 1.87 Allowed 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.528 0.68 . . . . 1.67 110.366 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.564 ' CD ' ' O ' ' A' ' 98' ' ' ALA . 0.1 OUTLIER -130.39 -160.8 1.07 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.515 -0.74 . . . . 2.55 109.103 179.51 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.469 ' O ' ' HG3' ' A' ' 33' ' ' LYS . . . 40.23 34.86 0.66 Allowed Glycine 0 N--CA 1.495 2.581 0 N-CA-C 110.08 -1.208 . . . . 0.74 110.08 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.735 ' O ' HG11 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -167.96 129.02 1.16 Allowed Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.277 -1.131 . . . . 4.72 108.999 -179.921 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.502 ' HA ' ' CG2' ' A' ' 94' ' ' VAL . 20.3 Cg_endo -58.74 129.43 32.23 Favored 'Trans proline' 0 C--N 1.302 -1.883 0 C-N-CA 121.603 1.535 . . . . 1.91 109.869 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.654 ' H ' HG21 ' A' ' 94' ' ' VAL . 19.9 m-85 -79.36 40.95 0.45 Allowed 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 116.234 -0.439 . . . . 6.71 110.611 -178.051 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.482 ' C ' ' O ' ' A' ' 35' ' ' PHE . 24.4 m -35.01 91.45 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.534 -0.729 . . . . 1.48 110.585 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.681 HD21 ' HB2' ' A' ' 90' ' ' TYR . 1.0 OUTLIER -89.9 122.49 32.99 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.941 -1.133 . . . . 0.93 107.941 179.264 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.553 ' HG2' ' HG2' ' A' ' 89' ' ' LYS . 55.9 mt-10 -121.29 177.57 5.12 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 120.818 -1.176 . . . . 1.0 111.092 -178.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.518 ' O ' ' CD1' ' A' ' 41' ' ' PHE . . . 177.05 63.96 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 106.683 -1.599 . . . . 0.89 106.683 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.96 ' O ' HG23 ' A' ' 13' ' ' ILE . 0.6 OUTLIER -69.83 168.24 15.55 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 115.337 -0.847 . . . . 0.48 110.31 -178.281 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.658 ' CE2' ' CE2' ' A' ' 86' ' ' TYR . 6.3 p90 -178.73 146.97 0.36 Allowed 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.299 -0.875 . . . . 0.36 109.229 179.016 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.589 ' O ' ' C ' ' A' ' 43' ' ' ALA . 0.4 OUTLIER -94.44 98.22 10.72 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 106.314 -1.735 . . . . 4.87 106.314 177.664 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.716 ' HB1' ' O ' ' A' ' 81' ' ' VAL . . . -17.83 122.38 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 115.38 -0.827 . . . . 1.21 110.722 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.485 ' OD1' ' HG2' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -118.97 30.74 7.01 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.317 -0.865 . . . . 2.16 111.017 -177.866 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.962 ' OE1' HD21 ' A' ' 117' ' ' LEU . 2.0 pt20 -126.59 -142.15 0.28 Allowed 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.988 -1.115 . . . . 0.6 107.988 179.16 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.774 ' HA ' ' HB ' ' A' ' 81' ' ' VAL . 0.1 OUTLIER -154.04 68.31 0.75 Allowed 'General case' 0 C--N 1.292 -1.917 0 O-C-N 121.058 -1.026 . . . . 2.31 108.675 177.889 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.765 HG23 ' O ' ' A' ' 47' ' ' THR . 10.7 t -145.69 120.89 10.17 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 120.101 -1.624 . . . . 0.57 111.96 -177.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.614 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -67.59 -25.63 65.87 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.608 -1.307 . . . . 2.18 107.812 177.336 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.452 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 66.0 p -82.63 -163.57 0.72 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.695 -0.628 . . . . 0.7 109.373 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.957 ' CB ' ' HB3' ' A' ' 72' ' ' ALA . . . 175.63 160.46 0.26 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.284 -0.885 . . . . 0.27 109.817 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 1.026 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -126.66 -160.14 0.97 Allowed 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 106.516 -1.661 . . . . 3.25 106.516 177.581 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.469 ' HB ' ' O ' ' A' ' 51' ' ' LYS . 20.6 tt -177.56 164.41 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 C-N-CA 117.914 -1.515 . . . . 0.58 111.641 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.522 ' O ' ' HE2' ' A' ' 55' ' ' LYS . 2.3 mt-10 -165.46 59.28 0.12 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.124 -1.065 . . . . 0.9 108.124 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.896 ' HB ' HG21 ' A' ' 65' ' ' VAL . 0.4 OUTLIER -96.99 139.77 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.352 -0.842 . . . . 0.6 109.997 -179.462 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.693 ' HG3' ' O ' ' A' ' 54' ' ' ILE . 1.9 mtmt -150.96 93.38 1.93 Allowed 'General case' 0 C--N 1.284 -2.274 0 C-N-CA 119.833 -0.747 . . . . 0.88 109.781 178.579 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.507 ' HB3' ' HB ' ' A' ' 63' ' ' ILE . . . -110.35 150.4 28.83 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 108.022 -1.103 . . . . 0.58 108.022 178.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.494 ' HA ' ' HA ' ' A' ' 62' ' ' GLU . 0.8 OUTLIER -131.03 122.81 27.45 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.774 -1.204 . . . . 1.26 111.392 -178.622 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.969 HD13 ' N ' ' A' ' 59' ' ' ASP . 2.0 tm? -110.37 158.23 18.67 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.034 -1.099 . . . . 1.93 108.034 178.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.969 ' N ' HD13 ' A' ' 58' ' ' LEU . 23.4 t0 -40.89 -72.25 0.07 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.155 -0.966 . . . . 3.23 109.792 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -106.29 30.39 9.66 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.496 -1.442 . . . . 0.74 109.496 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.493 ' HB3' ' HB3' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -150.28 60.53 0.97 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.347 -1.09 . . . . 1.09 108.996 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 0.1 OUTLIER -63.42 86.82 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.661 -0.649 . . . . 3.4 110.653 -179.31 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.507 ' HB ' ' HB3' ' A' ' 56' ' ' ALA . 2.0 mt -54.69 160.96 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 107.442 -1.318 . . . . 0.42 107.442 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -168.42 146.95 4.29 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.678 -1.264 . . . . 2.6 110.097 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.896 HG21 ' HB ' ' A' ' 54' ' ' ILE . 4.9 t -149.0 74.83 9.99 Favored Pre-proline 0 N--CA 1.488 1.44 0 O-C-N 121.631 -0.668 . . . . 0.41 109.285 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -80.33 -7.59 13.92 Favored 'Trans proline' 0 C--N 1.302 -1.886 0 C-N-CA 123.028 2.486 . . . . 1.05 110.465 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 135.39 56.12 0.06 OUTLIER Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.464 -1.454 . . . . 0.88 109.464 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 21.0 mt -81.46 -59.48 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.273 -1.133 . . . . 1.7 109.729 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.507 ' HB3' ' HB2' ' A' ' 74' ' ' HIS . 8.9 p30 -66.75 142.74 57.28 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.117 -0.989 . . . . 1.65 109.228 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.416 ' O ' ' CG ' ' A' ' 71' ' ' ASN . 5.8 t -67.69 -10.27 50.91 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.084 -1.01 . . . . 2.89 108.848 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.588 ' CA ' ' O ' ' A' ' 50' ' ' ALA . 7.4 m-20 178.02 66.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.918 . . . . 0.31 110.347 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 1.026 ' HB2' ' O ' ' A' ' 51' ' ' LYS . . . 39.77 27.54 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 121.456 0.646 . . . . 0.28 110.674 177.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.478 ' N ' ' O ' ' A' ' 71' ' ' ASN . 6.7 t -102.76 -22.34 13.93 Favored 'General case' 0 C--N 1.293 -1.885 0 O-C-N 121.447 -0.783 . . . . 0.64 109.88 -179.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.507 ' HB2' ' HB3' ' A' ' 69' ' ' ASP . 0.4 OUTLIER -84.93 5.87 27.29 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.228 -0.92 . . . . 3.69 109.783 -179.881 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.683 ' C ' HG12 ' A' ' 76' ' ' VAL . 76.5 m-85 -135.37 0.79 2.83 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.044 -1.035 . . . . 0.85 110.841 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.777 ' HB ' ' CE1' ' A' ' 86' ' ' TYR . 0.2 OUTLIER -167.92 173.66 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.362 -1.461 . . . . 0.64 111.139 -178.094 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.635 ' N ' HG23 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -55.03 94.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 106.264 -1.754 . . . . 4.32 106.264 177.447 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 78' ' ' CYS . . . . . 0.605 ' HB2' ' HD3' ' A' ' 79' ' ' PRO . 2.4 m -33.47 -53.27 0.75 Allowed Pre-proline 0 N--CA 1.504 2.236 0 O-C-N 121.789 -0.569 . . . . 0.95 112.382 -176.395 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.614 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 33.9 Cg_endo -79.75 113.08 3.0 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 120.93 1.086 . . . . 0.86 110.193 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 1.089 HD12 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -97.37 -65.7 0.95 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.229 -0.919 . . . . 0.68 108.58 -179.59 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.774 ' HB ' ' HA ' ' A' ' 46' ' ' ASN . 1.3 m 41.38 -168.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 C-N-CA 120.32 -0.552 . . . . 0.8 109.701 178.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.74 ' H ' HG23 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -102.53 42.38 1.15 Allowed 'General case' 0 C--N 1.29 -1.982 0 O-C-N 120.133 -1.604 . . . . 1.27 110.999 -175.98 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.492 ' O ' ' OE1' ' A' ' 84' ' ' GLN . . . -151.83 31.73 0.9 Allowed Glycine 0 C--N 1.285 -2.264 0 N-CA-C 108.995 -1.642 . . . . 1.39 108.995 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.492 ' OE1' ' O ' ' A' ' 83' ' ' GLY . 0.2 OUTLIER -137.3 121.69 18.23 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.284 -1.127 . . . . 3.96 110.726 -179.018 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -97.01 125.56 41.52 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 105.435 -2.061 . . . . 2.39 105.435 176.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.945 ' OH ' HD13 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -153.51 161.08 42.59 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 117.657 -1.617 . . . . 0.65 109.759 -177.445 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.642 ' CB ' ' HG ' ' A' ' 40' ' ' LEU . 3.1 p-10 -129.23 101.09 5.85 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.97 -1.081 . . . . 0.84 113.285 -175.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.945 HD13 ' OH ' ' A' ' 86' ' ' TYR . 3.2 tp -69.17 -160.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 107.722 -1.214 . . . . 1.0 107.722 176.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.734 ' N ' HG23 ' A' ' 88' ' ' ILE . 0.0 OUTLIER 159.75 170.14 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.196 -0.94 . . . . 1.59 109.993 179.689 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.681 ' HB2' HD21 ' A' ' 37' ' ' LEU . 10.0 m-85 -162.48 67.83 0.24 Allowed 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.944 -0.762 . . . . 1.52 108.944 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.54 ' C ' ' CD1' ' A' ' 92' ' ' TRP . 3.0 t -56.39 176.19 0.09 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.474 -0.766 . . . . 2.42 109.94 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.667 ' CD1' ' N ' ' A' ' 92' ' ' TRP . 0.0 OUTLIER -142.36 147.79 36.85 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.229 -0.919 . . . . 5.33 109.914 -179.377 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.551 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 25.3 m-20 -74.93 94.64 2.85 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 104.338 -2.468 . . . . 5.51 104.338 175.306 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.976 HG13 ' CD1' ' A' ' 97' ' ' ILE . 60.8 t -106.3 96.04 12.72 Favored Pre-proline 0 N--CA 1.488 1.466 0 C-N-CA 118.817 -1.153 . . . . 2.29 113.777 -175.259 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.826 ' HD2' HD11 ' A' ' 97' ' ' ILE . 35.2 Cg_endo -77.42 -150.11 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.538 2.158 . . . . 2.64 107.319 174.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.553 ' O ' ' CB ' ' A' ' 31' ' ' ARG . 0.7 OUTLIER -72.12 -25.23 61.65 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.426 -1.421 . . . . 2.35 108.561 178.485 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.976 ' CD1' HG13 ' A' ' 94' ' ' VAL . 4.0 mt 43.25 14.49 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.505 -0.747 . . . . 1.34 112.842 179.086 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 1.049 ' HB1' ' HD2' ' A' ' 99' ' ' PRO . . . 52.64 175.38 0.03 OUTLIER Pre-proline 0 C--N 1.304 -1.403 0 O-C-N 119.769 -1.832 . . . . 1.27 109.226 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 1.049 ' HD2' ' HB1' ' A' ' 98' ' ' ALA . 37.3 Cg_endo -73.1 -7.17 20.21 Favored 'Trans proline' 0 C--N 1.299 -2.055 0 C-N-CA 123.293 2.662 . . . . 4.06 110.995 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.648 ' HD3' ' CB ' ' A' ' 128' ' ' ARG . 1.1 mmmt -149.73 126.58 11.12 Favored 'General case' 0 C--N 1.276 -2.623 0 C-N-CA 119.462 -0.895 . . . . 0.81 109.859 -178.597 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.647 ' HB3' HD13 ' A' ' 127' ' ' ILE . 4.3 t -89.3 159.09 17.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.187 -0.945 . . . . 1.03 109.642 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.63 -10.65 48.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.444 -0.785 . . . . 1.4 110.362 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.507 ' C ' ' CG2' ' A' ' 104' ' ' VAL . 0.1 OUTLIER 175.1 146.05 0.07 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.814 -1.178 . . . . 3.07 110.177 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.656 ' O ' HG23 ' A' ' 105' ' ' VAL . 0.2 OUTLIER -156.68 168.36 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.556 -0.715 . . . . 0.94 109.804 -179.781 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 104' ' ' VAL . 0.9 OUTLIER 161.87 125.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.261 -1.015 . . . . 1.16 108.261 -179.934 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.483 HG22 ' HH2' ' A' ' 92' ' ' TRP . 42.6 t -119.53 96.4 4.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 120.986 -1.071 . . . . 1.75 110.664 -179.266 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.539 ' O ' HG23 ' A' ' 108' ' ' VAL . 7.4 m -105.43 150.56 25.16 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.246 -1.39 . . . . 0.61 107.246 178.206 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.546 HG12 ' N ' ' A' ' 109' ' ' LYS . 75.6 t -157.84 160.76 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 C-N-CA 118.281 -1.368 . . . . 1.14 111.545 -178.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.546 ' N ' HG12 ' A' ' 108' ' ' VAL . 1.8 ttpt 177.54 126.39 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.524 -0.917 . . . . 1.16 108.524 178.428 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.492 ' HB3' ' HB2' ' A' ' 117' ' ' LEU . 11.5 tp -118.35 127.6 53.84 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 107.275 -1.38 . . . . 1.08 107.275 178.303 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.543 HD11 ' HG2' ' A' ' 109' ' ' LYS . 1.7 mt -124.97 116.93 48.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 O-C-N 121.262 -0.899 . . . . 1.09 111.503 -177.216 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.473 ' HA2' ' HA ' ' A' ' 50' ' ' ALA . . . -86.1 -110.1 0.78 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.122 -1.991 . . . . 0.36 108.122 177.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.407 ' O ' ' CG ' ' A' ' 113' ' ' ASP . 7.4 t70 -136.54 1.71 2.63 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.066 -1.255 . . . . 2.11 107.71 178.196 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.433 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 3.3 m120 -116.1 -20.42 9.88 Favored 'General case' 0 C--N 1.31 -1.139 0 O-C-N 121.491 -0.756 . . . . 0.65 109.601 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 169.76 -161.32 34.63 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.35 -1.5 . . . . 0.49 109.35 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.51 HG21 ' HB3' ' A' ' 119' ' ' CYS . 2.5 p -90.8 105.34 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.101 -1.235 . . . . 0.88 109.517 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 1.089 HD22 HD12 ' A' ' 80' ' ' LEU . 1.4 mt -49.58 -53.23 25.02 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.219 -0.926 . . . . 0.81 110.8 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.559 ' HA ' ' HA ' ' A' ' 9' ' ' ALA . . . -158.24 129.08 6.33 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.219 -0.926 . . . . 2.13 110.245 -178.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 0.51 ' HB3' HG21 ' A' ' 116' ' ' VAL . 10.2 p -134.29 169.2 17.56 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.484 -0.76 . . . . 1.07 109.439 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.446 ' O ' HG13 ' A' ' 121' ' ' ILE . . . -173.31 138.75 0.73 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.375 -0.828 . . . . 0.62 109.0 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 120' ' ' ALA . 2.7 mp -139.44 132.45 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.975 -1.078 . . . . 0.49 110.437 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.466 ' O ' ' C ' ' A' ' 123' ' ' THR . . . -114.74 93.5 4.35 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.994 -1.113 . . . . 0.43 107.994 179.009 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.466 ' C ' ' O ' ' A' ' 122' ' ' ALA . 98.6 m -33.47 99.2 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.489 0.661 . . . . 1.74 110.835 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' HIS . . . . . 0.41 ' N ' ' O ' ' A' ' 122' ' ' ALA . 0.1 OUTLIER 53.92 176.32 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.627 -0.671 . . . . 3.54 110.111 179.704 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.498 ' O ' ' HB ' ' A' ' 104' ' ' VAL . . . -160.31 119.35 0.88 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.546 -1.422 . . . . 0.73 109.546 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.803 ' O ' HG23 ' A' ' 28' ' ' ILE . 0.4 OUTLIER -128.61 104.72 7.83 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.14 -1.212 . . . . 2.02 109.461 -179.865 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.647 HD13 ' HB3' ' A' ' 101' ' ' SER . 2.8 mp -54.77 157.26 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.249 -0.907 . . . . 1.33 109.28 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.648 ' CB ' ' HD3' ' A' ' 100' ' ' LYS . 0.0 OUTLIER 134.66 -86.2 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.446 0 N-CA-C 108.266 -1.013 . . . . 3.85 108.266 179.37 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.62 ' C ' HG21 ' A' ' 28' ' ' ILE . 1.7 t0 . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 118.077 -0.963 . . . . 2.65 109.543 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 1' ' ' ASP . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.484 0.659 . . . . 2.31 109.817 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.574 ' HA ' ' HB3' ' A' ' 17' ' ' MET . 66.7 mt-30 53.99 -179.31 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.888 0.852 . . . . 3.85 110.887 178.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.852 HG13 ' N ' ' A' ' 4' ' ' ASP . 0.8 OUTLIER -170.94 -155.26 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 108.78 -0.822 . . . . 3.59 108.78 179.85 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.852 ' N ' HG13 ' A' ' 3' ' ' VAL . 17.7 m-20 -146.58 114.95 6.69 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.9 -1.125 . . . . 3.12 110.245 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.49 HG23 ' OD1' ' A' ' 7' ' ' ASP . 15.7 m -142.21 146.42 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 120.965 -1.085 . . . . 0.85 109.792 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.488 ' O ' HG12 ' A' ' 121' ' ' ILE . 8.5 mmtt -69.59 105.3 2.62 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.319 -0.863 . . . . 3.48 109.877 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.49 ' OD1' HG23 ' A' ' 5' ' ' VAL . 0.8 OUTLIER -95.91 167.42 11.26 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.145 -0.972 . . . . 3.44 108.641 179.335 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.561 ' HB2' HG21 ' A' ' 116' ' ' VAL . 6.3 m -140.07 7.98 2.26 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.052 -1.03 . . . . 1.19 109.755 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.529 ' CA ' ' HA ' ' A' ' 118' ' ' ALA . . . -49.62 -75.34 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.163 -0.961 . . . . 0.94 109.587 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.449 ' CB ' ' O ' ' A' ' 9' ' ' ALA . 0.9 OUTLIER 167.34 37.29 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.885 -0.783 . . . . 1.5 108.885 -178.478 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 58.41 26.27 13.93 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.908 -1.145 . . . . 2.72 107.908 -178.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.484 ' O ' ' C ' ' A' ' 13' ' ' ILE . 0.3 OUTLIER -116.98 -21.72 8.79 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.507 -0.746 . . . . 2.59 110.414 -179.16 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.88 HG23 ' O ' ' A' ' 40' ' ' LEU . 5.7 mt -43.09 139.87 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 108.144 -1.058 . . . . 1.15 108.144 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.27 -25.59 16.97 Favored 'General case' 0 C--N 1.292 -1.931 0 O-C-N 121.513 -0.742 . . . . 2.1 109.585 -178.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.7 mtmt -167.48 105.51 0.54 Allowed 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 118.006 -1.478 . . . . 1.34 111.981 -178.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.53 ' HA ' ' HA ' ' A' ' 39' ' ' ALA . 2.2 p -116.97 94.72 3.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 N-CA-C 106.152 -1.795 . . . . 0.94 106.152 177.135 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.574 ' HB3' ' HA ' ' A' ' 2' ' ' GLN . 12.3 mmt -132.46 142.51 49.27 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.558 -0.713 . . . . 3.13 111.392 -176.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.668 HG13 ' HG ' ' A' ' 37' ' ' LEU . 16.7 t -110.84 141.02 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 107.935 -1.135 . . . . 1.2 107.935 178.093 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.47 ' HB3' ' HA ' ' A' ' 35' ' ' PHE . 7.4 t70 -62.95 -40.93 99.16 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.094 -1.004 . . . . 2.52 110.538 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.542 ' O ' ' CB ' ' A' ' 21' ' ' CYS . . . -156.01 139.82 6.84 Favored Glycine 0 N--CA 1.489 2.212 0 C-N-CA 119.351 -1.404 . . . . 1.57 110.286 -179.454 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.897 ' CA ' HG23 ' A' ' 29' ' ' ILE . 0.0 OUTLIER 155.01 -56.76 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.572 -0.958 . . . . 0.84 108.812 179.288 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.614 ' HA ' HG23 ' A' ' 3' ' ' VAL . 1.6 t60 80.66 120.57 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 107.689 -1.226 . . . . 2.98 107.689 -177.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.735 ' H ' HG22 ' A' ' 3' ' ' VAL . . . -106.26 -166.88 22.97 Favored Glycine 0 N--CA 1.493 2.481 0 C-N-CA 119.25 -1.453 . . . . 0.76 111.341 -178.21 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.439 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 0.5 OUTLIER 69.86 -87.9 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.499 -1.0 . . . . 0.86 108.602 -179.241 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.653 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 3.0 p-10 -63.66 -163.61 0.01 OUTLIER Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 107.14 -1.43 . . . . 1.35 107.14 178.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.653 ' HD2' ' CB ' ' A' ' 25' ' ' ASP . 29.6 Cg_endo -72.32 106.09 1.99 Allowed 'Trans proline' 0 C--N 1.313 -1.323 0 N-CA-C 108.545 -1.367 . . . . 1.63 108.545 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.533 ' HB2' ' O ' ' A' ' 22' ' ' HIS . 1.3 t -62.44 92.47 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.756 -0.59 . . . . 0.96 112.579 -176.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.549 HD12 ' O ' ' A' ' 26' ' ' PRO . 1.7 mp -91.1 135.0 27.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 105.182 -2.155 . . . . 1.97 105.182 174.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.897 HG23 ' CA ' ' A' ' 21' ' ' CYS . 0.1 OUTLIER -108.82 173.79 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.196 0 O-C-N 120.666 -1.272 . . . . 0.46 111.147 -177.476 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.429 ' O ' ' CZ ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -102.43 132.51 48.4 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 122.2 1.0 . . . . 3.23 111.708 -178.467 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.724 ' HD3' ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -99.21 109.9 22.51 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 115.634 -0.712 . . . . 9.23 109.265 179.21 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' A' ' 95' ' ' PRO . . . 136.18 0.71 3.02 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.556 -1.307 . . . . 1.28 110.336 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.502 ' C ' ' HB ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -139.32 139.07 21.72 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 120.868 -1.372 . . . . 2.41 109.631 179.891 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.412 ' HA ' ' HB ' ' A' ' 94' ' ' VAL . 30.5 Cg_endo -70.99 123.32 9.59 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.713 2.275 . . . . 2.47 110.224 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.47 ' HA ' ' HB3' ' A' ' 19' ' ' ASP . 19.6 m-30 -103.91 -164.65 1.08 Allowed 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.777 0.799 . . . . 7.1 110.32 -178.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.72 HG22 ' O ' ' A' ' 36' ' ' THR . 1.3 m -179.84 90.36 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.679 -0.86 . . . . 0.7 108.679 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.668 ' HG ' HG13 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -57.35 152.7 13.71 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.086 -1.009 . . . . 3.84 108.438 179.729 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.53 ' HG3' ' O ' ' A' ' 36' ' ' THR . 72.8 mt-10 -154.13 176.6 12.05 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.89 -1.131 . . . . 0.42 111.015 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.53 ' HA ' ' HA ' ' A' ' 16' ' ' VAL . . . 168.71 85.89 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.252 -1.388 . . . . 0.62 107.252 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.88 ' O ' HG23 ' A' ' 13' ' ' ILE . 4.3 mp -88.22 144.52 26.4 Favored 'General case' 0 C--N 1.291 -1.97 0 O-C-N 121.85 -0.531 . . . . 1.11 110.095 -178.517 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.801 ' CE2' ' CD2' ' A' ' 86' ' ' TYR . 0.1 OUTLIER -136.2 174.69 10.34 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.942 -1.099 . . . . 0.89 108.26 176.841 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.495 ' O ' ' C ' ' A' ' 43' ' ' ALA . 0.2 OUTLIER -126.24 102.24 7.1 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 106.651 -1.611 . . . . 2.76 106.651 178.582 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.887 ' HB1' ' O ' ' A' ' 81' ' ' VAL . . . -34.79 117.59 0.38 Allowed 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 115.548 -0.751 . . . . 0.38 109.33 -179.322 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.492 ' O ' ' HB3' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -126.8 0.15 6.69 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.36 0.6 . . . . 0.63 109.68 -178.473 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.971 ' OE1' HD21 ' A' ' 117' ' ' LEU . 3.3 pt20 -90.86 -141.64 0.17 Allowed 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.405 -0.961 . . . . 0.9 108.405 179.3 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.827 ' HA ' ' HB ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -156.86 71.76 0.69 Allowed 'General case' 0 C--N 1.293 -1.848 0 O-C-N 120.962 -1.086 . . . . 0.9 109.641 178.94 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.715 HG23 ' O ' ' A' ' 47' ' ' THR . 7.5 t -150.33 122.19 8.15 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.17 -1.581 . . . . 1.14 111.003 -178.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.636 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 1.7 mtpt -69.17 -17.97 63.87 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.89 -1.131 . . . . 3.32 109.131 178.598 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.474 ' OG1' ' OG1' ' A' ' 47' ' ' THR . 1.1 p -76.32 176.41 8.18 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.16 -0.963 . . . . 1.33 109.719 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.774 ' HB1' ' HB3' ' A' ' 72' ' ' ALA . . . -176.23 136.89 0.29 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.242 -0.911 . . . . 0.6 109.962 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 1.059 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -121.1 -156.26 0.67 Allowed 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.723 -1.214 . . . . 2.4 107.723 178.393 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.521 ' CG1' HD13 ' A' ' 54' ' ' ILE . 17.3 tt -175.31 165.59 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 C-N-CA 118.616 -1.234 . . . . 0.42 111.293 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.542 ' C ' HD12 ' A' ' 54' ' ' ILE . 0.4 OUTLIER -168.09 68.94 0.08 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.718 -0.845 . . . . 3.18 108.718 179.778 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.978 HG21 ' CZ ' ' A' ' 90' ' ' TYR . 0.7 OUTLIER -109.17 149.76 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.308 -0.87 . . . . 0.62 110.066 -178.967 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.606 ' HG3' ' O ' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -164.98 100.73 0.76 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.331 -0.856 . . . . 1.43 109.602 178.16 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.516 ' HB3' ' HB ' ' A' ' 63' ' ' ILE . . . -106.74 147.9 29.07 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.114 -0.991 . . . . 0.95 108.375 178.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.546 ' HA ' ' HA ' ' A' ' 62' ' ' GLU . 37.2 t -132.5 129.12 38.73 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.868 -1.145 . . . . 1.7 110.315 -179.063 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.668 HD22 ' H ' ' A' ' 59' ' ' ASP . 0.1 OUTLIER -114.15 -152.13 0.5 Allowed 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.081 -1.081 . . . . 3.28 108.081 179.42 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.668 ' H ' HD22 ' A' ' 58' ' ' LEU . 48.4 t0 -106.72 87.73 2.59 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.71 -1.244 . . . . 4.15 108.403 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.71 -6.93 62.94 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 108.326 -1.91 . . . . 1.94 108.326 -178.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -128.02 49.66 2.13 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 107.581 -1.266 . . . . 1.28 107.581 179.359 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.546 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 1.8 tt0 -59.65 91.24 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.862 -0.524 . . . . 3.43 109.967 -179.047 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.591 HG21 ' HD2' ' A' ' 90' ' ' TYR . 8.3 mt -55.98 159.85 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 C-N-CA 118.773 -1.171 . . . . 1.27 107.952 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.431 ' C ' ' OD1' ' A' ' 64' ' ' ASP . 40.2 p-10 -156.27 162.92 40.08 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.174 -0.954 . . . . 5.12 110.202 -179.314 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.719 HG21 ' HB ' ' A' ' 54' ' ' ILE . 35.4 t -146.92 66.37 10.42 Favored Pre-proline 0 C--N 1.303 -1.442 0 O-C-N 121.499 -0.751 . . . . 1.77 109.11 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.523 ' O ' ' C ' ' A' ' 67' ' ' GLY . 37.3 Cg_endo -80.25 102.72 1.46 Allowed 'Trans proline' 0 C--N 1.3 -1.979 0 C-N-CA 123.329 2.686 . . . . 4.47 111.34 -179.091 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.523 ' C ' ' O ' ' A' ' 66' ' ' PRO . . . 22.99 51.8 0.02 OUTLIER Glycine 0 N--CA 1.5 2.914 0 N-CA-C 111.511 -0.635 . . . . 1.13 111.511 179.06 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.415 ' N ' ' O ' ' A' ' 66' ' ' PRO . 6.6 mt -60.73 -81.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.072 -1.252 . . . . 2.74 109.442 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.625 ' HB3' ' CG ' ' A' ' 74' ' ' HIS . 52.3 p30 -68.69 -167.62 0.1 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.342 -0.849 . . . . 2.25 109.957 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.462 ' O ' ' OD1' ' A' ' 71' ' ' ASN . 1.1 p -111.11 5.1 19.88 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.982 -0.747 . . . . 1.07 108.982 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.543 ' CA ' ' O ' ' A' ' 50' ' ' ALA . 2.2 m-20 172.95 69.1 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.177 -0.952 . . . . 1.36 110.972 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 1.059 ' HB2' ' O ' ' A' ' 51' ' ' LYS . . . 38.75 23.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 112.627 0.602 . . . . 0.45 112.627 177.011 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.508 ' N ' ' O ' ' A' ' 71' ' ' ASN . 22.9 t -99.19 4.56 46.8 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.651 -1.281 . . . . 1.74 111.422 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.625 ' CG ' ' HB3' ' A' ' 69' ' ' ASP . 4.2 m170 -95.63 -18.25 20.69 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.419 -1.425 . . . . 2.67 109.56 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.513 ' CD1' ' N ' ' A' ' 75' ' ' PHE . 5.4 m-85 -97.85 -26.69 14.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.346 -0.846 . . . . 2.23 108.884 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 1.278 HG21 ' CZ ' ' A' ' 86' ' ' TYR . 15.4 m -147.48 -139.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.811 -0.811 . . . . 3.16 108.811 -178.393 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.736 ' N ' HG23 ' A' ' 76' ' ' VAL . 15.0 mmmt -93.03 162.74 13.92 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.141 -1.429 . . . . 4.16 107.141 177.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' CYS . . . . . 0.53 ' N ' ' HD2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -83.16 -51.3 0.67 Allowed Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 120.469 -1.394 . . . . 1.15 109.949 -179.829 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.636 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 29.1 Cg_endo -76.77 120.7 5.6 Favored 'Trans proline' 0 C--N 1.302 -1.918 0 N-CA-C 108.447 -1.405 . . . . 1.14 108.447 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 1.061 HD12 HD22 ' A' ' 117' ' ' LEU . 0.3 OUTLIER -98.19 -67.38 0.85 Allowed 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.918 -1.142 . . . . 1.15 107.918 -178.958 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.887 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 1.4 m 41.26 -167.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 C-N-CA 120.353 -0.539 . . . . 0.62 109.872 177.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.737 ' H ' HG23 ' A' ' 81' ' ' VAL . 0.6 OUTLIER -99.96 42.23 1.12 Allowed 'General case' 0 C--N 1.293 -1.881 0 O-C-N 120.529 -1.357 . . . . 3.32 110.195 -177.4 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -148.79 44.78 0.74 Allowed Glycine 0 C--N 1.288 -2.12 0 N-CA-C 109.152 -1.579 . . . . 0.64 109.152 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -152.47 162.33 41.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.057 -1.26 . . . . 4.89 110.259 -179.138 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -117.26 141.63 48.06 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.099 -1.074 . . . . 5.2 108.099 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 1.278 ' CZ ' HG21 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -108.33 -173.55 2.31 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.908 -1.12 . . . . 3.02 112.27 -177.542 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.65 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 2.9 t70 159.52 74.45 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.28 0 CA-C-O 121.826 0.822 . . . . 2.04 109.54 178.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.563 HG22 ' CG1' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -106.92 137.49 37.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 107.581 -1.266 . . . . 2.53 107.581 179.37 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.57 ' O ' ' CD1' ' A' ' 90' ' ' TYR . 8.6 mttt -142.88 -166.42 2.29 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.613 -1.304 . . . . 1.17 111.57 -178.217 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.978 ' CZ ' HG21 ' A' ' 54' ' ' ILE . 77.3 m-85 -155.86 77.83 0.97 Allowed 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 108.62 -0.881 . . . . 0.8 108.62 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.554 HG22 ' H ' ' A' ' 92' ' ' TRP . 12.4 m -45.58 171.17 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.365 -0.834 . . . . 3.04 109.533 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.618 ' CZ2' ' HG ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -150.34 107.99 3.67 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 118.97 -1.092 . . . . 2.97 111.535 -179.311 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.459 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 0.7 OUTLIER -72.8 98.93 2.52 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 106.23 -1.767 . . . . 3.32 106.23 177.042 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.978 HG13 HD13 ' A' ' 97' ' ' ILE . 69.6 t -109.74 95.56 20.55 Favored Pre-proline 0 C--N 1.301 -1.504 0 C-N-CA 119.037 -1.065 . . . . 1.22 113.159 -176.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.77 ' HD2' HD11 ' A' ' 97' ' ' ILE . 31.1 Cg_endo -75.21 -92.86 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.833 2.356 . . . . 1.09 108.441 175.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.523 ' O ' ' HB3' ' A' ' 31' ' ' ARG . 1.3 mmtp -121.06 -53.12 2.06 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 105.223 -2.14 . . . . 4.13 105.223 176.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.978 HD13 HG13 ' A' ' 94' ' ' VAL . 1.6 mp 61.35 28.8 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 112.632 0.605 . . . . 1.01 112.632 175.338 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.587 ' O ' ' HG3' ' A' ' 31' ' ' ARG . . . 58.64 160.52 0.09 OUTLIER Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 120.949 -1.095 . . . . 2.13 111.011 177.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.633 ' O ' ' HA ' ' A' ' 128' ' ' ARG . 46.2 Cg_endo -84.69 4.99 6.52 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 124.087 3.191 . . . . 2.79 110.801 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.601 ' HD3' ' CB ' ' A' ' 128' ' ' ARG . 4.6 mmmt -161.78 139.27 8.74 Favored 'General case' 0 C--N 1.283 -2.285 0 C-N-CA 119.332 -0.947 . . . . 1.28 110.647 -177.211 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' SER . . . . . 1.063 ' CB ' HD13 ' A' ' 127' ' ' ILE . 32.3 t -109.06 2.59 21.28 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.417 -0.802 . . . . 1.55 109.043 178.513 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.529 ' O ' ' CB ' ' A' ' 103' ' ' ASN . 72.9 mt-10 64.54 2.05 1.5 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.557 -0.715 . . . . 5.54 110.144 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.529 ' CB ' ' O ' ' A' ' 102' ' ' GLU . 0.9 OUTLIER 163.94 152.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.02 -1.05 . . . . 3.01 109.919 179.908 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.462 ' CG2' ' C ' ' A' ' 103' ' ' ASN . 0.3 OUTLIER -153.78 168.52 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.686 -0.857 . . . . 1.76 108.686 179.52 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.425 ' O ' HG12 ' A' ' 105' ' ' VAL . 1.1 t -161.81 131.13 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.946 -1.097 . . . . 0.81 109.66 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.966 ' HB ' ' HB3' ' A' ' 122' ' ' ALA . 3.4 t -132.24 124.98 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.24 -0.913 . . . . 1.2 109.287 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.812 ' O ' HG23 ' A' ' 108' ' ' VAL . 1.9 m -147.46 156.36 42.79 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.378 -0.826 . . . . 0.68 108.838 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.812 HG23 ' O ' ' A' ' 107' ' ' THR . 7.5 t -165.9 162.76 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.146 -0.971 . . . . 0.5 109.773 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.562 ' N ' ' CG1' ' A' ' 108' ' ' VAL . 0.3 OUTLIER 174.95 139.02 0.05 OUTLIER 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.419 -0.8 . . . . 0.64 109.527 179.302 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.703 HD21 ' OH ' ' A' ' 86' ' ' TYR . 7.7 tp -126.57 129.28 48.26 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.289 -1.374 . . . . 0.78 107.289 178.219 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 12.5 mt -125.03 128.18 72.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 121.189 -0.945 . . . . 0.69 111.283 -177.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.41 ' HA3' HG21 ' A' ' 47' ' ' THR . . . -103.51 -114.16 3.9 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 107.443 -2.263 . . . . 1.19 107.443 177.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -137.64 4.35 2.58 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.138 -1.431 . . . . 1.21 107.138 177.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.446 ' ND2' ' N ' ' A' ' 114' ' ' ASN . 0.7 OUTLIER -124.03 13.92 9.12 Favored 'General case' 0 C--N 1.308 -1.238 0 O-C-N 121.545 -0.722 . . . . 1.13 109.402 -179.688 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 132.77 -158.97 23.32 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.653 -1.379 . . . . 0.67 109.653 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.561 HG21 ' HB2' ' A' ' 8' ' ' CYS . 0.2 OUTLIER -99.37 117.04 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.296 -1.12 . . . . 0.51 109.394 179.702 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 1.061 HD22 HD12 ' A' ' 80' ' ' LEU . 1.3 mt -61.63 -41.49 97.56 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.606 -0.684 . . . . 0.8 110.875 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.529 ' HA ' ' CA ' ' A' ' 9' ' ' ALA . . . -168.51 136.16 2.08 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.114 -0.991 . . . . 1.66 110.235 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 0.548 ' SG ' ' N ' ' A' ' 8' ' ' CYS . 0.5 OUTLIER -137.32 177.72 7.65 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.533 -0.729 . . . . 0.95 109.452 179.852 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.591 ' C ' HD13 ' A' ' 121' ' ' ILE . . . -173.95 123.49 0.33 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.238 -0.914 . . . . 0.39 108.804 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.591 HD13 ' C ' ' A' ' 120' ' ' ALA . 0.0 OUTLIER -127.48 140.87 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.055 -1.028 . . . . 1.69 111.429 -178.633 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.966 ' HB3' ' HB ' ' A' ' 106' ' ' VAL . . . -119.37 136.52 54.24 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.771 -1.196 . . . . 1.61 107.771 177.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.412 ' O ' ' O ' ' A' ' 124' ' ' HIS . 17.7 m -89.62 94.69 9.95 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.813 -1.18 . . . . 1.22 110.695 -178.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' HIS . . . . . 0.412 ' O ' ' O ' ' A' ' 123' ' ' THR . 1.6 t60 54.26 166.04 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.693 0.758 . . . . 3.52 110.991 178.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -156.05 170.22 33.75 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 108.348 -1.901 . . . . 2.11 108.348 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.54 ' HB2' HG13 ' A' ' 28' ' ' ILE . 0.4 OUTLIER -150.65 81.37 1.34 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.766 -1.432 . . . . 1.67 109.806 -179.932 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 1.063 HD13 ' CB ' ' A' ' 101' ' ' SER . 3.3 mp -41.63 138.07 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.65 -0.656 . . . . 0.82 110.573 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.674 ' HB3' ' O ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER 167.4 -165.58 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 122.274 1.035 . . . . 1.92 111.266 177.76 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.615 ' N ' ' CG ' ' A' ' 128' ' ' ARG . 3.5 m-20 . . . . . 0 C--N 1.299 -1.604 0 CA-C-O 117.982 -1.009 . . . . 6.87 109.703 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' ASP . . . . . 0.473 ' O ' ' HB3' ' A' ' 17' ' ' MET . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 121.358 0.599 . . . . 4.64 109.728 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.523 ' HB3' ' HG2' ' A' ' 17' ' ' MET . 1.3 pt20 -105.33 34.78 3.09 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.316 -0.994 . . . . 3.69 108.316 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.678 HG11 ' HA ' ' A' ' 22' ' ' HIS . 0.6 OUTLIER -28.51 123.51 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 CA-C-O 121.487 0.66 . . . . 2.07 110.239 -179.672 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -65.23 154.08 39.14 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.451 -0.781 . . . . 3.65 110.408 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.418 HG12 ' O ' ' A' ' 121' ' ' ILE . 0.0 OUTLIER -154.88 170.55 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.446 -0.946 . . . . 1.52 108.446 179.571 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.474 ' HB3' HD12 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -77.24 92.77 3.89 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.889 -1.132 . . . . 5.93 109.499 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' A' ' 119' ' ' CYS . 0.7 OUTLIER -88.13 -177.7 5.78 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.284 -0.885 . . . . 2.97 109.134 179.806 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.492 ' O ' ' C ' ' A' ' 9' ' ' ALA . 37.4 m -151.04 -29.55 0.19 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.198 -0.939 . . . . 2.29 110.794 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.617 ' O ' ' ND2' ' A' ' 10' ' ' ASN . . . -32.8 -77.23 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.425 -0.797 . . . . 1.3 110.938 -179.1 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.617 ' ND2' ' O ' ' A' ' 9' ' ' ALA . 0.3 OUTLIER 175.33 -77.33 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.415 -0.803 . . . . 3.19 109.265 -178.747 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.459 ' HB3' ' O ' ' A' ' 10' ' ' ASN . 17.8 p-10 173.56 36.28 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.523 -0.918 . . . . 4.04 108.523 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.443 ' O ' ' C ' ' A' ' 13' ' ' ILE . 0.3 OUTLIER -129.18 -4.77 4.94 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.386 -0.821 . . . . 1.77 109.78 -179.507 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.953 HG23 ' O ' ' A' ' 40' ' ' LEU . 18.5 mt -43.97 148.48 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.221 -0.924 . . . . 0.99 109.091 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.427 ' HE2' ' OD2' ' A' ' 42' ' ' ASP . 2.0 mmtt -96.86 -17.7 20.01 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.921 -0.77 . . . . 1.72 108.921 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.738 ' H ' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -170.03 100.89 0.29 Allowed 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 119.211 -0.995 . . . . 1.95 110.404 -178.164 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.558 ' HB ' HG21 ' A' ' 13' ' ' ILE . 1.4 p -124.75 97.09 4.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 107.897 -1.149 . . . . 1.25 107.897 179.168 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.523 ' HG2' ' HB3' ' A' ' 2' ' ' GLN . 2.4 mpt? -150.77 155.45 39.29 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.127 -0.983 . . . . 1.64 110.793 -178.286 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.591 HG13 ' HA ' ' A' ' 37' ' ' LEU . 2.1 t -112.06 128.9 68.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 106.982 -1.488 . . . . 1.29 106.982 178.095 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.534 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -87.75 89.29 7.94 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.852 -1.155 . . . . 2.67 111.191 -177.848 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.509 ' O ' ' CB ' ' A' ' 21' ' ' CYS . . . 90.6 112.41 1.59 Allowed Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.816 -1.183 . . . . 0.92 110.879 178.312 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.87 ' HA ' HG23 ' A' ' 29' ' ' ILE . 0.0 OUTLIER 159.12 -50.37 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.445 -1.032 . . . . 0.8 109.436 179.002 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.678 ' HA ' HG11 ' A' ' 3' ' ' VAL . 2.3 m-70 85.19 118.72 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 109.267 -0.642 . . . . 4.83 109.267 -178.353 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.448 ' O ' ' HB2' ' A' ' 24' ' ' SER . . . -95.74 -176.91 36.85 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 109.752 -1.339 . . . . 1.02 109.752 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.496 ' O ' ' O ' ' A' ' 25' ' ' ASP . 15.0 m 60.19 -89.41 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.236 -1.155 . . . . 1.48 109.414 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.638 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.2 OUTLIER -50.68 -176.56 0.02 OUTLIER Pre-proline 0 C--N 1.304 -1.37 0 N-CA-C 108.149 -1.056 . . . . 1.39 108.149 179.244 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.638 ' HD2' ' CB ' ' A' ' 25' ' ' ASP . 28.4 Cg_endo -70.24 82.9 0.81 Allowed 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 121.889 1.726 . . . . 1.6 109.29 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.54 ' HA ' ' O ' ' A' ' 22' ' ' HIS . 2.3 t -31.69 89.54 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 115.297 -0.865 . . . . 1.21 112.415 -178.088 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.492 HG21 ' C ' ' A' ' 129' ' ' ASP . 28.7 mm -90.6 132.37 35.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 104.783 -2.303 . . . . 1.16 104.783 175.355 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.87 HG23 ' HA ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -109.52 179.07 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.291 0 C-N-CA 118.666 -1.213 . . . . 0.66 111.319 -176.86 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.597 ' HE2' ' CE1' ' A' ' 22' ' ' HIS . 2.3 m-70 -128.08 154.34 45.81 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 119.767 -0.773 . . . . 0.59 110.881 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.545 ' CB ' ' O ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -100.54 155.54 17.79 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.886 -1.153 . . . . 4.6 107.886 178.404 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.22 0.79 76.52 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.84 -1.304 . . . . 0.85 109.84 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.713 ' N ' HG11 ' A' ' 94' ' ' VAL . 2.1 mtmm -129.66 145.7 58.07 Favored Pre-proline 0 N--CA 1.493 1.71 0 N-CA-C 107.564 -1.273 . . . . 1.68 107.564 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -71.35 82.71 1.07 Allowed 'Trans proline' 0 C--N 1.303 -1.846 0 C-N-CA 122.354 2.036 . . . . 1.07 112.152 -177.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.534 ' HA ' ' O ' ' A' ' 19' ' ' ASP . 12.3 t80 -52.01 114.13 1.22 Allowed 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 107.352 -1.351 . . . . 2.22 107.352 178.154 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.62 HG22 ' O ' ' A' ' 36' ' ' THR . 7.4 m -132.53 88.8 2.57 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 118.892 -1.123 . . . . 1.9 111.3 -178.218 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.683 HD12 ' C ' ' A' ' 37' ' ' LEU . 0.8 OUTLIER -80.56 126.48 31.3 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.236 -1.394 . . . . 2.21 107.236 177.975 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.582 ' CG ' HG22 ' A' ' 36' ' ' THR . 0.0 OUTLIER -140.22 -163.5 1.53 Allowed 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.578 -1.327 . . . . 3.2 110.728 -178.274 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.461 ' HB2' ' O ' ' A' ' 38' ' ' GLU . . . 170.02 101.65 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.886 -1.153 . . . . 1.07 107.886 179.041 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.953 ' O ' HG23 ' A' ' 13' ' ' ILE . 1.5 mp -93.29 173.17 7.85 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.295 -0.878 . . . . 0.71 109.818 -178.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.636 ' CE1' ' CE2' ' A' ' 86' ' ' TYR . 10.6 p90 175.05 139.9 0.05 OUTLIER 'General case' 0 C--N 1.305 -1.333 0 O-C-N 120.955 -1.09 . . . . 0.49 109.298 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.53 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 3.9 m-20 -86.28 108.49 18.42 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 107.334 -1.358 . . . . 3.65 107.334 178.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.736 ' HB1' ' O ' ' A' ' 81' ' ' VAL . . . -32.94 127.9 0.28 Allowed 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.727 -0.669 . . . . 0.31 109.602 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -122.58 1.65 9.51 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.221 -0.925 . . . . 1.04 110.221 -178.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.981 ' OE1' HD21 ' A' ' 117' ' ' LEU . 1.9 pt20 -93.53 -142.17 0.22 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.259 -0.9 . . . . 0.61 108.657 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.808 ' HA ' ' HB ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -154.31 66.66 0.71 Allowed 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.331 -0.856 . . . . 1.03 109.084 178.266 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.651 HG23 ' O ' ' A' ' 47' ' ' THR . 8.8 t -140.73 126.22 18.89 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.143 -1.598 . . . . 0.86 112.081 -177.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.667 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -72.19 -2.11 17.55 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.749 -1.219 . . . . 0.99 110.099 178.463 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.4 p -115.98 -175.44 2.73 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.906 -1.121 . . . . 2.19 111.546 -178.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 1.076 ' CB ' ' HB3' ' A' ' 72' ' ' ALA . . . -153.54 170.39 20.91 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.641 -0.874 . . . . 1.22 108.641 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.509 ' HG2' ' C ' ' A' ' 50' ' ' ALA . 0.4 OUTLIER -152.53 28.27 0.56 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.775 -1.203 . . . . 3.16 109.26 179.892 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.755 ' H ' ' HB2' ' A' ' 72' ' ' ALA . 20.5 tt -29.12 155.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.285 -2.23 0 CA-C-O 122.02 0.914 . . . . 1.68 112.206 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.463 ' O ' ' HB ' ' A' ' 54' ' ' ILE . 4.5 tt0 -117.06 -69.92 0.82 Allowed 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.005 -1.109 . . . . 3.13 108.005 178.265 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.697 HD12 HG13 ' A' ' 108' ' ' VAL . 0.3 OUTLIER 59.25 150.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.412 -0.805 . . . . 1.0 111.065 178.105 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.672 ' HG3' ' O ' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -178.23 94.08 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.976 -0.75 . . . . 1.4 108.976 178.373 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 105' ' ' VAL . . . -120.43 160.76 22.45 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.915 -1.115 . . . . 1.31 109.221 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.485 ' HB3' HG23 ' A' ' 105' ' ' VAL . 0.1 OUTLIER -130.19 123.89 31.31 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.97 -1.081 . . . . 1.55 109.789 -179.754 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.996 HD12 ' CZ2' ' A' ' 92' ' ' TRP . 0.1 OUTLIER -102.63 -147.99 0.38 Allowed 'General case' 0 N--CA 1.484 1.226 0 O-C-N 121.089 -1.007 . . . . 2.77 108.561 179.898 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.666 ' H ' HD13 ' A' ' 58' ' ' LEU . 24.2 t0 -94.11 81.62 4.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.067 -1.021 . . . . 3.32 109.084 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.5 1.63 90.19 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 108.936 -1.665 . . . . 4.17 108.936 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.413 ' O ' ' C ' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -115.25 57.1 0.73 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.331 -1.099 . . . . 3.1 108.566 179.606 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 61' ' ' LEU . 0.9 OUTLIER -40.79 115.9 0.64 Allowed 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 121.353 0.597 . . . . 2.58 110.724 -179.291 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.559 ' CG2' ' O ' ' A' ' 63' ' ' ILE . 0.5 OUTLIER -76.4 -3.11 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-O 122.125 0.964 . . . . 2.48 108.673 177.97 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.501 ' C ' ' O ' ' A' ' 63' ' ' ILE . 29.7 m-20 -25.6 134.56 0.02 OUTLIER 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 115.199 -0.91 . . . . 3.18 111.649 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.6 HG21 ' CG2' ' A' ' 54' ' ' ILE . 93.6 t -113.67 92.91 26.0 Favored Pre-proline 0 C--N 1.302 -1.476 0 N-CA-C 108.373 -0.973 . . . . 1.32 108.373 179.38 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 64' ' ' ASP . 36.4 Cg_endo -75.52 -94.84 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.535 2.157 . . . . 1.26 110.528 -178.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 68' ' ' ILE . . . -134.2 48.72 0.93 Allowed Glycine 0 N--CA 1.488 2.121 0 N-CA-C 110.108 -1.197 . . . . 2.07 110.108 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.429 ' O ' ' O ' ' A' ' 67' ' ' GLY . 13.5 mm -58.28 -104.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.148 -1.207 . . . . 1.34 108.63 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.489 ' OD2' ' HB2' ' A' ' 74' ' ' HIS . 0.4 OUTLIER -79.65 133.75 36.41 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.466 -1.396 . . . . 5.24 108.043 178.622 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.8 t -67.6 -13.84 62.42 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.254 -0.904 . . . . 5.26 111.864 -177.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.521 ' O ' ' N ' ' A' ' 73' ' ' CYS . 4.9 m-20 -138.28 49.42 1.92 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.328 -1.483 . . . . 0.84 111.803 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 1.076 ' HB3' ' CB ' ' A' ' 50' ' ' ALA . . . 40.67 19.48 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.843 0 O-C-N 121.116 -0.99 . . . . 1.39 112.879 176.516 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.521 ' N ' ' O ' ' A' ' 71' ' ' ASN . 80.8 m -68.45 -59.88 2.84 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 119.845 -1.784 . . . . 2.26 110.256 -179.235 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.489 ' HB2' ' OD2' ' A' ' 69' ' ' ASP . 11.9 t-160 -53.06 -27.25 19.08 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.321 -0.862 . . . . 2.96 111.025 -178.41 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.588 ' HB3' HD11 ' A' ' 88' ' ' ILE . 31.0 m-85 -83.95 -25.85 29.74 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.039 -1.038 . . . . 1.47 110.83 -179.002 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.795 ' HB ' ' CE1' ' A' ' 86' ' ' TYR . 0.2 OUTLIER -158.19 171.87 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 120.749 -1.22 . . . . 0.6 111.041 -177.961 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.658 ' N ' ' CG2' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -59.29 94.06 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 105.709 -1.96 . . . . 3.21 105.709 176.148 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 78' ' ' CYS . . . . . 0.516 ' SG ' ' O ' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -37.02 -51.85 2.11 Favored Pre-proline 0 C--N 1.297 -1.683 0 O-C-N 121.67 -0.644 . . . . 3.27 111.565 -177.182 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.667 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 29.6 Cg_endo -73.4 103.12 1.57 Allowed 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 120.886 1.058 . . . . 0.83 109.544 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.936 HD22 HD22 ' A' ' 117' ' ' LEU . 0.5 OUTLIER -97.85 -62.64 1.22 Allowed 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.99 -0.744 . . . . 2.48 108.99 -178.812 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.808 ' HB ' ' HA ' ' A' ' 46' ' ' ASN . 1.5 m 40.16 -166.64 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-N 116.176 -0.465 . . . . 0.76 109.846 178.119 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.729 ' H ' HG23 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -104.91 42.22 1.24 Allowed 'General case' 0 C--N 1.289 -2.036 0 O-C-N 120.302 -1.499 . . . . 1.65 110.126 -177.089 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -146.92 31.73 1.45 Allowed Glycine 0 C--N 1.288 -2.115 0 N-CA-C 109.439 -1.464 . . . . 0.6 109.439 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -153.46 132.12 12.27 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 120.89 -1.359 . . . . 3.15 110.554 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.53 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 3.6 pt20 -104.22 132.99 49.88 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 106.447 -1.686 . . . . 4.21 106.447 177.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.798 ' CE2' HD21 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -152.09 169.15 23.09 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 118.241 -1.383 . . . . 0.48 109.709 -178.377 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.614 ' CB ' ' HG ' ' A' ' 40' ' ' LEU . 6.9 p-10 -134.0 91.86 2.87 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.71 -1.243 . . . . 0.39 113.669 -175.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.588 HD11 ' HB3' ' A' ' 75' ' ' PHE . 4.4 tp -57.84 -172.3 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 106.333 -1.729 . . . . 1.06 106.333 175.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.577 ' O ' ' CD2' ' A' ' 90' ' ' TYR . 12.7 mttt 167.03 174.37 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.393 -1.442 . . . . 1.48 112.049 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.577 ' CD2' ' O ' ' A' ' 89' ' ' LYS . 82.5 m-85 -158.86 44.97 0.28 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.111 -1.07 . . . . 0.62 108.111 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.488 ' HA ' ' OG1' ' A' ' 36' ' ' THR . 74.4 p -51.94 -168.96 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.771 -0.581 . . . . 2.79 110.19 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.996 ' CZ2' HD12 ' A' ' 58' ' ' LEU . 1.4 t90 176.55 90.73 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.303 0 O-C-N 121.091 -1.006 . . . . 4.74 110.683 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.417 ' C ' ' O ' ' A' ' 92' ' ' TRP . 20.5 t-20 -49.47 98.53 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 106.463 -1.68 . . . . 4.71 106.463 178.083 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.903 HG13 ' CD1' ' A' ' 97' ' ' ILE . 1.0 OUTLIER -79.73 125.36 82.52 Favored Pre-proline 0 C--N 1.298 -1.635 0 O-C-N 121.343 -0.848 . . . . 1.36 112.297 -176.614 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.708 ' HD2' HD11 ' A' ' 97' ' ' ILE . 34.3 Cg_endo -82.62 -84.68 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 123.347 2.698 . . . . 1.54 108.853 176.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.545 ' O ' ' CB ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -138.05 -51.17 0.6 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 106.155 -1.794 . . . . 1.24 106.155 178.241 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.903 ' CD1' HG13 ' A' ' 94' ' ' VAL . 1.4 mp 62.81 5.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.756 -0.59 . . . . 1.52 111.956 176.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 1.012 ' HB1' ' HD2' ' A' ' 99' ' ' PRO . . . 51.87 173.63 0.03 OUTLIER Pre-proline 0 C--N 1.305 -1.346 0 O-C-N 120.778 -1.201 . . . . 1.73 110.176 179.016 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 1.012 ' HD2' ' HB1' ' A' ' 98' ' ' ALA . 50.1 Cg_endo -82.34 149.25 14.94 Favored 'Trans proline' 0 C--N 1.301 -1.928 0 C-N-CA 123.658 2.905 . . . . 1.72 109.744 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.626 ' HD3' ' CB ' ' A' ' 128' ' ' ARG . 1.1 mmmp? 55.79 114.56 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.033 0 C-N-CA 119.454 -0.899 . . . . 2.22 111.063 176.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' SER . . . . . 1.007 ' HB2' HD13 ' A' ' 127' ' ' ILE . 3.2 m -93.87 166.23 12.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.16 -0.962 . . . . 2.01 109.149 179.323 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.415 ' O ' ' CB ' ' A' ' 103' ' ' ASN . 0.2 OUTLIER -53.59 -19.08 3.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.278 -0.889 . . . . 2.49 109.139 179.603 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.459 ' O ' ' OG ' ' A' ' 57' ' ' SER . 0.5 OUTLIER 168.67 154.06 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.554 -0.906 . . . . 0.98 108.554 -179.996 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.949 HG21 HD12 ' A' ' 127' ' ' ILE . 0.1 OUTLIER -147.05 134.67 14.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 120.903 -1.123 . . . . 1.24 110.402 -179.649 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.485 HG23 ' HB3' ' A' ' 57' ' ' SER . 0.2 OUTLIER -155.01 145.47 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 107.973 -1.121 . . . . 2.21 107.973 179.629 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.563 ' HB ' ' HB3' ' A' ' 122' ' ' ALA . 71.1 t -129.01 128.96 67.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 120.641 -1.287 . . . . 1.06 110.401 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.504 ' O ' HG22 ' A' ' 108' ' ' VAL . 0.3 OUTLIER -150.43 140.56 22.11 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.19 -1.041 . . . . 0.63 108.19 179.305 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.697 HG13 HD12 ' A' ' 54' ' ' ILE . 2.4 t -157.16 156.75 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.748 -1.22 . . . . 1.69 110.463 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.513 ' HA ' ' HA ' ' A' ' 119' ' ' CYS . 0.1 OUTLIER 177.96 119.42 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.696 -0.853 . . . . 1.48 108.696 178.961 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.545 ' HB3' ' HB2' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -102.14 117.67 35.28 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 109.146 -0.686 . . . . 2.78 109.146 -179.866 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.486 ' O ' ' HG3' ' A' ' 51' ' ' LYS . 24.1 mt -110.34 139.78 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.333 -0.854 . . . . 1.15 110.331 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -108.39 -111.97 3.53 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 108.672 -1.771 . . . . 0.43 108.672 178.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.462 ' HB2' ' HB ' ' A' ' 47' ' ' THR . 2.3 m-20 -139.2 4.46 2.23 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.722 -1.214 . . . . 3.26 107.722 178.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.404 ' ND2' ' HB2' ' A' ' 45' ' ' GLN . 2.0 m-80 -118.49 -35.65 3.7 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.592 0.71 . . . . 0.89 109.36 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -173.43 -141.56 3.56 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.411 -1.476 . . . . 0.52 109.411 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.633 HG22 ' O ' ' A' ' 116' ' ' VAL . 0.1 OUTLIER -109.58 107.6 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.19 -1.183 . . . . 0.68 109.9 -179.87 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.981 HD21 ' OE1' ' A' ' 45' ' ' GLN . 1.1 mt -49.66 -49.7 46.3 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.252 -0.905 . . . . 0.78 109.113 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.547 ' HA ' ' CA ' ' A' ' 9' ' ' ALA . . . -161.98 -167.47 1.67 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.403 -0.811 . . . . 1.22 109.247 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 0.513 ' HA ' ' HA ' ' A' ' 109' ' ' LYS . 0.1 OUTLIER 172.91 170.59 0.13 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.257 -0.902 . . . . 0.67 109.605 179.781 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.416 ' N ' ' SG ' ' A' ' 119' ' ' CYS . . . -175.44 127.18 0.25 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.836 -0.801 . . . . 0.92 108.836 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.475 HG23 HG23 ' A' ' 107' ' ' THR . 2.5 mp -133.46 147.29 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.158 -0.964 . . . . 0.72 110.787 -179.05 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.563 ' HB3' ' HB ' ' A' ' 106' ' ' VAL . . . -112.72 -159.58 0.69 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.414 -0.803 . . . . 3.03 108.991 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.742 HG22 ' NE2' ' A' ' 124' ' ' HIS . 0.2 OUTLIER -161.66 115.49 1.91 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.933 -1.104 . . . . 1.16 110.495 -179.837 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 124' ' ' HIS . . . . . 0.742 ' NE2' HG22 ' A' ' 123' ' ' THR . 0.2 OUTLIER 57.67 118.4 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.387 -0.82 . . . . 4.14 110.562 178.882 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 27' ' ' CYS . . . -129.46 167.88 21.22 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 108.975 -1.65 . . . . 2.07 108.975 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.403 ' HB3' ' CD1' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -172.25 86.01 0.07 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.042 -1.269 . . . . 3.04 109.984 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 1.007 HD13 ' HB2' ' A' ' 101' ' ' SER . 2.4 mp -46.35 138.7 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.352 -0.843 . . . . 1.19 109.822 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.643 ' CB ' ' O ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER 147.07 -93.88 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.859 -0.793 . . . . 3.79 108.859 179.003 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.504 ' N ' ' CG ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.964 -1.017 . . . . 4.08 109.457 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.2 t0 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.328 0.585 . . . . 5.81 109.508 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.462 ' HB3' ' HG2' ' A' ' 17' ' ' MET . 0.0 OUTLIER -122.46 23.18 9.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.193 -0.942 . . . . 3.88 108.679 179.406 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.868 HG12 ' H ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER 38.71 -159.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-O 121.188 0.518 . . . . 1.07 109.908 179.376 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -141.28 32.86 1.7 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.093 -1.004 . . . . 1.44 109.48 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.474 ' H ' HG22 ' A' ' 5' ' ' VAL . 1.1 m -53.16 136.85 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.423 -0.798 . . . . 0.67 109.359 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -67.5 94.98 0.44 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.21 -0.931 . . . . 3.96 109.704 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.527 ' OD2' ' CD1' ' A' ' 13' ' ' ILE . 0.2 OUTLIER -93.25 -176.16 4.05 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.112 -0.992 . . . . 4.49 109.037 179.5 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 21.6 p -176.96 41.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.001 -1.062 . . . . 2.15 109.762 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.556 ' CB ' HG13 ' A' ' 13' ' ' ILE . . . -77.13 -72.43 0.35 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.37 -0.831 . . . . 0.65 109.244 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.453 ' O ' ' HG2' ' A' ' 12' ' ' GLU . 0.3 OUTLIER -157.18 25.02 0.31 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.456 -0.777 . . . . 2.96 109.561 -179.778 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.451 ' CB ' ' O ' ' A' ' 10' ' ' ASN . 0.5 OUTLIER 72.14 22.51 3.63 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.306 -0.871 . . . . 2.83 109.485 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.519 ' O ' ' HB ' ' A' ' 13' ' ' ILE . 0.6 OUTLIER -145.04 -83.52 0.14 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.849 -0.797 . . . . 3.78 108.849 179.834 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.718 HG22 ' H ' ' A' ' 15' ' ' LYS . 0.4 OUTLIER 71.44 -6.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.509 -0.744 . . . . 3.66 111.486 178.977 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.574 ' HB2' ' O ' ' A' ' 13' ' ' ILE . 1.7 mtpt 68.21 -21.79 0.13 Allowed 'General case' 0 C--N 1.293 -1.864 0 O-C-N 121.504 -0.747 . . . . 4.69 111.328 179.406 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.718 ' H ' HG22 ' A' ' 13' ' ' ILE . 0.1 OUTLIER 170.6 126.41 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 O-C-N 120.59 -1.319 . . . . 1.42 109.566 -177.581 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.627 ' O ' HG13 ' A' ' 16' ' ' VAL . 6.4 p -140.96 114.64 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.128 -0.983 . . . . 0.91 108.845 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.512 ' HG3' ' C ' ' A' ' 16' ' ' VAL . 1.8 mtt -153.47 168.49 25.93 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.063 -1.055 . . . . 1.91 110.63 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.674 HG12 ' H ' ' A' ' 19' ' ' ASP . 16.5 t -129.29 177.66 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 107.388 -1.338 . . . . 1.24 107.388 178.558 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.674 ' H ' HG12 ' A' ' 18' ' ' VAL . 3.6 t0 -117.54 66.44 0.74 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.597 -1.314 . . . . 2.11 112.019 -178.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 29' ' ' ILE . . . 120.53 -26.77 6.83 Favored Glycine 0 N--CA 1.493 2.497 0 C-N-CA 119.063 -1.541 . . . . 3.13 112.39 177.319 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.99 ' CA ' HG23 ' A' ' 29' ' ' ILE . 3.9 t -60.21 -118.6 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.484 -1.597 . . . . 1.97 109.572 -178.491 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.581 ' HA ' ' CG1' ' A' ' 3' ' ' VAL . 0.3 OUTLIER 155.48 123.27 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.771 -1.206 . . . . 2.27 108.836 -179.778 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.868 ' H ' HG12 ' A' ' 3' ' ' VAL . . . -75.67 155.24 46.48 Favored Glycine 0 N--CA 1.494 2.519 0 O-C-N 121.027 -1.046 . . . . 0.78 110.718 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.433 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 5.4 m 70.22 155.87 0.14 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.356 -1.085 . . . . 2.62 108.887 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.608 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.1 OUTLIER 57.9 175.36 0.04 OUTLIER Pre-proline 0 C--N 1.304 -1.378 0 N-CA-C 107.678 -1.23 . . . . 5.42 107.678 -179.824 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.608 ' HD2' ' CB ' ' A' ' 25' ' ' ASP . 25.3 Cg_endo -67.31 85.06 0.35 Allowed 'Trans proline' 0 C--N 1.295 -2.281 0 C-N-CA 122.037 1.825 . . . . 1.29 109.763 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.606 ' HB2' ' HB1' ' A' ' 122' ' ' ALA . 3.9 t -23.62 86.45 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.973 0 CA-C-N 115.332 -0.849 . . . . 1.82 111.808 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.507 ' HA ' ' O ' ' A' ' 126' ' ' LYS . 29.3 mm -77.97 143.43 12.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 C-N-CA 118.649 -1.22 . . . . 0.88 107.968 178.306 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.99 HG23 ' CA ' ' A' ' 21' ' ' CYS . 0.2 OUTLIER -129.67 -177.53 2.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 O-C-N 120.981 -1.074 . . . . 0.81 112.142 -177.194 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 36.5 m-70 -114.51 166.57 11.57 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.415 0.626 . . . . 1.63 110.496 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.885 ' O ' HD12 ' A' ' 97' ' ' ILE . 0.1 OUTLIER -122.13 10.54 10.05 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.732 0.777 . . . . 11.01 108.966 178.863 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.491 ' HA2' ' O ' ' A' ' 95' ' ' PRO . . . -116.93 -5.88 14.81 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.649 -1.381 . . . . 1.52 109.649 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.589 ' C ' ' HB ' ' A' ' 94' ' ' VAL . 6.9 mtpt -116.78 147.04 39.1 Favored Pre-proline 0 C--N 1.303 -1.441 0 N-CA-C 106.977 -1.49 . . . . 3.42 106.977 178.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.552 ' O ' ' N ' ' A' ' 36' ' ' THR . 28.3 Cg_endo -66.65 102.98 0.65 Allowed 'Trans proline' 0 C--N 1.299 -2.039 0 C-N-CA 122.178 1.919 . . . . 1.25 111.919 -177.001 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.54 ' O ' ' HA ' ' A' ' 91' ' ' THR . 49.4 t80 -41.65 94.66 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.822 -1.177 . . . . 3.65 107.822 178.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.816 HG23 ' CG2' ' A' ' 91' ' ' THR . 19.3 m -114.51 78.11 1.12 Allowed 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.529 -0.868 . . . . 2.39 110.548 -178.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.767 HD12 ' N ' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -77.46 131.25 37.87 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 106.294 -1.743 . . . . 1.42 106.294 177.91 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.767 ' N ' HD12 ' A' ' 37' ' ' LEU . 3.8 mt-10 -142.83 178.82 7.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.683 -1.261 . . . . 2.94 111.149 -177.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.449 ' HB2' ' O ' ' A' ' 38' ' ' GLU . . . 171.67 95.94 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.298 -1.371 . . . . 0.31 107.298 178.337 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.61 ' HG ' ' CB ' ' A' ' 87' ' ' ASP . 0.0 OUTLIER -90.38 174.13 7.73 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.464 -0.773 . . . . 0.41 109.652 -178.418 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.792 ' HZ ' ' HH ' ' A' ' 86' ' ' TYR . 20.8 p90 173.01 141.7 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.776 -1.202 . . . . 0.41 110.184 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.508 ' O ' ' C ' ' A' ' 43' ' ' ALA . 9.1 p-10 -90.87 112.86 24.87 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 107.445 -1.317 . . . . 4.11 107.445 178.34 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.711 ' HB1' ' O ' ' A' ' 81' ' ' VAL . . . -33.31 123.89 0.4 Allowed 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 115.613 -0.721 . . . . 0.42 110.012 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -120.08 3.88 10.92 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.497 -0.752 . . . . 3.66 110.822 -177.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.877 ' OE1' HD21 ' A' ' 117' ' ' LEU . 2.0 pt20 -97.69 -142.77 0.3 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.186 -0.946 . . . . 0.67 108.598 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.786 ' HA ' ' HB ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -153.16 68.17 0.8 Allowed 'General case' 0 C--N 1.295 -1.781 0 O-C-N 121.285 -0.884 . . . . 0.4 108.631 178.551 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.789 HG23 ' O ' ' A' ' 47' ' ' THR . 9.1 t -145.67 111.38 5.5 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.01 -1.681 . . . . 0.51 112.042 -177.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.66 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -59.69 -23.04 62.8 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.348 -1.353 . . . . 2.84 107.348 177.152 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.41 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 1.1 p -82.86 -165.09 0.97 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.856 -0.528 . . . . 0.83 109.6 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.805 ' CB ' ' HB3' ' A' ' 72' ' ' ALA . . . 178.14 155.5 0.37 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.277 -0.889 . . . . 0.42 109.128 -179.477 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.582 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 19.7 mtmt -127.75 171.13 12.0 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.061 -1.459 . . . . 1.45 107.061 178.053 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.874 HG12 HG11 ' A' ' 65' ' ' VAL . 3.0 tt -158.65 156.43 3.88 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 C-N-CA 118.221 -1.392 . . . . 0.89 110.949 -179.047 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.52 ' O ' ' NZ ' ' A' ' 55' ' ' LYS . 4.1 tp10 -159.71 48.93 0.3 Allowed 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.267 -1.382 . . . . 3.62 107.267 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.802 ' HB ' HG21 ' A' ' 65' ' ' VAL . 1.3 mt -85.7 136.92 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 CA-C-O 122.354 1.074 . . . . 1.84 111.201 -178.177 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.562 ' HG3' ' O ' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -144.01 98.05 3.16 Favored 'General case' 0 C--N 1.282 -2.365 0 O-C-N 121.0 -1.062 . . . . 0.98 109.972 178.972 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.631 ' HB3' HD12 ' A' ' 63' ' ' ILE . . . -107.35 132.5 53.07 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 107.814 -1.18 . . . . 0.44 107.814 178.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.454 ' HA ' ' HA ' ' A' ' 62' ' ' GLU . 58.6 m -117.66 113.66 22.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.819 -1.176 . . . . 2.32 110.598 -178.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.45 ' O ' ' C ' ' A' ' 59' ' ' ASP . 0.2 OUTLIER -94.63 176.99 6.07 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.153 -1.054 . . . . 4.55 108.153 178.909 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.493 ' HB2' ' HB2' ' A' ' 101' ' ' SER . 0.0 OUTLIER -44.12 -60.74 1.74 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.922 -1.111 . . . . 3.34 109.235 -179.752 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.66 ' C ' HD22 ' A' ' 61' ' ' LEU . . . -129.27 10.24 6.19 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.517 -1.433 . . . . 2.34 109.517 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.814 ' N ' HD22 ' A' ' 61' ' ' LEU . 2.9 mm? -110.11 47.06 0.98 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.06 -1.259 . . . . 3.02 107.851 178.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.454 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 1.4 mt-10 -42.67 87.77 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 115.61 -0.723 . . . . 2.3 110.929 -179.179 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.631 HD12 ' HB3' ' A' ' 56' ' ' ALA . 6.8 mt -62.93 164.9 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 N-CA-C 106.696 -1.594 . . . . 0.47 106.696 177.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.405 ' C ' HG23 ' A' ' 65' ' ' VAL . 1.7 t0 -168.26 153.29 6.53 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.614 -1.304 . . . . 2.01 110.186 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.874 HG11 HG12 ' A' ' 52' ' ' ILE . 23.7 t -150.89 62.79 5.4 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.636 -0.665 . . . . 0.44 110.04 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.596 ' HD3' ' N ' ' A' ' 65' ' ' VAL . 37.7 Cg_endo -84.96 95.45 0.66 Allowed 'Trans proline' 0 C--N 1.301 -1.938 0 C-N-CA 123.296 2.664 . . . . 1.16 110.979 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.478 ' C ' ' O ' ' A' ' 66' ' ' PRO . . . 38.31 57.9 1.72 Allowed Glycine 0 N--CA 1.495 2.61 0 N-CA-C 109.621 -1.392 . . . . 2.04 109.621 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.57 HG22 ' N ' ' A' ' 69' ' ' ASP . 22.7 mm -84.32 -94.04 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.278 -1.131 . . . . 2.99 109.948 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.57 ' N ' HG22 ' A' ' 68' ' ' ILE . 35.5 p30 -51.64 166.06 0.15 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.175 -0.953 . . . . 1.5 110.038 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -69.27 -20.02 63.92 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.363 -0.836 . . . . 2.19 109.607 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.604 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 6.6 m-20 -175.57 73.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.785 -1.197 . . . . 0.71 111.307 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.805 ' HB3' ' CB ' ' A' ' 50' ' ' ALA . . . 40.33 26.89 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.562 -0.711 . . . . 0.81 111.478 176.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.545 ' HB3' ' HB2' ' A' ' 78' ' ' CYS . 4.0 m -88.41 -49.25 7.05 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.909 -1.119 . . . . 3.09 110.046 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.497 ' HB2' ' HB3' ' A' ' 69' ' ' ASP . 0.2 OUTLIER -59.17 -7.14 1.07 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.348 -0.845 . . . . 1.18 111.957 -178.044 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.592 ' C ' HG12 ' A' ' 76' ' ' VAL . 83.8 m-85 -115.62 -10.12 11.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.489 -1.382 . . . . 0.42 110.644 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.795 HG21 ' CZ ' ' A' ' 86' ' ' TYR . 0.2 OUTLIER -164.51 175.91 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.871 -1.143 . . . . 0.38 110.153 -178.483 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.664 ' N ' ' CG2' ' A' ' 76' ' ' VAL . 11.8 mmmt -61.55 93.15 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 106.226 -1.768 . . . . 2.65 106.226 176.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' CYS . . . . . 0.545 ' HB2' ' HB3' ' A' ' 73' ' ' CYS . 4.1 t -37.91 -50.37 3.04 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.359 -0.838 . . . . 3.53 111.79 -177.18 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.66 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 30.6 Cg_endo -74.71 108.27 2.66 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 N-CA-C 108.674 -1.318 . . . . 0.54 108.674 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.966 HD22 HD22 ' A' ' 117' ' ' LEU . 0.6 OUTLIER -103.28 -66.71 0.92 Allowed 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 108.378 -0.971 . . . . 2.42 108.378 -178.701 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.786 ' HB ' ' HA ' ' A' ' 46' ' ' ASN . 1.4 m 41.45 -167.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 109.221 -0.659 . . . . 0.36 109.221 178.048 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.733 ' H ' HG23 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -101.82 42.71 1.11 Allowed 'General case' 0 C--N 1.284 -2.267 0 O-C-N 120.261 -1.524 . . . . 3.21 109.704 -176.98 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -146.62 37.3 1.21 Allowed Glycine 0 C--N 1.287 -2.143 0 N-CA-C 108.712 -1.755 . . . . 0.42 108.712 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 35.3 tp60 -152.52 143.44 22.99 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 121.157 -1.202 . . . . 2.33 110.78 -179.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.42 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 0.3 OUTLIER -117.59 134.5 54.81 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 105.596 -2.002 . . . . 3.14 105.596 177.653 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.798 ' HE2' HD21 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -163.4 163.58 24.95 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 117.514 -1.675 . . . . 0.58 109.95 -177.42 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.61 ' CB ' ' HG ' ' A' ' 40' ' ' LEU . 12.7 p-10 -133.14 102.29 5.53 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.852 -1.155 . . . . 0.59 112.968 -176.37 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.536 ' CD1' ' O ' ' A' ' 75' ' ' PHE . 3.0 tp -70.26 -175.9 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 107.423 -1.325 . . . . 1.66 107.423 176.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.544 ' O ' ' CD2' ' A' ' 90' ' ' TYR . 3.1 mttt 174.13 173.65 0.18 Allowed 'General case' 0 N--CA 1.5 2.07 0 O-C-N 120.852 -1.155 . . . . 0.77 110.83 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.544 ' CD2' ' O ' ' A' ' 89' ' ' LYS . 5.8 m-85 -172.43 60.56 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 106.908 -1.516 . . . . 2.41 106.908 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.816 ' CG2' HG23 ' A' ' 36' ' ' THR . 0.3 OUTLIER -90.25 -169.19 2.33 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.518 -0.739 . . . . 3.08 111.667 -177.306 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.564 ' CH2' ' HB3' ' A' ' 61' ' ' LEU . 0.2 OUTLIER -171.2 151.63 3.21 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.581 -0.699 . . . . 7.17 110.323 -178.973 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -81.89 142.73 32.23 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.908 -1.145 . . . . 2.25 107.908 178.479 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 1.068 HG13 ' CD1' ' A' ' 97' ' ' ILE . 51.5 t -147.89 112.97 3.92 Favored Pre-proline 0 C--N 1.305 -1.335 0 O-C-N 120.805 -1.185 . . . . 2.18 111.667 -177.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.943 ' HD2' HD11 ' A' ' 97' ' ' ILE . 29.9 Cg_endo -74.56 -67.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 123.259 2.639 . . . . 3.41 111.513 178.019 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.634 ' O ' ' HB3' ' A' ' 31' ' ' ARG . 0.4 OUTLIER -162.44 -33.65 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 107.368 -1.345 . . . . 5.74 107.368 -179.826 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 1.068 ' CD1' HG13 ' A' ' 94' ' ' VAL . 1.4 mt 34.48 24.37 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 114.02 1.118 . . . . 2.28 114.02 176.355 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 1.023 ' HB1' ' HD2' ' A' ' 99' ' ' PRO . . . 61.28 -177.2 0.03 OUTLIER Pre-proline 0 C--N 1.301 -1.513 0 O-C-N 120.279 -1.513 . . . . 1.35 109.926 178.213 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 1.023 ' HD2' ' HB1' ' A' ' 98' ' ' ALA . 46.8 Cg_endo -86.53 151.23 8.97 Favored 'Trans proline' 0 C--N 1.302 -1.896 0 C-N-CA 123.645 2.896 . . . . 0.74 111.052 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.521 ' HD2' ' HA ' ' A' ' 128' ' ' ARG . 2.0 mptm? 64.08 142.91 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.965 0.888 . . . . 3.05 112.419 175.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.725 ' HB3' HD13 ' A' ' 127' ' ' ILE . 2.9 p -111.15 12.31 21.89 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.918 -0.771 . . . . 3.5 108.918 179.055 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.549 ' O ' ' CB ' ' A' ' 103' ' ' ASN . 0.8 OUTLIER 76.66 -5.98 2.09 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.603 -0.685 . . . . 3.1 109.342 -179.425 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.549 ' CB ' ' O ' ' A' ' 102' ' ' GLU . 5.2 t30 159.19 146.04 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.453 -0.78 . . . . 2.83 109.45 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 1.092 HG21 HD12 ' A' ' 127' ' ' ILE . 0.1 OUTLIER -157.55 -174.3 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.255 -0.903 . . . . 0.65 110.065 -179.76 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.525 ' CB ' ' O ' ' A' ' 104' ' ' VAL . 1.2 t 159.27 125.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.2 -1.037 . . . . 0.6 108.2 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.742 ' O ' HG12 ' A' ' 106' ' ' VAL . 2.1 t -125.13 97.39 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 120.833 -1.167 . . . . 1.59 110.555 -178.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.515 ' HB ' ' HE3' ' A' ' 55' ' ' LYS . 25.6 m -116.52 143.61 45.37 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.504 -1.295 . . . . 0.69 107.504 178.466 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.753 HG13 ' CD1' ' A' ' 54' ' ' ILE . 88.0 t -151.15 152.89 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.59 -1.319 . . . . 1.0 110.585 -178.621 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -173.62 118.05 0.27 Allowed 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.798 0.809 . . . . 0.75 109.472 178.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.588 ' HB3' ' HB2' ' A' ' 117' ' ' LEU . 9.8 tp -106.26 121.8 44.93 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 106.777 -1.564 . . . . 1.34 106.777 178.552 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.511 ' HB ' ' HB2' ' A' ' 51' ' ' LYS . 4.0 mt -121.11 117.49 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.25 -0.906 . . . . 0.74 112.296 -176.487 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.499 ' HA3' HG21 ' A' ' 47' ' ' THR . . . -86.23 -112.37 0.83 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 107.806 -2.117 . . . . 0.75 107.806 176.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -141.1 -0.1 1.49 Allowed 'General case' 0 C--N 1.307 -1.268 0 O-C-N 120.928 -1.337 . . . . 1.46 108.123 178.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.463 ' ND2' ' N ' ' A' ' 114' ' ' ASN . 0.2 OUTLIER -120.98 -5.59 9.56 Favored 'General case' 0 C--N 1.313 -0.985 0 O-C-N 121.163 -0.961 . . . . 1.17 109.955 -179.923 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 160.56 164.47 15.6 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 109.641 -1.383 . . . . 1.4 109.641 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.41 HG13 ' O ' ' A' ' 116' ' ' VAL . 2.1 p -70.62 110.54 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.112 -1.228 . . . . 0.92 109.455 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.966 HD22 HD22 ' A' ' 80' ' ' LEU . 1.3 mt -48.52 -51.46 27.28 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.465 -0.772 . . . . 1.15 110.156 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -168.97 135.49 1.76 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.223 -0.923 . . . . 2.19 109.597 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 0.53 ' O ' ' HB2' ' A' ' 120' ' ' ALA . 22.0 p -126.13 -162.31 1.12 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.916 -1.115 . . . . 0.94 110.637 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.53 ' HB2' ' O ' ' A' ' 119' ' ' CYS . . . 171.24 124.86 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.38 -0.97 . . . . 0.37 108.38 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.523 HD12 ' C ' ' A' ' 120' ' ' ALA . 1.2 mp -133.69 126.62 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 120.976 -1.078 . . . . 1.5 110.798 -178.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.606 ' HB1' ' HB2' ' A' ' 27' ' ' CYS . . . -111.43 82.16 1.56 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.208 -1.034 . . . . 0.54 108.208 178.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.54 ' CG2' ' O ' ' A' ' 123' ' ' THR . 0.5 OUTLIER -33.52 125.04 0.42 Allowed 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.563 0.697 . . . . 2.68 110.666 -179.083 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 124' ' ' HIS . . . . . 0.475 ' O ' ' O ' ' A' ' 123' ' ' THR . 8.1 m170 54.41 163.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.555 -0.716 . . . . 2.17 109.786 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -153.88 129.72 2.73 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.401 -1.48 . . . . 1.66 109.401 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.507 ' O ' ' HA ' ' A' ' 28' ' ' ILE . 5.7 mtmt -153.23 119.17 5.39 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.328 -1.101 . . . . 1.85 108.536 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 1.092 HD12 HG21 ' A' ' 104' ' ' VAL . 1.5 mp -94.12 160.67 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.234 -0.916 . . . . 1.32 110.506 -178.704 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.528 ' HG2' ' O ' ' A' ' 127' ' ' ILE . 1.4 mtm180 -150.8 -174.72 4.87 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 109.016 -0.735 . . . . 2.69 109.016 178.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.541 ' N ' ' HB3' ' A' ' 99' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 117.917 -1.04 . . . . 7.78 109.708 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 1' ' ' ASP . . . . . 0.513 ' O ' ' HG3' ' A' ' 2' ' ' GLN . 14.5 m-20 . . . . . 0 N--CA 1.492 1.644 0 N-CA-C 109.6 -0.518 . . . . 4.36 109.6 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.513 ' HG3' ' O ' ' A' ' 1' ' ' ASP . 4.4 pt20 37.41 31.93 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.691 -0.485 . . . . 3.19 109.691 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.777 HG12 ' HA ' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -33.74 144.95 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-O 121.367 0.603 . . . . 2.0 110.402 -179.562 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.489 ' O ' ' N ' ' A' ' 24' ' ' SER . 5.3 t70 -89.64 148.83 23.09 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.419 -0.801 . . . . 2.47 109.437 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.421 HG13 ' O ' ' A' ' 4' ' ' ASP . 0.0 OUTLIER -156.08 167.24 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.353 -0.842 . . . . 1.65 108.988 179.961 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.564 ' HD3' ' N ' ' A' ' 6' ' ' LYS . 1.4 mptt -80.02 76.92 6.74 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.073 -1.084 . . . . 3.62 108.073 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.525 ' HB2' ' O ' ' A' ' 119' ' ' CYS . 51.6 p30 -94.35 168.38 10.93 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.832 0.825 . . . . 0.77 110.436 -178.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.54 ' N ' ' SG ' ' A' ' 119' ' ' CYS . 29.2 m -113.17 -36.1 5.16 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.031 -1.47 . . . . 3.26 107.031 178.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.835 ' HB2' ' CB ' ' A' ' 118' ' ' ALA . . . -64.14 -144.84 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.358 -0.979 . . . . 5.02 108.358 177.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.646 ' ND2' ' O ' ' A' ' 9' ' ' ALA . 0.0 OUTLIER 80.45 -42.92 0.22 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 120.506 -0.477 . . . . 9.64 110.874 177.372 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -63.38 -17.73 62.94 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.957 -1.089 . . . . 4.23 108.23 178.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.448 ' HG2' ' HB3' ' A' ' 44' ' ' ASN . 13.1 tp10 -132.37 -28.78 1.64 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.673 -0.642 . . . . 2.78 109.575 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.813 HG13 ' HB1' ' A' ' 9' ' ' ALA . 10.4 mt -48.43 154.7 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.09 -1.006 . . . . 1.61 109.825 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.444 ' N ' ' CG2' ' A' ' 13' ' ' ILE . 0.0 OUTLIER -110.91 -23.21 11.11 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.784 -0.821 . . . . 0.92 108.784 179.776 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -156.99 122.07 4.57 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 119.202 -0.999 . . . . 2.42 109.657 -178.305 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.631 ' O ' HG13 ' A' ' 16' ' ' VAL . 4.5 p -155.3 104.65 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.074 -1.016 . . . . 1.23 109.412 -179.179 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.497 ' HG2' ' HB3' ' A' ' 2' ' ' GLN . 3.0 mpp? -150.42 152.74 34.78 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.202 -0.936 . . . . 1.36 110.493 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.874 HG12 ' CE1' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -121.4 106.04 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 108.087 -1.079 . . . . 0.79 108.087 178.535 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.442 ' HB3' ' O ' ' A' ' 34' ' ' PRO . 1.2 t0 -52.49 86.92 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.644 -0.66 . . . . 1.87 110.928 -178.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.554 ' O ' ' HB3' ' A' ' 21' ' ' CYS . . . 98.46 -169.96 24.04 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 120.035 -1.078 . . . . 2.01 110.928 178.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.95 ' CA ' HG23 ' A' ' 29' ' ' ILE . 36.2 t 86.14 -25.52 0.11 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 122.268 -0.548 . . . . 1.53 110.193 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.777 ' HA ' HG12 ' A' ' 3' ' ' VAL . 0.3 OUTLIER 42.2 83.99 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.858 -1.151 . . . . 1.74 108.973 -179.192 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.497 ' O ' ' CB ' ' A' ' 24' ' ' SER . . . -83.39 -144.56 5.77 Favored Glycine 0 N--CA 1.498 2.811 0 O-C-N 121.489 -0.757 . . . . 1.26 112.327 -178.126 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.497 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 0.1 OUTLIER 78.46 -79.38 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 107.45 -1.315 . . . . 1.4 107.45 -177.818 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.691 ' HB2' ' CD ' ' A' ' 26' ' ' PRO . 7.3 p30 -84.87 -149.4 0.0 OUTLIER Pre-proline 0 C--N 1.298 -1.67 0 N-CA-C 105.263 -2.125 . . . . 2.39 105.263 177.355 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.691 ' CD ' ' HB2' ' A' ' 25' ' ' ASP . 25.9 Cg_endo -70.07 102.36 1.07 Allowed 'Trans proline' 0 C--N 1.32 -0.969 0 CA-C-N 121.168 1.453 . . . . 1.49 108.601 179.178 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.599 ' HA ' ' O ' ' A' ' 22' ' ' HIS . 3.2 t -54.72 81.23 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 115.42 -0.809 . . . . 1.63 113.07 -176.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.534 ' O ' ' O ' ' A' ' 21' ' ' CYS . 0.6 OUTLIER -83.09 145.29 8.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 106.863 -1.532 . . . . 2.11 106.863 176.475 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.95 HG23 ' CA ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -113.35 -175.95 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 O-C-N 120.756 -1.215 . . . . 1.11 111.827 -176.978 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -127.04 107.25 9.88 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 119.952 -0.699 . . . . 1.95 111.269 -178.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.583 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -53.86 149.1 9.22 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.492 -0.755 . . . . 3.21 109.038 178.353 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.518 ' HA2' ' O ' ' A' ' 95' ' ' PRO . . . 92.06 -1.97 74.78 Favored Glycine 0 N--CA 1.493 2.478 0 C-N-CA 119.814 -1.184 . . . . 2.11 110.61 178.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.584 ' O ' HG21 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -124.12 139.97 33.83 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 120.963 -1.316 . . . . 2.36 109.479 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.442 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 27.0 Cg_endo -64.93 134.72 41.21 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.398 2.065 . . . . 2.51 110.935 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.874 ' CE1' HG12 ' A' ' 18' ' ' VAL . 5.1 t80 -114.41 60.72 0.67 Allowed 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.466 -0.568 . . . . 1.33 109.466 -178.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.492 HG22 ' OE1' ' A' ' 38' ' ' GLU . 81.5 m -73.08 81.97 1.26 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.303 -0.873 . . . . 2.52 109.09 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.52 ' O ' ' CG ' ' A' ' 38' ' ' GLU . 3.0 mp -52.7 -178.21 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.189 -0.945 . . . . 4.85 108.653 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.536 ' CG ' ' HG2' ' A' ' 89' ' ' LYS . 0.1 OUTLIER 166.73 158.56 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.916 -1.115 . . . . 2.7 109.795 -179.602 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.522 ' HB2' ' O ' ' A' ' 38' ' ' GLU . . . 171.81 83.41 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.697 0.76 . . . . 1.19 109.506 178.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.73 ' O ' HG23 ' A' ' 13' ' ' ILE . 0.6 OUTLIER -82.12 165.05 20.89 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 108.269 -1.011 . . . . 2.17 108.269 179.031 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.763 ' CZ ' ' CD2' ' A' ' 86' ' ' TYR . 0.4 OUTLIER -156.79 164.85 37.63 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.323 -1.362 . . . . 1.2 107.323 176.285 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.411 ' O ' ' C ' ' A' ' 43' ' ' ALA . 1.0 OUTLIER -116.85 116.38 27.34 Favored 'General case' 0 C--N 1.29 -2.013 0 C-N-CA 119.309 -0.957 . . . . 2.49 108.584 -179.8 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.869 ' HB1' ' O ' ' A' ' 81' ' ' VAL . . . -46.81 119.59 2.57 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 107.386 -1.339 . . . . 0.44 107.386 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.461 ' C ' ' HB3' ' A' ' 82' ' ' LYS . 0.1 OUTLIER -130.63 19.38 5.16 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.699 0.761 . . . . 3.32 108.999 -178.15 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.788 ' CD ' HD21 ' A' ' 117' ' ' LEU . 3.0 pt20 -109.37 -139.41 0.38 Allowed 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.512 -0.742 . . . . 0.82 110.408 -178.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.689 ' C ' HG22 ' A' ' 81' ' ' VAL . 3.4 m120 -158.55 53.43 0.43 Allowed 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.531 -0.914 . . . . 3.98 108.531 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.798 ' N ' HG22 ' A' ' 81' ' ' VAL . 10.4 t -134.78 127.47 30.95 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.386 -1.446 . . . . 2.09 110.555 -178.493 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.648 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -70.71 -20.15 62.69 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.012 -1.055 . . . . 5.26 108.934 178.744 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 24.7 p -73.79 178.81 4.59 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.922 0.868 . . . . 3.19 111.077 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 1.062 ' HB1' ' HB3' ' A' ' 72' ' ' ALA . . . 177.52 131.06 0.06 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.258 -1.386 . . . . 1.48 107.258 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.522 ' O ' ' C ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -136.11 48.55 2.16 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 120.104 -1.623 . . . . 3.08 109.91 -178.628 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.883 ' H ' ' HB2' ' A' ' 72' ' ' ALA . 2.0 tt -28.29 146.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.178 0 CA-C-N 115.451 -0.795 . . . . 2.37 110.361 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.461 ' C ' HD12 ' A' ' 54' ' ' ILE . 0.3 OUTLIER -137.95 82.96 1.95 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.301 -0.874 . . . . 3.09 109.474 -179.818 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.896 ' HB ' HG21 ' A' ' 65' ' ' VAL . 0.5 OUTLIER -108.57 141.51 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.293 -0.879 . . . . 0.87 109.278 179.651 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.696 ' HG3' ' O ' ' A' ' 54' ' ' ILE . 0.2 OUTLIER -152.4 90.18 1.48 Allowed 'General case' 0 C--N 1.285 -2.204 0 O-C-N 121.348 -0.845 . . . . 1.15 109.175 178.462 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.793 ' HB3' ' HB ' ' A' ' 63' ' ' ILE . . . -109.36 145.21 36.44 Favored 'General case' 0 C--N 1.292 -1.897 0 O-C-N 121.512 -0.743 . . . . 0.24 109.551 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.476 ' O ' ' CG1' ' A' ' 104' ' ' VAL . 30.3 m -128.12 137.13 51.99 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.972 -1.08 . . . . 2.44 109.142 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.856 HD13 ' H ' ' A' ' 59' ' ' ASP . 0.2 OUTLIER -135.39 158.33 44.64 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.28 -0.887 . . . . 1.82 109.198 -179.604 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.856 ' H ' HD13 ' A' ' 58' ' ' LEU . 18.1 t70 -48.86 -63.89 0.96 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.274 -0.892 . . . . 3.24 108.608 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -108.17 24.89 21.85 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 108.862 -1.695 . . . . 1.15 108.862 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.608 ' CB ' ' HB3' ' A' ' 58' ' ' LEU . 0.4 OUTLIER -146.33 66.48 1.19 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.269 -1.136 . . . . 3.44 109.118 -179.709 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.09 82.44 0.51 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.469 -0.769 . . . . 2.18 109.985 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.793 ' HB ' ' HB3' ' A' ' 56' ' ' ALA . 8.5 mt -66.85 169.44 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 120.866 -1.146 . . . . 0.34 108.091 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.581 ' N ' HG22 ' A' ' 63' ' ' ILE . 0.5 OUTLIER 175.9 145.75 0.08 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.018 -1.052 . . . . 1.06 109.469 -179.791 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.896 HG21 ' HB ' ' A' ' 54' ' ' ILE . 14.5 t -144.39 63.93 11.59 Favored Pre-proline 0 N--CA 1.488 1.425 0 O-C-N 121.318 -0.864 . . . . 1.0 110.01 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.547 ' HD3' ' N ' ' A' ' 65' ' ' VAL . 36.4 Cg_endo -79.34 94.61 1.05 Allowed 'Trans proline' 0 C--N 1.298 -2.105 0 C-N-CA 122.918 2.412 . . . . 2.03 110.328 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.466 ' C ' ' O ' ' A' ' 66' ' ' PRO . . . 36.45 46.96 1.11 Allowed Glycine 0 N--CA 1.496 2.688 0 N-CA-C 110.119 -1.192 . . . . 1.13 110.119 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.745 HG22 ' N ' ' A' ' 69' ' ' ASP . 1.9 mm -63.5 -75.05 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.245 -1.15 . . . . 1.9 109.721 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.745 ' N ' HG22 ' A' ' 68' ' ' ILE . 6.4 p-10 -77.96 162.81 26.5 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.113 -0.992 . . . . 1.82 109.369 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.11 -55.57 33.0 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.435 -0.791 . . . . 2.51 110.318 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.562 ' CA ' ' O ' ' A' ' 50' ' ' ALA . 3.9 m-80 -147.45 87.69 1.66 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.913 -1.117 . . . . 3.05 111.488 -178.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 1.062 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . . . 37.2 26.77 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.895 -0.503 . . . . 0.4 111.986 176.541 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.525 ' N ' ' O ' ' A' ' 71' ' ' ASN . 4.3 t -99.46 0.73 43.16 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 120.88 -1.137 . . . . 1.14 111.23 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.613 ' CG ' ' HB3' ' A' ' 69' ' ' ASP . 0.3 OUTLIER -90.7 -29.54 17.64 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.757 -1.214 . . . . 2.98 109.687 179.811 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.508 ' O ' ' HB ' ' A' ' 76' ' ' VAL . 13.5 m-85 -103.6 14.07 31.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.362 -0.836 . . . . 1.73 109.29 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 1.198 HG11 ' CZ ' ' A' ' 86' ' ' TYR . 5.4 p 178.27 -142.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-O 121.787 0.804 . . . . 2.55 109.512 -177.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.841 ' N ' HG13 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -99.03 158.69 15.48 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 106.304 -1.739 . . . . 3.36 106.304 177.049 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' CYS . . . . . 0.568 ' N ' ' HD2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -81.96 -48.62 0.94 Allowed Pre-proline 0 N--CA 1.493 1.694 0 C-N-CA 118.054 -1.458 . . . . 2.17 109.544 179.866 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.648 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 32.0 Cg_endo -77.2 114.92 3.87 Favored 'Trans proline' 0 C--N 1.302 -1.904 0 N-CA-C 107.498 -1.77 . . . . 2.29 107.498 178.394 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.758 HD11 HD21 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -85.96 -69.19 0.68 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 106.588 -1.634 . . . . 1.39 106.588 -179.11 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.869 ' O ' ' HB1' ' A' ' 43' ' ' ALA 0.256 48.4 t 50.06 -174.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 C-N-CA 118.276 -1.37 . . . . 2.91 109.262 175.488 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.61 ' N ' HG12 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -104.56 47.32 0.88 Allowed 'General case' 0 C--N 1.293 -1.884 0 O-C-N 121.143 -0.973 . . . . 2.54 110.008 -179.381 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -137.43 11.19 3.78 Favored Glycine 0 N--CA 1.491 2.309 0 C-N-CA 118.734 -1.698 . . . . 0.5 113.059 -178.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.482 ' NE2' ' O ' ' A' ' 79' ' ' PRO . 1.2 pt20 -148.92 171.05 16.95 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 120.452 2.126 . . . . 5.53 111.334 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -108.02 142.1 38.68 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.775 0.798 . . . . 5.07 110.956 -178.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 1.198 ' CZ ' HG11 ' A' ' 76' ' ' VAL . 0.4 OUTLIER -99.62 173.18 6.85 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.069 0.462 . . . . 2.67 110.576 -179.61 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.626 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 9.9 p-10 176.83 83.64 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.464 -0.773 . . . . 3.47 110.918 178.34 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.548 HG12 ' N ' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -127.87 146.06 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 107.313 -1.366 . . . . 2.54 107.313 178.409 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.548 ' N ' HG12 ' A' ' 88' ' ' ILE . 1.7 mtmt -147.62 -169.37 3.3 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.955 -1.091 . . . . 3.15 111.797 -177.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.639 ' CZ ' HG21 ' A' ' 54' ' ' ILE . 67.4 m-85 -156.7 126.64 6.36 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 107.728 -1.212 . . . . 1.19 107.728 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.31 156.67 30.81 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.587 -1.32 . . . . 3.39 110.842 -178.545 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.753 ' CD2' HG22 ' A' ' 94' ' ' VAL . 3.3 t90 -143.19 109.97 5.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.548 -0.72 . . . . 5.33 109.168 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -61.08 120.13 9.68 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.685 -1.228 . . . . 3.09 107.685 178.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.813 HG13 HD13 ' A' ' 97' ' ' ILE . 18.4 t -114.68 95.94 42.34 Favored Pre-proline 0 N--CA 1.489 1.499 0 C-N-CA 119.028 -1.069 . . . . 2.63 111.573 -178.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.703 ' HD2' HD11 ' A' ' 97' ' ' ILE . 31.0 Cg_endo -75.88 -79.52 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.939 2.426 . . . . 2.84 109.269 177.472 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.599 ' C ' HD12 ' A' ' 97' ' ' ILE . 5.5 tptt -137.52 -59.63 0.67 Allowed 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 104.662 -2.347 . . . . 3.01 104.662 177.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.813 HD13 HG13 ' A' ' 94' ' ' VAL . 1.2 mp 66.59 5.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 O-C-N 121.679 -0.638 . . . . 1.75 112.711 174.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 1.075 ' HB1' ' HD2' ' A' ' 99' ' ' PRO . . . 54.86 177.96 0.03 OUTLIER Pre-proline 0 C--N 1.302 -1.459 0 O-C-N 120.408 -1.433 . . . . 1.3 109.256 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 1.075 ' HD2' ' HB1' ' A' ' 98' ' ' ALA . 46.4 Cg_endo -80.5 155.46 21.48 Favored 'Trans proline' 0 C--N 1.3 -1.984 0 C-N-CA 123.525 2.816 . . . . 1.26 110.345 -179.294 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.792 ' N ' HG22 ' A' ' 127' ' ' ILE . 1.4 mmmp? 56.91 149.47 0.01 OUTLIER 'General case' 0 C--N 1.29 -1.987 0 CA-C-O 122.157 0.98 . . . . 2.85 112.184 176.469 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.816 ' OG ' HD13 ' A' ' 127' ' ' ILE . 78.0 p -129.68 164.72 23.32 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.118 -0.697 . . . . 1.63 109.118 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.556 ' O ' ' CB ' ' A' ' 103' ' ' ASN . 4.3 mt-10 -51.04 -22.22 2.25 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.147 -0.971 . . . . 2.97 109.023 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.556 ' CB ' ' O ' ' A' ' 102' ' ' GLU . 0.3 OUTLIER 157.1 157.02 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.563 -0.903 . . . . 3.2 108.563 -179.713 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.642 HG21 ' CD1' ' A' ' 127' ' ' ILE . 0.2 OUTLIER -152.07 174.58 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.05 -1.031 . . . . 0.91 109.611 -179.919 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 56' ' ' ALA . 1.2 t 164.57 130.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 108.06 -1.089 . . . . 0.86 108.06 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.565 ' O ' HG12 ' A' ' 106' ' ' VAL . 3.6 t -128.56 102.98 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.899 -1.125 . . . . 1.68 110.562 -179.129 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.412 ' C ' ' CG2' ' A' ' 108' ' ' VAL . 0.2 OUTLIER -108.64 147.45 31.85 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.366 -0.975 . . . . 1.11 108.366 178.905 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.427 HG13 HG13 ' A' ' 54' ' ' ILE . 1.5 t -151.69 153.32 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.696 -1.252 . . . . 1.88 110.546 -179.163 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.522 ' HA ' ' HA ' ' A' ' 119' ' ' CYS . 0.4 OUTLIER 172.48 116.15 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.503 -0.748 . . . . 1.81 110.334 178.796 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.758 HD21 HD11 ' A' ' 80' ' ' LEU . 32.7 tp -104.04 127.89 51.61 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.684 -1.228 . . . . 1.37 107.684 177.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.508 ' O ' ' HG3' ' A' ' 51' ' ' LYS . 10.3 mt -125.88 136.83 59.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 O-C-N 121.277 -0.89 . . . . 0.9 110.431 -178.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.737 ' HA3' HG21 ' A' ' 47' ' ' THR . . . -100.07 -109.86 3.13 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 108.099 -2.0 . . . . 1.43 108.099 178.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -145.34 11.91 1.34 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.353 -1.351 . . . . 3.14 107.353 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.419 ' OD1' ' NE2' ' A' ' 45' ' ' GLN . 1.3 p30 -127.53 -33.17 2.35 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.547 0.689 . . . . 4.15 109.483 -178.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -179.91 156.61 18.45 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.107 -1.597 . . . . 1.69 109.107 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.484 ' O ' HG22 ' A' ' 116' ' ' VAL . 0.2 OUTLIER -57.02 112.54 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.147 -1.208 . . . . 0.9 109.918 -179.642 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.788 HD21 ' CD ' ' A' ' 45' ' ' GLN . 2.9 mt -55.54 -68.02 0.23 Allowed 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.608 -0.886 . . . . 1.08 108.608 179.14 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.835 ' CB ' ' HB2' ' A' ' 9' ' ' ALA . . . -130.39 -177.98 4.56 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.296 -1.002 . . . . 0.66 108.296 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 0.566 ' HB3' ' O ' ' A' ' 118' ' ' ALA . 0.1 OUTLIER 169.15 155.8 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.08 -1.013 . . . . 0.86 110.145 179.777 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.474 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . . . -176.88 129.68 0.18 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.314 -0.866 . . . . 1.22 109.416 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.3 mt -122.73 131.72 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.138 -0.977 . . . . 0.77 109.886 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.46 ' HB1' ' HB2' ' A' ' 27' ' ' CYS . . . -85.79 -35.81 20.48 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.337 -0.986 . . . . 2.26 108.337 179.213 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.408 ' O ' ' O ' ' A' ' 124' ' ' HIS . 2.4 m 64.77 121.41 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.61 -0.681 . . . . 1.74 110.372 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' HIS . . . . . 0.408 ' O ' ' O ' ' A' ' 123' ' ' THR . 3.9 m170 48.02 98.03 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.543 -0.723 . . . . 3.09 110.771 178.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.477 ' O ' ' HB ' ' A' ' 104' ' ' VAL . . . -116.83 119.38 4.46 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 108.294 -1.922 . . . . 1.14 108.294 178.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.455 ' O ' HG23 ' A' ' 28' ' ' ILE . 0.8 OUTLIER -137.27 140.02 41.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.949 -1.324 . . . . 2.76 110.587 -178.892 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.816 HD13 ' OG ' ' A' ' 101' ' ' SER . 2.2 mp -83.16 149.53 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 108.292 -1.003 . . . . 1.15 108.292 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.685 ' CB ' ' O ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER 137.22 -82.11 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 108.96 -0.755 . . . . 3.86 108.96 179.355 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.442 ' N ' ' CD ' ' A' ' 128' ' ' ARG . 13.1 t70 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 117.948 -1.025 . . . . 4.22 109.382 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' ASP . . . . . 0.526 ' C ' ' CG ' ' A' ' 2' ' ' GLN . 5.2 m-20 . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.31 -0.626 . . . . 3.24 109.31 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.561 ' HA ' ' CG ' ' A' ' 17' ' ' MET . 0.8 OUTLIER 37.35 30.07 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.647 -0.658 . . . . 4.54 110.589 179.166 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.778 HG11 ' H ' ' A' ' 22' ' ' HIS . 28.8 m -44.46 122.17 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.28 -0.887 . . . . 2.42 108.815 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.48 ' O ' ' HA3' ' A' ' 23' ' ' GLY . 8.3 t70 -55.39 134.61 50.39 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.449 -0.782 . . . . 2.17 110.586 -179.028 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.3 171.16 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 108.224 -1.028 . . . . 1.13 108.224 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 120' ' ' ALA . 27.4 mtpt -105.33 101.47 11.0 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.787 -1.196 . . . . 3.3 110.007 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.491 ' HA ' ' O ' ' A' ' 119' ' ' CYS . 65.1 m-20 -97.19 170.69 8.93 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.472 -0.768 . . . . 4.04 109.362 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.515 ' N ' ' SG ' ' A' ' 119' ' ' CYS . 3.8 m -138.69 4.64 2.36 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.34 -0.85 . . . . 1.49 109.639 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.595 ' HB2' ' HA ' ' A' ' 118' ' ' ALA . . . -47.09 -62.73 1.28 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.07 -1.019 . . . . 0.56 109.586 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.444 ' OD1' ' OD1' ' A' ' 11' ' ' ASN . 1.1 t-20 178.83 -81.85 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.919 -0.712 . . . . 4.78 109.301 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.444 ' OD1' ' OD1' ' A' ' 10' ' ' ASN . 14.3 p-10 -164.45 42.26 0.09 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.55 -0.719 . . . . 4.35 109.214 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.532 ' O ' ' HB ' ' A' ' 13' ' ' ILE . 0.7 OUTLIER -163.68 -81.94 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.231 -0.918 . . . . 3.78 109.566 -179.819 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.654 HG22 ' H ' ' A' ' 15' ' ' LYS . 0.1 OUTLIER 74.22 -2.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 CA-C-O 121.784 0.802 . . . . 3.79 110.257 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.524 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 15.1 mttm 65.99 -19.21 0.1 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.043 -1.036 . . . . 1.86 111.771 178.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.654 ' H ' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER 166.14 151.24 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.399 0 O-C-N 120.685 -1.26 . . . . 1.65 109.029 -178.073 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.794 ' O ' HG13 ' A' ' 16' ' ' VAL . 12.6 p -169.46 100.8 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.129 -0.982 . . . . 0.82 109.019 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.561 ' CG ' ' HA ' ' A' ' 2' ' ' GLN . 2.1 mpp? -151.19 150.16 30.28 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.589 -0.845 . . . . 1.34 110.196 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.677 HG11 ' CE1' ' A' ' 35' ' ' PHE . 19.2 t -117.0 160.24 16.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 107.794 -1.188 . . . . 1.35 107.794 178.404 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.569 ' CB ' ' O ' ' A' ' 34' ' ' PRO . 16.3 m-20 -94.91 36.17 1.21 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.835 -1.166 . . . . 1.69 110.021 -179.272 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.547 ' O ' ' CB ' ' A' ' 21' ' ' CYS . . . 130.45 128.9 3.04 Favored Glycine 0 N--CA 1.487 2.079 0 C-N-CA 119.523 -1.322 . . . . 1.05 110.131 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.877 ' CA ' HG23 ' A' ' 29' ' ' ILE . 0.0 OUTLIER 154.67 -36.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.538 -0.912 . . . . 0.91 108.538 179.132 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.778 ' H ' HG11 ' A' ' 3' ' ' VAL . 7.2 t-160 66.44 116.27 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.181 -1.044 . . . . 3.74 108.181 -178.051 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.537 ' O ' ' CB ' ' A' ' 24' ' ' SER . . . -103.67 176.2 23.9 Favored Glycine 0 N--CA 1.496 2.657 0 C-N-CA 119.064 -1.541 . . . . 0.79 110.392 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.537 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 1.3 t 84.75 -69.4 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.677 -0.896 . . . . 0.92 110.164 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.692 ' CB ' ' CD ' ' A' ' 26' ' ' PRO . 0.8 OUTLIER -83.57 -157.2 0.01 OUTLIER Pre-proline 0 C--N 1.304 -1.388 0 N-CA-C 108.274 -1.01 . . . . 4.49 108.274 -179.779 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.692 ' CD ' ' CB ' ' A' ' 25' ' ' ASP . 28.4 Cg_endo -74.38 89.53 1.07 Allowed 'Trans proline' 0 C--N 1.324 -0.76 0 N-CA-C 108.483 -1.391 . . . . 0.68 108.483 179.173 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.562 ' HA ' ' O ' ' A' ' 22' ' ' HIS . 1.6 t -38.4 95.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 113.244 0.831 . . . . 0.83 113.244 -177.012 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.493 ' O ' ' O ' ' A' ' 21' ' ' CYS . 24.1 mm -89.9 141.29 14.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 104.784 -2.302 . . . . 0.7 104.784 174.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.877 HG23 ' CA ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -119.45 179.94 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 O-C-N 120.215 -1.553 . . . . 0.79 112.886 -176.086 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.511 ' NE2' ' OD2' ' A' ' 129' ' ' ASP . 14.3 m170 -117.55 157.18 26.79 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.787 0.803 . . . . 2.87 110.828 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.583 ' HD3' ' CA ' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -115.43 154.55 29.06 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 107.76 -1.2 . . . . 1.54 107.76 178.285 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.415 ' H ' ' CG1' ' A' ' 94' ' ' VAL . . . 89.51 -1.01 81.3 Favored Glycine 0 N--CA 1.495 2.602 0 C-N-CA 119.582 -1.294 . . . . 0.35 110.073 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.753 ' N ' HG11 ' A' ' 94' ' ' VAL . 12.6 mtmt -128.65 146.72 61.28 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.257 -1.143 . . . . 1.74 108.284 179.092 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.569 ' O ' ' CB ' ' A' ' 19' ' ' ASP . 28.9 Cg_endo -66.26 109.89 1.66 Allowed 'Trans proline' 0 C--N 1.303 -1.855 0 C-N-CA 122.487 2.125 . . . . 0.43 110.199 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.677 ' CE1' HG11 ' A' ' 18' ' ' VAL . 47.5 t80 -81.11 70.3 7.91 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.414 0.626 . . . . 1.57 109.602 -179.133 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.605 HG22 ' O ' ' A' ' 36' ' ' THR . 32.9 m -90.91 76.69 6.25 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.439 -0.788 . . . . 0.8 109.816 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.523 ' CA ' HG13 ' A' ' 18' ' ' VAL . 1.6 pp -68.48 141.79 55.5 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.611 -1.255 . . . . 1.13 107.611 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.678 ' O ' ' HB2' ' A' ' 39' ' ' ALA . 14.2 mt-10 -142.21 -160.17 1.06 Allowed 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.82 -1.175 . . . . 1.04 110.995 -178.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.678 ' HB2' ' O ' ' A' ' 38' ' ' GLU . . . 156.35 96.44 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.153 -1.425 . . . . 0.59 107.153 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.686 ' HG ' ' CB ' ' A' ' 87' ' ' ASP . 0.3 OUTLIER -91.4 -176.88 4.68 Favored 'General case' 0 C--N 1.294 -1.82 0 O-C-N 121.546 -0.721 . . . . 0.57 110.371 -177.813 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.654 ' CE1' ' CE2' ' A' ' 86' ' ' TYR . 12.0 p90 175.37 147.74 0.09 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.393 -0.817 . . . . 0.38 109.147 177.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.618 ' O ' ' ND2' ' A' ' 44' ' ' ASN . 0.6 OUTLIER -98.72 112.41 24.49 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.441 -0.948 . . . . 4.36 108.441 179.747 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.791 ' HB1' ' O ' ' A' ' 81' ' ' VAL . . . -36.78 125.32 0.88 Allowed 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 115.932 -0.576 . . . . 0.45 110.245 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.618 ' ND2' ' O ' ' A' ' 42' ' ' ASP . 2.0 m120 -125.77 38.98 4.05 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.23 -0.919 . . . . 1.09 109.417 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.829 ' CD ' HD21 ' A' ' 117' ' ' LEU . 3.4 pt20 -128.1 -129.72 0.22 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.417 -0.802 . . . . 0.87 110.327 -178.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.701 ' C ' HG22 ' A' ' 81' ' ' VAL . 0.8 OUTLIER -169.78 54.61 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.644 -0.873 . . . . 4.96 108.644 179.469 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.643 ' N ' HG22 ' A' ' 81' ' ' VAL . 10.1 t -133.68 138.21 45.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.809 -1.182 . . . . 0.88 110.57 -178.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.659 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 0.6 OUTLIER -83.91 -11.55 56.74 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 120.897 -1.127 . . . . 2.59 108.251 177.625 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.429 ' O ' ' O ' ' A' ' 78' ' ' CYS . 2.6 p -95.67 -155.87 0.49 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.394 -0.816 . . . . 1.02 109.449 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.828 ' CB ' ' HB3' ' A' ' 72' ' ' ALA . . . 177.64 154.14 0.29 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.389 -0.819 . . . . 0.41 109.963 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.876 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 19.9 mtpt -115.92 -175.38 2.72 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 106.385 -1.709 . . . . 1.53 106.385 177.209 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.642 HG13 HD13 ' A' ' 54' ' ' ILE . 3.1 tt -164.87 158.67 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 C-N-CA 117.692 -1.603 . . . . 0.89 111.343 -179.08 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.473 ' C ' ' HE2' ' A' ' 55' ' ' LYS . 0.8 OUTLIER -157.89 48.79 0.4 Allowed 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.35 -0.982 . . . . 1.61 108.35 179.845 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 1.007 ' HB ' HG21 ' A' ' 65' ' ' VAL . 0.4 OUTLIER -83.02 155.48 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.665 -0.647 . . . . 0.47 109.492 -179.533 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.661 ' HG3' ' O ' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -170.79 100.69 0.23 Allowed 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.109 -0.7 . . . . 1.59 109.109 178.577 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.518 ' O ' ' HB ' ' A' ' 63' ' ' ILE . . . -126.66 124.04 38.95 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.363 -0.836 . . . . 0.5 110.02 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -108.76 128.28 54.74 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.187 -0.946 . . . . 1.92 109.241 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.851 HD13 ' N ' ' A' ' 59' ' ' ASP . 1.8 tm? -122.94 154.64 38.11 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.132 -0.98 . . . . 1.67 109.078 -179.264 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.851 ' N ' HD13 ' A' ' 58' ' ' LEU . 0.4 OUTLIER -47.27 -59.31 3.26 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.262 -0.899 . . . . 4.07 110.262 -179.205 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -104.07 24.02 30.48 Favored Glycine 0 N--CA 1.493 2.444 0 C-N-CA 119.731 -1.223 . . . . 1.39 110.46 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.439 ' O ' ' HB3' ' A' ' 58' ' ' LEU . 0.5 OUTLIER -164.51 87.69 0.48 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.024 -1.28 . . . . 3.02 109.327 179.666 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.426 ' O ' ' C ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -79.09 70.88 5.52 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.732 -0.605 . . . . 2.85 110.301 -179.666 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.518 ' HB ' ' O ' ' A' ' 56' ' ' ALA . 6.0 mt -48.1 160.62 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 107.115 -1.439 . . . . 0.56 107.115 178.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.421 ' C ' ' HD3' ' A' ' 66' ' ' PRO . 23.3 t0 -170.4 142.77 2.2 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.867 -1.146 . . . . 2.69 109.215 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 1.007 HG21 ' HB ' ' A' ' 54' ' ' ILE . 11.7 t -132.82 69.42 79.24 Favored Pre-proline 0 C--N 1.298 -1.647 0 O-C-N 121.353 -0.842 . . . . 0.7 109.223 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.421 ' HD3' ' C ' ' A' ' 64' ' ' ASP . 34.8 Cg_endo -76.37 -2.08 12.23 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 122.994 2.462 . . . . 1.0 110.625 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 136.44 42.22 0.11 Allowed Glycine 0 N--CA 1.489 2.199 0 C-N-CA 119.864 -1.16 . . . . 1.06 110.308 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.466 HD13 ' HA ' ' A' ' 68' ' ' ILE . 35.4 mm -52.92 -77.32 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 O-C-N 120.964 -1.315 . . . . 1.46 108.875 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -87.77 160.13 18.17 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.062 -1.024 . . . . 4.6 108.866 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.432 ' O ' ' CG ' ' A' ' 71' ' ' ASN . 13.8 t -78.51 -12.23 60.0 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.242 -0.911 . . . . 5.22 109.968 -179.287 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.58 ' CA ' ' O ' ' A' ' 50' ' ' ALA . 47.8 m-20 -164.31 77.0 0.34 Allowed 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 118.661 -1.216 . . . . 2.93 112.324 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.876 ' HB2' ' O ' ' A' ' 51' ' ' LYS . . . 22.34 46.01 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 121.492 0.663 . . . . 0.88 112.032 175.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.543 ' N ' ' O ' ' A' ' 71' ' ' ASN . 6.1 t -106.6 -42.12 5.07 Favored 'General case' 0 C--N 1.285 -2.219 0 O-C-N 121.346 -0.846 . . . . 0.95 110.531 -178.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 4.6 m170 -78.46 -1.2 32.52 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.993 -1.067 . . . . 3.94 109.79 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.518 ' HB3' HD11 ' A' ' 88' ' ' ILE . 57.9 m-85 -110.47 -14.7 14.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.233 -0.917 . . . . 0.45 109.898 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.82 ' HB ' ' CE1' ' A' ' 86' ' ' TYR . 0.2 OUTLIER -157.39 175.28 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 120.81 -1.181 . . . . 0.43 110.731 -177.316 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.647 ' N ' ' CG2' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -57.73 93.3 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 105.373 -2.084 . . . . 1.67 105.373 176.758 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 78' ' ' CYS . . . . . 0.553 ' HB2' ' HD3' ' A' ' 79' ' ' PRO . 2.7 m -34.57 -51.51 1.03 Allowed Pre-proline 0 N--CA 1.5 2.033 0 O-C-N 121.628 -0.67 . . . . 1.04 112.021 -176.011 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.659 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 32.1 Cg_endo -79.1 108.79 2.43 Favored 'Trans proline' 0 C--N 1.303 -1.842 0 N-CA-C 109.401 -1.038 . . . . 0.46 109.401 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.883 HD12 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -92.26 -65.47 1.0 Allowed 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.518 -1.29 . . . . 0.46 107.518 -179.86 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.791 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 14.0 t 54.84 -178.26 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 C-N-CA 119.29 -0.964 . . . . 2.89 109.134 177.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.569 ' N ' HG12 ' A' ' 81' ' ' VAL . 13.0 ptmt -102.2 37.01 1.96 Allowed 'General case' 0 C--N 1.296 -1.759 0 O-C-N 120.467 -1.395 . . . . 1.52 110.206 -178.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -145.65 37.22 1.29 Allowed Glycine 0 C--N 1.288 -2.105 0 N-CA-C 108.664 -1.774 . . . . 1.05 108.664 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -146.58 142.62 28.17 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 121.23 -1.159 . . . . 3.1 110.627 -178.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.457 ' O ' ' CG ' ' A' ' 85' ' ' GLN . 11.2 pt20 -115.88 130.69 56.94 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 105.977 -1.86 . . . . 2.56 105.977 177.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.82 ' CE1' ' HB ' ' A' ' 76' ' ' VAL . 0.1 OUTLIER -152.71 156.91 40.08 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 117.74 -1.584 . . . . 0.36 109.968 -177.641 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.686 ' CB ' ' HG ' ' A' ' 40' ' ' LEU . 7.2 p-10 -127.89 96.95 4.65 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 113.915 1.08 . . . . 0.36 113.915 -175.234 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.579 HG23 ' N ' ' A' ' 89' ' ' LYS . 6.2 tp -62.99 -163.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 N-CA-C 106.362 -1.718 . . . . 1.06 106.362 175.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.587 ' O ' ' CG ' ' A' ' 90' ' ' TYR . 1.0 OUTLIER 161.83 179.49 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.718 -1.239 . . . . 2.25 111.519 179.74 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.674 ' CZ ' HG21 ' A' ' 54' ' ' ILE . 62.9 m-85 -162.81 61.14 0.2 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 107.027 -1.472 . . . . 0.55 107.027 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.564 ' HA ' HG23 ' A' ' 36' ' ' THR . 7.1 p -43.36 178.05 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.132 0 CA-C-O 121.402 0.62 . . . . 1.19 111.382 -178.332 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.704 ' CZ2' ' HB2' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -173.82 116.35 0.24 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 118.71 -1.196 . . . . 3.44 112.516 -179.345 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -84.31 126.81 33.54 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 105.729 -1.952 . . . . 2.12 105.729 176.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.805 HG13 HD12 ' A' ' 97' ' ' ILE . 1.7 t -112.42 102.78 54.81 Favored Pre-proline 0 C--N 1.302 -1.481 0 O-C-N 120.626 -1.297 . . . . 0.88 113.033 -176.248 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.993 ' HD2' HD11 ' A' ' 97' ' ' ILE . 31.8 Cg_endo -79.04 44.2 1.64 Allowed 'Trans proline' 0 C--N 1.314 -1.255 0 C-N-CA 123.088 2.525 . . . . 2.3 110.905 176.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.539 ' O ' ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER 82.32 -70.03 0.06 Allowed 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 107.458 -1.312 . . . . 3.52 107.458 -178.48 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.993 HD11 ' HD2' ' A' ' 95' ' ' PRO . 2.7 mp 69.16 17.95 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 112.745 0.646 . . . . 0.98 112.745 176.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 1.059 ' HB1' ' HD2' ' A' ' 99' ' ' PRO . . . 49.06 177.65 0.01 OUTLIER Pre-proline 0 C--N 1.304 -1.377 0 O-C-N 120.774 -1.204 . . . . 0.58 110.477 178.451 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 1.059 ' HD2' ' HB1' ' A' ' 98' ' ' ALA . 50.8 Cg_endo -85.17 165.09 11.25 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 123.746 2.964 . . . . 0.67 110.044 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.634 ' HD3' ' CB ' ' A' ' 128' ' ' ARG . 3.8 mmmm 43.04 115.69 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 113.23 0.826 . . . . 2.06 113.23 175.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.836 ' CB ' HD13 ' A' ' 127' ' ' ILE . 10.1 t -92.31 161.61 14.62 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.961 -1.087 . . . . 0.4 108.242 177.373 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.473 ' O ' ' CB ' ' A' ' 103' ' ' ASN . 0.3 OUTLIER -61.93 -10.4 9.47 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.05 -1.031 . . . . 4.04 110.055 -179.77 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.501 ' N ' ' OD1' ' A' ' 103' ' ' ASN . 1.1 p30 167.27 158.63 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.058 -1.026 . . . . 4.69 109.569 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.573 ' O ' HG23 ' A' ' 105' ' ' VAL . 0.1 OUTLIER -158.65 -178.48 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.107 -0.995 . . . . 0.76 109.677 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 104' ' ' VAL . 0.9 OUTLIER 159.79 123.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 108.561 -0.903 . . . . 0.35 108.561 -179.758 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.649 ' HB ' ' HB3' ' A' ' 122' ' ' ALA . 2.4 t -118.99 144.6 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 120.883 -1.136 . . . . 0.56 110.197 -179.27 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.474 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -159.16 175.67 13.17 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.263 -1.014 . . . . 0.65 108.263 179.789 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.877 HG22 ' CD1' ' A' ' 54' ' ' ILE . 1.1 t 171.33 169.0 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 120.721 -1.237 . . . . 0.83 110.528 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.655 ' N ' HG13 ' A' ' 108' ' ' VAL . 11.2 ttpt 164.28 121.91 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.634 0.73 . . . . 0.81 109.091 178.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.732 HD11 ' HB1' ' A' ' 72' ' ' ALA . 7.7 tp -108.92 125.44 52.02 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.585 -1.265 . . . . 0.75 107.585 178.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.53 ' HB ' ' HB2' ' A' ' 51' ' ' LYS . 4.0 mt -130.31 114.7 29.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.162 -0.961 . . . . 0.92 110.71 -178.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.461 ' HA3' HG21 ' A' ' 47' ' ' THR . . . -70.84 -116.18 0.04 OUTLIER Glycine 0 N--CA 1.485 1.947 0 N-CA-C 107.75 -2.14 . . . . 0.37 107.75 177.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -135.07 -0.56 2.75 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.023 -1.281 . . . . 2.43 107.546 178.189 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -109.85 -24.81 10.65 Favored 'General case' 0 C--N 1.312 -1.057 0 O-C-N 121.35 -0.844 . . . . 0.96 109.428 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -179.85 176.72 47.69 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.401 -1.479 . . . . 1.26 109.401 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.48 ' HA ' ' HA ' ' A' ' 111' ' ' ILE . 0.9 OUTLIER -81.38 106.61 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.195 -1.18 . . . . 0.5 109.834 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.883 HD22 HD12 ' A' ' 80' ' ' LEU . 4.0 mt -52.3 -54.61 29.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.419 -0.801 . . . . 0.44 110.543 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.595 ' HA ' ' HB2' ' A' ' 9' ' ' ALA . . . -140.63 -170.9 3.11 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.061 -1.024 . . . . 0.44 110.847 -178.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 0.531 ' SG ' ' N ' ' A' ' 120' ' ' ALA . 0.0 OUTLIER 175.5 159.61 0.24 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.578 -0.701 . . . . 0.48 109.563 -179.652 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.531 ' N ' ' SG ' ' A' ' 119' ' ' CYS . . . -176.91 126.96 0.16 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.274 -0.891 . . . . 0.64 109.055 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.586 HG22 ' H ' ' A' ' 123' ' ' THR . 6.4 mt -129.37 132.24 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.175 -0.953 . . . . 0.74 109.902 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.649 ' HB3' ' HB ' ' A' ' 106' ' ' VAL . . . -115.8 20.89 14.28 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.156 -0.965 . . . . 1.43 108.759 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.586 ' H ' HG22 ' A' ' 121' ' ' ILE . 82.5 p 47.02 -160.7 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.413 -0.804 . . . . 3.69 109.272 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' HIS . . . . . 0.574 ' CE1' ' HB3' ' A' ' 26' ' ' PRO . 42.2 p-80 -71.06 160.09 33.53 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.223 -0.923 . . . . 4.29 109.115 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.49 ' HA2' ' O ' ' A' ' 27' ' ' CYS . . . -120.24 -169.76 14.1 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.621 -1.392 . . . . 1.79 109.621 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.414 ' O ' ' C ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER 178.41 74.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.285 -1.127 . . . . 1.48 109.574 179.736 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.836 HD13 ' CB ' ' A' ' 101' ' ' SER . 2.5 mp -39.41 157.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.6 -0.688 . . . . 0.47 110.463 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.662 ' CB ' ' O ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER 132.97 -87.19 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.142 0 CA-C-O 121.357 0.599 . . . . 2.82 109.956 178.476 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.511 ' OD2' ' NE2' ' A' ' 30' ' ' HIS . 1.7 t0 . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 118.112 -0.946 . . . . 4.27 109.693 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.501 0.667 . . . . 3.2 109.574 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.572 ' HA ' ' CG ' ' A' ' 17' ' ' MET . 12.2 pt20 -133.92 41.89 2.97 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.498 -0.751 . . . . 3.33 108.984 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.56 HG23 HG23 ' A' ' 18' ' ' VAL . 2.0 m -45.86 120.89 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 108.16 -1.052 . . . . 3.03 108.16 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.473 ' C ' ' HA3' ' A' ' 23' ' ' GLY . 71.3 m-20 -94.41 127.84 40.56 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.379 -0.826 . . . . 5.39 110.913 -178.306 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.643 HG13 ' HA2' ' A' ' 23' ' ' GLY . 0.1 OUTLIER -95.72 -170.67 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.013 -1.106 . . . . 1.5 108.013 178.655 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.81 94.62 9.19 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.83 -1.169 . . . . 2.14 109.153 179.306 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.479 ' HA ' ' O ' ' A' ' 119' ' ' CYS . 1.6 m-20 -99.07 174.35 6.38 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.537 -0.727 . . . . 4.44 109.286 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.514 ' N ' ' SG ' ' A' ' 119' ' ' CYS . 31.6 p -163.62 49.14 0.14 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.238 -0.913 . . . . 2.23 109.725 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.571 ' O ' ' ND2' ' A' ' 10' ' ' ASN . . . -83.3 -66.33 0.9 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.112 -0.993 . . . . 0.61 109.859 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.571 ' ND2' ' O ' ' A' ' 9' ' ' ALA . 0.4 OUTLIER 164.34 42.33 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.46 -0.896 . . . . 1.65 109.788 -178.779 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.2 m120 49.88 23.93 1.18 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.937 -1.102 . . . . 3.04 108.042 -179.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 13' ' ' ILE . 0.0 OUTLIER -105.76 -28.54 10.62 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.574 -0.704 . . . . 3.38 109.234 -179.764 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 1.038 HG23 ' O ' ' A' ' 40' ' ' LEU . 11.9 mt -41.81 143.7 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 109.077 -0.712 . . . . 0.6 109.077 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -105.02 -19.2 13.91 Favored 'General case' 0 C--N 1.295 -1.767 0 O-C-N 121.402 -0.811 . . . . 3.89 108.998 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.403 ' H ' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -160.35 104.98 1.46 Allowed 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 119.031 -1.067 . . . . 2.74 110.363 -177.985 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.546 ' O ' HG13 ' A' ' 16' ' ' VAL . 2.6 p -120.87 95.82 3.81 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 107.075 -1.454 . . . . 1.48 107.075 178.418 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.572 ' CG ' ' HA ' ' A' ' 2' ' ' GLN . 2.3 mpt? -144.7 145.57 31.78 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.63 -0.669 . . . . 2.24 109.751 -178.227 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.992 HG13 ' HA ' ' A' ' 37' ' ' LEU . 1.7 t -110.93 120.36 61.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 108.255 -1.017 . . . . 0.61 108.255 179.058 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -41.93 -26.1 0.08 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.39 -0.819 . . . . 2.76 109.714 -179.44 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -158.1 -148.42 5.14 Favored Glycine 0 N--CA 1.488 2.116 0 C-N-CA 119.615 -1.279 . . . . 2.0 109.964 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.634 ' HA ' ' HA ' ' A' ' 29' ' ' ILE . 50.4 t 65.15 -111.47 0.24 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.629 -0.924 . . . . 2.27 109.664 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.572 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 0.3 OUTLIER 155.2 139.7 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 106.621 -1.622 . . . . 2.26 106.621 -178.723 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.643 ' HA2' HG13 ' A' ' 5' ' ' VAL . . . -107.99 157.59 15.29 Favored Glycine 0 C--N 1.288 -2.119 0 N-CA-C 109.409 -1.477 . . . . 1.51 109.409 -179.399 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.457 ' O ' ' CB ' ' A' ' 25' ' ' ASP . 0.2 OUTLIER 66.61 137.2 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.216 -1.167 . . . . 2.86 108.279 -179.163 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.558 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.2 OUTLIER 66.48 177.29 0.05 OUTLIER Pre-proline 0 C--N 1.304 -1.385 0 O-C-N 120.455 -1.403 . . . . 5.52 107.998 -179.815 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.558 ' HD2' ' CB ' ' A' ' 25' ' ' ASP . 30.7 Cg_endo -74.8 123.67 8.15 Favored 'Trans proline' 0 C--N 1.299 -2.055 0 C-N-CA 122.747 2.298 . . . . 2.11 109.397 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.572 ' HB2' ' O ' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -97.08 113.94 25.55 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.291 -0.881 . . . . 1.44 111.491 -177.819 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.637 HD13 ' HG3' ' A' ' 126' ' ' LYS . 20.1 mm -86.77 83.72 2.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 107.147 -1.427 . . . . 1.97 107.147 176.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.634 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -50.08 -177.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 O-C-N 121.699 -0.626 . . . . 2.02 109.977 -179.138 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 79.5 m-70 -134.2 160.44 37.84 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.507 -0.877 . . . . 1.3 110.659 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.586 ' HD3' ' CA ' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -108.83 113.02 25.6 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.528 -0.732 . . . . 1.74 109.399 179.626 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 134.42 0.2 3.75 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 110.206 -1.158 . . . . 0.8 110.206 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.579 ' O ' HG21 ' A' ' 94' ' ' VAL . 13.3 mttt -130.23 144.43 53.17 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 120.93 -1.335 . . . . 1.46 110.184 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -69.41 81.08 0.75 Allowed 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 123.166 2.577 . . . . 0.81 111.19 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.728 ' H ' HG21 ' A' ' 94' ' ' VAL . 5.2 t80 -55.42 122.13 10.52 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 109.433 -0.581 . . . . 2.37 109.433 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 37.5 m -134.04 85.44 2.2 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.075 -1.015 . . . . 1.5 109.571 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.992 ' HA ' HG13 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -62.66 141.38 58.55 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.235 -0.915 . . . . 1.94 108.891 179.746 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.963 ' N ' HD12 ' A' ' 37' ' ' LEU . 87.2 mt-10 -139.17 -171.23 3.06 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.147 -0.971 . . . . 2.21 110.06 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.703 ' HB2' ' O ' ' A' ' 38' ' ' GLU . . . 155.13 70.7 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.906 -1.146 . . . . 1.36 107.906 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 1.038 ' O ' HG23 ' A' ' 13' ' ' ILE . 0.8 OUTLIER -71.98 171.73 11.3 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 115.912 -0.585 . . . . 0.5 110.162 -178.841 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.746 ' HZ ' ' HH ' ' A' ' 86' ' ' TYR . 5.5 p90 -176.01 148.39 0.82 Allowed 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.583 -0.895 . . . . 0.37 108.583 179.108 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.509 ' O ' ' C ' ' A' ' 43' ' ' ALA . 6.7 t70 -95.28 112.19 23.94 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 107.286 -1.375 . . . . 2.09 107.286 178.501 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.699 ' HB1' ' O ' ' A' ' 81' ' ' VAL . . . -36.1 125.53 0.76 Allowed 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 115.61 -0.723 . . . . 0.66 109.1 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -124.04 15.02 9.19 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.171 -0.956 . . . . 4.08 110.33 -177.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.959 ' OE1' HD21 ' A' ' 117' ' ' LEU . 2.3 pt20 -105.56 -139.41 0.37 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.379 -0.971 . . . . 0.31 108.379 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.794 ' HA ' ' HB ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -156.73 67.98 0.57 Allowed 'General case' 0 C--N 1.294 -1.845 0 O-C-N 121.08 -1.013 . . . . 1.1 109.306 178.59 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.753 HG23 ' O ' ' A' ' 47' ' ' THR . 10.3 t -146.33 118.47 8.31 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.263 -1.523 . . . . 0.52 111.607 -178.11 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.611 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 0.6 OUTLIER -66.4 -10.6 45.3 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.66 -1.275 . . . . 2.37 107.847 177.262 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.482 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 30.5 p -98.44 -161.3 0.86 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.335 -0.853 . . . . 0.77 108.807 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.912 ' CB ' ' HB3' ' A' ' 72' ' ' ALA . . . 174.67 160.4 0.19 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.168 -0.958 . . . . 0.3 109.863 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 1.011 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 20.3 mtmt -123.14 169.04 11.64 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 107.227 -1.398 . . . . 0.98 107.227 177.303 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.572 HD13 ' CD1' ' A' ' 75' ' ' PHE . 11.1 tt -148.19 144.74 18.89 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.239 0 C-N-CA 118.413 -1.315 . . . . 0.55 110.558 -178.215 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.456 ' O ' ' CE ' ' A' ' 55' ' ' LYS . 6.1 mt-10 -139.84 56.42 1.64 Allowed 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 107.101 -1.444 . . . . 1.67 107.101 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.948 ' HB ' HG21 ' A' ' 65' ' ' VAL . 0.3 OUTLIER -87.62 151.91 3.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 O-C-N 121.312 -0.867 . . . . 1.13 110.096 -178.392 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.686 ' HG3' ' O ' ' A' ' 54' ' ' ILE . 0.1 OUTLIER -166.51 95.22 0.54 Allowed 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 109.053 -0.721 . . . . 1.02 109.053 178.305 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.726 ' HB3' ' HB ' ' A' ' 63' ' ' ILE . . . -118.78 138.66 52.53 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.394 -0.816 . . . . 0.54 109.563 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.455 ' O ' ' CG1' ' A' ' 104' ' ' VAL . 1.6 t -124.4 124.8 43.14 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.925 -1.109 . . . . 1.11 110.125 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 1.011 HD13 ' N ' ' A' ' 59' ' ' ASP . 2.6 tm? -117.85 152.86 34.52 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.255 -1.017 . . . . 1.46 108.255 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 1.011 ' N ' HD13 ' A' ' 58' ' ' LEU . 5.4 t0 -43.61 -66.06 0.42 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.061 -1.025 . . . . 2.17 109.938 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.496 ' O ' HD12 ' A' ' 61' ' ' LEU . . . -101.09 20.18 48.63 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.058 -1.217 . . . . 0.75 110.058 -179.462 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.496 HD12 ' O ' ' A' ' 60' ' ' GLY . 1.9 tp -152.69 79.13 1.21 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.141 -1.211 . . . . 2.46 108.935 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.445 ' O ' ' C ' ' A' ' 63' ' ' ILE . 0.5 OUTLIER -74.9 76.05 2.15 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 116.203 -0.453 . . . . 3.91 110.869 -179.19 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.726 ' HB ' ' HB3' ' A' ' 56' ' ' ALA . 3.2 mt -49.08 162.81 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 106.54 -1.652 . . . . 0.58 106.54 178.167 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -176.02 147.43 0.75 Allowed 'General case' 0 C--N 1.297 -1.707 0 O-C-N 120.424 -1.423 . . . . 0.9 109.004 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.948 HG21 ' HB ' ' A' ' 54' ' ' ILE . 17.1 t -140.77 62.28 17.27 Favored Pre-proline 0 C--N 1.299 -1.598 0 C-N-CA 119.279 -0.969 . . . . 1.21 110.215 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.562 ' HD3' ' N ' ' A' ' 65' ' ' VAL . 36.2 Cg_endo -78.32 -5.05 14.76 Favored 'Trans proline' 0 C--N 1.301 -1.964 0 C-N-CA 122.82 2.347 . . . . 1.27 109.094 178.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 68' ' ' ILE . . . -177.62 -110.25 0.27 Allowed Glycine 0 N--CA 1.487 2.073 0 N-CA-C 108.14 -1.984 . . . . 1.94 108.14 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.45 ' C ' ' O ' ' A' ' 67' ' ' GLY . 0.0 OUTLIER 39.97 85.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.421 -1.046 . . . . 2.42 109.779 179.103 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 46.28 80.38 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.003 -1.061 . . . . 5.99 108.856 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.37 50.17 1.95 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.361 -0.837 . . . . 7.87 109.467 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.529 ' CA ' ' O ' ' A' ' 50' ' ' ALA . 8.6 m-20 -136.86 38.04 2.6 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.195 -0.941 . . . . 1.97 109.935 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 1.011 ' HB2' ' O ' ' A' ' 51' ' ' LYS . . . 37.92 29.18 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 121.419 0.628 . . . . 0.94 110.466 177.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.499 ' N ' ' O ' ' A' ' 71' ' ' ASN . 9.8 t -105.2 -52.29 2.87 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.455 -0.778 . . . . 0.96 110.003 -179.329 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -67.27 -16.91 64.56 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.957 -1.089 . . . . 1.05 109.706 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.655 ' C ' HG12 ' A' ' 76' ' ' VAL . 91.7 m-85 -101.05 -9.14 21.69 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.173 -0.954 . . . . 0.95 110.169 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.789 ' HB ' ' CE1' ' A' ' 86' ' ' TYR . 0.2 OUTLIER -165.66 173.98 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 120.591 -1.318 . . . . 0.55 111.366 -177.298 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.64 ' N ' ' CG2' ' A' ' 76' ' ' VAL . 2.5 mmmt -56.23 92.3 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.119 -1.437 . . . . 1.54 107.119 177.571 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' CYS . . . . . 0.509 ' N ' ' O ' ' A' ' 76' ' ' VAL . 0.4 OUTLIER -35.22 -52.53 1.22 Allowed Pre-proline 0 N--CA 1.502 2.15 0 CA-C-N 116.323 -0.399 . . . . 0.97 110.955 -177.596 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.611 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 31.2 Cg_endo -76.59 109.52 2.88 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 121.115 1.21 . . . . 0.64 109.269 179.35 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 1.092 HD22 HD22 ' A' ' 117' ' ' LEU . 0.5 OUTLIER -103.15 -63.51 1.17 Allowed 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 121.41 0.624 . . . . 2.55 109.399 -178.519 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.794 ' HB ' ' HA ' ' A' ' 46' ' ' ASN . 1.3 m 40.18 -167.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 C-N-CA 120.56 -0.456 . . . . 0.52 109.884 178.274 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.711 ' H ' HG23 ' A' ' 81' ' ' VAL . 1.0 OUTLIER -104.38 41.96 1.25 Allowed 'General case' 0 C--N 1.289 -2.054 0 O-C-N 120.39 -1.444 . . . . 2.7 110.411 -176.848 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -146.65 35.88 1.28 Allowed Glycine 0 C--N 1.287 -2.19 0 N-CA-C 108.583 -1.807 . . . . 0.85 108.583 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.404 HE21 ' HB2' ' A' ' 84' ' ' GLN . 0.7 OUTLIER -150.0 140.1 22.08 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 121.237 -1.155 . . . . 3.09 110.578 -179.046 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.504 ' HG2' ' HB2' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -112.42 129.31 56.36 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 105.566 -2.013 . . . . 2.42 105.566 177.048 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.789 ' CE1' ' HB ' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -151.21 160.94 43.55 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 117.525 -1.67 . . . . 0.51 110.124 -177.371 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.636 ' CB ' ' HG ' ' A' ' 40' ' ' LEU . 1.8 m-20 -129.03 99.5 5.29 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.948 -1.095 . . . . 4.08 113.456 -175.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.638 HG23 ' N ' ' A' ' 89' ' ' LYS . 3.8 tp -66.78 -163.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 106.839 -1.541 . . . . 1.14 106.839 176.158 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.638 ' N ' HG23 ' A' ' 88' ' ' ILE . 10.4 mttt 161.39 175.4 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.271 0 O-C-N 120.927 -1.108 . . . . 1.26 111.071 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.592 ' CG ' ' O ' ' A' ' 89' ' ' LYS . 41.9 m-85 -165.37 103.11 0.73 Allowed 'General case' 0 N--CA 1.504 2.269 0 N-CA-C 108.154 -1.054 . . . . 0.75 108.154 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.415 HG22 ' H ' ' A' ' 92' ' ' TRP . 0.2 OUTLIER -96.03 179.18 5.16 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.282 -0.887 . . . . 3.11 111.467 -177.976 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.828 ' O ' HG23 ' A' ' 94' ' ' VAL . 1.7 t90 -167.62 101.57 0.49 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.759 -0.588 . . . . 4.35 109.472 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.507 ' O ' ' CD1' ' A' ' 92' ' ' TRP . 49.4 t-20 -47.47 123.33 5.58 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 106.842 -1.54 . . . . 1.79 106.842 178.224 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.874 HG13 ' CD1' ' A' ' 97' ' ' ILE . 58.2 t -116.21 90.5 29.28 Favored Pre-proline 0 C--N 1.3 -1.547 0 C-N-CA 118.568 -1.253 . . . . 1.39 111.934 -177.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.709 ' HD2' HD11 ' A' ' 97' ' ' ILE . 33.7 Cg_endo -83.07 58.65 6.38 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 123.423 2.749 . . . . 2.72 109.809 178.019 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.729 ' C ' HD12 ' A' ' 97' ' ' ILE . 0.1 OUTLIER 71.04 -80.37 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.386 -1.339 . . . . 3.05 107.386 -177.843 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.874 ' CD1' HG13 ' A' ' 94' ' ' VAL . 2.6 mp 76.44 34.58 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.638 -0.664 . . . . 1.04 112.24 177.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.959 ' HB1' ' HD2' ' A' ' 99' ' ' PRO . . . 53.32 171.4 0.04 OUTLIER Pre-proline 0 C--N 1.3 -1.578 0 O-C-N 120.98 -1.075 . . . . 0.45 110.991 178.173 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.959 ' HD2' ' HB1' ' A' ' 98' ' ' ALA . 61.4 Cg_endo -87.45 83.91 0.92 Allowed 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 123.951 3.101 . . . . 1.7 110.487 -178.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.728 ' CB ' ' O ' ' A' ' 99' ' ' PRO . 0.1 OUTLIER 116.25 121.14 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 118.896 0.771 . . . . 2.0 111.02 178.279 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.455 ' O ' ' N ' ' A' ' 103' ' ' ASN . 1.9 p -92.29 148.7 21.93 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.754 -1.202 . . . . 2.11 107.754 177.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 101' ' ' SER . 0.0 OUTLIER -42.58 -26.47 0.12 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.947 -1.096 . . . . 4.38 109.727 -179.231 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.478 ' C ' ' CG2' ' A' ' 104' ' ' VAL . 1.4 t-20 171.23 160.22 0.08 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.317 -0.864 . . . . 2.22 109.246 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.478 ' CG2' ' C ' ' A' ' 103' ' ' ASN . 0.1 OUTLIER -155.99 140.38 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.157 -0.964 . . . . 1.05 109.64 179.942 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -143.09 134.37 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.352 -0.843 . . . . 0.96 109.179 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.85 ' HB ' ' HB3' ' A' ' 122' ' ' ALA . 49.5 t -126.04 125.03 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.033 -1.042 . . . . 0.58 109.775 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.529 ' O ' HG22 ' A' ' 108' ' ' VAL . 74.6 m -147.18 136.11 22.26 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.881 -1.155 . . . . 1.08 107.881 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.637 HG12 ' CD1' ' A' ' 54' ' ' ILE . 0.3 OUTLIER -157.19 162.18 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 120.419 -1.426 . . . . 2.18 110.881 -179.284 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.558 ' HA ' ' HA ' ' A' ' 119' ' ' CYS . 2.4 tttt 175.19 118.6 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.726 0.774 . . . . 3.03 110.215 178.004 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.605 ' HB3' ' HB2' ' A' ' 117' ' ' LEU . 4.6 tp -92.89 122.26 35.09 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.367 -1.346 . . . . 0.97 107.367 178.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.526 ' HB ' ' HB2' ' A' ' 51' ' ' LYS . 5.7 mt -122.12 114.99 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.766 -1.209 . . . . 0.49 111.932 -177.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -80.01 -127.58 0.67 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 107.91 -2.076 . . . . 1.07 107.91 177.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -135.2 -2.97 2.48 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.878 -1.366 . . . . 2.67 107.881 178.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.401 ' CG ' ' ND2' ' A' ' 46' ' ' ASN . 1.2 m-80 -115.03 -7.54 12.51 Favored 'General case' 0 C--N 1.313 -0.991 0 O-C-N 121.24 -0.913 . . . . 1.3 110.082 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 163.91 139.85 2.73 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 110.015 -1.234 . . . . 2.12 110.015 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.529 ' CG2' ' HE3' ' A' ' 109' ' ' LYS . 0.1 OUTLIER -52.29 119.42 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.36 -1.082 . . . . 0.9 109.823 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 1.092 HD22 HD22 ' A' ' 80' ' ' LEU . 1.7 mt -62.73 -59.98 4.13 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.274 -0.891 . . . . 0.55 109.329 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.553 ' HA ' ' HA ' ' A' ' 9' ' ' ALA . . . -158.23 -173.02 4.12 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.54 -0.725 . . . . 0.96 109.274 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 0.558 ' HA ' ' HA ' ' A' ' 109' ' ' LYS . 13.5 p 176.96 170.16 0.52 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.343 -0.848 . . . . 1.11 109.422 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -164.21 131.45 3.26 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.495 -0.753 . . . . 0.5 109.057 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.489 ' O ' HG12 ' A' ' 5' ' ' VAL . 2.7 mp -128.18 142.82 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.089 -1.007 . . . . 0.68 110.57 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.85 ' HB3' ' HB ' ' A' ' 106' ' ' VAL . . . -138.19 64.41 1.5 Allowed 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.028 -1.101 . . . . 0.8 108.028 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.484 ' O ' ' O ' ' A' ' 124' ' ' HIS . 0.4 OUTLIER -38.74 132.28 1.22 Allowed 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.681 0.753 . . . . 2.39 111.533 -178.472 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 124' ' ' HIS . . . . . 0.484 ' O ' ' O ' ' A' ' 123' ' ' THR . 1.4 m-70 47.74 173.0 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.866 0.841 . . . . 2.81 111.495 178.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 167.49 141.83 3.28 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.39 -1.484 . . . . 0.64 109.39 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.637 ' HG3' HD13 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -147.01 134.11 20.42 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.116 -1.226 . . . . 1.66 109.343 179.683 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.591 ' CD1' HG13 ' A' ' 29' ' ' ILE . 0.8 OUTLIER -79.27 124.1 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.408 -0.808 . . . . 1.67 111.172 -178.306 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.623 ' HB2' ' HG2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER 168.64 -89.78 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.887 -1.133 . . . . 2.26 109.491 177.172 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.608 ' N ' HG21 ' A' ' 28' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 118.013 -0.994 . . . . 3.65 109.212 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.183 -0.673 . . . . 4.3 109.183 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.556 ' HB3' ' CG ' ' A' ' 17' ' ' MET . 1.2 pt20 -100.6 -172.97 2.29 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.063 -1.023 . . . . 2.37 109.508 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 1.0 HG12 ' HA ' ' A' ' 22' ' ' HIS . 5.5 m -128.92 -168.26 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.348 -0.845 . . . . 1.74 109.409 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -130.87 77.8 1.8 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.178 -0.951 . . . . 1.44 109.305 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.8 m -100.6 150.78 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.162 -0.961 . . . . 1.43 109.596 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.507 ' O ' HD12 ' A' ' 121' ' ' ILE . 12.8 mtpp -75.05 93.68 2.77 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.496 -0.752 . . . . 2.31 109.701 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.523 ' HB2' HD12 ' A' ' 13' ' ' ILE . 35.4 p-10 -82.81 176.08 9.59 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.197 -0.939 . . . . 2.3 109.122 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.517 ' N ' ' SG ' ' A' ' 119' ' ' CYS . 7.8 m -138.59 9.09 2.64 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.124 -0.985 . . . . 1.32 109.919 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.668 ' HB2' HG13 ' A' ' 13' ' ' ILE . . . -56.55 -43.99 80.48 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.932 -1.105 . . . . 0.69 109.035 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.51 ' CB ' ' O ' ' A' ' 9' ' ' ALA . 0.5 OUTLIER 163.61 -58.09 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.948 -0.76 . . . . 5.01 108.948 -179.185 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 10' ' ' ASN . 1.9 t-20 174.46 38.0 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.921 -0.77 . . . . 3.63 108.921 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -171.56 -62.71 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.025 -1.047 . . . . 4.65 110.859 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.668 HG13 ' HB2' ' A' ' 9' ' ' ALA . 0.1 OUTLIER 67.76 4.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.122 -0.987 . . . . 3.91 110.155 -179.047 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.548 ' HB2' ' O ' ' A' ' 13' ' ' ILE . 0.0 OUTLIER 75.08 -31.95 0.22 Allowed 'General case' 0 C--N 1.293 -1.876 0 O-C-N 121.386 -0.821 . . . . 2.23 111.036 178.747 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.532 ' CB ' ' O ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER 165.81 109.93 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 118.785 -1.166 . . . . 2.93 110.569 -178.622 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.656 ' O ' HG13 ' A' ' 16' ' ' VAL . 6.8 p -120.07 107.85 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.096 -1.002 . . . . 1.2 108.76 178.611 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.556 ' CG ' ' HB3' ' A' ' 2' ' ' GLN . 0.5 OUTLIER -145.83 146.91 31.33 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.366 -0.934 . . . . 1.43 110.332 -179.605 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.71 HG22 ' HA ' ' A' ' 37' ' ' LEU . 42.1 t -117.62 148.95 20.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 108.255 -1.017 . . . . 1.3 108.255 179.088 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.439 ' HB3' ' HA ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -81.17 71.2 8.14 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.069 -1.086 . . . . 1.0 108.069 179.446 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.542 ' O ' ' CB ' ' A' ' 21' ' ' CYS . . . 108.02 -167.85 13.56 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 109.157 -1.577 . . . . 1.76 109.157 -178.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 1.002 ' CA ' HG23 ' A' ' 29' ' ' ILE . 15.5 t 83.54 -57.71 0.14 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.782 -0.834 . . . . 1.42 109.984 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 1.0 ' HA ' HG12 ' A' ' 3' ' ' VAL . 0.3 OUTLIER 58.14 107.39 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.561 -1.337 . . . . 4.12 109.145 -178.799 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.573 ' O ' ' CB ' ' A' ' 24' ' ' SER . . . -92.54 -143.8 13.18 Favored Glycine 0 N--CA 1.497 2.737 0 O-C-N 121.163 -0.961 . . . . 1.12 111.236 -178.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.573 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 1.0 OUTLIER 86.09 -48.73 0.06 Allowed 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.38 -0.97 . . . . 2.33 108.38 -178.823 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.701 ' CB ' ' CD ' ' A' ' 26' ' ' PRO . 5.2 m-20 -120.11 -149.86 0.01 OUTLIER Pre-proline 0 C--N 1.303 -1.426 0 N-CA-C 105.665 -1.976 . . . . 4.45 105.665 178.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.701 ' CD ' ' CB ' ' A' ' 25' ' ' ASP . 30.9 Cg_endo -74.34 85.69 1.39 Allowed 'Trans proline' 0 C--O 1.208 -1.012 0 N-CA-C 107.169 -1.896 . . . . 0.48 107.169 178.073 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.542 ' HA ' ' O ' ' A' ' 22' ' ' HIS . 4.1 t -34.51 80.17 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 113.697 0.999 . . . . 1.69 113.697 -176.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.762 HG23 ' O ' ' A' ' 126' ' ' LYS . 0.7 OUTLIER -71.68 144.51 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 N-CA-C 106.772 -1.566 . . . . 1.46 106.772 176.343 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 1.002 HG23 ' CA ' ' A' ' 21' ' ' CYS . 0.1 OUTLIER -122.99 -159.9 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 O-C-N 120.371 -1.456 . . . . 0.89 112.706 -176.425 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.481 ' H ' HG22 ' A' ' 29' ' ' ILE . 40.5 m-70 -131.07 166.55 20.82 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.657 0.742 . . . . 1.45 110.418 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.563 ' HD3' ' HA ' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -116.05 -167.15 1.22 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.617 -0.677 . . . . 2.57 109.464 -179.98 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.431 ' HA2' ' O ' ' A' ' 95' ' ' PRO . . . 42.74 27.96 0.6 Allowed Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.692 -0.963 . . . . 0.99 110.692 179.085 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.493 ' O ' HG11 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -151.76 133.87 8.4 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 120.754 -1.439 . . . . 1.55 109.493 179.789 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.423 ' HA ' ' HB ' ' A' ' 94' ' ' VAL . 28.8 Cg_endo -68.26 78.99 0.6 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.601 2.2 . . . . 1.66 111.325 -179.546 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.483 ' CD1' ' C ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -62.05 149.52 40.81 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.281 -1.007 . . . . 3.29 108.281 178.944 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.732 HG23 HG22 ' A' ' 91' ' ' THR . 6.4 m -153.71 95.81 1.93 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.918 -1.114 . . . . 0.75 110.211 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.71 ' HA ' HG22 ' A' ' 18' ' ' VAL . 2.3 pp -61.1 142.28 56.8 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.818 -1.179 . . . . 0.67 107.818 178.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.532 ' HG3' ' CG ' ' A' ' 89' ' ' LYS . 2.0 tt0 -136.04 131.6 35.14 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.995 -1.066 . . . . 3.95 109.882 -179.285 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.526 ' O ' HG22 ' A' ' 88' ' ' ILE . . . -141.28 90.58 2.32 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.765 -1.198 . . . . 0.95 107.765 178.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.618 ' HG ' ' CB ' ' A' ' 87' ' ' ASP . 0.2 OUTLIER -83.07 -176.36 6.29 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 109.236 -0.653 . . . . 1.17 109.236 -178.567 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.596 ' O ' ' CD1' ' A' ' 41' ' ' PHE . 6.2 p90 171.08 133.86 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.361 -1.348 . . . . 1.24 107.361 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.585 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 0.0 OUTLIER -90.13 119.88 30.84 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 107.969 -1.122 . . . . 3.71 107.969 179.86 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.78 ' HB3' ' O ' ' A' ' 84' ' ' GLN . . . -38.79 112.44 0.24 Allowed 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 109.47 -0.567 . . . . 0.42 109.47 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.501 ' CG ' ' O ' ' A' ' 42' ' ' ASP . 2.5 m-80 -122.14 45.75 2.27 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.479 -0.763 . . . . 1.75 109.023 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.638 ' OE1' ' HB2' ' A' ' 80' ' ' LEU . 3.5 pt20 -133.5 -133.12 0.17 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.267 -0.896 . . . . 1.35 110.198 -178.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.685 ' C ' HG22 ' A' ' 81' ' ' VAL . 47.3 t30 -169.89 53.0 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.441 -0.787 . . . . 4.34 109.604 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.712 ' N ' HG22 ' A' ' 81' ' ' VAL . 3.9 t -139.18 138.25 36.77 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.613 -1.304 . . . . 0.88 110.576 -178.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.612 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 1.2 mtmp? -78.84 -0.84 32.23 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.81 -1.181 . . . . 3.06 108.478 177.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.5 p -107.55 165.9 11.07 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.262 -0.899 . . . . 0.82 108.962 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.839 ' CB ' ' HB3' ' A' ' 72' ' ' ALA . . . -144.21 148.21 34.65 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.402 -0.962 . . . . 0.92 108.402 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.898 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 56.6 mttt -118.03 -169.45 1.69 Allowed 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.17 -1.418 . . . . 1.75 107.17 177.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.417 ' HB ' ' O ' ' A' ' 51' ' ' LYS . 5.5 tt -176.4 151.4 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 C-N-CA 118.731 -1.188 . . . . 0.63 110.179 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.49 ' O ' ' NZ ' ' A' ' 55' ' ' LYS . 0.4 OUTLIER -148.45 57.54 1.06 Allowed 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.583 -0.895 . . . . 2.86 108.583 179.916 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.907 ' CD1' HG13 ' A' ' 108' ' ' VAL . 1.6 mm -73.58 160.39 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.486 -0.759 . . . . 2.75 109.675 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.576 ' N ' ' CG2' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -173.14 81.57 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.252 0.548 . . . . 1.14 110.055 178.548 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.475 ' HB3' ' HB ' ' A' ' 63' ' ' ILE . . . -122.16 155.42 35.82 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 108.78 -0.822 . . . . 1.54 108.78 179.113 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.442 ' OG ' ' HA ' ' A' ' 104' ' ' VAL . 0.0 OUTLIER -129.7 136.56 49.83 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.035 -1.041 . . . . 1.23 109.402 -179.609 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.541 ' HG ' ' CE3' ' A' ' 92' ' ' TRP . 0.0 OUTLIER -128.0 164.49 22.23 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.286 -0.884 . . . . 3.89 109.202 -179.506 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.498 ' OD2' ' N ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -39.47 -68.03 0.19 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.38 -0.825 . . . . 4.27 109.617 -179.796 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.624 ' O ' HD22 ' A' ' 61' ' ' LEU . . . -118.81 30.1 6.03 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.146 -1.582 . . . . 0.96 109.146 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.624 HD22 ' O ' ' A' ' 60' ' ' GLY . 0.2 OUTLIER -139.81 61.24 1.54 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.257 -1.143 . . . . 0.9 110.049 -179.578 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.483 ' HG3' ' O ' ' A' ' 62' ' ' GLU . 0.3 OUTLIER -55.69 100.2 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.967 -1.083 . . . . 3.46 108.162 179.348 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.572 HG22 ' O ' ' A' ' 63' ' ' ILE . 2.9 mt -71.8 -2.68 3.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.364 -0.835 . . . . 2.47 111.087 -178.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.507 ' C ' ' O ' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -30.97 137.65 0.04 OUTLIER 'General case' 0 C--N 1.285 -2.213 0 CA-C-O 121.532 0.682 . . . . 2.85 110.009 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.705 HG21 ' HB ' ' A' ' 54' ' ' ILE . 70.1 t -126.01 90.26 50.62 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.396 -0.815 . . . . 1.61 109.755 -178.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.89 -4.53 13.42 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.92 2.413 . . . . 1.41 110.757 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 68' ' ' ILE . . . 167.83 -92.09 0.1 Allowed Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.617 -1.393 . . . . 2.99 109.617 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.482 ' O ' ' O ' ' A' ' 69' ' ' ASP . 1.2 mm 49.95 99.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.216 -1.167 . . . . 3.21 109.791 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.524 ' CG ' ' HB2' ' A' ' 74' ' ' HIS . 13.0 m-20 53.23 104.91 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.337 -0.852 . . . . 5.5 108.91 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -82.32 31.55 0.4 Allowed 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.383 -0.823 . . . . 5.26 111.113 -178.52 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.611 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -154.16 40.16 0.47 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.449 -1.407 . . . . 4.78 111.445 179.79 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.898 ' HB2' ' O ' ' A' ' 51' ' ' LYS . . . 32.27 31.71 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.173 0.511 . . . . 0.55 111.894 176.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.562 ' N ' ' O ' ' A' ' 71' ' ' ASN . 16.6 t -98.0 -21.34 16.87 Favored 'General case' 0 C--N 1.293 -1.857 0 O-C-N 121.142 -0.974 . . . . 0.69 111.256 -178.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.524 ' HB2' ' CG ' ' A' ' 69' ' ' ASP . 11.4 t-160 -71.57 -25.89 62.39 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.898 -1.126 . . . . 2.03 111.434 -178.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.444 ' CD1' ' N ' ' A' ' 75' ' ' PHE . 8.2 m-85 -95.62 -29.47 14.31 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.533 -1.354 . . . . 2.08 111.375 -178.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 1.039 HG21 ' CE2' ' A' ' 86' ' ' TYR . 3.3 m -148.37 -149.46 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.915 -1.116 . . . . 3.06 111.259 -177.497 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.783 ' N ' HG23 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -85.49 105.37 16.05 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.727 -0.842 . . . . 2.69 108.727 179.445 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' CYS . . . . . 0.612 ' N ' ' HD2' ' A' ' 79' ' ' PRO . 0.1 OUTLIER -47.78 -44.62 58.02 Favored Pre-proline 0 N--CA 1.493 1.722 0 C-N-CA 118.277 -1.369 . . . . 0.78 109.066 179.897 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.612 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 28.9 Cg_endo -72.78 104.1 1.69 Allowed 'Trans proline' 0 C--N 1.317 -1.125 0 N-CA-C 108.471 -1.396 . . . . 0.64 108.471 177.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.839 HD13 ' CD1' ' A' ' 117' ' ' LEU . 0.2 OUTLIER -96.31 -64.49 1.05 Allowed 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 108.914 -0.773 . . . . 2.44 108.914 -178.214 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.755 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 24.5 t 53.54 177.68 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 C-N-CA 118.784 -1.166 . . . . 2.95 108.748 177.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.581 ' HA ' ' O ' ' A' ' 43' ' ' ALA . 0.6 OUTLIER -96.52 31.01 2.38 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 120.797 -1.189 . . . . 2.69 109.029 -179.315 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -132.49 27.4 3.56 Favored Glycine 0 C--N 1.289 -2.039 0 N-CA-C 108.14 -1.984 . . . . 0.84 108.14 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.78 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 9.0 tp-100 -142.39 159.55 42.0 Favored 'General case' 0 C--N 1.308 -1.229 0 O-C-N 121.486 -1.008 . . . . 1.26 108.37 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.585 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 2.7 tt0 -154.53 137.28 15.27 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.452 -0.944 . . . . 1.99 108.452 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 1.039 ' CE2' HG21 ' A' ' 76' ' ' VAL . 12.1 p90 -158.55 177.41 11.25 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 117.581 -1.648 . . . . 3.34 111.386 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.618 ' CB ' ' HG ' ' A' ' 40' ' ' LEU . 8.9 p-10 -121.08 89.02 3.05 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 119.664 -0.815 . . . . 1.1 112.49 -177.004 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.846 HD12 ' CG1' ' A' ' 76' ' ' VAL . 0.6 OUTLIER -59.05 -164.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 106.761 -1.57 . . . . 0.91 106.761 176.751 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.819 ' N ' HG23 ' A' ' 88' ' ' ILE . 0.2 OUTLIER 163.15 174.15 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.955 -1.091 . . . . 1.75 110.725 179.286 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.636 ' CE2' ' CD1' ' A' ' 54' ' ' ILE . 13.6 m-85 -160.87 75.4 0.53 Allowed 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.524 -0.917 . . . . 1.01 108.524 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.732 HG22 HG23 ' A' ' 36' ' ' THR . 1.6 p -74.36 -167.62 0.56 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.421 -0.799 . . . . 1.72 110.151 -179.234 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 1.001 ' O ' HG23 ' A' ' 94' ' ' VAL . 3.0 t90 -171.62 112.5 0.33 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.425 -0.797 . . . . 4.51 110.065 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.534 ' O ' ' NE1' ' A' ' 92' ' ' TRP . 1.6 t30 -49.31 122.27 5.9 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 106.02 -1.845 . . . . 1.86 106.02 177.632 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 1.001 HG23 ' O ' ' A' ' 92' ' ' TRP . 60.6 t -123.28 101.51 37.85 Favored Pre-proline 0 C--N 1.301 -1.515 0 C-N-CA 117.888 -1.525 . . . . 1.64 113.277 -176.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 1.044 ' HD2' HD11 ' A' ' 97' ' ' ILE . 31.4 Cg_endo -72.33 -149.36 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.806 2.338 . . . . 1.77 108.734 176.218 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.5 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -69.39 -49.48 54.97 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.443 -1.411 . . . . 2.57 108.098 178.514 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 1.044 HD11 ' HD2' ' A' ' 95' ' ' PRO . 2.8 mp 62.32 -2.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 113.227 0.825 . . . . 1.18 113.227 177.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 1.028 ' HB1' ' HD2' ' A' ' 99' ' ' PRO . . . 57.53 178.31 0.04 OUTLIER Pre-proline 0 C--N 1.3 -1.568 0 O-C-N 119.942 -1.724 . . . . 0.34 108.49 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 1.028 ' HD2' ' HB1' ' A' ' 98' ' ' ALA . 52.9 Cg_endo -82.52 151.77 15.27 Favored 'Trans proline' 0 C--N 1.299 -2.06 0 C-N-CA 123.454 2.769 . . . . 0.45 110.204 -178.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.611 ' CD ' ' O ' ' A' ' 127' ' ' ILE . 0.3 OUTLIER 55.02 115.27 0.01 OUTLIER 'General case' 0 C--N 1.288 -2.079 0 C-N-CA 119.403 -0.919 . . . . 2.1 111.413 176.213 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 101' ' ' SER . . . . . 1.001 ' OG ' HD13 ' A' ' 127' ' ' ILE . 67.6 m -86.91 158.74 19.24 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.186 -0.946 . . . . 2.47 108.686 178.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -50.29 -21.29 1.33 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.009 -1.057 . . . . 5.17 109.582 -179.499 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.475 ' C ' ' CG2' ' A' ' 104' ' ' VAL . 15.4 t-20 -179.22 159.95 0.99 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.127 -0.983 . . . . 1.3 109.597 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.698 ' O ' HG23 ' A' ' 105' ' ' VAL . 0.9 OUTLIER -154.76 171.6 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.33 -0.856 . . . . 0.96 110.003 179.793 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.698 HG23 ' O ' ' A' ' 104' ' ' VAL . 0.9 OUTLIER 170.61 147.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 108.019 -1.104 . . . . 1.4 108.019 -179.863 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 1.5 t -143.56 137.42 25.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 120.331 -1.48 . . . . 1.25 110.29 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.992 HG23 HG23 ' A' ' 121' ' ' ILE . 0.9 OUTLIER -167.88 148.98 5.24 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.159 -1.052 . . . . 0.79 108.159 179.691 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.907 HG13 ' CD1' ' A' ' 54' ' ' ILE . 2.7 t -157.19 163.6 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.848 -1.158 . . . . 1.31 110.83 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.56 ' HG3' ' N ' ' A' ' 110' ' ' LEU . 0.3 OUTLIER -169.87 146.39 3.16 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.721 -0.844 . . . . 1.31 108.721 178.801 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.56 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 11.5 tp -139.03 126.45 21.64 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 106.774 -1.565 . . . . 0.63 106.774 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.52 ' HB ' ' HB2' ' A' ' 51' ' ' LYS . 7.6 mt -134.24 120.02 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.214 -0.929 . . . . 0.9 111.586 -177.267 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.585 ' CA ' HG21 ' A' ' 47' ' ' THR . . . -83.94 -108.37 0.57 Allowed Glycine 0 N--CA 1.486 2.016 0 N-CA-C 108.026 -2.03 . . . . 0.72 108.026 177.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -145.62 7.87 1.13 Allowed 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.072 -1.252 . . . . 1.54 107.951 178.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.569 ' ND2' ' HB3' ' A' ' 46' ' ' ASN . 2.5 m120 -124.8 -17.35 5.9 Favored 'General case' 0 C--N 1.308 -1.196 0 O-C-N 121.466 -0.771 . . . . 1.48 109.922 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 169.37 144.88 4.41 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.695 -1.362 . . . . 2.35 109.695 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.611 HG22 ' O ' ' A' ' 116' ' ' VAL . 0.1 OUTLIER -53.35 111.16 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.174 -1.192 . . . . 1.0 109.975 -179.644 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.839 ' CD1' HD13 ' A' ' 80' ' ' LEU . 10.7 mt -54.42 -51.66 64.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.633 -0.667 . . . . 0.83 111.064 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.583 ' HA ' ' CA ' ' A' ' 9' ' ' ALA . . . -166.59 147.19 6.06 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.841 -1.162 . . . . 1.33 111.269 -178.429 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 0.525 ' SG ' ' N ' ' A' ' 120' ' ' ALA . 0.5 OUTLIER -139.89 178.31 7.34 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 109.026 -0.731 . . . . 0.8 109.026 179.279 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.525 ' N ' ' SG ' ' A' ' 119' ' ' CYS . . . -179.12 125.93 0.09 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.097 -1.002 . . . . 0.89 109.423 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.992 HG23 HG23 ' A' ' 107' ' ' THR . 1.0 OUTLIER -129.78 138.36 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.162 -0.961 . . . . 1.04 109.799 -179.875 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -107.36 -23.27 12.28 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.213 -0.929 . . . . 2.77 109.321 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.462 ' O ' ' HB2' ' A' ' 124' ' ' HIS . 6.9 m 66.32 98.65 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.564 -0.71 . . . . 0.96 110.442 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' HIS . . . . . 0.462 ' HB2' ' O ' ' A' ' 123' ' ' THR . 0.0 OUTLIER 71.95 177.67 0.26 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.226 -0.921 . . . . 2.05 110.573 178.899 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -176.45 137.41 3.61 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.006 -1.638 . . . . 0.79 109.006 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.762 ' O ' HG23 ' A' ' 28' ' ' ILE . 22.7 mtmt -144.0 95.94 2.81 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.959 -1.318 . . . . 2.96 110.284 -179.429 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 1.001 HD13 ' OG ' ' A' ' 101' ' ' SER . 1.2 mp -58.32 143.44 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.151 -0.968 . . . . 0.98 109.41 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.607 ' HB2' ' HD3' ' A' ' 100' ' ' LYS . 13.7 ttt-85 149.45 -94.68 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 108.557 -0.905 . . . . 2.19 108.557 178.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.526 ' N ' ' HG2' ' A' ' 128' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.497 1.875 0 CA-C-O 117.984 -1.008 . . . . 4.55 110.247 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.1 p30 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.418 0.628 . . . . 3.95 109.713 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.522 ' HB3' ' HG2' ' A' ' 17' ' ' MET . 1.4 pt20 -117.4 -168.36 1.47 Allowed 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.369 -0.832 . . . . 1.78 109.436 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.614 HG12 ' HA ' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -135.84 -173.4 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 108.53 -0.915 . . . . 0.7 108.53 179.024 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.87 41.58 1.58 Allowed 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.203 -0.935 . . . . 1.01 109.057 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.9 m -54.02 161.9 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.372 -0.83 . . . . 1.22 109.408 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.47 ' O ' ' C ' ' A' ' 7' ' ' ASP . 11.2 mmtm -87.61 52.44 2.49 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.151 -0.968 . . . . 2.67 109.574 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.47 ' C ' ' O ' ' A' ' 6' ' ' LYS . 5.3 p30 -38.78 156.1 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 109.327 -0.62 . . . . 1.46 109.327 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -153.08 34.35 0.47 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.986 -1.072 . . . . 1.22 110.531 -179.253 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.542 ' HA ' ' HA ' ' A' ' 118' ' ' ALA . . . -69.59 -174.05 0.66 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.592 -1.317 . . . . 2.12 109.048 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.583 ' O ' ' CB ' ' A' ' 11' ' ' ASN . 0.7 OUTLIER -54.56 -53.33 55.96 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 108.342 -0.985 . . . . 2.81 108.342 178.174 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.583 ' CB ' ' O ' ' A' ' 10' ' ' ASN . 12.3 p30 147.19 40.88 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.036 -1.098 . . . . 6.47 108.036 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.479 ' HB2' ' OD2' ' A' ' 42' ' ' ASP . 7.2 mt-10 -147.33 8.3 0.91 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.178 -0.951 . . . . 2.68 110.654 -178.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 1.009 HG23 ' O ' ' A' ' 40' ' ' LEU . 36.1 mt -44.59 148.35 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.891 -1.13 . . . . 0.29 108.798 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.82 -19.33 18.21 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.423 -0.798 . . . . 2.46 109.462 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.611 ' H ' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -172.65 134.95 0.65 Allowed 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 118.725 -1.19 . . . . 1.02 110.631 -177.854 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.753 ' O ' HG12 ' A' ' 16' ' ' VAL . 0.9 OUTLIER -139.02 104.26 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 107.246 -1.39 . . . . 2.1 107.246 179.158 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.522 ' HG2' ' HB3' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -149.46 140.73 23.15 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 118.901 -1.12 . . . . 1.64 111.234 -177.805 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.876 HG22 ' HA ' ' A' ' 37' ' ' LEU . 39.6 t -118.2 132.53 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 108.236 -1.024 . . . . 1.31 108.236 178.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -76.84 79.65 3.43 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.193 -0.942 . . . . 1.61 110.213 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.553 ' O ' ' CB ' ' A' ' 21' ' ' CYS . . . 87.9 121.98 1.72 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 110.014 -1.234 . . . . 0.59 110.014 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.851 ' CA ' HG23 ' A' ' 29' ' ' ILE . 0.0 OUTLIER 157.24 -41.46 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.629 -0.924 . . . . 0.37 109.298 179.319 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.614 ' HA ' HG12 ' A' ' 3' ' ' VAL . 0.9 OUTLIER 80.73 122.69 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.293 -0.879 . . . . 1.1 110.248 -179.547 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.467 ' O ' ' HB3' ' A' ' 24' ' ' SER . . . -96.85 178.74 33.75 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.622 -1.391 . . . . 0.44 109.622 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.505 ' O ' ' O ' ' A' ' 25' ' ' ASP . 27.7 t 63.63 -91.32 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.223 -1.163 . . . . 1.45 110.217 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.638 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.1 OUTLIER -50.18 -175.33 0.01 OUTLIER Pre-proline 0 C--N 1.305 -1.369 0 N-CA-C 108.83 -0.804 . . . . 0.4 108.83 179.681 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.638 ' HD2' ' CB ' ' A' ' 25' ' ' ASP . 28.4 Cg_endo -70.14 84.8 0.7 Allowed 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 121.462 1.442 . . . . 0.47 108.552 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.488 ' SG ' ' O ' ' A' ' 27' ' ' CYS . 0.9 OUTLIER -28.54 95.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 115.325 -0.852 . . . . 0.23 112.453 -178.039 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.617 HG23 ' O ' ' A' ' 126' ' ' LYS . 23.3 mm -90.92 137.6 21.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 105.289 -2.115 . . . . 0.26 105.289 175.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.851 HG23 ' CA ' ' A' ' 21' ' ' CYS . 0.2 OUTLIER -119.69 177.69 2.79 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 O-C-N 120.553 -1.342 . . . . 0.29 112.898 -175.556 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 51.2 m-70 -112.37 158.13 20.18 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.916 0.865 . . . . 1.09 110.817 -179.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.545 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -111.3 141.32 44.99 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.123 -1.066 . . . . 2.95 108.123 178.408 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' A' ' 95' ' ' PRO . . . 101.11 3.34 54.48 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.469 -1.452 . . . . 0.67 109.469 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.715 ' N ' HG11 ' A' ' 94' ' ' VAL . 1.9 mtmt -133.87 144.51 52.04 Favored Pre-proline 0 C--N 1.305 -1.355 0 O-C-N 121.42 -1.047 . . . . 0.49 108.328 179.038 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -69.62 81.4 0.79 Allowed 'Trans proline' 0 C--N 1.301 -1.944 0 C-N-CA 122.346 2.031 . . . . 0.9 111.175 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.585 ' CD1' ' O ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -59.58 122.84 15.07 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.998 -1.112 . . . . 2.54 107.998 178.974 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.756 HG23 ' HA ' ' A' ' 91' ' ' THR . 88.0 m -141.19 91.83 2.43 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.11 -0.994 . . . . 1.24 110.226 -178.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.876 ' HA ' HG22 ' A' ' 18' ' ' VAL . 1.2 pp -64.26 137.78 58.1 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.294 -0.879 . . . . 1.02 108.714 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.559 ' HG2' ' CG ' ' A' ' 89' ' ' LYS . 4.3 mt-10 -128.0 168.17 15.66 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.134 -0.979 . . . . 1.95 109.731 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.437 ' HB2' ' O ' ' A' ' 38' ' ' GLU . . . 176.83 74.01 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.984 0.897 . . . . 0.88 109.407 178.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 1.009 ' O ' HG23 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -67.76 169.98 8.72 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 109.529 -0.545 . . . . 0.35 109.529 179.931 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.748 ' CE2' ' CD2' ' A' ' 86' ' ' TYR . 1.4 p90 -165.85 162.42 18.36 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.156 -0.965 . . . . 0.64 108.674 177.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.479 ' OD2' ' HB2' ' A' ' 12' ' ' GLU . 4.3 p30 -120.03 115.93 24.72 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 122.037 0.923 . . . . 4.95 109.022 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.907 ' HB1' ' O ' ' A' ' 81' ' ' VAL . . . -42.2 115.43 0.68 Allowed 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 108.854 -0.795 . . . . 0.31 108.854 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.4 ' OD1' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -124.31 -0.87 8.2 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.364 -0.835 . . . . 0.8 109.968 -178.608 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.79 ' OE1' HD21 ' A' ' 117' ' ' LEU . 2.5 pt20 -92.59 -142.63 0.21 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.384 -0.822 . . . . 0.69 109.017 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.792 ' HA ' ' HB ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -155.62 71.41 0.76 Allowed 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.174 -0.954 . . . . 0.7 109.561 179.002 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.639 HG23 ' O ' ' A' ' 47' ' ' THR . 4.8 t -150.15 121.6 7.93 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 119.959 -1.713 . . . . 0.93 111.123 -178.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.608 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 7.0 mtmt -68.63 -7.55 34.08 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.785 -1.197 . . . . 2.05 109.186 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.85 158.88 18.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.176 -0.952 . . . . 1.6 109.492 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.796 ' HB1' ' HB3' ' A' ' 72' ' ' ALA . . . -151.66 135.08 16.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.369 -0.832 . . . . 0.38 108.882 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 1.083 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 0.1 OUTLIER -117.64 -158.99 0.73 Allowed 'General case' 0 C--N 1.298 -1.662 0 O-C-N 120.564 -1.335 . . . . 1.78 108.028 178.475 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.485 HG13 HD13 ' A' ' 54' ' ' ILE . 1.5 tt -177.93 161.74 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 C-N-CA 118.647 -1.221 . . . . 0.58 110.481 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.535 ' O ' ' CE ' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -160.33 40.0 0.17 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.804 -0.813 . . . . 0.54 108.804 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.95 ' HB ' HG21 ' A' ' 65' ' ' VAL . 0.3 OUTLIER -72.77 148.01 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.138 -0.976 . . . . 0.38 109.801 -179.656 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.595 ' HG3' ' O ' ' A' ' 54' ' ' ILE . 0.3 OUTLIER -163.19 94.62 0.82 Allowed 'General case' 0 C--N 1.287 -2.121 0 O-C-N 121.282 -0.886 . . . . 1.17 109.005 178.515 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.525 ' O ' HG13 ' A' ' 63' ' ' ILE . . . -119.77 120.01 35.28 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 119.639 -0.824 . . . . 0.67 110.584 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.47 124.62 47.44 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.012 -1.107 . . . . 0.68 108.012 178.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.577 HD21 ' CD1' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.87 169.1 10.46 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.844 -1.16 . . . . 4.25 110.109 -178.517 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.482 ' HB2' ' CB ' ' A' ' 101' ' ' SER . 67.4 t0 -77.79 80.4 4.25 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.546 -0.909 . . . . 4.91 108.546 179.371 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.601 ' O ' HD22 ' A' ' 61' ' ' LEU . . . 105.08 1.41 41.77 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 108.537 -1.825 . . . . 1.08 108.537 -178.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.601 HD22 ' O ' ' A' ' 60' ' ' GLY . 0.4 OUTLIER -136.64 59.53 1.69 Allowed 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.027 -1.101 . . . . 1.46 108.027 179.397 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -69.11 81.87 0.33 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.714 -0.616 . . . . 1.05 110.229 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.525 HG13 ' O ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -82.98 125.61 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 118.445 -1.302 . . . . 2.08 108.682 178.895 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -128.58 164.42 22.88 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.699 -0.852 . . . . 1.49 108.699 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.95 HG21 ' HB ' ' A' ' 54' ' ' ILE . 43.3 t -143.4 68.7 17.32 Favored Pre-proline 0 C--N 1.3 -1.551 0 O-C-N 121.01 -1.056 . . . . 0.77 110.114 -179.104 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.501 ' HD2' ' CG1' ' A' ' 68' ' ' ILE . 36.4 Cg_endo -80.72 95.94 0.99 Allowed 'Trans proline' 0 C--N 1.301 -1.938 0 C-N-CA 123.063 2.509 . . . . 2.67 110.264 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.499 ' C ' ' O ' ' A' ' 66' ' ' PRO . . . 33.53 50.08 0.54 Allowed Glycine 0 N--CA 1.497 2.702 0 N-CA-C 109.85 -1.3 . . . . 0.75 109.85 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.501 ' CG1' ' HD2' ' A' ' 66' ' ' PRO . 5.8 mt -76.08 -76.7 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.376 -1.073 . . . . 1.24 109.842 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.63 ' HB3' ' HB2' ' A' ' 74' ' ' HIS . 15.1 p30 -59.26 157.62 10.46 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.329 -0.857 . . . . 1.27 109.262 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.464 ' O ' ' CG ' ' A' ' 71' ' ' ASN . 20.0 p -77.4 -20.2 54.99 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.843 -1.169 . . . . 0.89 107.843 178.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.712 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 47.8 m-20 -173.96 73.93 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.369 0.604 . . . . 2.5 109.661 179.267 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 1.083 ' HB2' ' O ' ' A' ' 51' ' ' LYS . . . 38.85 26.59 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.547 -0.72 . . . . 0.74 111.56 177.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.517 ' SG ' ' N ' ' A' ' 78' ' ' CYS . 2.4 t -100.85 -17.77 16.71 Favored 'General case' 0 C--N 1.29 -2.013 0 O-C-N 121.151 -0.968 . . . . 1.36 110.433 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.63 ' HB2' ' HB3' ' A' ' 69' ' ' ASP . 3.1 t-80 -61.23 -28.97 69.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.801 -1.187 . . . . 2.07 109.829 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -99.74 -54.83 2.81 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.696 -1.253 . . . . 2.36 110.319 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 1.173 HG21 ' CZ ' ' A' ' 86' ' ' TYR . 8.3 m -108.67 -145.52 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 CA-C-O 121.775 0.798 . . . . 2.82 109.186 -178.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.769 ' N ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -93.1 167.68 11.62 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.124 -1.436 . . . . 2.86 107.124 177.629 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' CYS . . . . . 0.735 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -91.36 -43.76 0.38 Allowed Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 120.476 -1.39 . . . . 1.1 110.469 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.608 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 31.0 Cg_endo -78.65 117.02 3.89 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 121.211 1.274 . . . . 0.99 109.385 178.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.997 HD12 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -97.11 -68.12 0.81 Allowed 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.375 -0.972 . . . . 0.73 108.375 -179.074 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.907 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 1.1 m 40.9 -168.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 116.051 -0.522 . . . . 0.47 109.812 178.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.722 ' H ' HG23 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -99.22 41.13 1.16 Allowed 'General case' 0 C--N 1.295 -1.803 0 O-C-N 120.378 -1.451 . . . . 0.93 109.972 -177.649 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -143.94 39.73 1.24 Allowed Glycine 0 C--N 1.293 -1.812 0 N-CA-C 109.95 -1.26 . . . . 0.76 109.95 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 50.3 tp60 -158.88 154.12 25.5 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.93 -1.335 . . . . 1.5 110.001 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -111.85 160.44 17.37 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.65 -0.87 . . . . 2.38 108.65 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 1.173 ' CZ ' HG21 ' A' ' 76' ' ' VAL . 0.9 OUTLIER -127.45 -170.25 2.19 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.798 -1.189 . . . . 3.4 110.546 -179.005 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.572 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 3.2 p30 174.68 39.12 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.65 -0.87 . . . . 1.61 108.65 178.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.754 HD12 HG13 ' A' ' 76' ' ' VAL . 0.4 OUTLIER -53.01 -170.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.867 -0.79 . . . . 0.82 108.867 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.68 ' N ' HG23 ' A' ' 88' ' ' ILE . 0.2 OUTLIER 165.81 -179.32 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 119.07 -1.052 . . . . 1.3 110.442 -179.323 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.667 ' CZ ' HG21 ' A' ' 54' ' ' ILE . 31.1 m-85 -167.35 93.62 0.43 Allowed 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.122 -1.066 . . . . 1.06 108.122 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.756 ' HA ' HG23 ' A' ' 36' ' ' THR . 0.6 OUTLIER -87.17 -162.86 0.84 Allowed 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.773 0.797 . . . . 1.75 110.959 -178.183 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.566 ' CE3' HD21 ' A' ' 58' ' ' LEU . 7.1 t90 -175.18 90.48 0.05 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.531 -0.731 . . . . 4.32 109.599 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.461 ' C ' ' O ' ' A' ' 92' ' ' TRP . 3.1 t-20 -45.48 108.76 0.14 Allowed 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 106.8 -1.555 . . . . 1.29 106.8 178.322 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.873 HG13 ' CD1' ' A' ' 97' ' ' ILE . 2.4 t -104.58 116.21 61.47 Favored Pre-proline 0 C--N 1.301 -1.508 0 C-N-CA 118.854 -1.139 . . . . 0.57 113.128 -176.024 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.773 ' HD2' HD11 ' A' ' 97' ' ' ILE . 33.4 Cg_endo -81.08 -86.12 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 123.206 2.604 . . . . 0.49 108.538 176.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.545 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -135.7 -56.14 0.78 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 105.679 -1.971 . . . . 2.36 105.679 177.766 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.873 ' CD1' HG13 ' A' ' 94' ' ' VAL . 1.5 mp 67.91 7.32 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 113.203 0.816 . . . . 0.53 113.203 175.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 1.016 ' HB1' ' HD2' ' A' ' 99' ' ' PRO . . . 52.96 177.87 0.03 OUTLIER Pre-proline 0 C--N 1.302 -1.482 0 O-C-N 120.241 -1.537 . . . . 0.6 109.626 179.01 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 1.016 ' HD2' ' HB1' ' A' ' 98' ' ' ALA . 51.8 Cg_endo -83.59 152.78 13.46 Favored 'Trans proline' 0 C--N 1.303 -1.867 0 C-N-CA 123.751 2.968 . . . . 0.81 110.086 -179.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.646 ' HD3' ' CB ' ' A' ' 128' ' ' ARG . 1.7 mmmp? 55.98 127.35 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.97 0 C-N-CA 119.683 -0.807 . . . . 0.9 111.674 176.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.908 ' CB ' HD13 ' A' ' 127' ' ' ILE . 12.3 t -97.67 154.6 17.46 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.196 -0.94 . . . . 0.97 108.595 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.438 ' O ' ' CB ' ' A' ' 103' ' ' ASN . 76.1 mt-10 -48.85 -22.45 0.83 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.118 -0.989 . . . . 1.31 109.624 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.438 ' CB ' ' O ' ' A' ' 102' ' ' GLU . 0.4 OUTLIER 165.02 152.0 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.036 -1.098 . . . . 3.17 108.036 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.466 ' C ' HG23 ' A' ' 105' ' ' VAL . 0.1 OUTLIER -142.76 153.76 17.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 120.814 -1.179 . . . . 0.83 110.949 -178.944 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.466 HG23 ' C ' ' A' ' 104' ' ' VAL . 25.4 t -157.64 104.04 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 107.561 -1.274 . . . . 1.4 107.561 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.704 ' HB ' ' HB3' ' A' ' 122' ' ' ALA . 15.7 t -103.55 111.06 31.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 120.988 -1.07 . . . . 0.92 109.484 -178.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.587 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -129.98 175.27 9.02 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 120.877 -1.139 . . . . 1.21 108.269 179.269 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.797 HG22 ' CD1' ' A' ' 54' ' ' ILE . 1.2 t 175.07 168.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 C-N-CA 118.835 -1.146 . . . . 0.58 110.318 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.633 ' N ' HG13 ' A' ' 108' ' ' VAL . 1.1 ttpt 162.94 134.63 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.838 0.828 . . . . 1.36 109.67 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.561 ' HB3' ' HB2' ' A' ' 117' ' ' LEU . 9.4 tp -113.22 130.04 56.34 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 106.873 -1.528 . . . . 0.59 106.873 178.052 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.464 ' HB ' ' HB2' ' A' ' 51' ' ' LYS . 9.4 mt -127.25 120.12 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.154 -0.966 . . . . 0.68 111.737 -177.24 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.414 ' HA3' HG21 ' A' ' 47' ' ' THR . . . -92.4 -114.25 2.11 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 108.812 -1.715 . . . . 0.83 108.812 178.178 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -138.21 1.94 2.26 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.044 -1.268 . . . . 1.09 108.004 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -112.58 -39.31 4.38 Favored 'General case' 0 C--N 1.31 -1.129 0 O-C-N 121.415 -0.803 . . . . 0.75 109.048 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -177.38 155.38 17.65 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.07 -1.612 . . . . 1.54 109.07 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.533 ' CG2' ' O ' ' A' ' 118' ' ' ALA . 0.2 OUTLIER -50.18 111.88 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.167 -1.196 . . . . 0.7 109.82 -179.647 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.997 HD22 HD12 ' A' ' 80' ' ' LEU . 1.4 mt -57.49 -62.89 1.46 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.294 -0.879 . . . . 0.72 109.666 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.542 ' HA ' ' HA ' ' A' ' 9' ' ' ALA . . . -123.97 -175.26 3.19 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.13 -0.981 . . . . 0.22 110.083 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.542 ' HA ' ' HA ' ' A' ' 109' ' ' LYS . 1.9 t 172.37 150.51 0.06 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.155 -0.966 . . . . 0.85 110.15 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.444 ' C ' HG13 ' A' ' 121' ' ' ILE . . . -170.02 130.98 1.0 Allowed 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.79 -0.818 . . . . 0.58 108.79 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.444 HG13 ' C ' ' A' ' 120' ' ' ALA . 2.8 mt -134.15 139.47 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.177 -0.952 . . . . 0.46 110.075 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.704 ' HB3' ' HB ' ' A' ' 106' ' ' VAL . . . -106.77 -17.92 14.08 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.487 -0.931 . . . . 2.08 108.487 179.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.415 HG22 ' CE1' ' A' ' 124' ' ' HIS . 0.3 OUTLIER 58.51 89.08 0.06 Allowed 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 121.519 0.676 . . . . 1.43 110.196 179.718 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.415 ' CE1' HG22 ' A' ' 123' ' ' THR . 7.4 m80 61.9 -160.93 0.3 Allowed 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.724 0.773 . . . . 3.56 110.378 179.143 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 153.91 150.61 5.52 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.346 -1.902 . . . . 1.11 108.346 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.617 ' O ' HG23 ' A' ' 28' ' ' ILE . 69.0 mttt -140.38 96.56 3.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.95 -1.323 . . . . 1.78 109.987 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.908 HD13 ' CB ' ' A' ' 101' ' ' SER . 2.1 mp -46.05 152.43 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.649 -0.657 . . . . 0.37 109.843 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.646 ' CB ' ' HD3' ' A' ' 100' ' ' LYS . 0.0 OUTLIER 141.79 -77.3 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.692 0.758 . . . . 0.58 109.132 178.823 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.587 ' CB ' HG21 ' A' ' 28' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--N 1.301 -1.533 0 CA-C-O 118.017 -0.992 . . . . 3.57 109.63 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.478 ' O ' ' O ' ' A' ' 2' ' ' GLN . 65.7 m-20 . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.5 0.667 . . . . 4.81 109.804 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.549 ' HA ' ' HB3' ' A' ' 17' ' ' MET . 93.6 mt-30 47.91 179.08 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 122.158 0.98 . . . . 3.84 110.999 178.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.839 HG13 ' N ' ' A' ' 4' ' ' ASP . 2.2 p -162.72 -149.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 108.642 -0.873 . . . . 4.17 108.642 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.839 ' N ' HG13 ' A' ' 3' ' ' VAL . 32.2 t0 -163.73 54.74 0.16 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.652 -1.28 . . . . 2.24 110.222 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.621 HG12 ' HB2' ' A' ' 122' ' ' ALA . 19.4 m -89.12 152.39 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.031 -1.043 . . . . 0.9 109.83 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.48 95.57 3.31 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.319 -0.863 . . . . 2.79 109.238 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -89.88 173.97 7.95 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.358 -0.839 . . . . 1.47 109.582 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.487 ' N ' ' SG ' ' A' ' 119' ' ' CYS . 24.8 p -164.76 47.79 0.1 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.258 -0.901 . . . . 2.03 109.696 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.591 ' HB1' ' O ' ' A' ' 117' ' ' LEU . . . -76.4 -67.31 0.7 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.304 -0.873 . . . . 0.38 109.244 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.554 ' CB ' ' O ' ' A' ' 9' ' ' ALA . 0.7 OUTLIER 160.37 39.5 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.487 -0.931 . . . . 0.98 108.487 -178.285 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 54.4 t30 55.87 21.67 5.03 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.316 -0.994 . . . . 1.75 108.316 -178.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -104.48 -22.18 13.34 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.21 -0.663 . . . . 2.02 109.21 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.917 HG23 ' O ' ' A' ' 40' ' ' LEU . 3.8 mt -52.03 143.16 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.073 -1.017 . . . . 0.59 108.925 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.89 -22.7 13.11 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.351 -0.843 . . . . 1.91 109.223 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -168.75 108.95 0.49 Allowed 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 118.426 -1.31 . . . . 1.81 111.595 -178.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.622 ' O ' HG13 ' A' ' 16' ' ' VAL . 3.2 p -118.12 94.09 2.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 N-CA-C 106.819 -1.549 . . . . 0.78 106.819 177.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.549 ' HB3' ' HA ' ' A' ' 2' ' ' GLN . 7.0 mmt -134.87 118.32 16.83 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.487 -0.885 . . . . 2.63 111.356 -177.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.535 HG23 HG11 ' A' ' 3' ' ' VAL . 11.2 t -85.86 126.25 40.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 107.171 -1.418 . . . . 1.36 107.171 177.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.592 ' HB3' ' CB ' ' A' ' 35' ' ' PHE . 2.0 t0 -45.8 -22.17 0.17 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.071 -1.018 . . . . 2.35 110.396 -178.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.61 ' C ' HG23 ' A' ' 29' ' ' ILE . . . -177.82 135.32 2.68 Favored Glycine 0 N--CA 1.49 2.299 0 C-N-CA 118.947 -1.597 . . . . 1.76 110.857 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.972 ' CA ' HG23 ' A' ' 29' ' ' ILE . 0.0 OUTLIER 153.12 -37.0 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.881 -0.776 . . . . 0.91 109.614 178.671 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.636 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 42.6 t-80 53.76 102.85 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.78 -1.2 . . . . 3.46 109.362 -179.27 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.705 ' H ' HG22 ' A' ' 3' ' ' VAL . . . -90.03 -147.18 16.73 Favored Glycine 0 N--CA 1.499 2.867 0 O-C-N 121.044 -1.035 . . . . 1.03 111.407 -178.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.525 ' N ' ' O ' ' A' ' 4' ' ' ASP . 0.1 OUTLIER 80.92 -77.9 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.626 -0.926 . . . . 1.08 108.667 -178.986 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.676 ' HB2' ' CD ' ' A' ' 26' ' ' PRO . 7.4 p30 -86.17 -152.84 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.51 0 N-CA-C 105.727 -1.953 . . . . 1.84 105.727 178.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.676 ' CD ' ' HB2' ' A' ' 25' ' ' ASP . 28.7 Cg_endo -72.99 91.72 0.82 Allowed 'Trans proline' 0 C--N 1.319 -1.016 0 N-CA-C 108.395 -1.425 . . . . 0.43 108.395 179.14 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.636 ' HA ' ' O ' ' A' ' 22' ' ' HIS . 0.3 OUTLIER -34.36 101.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.559 0.695 . . . . 0.3 112.036 -177.202 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.756 HG21 ' HB3' ' A' ' 129' ' ' ASP . 28.4 mm -97.05 135.82 29.91 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 106.829 -1.545 . . . . 0.47 106.829 176.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.972 HG23 ' CA ' ' A' ' 21' ' ' CYS . 0.5 OUTLIER -122.87 -166.77 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 O-C-N 121.005 -1.06 . . . . 0.76 111.676 -177.468 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.577 ' H ' HG22 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -123.77 168.67 12.41 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 115.863 -0.608 . . . . 2.94 109.446 179.628 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.565 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -115.6 -163.96 0.92 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.089 -1.007 . . . . 1.56 109.453 179.43 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 31' ' ' ARG . . . 39.19 44.62 2.17 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.902 -1.279 . . . . 1.43 109.902 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.483 ' C ' ' HB ' ' A' ' 94' ' ' VAL . 0.1 OUTLIER -172.08 109.7 0.37 Allowed Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.153 -1.204 . . . . 2.37 109.577 -179.742 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.538 ' HA ' ' HB ' ' A' ' 94' ' ' VAL . 29.3 Cg_endo -70.37 115.5 4.21 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.821 2.348 . . . . 3.46 110.949 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.592 ' CB ' ' HB3' ' A' ' 19' ' ' ASP . 22.5 m-85 -100.13 -157.41 0.6 Allowed 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.773 -0.825 . . . . 7.48 108.773 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.551 ' O ' ' HG3' ' A' ' 38' ' ' GLU . 1.8 m -175.63 102.22 0.07 Allowed 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.368 -0.833 . . . . 0.78 108.768 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.468 ' HA ' HG13 ' A' ' 18' ' ' VAL . 0.2 OUTLIER -52.2 153.25 2.88 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.235 -1.024 . . . . 3.48 108.235 179.8 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.575 ' O ' ' HB2' ' A' ' 39' ' ' ALA . 63.0 mt-10 -154.38 166.75 32.24 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.791 -1.193 . . . . 0.64 110.96 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.575 ' HB2' ' O ' ' A' ' 38' ' ' GLU . . . 168.18 96.6 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.58 -0.896 . . . . 0.45 108.58 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.917 ' O ' HG23 ' A' ' 13' ' ' ILE . 0.5 OUTLIER -90.12 154.82 19.49 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.394 -0.595 . . . . 0.9 109.394 -179.517 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.762 ' CE2' ' CD2' ' A' ' 86' ' ' TYR . 0.2 OUTLIER -152.52 169.87 21.56 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.056 -1.027 . . . . 0.78 109.349 178.41 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.613 ' OD2' ' NE2' ' A' ' 85' ' ' GLN . 6.7 t0 -119.46 112.45 19.41 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 122.195 0.998 . . . . 1.5 109.206 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.884 ' HB1' ' O ' ' A' ' 81' ' ' VAL . . . -42.28 116.39 0.83 Allowed 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 115.431 -0.804 . . . . 0.73 109.198 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.491 ' O ' ' HB3' ' A' ' 82' ' ' LYS . 11.3 p30 -126.17 -0.1 7.11 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.243 -0.911 . . . . 4.4 109.731 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.89 ' CD ' HD21 ' A' ' 117' ' ' LEU . 3.1 pt20 -90.68 -137.61 0.14 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.413 -0.805 . . . . 0.69 109.01 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.858 ' HA ' ' HB ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -159.23 68.87 0.44 Allowed 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 119.59 -0.844 . . . . 1.6 109.637 179.215 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.71 HG21 ' HA3' ' A' ' 112' ' ' GLY . 3.5 t -145.25 120.01 9.88 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.045 -1.659 . . . . 0.56 110.764 -178.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.638 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 0.2 OUTLIER -68.74 -5.53 21.09 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.841 -1.162 . . . . 1.92 109.075 178.553 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.0 p -98.79 -177.6 3.7 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.058 -1.026 . . . . 1.14 109.893 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.922 ' HB1' ' HB3' ' A' ' 72' ' ' ALA . . . -163.94 145.62 9.01 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.442 -0.948 . . . . 0.55 108.442 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.656 ' HG2' HD21 ' A' ' 71' ' ' ASN . 16.6 mtmt -138.36 91.97 2.6 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 122.964 1.364 . . . . 2.27 109.506 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.674 ' HA ' HD12 ' A' ' 110' ' ' LEU . 1.2 tt -67.98 158.15 5.85 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.474 0 CA-C-N 114.063 -1.426 . . . . 1.47 110.086 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -150.93 49.16 0.85 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.33 -0.857 . . . . 2.0 109.127 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.958 ' HB ' HG21 ' A' ' 65' ' ' VAL . 0.2 OUTLIER -75.64 159.49 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.42 -0.8 . . . . 0.77 108.925 -179.869 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.555 ' HD3' ' O ' ' A' ' 54' ' ' ILE . 0.4 OUTLIER -166.13 29.71 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.178 -1.009 . . . . 1.46 110.774 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 1.029 ' HB3' HG21 ' A' ' 63' ' ' ILE . . . -66.7 159.04 28.63 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 108.809 -0.811 . . . . 1.27 108.809 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.15 130.08 24.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.032 -1.043 . . . . 0.87 109.736 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 1.066 HD13 ' N ' ' A' ' 59' ' ' ASP . 2.5 tm? -119.91 154.92 33.69 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.212 -0.93 . . . . 1.35 108.78 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 1.066 ' N ' HD13 ' A' ' 58' ' ' LEU . 5.6 t70 -76.93 79.24 3.49 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 107.818 -1.179 . . . . 3.91 107.818 178.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.703 ' O ' HD22 ' A' ' 61' ' ' LEU . . . 125.8 -5.83 7.92 Favored Glycine 0 N--CA 1.485 1.91 0 N-CA-C 108.787 -1.725 . . . . 0.9 108.787 -178.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.703 HD22 ' O ' ' A' ' 60' ' ' GLY . 0.4 OUTLIER -141.86 53.48 1.49 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.238 -1.154 . . . . 1.42 109.263 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 61' ' ' LEU . 36.1 mm-40 -41.18 97.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.544 -0.722 . . . . 3.07 109.625 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 1.029 HG21 ' HB3' ' A' ' 56' ' ' ALA . 0.3 OUTLIER -75.09 -2.93 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 CA-C-O 121.952 0.882 . . . . 2.88 110.133 -179.986 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.462 ' C ' ' O ' ' A' ' 63' ' ' ILE . 0.6 OUTLIER -40.03 140.13 0.61 Allowed 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 108.925 -0.768 . . . . 1.83 108.925 179.317 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.958 HG21 ' HB ' ' A' ' 54' ' ' ILE . 98.8 t -123.0 86.2 50.92 Favored Pre-proline 0 C--N 1.301 -1.533 0 O-C-N 121.168 -0.957 . . . . 1.44 110.556 -178.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.465 ' O ' ' C ' ' A' ' 67' ' ' GLY . 35.7 Cg_endo -79.29 89.34 1.36 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.791 2.327 . . . . 3.72 110.422 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.465 ' C ' ' O ' ' A' ' 66' ' ' PRO . . . 37.14 68.94 0.31 Allowed Glycine 0 N--CA 1.495 2.585 0 N-CA-C 110.117 -1.193 . . . . 1.33 110.117 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 21.2 mt -83.94 -78.03 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.13 -1.217 . . . . 2.45 109.613 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.469 ' OD2' ' CE1' ' A' ' 75' ' ' PHE . 5.2 p30 -78.47 130.58 36.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.212 -0.93 . . . . 2.45 109.233 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.436 ' O ' ' CG ' ' A' ' 71' ' ' ASN . 13.7 t -51.58 -23.02 3.72 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.09 -1.006 . . . . 2.82 109.715 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.656 HD21 ' HG2' ' A' ' 51' ' ' LYS . 6.9 m120 -168.32 76.05 0.12 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.953 -1.092 . . . . 1.32 111.225 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.922 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . . . 32.02 33.75 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.283 0.563 . . . . 0.8 111.921 176.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.535 ' N ' ' O ' ' A' ' 71' ' ' ASN . 31.0 t -109.79 21.64 16.66 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 121.179 -0.95 . . . . 1.0 110.393 -179.003 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 17.6 t-160 -121.64 -18.26 7.22 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.374 -1.454 . . . . 2.83 109.45 178.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' A' ' 75' ' ' PHE . 7.3 m-85 -104.67 -15.09 15.37 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -0.887 . . . . 2.49 108.695 179.03 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 1.076 HG21 ' CE2' ' A' ' 86' ' ' TYR . 18.2 m -150.73 -153.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 N-CA-C 107.097 -1.445 . . . . 3.17 107.097 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.843 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -81.65 -177.65 6.63 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 106.287 -1.745 . . . . 2.36 106.287 176.325 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' CYS . . . . . 0.588 ' H ' ' HD2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -109.1 -51.87 0.07 OUTLIER Pre-proline 0 C--N 1.293 -1.86 0 O-C-N 120.64 -1.287 . . . . 0.88 110.796 -179.559 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.638 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 29.6 Cg_endo -77.83 111.6 3.14 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 N-CA-C 108.506 -1.382 . . . . 0.85 108.506 178.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.984 HD22 HD13 ' A' ' 117' ' ' LEU . 0.6 OUTLIER -93.6 -67.54 0.85 Allowed 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.622 -0.673 . . . . 2.63 109.363 -178.1 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.884 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 1.4 m 40.8 -167.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 C-N-CA 120.46 -0.496 . . . . 0.6 110.072 177.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.734 ' H ' HG23 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -98.47 41.62 1.13 Allowed 'General case' 0 C--N 1.292 -1.91 0 O-C-N 120.629 -1.294 . . . . 0.76 109.81 -177.45 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -150.68 46.4 0.62 Allowed Glycine 0 C--N 1.288 -2.123 0 N-CA-C 108.863 -1.695 . . . . 0.99 108.863 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.495 ' NE2' ' O ' ' A' ' 85' ' ' GLN . 31.4 tp60 -159.4 150.07 19.46 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.132 -1.217 . . . . 1.96 110.18 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.613 ' NE2' ' OD2' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -104.25 157.37 17.18 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.569 -1.271 . . . . 2.43 107.569 178.412 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 1.076 ' CE2' HG21 ' A' ' 76' ' ' VAL . 0.4 OUTLIER -125.64 -167.65 1.72 Allowed 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.313 -1.492 . . . . 3.95 111.592 -178.928 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.616 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER 170.98 38.44 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.409 -0.814 . . . . 3.04 109.088 179.342 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.7 HD12 ' CG1' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -49.52 -178.01 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 108.256 -1.016 . . . . 0.64 108.256 179.129 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.57 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 1.2 mtmt 170.5 164.56 0.07 Allowed 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 119.069 -1.052 . . . . 0.83 109.957 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.616 ' CE2' HG12 ' A' ' 54' ' ' ILE . 17.0 m-85 -150.58 91.21 1.71 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.467 -0.771 . . . . 0.87 109.246 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.476 ' O ' ' O ' ' A' ' 90' ' ' TYR . 1.4 t -44.71 171.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.7 -0.625 . . . . 3.34 109.612 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.586 ' O ' HG23 ' A' ' 94' ' ' VAL . 0.3 OUTLIER -146.36 92.53 2.19 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.147 -0.971 . . . . 3.8 110.131 -179.938 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -65.43 112.43 3.54 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.126 -1.435 . . . . 4.53 107.126 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.849 HG13 ' CD1' ' A' ' 97' ' ' ILE . 59.5 t -125.05 93.94 44.74 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 120.917 -1.115 . . . . 2.48 112.451 -177.17 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.908 ' HD2' HD11 ' A' ' 97' ' ' ILE . 33.3 Cg_endo -73.65 -151.42 0.03 OUTLIER 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 122.105 1.87 . . . . 3.32 108.26 176.432 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.565 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 2.7 mmtt -67.54 -32.61 73.51 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.215 -1.553 . . . . 2.44 109.184 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.908 HD11 ' HD2' ' A' ' 95' ' ' PRO . 4.0 mt 42.39 15.87 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.125 -0.984 . . . . 1.77 112.354 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.982 ' HB1' ' HD2' ' A' ' 99' ' ' PRO . . . 50.65 173.37 0.03 OUTLIER Pre-proline 0 C--N 1.307 -1.242 0 O-C-N 120.292 -1.505 . . . . 1.6 109.93 179.236 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.982 ' HD2' ' HB1' ' A' ' 98' ' ' ALA . 57.4 Cg_endo -81.66 76.29 4.43 Favored 'Trans proline' 0 C--N 1.296 -2.208 0 C-N-CA 123.163 2.575 . . . . 2.62 108.418 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.698 ' CB ' ' O ' ' A' ' 99' ' ' PRO . 4.6 mmmm 119.2 127.11 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 123.8 0.687 . . . . 2.54 109.751 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.507 ' O ' ' HB2' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -87.38 11.49 14.38 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.271 -0.893 . . . . 1.51 109.392 179.638 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.562 ' O ' ' CB ' ' A' ' 103' ' ' ASN . 2.1 mp0 67.63 -0.42 1.94 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.656 -0.652 . . . . 6.1 109.906 -179.24 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.562 ' CB ' ' O ' ' A' ' 102' ' ' GLU . 3.3 t30 160.91 143.23 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.275 -0.89 . . . . 2.28 109.928 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 125' ' ' GLY . 0.1 OUTLIER -159.9 158.67 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.423 -0.798 . . . . 1.05 109.295 -179.772 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.435 ' O ' HG12 ' A' ' 105' ' ' VAL . 1.2 t -149.33 131.22 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.042 -1.036 . . . . 0.58 109.66 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.857 ' HB ' ' HB3' ' A' ' 122' ' ' ALA . 10.5 t -119.87 130.3 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.135 -0.978 . . . . 1.28 109.62 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.542 ' HB ' ' HB2' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -154.34 140.19 18.16 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.529 -0.915 . . . . 1.08 108.529 179.711 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.955 HG13 ' CD1' ' A' ' 54' ' ' ILE . 34.7 t -158.49 151.14 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.872 -1.143 . . . . 1.26 110.266 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.538 ' HA ' ' HA ' ' A' ' 119' ' ' CYS . 6.7 ttpt -172.46 134.5 0.67 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.222 -0.924 . . . . 1.25 110.284 178.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.691 ' O ' HG23 ' A' ' 116' ' ' VAL . 9.8 tp -111.15 132.65 54.13 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 106.833 -1.543 . . . . 0.62 106.833 177.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.468 ' HB ' ' HB2' ' A' ' 51' ' ' LYS . 8.4 mt -133.71 113.78 19.04 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 O-C-N 121.128 -0.983 . . . . 0.63 110.972 -177.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.71 ' HA3' HG21 ' A' ' 47' ' ' THR . . . -76.88 -110.76 0.14 Allowed Glycine 0 N--CA 1.486 1.993 0 N-CA-C 107.944 -2.062 . . . . 0.65 107.944 178.203 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -142.48 9.39 1.82 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.531 -1.285 . . . . 1.63 107.531 178.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.507 ' OD1' ' HB2' ' A' ' 45' ' ' GLN . 0.3 OUTLIER -123.88 -31.86 3.35 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.693 0.759 . . . . 3.9 109.362 -178.997 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -171.37 -142.87 3.81 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 108.708 -1.757 . . . . 0.76 108.708 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 110' ' ' LEU . 2.4 p -114.87 131.83 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.087 -1.243 . . . . 0.74 109.121 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.984 HD13 HD22 ' A' ' 80' ' ' LEU . 4.0 mt -78.85 -49.42 12.95 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.435 -0.791 . . . . 0.38 109.78 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.446 ' HA ' ' HB2' ' A' ' 9' ' ' ALA . . . -161.4 130.61 4.61 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.302 -0.874 . . . . 2.06 109.688 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.538 ' HA ' ' HA ' ' A' ' 109' ' ' LYS . 16.4 p -129.19 -172.11 2.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.207 -0.933 . . . . 0.93 110.01 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.491 ' HB2' ' O ' ' A' ' 119' ' ' CYS . . . 175.18 127.06 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.34 -0.85 . . . . 0.26 109.206 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.451 ' N ' HD12 ' A' ' 121' ' ' ILE . 5.2 mp -127.66 139.78 50.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.183 -0.948 . . . . 0.41 110.385 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.857 ' HB3' ' HB ' ' A' ' 106' ' ' VAL . . . -144.71 33.32 1.15 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.061 -1.089 . . . . 1.06 108.061 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.49 ' O ' ' O ' ' A' ' 122' ' ' ALA . 3.2 m -40.5 168.02 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.536 0.684 . . . . 4.52 110.662 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.462 ' H ' HG22 ' A' ' 123' ' ' THR . 0.2 OUTLIER 59.26 66.94 0.96 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.513 -0.742 . . . . 1.66 109.457 179.768 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.618 ' O ' HG23 ' A' ' 104' ' ' VAL . . . -94.86 147.2 18.51 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.313 -1.515 . . . . 1.06 109.313 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.516 ' CG ' ' HE3' ' A' ' 100' ' ' LYS . 7.6 mtmt -153.9 121.58 5.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.427 -1.043 . . . . 2.73 108.509 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.545 ' O ' ' CD ' ' A' ' 100' ' ' LYS . 1.6 mp -90.37 118.39 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.11 -0.994 . . . . 1.05 112.102 -177.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.628 ' HB2' ' HG2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER 176.14 -62.22 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.771 -1.206 . . . . 3.02 109.302 177.595 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.756 ' HB3' HG21 ' A' ' 28' ' ' ILE . 6.9 t70 . . . . . 0 N--CA 1.494 1.74 0 CA-C-O 117.953 -1.023 . . . . 4.09 109.339 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.503 ' O ' ' HB3' ' A' ' 17' ' ' MET . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.524 0.678 . . . . 5.04 109.643 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.515 ' HA ' ' HB3' ' A' ' 17' ' ' MET . 31.1 mt-30 -94.77 178.77 5.47 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.901 0.858 . . . . 4.24 110.169 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.977 HG21 ' CG2' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -133.58 -169.2 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.035 -1.098 . . . . 1.38 108.035 179.494 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -117.88 52.76 0.98 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.909 -1.119 . . . . 1.08 109.017 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 26.9 m -73.33 159.34 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.414 -0.804 . . . . 1.07 110.143 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.14 74.49 9.59 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.448 -0.782 . . . . 3.85 109.278 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.505 ' OD1' ' N ' ' A' ' 8' ' ' CYS . 0.7 OUTLIER -75.22 -170.03 1.08 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.257 -0.902 . . . . 1.86 109.55 -179.866 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.505 ' N ' ' OD1' ' A' ' 7' ' ' ASP . 16.6 p 179.25 33.76 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.112 -0.993 . . . . 2.24 109.58 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.615 ' HB1' ' O ' ' A' ' 117' ' ' LEU . . . -62.88 -58.66 6.62 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.296 -0.877 . . . . 0.68 109.607 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.503 ' CB ' ' O ' ' A' ' 9' ' ' ALA . 0.3 OUTLIER 166.59 36.73 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.612 -0.835 . . . . 3.19 109.398 -178.943 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.8 t30 51.19 34.39 11.2 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.14 -0.975 . . . . 1.69 108.716 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.485 ' HG2' ' OD1' ' A' ' 44' ' ' ASN . 6.6 tp10 -128.73 -21.85 3.35 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.366 -0.834 . . . . 3.25 110.034 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.96 HG23 ' O ' ' A' ' 40' ' ' LEU . 5.9 mt -42.51 139.25 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.146 -0.971 . . . . 0.97 108.931 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.438 ' HD2' ' OD1' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -100.59 -31.38 11.27 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-O 121.956 0.884 . . . . 1.67 108.813 -179.783 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.08 120.09 12.07 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 119.909 -0.716 . . . . 2.13 109.667 -178.065 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.632 ' O ' HG13 ' A' ' 16' ' ' VAL . 11.3 p -136.82 118.12 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.272 -0.892 . . . . 1.15 108.845 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.515 ' HB3' ' HA ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -156.05 173.41 16.84 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.426 -0.796 . . . . 5.09 109.606 -179.258 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.977 ' CG2' HG21 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -132.55 9.54 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 O-C-N 121.085 -1.009 . . . . 3.91 108.975 178.34 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.556 ' CB ' ' HA ' ' A' ' 35' ' ' PHE . 7.9 t70 77.55 58.54 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 112.551 0.575 . . . . 3.1 112.551 178.095 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' A' ' 29' ' ' ILE . . . 70.67 31.42 67.75 Favored Glycine 0 N--CA 1.499 2.876 0 O-C-N 120.777 -1.202 . . . . 2.69 111.811 177.276 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.852 ' HA ' HG23 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -92.96 -19.44 21.6 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.889 -1.359 . . . . 1.21 108.247 178.839 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.792 ' HA ' HG12 ' A' ' 3' ' ' VAL . 1.2 m-70 67.65 109.69 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.515 -0.741 . . . . 4.38 109.447 -179.094 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.46 ' O ' ' HB3' ' A' ' 24' ' ' SER . . . -80.88 178.18 54.11 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 110.175 -1.17 . . . . 0.47 110.175 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.46 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 41.0 t 62.3 151.73 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.351 -1.088 . . . . 2.68 108.509 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.61 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.2 OUTLIER 59.6 179.92 0.04 OUTLIER Pre-proline 0 C--N 1.306 -1.302 0 N-CA-C 107.336 -1.357 . . . . 5.49 107.336 -179.644 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.61 ' HD2' ' CB ' ' A' ' 25' ' ' ASP . 26.8 Cg_endo -70.78 83.74 0.86 Allowed 'Trans proline' 0 C--N 1.296 -2.228 0 C-N-CA 121.94 1.76 . . . . 0.92 108.404 178.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.462 ' O ' ' HA2' ' A' ' 125' ' ' GLY . 0.0 OUTLIER -33.37 115.54 0.22 Allowed 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 115.422 -0.808 . . . . 0.63 111.982 -178.009 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.803 HG23 ' O ' ' A' ' 126' ' ' LYS . 25.2 mm -107.72 139.56 29.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 107.46 -1.311 . . . . 0.58 107.46 176.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.852 HG23 ' HA ' ' A' ' 21' ' ' CYS . 0.7 OUTLIER -122.55 -175.57 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 O-C-N 120.981 -1.074 . . . . 0.9 111.572 -177.442 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.508 ' O ' ' CE1' ' A' ' 35' ' ' PHE . 98.1 m-70 -111.92 -171.55 1.87 Allowed 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.528 0.68 . . . . 1.67 110.366 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.564 ' CD ' ' O ' ' A' ' 98' ' ' ALA . 0.1 OUTLIER -130.39 -160.8 1.07 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.515 -0.74 . . . . 2.55 109.103 179.51 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.469 ' O ' ' HG3' ' A' ' 33' ' ' LYS . . . 40.23 34.86 0.66 Allowed Glycine 0 N--CA 1.495 2.581 0 N-CA-C 110.08 -1.208 . . . . 0.74 110.08 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.735 ' O ' HG11 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -167.96 129.02 1.16 Allowed Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.277 -1.131 . . . . 4.72 108.999 -179.921 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.502 ' HA ' ' CG2' ' A' ' 94' ' ' VAL . 20.3 Cg_endo -58.74 129.43 32.23 Favored 'Trans proline' 0 C--N 1.302 -1.883 0 C-N-CA 121.603 1.535 . . . . 1.91 109.869 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.654 ' H ' HG21 ' A' ' 94' ' ' VAL . 19.9 m-85 -79.36 40.95 0.45 Allowed 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 116.234 -0.439 . . . . 6.71 110.611 -178.051 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.482 ' C ' ' O ' ' A' ' 35' ' ' PHE . 24.4 m -35.01 91.45 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.534 -0.729 . . . . 1.48 110.585 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.681 HD21 ' HB2' ' A' ' 90' ' ' TYR . 1.0 OUTLIER -89.9 122.49 32.99 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.941 -1.133 . . . . 0.93 107.941 179.264 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.553 ' HG2' ' HG2' ' A' ' 89' ' ' LYS . 55.9 mt-10 -121.29 177.57 5.12 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 120.818 -1.176 . . . . 1.0 111.092 -178.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.518 ' O ' ' CD1' ' A' ' 41' ' ' PHE . . . 177.05 63.96 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 106.683 -1.599 . . . . 0.89 106.683 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.96 ' O ' HG23 ' A' ' 13' ' ' ILE . 0.6 OUTLIER -69.83 168.24 15.55 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 115.337 -0.847 . . . . 0.48 110.31 -178.281 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.658 ' CE2' ' CE2' ' A' ' 86' ' ' TYR . 6.3 p90 -178.73 146.97 0.36 Allowed 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.299 -0.875 . . . . 0.36 109.229 179.016 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.589 ' O ' ' C ' ' A' ' 43' ' ' ALA . 0.4 OUTLIER -94.44 98.22 10.72 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 106.314 -1.735 . . . . 4.87 106.314 177.664 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.716 ' HB1' ' O ' ' A' ' 81' ' ' VAL . . . -17.83 122.38 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 115.38 -0.827 . . . . 1.21 110.722 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.485 ' OD1' ' HG2' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -118.97 30.74 7.01 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.317 -0.865 . . . . 2.16 111.017 -177.866 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.962 ' OE1' HD21 ' A' ' 117' ' ' LEU . 2.0 pt20 -126.59 -142.15 0.28 Allowed 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.988 -1.115 . . . . 0.6 107.988 179.16 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.774 ' HA ' ' HB ' ' A' ' 81' ' ' VAL . 0.1 OUTLIER -154.04 68.31 0.75 Allowed 'General case' 0 C--N 1.292 -1.917 0 O-C-N 121.058 -1.026 . . . . 2.31 108.675 177.889 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.765 HG23 ' O ' ' A' ' 47' ' ' THR . 10.7 t -145.69 120.89 10.17 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 120.101 -1.624 . . . . 0.57 111.96 -177.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.614 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -67.59 -25.63 65.87 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.608 -1.307 . . . . 2.18 107.812 177.336 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.452 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 66.0 p -82.63 -163.57 0.72 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.695 -0.628 . . . . 0.7 109.373 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.957 ' CB ' ' HB3' ' A' ' 72' ' ' ALA . . . 175.63 160.46 0.26 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.284 -0.885 . . . . 0.27 109.817 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 1.026 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -126.66 -160.14 0.97 Allowed 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 106.516 -1.661 . . . . 3.25 106.516 177.581 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.469 ' HB ' ' O ' ' A' ' 51' ' ' LYS . 20.6 tt -177.56 164.41 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 C-N-CA 117.914 -1.515 . . . . 0.58 111.641 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.522 ' O ' ' HE2' ' A' ' 55' ' ' LYS . 2.3 mt-10 -165.46 59.28 0.12 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.124 -1.065 . . . . 0.9 108.124 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.896 ' HB ' HG21 ' A' ' 65' ' ' VAL . 0.4 OUTLIER -96.99 139.77 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.352 -0.842 . . . . 0.6 109.997 -179.462 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.693 ' HG3' ' O ' ' A' ' 54' ' ' ILE . 1.9 mtmt -150.96 93.38 1.93 Allowed 'General case' 0 C--N 1.284 -2.274 0 C-N-CA 119.833 -0.747 . . . . 0.88 109.781 178.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.507 ' HB3' ' HB ' ' A' ' 63' ' ' ILE . . . -110.35 150.4 28.83 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 108.022 -1.103 . . . . 0.58 108.022 178.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.494 ' HA ' ' HA ' ' A' ' 62' ' ' GLU . 0.8 OUTLIER -131.03 122.81 27.45 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.774 -1.204 . . . . 1.26 111.392 -178.622 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.969 HD13 ' N ' ' A' ' 59' ' ' ASP . 2.0 tm? -110.37 158.23 18.67 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.034 -1.099 . . . . 1.93 108.034 178.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.969 ' N ' HD13 ' A' ' 58' ' ' LEU . 23.4 t0 -40.89 -72.25 0.07 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.155 -0.966 . . . . 3.23 109.792 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -106.29 30.39 9.66 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.496 -1.442 . . . . 0.74 109.496 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.493 ' HB3' ' HB3' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -150.28 60.53 0.97 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.347 -1.09 . . . . 1.09 108.996 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 0.1 OUTLIER -63.42 86.82 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.661 -0.649 . . . . 3.4 110.653 -179.31 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.507 ' HB ' ' HB3' ' A' ' 56' ' ' ALA . 2.0 mt -54.69 160.96 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 107.442 -1.318 . . . . 0.42 107.442 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -168.42 146.95 4.29 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.678 -1.264 . . . . 2.6 110.097 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.896 HG21 ' HB ' ' A' ' 54' ' ' ILE . 4.9 t -149.0 74.83 9.99 Favored Pre-proline 0 N--CA 1.488 1.44 0 O-C-N 121.631 -0.668 . . . . 0.41 109.285 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -80.33 -7.59 13.92 Favored 'Trans proline' 0 C--N 1.302 -1.886 0 C-N-CA 123.028 2.486 . . . . 1.05 110.465 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 135.39 56.12 0.06 OUTLIER Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.464 -1.454 . . . . 0.88 109.464 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 21.0 mt -81.46 -59.48 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.273 -1.133 . . . . 1.7 109.729 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.507 ' HB3' ' HB2' ' A' ' 74' ' ' HIS . 8.9 p30 -66.75 142.74 57.28 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.117 -0.989 . . . . 1.65 109.228 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.416 ' O ' ' CG ' ' A' ' 71' ' ' ASN . 5.8 t -67.69 -10.27 50.91 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.084 -1.01 . . . . 2.89 108.848 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.588 ' CA ' ' O ' ' A' ' 50' ' ' ALA . 7.4 m-20 178.02 66.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.918 . . . . 0.31 110.347 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 1.026 ' HB2' ' O ' ' A' ' 51' ' ' LYS . . . 39.77 27.54 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 121.456 0.646 . . . . 0.28 110.674 177.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.478 ' N ' ' O ' ' A' ' 71' ' ' ASN . 6.7 t -102.76 -22.34 13.93 Favored 'General case' 0 C--N 1.293 -1.885 0 O-C-N 121.447 -0.783 . . . . 0.64 109.88 -179.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.507 ' HB2' ' HB3' ' A' ' 69' ' ' ASP . 0.4 OUTLIER -84.93 5.87 27.29 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.228 -0.92 . . . . 3.69 109.783 -179.881 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.683 ' C ' HG12 ' A' ' 76' ' ' VAL . 76.5 m-85 -135.37 0.79 2.83 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.044 -1.035 . . . . 0.85 110.841 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.777 ' HB ' ' CE1' ' A' ' 86' ' ' TYR . 0.2 OUTLIER -167.92 173.66 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.362 -1.461 . . . . 0.64 111.139 -178.094 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.635 ' N ' HG23 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -55.03 94.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 106.264 -1.754 . . . . 4.32 106.264 177.447 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' CYS . . . . . 0.605 ' HB2' ' HD3' ' A' ' 79' ' ' PRO . 2.4 m -33.47 -53.27 0.75 Allowed Pre-proline 0 N--CA 1.504 2.236 0 O-C-N 121.789 -0.569 . . . . 0.95 112.382 -176.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.614 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 33.9 Cg_endo -79.75 113.08 3.0 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 120.93 1.086 . . . . 0.86 110.193 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 1.089 HD12 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -97.37 -65.7 0.95 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.229 -0.919 . . . . 0.68 108.58 -179.59 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.774 ' HB ' ' HA ' ' A' ' 46' ' ' ASN . 1.3 m 41.38 -168.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 C-N-CA 120.32 -0.552 . . . . 0.8 109.701 178.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.74 ' H ' HG23 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -102.53 42.38 1.15 Allowed 'General case' 0 C--N 1.29 -1.982 0 O-C-N 120.133 -1.604 . . . . 1.27 110.999 -175.98 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.492 ' O ' ' OE1' ' A' ' 84' ' ' GLN . . . -151.83 31.73 0.9 Allowed Glycine 0 C--N 1.285 -2.264 0 N-CA-C 108.995 -1.642 . . . . 1.39 108.995 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.492 ' OE1' ' O ' ' A' ' 83' ' ' GLY . 0.2 OUTLIER -137.3 121.69 18.23 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.284 -1.127 . . . . 3.96 110.726 -179.018 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -97.01 125.56 41.52 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 105.435 -2.061 . . . . 2.39 105.435 176.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.945 ' OH ' HD13 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -153.51 161.08 42.59 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 117.657 -1.617 . . . . 0.65 109.759 -177.445 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.642 ' CB ' ' HG ' ' A' ' 40' ' ' LEU . 3.1 p-10 -129.23 101.09 5.85 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.97 -1.081 . . . . 0.84 113.285 -175.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.945 HD13 ' OH ' ' A' ' 86' ' ' TYR . 3.2 tp -69.17 -160.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 107.722 -1.214 . . . . 1.0 107.722 176.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.734 ' N ' HG23 ' A' ' 88' ' ' ILE . 0.0 OUTLIER 159.75 170.14 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.196 -0.94 . . . . 1.59 109.993 179.689 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.681 ' HB2' HD21 ' A' ' 37' ' ' LEU . 10.0 m-85 -162.48 67.83 0.24 Allowed 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.944 -0.762 . . . . 1.52 108.944 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.54 ' C ' ' CD1' ' A' ' 92' ' ' TRP . 3.0 t -56.39 176.19 0.09 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.474 -0.766 . . . . 2.42 109.94 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.667 ' CD1' ' N ' ' A' ' 92' ' ' TRP . 0.0 OUTLIER -142.36 147.79 36.85 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.229 -0.919 . . . . 5.33 109.914 -179.377 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.551 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 25.3 m-20 -74.93 94.64 2.85 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 104.338 -2.468 . . . . 5.51 104.338 175.306 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.976 HG13 ' CD1' ' A' ' 97' ' ' ILE . 60.8 t -106.3 96.04 12.72 Favored Pre-proline 0 N--CA 1.488 1.466 0 C-N-CA 118.817 -1.153 . . . . 2.29 113.777 -175.259 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.826 ' HD2' HD11 ' A' ' 97' ' ' ILE . 35.2 Cg_endo -77.42 -150.11 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.538 2.158 . . . . 2.64 107.319 174.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.553 ' O ' ' CB ' ' A' ' 31' ' ' ARG . 0.7 OUTLIER -72.12 -25.23 61.65 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.426 -1.421 . . . . 2.35 108.561 178.485 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.976 ' CD1' HG13 ' A' ' 94' ' ' VAL . 4.0 mt 43.25 14.49 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.505 -0.747 . . . . 1.34 112.842 179.086 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 1.049 ' HB1' ' HD2' ' A' ' 99' ' ' PRO . . . 52.64 175.38 0.03 OUTLIER Pre-proline 0 C--N 1.304 -1.403 0 O-C-N 119.769 -1.832 . . . . 1.27 109.226 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 1.049 ' HD2' ' HB1' ' A' ' 98' ' ' ALA . 37.3 Cg_endo -73.1 -7.17 20.21 Favored 'Trans proline' 0 C--N 1.299 -2.055 0 C-N-CA 123.293 2.662 . . . . 4.06 110.995 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.648 ' HD3' ' CB ' ' A' ' 128' ' ' ARG . 1.1 mmmt -149.73 126.58 11.12 Favored 'General case' 0 C--N 1.276 -2.623 0 C-N-CA 119.462 -0.895 . . . . 0.81 109.859 -178.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.647 ' HB3' HD13 ' A' ' 127' ' ' ILE . 4.3 t -89.3 159.09 17.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.187 -0.945 . . . . 1.03 109.642 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.63 -10.65 48.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.444 -0.785 . . . . 1.4 110.362 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.507 ' C ' ' CG2' ' A' ' 104' ' ' VAL . 0.1 OUTLIER 175.1 146.05 0.07 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.814 -1.178 . . . . 3.07 110.177 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.656 ' O ' HG23 ' A' ' 105' ' ' VAL . 0.2 OUTLIER -156.68 168.36 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.556 -0.715 . . . . 0.94 109.804 -179.781 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 104' ' ' VAL . 0.9 OUTLIER 161.87 125.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.261 -1.015 . . . . 1.16 108.261 -179.934 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.483 HG22 ' HH2' ' A' ' 92' ' ' TRP . 42.6 t -119.53 96.4 4.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 120.986 -1.071 . . . . 1.75 110.664 -179.266 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.539 ' O ' HG23 ' A' ' 108' ' ' VAL . 7.4 m -105.43 150.56 25.16 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.246 -1.39 . . . . 0.61 107.246 178.206 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.546 HG12 ' N ' ' A' ' 109' ' ' LYS . 75.6 t -157.84 160.76 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 C-N-CA 118.281 -1.368 . . . . 1.14 111.545 -178.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.546 ' N ' HG12 ' A' ' 108' ' ' VAL . 1.8 ttpt 177.54 126.39 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.524 -0.917 . . . . 1.16 108.524 178.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.492 ' HB3' ' HB2' ' A' ' 117' ' ' LEU . 11.5 tp -118.35 127.6 53.84 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 107.275 -1.38 . . . . 1.08 107.275 178.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.543 HD11 ' HG2' ' A' ' 109' ' ' LYS . 1.7 mt -124.97 116.93 48.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 O-C-N 121.262 -0.899 . . . . 1.09 111.503 -177.216 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.473 ' HA2' ' HA ' ' A' ' 50' ' ' ALA . . . -86.1 -110.1 0.78 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.122 -1.991 . . . . 0.36 108.122 177.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.407 ' O ' ' CG ' ' A' ' 113' ' ' ASP . 7.4 t70 -136.54 1.71 2.63 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.066 -1.255 . . . . 2.11 107.71 178.196 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.433 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 3.3 m120 -116.1 -20.42 9.88 Favored 'General case' 0 C--N 1.31 -1.139 0 O-C-N 121.491 -0.756 . . . . 0.65 109.601 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 169.76 -161.32 34.63 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.35 -1.5 . . . . 0.49 109.35 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.51 HG21 ' HB3' ' A' ' 119' ' ' CYS . 2.5 p -90.8 105.34 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.101 -1.235 . . . . 0.88 109.517 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 1.089 HD22 HD12 ' A' ' 80' ' ' LEU . 1.4 mt -49.58 -53.23 25.02 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.219 -0.926 . . . . 0.81 110.8 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.559 ' HA ' ' HA ' ' A' ' 9' ' ' ALA . . . -158.24 129.08 6.33 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.219 -0.926 . . . . 2.13 110.245 -178.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.51 ' HB3' HG21 ' A' ' 116' ' ' VAL . 10.2 p -134.29 169.2 17.56 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.484 -0.76 . . . . 1.07 109.439 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.446 ' O ' HG13 ' A' ' 121' ' ' ILE . . . -173.31 138.75 0.73 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.375 -0.828 . . . . 0.62 109.0 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 120' ' ' ALA . 2.7 mp -139.44 132.45 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.975 -1.078 . . . . 0.49 110.437 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.466 ' O ' ' C ' ' A' ' 123' ' ' THR . . . -114.74 93.5 4.35 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.994 -1.113 . . . . 0.43 107.994 179.009 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.466 ' C ' ' O ' ' A' ' 122' ' ' ALA . 98.6 m -33.47 99.2 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.489 0.661 . . . . 1.74 110.835 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.41 ' N ' ' O ' ' A' ' 122' ' ' ALA . 0.1 OUTLIER 53.92 176.32 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.627 -0.671 . . . . 3.54 110.111 179.704 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.498 ' O ' ' HB ' ' A' ' 104' ' ' VAL . . . -160.31 119.35 0.88 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.546 -1.422 . . . . 0.73 109.546 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.803 ' O ' HG23 ' A' ' 28' ' ' ILE . 0.4 OUTLIER -128.61 104.72 7.83 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.14 -1.212 . . . . 2.02 109.461 -179.865 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.647 HD13 ' HB3' ' A' ' 101' ' ' SER . 2.8 mp -54.77 157.26 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.249 -0.907 . . . . 1.33 109.28 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.648 ' CB ' ' HD3' ' A' ' 100' ' ' LYS . 0.0 OUTLIER 134.66 -86.2 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.446 0 N-CA-C 108.266 -1.013 . . . . 3.85 108.266 179.37 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.62 ' C ' HG21 ' A' ' 28' ' ' ILE . 1.7 t0 . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 118.077 -0.963 . . . . 2.65 109.543 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 1' ' ' ASP . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.484 0.659 . . . . 2.31 109.817 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.574 ' HA ' ' HB3' ' A' ' 17' ' ' MET . 66.7 mt-30 53.99 -179.31 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.888 0.852 . . . . 3.85 110.887 178.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.852 HG13 ' N ' ' A' ' 4' ' ' ASP . 0.8 OUTLIER -170.94 -155.26 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 108.78 -0.822 . . . . 3.59 108.78 179.85 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.852 ' N ' HG13 ' A' ' 3' ' ' VAL . 17.7 m-20 -146.58 114.95 6.69 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.9 -1.125 . . . . 3.12 110.245 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.49 HG23 ' OD1' ' A' ' 7' ' ' ASP . 15.7 m -142.21 146.42 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 120.965 -1.085 . . . . 0.85 109.792 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.488 ' O ' HG12 ' A' ' 121' ' ' ILE . 8.5 mmtt -69.59 105.3 2.62 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.319 -0.863 . . . . 3.48 109.877 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.49 ' OD1' HG23 ' A' ' 5' ' ' VAL . 0.8 OUTLIER -95.91 167.42 11.26 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.145 -0.972 . . . . 3.44 108.641 179.335 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.561 ' HB2' HG21 ' A' ' 116' ' ' VAL . 6.3 m -140.07 7.98 2.26 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.052 -1.03 . . . . 1.19 109.755 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.529 ' CA ' ' HA ' ' A' ' 118' ' ' ALA . . . -49.62 -75.34 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.163 -0.961 . . . . 0.94 109.587 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.449 ' CB ' ' O ' ' A' ' 9' ' ' ALA . 0.9 OUTLIER 167.34 37.29 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.885 -0.783 . . . . 1.5 108.885 -178.478 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 58.41 26.27 13.93 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.908 -1.145 . . . . 2.72 107.908 -178.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.484 ' O ' ' C ' ' A' ' 13' ' ' ILE . 0.3 OUTLIER -116.98 -21.72 8.79 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.507 -0.746 . . . . 2.59 110.414 -179.16 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.88 HG23 ' O ' ' A' ' 40' ' ' LEU . 5.7 mt -43.09 139.87 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 108.144 -1.058 . . . . 1.15 108.144 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.27 -25.59 16.97 Favored 'General case' 0 C--N 1.292 -1.931 0 O-C-N 121.513 -0.742 . . . . 2.1 109.585 -178.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.7 mtmt -167.48 105.51 0.54 Allowed 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 118.006 -1.478 . . . . 1.34 111.981 -178.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.53 ' HA ' ' HA ' ' A' ' 39' ' ' ALA . 2.2 p -116.97 94.72 3.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 N-CA-C 106.152 -1.795 . . . . 0.94 106.152 177.135 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.574 ' HB3' ' HA ' ' A' ' 2' ' ' GLN . 12.3 mmt -132.46 142.51 49.27 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.558 -0.713 . . . . 3.13 111.392 -176.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.668 HG13 ' HG ' ' A' ' 37' ' ' LEU . 16.7 t -110.84 141.02 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 107.935 -1.135 . . . . 1.2 107.935 178.093 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.47 ' HB3' ' HA ' ' A' ' 35' ' ' PHE . 7.4 t70 -62.95 -40.93 99.16 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.094 -1.004 . . . . 2.52 110.538 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.542 ' O ' ' CB ' ' A' ' 21' ' ' CYS . . . -156.01 139.82 6.84 Favored Glycine 0 N--CA 1.489 2.212 0 C-N-CA 119.351 -1.404 . . . . 1.57 110.286 -179.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.897 ' CA ' HG23 ' A' ' 29' ' ' ILE . 0.0 OUTLIER 155.01 -56.76 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.572 -0.958 . . . . 0.84 108.812 179.288 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.614 ' HA ' HG23 ' A' ' 3' ' ' VAL . 1.6 t60 80.66 120.57 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 107.689 -1.226 . . . . 2.98 107.689 -177.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.735 ' H ' HG22 ' A' ' 3' ' ' VAL . . . -106.26 -166.88 22.97 Favored Glycine 0 N--CA 1.493 2.481 0 C-N-CA 119.25 -1.453 . . . . 0.76 111.341 -178.21 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.439 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 0.5 OUTLIER 69.86 -87.9 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.499 -1.0 . . . . 0.86 108.602 -179.241 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.653 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 3.0 p-10 -63.66 -163.61 0.01 OUTLIER Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 107.14 -1.43 . . . . 1.35 107.14 178.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.653 ' HD2' ' CB ' ' A' ' 25' ' ' ASP . 29.6 Cg_endo -72.32 106.09 1.99 Allowed 'Trans proline' 0 C--N 1.313 -1.323 0 N-CA-C 108.545 -1.367 . . . . 1.63 108.545 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.533 ' HB2' ' O ' ' A' ' 22' ' ' HIS . 1.3 t -62.44 92.47 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.756 -0.59 . . . . 0.96 112.579 -176.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.549 HD12 ' O ' ' A' ' 26' ' ' PRO . 1.7 mp -91.1 135.0 27.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 105.182 -2.155 . . . . 1.97 105.182 174.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.897 HG23 ' CA ' ' A' ' 21' ' ' CYS . 0.1 OUTLIER -108.82 173.79 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.196 0 O-C-N 120.666 -1.272 . . . . 0.46 111.147 -177.476 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.429 ' O ' ' CZ ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -102.43 132.51 48.4 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 122.2 1.0 . . . . 3.23 111.708 -178.467 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.724 ' HD3' ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -99.21 109.9 22.51 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 115.634 -0.712 . . . . 9.23 109.265 179.21 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' A' ' 95' ' ' PRO . . . 136.18 0.71 3.02 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.556 -1.307 . . . . 1.28 110.336 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.502 ' C ' ' HB ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -139.32 139.07 21.72 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 120.868 -1.372 . . . . 2.41 109.631 179.891 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.412 ' HA ' ' HB ' ' A' ' 94' ' ' VAL . 30.5 Cg_endo -70.99 123.32 9.59 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.713 2.275 . . . . 2.47 110.224 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.47 ' HA ' ' HB3' ' A' ' 19' ' ' ASP . 19.6 m-30 -103.91 -164.65 1.08 Allowed 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.777 0.799 . . . . 7.1 110.32 -178.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.72 HG22 ' O ' ' A' ' 36' ' ' THR . 1.3 m -179.84 90.36 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.679 -0.86 . . . . 0.7 108.679 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.668 ' HG ' HG13 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -57.35 152.7 13.71 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.086 -1.009 . . . . 3.84 108.438 179.729 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.53 ' HG3' ' O ' ' A' ' 36' ' ' THR . 72.8 mt-10 -154.13 176.6 12.05 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.89 -1.131 . . . . 0.42 111.015 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.53 ' HA ' ' HA ' ' A' ' 16' ' ' VAL . . . 168.71 85.89 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.252 -1.388 . . . . 0.62 107.252 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.88 ' O ' HG23 ' A' ' 13' ' ' ILE . 4.3 mp -88.22 144.52 26.4 Favored 'General case' 0 C--N 1.291 -1.97 0 O-C-N 121.85 -0.531 . . . . 1.11 110.095 -178.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.801 ' CE2' ' CD2' ' A' ' 86' ' ' TYR . 0.1 OUTLIER -136.2 174.69 10.34 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.942 -1.099 . . . . 0.89 108.26 176.841 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.495 ' O ' ' C ' ' A' ' 43' ' ' ALA . 0.2 OUTLIER -126.24 102.24 7.1 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 106.651 -1.611 . . . . 2.76 106.651 178.582 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.887 ' HB1' ' O ' ' A' ' 81' ' ' VAL . . . -34.79 117.59 0.38 Allowed 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 115.548 -0.751 . . . . 0.38 109.33 -179.322 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.492 ' O ' ' HB3' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -126.8 0.15 6.69 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.36 0.6 . . . . 0.63 109.68 -178.473 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.971 ' OE1' HD21 ' A' ' 117' ' ' LEU . 3.3 pt20 -90.86 -141.64 0.17 Allowed 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.405 -0.961 . . . . 0.9 108.405 179.3 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.827 ' HA ' ' HB ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -156.86 71.76 0.69 Allowed 'General case' 0 C--N 1.293 -1.848 0 O-C-N 120.962 -1.086 . . . . 0.9 109.641 178.94 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.715 HG23 ' O ' ' A' ' 47' ' ' THR . 7.5 t -150.33 122.19 8.15 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.17 -1.581 . . . . 1.14 111.003 -178.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.636 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 1.7 mtpt -69.17 -17.97 63.87 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.89 -1.131 . . . . 3.32 109.131 178.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.474 ' OG1' ' OG1' ' A' ' 47' ' ' THR . 1.1 p -76.32 176.41 8.18 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.16 -0.963 . . . . 1.33 109.719 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.774 ' HB1' ' HB3' ' A' ' 72' ' ' ALA . . . -176.23 136.89 0.29 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.242 -0.911 . . . . 0.6 109.962 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 1.059 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -121.1 -156.26 0.67 Allowed 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.723 -1.214 . . . . 2.4 107.723 178.393 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.521 ' CG1' HD13 ' A' ' 54' ' ' ILE . 17.3 tt -175.31 165.59 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 C-N-CA 118.616 -1.234 . . . . 0.42 111.293 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.542 ' C ' HD12 ' A' ' 54' ' ' ILE . 0.4 OUTLIER -168.09 68.94 0.08 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.718 -0.845 . . . . 3.18 108.718 179.778 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.978 HG21 ' CZ ' ' A' ' 90' ' ' TYR . 0.7 OUTLIER -109.17 149.76 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.308 -0.87 . . . . 0.62 110.066 -178.967 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.606 ' HG3' ' O ' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -164.98 100.73 0.76 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.331 -0.856 . . . . 1.43 109.602 178.16 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.516 ' HB3' ' HB ' ' A' ' 63' ' ' ILE . . . -106.74 147.9 29.07 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.114 -0.991 . . . . 0.95 108.375 178.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.546 ' HA ' ' HA ' ' A' ' 62' ' ' GLU . 37.2 t -132.5 129.12 38.73 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.868 -1.145 . . . . 1.7 110.315 -179.063 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.668 HD22 ' H ' ' A' ' 59' ' ' ASP . 0.1 OUTLIER -114.15 -152.13 0.5 Allowed 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.081 -1.081 . . . . 3.28 108.081 179.42 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.668 ' H ' HD22 ' A' ' 58' ' ' LEU . 48.4 t0 -106.72 87.73 2.59 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.71 -1.244 . . . . 4.15 108.403 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.71 -6.93 62.94 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 108.326 -1.91 . . . . 1.94 108.326 -178.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -128.02 49.66 2.13 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 107.581 -1.266 . . . . 1.28 107.581 179.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.546 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 1.8 tt0 -59.65 91.24 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.862 -0.524 . . . . 3.43 109.967 -179.047 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.591 HG21 ' HD2' ' A' ' 90' ' ' TYR . 8.3 mt -55.98 159.85 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 C-N-CA 118.773 -1.171 . . . . 1.27 107.952 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.431 ' C ' ' OD1' ' A' ' 64' ' ' ASP . 40.2 p-10 -156.27 162.92 40.08 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.174 -0.954 . . . . 5.12 110.202 -179.314 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.719 HG21 ' HB ' ' A' ' 54' ' ' ILE . 35.4 t -146.92 66.37 10.42 Favored Pre-proline 0 C--N 1.303 -1.442 0 O-C-N 121.499 -0.751 . . . . 1.77 109.11 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.523 ' O ' ' C ' ' A' ' 67' ' ' GLY . 37.3 Cg_endo -80.25 102.72 1.46 Allowed 'Trans proline' 0 C--N 1.3 -1.979 0 C-N-CA 123.329 2.686 . . . . 4.47 111.34 -179.091 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.523 ' C ' ' O ' ' A' ' 66' ' ' PRO . . . 22.99 51.8 0.02 OUTLIER Glycine 0 N--CA 1.5 2.914 0 N-CA-C 111.511 -0.635 . . . . 1.13 111.511 179.06 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.415 ' N ' ' O ' ' A' ' 66' ' ' PRO . 6.6 mt -60.73 -81.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.072 -1.252 . . . . 2.74 109.442 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.625 ' HB3' ' CG ' ' A' ' 74' ' ' HIS . 52.3 p30 -68.69 -167.62 0.1 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.342 -0.849 . . . . 2.25 109.957 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.462 ' O ' ' OD1' ' A' ' 71' ' ' ASN . 1.1 p -111.11 5.1 19.88 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.982 -0.747 . . . . 1.07 108.982 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.543 ' CA ' ' O ' ' A' ' 50' ' ' ALA . 2.2 m-20 172.95 69.1 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.177 -0.952 . . . . 1.36 110.972 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 1.059 ' HB2' ' O ' ' A' ' 51' ' ' LYS . . . 38.75 23.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 112.627 0.602 . . . . 0.45 112.627 177.011 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.508 ' N ' ' O ' ' A' ' 71' ' ' ASN . 22.9 t -99.19 4.56 46.8 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.651 -1.281 . . . . 1.74 111.422 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.625 ' CG ' ' HB3' ' A' ' 69' ' ' ASP . 4.2 m170 -95.63 -18.25 20.69 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.419 -1.425 . . . . 2.67 109.56 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.513 ' CD1' ' N ' ' A' ' 75' ' ' PHE . 5.4 m-85 -97.85 -26.69 14.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.346 -0.846 . . . . 2.23 108.884 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 1.278 HG21 ' CZ ' ' A' ' 86' ' ' TYR . 15.4 m -147.48 -139.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.811 -0.811 . . . . 3.16 108.811 -178.393 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.736 ' N ' HG23 ' A' ' 76' ' ' VAL . 15.0 mmmt -93.03 162.74 13.92 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.141 -1.429 . . . . 4.16 107.141 177.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' CYS . . . . . 0.53 ' N ' ' HD2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -83.16 -51.3 0.67 Allowed Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 120.469 -1.394 . . . . 1.15 109.949 -179.829 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.636 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 29.1 Cg_endo -76.77 120.7 5.6 Favored 'Trans proline' 0 C--N 1.302 -1.918 0 N-CA-C 108.447 -1.405 . . . . 1.14 108.447 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 1.061 HD12 HD22 ' A' ' 117' ' ' LEU . 0.3 OUTLIER -98.19 -67.38 0.85 Allowed 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.918 -1.142 . . . . 1.15 107.918 -178.958 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.887 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 1.4 m 41.26 -167.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 C-N-CA 120.353 -0.539 . . . . 0.62 109.872 177.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.737 ' H ' HG23 ' A' ' 81' ' ' VAL . 0.6 OUTLIER -99.96 42.23 1.12 Allowed 'General case' 0 C--N 1.293 -1.881 0 O-C-N 120.529 -1.357 . . . . 3.32 110.195 -177.4 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -148.79 44.78 0.74 Allowed Glycine 0 C--N 1.288 -2.12 0 N-CA-C 109.152 -1.579 . . . . 0.64 109.152 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -152.47 162.33 41.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.057 -1.26 . . . . 4.89 110.259 -179.138 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -117.26 141.63 48.06 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.099 -1.074 . . . . 5.2 108.099 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 1.278 ' CZ ' HG21 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -108.33 -173.55 2.31 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.908 -1.12 . . . . 3.02 112.27 -177.542 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.65 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 2.9 t70 159.52 74.45 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.28 0 CA-C-O 121.826 0.822 . . . . 2.04 109.54 178.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.563 HG22 ' CG1' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -106.92 137.49 37.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 107.581 -1.266 . . . . 2.53 107.581 179.37 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.57 ' O ' ' CD1' ' A' ' 90' ' ' TYR . 8.6 mttt -142.88 -166.42 2.29 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.613 -1.304 . . . . 1.17 111.57 -178.217 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.978 ' CZ ' HG21 ' A' ' 54' ' ' ILE . 77.3 m-85 -155.86 77.83 0.97 Allowed 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 108.62 -0.881 . . . . 0.8 108.62 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.554 HG22 ' H ' ' A' ' 92' ' ' TRP . 12.4 m -45.58 171.17 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.365 -0.834 . . . . 3.04 109.533 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.618 ' CZ2' ' HG ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -150.34 107.99 3.67 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 118.97 -1.092 . . . . 2.97 111.535 -179.311 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.459 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 0.7 OUTLIER -72.8 98.93 2.52 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 106.23 -1.767 . . . . 3.32 106.23 177.042 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.978 HG13 HD13 ' A' ' 97' ' ' ILE . 69.6 t -109.74 95.56 20.55 Favored Pre-proline 0 C--N 1.301 -1.504 0 C-N-CA 119.037 -1.065 . . . . 1.22 113.159 -176.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.77 ' HD2' HD11 ' A' ' 97' ' ' ILE . 31.1 Cg_endo -75.21 -92.86 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.833 2.356 . . . . 1.09 108.441 175.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.523 ' O ' ' HB3' ' A' ' 31' ' ' ARG . 1.3 mmtp -121.06 -53.12 2.06 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 105.223 -2.14 . . . . 4.13 105.223 176.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.978 HD13 HG13 ' A' ' 94' ' ' VAL . 1.6 mp 61.35 28.8 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 112.632 0.605 . . . . 1.01 112.632 175.338 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.587 ' O ' ' HG3' ' A' ' 31' ' ' ARG . . . 58.64 160.52 0.09 OUTLIER Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 120.949 -1.095 . . . . 2.13 111.011 177.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.633 ' O ' ' HA ' ' A' ' 128' ' ' ARG . 46.2 Cg_endo -84.69 4.99 6.52 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 124.087 3.191 . . . . 2.79 110.801 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.601 ' HD3' ' CB ' ' A' ' 128' ' ' ARG . 4.6 mmmt -161.78 139.27 8.74 Favored 'General case' 0 C--N 1.283 -2.285 0 C-N-CA 119.332 -0.947 . . . . 1.28 110.647 -177.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' SER . . . . . 1.063 ' CB ' HD13 ' A' ' 127' ' ' ILE . 32.3 t -109.06 2.59 21.28 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.417 -0.802 . . . . 1.55 109.043 178.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.529 ' O ' ' CB ' ' A' ' 103' ' ' ASN . 72.9 mt-10 64.54 2.05 1.5 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.557 -0.715 . . . . 5.54 110.144 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.529 ' CB ' ' O ' ' A' ' 102' ' ' GLU . 0.9 OUTLIER 163.94 152.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.02 -1.05 . . . . 3.01 109.919 179.908 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.462 ' CG2' ' C ' ' A' ' 103' ' ' ASN . 0.3 OUTLIER -153.78 168.52 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.686 -0.857 . . . . 1.76 108.686 179.52 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.425 ' O ' HG12 ' A' ' 105' ' ' VAL . 1.1 t -161.81 131.13 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.946 -1.097 . . . . 0.81 109.66 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.966 ' HB ' ' HB3' ' A' ' 122' ' ' ALA . 3.4 t -132.24 124.98 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.24 -0.913 . . . . 1.2 109.287 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.812 ' O ' HG23 ' A' ' 108' ' ' VAL . 1.9 m -147.46 156.36 42.79 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.378 -0.826 . . . . 0.68 108.838 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.812 HG23 ' O ' ' A' ' 107' ' ' THR . 7.5 t -165.9 162.76 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.146 -0.971 . . . . 0.5 109.773 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.562 ' N ' ' CG1' ' A' ' 108' ' ' VAL . 0.3 OUTLIER 174.95 139.02 0.05 OUTLIER 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.419 -0.8 . . . . 0.64 109.527 179.302 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.703 HD21 ' OH ' ' A' ' 86' ' ' TYR . 7.7 tp -126.57 129.28 48.26 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.289 -1.374 . . . . 0.78 107.289 178.219 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 12.5 mt -125.03 128.18 72.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 121.189 -0.945 . . . . 0.69 111.283 -177.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.41 ' HA3' HG21 ' A' ' 47' ' ' THR . . . -103.51 -114.16 3.9 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 107.443 -2.263 . . . . 1.19 107.443 177.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -137.64 4.35 2.58 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.138 -1.431 . . . . 1.21 107.138 177.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.446 ' ND2' ' N ' ' A' ' 114' ' ' ASN . 0.7 OUTLIER -124.03 13.92 9.12 Favored 'General case' 0 C--N 1.308 -1.238 0 O-C-N 121.545 -0.722 . . . . 1.13 109.402 -179.688 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 132.77 -158.97 23.32 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.653 -1.379 . . . . 0.67 109.653 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.561 HG21 ' HB2' ' A' ' 8' ' ' CYS . 0.2 OUTLIER -99.37 117.04 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.296 -1.12 . . . . 0.51 109.394 179.702 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 1.061 HD22 HD12 ' A' ' 80' ' ' LEU . 1.3 mt -61.63 -41.49 97.56 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.606 -0.684 . . . . 0.8 110.875 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.529 ' HA ' ' CA ' ' A' ' 9' ' ' ALA . . . -168.51 136.16 2.08 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.114 -0.991 . . . . 1.66 110.235 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.548 ' SG ' ' N ' ' A' ' 8' ' ' CYS . 0.5 OUTLIER -137.32 177.72 7.65 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.533 -0.729 . . . . 0.95 109.452 179.852 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.591 ' C ' HD13 ' A' ' 121' ' ' ILE . . . -173.95 123.49 0.33 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.238 -0.914 . . . . 0.39 108.804 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.591 HD13 ' C ' ' A' ' 120' ' ' ALA . 0.0 OUTLIER -127.48 140.87 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.055 -1.028 . . . . 1.69 111.429 -178.633 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.966 ' HB3' ' HB ' ' A' ' 106' ' ' VAL . . . -119.37 136.52 54.24 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.771 -1.196 . . . . 1.61 107.771 177.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.412 ' O ' ' O ' ' A' ' 124' ' ' HIS . 17.7 m -89.62 94.69 9.95 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.813 -1.18 . . . . 1.22 110.695 -178.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.412 ' O ' ' O ' ' A' ' 123' ' ' THR . 1.6 t60 54.26 166.04 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.693 0.758 . . . . 3.52 110.991 178.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -156.05 170.22 33.75 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 108.348 -1.901 . . . . 2.11 108.348 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.54 ' HB2' HG13 ' A' ' 28' ' ' ILE . 0.4 OUTLIER -150.65 81.37 1.34 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.766 -1.432 . . . . 1.67 109.806 -179.932 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 1.063 HD13 ' CB ' ' A' ' 101' ' ' SER . 3.3 mp -41.63 138.07 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.65 -0.656 . . . . 0.82 110.573 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.674 ' HB3' ' O ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER 167.4 -165.58 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 122.274 1.035 . . . . 1.92 111.266 177.76 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.615 ' N ' ' CG ' ' A' ' 128' ' ' ARG . 3.5 m-20 . . . . . 0 C--N 1.299 -1.604 0 CA-C-O 117.982 -1.009 . . . . 6.87 109.703 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.473 ' O ' ' HB3' ' A' ' 17' ' ' MET . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 121.358 0.599 . . . . 4.64 109.728 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.523 ' HB3' ' HG2' ' A' ' 17' ' ' MET . 1.3 pt20 -105.33 34.78 3.09 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.316 -0.994 . . . . 3.69 108.316 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.678 HG11 ' HA ' ' A' ' 22' ' ' HIS . 0.6 OUTLIER -28.51 123.51 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 CA-C-O 121.487 0.66 . . . . 2.07 110.239 -179.672 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -65.23 154.08 39.14 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.451 -0.781 . . . . 3.65 110.408 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.418 HG12 ' O ' ' A' ' 121' ' ' ILE . 0.0 OUTLIER -154.88 170.55 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.446 -0.946 . . . . 1.52 108.446 179.571 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.474 ' HB3' HD12 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -77.24 92.77 3.89 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.889 -1.132 . . . . 5.93 109.499 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' A' ' 119' ' ' CYS . 0.7 OUTLIER -88.13 -177.7 5.78 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.284 -0.885 . . . . 2.97 109.134 179.806 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.492 ' O ' ' C ' ' A' ' 9' ' ' ALA . 37.4 m -151.04 -29.55 0.19 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.198 -0.939 . . . . 2.29 110.794 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.617 ' O ' ' ND2' ' A' ' 10' ' ' ASN . . . -32.8 -77.23 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.425 -0.797 . . . . 1.3 110.938 -179.1 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.617 ' ND2' ' O ' ' A' ' 9' ' ' ALA . 0.3 OUTLIER 175.33 -77.33 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.415 -0.803 . . . . 3.19 109.265 -178.747 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.459 ' HB3' ' O ' ' A' ' 10' ' ' ASN . 17.8 p-10 173.56 36.28 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.523 -0.918 . . . . 4.04 108.523 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.443 ' O ' ' C ' ' A' ' 13' ' ' ILE . 0.3 OUTLIER -129.18 -4.77 4.94 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.386 -0.821 . . . . 1.77 109.78 -179.507 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.953 HG23 ' O ' ' A' ' 40' ' ' LEU . 18.5 mt -43.97 148.48 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.221 -0.924 . . . . 0.99 109.091 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.427 ' HE2' ' OD2' ' A' ' 42' ' ' ASP . 2.0 mmtt -96.86 -17.7 20.01 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.921 -0.77 . . . . 1.72 108.921 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.738 ' H ' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -170.03 100.89 0.29 Allowed 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 119.211 -0.995 . . . . 1.95 110.404 -178.164 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.558 ' HB ' HG21 ' A' ' 13' ' ' ILE . 1.4 p -124.75 97.09 4.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 107.897 -1.149 . . . . 1.25 107.897 179.168 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.523 ' HG2' ' HB3' ' A' ' 2' ' ' GLN . 2.4 mpt? -150.77 155.45 39.29 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.127 -0.983 . . . . 1.64 110.793 -178.286 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.591 HG13 ' HA ' ' A' ' 37' ' ' LEU . 2.1 t -112.06 128.9 68.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 106.982 -1.488 . . . . 1.29 106.982 178.095 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.534 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -87.75 89.29 7.94 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.852 -1.155 . . . . 2.67 111.191 -177.848 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.509 ' O ' ' CB ' ' A' ' 21' ' ' CYS . . . 90.6 112.41 1.59 Allowed Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.816 -1.183 . . . . 0.92 110.879 178.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.87 ' HA ' HG23 ' A' ' 29' ' ' ILE . 0.0 OUTLIER 159.12 -50.37 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.445 -1.032 . . . . 0.8 109.436 179.002 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.678 ' HA ' HG11 ' A' ' 3' ' ' VAL . 2.3 m-70 85.19 118.72 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 109.267 -0.642 . . . . 4.83 109.267 -178.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.448 ' O ' ' HB2' ' A' ' 24' ' ' SER . . . -95.74 -176.91 36.85 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 109.752 -1.339 . . . . 1.02 109.752 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.496 ' O ' ' O ' ' A' ' 25' ' ' ASP . 15.0 m 60.19 -89.41 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.236 -1.155 . . . . 1.48 109.414 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.638 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.2 OUTLIER -50.68 -176.56 0.02 OUTLIER Pre-proline 0 C--N 1.304 -1.37 0 N-CA-C 108.149 -1.056 . . . . 1.39 108.149 179.244 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.638 ' HD2' ' CB ' ' A' ' 25' ' ' ASP . 28.4 Cg_endo -70.24 82.9 0.81 Allowed 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 121.889 1.726 . . . . 1.6 109.29 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.54 ' HA ' ' O ' ' A' ' 22' ' ' HIS . 2.3 t -31.69 89.54 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 115.297 -0.865 . . . . 1.21 112.415 -178.088 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.492 HG21 ' C ' ' A' ' 129' ' ' ASP . 28.7 mm -90.6 132.37 35.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 104.783 -2.303 . . . . 1.16 104.783 175.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.87 HG23 ' HA ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -109.52 179.07 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.291 0 C-N-CA 118.666 -1.213 . . . . 0.66 111.319 -176.86 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.597 ' HE2' ' CE1' ' A' ' 22' ' ' HIS . 2.3 m-70 -128.08 154.34 45.81 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 119.767 -0.773 . . . . 0.59 110.881 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.545 ' CB ' ' O ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -100.54 155.54 17.79 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.886 -1.153 . . . . 4.6 107.886 178.404 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.22 0.79 76.52 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.84 -1.304 . . . . 0.85 109.84 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.713 ' N ' HG11 ' A' ' 94' ' ' VAL . 2.1 mtmm -129.66 145.7 58.07 Favored Pre-proline 0 N--CA 1.493 1.71 0 N-CA-C 107.564 -1.273 . . . . 1.68 107.564 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -71.35 82.71 1.07 Allowed 'Trans proline' 0 C--N 1.303 -1.846 0 C-N-CA 122.354 2.036 . . . . 1.07 112.152 -177.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.534 ' HA ' ' O ' ' A' ' 19' ' ' ASP . 12.3 t80 -52.01 114.13 1.22 Allowed 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 107.352 -1.351 . . . . 2.22 107.352 178.154 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.62 HG22 ' O ' ' A' ' 36' ' ' THR . 7.4 m -132.53 88.8 2.57 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 118.892 -1.123 . . . . 1.9 111.3 -178.218 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.683 HD12 ' C ' ' A' ' 37' ' ' LEU . 0.8 OUTLIER -80.56 126.48 31.3 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.236 -1.394 . . . . 2.21 107.236 177.975 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.582 ' CG ' HG22 ' A' ' 36' ' ' THR . 0.0 OUTLIER -140.22 -163.5 1.53 Allowed 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.578 -1.327 . . . . 3.2 110.728 -178.274 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.461 ' HB2' ' O ' ' A' ' 38' ' ' GLU . . . 170.02 101.65 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.886 -1.153 . . . . 1.07 107.886 179.041 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.953 ' O ' HG23 ' A' ' 13' ' ' ILE . 1.5 mp -93.29 173.17 7.85 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.295 -0.878 . . . . 0.71 109.818 -178.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.636 ' CE1' ' CE2' ' A' ' 86' ' ' TYR . 10.6 p90 175.05 139.9 0.05 OUTLIER 'General case' 0 C--N 1.305 -1.333 0 O-C-N 120.955 -1.09 . . . . 0.49 109.298 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.53 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 3.9 m-20 -86.28 108.49 18.42 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 107.334 -1.358 . . . . 3.65 107.334 178.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.736 ' HB1' ' O ' ' A' ' 81' ' ' VAL . . . -32.94 127.9 0.28 Allowed 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.727 -0.669 . . . . 0.31 109.602 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -122.58 1.65 9.51 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.221 -0.925 . . . . 1.04 110.221 -178.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.981 ' OE1' HD21 ' A' ' 117' ' ' LEU . 1.9 pt20 -93.53 -142.17 0.22 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.259 -0.9 . . . . 0.61 108.657 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.808 ' HA ' ' HB ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -154.31 66.66 0.71 Allowed 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.331 -0.856 . . . . 1.03 109.084 178.266 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.651 HG23 ' O ' ' A' ' 47' ' ' THR . 8.8 t -140.73 126.22 18.89 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.143 -1.598 . . . . 0.86 112.081 -177.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.667 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -72.19 -2.11 17.55 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.749 -1.219 . . . . 0.99 110.099 178.463 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.4 p -115.98 -175.44 2.73 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.906 -1.121 . . . . 2.19 111.546 -178.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 1.076 ' CB ' ' HB3' ' A' ' 72' ' ' ALA . . . -153.54 170.39 20.91 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.641 -0.874 . . . . 1.22 108.641 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.509 ' HG2' ' C ' ' A' ' 50' ' ' ALA . 0.4 OUTLIER -152.53 28.27 0.56 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.775 -1.203 . . . . 3.16 109.26 179.892 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.755 ' H ' ' HB2' ' A' ' 72' ' ' ALA . 20.5 tt -29.12 155.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.285 -2.23 0 CA-C-O 122.02 0.914 . . . . 1.68 112.206 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.463 ' O ' ' HB ' ' A' ' 54' ' ' ILE . 4.5 tt0 -117.06 -69.92 0.82 Allowed 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.005 -1.109 . . . . 3.13 108.005 178.265 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.697 HD12 HG13 ' A' ' 108' ' ' VAL . 0.3 OUTLIER 59.25 150.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.412 -0.805 . . . . 1.0 111.065 178.105 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.672 ' HG3' ' O ' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -178.23 94.08 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.976 -0.75 . . . . 1.4 108.976 178.373 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 105' ' ' VAL . . . -120.43 160.76 22.45 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.915 -1.115 . . . . 1.31 109.221 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.485 ' HB3' HG23 ' A' ' 105' ' ' VAL . 0.1 OUTLIER -130.19 123.89 31.31 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.97 -1.081 . . . . 1.55 109.789 -179.754 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.996 HD12 ' CZ2' ' A' ' 92' ' ' TRP . 0.1 OUTLIER -102.63 -147.99 0.38 Allowed 'General case' 0 N--CA 1.484 1.226 0 O-C-N 121.089 -1.007 . . . . 2.77 108.561 179.898 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.666 ' H ' HD13 ' A' ' 58' ' ' LEU . 24.2 t0 -94.11 81.62 4.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.067 -1.021 . . . . 3.32 109.084 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.5 1.63 90.19 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 108.936 -1.665 . . . . 4.17 108.936 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.413 ' O ' ' C ' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -115.25 57.1 0.73 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.331 -1.099 . . . . 3.1 108.566 179.606 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 61' ' ' LEU . 0.9 OUTLIER -40.79 115.9 0.64 Allowed 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 121.353 0.597 . . . . 2.58 110.724 -179.291 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.559 ' CG2' ' O ' ' A' ' 63' ' ' ILE . 0.5 OUTLIER -76.4 -3.11 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-O 122.125 0.964 . . . . 2.48 108.673 177.97 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.501 ' C ' ' O ' ' A' ' 63' ' ' ILE . 29.7 m-20 -25.6 134.56 0.02 OUTLIER 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 115.199 -0.91 . . . . 3.18 111.649 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.6 HG21 ' CG2' ' A' ' 54' ' ' ILE . 93.6 t -113.67 92.91 26.0 Favored Pre-proline 0 C--N 1.302 -1.476 0 N-CA-C 108.373 -0.973 . . . . 1.32 108.373 179.38 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 64' ' ' ASP . 36.4 Cg_endo -75.52 -94.84 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.535 2.157 . . . . 1.26 110.528 -178.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 68' ' ' ILE . . . -134.2 48.72 0.93 Allowed Glycine 0 N--CA 1.488 2.121 0 N-CA-C 110.108 -1.197 . . . . 2.07 110.108 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.429 ' O ' ' O ' ' A' ' 67' ' ' GLY . 13.5 mm -58.28 -104.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.148 -1.207 . . . . 1.34 108.63 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.489 ' OD2' ' HB2' ' A' ' 74' ' ' HIS . 0.4 OUTLIER -79.65 133.75 36.41 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.466 -1.396 . . . . 5.24 108.043 178.622 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.8 t -67.6 -13.84 62.42 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.254 -0.904 . . . . 5.26 111.864 -177.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.521 ' O ' ' N ' ' A' ' 73' ' ' CYS . 4.9 m-20 -138.28 49.42 1.92 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.328 -1.483 . . . . 0.84 111.803 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 1.076 ' HB3' ' CB ' ' A' ' 50' ' ' ALA . . . 40.67 19.48 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.843 0 O-C-N 121.116 -0.99 . . . . 1.39 112.879 176.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.521 ' N ' ' O ' ' A' ' 71' ' ' ASN . 80.8 m -68.45 -59.88 2.84 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 119.845 -1.784 . . . . 2.26 110.256 -179.235 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.489 ' HB2' ' OD2' ' A' ' 69' ' ' ASP . 11.9 t-160 -53.06 -27.25 19.08 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.321 -0.862 . . . . 2.96 111.025 -178.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.588 ' HB3' HD11 ' A' ' 88' ' ' ILE . 31.0 m-85 -83.95 -25.85 29.74 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.039 -1.038 . . . . 1.47 110.83 -179.002 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.795 ' HB ' ' CE1' ' A' ' 86' ' ' TYR . 0.2 OUTLIER -158.19 171.87 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 120.749 -1.22 . . . . 0.6 111.041 -177.961 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.658 ' N ' ' CG2' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -59.29 94.06 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 105.709 -1.96 . . . . 3.21 105.709 176.148 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' CYS . . . . . 0.516 ' SG ' ' O ' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -37.02 -51.85 2.11 Favored Pre-proline 0 C--N 1.297 -1.683 0 O-C-N 121.67 -0.644 . . . . 3.27 111.565 -177.182 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.667 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 29.6 Cg_endo -73.4 103.12 1.57 Allowed 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 120.886 1.058 . . . . 0.83 109.544 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.936 HD22 HD22 ' A' ' 117' ' ' LEU . 0.5 OUTLIER -97.85 -62.64 1.22 Allowed 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.99 -0.744 . . . . 2.48 108.99 -178.812 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.808 ' HB ' ' HA ' ' A' ' 46' ' ' ASN . 1.5 m 40.16 -166.64 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-N 116.176 -0.465 . . . . 0.76 109.846 178.119 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.729 ' H ' HG23 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -104.91 42.22 1.24 Allowed 'General case' 0 C--N 1.289 -2.036 0 O-C-N 120.302 -1.499 . . . . 1.65 110.126 -177.089 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -146.92 31.73 1.45 Allowed Glycine 0 C--N 1.288 -2.115 0 N-CA-C 109.439 -1.464 . . . . 0.6 109.439 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -153.46 132.12 12.27 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 120.89 -1.359 . . . . 3.15 110.554 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.53 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 3.6 pt20 -104.22 132.99 49.88 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 106.447 -1.686 . . . . 4.21 106.447 177.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.798 ' CE2' HD21 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -152.09 169.15 23.09 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 118.241 -1.383 . . . . 0.48 109.709 -178.377 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.614 ' CB ' ' HG ' ' A' ' 40' ' ' LEU . 6.9 p-10 -134.0 91.86 2.87 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.71 -1.243 . . . . 0.39 113.669 -175.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.588 HD11 ' HB3' ' A' ' 75' ' ' PHE . 4.4 tp -57.84 -172.3 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 106.333 -1.729 . . . . 1.06 106.333 175.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.577 ' O ' ' CD2' ' A' ' 90' ' ' TYR . 12.7 mttt 167.03 174.37 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.393 -1.442 . . . . 1.48 112.049 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.577 ' CD2' ' O ' ' A' ' 89' ' ' LYS . 82.5 m-85 -158.86 44.97 0.28 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.111 -1.07 . . . . 0.62 108.111 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.488 ' HA ' ' OG1' ' A' ' 36' ' ' THR . 74.4 p -51.94 -168.96 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.771 -0.581 . . . . 2.79 110.19 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.996 ' CZ2' HD12 ' A' ' 58' ' ' LEU . 1.4 t90 176.55 90.73 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.303 0 O-C-N 121.091 -1.006 . . . . 4.74 110.683 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.417 ' C ' ' O ' ' A' ' 92' ' ' TRP . 20.5 t-20 -49.47 98.53 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 106.463 -1.68 . . . . 4.71 106.463 178.083 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.903 HG13 ' CD1' ' A' ' 97' ' ' ILE . 1.0 OUTLIER -79.73 125.36 82.52 Favored Pre-proline 0 C--N 1.298 -1.635 0 O-C-N 121.343 -0.848 . . . . 1.36 112.297 -176.614 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.708 ' HD2' HD11 ' A' ' 97' ' ' ILE . 34.3 Cg_endo -82.62 -84.68 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 123.347 2.698 . . . . 1.54 108.853 176.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.545 ' O ' ' CB ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -138.05 -51.17 0.6 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 106.155 -1.794 . . . . 1.24 106.155 178.241 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.903 ' CD1' HG13 ' A' ' 94' ' ' VAL . 1.4 mp 62.81 5.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.756 -0.59 . . . . 1.52 111.956 176.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 1.012 ' HB1' ' HD2' ' A' ' 99' ' ' PRO . . . 51.87 173.63 0.03 OUTLIER Pre-proline 0 C--N 1.305 -1.346 0 O-C-N 120.778 -1.201 . . . . 1.73 110.176 179.016 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 1.012 ' HD2' ' HB1' ' A' ' 98' ' ' ALA . 50.1 Cg_endo -82.34 149.25 14.94 Favored 'Trans proline' 0 C--N 1.301 -1.928 0 C-N-CA 123.658 2.905 . . . . 1.72 109.744 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.626 ' HD3' ' CB ' ' A' ' 128' ' ' ARG . 1.1 mmmp? 55.79 114.56 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.033 0 C-N-CA 119.454 -0.899 . . . . 2.22 111.063 176.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' SER . . . . . 1.007 ' HB2' HD13 ' A' ' 127' ' ' ILE . 3.2 m -93.87 166.23 12.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.16 -0.962 . . . . 2.01 109.149 179.323 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.415 ' O ' ' CB ' ' A' ' 103' ' ' ASN . 0.2 OUTLIER -53.59 -19.08 3.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.278 -0.889 . . . . 2.49 109.139 179.603 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.459 ' O ' ' OG ' ' A' ' 57' ' ' SER . 0.5 OUTLIER 168.67 154.06 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.554 -0.906 . . . . 0.98 108.554 -179.996 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.949 HG21 HD12 ' A' ' 127' ' ' ILE . 0.1 OUTLIER -147.05 134.67 14.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 120.903 -1.123 . . . . 1.24 110.402 -179.649 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.485 HG23 ' HB3' ' A' ' 57' ' ' SER . 0.2 OUTLIER -155.01 145.47 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 107.973 -1.121 . . . . 2.21 107.973 179.629 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.563 ' HB ' ' HB3' ' A' ' 122' ' ' ALA . 71.1 t -129.01 128.96 67.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 120.641 -1.287 . . . . 1.06 110.401 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.504 ' O ' HG22 ' A' ' 108' ' ' VAL . 0.3 OUTLIER -150.43 140.56 22.11 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.19 -1.041 . . . . 0.63 108.19 179.305 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.697 HG13 HD12 ' A' ' 54' ' ' ILE . 2.4 t -157.16 156.75 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.748 -1.22 . . . . 1.69 110.463 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.513 ' HA ' ' HA ' ' A' ' 119' ' ' CYS . 0.1 OUTLIER 177.96 119.42 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.696 -0.853 . . . . 1.48 108.696 178.961 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.545 ' HB3' ' HB2' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -102.14 117.67 35.28 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 109.146 -0.686 . . . . 2.78 109.146 -179.866 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.486 ' O ' ' HG3' ' A' ' 51' ' ' LYS . 24.1 mt -110.34 139.78 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.333 -0.854 . . . . 1.15 110.331 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -108.39 -111.97 3.53 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 108.672 -1.771 . . . . 0.43 108.672 178.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.462 ' HB2' ' HB ' ' A' ' 47' ' ' THR . 2.3 m-20 -139.2 4.46 2.23 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.722 -1.214 . . . . 3.26 107.722 178.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.404 ' ND2' ' HB2' ' A' ' 45' ' ' GLN . 2.0 m-80 -118.49 -35.65 3.7 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.592 0.71 . . . . 0.89 109.36 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -173.43 -141.56 3.56 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.411 -1.476 . . . . 0.52 109.411 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.633 HG22 ' O ' ' A' ' 116' ' ' VAL . 0.1 OUTLIER -109.58 107.6 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.19 -1.183 . . . . 0.68 109.9 -179.87 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.981 HD21 ' OE1' ' A' ' 45' ' ' GLN . 1.1 mt -49.66 -49.7 46.3 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.252 -0.905 . . . . 0.78 109.113 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.547 ' HA ' ' CA ' ' A' ' 9' ' ' ALA . . . -161.98 -167.47 1.67 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.403 -0.811 . . . . 1.22 109.247 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.513 ' HA ' ' HA ' ' A' ' 109' ' ' LYS . 0.1 OUTLIER 172.91 170.59 0.13 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.257 -0.902 . . . . 0.67 109.605 179.781 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.416 ' N ' ' SG ' ' A' ' 119' ' ' CYS . . . -175.44 127.18 0.25 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.836 -0.801 . . . . 0.92 108.836 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.475 HG23 HG23 ' A' ' 107' ' ' THR . 2.5 mp -133.46 147.29 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.158 -0.964 . . . . 0.72 110.787 -179.05 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.563 ' HB3' ' HB ' ' A' ' 106' ' ' VAL . . . -112.72 -159.58 0.69 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.414 -0.803 . . . . 3.03 108.991 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.742 HG22 ' NE2' ' A' ' 124' ' ' HIS . 0.2 OUTLIER -161.66 115.49 1.91 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.933 -1.104 . . . . 1.16 110.495 -179.837 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.742 ' NE2' HG22 ' A' ' 123' ' ' THR . 0.2 OUTLIER 57.67 118.4 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.387 -0.82 . . . . 4.14 110.562 178.882 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 27' ' ' CYS . . . -129.46 167.88 21.22 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 108.975 -1.65 . . . . 2.07 108.975 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.403 ' HB3' ' CD1' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -172.25 86.01 0.07 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.042 -1.269 . . . . 3.04 109.984 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 1.007 HD13 ' HB2' ' A' ' 101' ' ' SER . 2.4 mp -46.35 138.7 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.352 -0.843 . . . . 1.19 109.822 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.643 ' CB ' ' O ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER 147.07 -93.88 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.859 -0.793 . . . . 3.79 108.859 179.003 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.504 ' N ' ' CG ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.964 -1.017 . . . . 4.08 109.457 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.2 t0 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.328 0.585 . . . . 5.81 109.508 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.462 ' HB3' ' HG2' ' A' ' 17' ' ' MET . 0.0 OUTLIER -122.46 23.18 9.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.193 -0.942 . . . . 3.88 108.679 179.406 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.868 HG12 ' H ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER 38.71 -159.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-O 121.188 0.518 . . . . 1.07 109.908 179.376 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -141.28 32.86 1.7 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.093 -1.004 . . . . 1.44 109.48 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.474 ' H ' HG22 ' A' ' 5' ' ' VAL . 1.1 m -53.16 136.85 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.423 -0.798 . . . . 0.67 109.359 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -67.5 94.98 0.44 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.21 -0.931 . . . . 3.96 109.704 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.527 ' OD2' ' CD1' ' A' ' 13' ' ' ILE . 0.2 OUTLIER -93.25 -176.16 4.05 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.112 -0.992 . . . . 4.49 109.037 179.5 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 21.6 p -176.96 41.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.001 -1.062 . . . . 2.15 109.762 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.556 ' CB ' HG13 ' A' ' 13' ' ' ILE . . . -77.13 -72.43 0.35 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.37 -0.831 . . . . 0.65 109.244 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.453 ' O ' ' HG2' ' A' ' 12' ' ' GLU . 0.3 OUTLIER -157.18 25.02 0.31 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.456 -0.777 . . . . 2.96 109.561 -179.778 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.451 ' CB ' ' O ' ' A' ' 10' ' ' ASN . 0.5 OUTLIER 72.14 22.51 3.63 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.306 -0.871 . . . . 2.83 109.485 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.519 ' O ' ' HB ' ' A' ' 13' ' ' ILE . 0.6 OUTLIER -145.04 -83.52 0.14 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.849 -0.797 . . . . 3.78 108.849 179.834 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.718 HG22 ' H ' ' A' ' 15' ' ' LYS . 0.4 OUTLIER 71.44 -6.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.509 -0.744 . . . . 3.66 111.486 178.977 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.574 ' HB2' ' O ' ' A' ' 13' ' ' ILE . 1.7 mtpt 68.21 -21.79 0.13 Allowed 'General case' 0 C--N 1.293 -1.864 0 O-C-N 121.504 -0.747 . . . . 4.69 111.328 179.406 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.718 ' H ' HG22 ' A' ' 13' ' ' ILE . 0.1 OUTLIER 170.6 126.41 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 O-C-N 120.59 -1.319 . . . . 1.42 109.566 -177.581 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.627 ' O ' HG13 ' A' ' 16' ' ' VAL . 6.4 p -140.96 114.64 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.128 -0.983 . . . . 0.91 108.845 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.512 ' HG3' ' C ' ' A' ' 16' ' ' VAL . 1.8 mtt -153.47 168.49 25.93 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.063 -1.055 . . . . 1.91 110.63 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.674 HG12 ' H ' ' A' ' 19' ' ' ASP . 16.5 t -129.29 177.66 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 107.388 -1.338 . . . . 1.24 107.388 178.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.674 ' H ' HG12 ' A' ' 18' ' ' VAL . 3.6 t0 -117.54 66.44 0.74 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.597 -1.314 . . . . 2.11 112.019 -178.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 29' ' ' ILE . . . 120.53 -26.77 6.83 Favored Glycine 0 N--CA 1.493 2.497 0 C-N-CA 119.063 -1.541 . . . . 3.13 112.39 177.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.99 ' CA ' HG23 ' A' ' 29' ' ' ILE . 3.9 t -60.21 -118.6 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.484 -1.597 . . . . 1.97 109.572 -178.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.581 ' HA ' ' CG1' ' A' ' 3' ' ' VAL . 0.3 OUTLIER 155.48 123.27 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.771 -1.206 . . . . 2.27 108.836 -179.778 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.868 ' H ' HG12 ' A' ' 3' ' ' VAL . . . -75.67 155.24 46.48 Favored Glycine 0 N--CA 1.494 2.519 0 O-C-N 121.027 -1.046 . . . . 0.78 110.718 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.433 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 5.4 m 70.22 155.87 0.14 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.356 -1.085 . . . . 2.62 108.887 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.608 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.1 OUTLIER 57.9 175.36 0.04 OUTLIER Pre-proline 0 C--N 1.304 -1.378 0 N-CA-C 107.678 -1.23 . . . . 5.42 107.678 -179.824 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.608 ' HD2' ' CB ' ' A' ' 25' ' ' ASP . 25.3 Cg_endo -67.31 85.06 0.35 Allowed 'Trans proline' 0 C--N 1.295 -2.281 0 C-N-CA 122.037 1.825 . . . . 1.29 109.763 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.606 ' HB2' ' HB1' ' A' ' 122' ' ' ALA . 3.9 t -23.62 86.45 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.973 0 CA-C-N 115.332 -0.849 . . . . 1.82 111.808 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.507 ' HA ' ' O ' ' A' ' 126' ' ' LYS . 29.3 mm -77.97 143.43 12.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 C-N-CA 118.649 -1.22 . . . . 0.88 107.968 178.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.99 HG23 ' CA ' ' A' ' 21' ' ' CYS . 0.2 OUTLIER -129.67 -177.53 2.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 O-C-N 120.981 -1.074 . . . . 0.81 112.142 -177.194 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 36.5 m-70 -114.51 166.57 11.57 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.415 0.626 . . . . 1.63 110.496 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.885 ' O ' HD12 ' A' ' 97' ' ' ILE . 0.1 OUTLIER -122.13 10.54 10.05 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.732 0.777 . . . . 11.01 108.966 178.863 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.491 ' HA2' ' O ' ' A' ' 95' ' ' PRO . . . -116.93 -5.88 14.81 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.649 -1.381 . . . . 1.52 109.649 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.589 ' C ' ' HB ' ' A' ' 94' ' ' VAL . 6.9 mtpt -116.78 147.04 39.1 Favored Pre-proline 0 C--N 1.303 -1.441 0 N-CA-C 106.977 -1.49 . . . . 3.42 106.977 178.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.552 ' O ' ' N ' ' A' ' 36' ' ' THR . 28.3 Cg_endo -66.65 102.98 0.65 Allowed 'Trans proline' 0 C--N 1.299 -2.039 0 C-N-CA 122.178 1.919 . . . . 1.25 111.919 -177.001 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.54 ' O ' ' HA ' ' A' ' 91' ' ' THR . 49.4 t80 -41.65 94.66 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.822 -1.177 . . . . 3.65 107.822 178.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.816 HG23 ' CG2' ' A' ' 91' ' ' THR . 19.3 m -114.51 78.11 1.12 Allowed 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.529 -0.868 . . . . 2.39 110.548 -178.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.767 HD12 ' N ' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -77.46 131.25 37.87 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 106.294 -1.743 . . . . 1.42 106.294 177.91 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.767 ' N ' HD12 ' A' ' 37' ' ' LEU . 3.8 mt-10 -142.83 178.82 7.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.683 -1.261 . . . . 2.94 111.149 -177.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.449 ' HB2' ' O ' ' A' ' 38' ' ' GLU . . . 171.67 95.94 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.298 -1.371 . . . . 0.31 107.298 178.337 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.61 ' HG ' ' CB ' ' A' ' 87' ' ' ASP . 0.0 OUTLIER -90.38 174.13 7.73 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.464 -0.773 . . . . 0.41 109.652 -178.418 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.792 ' HZ ' ' HH ' ' A' ' 86' ' ' TYR . 20.8 p90 173.01 141.7 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.776 -1.202 . . . . 0.41 110.184 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.508 ' O ' ' C ' ' A' ' 43' ' ' ALA . 9.1 p-10 -90.87 112.86 24.87 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 107.445 -1.317 . . . . 4.11 107.445 178.34 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.711 ' HB1' ' O ' ' A' ' 81' ' ' VAL . . . -33.31 123.89 0.4 Allowed 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 115.613 -0.721 . . . . 0.42 110.012 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -120.08 3.88 10.92 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.497 -0.752 . . . . 3.66 110.822 -177.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.877 ' OE1' HD21 ' A' ' 117' ' ' LEU . 2.0 pt20 -97.69 -142.77 0.3 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.186 -0.946 . . . . 0.67 108.598 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.786 ' HA ' ' HB ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -153.16 68.17 0.8 Allowed 'General case' 0 C--N 1.295 -1.781 0 O-C-N 121.285 -0.884 . . . . 0.4 108.631 178.551 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.789 HG23 ' O ' ' A' ' 47' ' ' THR . 9.1 t -145.67 111.38 5.5 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.01 -1.681 . . . . 0.51 112.042 -177.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.66 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -59.69 -23.04 62.8 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.348 -1.353 . . . . 2.84 107.348 177.152 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.41 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 1.1 p -82.86 -165.09 0.97 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.856 -0.528 . . . . 0.83 109.6 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.805 ' CB ' ' HB3' ' A' ' 72' ' ' ALA . . . 178.14 155.5 0.37 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.277 -0.889 . . . . 0.42 109.128 -179.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.582 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 19.7 mtmt -127.75 171.13 12.0 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.061 -1.459 . . . . 1.45 107.061 178.053 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.874 HG12 HG11 ' A' ' 65' ' ' VAL . 3.0 tt -158.65 156.43 3.88 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 C-N-CA 118.221 -1.392 . . . . 0.89 110.949 -179.047 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.52 ' O ' ' NZ ' ' A' ' 55' ' ' LYS . 4.1 tp10 -159.71 48.93 0.3 Allowed 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.267 -1.382 . . . . 3.62 107.267 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.802 ' HB ' HG21 ' A' ' 65' ' ' VAL . 1.3 mt -85.7 136.92 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 CA-C-O 122.354 1.074 . . . . 1.84 111.201 -178.177 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.562 ' HG3' ' O ' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -144.01 98.05 3.16 Favored 'General case' 0 C--N 1.282 -2.365 0 O-C-N 121.0 -1.062 . . . . 0.98 109.972 178.972 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.631 ' HB3' HD12 ' A' ' 63' ' ' ILE . . . -107.35 132.5 53.07 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 107.814 -1.18 . . . . 0.44 107.814 178.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.454 ' HA ' ' HA ' ' A' ' 62' ' ' GLU . 58.6 m -117.66 113.66 22.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.819 -1.176 . . . . 2.32 110.598 -178.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.45 ' O ' ' C ' ' A' ' 59' ' ' ASP . 0.2 OUTLIER -94.63 176.99 6.07 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.153 -1.054 . . . . 4.55 108.153 178.909 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.493 ' HB2' ' HB2' ' A' ' 101' ' ' SER . 0.0 OUTLIER -44.12 -60.74 1.74 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.922 -1.111 . . . . 3.34 109.235 -179.752 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.66 ' C ' HD22 ' A' ' 61' ' ' LEU . . . -129.27 10.24 6.19 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.517 -1.433 . . . . 2.34 109.517 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.814 ' N ' HD22 ' A' ' 61' ' ' LEU . 2.9 mm? -110.11 47.06 0.98 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.06 -1.259 . . . . 3.02 107.851 178.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.454 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 1.4 mt-10 -42.67 87.77 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 115.61 -0.723 . . . . 2.3 110.929 -179.179 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.631 HD12 ' HB3' ' A' ' 56' ' ' ALA . 6.8 mt -62.93 164.9 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 N-CA-C 106.696 -1.594 . . . . 0.47 106.696 177.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.405 ' C ' HG23 ' A' ' 65' ' ' VAL . 1.7 t0 -168.26 153.29 6.53 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.614 -1.304 . . . . 2.01 110.186 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.874 HG11 HG12 ' A' ' 52' ' ' ILE . 23.7 t -150.89 62.79 5.4 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.636 -0.665 . . . . 0.44 110.04 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.596 ' HD3' ' N ' ' A' ' 65' ' ' VAL . 37.7 Cg_endo -84.96 95.45 0.66 Allowed 'Trans proline' 0 C--N 1.301 -1.938 0 C-N-CA 123.296 2.664 . . . . 1.16 110.979 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.478 ' C ' ' O ' ' A' ' 66' ' ' PRO . . . 38.31 57.9 1.72 Allowed Glycine 0 N--CA 1.495 2.61 0 N-CA-C 109.621 -1.392 . . . . 2.04 109.621 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.57 HG22 ' N ' ' A' ' 69' ' ' ASP . 22.7 mm -84.32 -94.04 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.278 -1.131 . . . . 2.99 109.948 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.57 ' N ' HG22 ' A' ' 68' ' ' ILE . 35.5 p30 -51.64 166.06 0.15 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.175 -0.953 . . . . 1.5 110.038 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -69.27 -20.02 63.92 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.363 -0.836 . . . . 2.19 109.607 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.604 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 6.6 m-20 -175.57 73.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.785 -1.197 . . . . 0.71 111.307 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.805 ' HB3' ' CB ' ' A' ' 50' ' ' ALA . . . 40.33 26.89 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.562 -0.711 . . . . 0.81 111.478 176.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.545 ' HB3' ' HB2' ' A' ' 78' ' ' CYS . 4.0 m -88.41 -49.25 7.05 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.909 -1.119 . . . . 3.09 110.046 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.497 ' HB2' ' HB3' ' A' ' 69' ' ' ASP . 0.2 OUTLIER -59.17 -7.14 1.07 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.348 -0.845 . . . . 1.18 111.957 -178.044 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.592 ' C ' HG12 ' A' ' 76' ' ' VAL . 83.8 m-85 -115.62 -10.12 11.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.489 -1.382 . . . . 0.42 110.644 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.795 HG21 ' CZ ' ' A' ' 86' ' ' TYR . 0.2 OUTLIER -164.51 175.91 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.871 -1.143 . . . . 0.38 110.153 -178.483 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.664 ' N ' ' CG2' ' A' ' 76' ' ' VAL . 11.8 mmmt -61.55 93.15 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 106.226 -1.768 . . . . 2.65 106.226 176.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' CYS . . . . . 0.545 ' HB2' ' HB3' ' A' ' 73' ' ' CYS . 4.1 t -37.91 -50.37 3.04 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.359 -0.838 . . . . 3.53 111.79 -177.18 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.66 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 30.6 Cg_endo -74.71 108.27 2.66 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 N-CA-C 108.674 -1.318 . . . . 0.54 108.674 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.966 HD22 HD22 ' A' ' 117' ' ' LEU . 0.6 OUTLIER -103.28 -66.71 0.92 Allowed 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 108.378 -0.971 . . . . 2.42 108.378 -178.701 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.786 ' HB ' ' HA ' ' A' ' 46' ' ' ASN . 1.4 m 41.45 -167.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 109.221 -0.659 . . . . 0.36 109.221 178.048 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.733 ' H ' HG23 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -101.82 42.71 1.11 Allowed 'General case' 0 C--N 1.284 -2.267 0 O-C-N 120.261 -1.524 . . . . 3.21 109.704 -176.98 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -146.62 37.3 1.21 Allowed Glycine 0 C--N 1.287 -2.143 0 N-CA-C 108.712 -1.755 . . . . 0.42 108.712 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 35.3 tp60 -152.52 143.44 22.99 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 121.157 -1.202 . . . . 2.33 110.78 -179.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.42 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 0.3 OUTLIER -117.59 134.5 54.81 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 105.596 -2.002 . . . . 3.14 105.596 177.653 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.798 ' HE2' HD21 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -163.4 163.58 24.95 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 117.514 -1.675 . . . . 0.58 109.95 -177.42 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.61 ' CB ' ' HG ' ' A' ' 40' ' ' LEU . 12.7 p-10 -133.14 102.29 5.53 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.852 -1.155 . . . . 0.59 112.968 -176.37 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.536 ' CD1' ' O ' ' A' ' 75' ' ' PHE . 3.0 tp -70.26 -175.9 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 107.423 -1.325 . . . . 1.66 107.423 176.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.544 ' O ' ' CD2' ' A' ' 90' ' ' TYR . 3.1 mttt 174.13 173.65 0.18 Allowed 'General case' 0 N--CA 1.5 2.07 0 O-C-N 120.852 -1.155 . . . . 0.77 110.83 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.544 ' CD2' ' O ' ' A' ' 89' ' ' LYS . 5.8 m-85 -172.43 60.56 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 106.908 -1.516 . . . . 2.41 106.908 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.816 ' CG2' HG23 ' A' ' 36' ' ' THR . 0.3 OUTLIER -90.25 -169.19 2.33 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.518 -0.739 . . . . 3.08 111.667 -177.306 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.564 ' CH2' ' HB3' ' A' ' 61' ' ' LEU . 0.2 OUTLIER -171.2 151.63 3.21 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.581 -0.699 . . . . 7.17 110.323 -178.973 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -81.89 142.73 32.23 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.908 -1.145 . . . . 2.25 107.908 178.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 1.068 HG13 ' CD1' ' A' ' 97' ' ' ILE . 51.5 t -147.89 112.97 3.92 Favored Pre-proline 0 C--N 1.305 -1.335 0 O-C-N 120.805 -1.185 . . . . 2.18 111.667 -177.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.943 ' HD2' HD11 ' A' ' 97' ' ' ILE . 29.9 Cg_endo -74.56 -67.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 123.259 2.639 . . . . 3.41 111.513 178.019 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.634 ' O ' ' HB3' ' A' ' 31' ' ' ARG . 0.4 OUTLIER -162.44 -33.65 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 107.368 -1.345 . . . . 5.74 107.368 -179.826 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 1.068 ' CD1' HG13 ' A' ' 94' ' ' VAL . 1.4 mt 34.48 24.37 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 114.02 1.118 . . . . 2.28 114.02 176.355 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 1.023 ' HB1' ' HD2' ' A' ' 99' ' ' PRO . . . 61.28 -177.2 0.03 OUTLIER Pre-proline 0 C--N 1.301 -1.513 0 O-C-N 120.279 -1.513 . . . . 1.35 109.926 178.213 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 1.023 ' HD2' ' HB1' ' A' ' 98' ' ' ALA . 46.8 Cg_endo -86.53 151.23 8.97 Favored 'Trans proline' 0 C--N 1.302 -1.896 0 C-N-CA 123.645 2.896 . . . . 0.74 111.052 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.521 ' HD2' ' HA ' ' A' ' 128' ' ' ARG . 2.0 mptm? 64.08 142.91 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.965 0.888 . . . . 3.05 112.419 175.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.725 ' HB3' HD13 ' A' ' 127' ' ' ILE . 2.9 p -111.15 12.31 21.89 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.918 -0.771 . . . . 3.5 108.918 179.055 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.549 ' O ' ' CB ' ' A' ' 103' ' ' ASN . 0.8 OUTLIER 76.66 -5.98 2.09 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.603 -0.685 . . . . 3.1 109.342 -179.425 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.549 ' CB ' ' O ' ' A' ' 102' ' ' GLU . 5.2 t30 159.19 146.04 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.453 -0.78 . . . . 2.83 109.45 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 1.092 HG21 HD12 ' A' ' 127' ' ' ILE . 0.1 OUTLIER -157.55 -174.3 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.255 -0.903 . . . . 0.65 110.065 -179.76 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.525 ' CB ' ' O ' ' A' ' 104' ' ' VAL . 1.2 t 159.27 125.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.2 -1.037 . . . . 0.6 108.2 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.742 ' O ' HG12 ' A' ' 106' ' ' VAL . 2.1 t -125.13 97.39 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 120.833 -1.167 . . . . 1.59 110.555 -178.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.515 ' HB ' ' HE3' ' A' ' 55' ' ' LYS . 25.6 m -116.52 143.61 45.37 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.504 -1.295 . . . . 0.69 107.504 178.466 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.753 HG13 ' CD1' ' A' ' 54' ' ' ILE . 88.0 t -151.15 152.89 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.59 -1.319 . . . . 1.0 110.585 -178.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -173.62 118.05 0.27 Allowed 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.798 0.809 . . . . 0.75 109.472 178.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.588 ' HB3' ' HB2' ' A' ' 117' ' ' LEU . 9.8 tp -106.26 121.8 44.93 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 106.777 -1.564 . . . . 1.34 106.777 178.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.511 ' HB ' ' HB2' ' A' ' 51' ' ' LYS . 4.0 mt -121.11 117.49 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.25 -0.906 . . . . 0.74 112.296 -176.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.499 ' HA3' HG21 ' A' ' 47' ' ' THR . . . -86.23 -112.37 0.83 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 107.806 -2.117 . . . . 0.75 107.806 176.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -141.1 -0.1 1.49 Allowed 'General case' 0 C--N 1.307 -1.268 0 O-C-N 120.928 -1.337 . . . . 1.46 108.123 178.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.463 ' ND2' ' N ' ' A' ' 114' ' ' ASN . 0.2 OUTLIER -120.98 -5.59 9.56 Favored 'General case' 0 C--N 1.313 -0.985 0 O-C-N 121.163 -0.961 . . . . 1.17 109.955 -179.923 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 160.56 164.47 15.6 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 109.641 -1.383 . . . . 1.4 109.641 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.41 HG13 ' O ' ' A' ' 116' ' ' VAL . 2.1 p -70.62 110.54 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.112 -1.228 . . . . 0.92 109.455 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.966 HD22 HD22 ' A' ' 80' ' ' LEU . 1.3 mt -48.52 -51.46 27.28 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.465 -0.772 . . . . 1.15 110.156 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -168.97 135.49 1.76 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.223 -0.923 . . . . 2.19 109.597 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.53 ' O ' ' HB2' ' A' ' 120' ' ' ALA . 22.0 p -126.13 -162.31 1.12 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.916 -1.115 . . . . 0.94 110.637 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.53 ' HB2' ' O ' ' A' ' 119' ' ' CYS . . . 171.24 124.86 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.38 -0.97 . . . . 0.37 108.38 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.523 HD12 ' C ' ' A' ' 120' ' ' ALA . 1.2 mp -133.69 126.62 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 120.976 -1.078 . . . . 1.5 110.798 -178.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.606 ' HB1' ' HB2' ' A' ' 27' ' ' CYS . . . -111.43 82.16 1.56 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.208 -1.034 . . . . 0.54 108.208 178.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.54 ' CG2' ' O ' ' A' ' 123' ' ' THR . 0.5 OUTLIER -33.52 125.04 0.42 Allowed 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.563 0.697 . . . . 2.68 110.666 -179.083 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.475 ' O ' ' O ' ' A' ' 123' ' ' THR . 8.1 m170 54.41 163.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.555 -0.716 . . . . 2.17 109.786 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -153.88 129.72 2.73 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.401 -1.48 . . . . 1.66 109.401 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.507 ' O ' ' HA ' ' A' ' 28' ' ' ILE . 5.7 mtmt -153.23 119.17 5.39 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.328 -1.101 . . . . 1.85 108.536 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 1.092 HD12 HG21 ' A' ' 104' ' ' VAL . 1.5 mp -94.12 160.67 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.234 -0.916 . . . . 1.32 110.506 -178.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.528 ' HG2' ' O ' ' A' ' 127' ' ' ILE . 1.4 mtm180 -150.8 -174.72 4.87 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 109.016 -0.735 . . . . 2.69 109.016 178.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.541 ' N ' ' HB3' ' A' ' 99' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 117.917 -1.04 . . . . 7.78 109.708 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.513 ' O ' ' HG3' ' A' ' 2' ' ' GLN . 14.5 m-20 . . . . . 0 N--CA 1.492 1.644 0 N-CA-C 109.6 -0.518 . . . . 4.36 109.6 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.513 ' HG3' ' O ' ' A' ' 1' ' ' ASP . 4.4 pt20 37.41 31.93 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.691 -0.485 . . . . 3.19 109.691 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.777 HG12 ' HA ' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -33.74 144.95 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-O 121.367 0.603 . . . . 2.0 110.402 -179.562 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.489 ' O ' ' N ' ' A' ' 24' ' ' SER . 5.3 t70 -89.64 148.83 23.09 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.419 -0.801 . . . . 2.47 109.437 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.421 HG13 ' O ' ' A' ' 4' ' ' ASP . 0.0 OUTLIER -156.08 167.24 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.353 -0.842 . . . . 1.65 108.988 179.961 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.564 ' HD3' ' N ' ' A' ' 6' ' ' LYS . 1.4 mptt -80.02 76.92 6.74 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.073 -1.084 . . . . 3.62 108.073 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.525 ' HB2' ' O ' ' A' ' 119' ' ' CYS . 51.6 p30 -94.35 168.38 10.93 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.832 0.825 . . . . 0.77 110.436 -178.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.54 ' N ' ' SG ' ' A' ' 119' ' ' CYS . 29.2 m -113.17 -36.1 5.16 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.031 -1.47 . . . . 3.26 107.031 178.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.835 ' HB2' ' CB ' ' A' ' 118' ' ' ALA . . . -64.14 -144.84 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.358 -0.979 . . . . 5.02 108.358 177.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.646 ' ND2' ' O ' ' A' ' 9' ' ' ALA . 0.0 OUTLIER 80.45 -42.92 0.22 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 120.506 -0.477 . . . . 9.64 110.874 177.372 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -63.38 -17.73 62.94 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.957 -1.089 . . . . 4.23 108.23 178.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.448 ' HG2' ' HB3' ' A' ' 44' ' ' ASN . 13.1 tp10 -132.37 -28.78 1.64 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.673 -0.642 . . . . 2.78 109.575 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.813 HG13 ' HB1' ' A' ' 9' ' ' ALA . 10.4 mt -48.43 154.7 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.09 -1.006 . . . . 1.61 109.825 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.444 ' N ' ' CG2' ' A' ' 13' ' ' ILE . 0.0 OUTLIER -110.91 -23.21 11.11 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.784 -0.821 . . . . 0.92 108.784 179.776 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -156.99 122.07 4.57 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 119.202 -0.999 . . . . 2.42 109.657 -178.305 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.631 ' O ' HG13 ' A' ' 16' ' ' VAL . 4.5 p -155.3 104.65 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.074 -1.016 . . . . 1.23 109.412 -179.179 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.497 ' HG2' ' HB3' ' A' ' 2' ' ' GLN . 3.0 mpp? -150.42 152.74 34.78 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.202 -0.936 . . . . 1.36 110.493 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.874 HG12 ' CE1' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -121.4 106.04 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 108.087 -1.079 . . . . 0.79 108.087 178.535 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.442 ' HB3' ' O ' ' A' ' 34' ' ' PRO . 1.2 t0 -52.49 86.92 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.644 -0.66 . . . . 1.87 110.928 -178.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.554 ' O ' ' HB3' ' A' ' 21' ' ' CYS . . . 98.46 -169.96 24.04 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 120.035 -1.078 . . . . 2.01 110.928 178.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.95 ' CA ' HG23 ' A' ' 29' ' ' ILE . 36.2 t 86.14 -25.52 0.11 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 122.268 -0.548 . . . . 1.53 110.193 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.777 ' HA ' HG12 ' A' ' 3' ' ' VAL . 0.3 OUTLIER 42.2 83.99 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.858 -1.151 . . . . 1.74 108.973 -179.192 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.497 ' O ' ' CB ' ' A' ' 24' ' ' SER . . . -83.39 -144.56 5.77 Favored Glycine 0 N--CA 1.498 2.811 0 O-C-N 121.489 -0.757 . . . . 1.26 112.327 -178.126 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.497 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 0.1 OUTLIER 78.46 -79.38 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 107.45 -1.315 . . . . 1.4 107.45 -177.818 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.691 ' HB2' ' CD ' ' A' ' 26' ' ' PRO . 7.3 p30 -84.87 -149.4 0.0 OUTLIER Pre-proline 0 C--N 1.298 -1.67 0 N-CA-C 105.263 -2.125 . . . . 2.39 105.263 177.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.691 ' CD ' ' HB2' ' A' ' 25' ' ' ASP . 25.9 Cg_endo -70.07 102.36 1.07 Allowed 'Trans proline' 0 C--N 1.32 -0.969 0 CA-C-N 121.168 1.453 . . . . 1.49 108.601 179.178 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.599 ' HA ' ' O ' ' A' ' 22' ' ' HIS . 3.2 t -54.72 81.23 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 115.42 -0.809 . . . . 1.63 113.07 -176.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.534 ' O ' ' O ' ' A' ' 21' ' ' CYS . 0.6 OUTLIER -83.09 145.29 8.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 106.863 -1.532 . . . . 2.11 106.863 176.475 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.95 HG23 ' CA ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -113.35 -175.95 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 O-C-N 120.756 -1.215 . . . . 1.11 111.827 -176.978 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -127.04 107.25 9.88 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 119.952 -0.699 . . . . 1.95 111.269 -178.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.583 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -53.86 149.1 9.22 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.492 -0.755 . . . . 3.21 109.038 178.353 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.518 ' HA2' ' O ' ' A' ' 95' ' ' PRO . . . 92.06 -1.97 74.78 Favored Glycine 0 N--CA 1.493 2.478 0 C-N-CA 119.814 -1.184 . . . . 2.11 110.61 178.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.584 ' O ' HG21 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -124.12 139.97 33.83 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 120.963 -1.316 . . . . 2.36 109.479 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.442 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 27.0 Cg_endo -64.93 134.72 41.21 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.398 2.065 . . . . 2.51 110.935 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.874 ' CE1' HG12 ' A' ' 18' ' ' VAL . 5.1 t80 -114.41 60.72 0.67 Allowed 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.466 -0.568 . . . . 1.33 109.466 -178.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.492 HG22 ' OE1' ' A' ' 38' ' ' GLU . 81.5 m -73.08 81.97 1.26 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.303 -0.873 . . . . 2.52 109.09 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.52 ' O ' ' CG ' ' A' ' 38' ' ' GLU . 3.0 mp -52.7 -178.21 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.189 -0.945 . . . . 4.85 108.653 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.536 ' CG ' ' HG2' ' A' ' 89' ' ' LYS . 0.1 OUTLIER 166.73 158.56 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.916 -1.115 . . . . 2.7 109.795 -179.602 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.522 ' HB2' ' O ' ' A' ' 38' ' ' GLU . . . 171.81 83.41 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.697 0.76 . . . . 1.19 109.506 178.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.73 ' O ' HG23 ' A' ' 13' ' ' ILE . 0.6 OUTLIER -82.12 165.05 20.89 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 108.269 -1.011 . . . . 2.17 108.269 179.031 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.763 ' CZ ' ' CD2' ' A' ' 86' ' ' TYR . 0.4 OUTLIER -156.79 164.85 37.63 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.323 -1.362 . . . . 1.2 107.323 176.285 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.411 ' O ' ' C ' ' A' ' 43' ' ' ALA . 1.0 OUTLIER -116.85 116.38 27.34 Favored 'General case' 0 C--N 1.29 -2.013 0 C-N-CA 119.309 -0.957 . . . . 2.49 108.584 -179.8 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.869 ' HB1' ' O ' ' A' ' 81' ' ' VAL . . . -46.81 119.59 2.57 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 107.386 -1.339 . . . . 0.44 107.386 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.461 ' C ' ' HB3' ' A' ' 82' ' ' LYS . 0.1 OUTLIER -130.63 19.38 5.16 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.699 0.761 . . . . 3.32 108.999 -178.15 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.788 ' CD ' HD21 ' A' ' 117' ' ' LEU . 3.0 pt20 -109.37 -139.41 0.38 Allowed 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.512 -0.742 . . . . 0.82 110.408 -178.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.689 ' C ' HG22 ' A' ' 81' ' ' VAL . 3.4 m120 -158.55 53.43 0.43 Allowed 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.531 -0.914 . . . . 3.98 108.531 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.798 ' N ' HG22 ' A' ' 81' ' ' VAL . 10.4 t -134.78 127.47 30.95 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.386 -1.446 . . . . 2.09 110.555 -178.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.648 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -70.71 -20.15 62.69 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.012 -1.055 . . . . 5.26 108.934 178.744 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 24.7 p -73.79 178.81 4.59 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.922 0.868 . . . . 3.19 111.077 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 1.062 ' HB1' ' HB3' ' A' ' 72' ' ' ALA . . . 177.52 131.06 0.06 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.258 -1.386 . . . . 1.48 107.258 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.522 ' O ' ' C ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -136.11 48.55 2.16 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 120.104 -1.623 . . . . 3.08 109.91 -178.628 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.883 ' H ' ' HB2' ' A' ' 72' ' ' ALA . 2.0 tt -28.29 146.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.178 0 CA-C-N 115.451 -0.795 . . . . 2.37 110.361 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.461 ' C ' HD12 ' A' ' 54' ' ' ILE . 0.3 OUTLIER -137.95 82.96 1.95 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.301 -0.874 . . . . 3.09 109.474 -179.818 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.896 ' HB ' HG21 ' A' ' 65' ' ' VAL . 0.5 OUTLIER -108.57 141.51 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.293 -0.879 . . . . 0.87 109.278 179.651 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.696 ' HG3' ' O ' ' A' ' 54' ' ' ILE . 0.2 OUTLIER -152.4 90.18 1.48 Allowed 'General case' 0 C--N 1.285 -2.204 0 O-C-N 121.348 -0.845 . . . . 1.15 109.175 178.462 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.793 ' HB3' ' HB ' ' A' ' 63' ' ' ILE . . . -109.36 145.21 36.44 Favored 'General case' 0 C--N 1.292 -1.897 0 O-C-N 121.512 -0.743 . . . . 0.24 109.551 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.476 ' O ' ' CG1' ' A' ' 104' ' ' VAL . 30.3 m -128.12 137.13 51.99 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.972 -1.08 . . . . 2.44 109.142 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.856 HD13 ' H ' ' A' ' 59' ' ' ASP . 0.2 OUTLIER -135.39 158.33 44.64 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.28 -0.887 . . . . 1.82 109.198 -179.604 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.856 ' H ' HD13 ' A' ' 58' ' ' LEU . 18.1 t70 -48.86 -63.89 0.96 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.274 -0.892 . . . . 3.24 108.608 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -108.17 24.89 21.85 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 108.862 -1.695 . . . . 1.15 108.862 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.608 ' CB ' ' HB3' ' A' ' 58' ' ' LEU . 0.4 OUTLIER -146.33 66.48 1.19 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.269 -1.136 . . . . 3.44 109.118 -179.709 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.09 82.44 0.51 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.469 -0.769 . . . . 2.18 109.985 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.793 ' HB ' ' HB3' ' A' ' 56' ' ' ALA . 8.5 mt -66.85 169.44 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 120.866 -1.146 . . . . 0.34 108.091 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.581 ' N ' HG22 ' A' ' 63' ' ' ILE . 0.5 OUTLIER 175.9 145.75 0.08 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.018 -1.052 . . . . 1.06 109.469 -179.791 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.896 HG21 ' HB ' ' A' ' 54' ' ' ILE . 14.5 t -144.39 63.93 11.59 Favored Pre-proline 0 N--CA 1.488 1.425 0 O-C-N 121.318 -0.864 . . . . 1.0 110.01 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.547 ' HD3' ' N ' ' A' ' 65' ' ' VAL . 36.4 Cg_endo -79.34 94.61 1.05 Allowed 'Trans proline' 0 C--N 1.298 -2.105 0 C-N-CA 122.918 2.412 . . . . 2.03 110.328 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.466 ' C ' ' O ' ' A' ' 66' ' ' PRO . . . 36.45 46.96 1.11 Allowed Glycine 0 N--CA 1.496 2.688 0 N-CA-C 110.119 -1.192 . . . . 1.13 110.119 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.745 HG22 ' N ' ' A' ' 69' ' ' ASP . 1.9 mm -63.5 -75.05 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.245 -1.15 . . . . 1.9 109.721 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.745 ' N ' HG22 ' A' ' 68' ' ' ILE . 6.4 p-10 -77.96 162.81 26.5 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.113 -0.992 . . . . 1.82 109.369 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.11 -55.57 33.0 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.435 -0.791 . . . . 2.51 110.318 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.562 ' CA ' ' O ' ' A' ' 50' ' ' ALA . 3.9 m-80 -147.45 87.69 1.66 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.913 -1.117 . . . . 3.05 111.488 -178.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 1.062 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . . . 37.2 26.77 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.895 -0.503 . . . . 0.4 111.986 176.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.525 ' N ' ' O ' ' A' ' 71' ' ' ASN . 4.3 t -99.46 0.73 43.16 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 120.88 -1.137 . . . . 1.14 111.23 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.613 ' CG ' ' HB3' ' A' ' 69' ' ' ASP . 0.3 OUTLIER -90.7 -29.54 17.64 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.757 -1.214 . . . . 2.98 109.687 179.811 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.508 ' O ' ' HB ' ' A' ' 76' ' ' VAL . 13.5 m-85 -103.6 14.07 31.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.362 -0.836 . . . . 1.73 109.29 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 1.198 HG11 ' CZ ' ' A' ' 86' ' ' TYR . 5.4 p 178.27 -142.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-O 121.787 0.804 . . . . 2.55 109.512 -177.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.841 ' N ' HG13 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -99.03 158.69 15.48 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 106.304 -1.739 . . . . 3.36 106.304 177.049 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' CYS . . . . . 0.568 ' N ' ' HD2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -81.96 -48.62 0.94 Allowed Pre-proline 0 N--CA 1.493 1.694 0 C-N-CA 118.054 -1.458 . . . . 2.17 109.544 179.866 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.648 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 32.0 Cg_endo -77.2 114.92 3.87 Favored 'Trans proline' 0 C--N 1.302 -1.904 0 N-CA-C 107.498 -1.77 . . . . 2.29 107.498 178.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.758 HD11 HD21 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -85.96 -69.19 0.68 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 106.588 -1.634 . . . . 1.39 106.588 -179.11 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.869 ' O ' ' HB1' ' A' ' 43' ' ' ALA 0.256 48.4 t 50.06 -174.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 C-N-CA 118.276 -1.37 . . . . 2.91 109.262 175.488 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.61 ' N ' HG12 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -104.56 47.32 0.88 Allowed 'General case' 0 C--N 1.293 -1.884 0 O-C-N 121.143 -0.973 . . . . 2.54 110.008 -179.381 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -137.43 11.19 3.78 Favored Glycine 0 N--CA 1.491 2.309 0 C-N-CA 118.734 -1.698 . . . . 0.5 113.059 -178.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.482 ' NE2' ' O ' ' A' ' 79' ' ' PRO . 1.2 pt20 -148.92 171.05 16.95 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 120.452 2.126 . . . . 5.53 111.334 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -108.02 142.1 38.68 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.775 0.798 . . . . 5.07 110.956 -178.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 1.198 ' CZ ' HG11 ' A' ' 76' ' ' VAL . 0.4 OUTLIER -99.62 173.18 6.85 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.069 0.462 . . . . 2.67 110.576 -179.61 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.626 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 9.9 p-10 176.83 83.64 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.464 -0.773 . . . . 3.47 110.918 178.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.548 HG12 ' N ' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -127.87 146.06 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 107.313 -1.366 . . . . 2.54 107.313 178.409 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.548 ' N ' HG12 ' A' ' 88' ' ' ILE . 1.7 mtmt -147.62 -169.37 3.3 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.955 -1.091 . . . . 3.15 111.797 -177.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.639 ' CZ ' HG21 ' A' ' 54' ' ' ILE . 67.4 m-85 -156.7 126.64 6.36 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 107.728 -1.212 . . . . 1.19 107.728 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.31 156.67 30.81 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.587 -1.32 . . . . 3.39 110.842 -178.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.753 ' CD2' HG22 ' A' ' 94' ' ' VAL . 3.3 t90 -143.19 109.97 5.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.548 -0.72 . . . . 5.33 109.168 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -61.08 120.13 9.68 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.685 -1.228 . . . . 3.09 107.685 178.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.813 HG13 HD13 ' A' ' 97' ' ' ILE . 18.4 t -114.68 95.94 42.34 Favored Pre-proline 0 N--CA 1.489 1.499 0 C-N-CA 119.028 -1.069 . . . . 2.63 111.573 -178.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.703 ' HD2' HD11 ' A' ' 97' ' ' ILE . 31.0 Cg_endo -75.88 -79.52 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.939 2.426 . . . . 2.84 109.269 177.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.599 ' C ' HD12 ' A' ' 97' ' ' ILE . 5.5 tptt -137.52 -59.63 0.67 Allowed 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 104.662 -2.347 . . . . 3.01 104.662 177.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.813 HD13 HG13 ' A' ' 94' ' ' VAL . 1.2 mp 66.59 5.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 O-C-N 121.679 -0.638 . . . . 1.75 112.711 174.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 1.075 ' HB1' ' HD2' ' A' ' 99' ' ' PRO . . . 54.86 177.96 0.03 OUTLIER Pre-proline 0 C--N 1.302 -1.459 0 O-C-N 120.408 -1.433 . . . . 1.3 109.256 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 1.075 ' HD2' ' HB1' ' A' ' 98' ' ' ALA . 46.4 Cg_endo -80.5 155.46 21.48 Favored 'Trans proline' 0 C--N 1.3 -1.984 0 C-N-CA 123.525 2.816 . . . . 1.26 110.345 -179.294 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.792 ' N ' HG22 ' A' ' 127' ' ' ILE . 1.4 mmmp? 56.91 149.47 0.01 OUTLIER 'General case' 0 C--N 1.29 -1.987 0 CA-C-O 122.157 0.98 . . . . 2.85 112.184 176.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.816 ' OG ' HD13 ' A' ' 127' ' ' ILE . 78.0 p -129.68 164.72 23.32 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.118 -0.697 . . . . 1.63 109.118 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.556 ' O ' ' CB ' ' A' ' 103' ' ' ASN . 4.3 mt-10 -51.04 -22.22 2.25 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.147 -0.971 . . . . 2.97 109.023 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.556 ' CB ' ' O ' ' A' ' 102' ' ' GLU . 0.3 OUTLIER 157.1 157.02 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.563 -0.903 . . . . 3.2 108.563 -179.713 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.642 HG21 ' CD1' ' A' ' 127' ' ' ILE . 0.2 OUTLIER -152.07 174.58 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.05 -1.031 . . . . 0.91 109.611 -179.919 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 56' ' ' ALA . 1.2 t 164.57 130.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 108.06 -1.089 . . . . 0.86 108.06 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.565 ' O ' HG12 ' A' ' 106' ' ' VAL . 3.6 t -128.56 102.98 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.899 -1.125 . . . . 1.68 110.562 -179.129 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.412 ' C ' ' CG2' ' A' ' 108' ' ' VAL . 0.2 OUTLIER -108.64 147.45 31.85 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.366 -0.975 . . . . 1.11 108.366 178.905 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.427 HG13 HG13 ' A' ' 54' ' ' ILE . 1.5 t -151.69 153.32 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.696 -1.252 . . . . 1.88 110.546 -179.163 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.522 ' HA ' ' HA ' ' A' ' 119' ' ' CYS . 0.4 OUTLIER 172.48 116.15 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.503 -0.748 . . . . 1.81 110.334 178.796 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.758 HD21 HD11 ' A' ' 80' ' ' LEU . 32.7 tp -104.04 127.89 51.61 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.684 -1.228 . . . . 1.37 107.684 177.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.508 ' O ' ' HG3' ' A' ' 51' ' ' LYS . 10.3 mt -125.88 136.83 59.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 O-C-N 121.277 -0.89 . . . . 0.9 110.431 -178.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.737 ' HA3' HG21 ' A' ' 47' ' ' THR . . . -100.07 -109.86 3.13 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 108.099 -2.0 . . . . 1.43 108.099 178.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -145.34 11.91 1.34 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.353 -1.351 . . . . 3.14 107.353 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.419 ' OD1' ' NE2' ' A' ' 45' ' ' GLN . 1.3 p30 -127.53 -33.17 2.35 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.547 0.689 . . . . 4.15 109.483 -178.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -179.91 156.61 18.45 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.107 -1.597 . . . . 1.69 109.107 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.484 ' O ' HG22 ' A' ' 116' ' ' VAL . 0.2 OUTLIER -57.02 112.54 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.147 -1.208 . . . . 0.9 109.918 -179.642 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.788 HD21 ' CD ' ' A' ' 45' ' ' GLN . 2.9 mt -55.54 -68.02 0.23 Allowed 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.608 -0.886 . . . . 1.08 108.608 179.14 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.835 ' CB ' ' HB2' ' A' ' 9' ' ' ALA . . . -130.39 -177.98 4.56 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.296 -1.002 . . . . 0.66 108.296 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.566 ' HB3' ' O ' ' A' ' 118' ' ' ALA . 0.1 OUTLIER 169.15 155.8 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.08 -1.013 . . . . 0.86 110.145 179.777 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.474 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . . . -176.88 129.68 0.18 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.314 -0.866 . . . . 1.22 109.416 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.3 mt -122.73 131.72 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.138 -0.977 . . . . 0.77 109.886 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.46 ' HB1' ' HB2' ' A' ' 27' ' ' CYS . . . -85.79 -35.81 20.48 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.337 -0.986 . . . . 2.26 108.337 179.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.408 ' O ' ' O ' ' A' ' 124' ' ' HIS . 2.4 m 64.77 121.41 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.61 -0.681 . . . . 1.74 110.372 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.408 ' O ' ' O ' ' A' ' 123' ' ' THR . 3.9 m170 48.02 98.03 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.543 -0.723 . . . . 3.09 110.771 178.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.477 ' O ' ' HB ' ' A' ' 104' ' ' VAL . . . -116.83 119.38 4.46 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 108.294 -1.922 . . . . 1.14 108.294 178.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.455 ' O ' HG23 ' A' ' 28' ' ' ILE . 0.8 OUTLIER -137.27 140.02 41.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.949 -1.324 . . . . 2.76 110.587 -178.892 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.816 HD13 ' OG ' ' A' ' 101' ' ' SER . 2.2 mp -83.16 149.53 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 108.292 -1.003 . . . . 1.15 108.292 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.685 ' CB ' ' O ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER 137.22 -82.11 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 108.96 -0.755 . . . . 3.86 108.96 179.355 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.442 ' N ' ' CD ' ' A' ' 128' ' ' ARG . 13.1 t70 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 117.948 -1.025 . . . . 4.22 109.382 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.526 ' C ' ' CG ' ' A' ' 2' ' ' GLN . 5.2 m-20 . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.31 -0.626 . . . . 3.24 109.31 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.561 ' HA ' ' CG ' ' A' ' 17' ' ' MET . 0.8 OUTLIER 37.35 30.07 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.647 -0.658 . . . . 4.54 110.589 179.166 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.778 HG11 ' H ' ' A' ' 22' ' ' HIS . 28.8 m -44.46 122.17 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.28 -0.887 . . . . 2.42 108.815 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.48 ' O ' ' HA3' ' A' ' 23' ' ' GLY . 8.3 t70 -55.39 134.61 50.39 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.449 -0.782 . . . . 2.17 110.586 -179.028 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.3 171.16 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 108.224 -1.028 . . . . 1.13 108.224 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 120' ' ' ALA . 27.4 mtpt -105.33 101.47 11.0 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.787 -1.196 . . . . 3.3 110.007 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.491 ' HA ' ' O ' ' A' ' 119' ' ' CYS . 65.1 m-20 -97.19 170.69 8.93 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.472 -0.768 . . . . 4.04 109.362 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.515 ' N ' ' SG ' ' A' ' 119' ' ' CYS . 3.8 m -138.69 4.64 2.36 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.34 -0.85 . . . . 1.49 109.639 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.595 ' HB2' ' HA ' ' A' ' 118' ' ' ALA . . . -47.09 -62.73 1.28 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.07 -1.019 . . . . 0.56 109.586 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.444 ' OD1' ' OD1' ' A' ' 11' ' ' ASN . 1.1 t-20 178.83 -81.85 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.919 -0.712 . . . . 4.78 109.301 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.444 ' OD1' ' OD1' ' A' ' 10' ' ' ASN . 14.3 p-10 -164.45 42.26 0.09 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.55 -0.719 . . . . 4.35 109.214 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.532 ' O ' ' HB ' ' A' ' 13' ' ' ILE . 0.7 OUTLIER -163.68 -81.94 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.231 -0.918 . . . . 3.78 109.566 -179.819 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.654 HG22 ' H ' ' A' ' 15' ' ' LYS . 0.1 OUTLIER 74.22 -2.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 CA-C-O 121.784 0.802 . . . . 3.79 110.257 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.524 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 15.1 mttm 65.99 -19.21 0.1 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.043 -1.036 . . . . 1.86 111.771 178.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.654 ' H ' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER 166.14 151.24 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.399 0 O-C-N 120.685 -1.26 . . . . 1.65 109.029 -178.073 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.794 ' O ' HG13 ' A' ' 16' ' ' VAL . 12.6 p -169.46 100.8 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.129 -0.982 . . . . 0.82 109.019 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.561 ' CG ' ' HA ' ' A' ' 2' ' ' GLN . 2.1 mpp? -151.19 150.16 30.28 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.589 -0.845 . . . . 1.34 110.196 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.677 HG11 ' CE1' ' A' ' 35' ' ' PHE . 19.2 t -117.0 160.24 16.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 107.794 -1.188 . . . . 1.35 107.794 178.404 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.569 ' CB ' ' O ' ' A' ' 34' ' ' PRO . 16.3 m-20 -94.91 36.17 1.21 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.835 -1.166 . . . . 1.69 110.021 -179.272 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.547 ' O ' ' CB ' ' A' ' 21' ' ' CYS . . . 130.45 128.9 3.04 Favored Glycine 0 N--CA 1.487 2.079 0 C-N-CA 119.523 -1.322 . . . . 1.05 110.131 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.877 ' CA ' HG23 ' A' ' 29' ' ' ILE . 0.0 OUTLIER 154.67 -36.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.538 -0.912 . . . . 0.91 108.538 179.132 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.778 ' H ' HG11 ' A' ' 3' ' ' VAL . 7.2 t-160 66.44 116.27 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.181 -1.044 . . . . 3.74 108.181 -178.051 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.537 ' O ' ' CB ' ' A' ' 24' ' ' SER . . . -103.67 176.2 23.9 Favored Glycine 0 N--CA 1.496 2.657 0 C-N-CA 119.064 -1.541 . . . . 0.79 110.392 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.537 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 1.3 t 84.75 -69.4 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.677 -0.896 . . . . 0.92 110.164 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.692 ' CB ' ' CD ' ' A' ' 26' ' ' PRO . 0.8 OUTLIER -83.57 -157.2 0.01 OUTLIER Pre-proline 0 C--N 1.304 -1.388 0 N-CA-C 108.274 -1.01 . . . . 4.49 108.274 -179.779 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.692 ' CD ' ' CB ' ' A' ' 25' ' ' ASP . 28.4 Cg_endo -74.38 89.53 1.07 Allowed 'Trans proline' 0 C--N 1.324 -0.76 0 N-CA-C 108.483 -1.391 . . . . 0.68 108.483 179.173 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.562 ' HA ' ' O ' ' A' ' 22' ' ' HIS . 1.6 t -38.4 95.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 113.244 0.831 . . . . 0.83 113.244 -177.012 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.493 ' O ' ' O ' ' A' ' 21' ' ' CYS . 24.1 mm -89.9 141.29 14.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 104.784 -2.302 . . . . 0.7 104.784 174.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.877 HG23 ' CA ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -119.45 179.94 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 O-C-N 120.215 -1.553 . . . . 0.79 112.886 -176.086 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.511 ' NE2' ' OD2' ' A' ' 129' ' ' ASP . 14.3 m170 -117.55 157.18 26.79 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.787 0.803 . . . . 2.87 110.828 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.583 ' HD3' ' CA ' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -115.43 154.55 29.06 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 107.76 -1.2 . . . . 1.54 107.76 178.285 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.415 ' H ' ' CG1' ' A' ' 94' ' ' VAL . . . 89.51 -1.01 81.3 Favored Glycine 0 N--CA 1.495 2.602 0 C-N-CA 119.582 -1.294 . . . . 0.35 110.073 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.753 ' N ' HG11 ' A' ' 94' ' ' VAL . 12.6 mtmt -128.65 146.72 61.28 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.257 -1.143 . . . . 1.74 108.284 179.092 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.569 ' O ' ' CB ' ' A' ' 19' ' ' ASP . 28.9 Cg_endo -66.26 109.89 1.66 Allowed 'Trans proline' 0 C--N 1.303 -1.855 0 C-N-CA 122.487 2.125 . . . . 0.43 110.199 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.677 ' CE1' HG11 ' A' ' 18' ' ' VAL . 47.5 t80 -81.11 70.3 7.91 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.414 0.626 . . . . 1.57 109.602 -179.133 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.605 HG22 ' O ' ' A' ' 36' ' ' THR . 32.9 m -90.91 76.69 6.25 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.439 -0.788 . . . . 0.8 109.816 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.523 ' CA ' HG13 ' A' ' 18' ' ' VAL . 1.6 pp -68.48 141.79 55.5 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.611 -1.255 . . . . 1.13 107.611 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.678 ' O ' ' HB2' ' A' ' 39' ' ' ALA . 14.2 mt-10 -142.21 -160.17 1.06 Allowed 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.82 -1.175 . . . . 1.04 110.995 -178.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.678 ' HB2' ' O ' ' A' ' 38' ' ' GLU . . . 156.35 96.44 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.153 -1.425 . . . . 0.59 107.153 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.686 ' HG ' ' CB ' ' A' ' 87' ' ' ASP . 0.3 OUTLIER -91.4 -176.88 4.68 Favored 'General case' 0 C--N 1.294 -1.82 0 O-C-N 121.546 -0.721 . . . . 0.57 110.371 -177.813 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.654 ' CE1' ' CE2' ' A' ' 86' ' ' TYR . 12.0 p90 175.37 147.74 0.09 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.393 -0.817 . . . . 0.38 109.147 177.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.618 ' O ' ' ND2' ' A' ' 44' ' ' ASN . 0.6 OUTLIER -98.72 112.41 24.49 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.441 -0.948 . . . . 4.36 108.441 179.747 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.791 ' HB1' ' O ' ' A' ' 81' ' ' VAL . . . -36.78 125.32 0.88 Allowed 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 115.932 -0.576 . . . . 0.45 110.245 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.618 ' ND2' ' O ' ' A' ' 42' ' ' ASP . 2.0 m120 -125.77 38.98 4.05 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.23 -0.919 . . . . 1.09 109.417 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.829 ' CD ' HD21 ' A' ' 117' ' ' LEU . 3.4 pt20 -128.1 -129.72 0.22 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.417 -0.802 . . . . 0.87 110.327 -178.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.701 ' C ' HG22 ' A' ' 81' ' ' VAL . 0.8 OUTLIER -169.78 54.61 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.644 -0.873 . . . . 4.96 108.644 179.469 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.643 ' N ' HG22 ' A' ' 81' ' ' VAL . 10.1 t -133.68 138.21 45.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.809 -1.182 . . . . 0.88 110.57 -178.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.659 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 0.6 OUTLIER -83.91 -11.55 56.74 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 120.897 -1.127 . . . . 2.59 108.251 177.625 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.429 ' O ' ' O ' ' A' ' 78' ' ' CYS . 2.6 p -95.67 -155.87 0.49 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.394 -0.816 . . . . 1.02 109.449 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.828 ' CB ' ' HB3' ' A' ' 72' ' ' ALA . . . 177.64 154.14 0.29 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.389 -0.819 . . . . 0.41 109.963 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.876 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 19.9 mtpt -115.92 -175.38 2.72 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 106.385 -1.709 . . . . 1.53 106.385 177.209 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.642 HG13 HD13 ' A' ' 54' ' ' ILE . 3.1 tt -164.87 158.67 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 C-N-CA 117.692 -1.603 . . . . 0.89 111.343 -179.08 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.473 ' C ' ' HE2' ' A' ' 55' ' ' LYS . 0.8 OUTLIER -157.89 48.79 0.4 Allowed 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.35 -0.982 . . . . 1.61 108.35 179.845 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 1.007 ' HB ' HG21 ' A' ' 65' ' ' VAL . 0.4 OUTLIER -83.02 155.48 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.665 -0.647 . . . . 0.47 109.492 -179.533 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.661 ' HG3' ' O ' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -170.79 100.69 0.23 Allowed 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.109 -0.7 . . . . 1.59 109.109 178.577 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.518 ' O ' ' HB ' ' A' ' 63' ' ' ILE . . . -126.66 124.04 38.95 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.363 -0.836 . . . . 0.5 110.02 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -108.76 128.28 54.74 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.187 -0.946 . . . . 1.92 109.241 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.851 HD13 ' N ' ' A' ' 59' ' ' ASP . 1.8 tm? -122.94 154.64 38.11 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.132 -0.98 . . . . 1.67 109.078 -179.264 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.851 ' N ' HD13 ' A' ' 58' ' ' LEU . 0.4 OUTLIER -47.27 -59.31 3.26 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.262 -0.899 . . . . 4.07 110.262 -179.205 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -104.07 24.02 30.48 Favored Glycine 0 N--CA 1.493 2.444 0 C-N-CA 119.731 -1.223 . . . . 1.39 110.46 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.439 ' O ' ' HB3' ' A' ' 58' ' ' LEU . 0.5 OUTLIER -164.51 87.69 0.48 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.024 -1.28 . . . . 3.02 109.327 179.666 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.426 ' O ' ' C ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -79.09 70.88 5.52 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.732 -0.605 . . . . 2.85 110.301 -179.666 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.518 ' HB ' ' O ' ' A' ' 56' ' ' ALA . 6.0 mt -48.1 160.62 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 107.115 -1.439 . . . . 0.56 107.115 178.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.421 ' C ' ' HD3' ' A' ' 66' ' ' PRO . 23.3 t0 -170.4 142.77 2.2 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.867 -1.146 . . . . 2.69 109.215 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 1.007 HG21 ' HB ' ' A' ' 54' ' ' ILE . 11.7 t -132.82 69.42 79.24 Favored Pre-proline 0 C--N 1.298 -1.647 0 O-C-N 121.353 -0.842 . . . . 0.7 109.223 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.421 ' HD3' ' C ' ' A' ' 64' ' ' ASP . 34.8 Cg_endo -76.37 -2.08 12.23 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 122.994 2.462 . . . . 1.0 110.625 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 136.44 42.22 0.11 Allowed Glycine 0 N--CA 1.489 2.199 0 C-N-CA 119.864 -1.16 . . . . 1.06 110.308 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.466 HD13 ' HA ' ' A' ' 68' ' ' ILE . 35.4 mm -52.92 -77.32 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 O-C-N 120.964 -1.315 . . . . 1.46 108.875 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -87.77 160.13 18.17 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.062 -1.024 . . . . 4.6 108.866 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.432 ' O ' ' CG ' ' A' ' 71' ' ' ASN . 13.8 t -78.51 -12.23 60.0 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.242 -0.911 . . . . 5.22 109.968 -179.287 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.58 ' CA ' ' O ' ' A' ' 50' ' ' ALA . 47.8 m-20 -164.31 77.0 0.34 Allowed 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 118.661 -1.216 . . . . 2.93 112.324 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.876 ' HB2' ' O ' ' A' ' 51' ' ' LYS . . . 22.34 46.01 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 121.492 0.663 . . . . 0.88 112.032 175.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.543 ' N ' ' O ' ' A' ' 71' ' ' ASN . 6.1 t -106.6 -42.12 5.07 Favored 'General case' 0 C--N 1.285 -2.219 0 O-C-N 121.346 -0.846 . . . . 0.95 110.531 -178.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 4.6 m170 -78.46 -1.2 32.52 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.993 -1.067 . . . . 3.94 109.79 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.518 ' HB3' HD11 ' A' ' 88' ' ' ILE . 57.9 m-85 -110.47 -14.7 14.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.233 -0.917 . . . . 0.45 109.898 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.82 ' HB ' ' CE1' ' A' ' 86' ' ' TYR . 0.2 OUTLIER -157.39 175.28 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 120.81 -1.181 . . . . 0.43 110.731 -177.316 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.647 ' N ' ' CG2' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -57.73 93.3 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 105.373 -2.084 . . . . 1.67 105.373 176.758 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' CYS . . . . . 0.553 ' HB2' ' HD3' ' A' ' 79' ' ' PRO . 2.7 m -34.57 -51.51 1.03 Allowed Pre-proline 0 N--CA 1.5 2.033 0 O-C-N 121.628 -0.67 . . . . 1.04 112.021 -176.011 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.659 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 32.1 Cg_endo -79.1 108.79 2.43 Favored 'Trans proline' 0 C--N 1.303 -1.842 0 N-CA-C 109.401 -1.038 . . . . 0.46 109.401 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.883 HD12 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -92.26 -65.47 1.0 Allowed 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.518 -1.29 . . . . 0.46 107.518 -179.86 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.791 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 14.0 t 54.84 -178.26 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 C-N-CA 119.29 -0.964 . . . . 2.89 109.134 177.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.569 ' N ' HG12 ' A' ' 81' ' ' VAL . 13.0 ptmt -102.2 37.01 1.96 Allowed 'General case' 0 C--N 1.296 -1.759 0 O-C-N 120.467 -1.395 . . . . 1.52 110.206 -178.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -145.65 37.22 1.29 Allowed Glycine 0 C--N 1.288 -2.105 0 N-CA-C 108.664 -1.774 . . . . 1.05 108.664 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -146.58 142.62 28.17 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 121.23 -1.159 . . . . 3.1 110.627 -178.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.457 ' O ' ' CG ' ' A' ' 85' ' ' GLN . 11.2 pt20 -115.88 130.69 56.94 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 105.977 -1.86 . . . . 2.56 105.977 177.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.82 ' CE1' ' HB ' ' A' ' 76' ' ' VAL . 0.1 OUTLIER -152.71 156.91 40.08 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 117.74 -1.584 . . . . 0.36 109.968 -177.641 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.686 ' CB ' ' HG ' ' A' ' 40' ' ' LEU . 7.2 p-10 -127.89 96.95 4.65 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 113.915 1.08 . . . . 0.36 113.915 -175.234 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.579 HG23 ' N ' ' A' ' 89' ' ' LYS . 6.2 tp -62.99 -163.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 N-CA-C 106.362 -1.718 . . . . 1.06 106.362 175.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.587 ' O ' ' CG ' ' A' ' 90' ' ' TYR . 1.0 OUTLIER 161.83 179.49 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.718 -1.239 . . . . 2.25 111.519 179.74 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.674 ' CZ ' HG21 ' A' ' 54' ' ' ILE . 62.9 m-85 -162.81 61.14 0.2 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 107.027 -1.472 . . . . 0.55 107.027 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.564 ' HA ' HG23 ' A' ' 36' ' ' THR . 7.1 p -43.36 178.05 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.132 0 CA-C-O 121.402 0.62 . . . . 1.19 111.382 -178.332 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.704 ' CZ2' ' HB2' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -173.82 116.35 0.24 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 118.71 -1.196 . . . . 3.44 112.516 -179.345 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -84.31 126.81 33.54 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 105.729 -1.952 . . . . 2.12 105.729 176.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.805 HG13 HD12 ' A' ' 97' ' ' ILE . 1.7 t -112.42 102.78 54.81 Favored Pre-proline 0 C--N 1.302 -1.481 0 O-C-N 120.626 -1.297 . . . . 0.88 113.033 -176.248 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.993 ' HD2' HD11 ' A' ' 97' ' ' ILE . 31.8 Cg_endo -79.04 44.2 1.64 Allowed 'Trans proline' 0 C--N 1.314 -1.255 0 C-N-CA 123.088 2.525 . . . . 2.3 110.905 176.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.539 ' O ' ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER 82.32 -70.03 0.06 Allowed 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 107.458 -1.312 . . . . 3.52 107.458 -178.48 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.993 HD11 ' HD2' ' A' ' 95' ' ' PRO . 2.7 mp 69.16 17.95 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 112.745 0.646 . . . . 0.98 112.745 176.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 1.059 ' HB1' ' HD2' ' A' ' 99' ' ' PRO . . . 49.06 177.65 0.01 OUTLIER Pre-proline 0 C--N 1.304 -1.377 0 O-C-N 120.774 -1.204 . . . . 0.58 110.477 178.451 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 1.059 ' HD2' ' HB1' ' A' ' 98' ' ' ALA . 50.8 Cg_endo -85.17 165.09 11.25 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 123.746 2.964 . . . . 0.67 110.044 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.634 ' HD3' ' CB ' ' A' ' 128' ' ' ARG . 3.8 mmmm 43.04 115.69 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 113.23 0.826 . . . . 2.06 113.23 175.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.836 ' CB ' HD13 ' A' ' 127' ' ' ILE . 10.1 t -92.31 161.61 14.62 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.961 -1.087 . . . . 0.4 108.242 177.373 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.473 ' O ' ' CB ' ' A' ' 103' ' ' ASN . 0.3 OUTLIER -61.93 -10.4 9.47 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.05 -1.031 . . . . 4.04 110.055 -179.77 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.501 ' N ' ' OD1' ' A' ' 103' ' ' ASN . 1.1 p30 167.27 158.63 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.058 -1.026 . . . . 4.69 109.569 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.573 ' O ' HG23 ' A' ' 105' ' ' VAL . 0.1 OUTLIER -158.65 -178.48 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.107 -0.995 . . . . 0.76 109.677 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 104' ' ' VAL . 0.9 OUTLIER 159.79 123.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 108.561 -0.903 . . . . 0.35 108.561 -179.758 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.649 ' HB ' ' HB3' ' A' ' 122' ' ' ALA . 2.4 t -118.99 144.6 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 120.883 -1.136 . . . . 0.56 110.197 -179.27 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.474 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -159.16 175.67 13.17 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.263 -1.014 . . . . 0.65 108.263 179.789 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.877 HG22 ' CD1' ' A' ' 54' ' ' ILE . 1.1 t 171.33 169.0 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 120.721 -1.237 . . . . 0.83 110.528 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.655 ' N ' HG13 ' A' ' 108' ' ' VAL . 11.2 ttpt 164.28 121.91 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.634 0.73 . . . . 0.81 109.091 178.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.732 HD11 ' HB1' ' A' ' 72' ' ' ALA . 7.7 tp -108.92 125.44 52.02 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.585 -1.265 . . . . 0.75 107.585 178.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.53 ' HB ' ' HB2' ' A' ' 51' ' ' LYS . 4.0 mt -130.31 114.7 29.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.162 -0.961 . . . . 0.92 110.71 -178.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.461 ' HA3' HG21 ' A' ' 47' ' ' THR . . . -70.84 -116.18 0.04 OUTLIER Glycine 0 N--CA 1.485 1.947 0 N-CA-C 107.75 -2.14 . . . . 0.37 107.75 177.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -135.07 -0.56 2.75 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.023 -1.281 . . . . 2.43 107.546 178.189 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -109.85 -24.81 10.65 Favored 'General case' 0 C--N 1.312 -1.057 0 O-C-N 121.35 -0.844 . . . . 0.96 109.428 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -179.85 176.72 47.69 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.401 -1.479 . . . . 1.26 109.401 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.48 ' HA ' ' HA ' ' A' ' 111' ' ' ILE . 0.9 OUTLIER -81.38 106.61 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.195 -1.18 . . . . 0.5 109.834 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.883 HD22 HD12 ' A' ' 80' ' ' LEU . 4.0 mt -52.3 -54.61 29.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.419 -0.801 . . . . 0.44 110.543 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.595 ' HA ' ' HB2' ' A' ' 9' ' ' ALA . . . -140.63 -170.9 3.11 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.061 -1.024 . . . . 0.44 110.847 -178.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.531 ' SG ' ' N ' ' A' ' 120' ' ' ALA . 0.0 OUTLIER 175.5 159.61 0.24 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.578 -0.701 . . . . 0.48 109.563 -179.652 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.531 ' N ' ' SG ' ' A' ' 119' ' ' CYS . . . -176.91 126.96 0.16 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.274 -0.891 . . . . 0.64 109.055 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.586 HG22 ' H ' ' A' ' 123' ' ' THR . 6.4 mt -129.37 132.24 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.175 -0.953 . . . . 0.74 109.902 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.649 ' HB3' ' HB ' ' A' ' 106' ' ' VAL . . . -115.8 20.89 14.28 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.156 -0.965 . . . . 1.43 108.759 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.586 ' H ' HG22 ' A' ' 121' ' ' ILE . 82.5 p 47.02 -160.7 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.413 -0.804 . . . . 3.69 109.272 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.574 ' CE1' ' HB3' ' A' ' 26' ' ' PRO . 42.2 p-80 -71.06 160.09 33.53 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.223 -0.923 . . . . 4.29 109.115 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.49 ' HA2' ' O ' ' A' ' 27' ' ' CYS . . . -120.24 -169.76 14.1 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.621 -1.392 . . . . 1.79 109.621 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.414 ' O ' ' C ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER 178.41 74.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.285 -1.127 . . . . 1.48 109.574 179.736 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.836 HD13 ' CB ' ' A' ' 101' ' ' SER . 2.5 mp -39.41 157.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.6 -0.688 . . . . 0.47 110.463 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.662 ' CB ' ' O ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER 132.97 -87.19 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.142 0 CA-C-O 121.357 0.599 . . . . 2.82 109.956 178.476 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.511 ' OD2' ' NE2' ' A' ' 30' ' ' HIS . 1.7 t0 . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 118.112 -0.946 . . . . 4.27 109.693 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.501 0.667 . . . . 3.2 109.574 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.572 ' HA ' ' CG ' ' A' ' 17' ' ' MET . 12.2 pt20 -133.92 41.89 2.97 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.498 -0.751 . . . . 3.33 108.984 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.56 HG23 HG23 ' A' ' 18' ' ' VAL . 2.0 m -45.86 120.89 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 108.16 -1.052 . . . . 3.03 108.16 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.473 ' C ' ' HA3' ' A' ' 23' ' ' GLY . 71.3 m-20 -94.41 127.84 40.56 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.379 -0.826 . . . . 5.39 110.913 -178.306 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.643 HG13 ' HA2' ' A' ' 23' ' ' GLY . 0.1 OUTLIER -95.72 -170.67 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.013 -1.106 . . . . 1.5 108.013 178.655 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.81 94.62 9.19 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.83 -1.169 . . . . 2.14 109.153 179.306 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.479 ' HA ' ' O ' ' A' ' 119' ' ' CYS . 1.6 m-20 -99.07 174.35 6.38 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.537 -0.727 . . . . 4.44 109.286 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.514 ' N ' ' SG ' ' A' ' 119' ' ' CYS . 31.6 p -163.62 49.14 0.14 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.238 -0.913 . . . . 2.23 109.725 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.571 ' O ' ' ND2' ' A' ' 10' ' ' ASN . . . -83.3 -66.33 0.9 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.112 -0.993 . . . . 0.61 109.859 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.571 ' ND2' ' O ' ' A' ' 9' ' ' ALA . 0.4 OUTLIER 164.34 42.33 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.46 -0.896 . . . . 1.65 109.788 -178.779 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.2 m120 49.88 23.93 1.18 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.937 -1.102 . . . . 3.04 108.042 -179.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 13' ' ' ILE . 0.0 OUTLIER -105.76 -28.54 10.62 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.574 -0.704 . . . . 3.38 109.234 -179.764 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 1.038 HG23 ' O ' ' A' ' 40' ' ' LEU . 11.9 mt -41.81 143.7 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 109.077 -0.712 . . . . 0.6 109.077 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -105.02 -19.2 13.91 Favored 'General case' 0 C--N 1.295 -1.767 0 O-C-N 121.402 -0.811 . . . . 3.89 108.998 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.403 ' H ' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -160.35 104.98 1.46 Allowed 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 119.031 -1.067 . . . . 2.74 110.363 -177.985 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.546 ' O ' HG13 ' A' ' 16' ' ' VAL . 2.6 p -120.87 95.82 3.81 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 107.075 -1.454 . . . . 1.48 107.075 178.418 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.572 ' CG ' ' HA ' ' A' ' 2' ' ' GLN . 2.3 mpt? -144.7 145.57 31.78 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.63 -0.669 . . . . 2.24 109.751 -178.227 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.992 HG13 ' HA ' ' A' ' 37' ' ' LEU . 1.7 t -110.93 120.36 61.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 108.255 -1.017 . . . . 0.61 108.255 179.058 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -41.93 -26.1 0.08 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.39 -0.819 . . . . 2.76 109.714 -179.44 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -158.1 -148.42 5.14 Favored Glycine 0 N--CA 1.488 2.116 0 C-N-CA 119.615 -1.279 . . . . 2.0 109.964 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.634 ' HA ' ' HA ' ' A' ' 29' ' ' ILE . 50.4 t 65.15 -111.47 0.24 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.629 -0.924 . . . . 2.27 109.664 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.572 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 0.3 OUTLIER 155.2 139.7 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 106.621 -1.622 . . . . 2.26 106.621 -178.723 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.643 ' HA2' HG13 ' A' ' 5' ' ' VAL . . . -107.99 157.59 15.29 Favored Glycine 0 C--N 1.288 -2.119 0 N-CA-C 109.409 -1.477 . . . . 1.51 109.409 -179.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.457 ' O ' ' CB ' ' A' ' 25' ' ' ASP . 0.2 OUTLIER 66.61 137.2 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.216 -1.167 . . . . 2.86 108.279 -179.163 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.558 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.2 OUTLIER 66.48 177.29 0.05 OUTLIER Pre-proline 0 C--N 1.304 -1.385 0 O-C-N 120.455 -1.403 . . . . 5.52 107.998 -179.815 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.558 ' HD2' ' CB ' ' A' ' 25' ' ' ASP . 30.7 Cg_endo -74.8 123.67 8.15 Favored 'Trans proline' 0 C--N 1.299 -2.055 0 C-N-CA 122.747 2.298 . . . . 2.11 109.397 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.572 ' HB2' ' O ' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -97.08 113.94 25.55 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.291 -0.881 . . . . 1.44 111.491 -177.819 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.637 HD13 ' HG3' ' A' ' 126' ' ' LYS . 20.1 mm -86.77 83.72 2.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 107.147 -1.427 . . . . 1.97 107.147 176.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.634 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -50.08 -177.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 O-C-N 121.699 -0.626 . . . . 2.02 109.977 -179.138 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 79.5 m-70 -134.2 160.44 37.84 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.507 -0.877 . . . . 1.3 110.659 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.586 ' HD3' ' CA ' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -108.83 113.02 25.6 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.528 -0.732 . . . . 1.74 109.399 179.626 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 134.42 0.2 3.75 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 110.206 -1.158 . . . . 0.8 110.206 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.579 ' O ' HG21 ' A' ' 94' ' ' VAL . 13.3 mttt -130.23 144.43 53.17 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 120.93 -1.335 . . . . 1.46 110.184 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -69.41 81.08 0.75 Allowed 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 123.166 2.577 . . . . 0.81 111.19 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.728 ' H ' HG21 ' A' ' 94' ' ' VAL . 5.2 t80 -55.42 122.13 10.52 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 109.433 -0.581 . . . . 2.37 109.433 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 37.5 m -134.04 85.44 2.2 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.075 -1.015 . . . . 1.5 109.571 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.992 ' HA ' HG13 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -62.66 141.38 58.55 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.235 -0.915 . . . . 1.94 108.891 179.746 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.963 ' N ' HD12 ' A' ' 37' ' ' LEU . 87.2 mt-10 -139.17 -171.23 3.06 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.147 -0.971 . . . . 2.21 110.06 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.703 ' HB2' ' O ' ' A' ' 38' ' ' GLU . . . 155.13 70.7 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.906 -1.146 . . . . 1.36 107.906 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 1.038 ' O ' HG23 ' A' ' 13' ' ' ILE . 0.8 OUTLIER -71.98 171.73 11.3 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 115.912 -0.585 . . . . 0.5 110.162 -178.841 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.746 ' HZ ' ' HH ' ' A' ' 86' ' ' TYR . 5.5 p90 -176.01 148.39 0.82 Allowed 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.583 -0.895 . . . . 0.37 108.583 179.108 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.509 ' O ' ' C ' ' A' ' 43' ' ' ALA . 6.7 t70 -95.28 112.19 23.94 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 107.286 -1.375 . . . . 2.09 107.286 178.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.699 ' HB1' ' O ' ' A' ' 81' ' ' VAL . . . -36.1 125.53 0.76 Allowed 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 115.61 -0.723 . . . . 0.66 109.1 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -124.04 15.02 9.19 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.171 -0.956 . . . . 4.08 110.33 -177.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.959 ' OE1' HD21 ' A' ' 117' ' ' LEU . 2.3 pt20 -105.56 -139.41 0.37 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.379 -0.971 . . . . 0.31 108.379 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.794 ' HA ' ' HB ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -156.73 67.98 0.57 Allowed 'General case' 0 C--N 1.294 -1.845 0 O-C-N 121.08 -1.013 . . . . 1.1 109.306 178.59 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.753 HG23 ' O ' ' A' ' 47' ' ' THR . 10.3 t -146.33 118.47 8.31 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.263 -1.523 . . . . 0.52 111.607 -178.11 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.611 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 0.6 OUTLIER -66.4 -10.6 45.3 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.66 -1.275 . . . . 2.37 107.847 177.262 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.482 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 30.5 p -98.44 -161.3 0.86 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.335 -0.853 . . . . 0.77 108.807 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.912 ' CB ' ' HB3' ' A' ' 72' ' ' ALA . . . 174.67 160.4 0.19 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.168 -0.958 . . . . 0.3 109.863 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 1.011 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 20.3 mtmt -123.14 169.04 11.64 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 107.227 -1.398 . . . . 0.98 107.227 177.303 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.572 HD13 ' CD1' ' A' ' 75' ' ' PHE . 11.1 tt -148.19 144.74 18.89 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.239 0 C-N-CA 118.413 -1.315 . . . . 0.55 110.558 -178.215 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.456 ' O ' ' CE ' ' A' ' 55' ' ' LYS . 6.1 mt-10 -139.84 56.42 1.64 Allowed 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 107.101 -1.444 . . . . 1.67 107.101 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.948 ' HB ' HG21 ' A' ' 65' ' ' VAL . 0.3 OUTLIER -87.62 151.91 3.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 O-C-N 121.312 -0.867 . . . . 1.13 110.096 -178.392 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.686 ' HG3' ' O ' ' A' ' 54' ' ' ILE . 0.1 OUTLIER -166.51 95.22 0.54 Allowed 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 109.053 -0.721 . . . . 1.02 109.053 178.305 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.726 ' HB3' ' HB ' ' A' ' 63' ' ' ILE . . . -118.78 138.66 52.53 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.394 -0.816 . . . . 0.54 109.563 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.455 ' O ' ' CG1' ' A' ' 104' ' ' VAL . 1.6 t -124.4 124.8 43.14 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.925 -1.109 . . . . 1.11 110.125 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 1.011 HD13 ' N ' ' A' ' 59' ' ' ASP . 2.6 tm? -117.85 152.86 34.52 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.255 -1.017 . . . . 1.46 108.255 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 1.011 ' N ' HD13 ' A' ' 58' ' ' LEU . 5.4 t0 -43.61 -66.06 0.42 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.061 -1.025 . . . . 2.17 109.938 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.496 ' O ' HD12 ' A' ' 61' ' ' LEU . . . -101.09 20.18 48.63 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.058 -1.217 . . . . 0.75 110.058 -179.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.496 HD12 ' O ' ' A' ' 60' ' ' GLY . 1.9 tp -152.69 79.13 1.21 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.141 -1.211 . . . . 2.46 108.935 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.445 ' O ' ' C ' ' A' ' 63' ' ' ILE . 0.5 OUTLIER -74.9 76.05 2.15 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 116.203 -0.453 . . . . 3.91 110.869 -179.19 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.726 ' HB ' ' HB3' ' A' ' 56' ' ' ALA . 3.2 mt -49.08 162.81 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 106.54 -1.652 . . . . 0.58 106.54 178.167 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -176.02 147.43 0.75 Allowed 'General case' 0 C--N 1.297 -1.707 0 O-C-N 120.424 -1.423 . . . . 0.9 109.004 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.948 HG21 ' HB ' ' A' ' 54' ' ' ILE . 17.1 t -140.77 62.28 17.27 Favored Pre-proline 0 C--N 1.299 -1.598 0 C-N-CA 119.279 -0.969 . . . . 1.21 110.215 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.562 ' HD3' ' N ' ' A' ' 65' ' ' VAL . 36.2 Cg_endo -78.32 -5.05 14.76 Favored 'Trans proline' 0 C--N 1.301 -1.964 0 C-N-CA 122.82 2.347 . . . . 1.27 109.094 178.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 68' ' ' ILE . . . -177.62 -110.25 0.27 Allowed Glycine 0 N--CA 1.487 2.073 0 N-CA-C 108.14 -1.984 . . . . 1.94 108.14 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.45 ' C ' ' O ' ' A' ' 67' ' ' GLY . 0.0 OUTLIER 39.97 85.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.421 -1.046 . . . . 2.42 109.779 179.103 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 46.28 80.38 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.003 -1.061 . . . . 5.99 108.856 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.37 50.17 1.95 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.361 -0.837 . . . . 7.87 109.467 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.529 ' CA ' ' O ' ' A' ' 50' ' ' ALA . 8.6 m-20 -136.86 38.04 2.6 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.195 -0.941 . . . . 1.97 109.935 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 1.011 ' HB2' ' O ' ' A' ' 51' ' ' LYS . . . 37.92 29.18 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 121.419 0.628 . . . . 0.94 110.466 177.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.499 ' N ' ' O ' ' A' ' 71' ' ' ASN . 9.8 t -105.2 -52.29 2.87 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.455 -0.778 . . . . 0.96 110.003 -179.329 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -67.27 -16.91 64.56 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.957 -1.089 . . . . 1.05 109.706 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.655 ' C ' HG12 ' A' ' 76' ' ' VAL . 91.7 m-85 -101.05 -9.14 21.69 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.173 -0.954 . . . . 0.95 110.169 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.789 ' HB ' ' CE1' ' A' ' 86' ' ' TYR . 0.2 OUTLIER -165.66 173.98 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 120.591 -1.318 . . . . 0.55 111.366 -177.298 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.64 ' N ' ' CG2' ' A' ' 76' ' ' VAL . 2.5 mmmt -56.23 92.3 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.119 -1.437 . . . . 1.54 107.119 177.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' CYS . . . . . 0.509 ' N ' ' O ' ' A' ' 76' ' ' VAL . 0.4 OUTLIER -35.22 -52.53 1.22 Allowed Pre-proline 0 N--CA 1.502 2.15 0 CA-C-N 116.323 -0.399 . . . . 0.97 110.955 -177.596 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.611 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 31.2 Cg_endo -76.59 109.52 2.88 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 121.115 1.21 . . . . 0.64 109.269 179.35 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 1.092 HD22 HD22 ' A' ' 117' ' ' LEU . 0.5 OUTLIER -103.15 -63.51 1.17 Allowed 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 121.41 0.624 . . . . 2.55 109.399 -178.519 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.794 ' HB ' ' HA ' ' A' ' 46' ' ' ASN . 1.3 m 40.18 -167.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 C-N-CA 120.56 -0.456 . . . . 0.52 109.884 178.274 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.711 ' H ' HG23 ' A' ' 81' ' ' VAL . 1.0 OUTLIER -104.38 41.96 1.25 Allowed 'General case' 0 C--N 1.289 -2.054 0 O-C-N 120.39 -1.444 . . . . 2.7 110.411 -176.848 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -146.65 35.88 1.28 Allowed Glycine 0 C--N 1.287 -2.19 0 N-CA-C 108.583 -1.807 . . . . 0.85 108.583 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.404 HE21 ' HB2' ' A' ' 84' ' ' GLN . 0.7 OUTLIER -150.0 140.1 22.08 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 121.237 -1.155 . . . . 3.09 110.578 -179.046 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.504 ' HG2' ' HB2' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -112.42 129.31 56.36 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 105.566 -2.013 . . . . 2.42 105.566 177.048 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.789 ' CE1' ' HB ' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -151.21 160.94 43.55 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 117.525 -1.67 . . . . 0.51 110.124 -177.371 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.636 ' CB ' ' HG ' ' A' ' 40' ' ' LEU . 1.8 m-20 -129.03 99.5 5.29 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.948 -1.095 . . . . 4.08 113.456 -175.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.638 HG23 ' N ' ' A' ' 89' ' ' LYS . 3.8 tp -66.78 -163.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 106.839 -1.541 . . . . 1.14 106.839 176.158 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.638 ' N ' HG23 ' A' ' 88' ' ' ILE . 10.4 mttt 161.39 175.4 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.271 0 O-C-N 120.927 -1.108 . . . . 1.26 111.071 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.592 ' CG ' ' O ' ' A' ' 89' ' ' LYS . 41.9 m-85 -165.37 103.11 0.73 Allowed 'General case' 0 N--CA 1.504 2.269 0 N-CA-C 108.154 -1.054 . . . . 0.75 108.154 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.415 HG22 ' H ' ' A' ' 92' ' ' TRP . 0.2 OUTLIER -96.03 179.18 5.16 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.282 -0.887 . . . . 3.11 111.467 -177.976 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.828 ' O ' HG23 ' A' ' 94' ' ' VAL . 1.7 t90 -167.62 101.57 0.49 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.759 -0.588 . . . . 4.35 109.472 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.507 ' O ' ' CD1' ' A' ' 92' ' ' TRP . 49.4 t-20 -47.47 123.33 5.58 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 106.842 -1.54 . . . . 1.79 106.842 178.224 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.874 HG13 ' CD1' ' A' ' 97' ' ' ILE . 58.2 t -116.21 90.5 29.28 Favored Pre-proline 0 C--N 1.3 -1.547 0 C-N-CA 118.568 -1.253 . . . . 1.39 111.934 -177.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.709 ' HD2' HD11 ' A' ' 97' ' ' ILE . 33.7 Cg_endo -83.07 58.65 6.38 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 123.423 2.749 . . . . 2.72 109.809 178.019 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.729 ' C ' HD12 ' A' ' 97' ' ' ILE . 0.1 OUTLIER 71.04 -80.37 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.386 -1.339 . . . . 3.05 107.386 -177.843 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.874 ' CD1' HG13 ' A' ' 94' ' ' VAL . 2.6 mp 76.44 34.58 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.638 -0.664 . . . . 1.04 112.24 177.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.959 ' HB1' ' HD2' ' A' ' 99' ' ' PRO . . . 53.32 171.4 0.04 OUTLIER Pre-proline 0 C--N 1.3 -1.578 0 O-C-N 120.98 -1.075 . . . . 0.45 110.991 178.173 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.959 ' HD2' ' HB1' ' A' ' 98' ' ' ALA . 61.4 Cg_endo -87.45 83.91 0.92 Allowed 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 123.951 3.101 . . . . 1.7 110.487 -178.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.728 ' CB ' ' O ' ' A' ' 99' ' ' PRO . 0.1 OUTLIER 116.25 121.14 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 118.896 0.771 . . . . 2.0 111.02 178.279 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.455 ' O ' ' N ' ' A' ' 103' ' ' ASN . 1.9 p -92.29 148.7 21.93 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.754 -1.202 . . . . 2.11 107.754 177.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 101' ' ' SER . 0.0 OUTLIER -42.58 -26.47 0.12 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.947 -1.096 . . . . 4.38 109.727 -179.231 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.478 ' C ' ' CG2' ' A' ' 104' ' ' VAL . 1.4 t-20 171.23 160.22 0.08 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.317 -0.864 . . . . 2.22 109.246 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.478 ' CG2' ' C ' ' A' ' 103' ' ' ASN . 0.1 OUTLIER -155.99 140.38 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.157 -0.964 . . . . 1.05 109.64 179.942 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -143.09 134.37 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.352 -0.843 . . . . 0.96 109.179 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.85 ' HB ' ' HB3' ' A' ' 122' ' ' ALA . 49.5 t -126.04 125.03 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.033 -1.042 . . . . 0.58 109.775 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.529 ' O ' HG22 ' A' ' 108' ' ' VAL . 74.6 m -147.18 136.11 22.26 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.881 -1.155 . . . . 1.08 107.881 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.637 HG12 ' CD1' ' A' ' 54' ' ' ILE . 0.3 OUTLIER -157.19 162.18 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 120.419 -1.426 . . . . 2.18 110.881 -179.284 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.558 ' HA ' ' HA ' ' A' ' 119' ' ' CYS . 2.4 tttt 175.19 118.6 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.726 0.774 . . . . 3.03 110.215 178.004 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.605 ' HB3' ' HB2' ' A' ' 117' ' ' LEU . 4.6 tp -92.89 122.26 35.09 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.367 -1.346 . . . . 0.97 107.367 178.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.526 ' HB ' ' HB2' ' A' ' 51' ' ' LYS . 5.7 mt -122.12 114.99 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.766 -1.209 . . . . 0.49 111.932 -177.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -80.01 -127.58 0.67 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 107.91 -2.076 . . . . 1.07 107.91 177.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -135.2 -2.97 2.48 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.878 -1.366 . . . . 2.67 107.881 178.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.401 ' CG ' ' ND2' ' A' ' 46' ' ' ASN . 1.2 m-80 -115.03 -7.54 12.51 Favored 'General case' 0 C--N 1.313 -0.991 0 O-C-N 121.24 -0.913 . . . . 1.3 110.082 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 163.91 139.85 2.73 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 110.015 -1.234 . . . . 2.12 110.015 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.529 ' CG2' ' HE3' ' A' ' 109' ' ' LYS . 0.1 OUTLIER -52.29 119.42 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.36 -1.082 . . . . 0.9 109.823 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 1.092 HD22 HD22 ' A' ' 80' ' ' LEU . 1.7 mt -62.73 -59.98 4.13 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.274 -0.891 . . . . 0.55 109.329 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.553 ' HA ' ' HA ' ' A' ' 9' ' ' ALA . . . -158.23 -173.02 4.12 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.54 -0.725 . . . . 0.96 109.274 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.558 ' HA ' ' HA ' ' A' ' 109' ' ' LYS . 13.5 p 176.96 170.16 0.52 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.343 -0.848 . . . . 1.11 109.422 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -164.21 131.45 3.26 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.495 -0.753 . . . . 0.5 109.057 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.489 ' O ' HG12 ' A' ' 5' ' ' VAL . 2.7 mp -128.18 142.82 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.089 -1.007 . . . . 0.68 110.57 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.85 ' HB3' ' HB ' ' A' ' 106' ' ' VAL . . . -138.19 64.41 1.5 Allowed 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.028 -1.101 . . . . 0.8 108.028 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.484 ' O ' ' O ' ' A' ' 124' ' ' HIS . 0.4 OUTLIER -38.74 132.28 1.22 Allowed 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.681 0.753 . . . . 2.39 111.533 -178.472 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.484 ' O ' ' O ' ' A' ' 123' ' ' THR . 1.4 m-70 47.74 173.0 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.866 0.841 . . . . 2.81 111.495 178.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 167.49 141.83 3.28 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.39 -1.484 . . . . 0.64 109.39 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.637 ' HG3' HD13 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -147.01 134.11 20.42 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.116 -1.226 . . . . 1.66 109.343 179.683 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.591 ' CD1' HG13 ' A' ' 29' ' ' ILE . 0.8 OUTLIER -79.27 124.1 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.408 -0.808 . . . . 1.67 111.172 -178.306 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.623 ' HB2' ' HG2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER 168.64 -89.78 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.887 -1.133 . . . . 2.26 109.491 177.172 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.608 ' N ' HG21 ' A' ' 28' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 118.013 -0.994 . . . . 3.65 109.212 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.183 -0.673 . . . . 4.3 109.183 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.556 ' HB3' ' CG ' ' A' ' 17' ' ' MET . 1.2 pt20 -100.6 -172.97 2.29 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.063 -1.023 . . . . 2.37 109.508 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 1.0 HG12 ' HA ' ' A' ' 22' ' ' HIS . 5.5 m -128.92 -168.26 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.348 -0.845 . . . . 1.74 109.409 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -130.87 77.8 1.8 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.178 -0.951 . . . . 1.44 109.305 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.8 m -100.6 150.78 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.162 -0.961 . . . . 1.43 109.596 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.507 ' O ' HD12 ' A' ' 121' ' ' ILE . 12.8 mtpp -75.05 93.68 2.77 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.496 -0.752 . . . . 2.31 109.701 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.523 ' HB2' HD12 ' A' ' 13' ' ' ILE . 35.4 p-10 -82.81 176.08 9.59 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.197 -0.939 . . . . 2.3 109.122 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.517 ' N ' ' SG ' ' A' ' 119' ' ' CYS . 7.8 m -138.59 9.09 2.64 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.124 -0.985 . . . . 1.32 109.919 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.668 ' HB2' HG13 ' A' ' 13' ' ' ILE . . . -56.55 -43.99 80.48 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.932 -1.105 . . . . 0.69 109.035 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.51 ' CB ' ' O ' ' A' ' 9' ' ' ALA . 0.5 OUTLIER 163.61 -58.09 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.948 -0.76 . . . . 5.01 108.948 -179.185 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 10' ' ' ASN . 1.9 t-20 174.46 38.0 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.921 -0.77 . . . . 3.63 108.921 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -171.56 -62.71 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.025 -1.047 . . . . 4.65 110.859 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.668 HG13 ' HB2' ' A' ' 9' ' ' ALA . 0.1 OUTLIER 67.76 4.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.122 -0.987 . . . . 3.91 110.155 -179.047 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.548 ' HB2' ' O ' ' A' ' 13' ' ' ILE . 0.0 OUTLIER 75.08 -31.95 0.22 Allowed 'General case' 0 C--N 1.293 -1.876 0 O-C-N 121.386 -0.821 . . . . 2.23 111.036 178.747 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.532 ' CB ' ' O ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER 165.81 109.93 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 118.785 -1.166 . . . . 2.93 110.569 -178.622 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.656 ' O ' HG13 ' A' ' 16' ' ' VAL . 6.8 p -120.07 107.85 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.096 -1.002 . . . . 1.2 108.76 178.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.556 ' CG ' ' HB3' ' A' ' 2' ' ' GLN . 0.5 OUTLIER -145.83 146.91 31.33 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.366 -0.934 . . . . 1.43 110.332 -179.605 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.71 HG22 ' HA ' ' A' ' 37' ' ' LEU . 42.1 t -117.62 148.95 20.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 108.255 -1.017 . . . . 1.3 108.255 179.088 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.439 ' HB3' ' HA ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -81.17 71.2 8.14 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.069 -1.086 . . . . 1.0 108.069 179.446 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.542 ' O ' ' CB ' ' A' ' 21' ' ' CYS . . . 108.02 -167.85 13.56 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 109.157 -1.577 . . . . 1.76 109.157 -178.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 1.002 ' CA ' HG23 ' A' ' 29' ' ' ILE . 15.5 t 83.54 -57.71 0.14 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.782 -0.834 . . . . 1.42 109.984 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 1.0 ' HA ' HG12 ' A' ' 3' ' ' VAL . 0.3 OUTLIER 58.14 107.39 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.561 -1.337 . . . . 4.12 109.145 -178.799 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.573 ' O ' ' CB ' ' A' ' 24' ' ' SER . . . -92.54 -143.8 13.18 Favored Glycine 0 N--CA 1.497 2.737 0 O-C-N 121.163 -0.961 . . . . 1.12 111.236 -178.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.573 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 1.0 OUTLIER 86.09 -48.73 0.06 Allowed 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.38 -0.97 . . . . 2.33 108.38 -178.823 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.701 ' CB ' ' CD ' ' A' ' 26' ' ' PRO . 5.2 m-20 -120.11 -149.86 0.01 OUTLIER Pre-proline 0 C--N 1.303 -1.426 0 N-CA-C 105.665 -1.976 . . . . 4.45 105.665 178.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.701 ' CD ' ' CB ' ' A' ' 25' ' ' ASP . 30.9 Cg_endo -74.34 85.69 1.39 Allowed 'Trans proline' 0 C--O 1.208 -1.012 0 N-CA-C 107.169 -1.896 . . . . 0.48 107.169 178.073 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.542 ' HA ' ' O ' ' A' ' 22' ' ' HIS . 4.1 t -34.51 80.17 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 113.697 0.999 . . . . 1.69 113.697 -176.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.762 HG23 ' O ' ' A' ' 126' ' ' LYS . 0.7 OUTLIER -71.68 144.51 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 N-CA-C 106.772 -1.566 . . . . 1.46 106.772 176.343 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 1.002 HG23 ' CA ' ' A' ' 21' ' ' CYS . 0.1 OUTLIER -122.99 -159.9 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 O-C-N 120.371 -1.456 . . . . 0.89 112.706 -176.425 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.481 ' H ' HG22 ' A' ' 29' ' ' ILE . 40.5 m-70 -131.07 166.55 20.82 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.657 0.742 . . . . 1.45 110.418 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.563 ' HD3' ' HA ' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -116.05 -167.15 1.22 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.617 -0.677 . . . . 2.57 109.464 -179.98 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.431 ' HA2' ' O ' ' A' ' 95' ' ' PRO . . . 42.74 27.96 0.6 Allowed Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.692 -0.963 . . . . 0.99 110.692 179.085 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.493 ' O ' HG11 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -151.76 133.87 8.4 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 120.754 -1.439 . . . . 1.55 109.493 179.789 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.423 ' HA ' ' HB ' ' A' ' 94' ' ' VAL . 28.8 Cg_endo -68.26 78.99 0.6 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.601 2.2 . . . . 1.66 111.325 -179.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.483 ' CD1' ' C ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -62.05 149.52 40.81 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.281 -1.007 . . . . 3.29 108.281 178.944 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.732 HG23 HG22 ' A' ' 91' ' ' THR . 6.4 m -153.71 95.81 1.93 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.918 -1.114 . . . . 0.75 110.211 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.71 ' HA ' HG22 ' A' ' 18' ' ' VAL . 2.3 pp -61.1 142.28 56.8 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.818 -1.179 . . . . 0.67 107.818 178.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.532 ' HG3' ' CG ' ' A' ' 89' ' ' LYS . 2.0 tt0 -136.04 131.6 35.14 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.995 -1.066 . . . . 3.95 109.882 -179.285 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.526 ' O ' HG22 ' A' ' 88' ' ' ILE . . . -141.28 90.58 2.32 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.765 -1.198 . . . . 0.95 107.765 178.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.618 ' HG ' ' CB ' ' A' ' 87' ' ' ASP . 0.2 OUTLIER -83.07 -176.36 6.29 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 109.236 -0.653 . . . . 1.17 109.236 -178.567 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.596 ' O ' ' CD1' ' A' ' 41' ' ' PHE . 6.2 p90 171.08 133.86 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.361 -1.348 . . . . 1.24 107.361 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.585 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 0.0 OUTLIER -90.13 119.88 30.84 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 107.969 -1.122 . . . . 3.71 107.969 179.86 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.78 ' HB3' ' O ' ' A' ' 84' ' ' GLN . . . -38.79 112.44 0.24 Allowed 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 109.47 -0.567 . . . . 0.42 109.47 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.501 ' CG ' ' O ' ' A' ' 42' ' ' ASP . 2.5 m-80 -122.14 45.75 2.27 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.479 -0.763 . . . . 1.75 109.023 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.638 ' OE1' ' HB2' ' A' ' 80' ' ' LEU . 3.5 pt20 -133.5 -133.12 0.17 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.267 -0.896 . . . . 1.35 110.198 -178.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.685 ' C ' HG22 ' A' ' 81' ' ' VAL . 47.3 t30 -169.89 53.0 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.441 -0.787 . . . . 4.34 109.604 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.712 ' N ' HG22 ' A' ' 81' ' ' VAL . 3.9 t -139.18 138.25 36.77 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.613 -1.304 . . . . 0.88 110.576 -178.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.612 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 1.2 mtmp? -78.84 -0.84 32.23 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.81 -1.181 . . . . 3.06 108.478 177.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.5 p -107.55 165.9 11.07 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.262 -0.899 . . . . 0.82 108.962 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.839 ' CB ' ' HB3' ' A' ' 72' ' ' ALA . . . -144.21 148.21 34.65 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.402 -0.962 . . . . 0.92 108.402 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.898 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 56.6 mttt -118.03 -169.45 1.69 Allowed 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.17 -1.418 . . . . 1.75 107.17 177.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.417 ' HB ' ' O ' ' A' ' 51' ' ' LYS . 5.5 tt -176.4 151.4 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 C-N-CA 118.731 -1.188 . . . . 0.63 110.179 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.49 ' O ' ' NZ ' ' A' ' 55' ' ' LYS . 0.4 OUTLIER -148.45 57.54 1.06 Allowed 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.583 -0.895 . . . . 2.86 108.583 179.916 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.907 ' CD1' HG13 ' A' ' 108' ' ' VAL . 1.6 mm -73.58 160.39 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.486 -0.759 . . . . 2.75 109.675 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.576 ' N ' ' CG2' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -173.14 81.57 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.252 0.548 . . . . 1.14 110.055 178.548 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.475 ' HB3' ' HB ' ' A' ' 63' ' ' ILE . . . -122.16 155.42 35.82 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 108.78 -0.822 . . . . 1.54 108.78 179.113 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.442 ' OG ' ' HA ' ' A' ' 104' ' ' VAL . 0.0 OUTLIER -129.7 136.56 49.83 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.035 -1.041 . . . . 1.23 109.402 -179.609 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.541 ' HG ' ' CE3' ' A' ' 92' ' ' TRP . 0.0 OUTLIER -128.0 164.49 22.23 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.286 -0.884 . . . . 3.89 109.202 -179.506 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.498 ' OD2' ' N ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -39.47 -68.03 0.19 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.38 -0.825 . . . . 4.27 109.617 -179.796 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.624 ' O ' HD22 ' A' ' 61' ' ' LEU . . . -118.81 30.1 6.03 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.146 -1.582 . . . . 0.96 109.146 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.624 HD22 ' O ' ' A' ' 60' ' ' GLY . 0.2 OUTLIER -139.81 61.24 1.54 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.257 -1.143 . . . . 0.9 110.049 -179.578 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.483 ' HG3' ' O ' ' A' ' 62' ' ' GLU . 0.3 OUTLIER -55.69 100.2 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.967 -1.083 . . . . 3.46 108.162 179.348 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.572 HG22 ' O ' ' A' ' 63' ' ' ILE . 2.9 mt -71.8 -2.68 3.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.364 -0.835 . . . . 2.47 111.087 -178.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.507 ' C ' ' O ' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -30.97 137.65 0.04 OUTLIER 'General case' 0 C--N 1.285 -2.213 0 CA-C-O 121.532 0.682 . . . . 2.85 110.009 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.705 HG21 ' HB ' ' A' ' 54' ' ' ILE . 70.1 t -126.01 90.26 50.62 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.396 -0.815 . . . . 1.61 109.755 -178.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.89 -4.53 13.42 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.92 2.413 . . . . 1.41 110.757 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 68' ' ' ILE . . . 167.83 -92.09 0.1 Allowed Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.617 -1.393 . . . . 2.99 109.617 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.482 ' O ' ' O ' ' A' ' 69' ' ' ASP . 1.2 mm 49.95 99.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.216 -1.167 . . . . 3.21 109.791 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.524 ' CG ' ' HB2' ' A' ' 74' ' ' HIS . 13.0 m-20 53.23 104.91 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.337 -0.852 . . . . 5.5 108.91 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -82.32 31.55 0.4 Allowed 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.383 -0.823 . . . . 5.26 111.113 -178.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.611 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -154.16 40.16 0.47 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.449 -1.407 . . . . 4.78 111.445 179.79 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.898 ' HB2' ' O ' ' A' ' 51' ' ' LYS . . . 32.27 31.71 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.173 0.511 . . . . 0.55 111.894 176.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.562 ' N ' ' O ' ' A' ' 71' ' ' ASN . 16.6 t -98.0 -21.34 16.87 Favored 'General case' 0 C--N 1.293 -1.857 0 O-C-N 121.142 -0.974 . . . . 0.69 111.256 -178.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.524 ' HB2' ' CG ' ' A' ' 69' ' ' ASP . 11.4 t-160 -71.57 -25.89 62.39 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.898 -1.126 . . . . 2.03 111.434 -178.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.444 ' CD1' ' N ' ' A' ' 75' ' ' PHE . 8.2 m-85 -95.62 -29.47 14.31 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.533 -1.354 . . . . 2.08 111.375 -178.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 1.039 HG21 ' CE2' ' A' ' 86' ' ' TYR . 3.3 m -148.37 -149.46 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.915 -1.116 . . . . 3.06 111.259 -177.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.783 ' N ' HG23 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -85.49 105.37 16.05 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.727 -0.842 . . . . 2.69 108.727 179.445 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' CYS . . . . . 0.612 ' N ' ' HD2' ' A' ' 79' ' ' PRO . 0.1 OUTLIER -47.78 -44.62 58.02 Favored Pre-proline 0 N--CA 1.493 1.722 0 C-N-CA 118.277 -1.369 . . . . 0.78 109.066 179.897 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.612 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 28.9 Cg_endo -72.78 104.1 1.69 Allowed 'Trans proline' 0 C--N 1.317 -1.125 0 N-CA-C 108.471 -1.396 . . . . 0.64 108.471 177.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.839 HD13 ' CD1' ' A' ' 117' ' ' LEU . 0.2 OUTLIER -96.31 -64.49 1.05 Allowed 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 108.914 -0.773 . . . . 2.44 108.914 -178.214 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.755 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 24.5 t 53.54 177.68 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 C-N-CA 118.784 -1.166 . . . . 2.95 108.748 177.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.581 ' HA ' ' O ' ' A' ' 43' ' ' ALA . 0.6 OUTLIER -96.52 31.01 2.38 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 120.797 -1.189 . . . . 2.69 109.029 -179.315 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -132.49 27.4 3.56 Favored Glycine 0 C--N 1.289 -2.039 0 N-CA-C 108.14 -1.984 . . . . 0.84 108.14 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.78 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 9.0 tp-100 -142.39 159.55 42.0 Favored 'General case' 0 C--N 1.308 -1.229 0 O-C-N 121.486 -1.008 . . . . 1.26 108.37 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.585 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 2.7 tt0 -154.53 137.28 15.27 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.452 -0.944 . . . . 1.99 108.452 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 1.039 ' CE2' HG21 ' A' ' 76' ' ' VAL . 12.1 p90 -158.55 177.41 11.25 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 117.581 -1.648 . . . . 3.34 111.386 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.618 ' CB ' ' HG ' ' A' ' 40' ' ' LEU . 8.9 p-10 -121.08 89.02 3.05 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 119.664 -0.815 . . . . 1.1 112.49 -177.004 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.846 HD12 ' CG1' ' A' ' 76' ' ' VAL . 0.6 OUTLIER -59.05 -164.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 106.761 -1.57 . . . . 0.91 106.761 176.751 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.819 ' N ' HG23 ' A' ' 88' ' ' ILE . 0.2 OUTLIER 163.15 174.15 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.955 -1.091 . . . . 1.75 110.725 179.286 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.636 ' CE2' ' CD1' ' A' ' 54' ' ' ILE . 13.6 m-85 -160.87 75.4 0.53 Allowed 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.524 -0.917 . . . . 1.01 108.524 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.732 HG22 HG23 ' A' ' 36' ' ' THR . 1.6 p -74.36 -167.62 0.56 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.421 -0.799 . . . . 1.72 110.151 -179.234 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 1.001 ' O ' HG23 ' A' ' 94' ' ' VAL . 3.0 t90 -171.62 112.5 0.33 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.425 -0.797 . . . . 4.51 110.065 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.534 ' O ' ' NE1' ' A' ' 92' ' ' TRP . 1.6 t30 -49.31 122.27 5.9 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 106.02 -1.845 . . . . 1.86 106.02 177.632 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 1.001 HG23 ' O ' ' A' ' 92' ' ' TRP . 60.6 t -123.28 101.51 37.85 Favored Pre-proline 0 C--N 1.301 -1.515 0 C-N-CA 117.888 -1.525 . . . . 1.64 113.277 -176.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 1.044 ' HD2' HD11 ' A' ' 97' ' ' ILE . 31.4 Cg_endo -72.33 -149.36 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.806 2.338 . . . . 1.77 108.734 176.218 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.5 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -69.39 -49.48 54.97 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.443 -1.411 . . . . 2.57 108.098 178.514 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 1.044 HD11 ' HD2' ' A' ' 95' ' ' PRO . 2.8 mp 62.32 -2.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 113.227 0.825 . . . . 1.18 113.227 177.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 1.028 ' HB1' ' HD2' ' A' ' 99' ' ' PRO . . . 57.53 178.31 0.04 OUTLIER Pre-proline 0 C--N 1.3 -1.568 0 O-C-N 119.942 -1.724 . . . . 0.34 108.49 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 1.028 ' HD2' ' HB1' ' A' ' 98' ' ' ALA . 52.9 Cg_endo -82.52 151.77 15.27 Favored 'Trans proline' 0 C--N 1.299 -2.06 0 C-N-CA 123.454 2.769 . . . . 0.45 110.204 -178.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.611 ' CD ' ' O ' ' A' ' 127' ' ' ILE . 0.3 OUTLIER 55.02 115.27 0.01 OUTLIER 'General case' 0 C--N 1.288 -2.079 0 C-N-CA 119.403 -0.919 . . . . 2.1 111.413 176.213 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 101' ' ' SER . . . . . 1.001 ' OG ' HD13 ' A' ' 127' ' ' ILE . 67.6 m -86.91 158.74 19.24 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.186 -0.946 . . . . 2.47 108.686 178.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -50.29 -21.29 1.33 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.009 -1.057 . . . . 5.17 109.582 -179.499 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.475 ' C ' ' CG2' ' A' ' 104' ' ' VAL . 15.4 t-20 -179.22 159.95 0.99 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.127 -0.983 . . . . 1.3 109.597 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.698 ' O ' HG23 ' A' ' 105' ' ' VAL . 0.9 OUTLIER -154.76 171.6 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.33 -0.856 . . . . 0.96 110.003 179.793 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.698 HG23 ' O ' ' A' ' 104' ' ' VAL . 0.9 OUTLIER 170.61 147.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 108.019 -1.104 . . . . 1.4 108.019 -179.863 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 1.5 t -143.56 137.42 25.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 120.331 -1.48 . . . . 1.25 110.29 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.992 HG23 HG23 ' A' ' 121' ' ' ILE . 0.9 OUTLIER -167.88 148.98 5.24 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.159 -1.052 . . . . 0.79 108.159 179.691 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.907 HG13 ' CD1' ' A' ' 54' ' ' ILE . 2.7 t -157.19 163.6 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.848 -1.158 . . . . 1.31 110.83 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.56 ' HG3' ' N ' ' A' ' 110' ' ' LEU . 0.3 OUTLIER -169.87 146.39 3.16 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.721 -0.844 . . . . 1.31 108.721 178.801 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.56 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 11.5 tp -139.03 126.45 21.64 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 106.774 -1.565 . . . . 0.63 106.774 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.52 ' HB ' ' HB2' ' A' ' 51' ' ' LYS . 7.6 mt -134.24 120.02 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.214 -0.929 . . . . 0.9 111.586 -177.267 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.585 ' CA ' HG21 ' A' ' 47' ' ' THR . . . -83.94 -108.37 0.57 Allowed Glycine 0 N--CA 1.486 2.016 0 N-CA-C 108.026 -2.03 . . . . 0.72 108.026 177.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -145.62 7.87 1.13 Allowed 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.072 -1.252 . . . . 1.54 107.951 178.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.569 ' ND2' ' HB3' ' A' ' 46' ' ' ASN . 2.5 m120 -124.8 -17.35 5.9 Favored 'General case' 0 C--N 1.308 -1.196 0 O-C-N 121.466 -0.771 . . . . 1.48 109.922 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 169.37 144.88 4.41 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.695 -1.362 . . . . 2.35 109.695 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.611 HG22 ' O ' ' A' ' 116' ' ' VAL . 0.1 OUTLIER -53.35 111.16 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.174 -1.192 . . . . 1.0 109.975 -179.644 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.839 ' CD1' HD13 ' A' ' 80' ' ' LEU . 10.7 mt -54.42 -51.66 64.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.633 -0.667 . . . . 0.83 111.064 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.583 ' HA ' ' CA ' ' A' ' 9' ' ' ALA . . . -166.59 147.19 6.06 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.841 -1.162 . . . . 1.33 111.269 -178.429 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.525 ' SG ' ' N ' ' A' ' 120' ' ' ALA . 0.5 OUTLIER -139.89 178.31 7.34 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 109.026 -0.731 . . . . 0.8 109.026 179.279 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.525 ' N ' ' SG ' ' A' ' 119' ' ' CYS . . . -179.12 125.93 0.09 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.097 -1.002 . . . . 0.89 109.423 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.992 HG23 HG23 ' A' ' 107' ' ' THR . 1.0 OUTLIER -129.78 138.36 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.162 -0.961 . . . . 1.04 109.799 -179.875 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -107.36 -23.27 12.28 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.213 -0.929 . . . . 2.77 109.321 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.462 ' O ' ' HB2' ' A' ' 124' ' ' HIS . 6.9 m 66.32 98.65 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.564 -0.71 . . . . 0.96 110.442 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.462 ' HB2' ' O ' ' A' ' 123' ' ' THR . 0.0 OUTLIER 71.95 177.67 0.26 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.226 -0.921 . . . . 2.05 110.573 178.899 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -176.45 137.41 3.61 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.006 -1.638 . . . . 0.79 109.006 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.762 ' O ' HG23 ' A' ' 28' ' ' ILE . 22.7 mtmt -144.0 95.94 2.81 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.959 -1.318 . . . . 2.96 110.284 -179.429 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 1.001 HD13 ' OG ' ' A' ' 101' ' ' SER . 1.2 mp -58.32 143.44 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.151 -0.968 . . . . 0.98 109.41 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.607 ' HB2' ' HD3' ' A' ' 100' ' ' LYS . 13.7 ttt-85 149.45 -94.68 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 108.557 -0.905 . . . . 2.19 108.557 178.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.526 ' N ' ' HG2' ' A' ' 128' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.497 1.875 0 CA-C-O 117.984 -1.008 . . . . 4.55 110.247 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.1 p30 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.418 0.628 . . . . 3.95 109.713 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.522 ' HB3' ' HG2' ' A' ' 17' ' ' MET . 1.4 pt20 -117.4 -168.36 1.47 Allowed 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.369 -0.832 . . . . 1.78 109.436 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.614 HG12 ' HA ' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -135.84 -173.4 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 108.53 -0.915 . . . . 0.7 108.53 179.024 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.87 41.58 1.58 Allowed 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.203 -0.935 . . . . 1.01 109.057 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.9 m -54.02 161.9 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.372 -0.83 . . . . 1.22 109.408 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.47 ' O ' ' C ' ' A' ' 7' ' ' ASP . 11.2 mmtm -87.61 52.44 2.49 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.151 -0.968 . . . . 2.67 109.574 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.47 ' C ' ' O ' ' A' ' 6' ' ' LYS . 5.3 p30 -38.78 156.1 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 109.327 -0.62 . . . . 1.46 109.327 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -153.08 34.35 0.47 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.986 -1.072 . . . . 1.22 110.531 -179.253 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.542 ' HA ' ' HA ' ' A' ' 118' ' ' ALA . . . -69.59 -174.05 0.66 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.592 -1.317 . . . . 2.12 109.048 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.583 ' O ' ' CB ' ' A' ' 11' ' ' ASN . 0.7 OUTLIER -54.56 -53.33 55.96 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 108.342 -0.985 . . . . 2.81 108.342 178.174 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.583 ' CB ' ' O ' ' A' ' 10' ' ' ASN . 12.3 p30 147.19 40.88 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.036 -1.098 . . . . 6.47 108.036 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.479 ' HB2' ' OD2' ' A' ' 42' ' ' ASP . 7.2 mt-10 -147.33 8.3 0.91 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.178 -0.951 . . . . 2.68 110.654 -178.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 1.009 HG23 ' O ' ' A' ' 40' ' ' LEU . 36.1 mt -44.59 148.35 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.891 -1.13 . . . . 0.29 108.798 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.82 -19.33 18.21 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.423 -0.798 . . . . 2.46 109.462 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.611 ' H ' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -172.65 134.95 0.65 Allowed 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 118.725 -1.19 . . . . 1.02 110.631 -177.854 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.753 ' O ' HG12 ' A' ' 16' ' ' VAL . 0.9 OUTLIER -139.02 104.26 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 107.246 -1.39 . . . . 2.1 107.246 179.158 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.522 ' HG2' ' HB3' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -149.46 140.73 23.15 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 118.901 -1.12 . . . . 1.64 111.234 -177.805 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.876 HG22 ' HA ' ' A' ' 37' ' ' LEU . 39.6 t -118.2 132.53 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 108.236 -1.024 . . . . 1.31 108.236 178.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -76.84 79.65 3.43 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.193 -0.942 . . . . 1.61 110.213 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.553 ' O ' ' CB ' ' A' ' 21' ' ' CYS . . . 87.9 121.98 1.72 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 110.014 -1.234 . . . . 0.59 110.014 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.851 ' CA ' HG23 ' A' ' 29' ' ' ILE . 0.0 OUTLIER 157.24 -41.46 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.629 -0.924 . . . . 0.37 109.298 179.319 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.614 ' HA ' HG12 ' A' ' 3' ' ' VAL . 0.9 OUTLIER 80.73 122.69 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.293 -0.879 . . . . 1.1 110.248 -179.547 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.467 ' O ' ' HB3' ' A' ' 24' ' ' SER . . . -96.85 178.74 33.75 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.622 -1.391 . . . . 0.44 109.622 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.505 ' O ' ' O ' ' A' ' 25' ' ' ASP . 27.7 t 63.63 -91.32 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.223 -1.163 . . . . 1.45 110.217 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.638 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.1 OUTLIER -50.18 -175.33 0.01 OUTLIER Pre-proline 0 C--N 1.305 -1.369 0 N-CA-C 108.83 -0.804 . . . . 0.4 108.83 179.681 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.638 ' HD2' ' CB ' ' A' ' 25' ' ' ASP . 28.4 Cg_endo -70.14 84.8 0.7 Allowed 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 121.462 1.442 . . . . 0.47 108.552 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.488 ' SG ' ' O ' ' A' ' 27' ' ' CYS . 0.9 OUTLIER -28.54 95.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 115.325 -0.852 . . . . 0.23 112.453 -178.039 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.617 HG23 ' O ' ' A' ' 126' ' ' LYS . 23.3 mm -90.92 137.6 21.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 105.289 -2.115 . . . . 0.26 105.289 175.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.851 HG23 ' CA ' ' A' ' 21' ' ' CYS . 0.2 OUTLIER -119.69 177.69 2.79 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 O-C-N 120.553 -1.342 . . . . 0.29 112.898 -175.556 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 51.2 m-70 -112.37 158.13 20.18 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.916 0.865 . . . . 1.09 110.817 -179.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.545 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -111.3 141.32 44.99 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.123 -1.066 . . . . 2.95 108.123 178.408 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' A' ' 95' ' ' PRO . . . 101.11 3.34 54.48 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.469 -1.452 . . . . 0.67 109.469 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.715 ' N ' HG11 ' A' ' 94' ' ' VAL . 1.9 mtmt -133.87 144.51 52.04 Favored Pre-proline 0 C--N 1.305 -1.355 0 O-C-N 121.42 -1.047 . . . . 0.49 108.328 179.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -69.62 81.4 0.79 Allowed 'Trans proline' 0 C--N 1.301 -1.944 0 C-N-CA 122.346 2.031 . . . . 0.9 111.175 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.585 ' CD1' ' O ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -59.58 122.84 15.07 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.998 -1.112 . . . . 2.54 107.998 178.974 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.756 HG23 ' HA ' ' A' ' 91' ' ' THR . 88.0 m -141.19 91.83 2.43 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.11 -0.994 . . . . 1.24 110.226 -178.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.876 ' HA ' HG22 ' A' ' 18' ' ' VAL . 1.2 pp -64.26 137.78 58.1 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.294 -0.879 . . . . 1.02 108.714 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.559 ' HG2' ' CG ' ' A' ' 89' ' ' LYS . 4.3 mt-10 -128.0 168.17 15.66 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.134 -0.979 . . . . 1.95 109.731 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.437 ' HB2' ' O ' ' A' ' 38' ' ' GLU . . . 176.83 74.01 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.984 0.897 . . . . 0.88 109.407 178.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 1.009 ' O ' HG23 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -67.76 169.98 8.72 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 109.529 -0.545 . . . . 0.35 109.529 179.931 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.748 ' CE2' ' CD2' ' A' ' 86' ' ' TYR . 1.4 p90 -165.85 162.42 18.36 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.156 -0.965 . . . . 0.64 108.674 177.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.479 ' OD2' ' HB2' ' A' ' 12' ' ' GLU . 4.3 p30 -120.03 115.93 24.72 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 122.037 0.923 . . . . 4.95 109.022 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.907 ' HB1' ' O ' ' A' ' 81' ' ' VAL . . . -42.2 115.43 0.68 Allowed 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 108.854 -0.795 . . . . 0.31 108.854 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.4 ' OD1' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -124.31 -0.87 8.2 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.364 -0.835 . . . . 0.8 109.968 -178.608 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.79 ' OE1' HD21 ' A' ' 117' ' ' LEU . 2.5 pt20 -92.59 -142.63 0.21 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.384 -0.822 . . . . 0.69 109.017 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.792 ' HA ' ' HB ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -155.62 71.41 0.76 Allowed 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.174 -0.954 . . . . 0.7 109.561 179.002 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.639 HG23 ' O ' ' A' ' 47' ' ' THR . 4.8 t -150.15 121.6 7.93 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 119.959 -1.713 . . . . 0.93 111.123 -178.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.608 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 7.0 mtmt -68.63 -7.55 34.08 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.785 -1.197 . . . . 2.05 109.186 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.85 158.88 18.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.176 -0.952 . . . . 1.6 109.492 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.796 ' HB1' ' HB3' ' A' ' 72' ' ' ALA . . . -151.66 135.08 16.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.369 -0.832 . . . . 0.38 108.882 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 1.083 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 0.1 OUTLIER -117.64 -158.99 0.73 Allowed 'General case' 0 C--N 1.298 -1.662 0 O-C-N 120.564 -1.335 . . . . 1.78 108.028 178.475 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.485 HG13 HD13 ' A' ' 54' ' ' ILE . 1.5 tt -177.93 161.74 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 C-N-CA 118.647 -1.221 . . . . 0.58 110.481 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.535 ' O ' ' CE ' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -160.33 40.0 0.17 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.804 -0.813 . . . . 0.54 108.804 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.95 ' HB ' HG21 ' A' ' 65' ' ' VAL . 0.3 OUTLIER -72.77 148.01 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.138 -0.976 . . . . 0.38 109.801 -179.656 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.595 ' HG3' ' O ' ' A' ' 54' ' ' ILE . 0.3 OUTLIER -163.19 94.62 0.82 Allowed 'General case' 0 C--N 1.287 -2.121 0 O-C-N 121.282 -0.886 . . . . 1.17 109.005 178.515 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.525 ' O ' HG13 ' A' ' 63' ' ' ILE . . . -119.77 120.01 35.28 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 119.639 -0.824 . . . . 0.67 110.584 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.47 124.62 47.44 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.012 -1.107 . . . . 0.68 108.012 178.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.577 HD21 ' CD1' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.87 169.1 10.46 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.844 -1.16 . . . . 4.25 110.109 -178.517 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.482 ' HB2' ' CB ' ' A' ' 101' ' ' SER . 67.4 t0 -77.79 80.4 4.25 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.546 -0.909 . . . . 4.91 108.546 179.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.601 ' O ' HD22 ' A' ' 61' ' ' LEU . . . 105.08 1.41 41.77 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 108.537 -1.825 . . . . 1.08 108.537 -178.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.601 HD22 ' O ' ' A' ' 60' ' ' GLY . 0.4 OUTLIER -136.64 59.53 1.69 Allowed 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.027 -1.101 . . . . 1.46 108.027 179.397 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -69.11 81.87 0.33 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.714 -0.616 . . . . 1.05 110.229 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.525 HG13 ' O ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -82.98 125.61 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 118.445 -1.302 . . . . 2.08 108.682 178.895 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -128.58 164.42 22.88 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.699 -0.852 . . . . 1.49 108.699 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.95 HG21 ' HB ' ' A' ' 54' ' ' ILE . 43.3 t -143.4 68.7 17.32 Favored Pre-proline 0 C--N 1.3 -1.551 0 O-C-N 121.01 -1.056 . . . . 0.77 110.114 -179.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.501 ' HD2' ' CG1' ' A' ' 68' ' ' ILE . 36.4 Cg_endo -80.72 95.94 0.99 Allowed 'Trans proline' 0 C--N 1.301 -1.938 0 C-N-CA 123.063 2.509 . . . . 2.67 110.264 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.499 ' C ' ' O ' ' A' ' 66' ' ' PRO . . . 33.53 50.08 0.54 Allowed Glycine 0 N--CA 1.497 2.702 0 N-CA-C 109.85 -1.3 . . . . 0.75 109.85 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.501 ' CG1' ' HD2' ' A' ' 66' ' ' PRO . 5.8 mt -76.08 -76.7 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.376 -1.073 . . . . 1.24 109.842 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.63 ' HB3' ' HB2' ' A' ' 74' ' ' HIS . 15.1 p30 -59.26 157.62 10.46 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.329 -0.857 . . . . 1.27 109.262 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.464 ' O ' ' CG ' ' A' ' 71' ' ' ASN . 20.0 p -77.4 -20.2 54.99 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.843 -1.169 . . . . 0.89 107.843 178.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.712 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 3.3 m120 -173.96 73.93 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.369 0.604 . . . . 2.5 109.661 179.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 1.083 ' HB2' ' O ' ' A' ' 51' ' ' LYS . . . 38.85 26.59 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.547 -0.72 . . . . 0.74 111.56 177.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.517 ' SG ' ' N ' ' A' ' 78' ' ' CYS . 2.4 t -100.85 -17.77 16.71 Favored 'General case' 0 C--N 1.29 -2.013 0 O-C-N 121.151 -0.968 . . . . 1.36 110.433 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.63 ' HB2' ' HB3' ' A' ' 69' ' ' ASP . 3.1 t-80 -61.23 -28.97 69.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.801 -1.187 . . . . 2.07 109.829 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -99.74 -54.83 2.81 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.696 -1.253 . . . . 2.36 110.319 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 1.173 HG21 ' CZ ' ' A' ' 86' ' ' TYR . 8.3 m -108.67 -145.52 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 CA-C-O 121.775 0.798 . . . . 2.82 109.186 -178.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.769 ' N ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -93.1 167.68 11.62 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.124 -1.436 . . . . 2.86 107.124 177.629 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . 0.735 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -91.36 -43.76 0.38 Allowed Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 120.476 -1.39 . . . . 1.1 110.469 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.608 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 31.0 Cg_endo -78.65 117.02 3.89 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 121.211 1.274 . . . . 0.99 109.385 178.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.997 HD12 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -97.11 -68.12 0.81 Allowed 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.375 -0.972 . . . . 0.73 108.375 -179.074 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.907 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 1.1 m 40.9 -168.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 116.051 -0.522 . . . . 0.47 109.812 178.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.722 ' H ' HG23 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -99.22 41.13 1.16 Allowed 'General case' 0 C--N 1.295 -1.803 0 O-C-N 120.378 -1.451 . . . . 0.93 109.972 -177.649 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -143.94 39.73 1.24 Allowed Glycine 0 C--N 1.293 -1.812 0 N-CA-C 109.95 -1.26 . . . . 0.76 109.95 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.439 ' NE2' ' HA ' ' A' ' 84' ' ' GLN . 7.8 tp-100 -158.88 154.12 25.5 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.93 -1.335 . . . . 1.5 110.001 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -111.85 160.44 17.37 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.65 -0.87 . . . . 2.38 108.65 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 1.173 ' CZ ' HG21 ' A' ' 76' ' ' VAL . 0.9 OUTLIER -127.45 -170.25 2.19 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.798 -1.189 . . . . 3.4 110.546 -179.005 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.572 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 3.2 p30 174.68 39.12 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.65 -0.87 . . . . 1.61 108.65 178.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.754 HD12 HG13 ' A' ' 76' ' ' VAL . 0.4 OUTLIER -53.01 -170.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.867 -0.79 . . . . 0.82 108.867 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.68 ' N ' HG23 ' A' ' 88' ' ' ILE . 0.2 OUTLIER 165.81 -179.32 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 119.07 -1.052 . . . . 1.3 110.442 -179.323 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.667 ' CZ ' HG21 ' A' ' 54' ' ' ILE . 31.1 m-85 -167.35 93.62 0.43 Allowed 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.122 -1.066 . . . . 1.06 108.122 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.756 ' HA ' HG23 ' A' ' 36' ' ' THR . 0.6 OUTLIER -87.17 -162.86 0.84 Allowed 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.773 0.797 . . . . 1.75 110.959 -178.183 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.566 ' CE3' HD21 ' A' ' 58' ' ' LEU . 7.1 t90 -175.18 90.48 0.05 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.531 -0.731 . . . . 4.32 109.599 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.461 ' C ' ' O ' ' A' ' 92' ' ' TRP . 3.1 t-20 -45.48 108.76 0.14 Allowed 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 106.8 -1.555 . . . . 1.29 106.8 178.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.873 HG13 ' CD1' ' A' ' 97' ' ' ILE . 2.4 t -104.58 116.21 61.47 Favored Pre-proline 0 C--N 1.301 -1.508 0 C-N-CA 118.854 -1.139 . . . . 0.57 113.128 -176.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.773 ' HD2' HD11 ' A' ' 97' ' ' ILE . 33.4 Cg_endo -81.08 -86.12 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 123.206 2.604 . . . . 0.49 108.538 176.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.545 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -135.7 -56.14 0.78 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 105.679 -1.971 . . . . 2.36 105.679 177.766 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.873 ' CD1' HG13 ' A' ' 94' ' ' VAL . 1.5 mp 67.91 7.32 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 113.203 0.816 . . . . 0.53 113.203 175.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 1.016 ' HB1' ' HD2' ' A' ' 99' ' ' PRO . . . 52.96 177.87 0.03 OUTLIER Pre-proline 0 C--N 1.302 -1.482 0 O-C-N 120.241 -1.537 . . . . 0.6 109.626 179.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 1.016 ' HD2' ' HB1' ' A' ' 98' ' ' ALA . 51.8 Cg_endo -83.59 152.78 13.46 Favored 'Trans proline' 0 C--N 1.303 -1.867 0 C-N-CA 123.751 2.968 . . . . 0.81 110.086 -179.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.646 ' HD3' ' CB ' ' A' ' 128' ' ' ARG . 1.7 mmmp? 55.98 127.35 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.97 0 C-N-CA 119.683 -0.807 . . . . 0.9 111.674 176.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.908 ' CB ' HD13 ' A' ' 127' ' ' ILE . 12.3 t -97.67 154.6 17.46 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.196 -0.94 . . . . 0.97 108.595 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.438 ' O ' ' CB ' ' A' ' 103' ' ' ASN . 76.1 mt-10 -48.85 -22.45 0.83 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.118 -0.989 . . . . 1.31 109.624 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.438 ' CB ' ' O ' ' A' ' 102' ' ' GLU . 0.4 OUTLIER 165.02 152.0 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.036 -1.098 . . . . 3.17 108.036 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.466 ' C ' HG23 ' A' ' 105' ' ' VAL . 0.1 OUTLIER -142.76 153.76 17.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 120.814 -1.179 . . . . 0.83 110.949 -178.944 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.466 HG23 ' C ' ' A' ' 104' ' ' VAL . 25.4 t -157.64 104.04 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 107.561 -1.274 . . . . 1.4 107.561 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.704 ' HB ' ' HB3' ' A' ' 122' ' ' ALA . 15.7 t -103.55 111.06 31.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 120.988 -1.07 . . . . 0.92 109.484 -178.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.587 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -129.98 175.27 9.02 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 120.877 -1.139 . . . . 1.21 108.269 179.269 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.797 HG22 ' CD1' ' A' ' 54' ' ' ILE . 1.2 t 175.07 168.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 C-N-CA 118.835 -1.146 . . . . 0.58 110.318 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.633 ' N ' HG13 ' A' ' 108' ' ' VAL . 1.1 ttpt 162.94 134.63 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.838 0.828 . . . . 1.36 109.67 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.561 ' HB3' ' HB2' ' A' ' 117' ' ' LEU . 9.4 tp -113.22 130.04 56.34 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 106.873 -1.528 . . . . 0.59 106.873 178.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.464 ' HB ' ' HB2' ' A' ' 51' ' ' LYS . 9.4 mt -127.25 120.12 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.154 -0.966 . . . . 0.68 111.737 -177.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.414 ' HA3' HG21 ' A' ' 47' ' ' THR . . . -92.4 -114.25 2.11 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 108.812 -1.715 . . . . 0.83 108.812 178.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -138.21 1.94 2.26 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.044 -1.268 . . . . 1.09 108.004 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -112.58 -39.31 4.38 Favored 'General case' 0 C--N 1.31 -1.129 0 O-C-N 121.415 -0.803 . . . . 0.75 109.048 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -177.38 155.38 17.65 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.07 -1.612 . . . . 1.54 109.07 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.533 ' CG2' ' O ' ' A' ' 118' ' ' ALA . 0.2 OUTLIER -50.18 111.88 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.167 -1.196 . . . . 0.7 109.82 -179.647 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.997 HD22 HD12 ' A' ' 80' ' ' LEU . 1.4 mt -57.49 -62.89 1.46 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.294 -0.879 . . . . 0.72 109.666 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.542 ' HA ' ' HA ' ' A' ' 9' ' ' ALA . . . -123.97 -175.26 3.19 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.13 -0.981 . . . . 0.22 110.083 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 0.542 ' HA ' ' HA ' ' A' ' 109' ' ' LYS . 1.9 t 172.37 150.51 0.06 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.155 -0.966 . . . . 0.85 110.15 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.444 ' C ' HG13 ' A' ' 121' ' ' ILE . . . -170.02 130.98 1.0 Allowed 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.79 -0.818 . . . . 0.58 108.79 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.444 HG13 ' C ' ' A' ' 120' ' ' ALA . 2.8 mt -134.15 139.47 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.177 -0.952 . . . . 0.46 110.075 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.704 ' HB3' ' HB ' ' A' ' 106' ' ' VAL . . . -106.77 -17.92 14.08 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.487 -0.931 . . . . 2.08 108.487 179.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.516 HG22 ' CD2' ' A' ' 124' ' ' HIS . 0.3 OUTLIER 58.51 89.08 0.06 Allowed 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 121.519 0.676 . . . . 1.43 110.196 179.718 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . 0.516 ' CD2' HG22 ' A' ' 123' ' ' THR . 15.8 m-70 61.9 -160.93 0.3 Allowed 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.724 0.773 . . . . 3.56 110.378 179.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 153.91 150.61 5.52 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.346 -1.902 . . . . 1.11 108.346 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.617 ' O ' HG23 ' A' ' 28' ' ' ILE . 69.0 mttt -140.38 96.56 3.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.95 -1.323 . . . . 1.78 109.987 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.908 HD13 ' CB ' ' A' ' 101' ' ' SER . 2.1 mp -46.05 152.43 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.649 -0.657 . . . . 0.37 109.843 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.646 ' CB ' ' HD3' ' A' ' 100' ' ' LYS . 0.0 OUTLIER 141.79 -77.3 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.692 0.758 . . . . 0.58 109.132 178.823 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.587 ' CB ' HG21 ' A' ' 28' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--N 1.301 -1.533 0 CA-C-O 118.017 -0.992 . . . . 3.57 109.63 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . 0.478 ' O ' ' O ' ' A' ' 2' ' ' GLN . 65.7 m-20 . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.5 0.667 . . . . 4.81 109.804 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.549 ' HA ' ' HB3' ' A' ' 17' ' ' MET . 93.6 mt-30 47.91 179.08 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 122.158 0.98 . . . . 3.84 110.999 178.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.839 HG13 ' N ' ' A' ' 4' ' ' ASP . 2.2 p -162.72 -149.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 108.642 -0.873 . . . . 4.17 108.642 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.839 ' N ' HG13 ' A' ' 3' ' ' VAL . 32.2 t0 -163.73 54.74 0.16 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.652 -1.28 . . . . 2.24 110.222 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.621 HG12 ' HB2' ' A' ' 122' ' ' ALA . 19.4 m -89.12 152.39 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.031 -1.043 . . . . 0.9 109.83 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.48 95.57 3.31 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.319 -0.863 . . . . 2.79 109.238 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -89.88 173.97 7.95 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.358 -0.839 . . . . 1.47 109.582 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.487 ' N ' ' SG ' ' A' ' 119' ' ' CYS . 24.8 p -164.76 47.79 0.1 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.258 -0.901 . . . . 2.03 109.696 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.591 ' HB1' ' O ' ' A' ' 117' ' ' LEU . . . -76.4 -67.31 0.7 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.304 -0.873 . . . . 0.38 109.244 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.554 ' CB ' ' O ' ' A' ' 9' ' ' ALA . 0.7 OUTLIER 160.37 39.5 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.487 -0.931 . . . . 0.98 108.487 -178.285 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 54.4 t30 55.87 21.67 5.03 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.316 -0.994 . . . . 1.75 108.316 -178.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -104.48 -22.18 13.34 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.21 -0.663 . . . . 2.02 109.21 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.917 HG23 ' O ' ' A' ' 40' ' ' LEU . 3.8 mt -52.03 143.16 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.073 -1.017 . . . . 0.59 108.925 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.89 -22.7 13.11 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.351 -0.843 . . . . 1.91 109.223 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -168.75 108.95 0.49 Allowed 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 118.426 -1.31 . . . . 1.81 111.595 -178.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.622 ' O ' HG13 ' A' ' 16' ' ' VAL . 3.2 p -118.12 94.09 2.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 N-CA-C 106.819 -1.549 . . . . 0.78 106.819 177.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.549 ' HB3' ' HA ' ' A' ' 2' ' ' GLN . 7.0 mmt -134.87 118.32 16.83 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.487 -0.885 . . . . 2.63 111.356 -177.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.535 HG23 HG11 ' A' ' 3' ' ' VAL . 11.2 t -85.86 126.25 40.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 107.171 -1.418 . . . . 1.36 107.171 177.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.592 ' HB3' ' CB ' ' A' ' 35' ' ' PHE . 2.0 t0 -45.8 -22.17 0.17 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.071 -1.018 . . . . 2.35 110.396 -178.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.61 ' C ' HG23 ' A' ' 29' ' ' ILE . . . -177.82 135.32 2.68 Favored Glycine 0 N--CA 1.49 2.299 0 C-N-CA 118.947 -1.597 . . . . 1.76 110.857 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.972 ' CA ' HG23 ' A' ' 29' ' ' ILE . 0.0 OUTLIER 153.12 -37.0 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.881 -0.776 . . . . 0.91 109.614 178.671 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.636 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 42.6 t-80 53.76 102.85 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.78 -1.2 . . . . 3.46 109.362 -179.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.705 ' H ' HG22 ' A' ' 3' ' ' VAL . . . -90.03 -147.18 16.73 Favored Glycine 0 N--CA 1.499 2.867 0 O-C-N 121.044 -1.035 . . . . 1.03 111.407 -178.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.525 ' N ' ' O ' ' A' ' 4' ' ' ASP . 0.1 OUTLIER 80.92 -77.9 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.626 -0.926 . . . . 1.08 108.667 -178.986 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.676 ' HB2' ' CD ' ' A' ' 26' ' ' PRO . 7.4 p30 -86.17 -152.84 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.51 0 N-CA-C 105.727 -1.953 . . . . 1.84 105.727 178.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.676 ' CD ' ' HB2' ' A' ' 25' ' ' ASP . 28.7 Cg_endo -72.99 91.72 0.82 Allowed 'Trans proline' 0 C--N 1.319 -1.016 0 N-CA-C 108.395 -1.425 . . . . 0.43 108.395 179.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.636 ' HA ' ' O ' ' A' ' 22' ' ' HIS . 0.3 OUTLIER -34.36 101.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.559 0.695 . . . . 0.3 112.036 -177.202 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.756 HG21 ' HB3' ' A' ' 129' ' ' ASP . 28.4 mm -97.05 135.82 29.91 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 106.829 -1.545 . . . . 0.47 106.829 176.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.972 HG23 ' CA ' ' A' ' 21' ' ' CYS . 0.5 OUTLIER -122.87 -166.77 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 O-C-N 121.005 -1.06 . . . . 0.76 111.676 -177.468 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.61 ' N ' ' CD2' ' A' ' 30' ' ' HIS . 0.0 OUTLIER -123.77 168.67 12.41 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 115.863 -0.608 . . . . 2.94 109.446 179.628 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.565 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -115.6 -163.96 0.92 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.089 -1.007 . . . . 1.56 109.453 179.43 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 31' ' ' ARG . . . 39.19 44.62 2.17 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.902 -1.279 . . . . 1.43 109.902 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.483 ' C ' ' HB ' ' A' ' 94' ' ' VAL . 0.1 OUTLIER -172.08 109.7 0.37 Allowed Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.153 -1.204 . . . . 2.37 109.577 -179.742 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.538 ' HA ' ' HB ' ' A' ' 94' ' ' VAL . 29.3 Cg_endo -70.37 115.5 4.21 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.821 2.348 . . . . 3.46 110.949 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.592 ' CB ' ' HB3' ' A' ' 19' ' ' ASP . 22.5 m-85 -100.13 -157.41 0.6 Allowed 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.773 -0.825 . . . . 7.48 108.773 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.551 ' O ' ' HG3' ' A' ' 38' ' ' GLU . 1.8 m -175.63 102.22 0.07 Allowed 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.368 -0.833 . . . . 0.78 108.768 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.468 ' HA ' HG13 ' A' ' 18' ' ' VAL . 0.2 OUTLIER -52.2 153.25 2.88 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.235 -1.024 . . . . 3.48 108.235 179.8 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.575 ' O ' ' HB2' ' A' ' 39' ' ' ALA . 63.0 mt-10 -154.38 166.75 32.24 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.791 -1.193 . . . . 0.64 110.96 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.575 ' HB2' ' O ' ' A' ' 38' ' ' GLU . . . 168.18 96.6 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.58 -0.896 . . . . 0.45 108.58 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.917 ' O ' HG23 ' A' ' 13' ' ' ILE . 0.5 OUTLIER -90.12 154.82 19.49 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.394 -0.595 . . . . 0.9 109.394 -179.517 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.762 ' CE2' ' CD2' ' A' ' 86' ' ' TYR . 0.2 OUTLIER -152.52 169.87 21.56 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.056 -1.027 . . . . 0.78 109.349 178.41 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.463 ' OD2' ' OE1' ' A' ' 85' ' ' GLN . 6.7 t0 -119.46 112.45 19.41 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 122.195 0.998 . . . . 1.5 109.206 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.884 ' HB1' ' O ' ' A' ' 81' ' ' VAL . . . -42.28 116.39 0.83 Allowed 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 115.431 -0.804 . . . . 0.73 109.198 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.491 ' O ' ' HB3' ' A' ' 82' ' ' LYS . 11.3 p30 -126.17 -0.1 7.11 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.243 -0.911 . . . . 4.4 109.731 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.89 ' CD ' HD21 ' A' ' 117' ' ' LEU . 3.1 pt20 -90.68 -137.61 0.14 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.413 -0.805 . . . . 0.69 109.01 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.858 ' HA ' ' HB ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -159.23 68.87 0.44 Allowed 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 119.59 -0.844 . . . . 1.6 109.637 179.215 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.71 HG21 ' HA3' ' A' ' 112' ' ' GLY . 3.5 t -145.25 120.01 9.88 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.045 -1.659 . . . . 0.56 110.764 -178.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.638 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 0.2 OUTLIER -68.74 -5.53 21.09 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.841 -1.162 . . . . 1.92 109.075 178.553 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.0 p -98.79 -177.6 3.7 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.058 -1.026 . . . . 1.14 109.893 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.922 ' HB1' ' HB3' ' A' ' 72' ' ' ALA . . . -163.94 145.62 9.01 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.442 -0.948 . . . . 0.55 108.442 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.477 ' HG2' ' OD1' ' A' ' 71' ' ' ASN . 16.6 mtmt -138.36 91.97 2.6 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 122.964 1.364 . . . . 2.27 109.506 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.674 ' HA ' HD12 ' A' ' 110' ' ' LEU . 1.2 tt -67.98 158.15 5.85 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.474 0 CA-C-N 114.063 -1.426 . . . . 1.47 110.086 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -150.93 49.16 0.85 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.33 -0.857 . . . . 2.0 109.127 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.958 ' HB ' HG21 ' A' ' 65' ' ' VAL . 0.2 OUTLIER -75.64 159.49 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.42 -0.8 . . . . 0.77 108.925 -179.869 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.555 ' HD3' ' O ' ' A' ' 54' ' ' ILE . 0.4 OUTLIER -166.13 29.71 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.178 -1.009 . . . . 1.46 110.774 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 1.029 ' HB3' HG21 ' A' ' 63' ' ' ILE . . . -66.7 159.04 28.63 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 108.809 -0.811 . . . . 1.27 108.809 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.15 130.08 24.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.032 -1.043 . . . . 0.87 109.736 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 1.066 HD13 ' N ' ' A' ' 59' ' ' ASP . 2.5 tm? -119.91 154.92 33.69 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.212 -0.93 . . . . 1.35 108.78 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 1.066 ' N ' HD13 ' A' ' 58' ' ' LEU . 5.6 t70 -76.93 79.24 3.49 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 107.818 -1.179 . . . . 3.91 107.818 178.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.703 ' O ' HD22 ' A' ' 61' ' ' LEU . . . 125.8 -5.83 7.92 Favored Glycine 0 N--CA 1.485 1.91 0 N-CA-C 108.787 -1.725 . . . . 0.9 108.787 -178.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.703 HD22 ' O ' ' A' ' 60' ' ' GLY . 0.4 OUTLIER -141.86 53.48 1.49 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.238 -1.154 . . . . 1.42 109.263 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 61' ' ' LEU . 36.1 mm-40 -41.18 97.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.544 -0.722 . . . . 3.07 109.625 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 1.029 HG21 ' HB3' ' A' ' 56' ' ' ALA . 0.3 OUTLIER -75.09 -2.93 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 CA-C-O 121.952 0.882 . . . . 2.88 110.133 -179.986 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.462 ' C ' ' O ' ' A' ' 63' ' ' ILE . 0.6 OUTLIER -40.03 140.13 0.61 Allowed 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 108.925 -0.768 . . . . 1.83 108.925 179.317 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.958 HG21 ' HB ' ' A' ' 54' ' ' ILE . 98.8 t -123.0 86.2 50.92 Favored Pre-proline 0 C--N 1.301 -1.533 0 O-C-N 121.168 -0.957 . . . . 1.44 110.556 -178.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.465 ' O ' ' C ' ' A' ' 67' ' ' GLY . 35.7 Cg_endo -79.29 89.34 1.36 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.791 2.327 . . . . 3.72 110.422 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.465 ' C ' ' O ' ' A' ' 66' ' ' PRO . . . 37.14 68.94 0.31 Allowed Glycine 0 N--CA 1.495 2.585 0 N-CA-C 110.117 -1.193 . . . . 1.33 110.117 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 21.2 mt -83.94 -78.03 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.13 -1.217 . . . . 2.45 109.613 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.469 ' OD2' ' CE1' ' A' ' 75' ' ' PHE . 5.2 p30 -78.47 130.58 36.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.212 -0.93 . . . . 2.45 109.233 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.516 ' O ' ' ND2' ' A' ' 71' ' ' ASN . 13.7 t -51.58 -23.02 3.72 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.09 -1.006 . . . . 2.82 109.715 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.574 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 23.3 m-80 -168.32 76.05 0.12 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.953 -1.092 . . . . 1.32 111.225 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.922 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . . . 32.02 33.75 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.283 0.563 . . . . 0.8 111.921 176.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.535 ' N ' ' O ' ' A' ' 71' ' ' ASN . 31.0 t -109.79 21.64 16.66 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 121.179 -0.95 . . . . 1.0 110.393 -179.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 17.6 t-160 -121.64 -18.26 7.22 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.374 -1.454 . . . . 2.83 109.45 178.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' A' ' 75' ' ' PHE . 7.3 m-85 -104.67 -15.09 15.37 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -0.887 . . . . 2.49 108.695 179.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 1.076 HG21 ' CE2' ' A' ' 86' ' ' TYR . 18.2 m -150.73 -153.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 N-CA-C 107.097 -1.445 . . . . 3.17 107.097 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.843 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -81.65 -177.65 6.63 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 106.287 -1.745 . . . . 2.36 106.287 176.325 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . 0.588 ' H ' ' HD2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -109.1 -51.87 0.07 OUTLIER Pre-proline 0 C--N 1.293 -1.86 0 O-C-N 120.64 -1.287 . . . . 0.88 110.796 -179.559 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.638 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 29.6 Cg_endo -77.83 111.6 3.14 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 N-CA-C 108.506 -1.382 . . . . 0.85 108.506 178.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.984 HD22 HD13 ' A' ' 117' ' ' LEU . 0.6 OUTLIER -93.6 -67.54 0.85 Allowed 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.622 -0.673 . . . . 2.63 109.363 -178.1 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.884 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 1.4 m 40.8 -167.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 C-N-CA 120.46 -0.496 . . . . 0.6 110.072 177.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.734 ' H ' HG23 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -98.47 41.62 1.13 Allowed 'General case' 0 C--N 1.292 -1.91 0 O-C-N 120.629 -1.294 . . . . 0.76 109.81 -177.45 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -150.68 46.4 0.62 Allowed Glycine 0 C--N 1.288 -2.123 0 N-CA-C 108.863 -1.695 . . . . 0.99 108.863 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.5 ' OE1' ' O ' ' A' ' 85' ' ' GLN . 3.0 tp-100 -159.4 150.07 19.46 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.132 -1.217 . . . . 1.96 110.18 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.5 ' O ' ' OE1' ' A' ' 84' ' ' GLN . 0.0 OUTLIER -104.25 157.37 17.18 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.569 -1.271 . . . . 2.43 107.569 178.412 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 1.076 ' CE2' HG21 ' A' ' 76' ' ' VAL . 0.4 OUTLIER -125.64 -167.65 1.72 Allowed 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.313 -1.492 . . . . 3.95 111.592 -178.928 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.616 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER 170.98 38.44 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.409 -0.814 . . . . 3.04 109.088 179.342 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.7 HD12 ' CG1' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -49.52 -178.01 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 108.256 -1.016 . . . . 0.64 108.256 179.129 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.57 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 1.2 mtmt 170.5 164.56 0.07 Allowed 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 119.069 -1.052 . . . . 0.83 109.957 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.616 ' CE2' HG12 ' A' ' 54' ' ' ILE . 17.0 m-85 -150.58 91.21 1.71 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.467 -0.771 . . . . 0.87 109.246 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.476 ' O ' ' O ' ' A' ' 90' ' ' TYR . 1.4 t -44.71 171.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.7 -0.625 . . . . 3.34 109.612 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.586 ' O ' HG23 ' A' ' 94' ' ' VAL . 0.3 OUTLIER -146.36 92.53 2.19 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.147 -0.971 . . . . 3.8 110.131 -179.938 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -65.43 112.43 3.54 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.126 -1.435 . . . . 4.53 107.126 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.849 HG13 ' CD1' ' A' ' 97' ' ' ILE . 59.5 t -125.05 93.94 44.74 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 120.917 -1.115 . . . . 2.48 112.451 -177.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.908 ' HD2' HD11 ' A' ' 97' ' ' ILE . 33.3 Cg_endo -73.65 -151.42 0.03 OUTLIER 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 122.105 1.87 . . . . 3.32 108.26 176.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.565 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 2.7 mmtt -67.54 -32.61 73.51 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.215 -1.553 . . . . 2.44 109.184 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.908 HD11 ' HD2' ' A' ' 95' ' ' PRO . 4.0 mt 42.39 15.87 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.125 -0.984 . . . . 1.77 112.354 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.982 ' HB1' ' HD2' ' A' ' 99' ' ' PRO . . . 50.65 173.37 0.03 OUTLIER Pre-proline 0 C--N 1.307 -1.242 0 O-C-N 120.292 -1.505 . . . . 1.6 109.93 179.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.982 ' HD2' ' HB1' ' A' ' 98' ' ' ALA . 57.4 Cg_endo -81.66 76.29 4.43 Favored 'Trans proline' 0 C--N 1.296 -2.208 0 C-N-CA 123.163 2.575 . . . . 2.62 108.418 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.698 ' CB ' ' O ' ' A' ' 99' ' ' PRO . 4.6 mmmm 119.2 127.11 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 123.8 0.687 . . . . 2.54 109.751 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.507 ' O ' ' HB2' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -87.38 11.49 14.38 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.271 -0.893 . . . . 1.51 109.392 179.638 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.562 ' O ' ' CB ' ' A' ' 103' ' ' ASN . 2.1 mp0 67.63 -0.42 1.94 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.656 -0.652 . . . . 6.1 109.906 -179.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.562 ' CB ' ' O ' ' A' ' 102' ' ' GLU . 3.3 t30 160.91 143.23 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.275 -0.89 . . . . 2.28 109.928 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 125' ' ' GLY . 0.1 OUTLIER -159.9 158.67 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.423 -0.798 . . . . 1.05 109.295 -179.772 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.435 ' O ' HG12 ' A' ' 105' ' ' VAL . 1.2 t -149.33 131.22 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.042 -1.036 . . . . 0.58 109.66 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.857 ' HB ' ' HB3' ' A' ' 122' ' ' ALA . 10.5 t -119.87 130.3 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.135 -0.978 . . . . 1.28 109.62 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.542 ' HB ' ' HB2' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -154.34 140.19 18.16 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.529 -0.915 . . . . 1.08 108.529 179.711 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.955 HG13 ' CD1' ' A' ' 54' ' ' ILE . 34.7 t -158.49 151.14 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.872 -1.143 . . . . 1.26 110.266 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.538 ' HA ' ' HA ' ' A' ' 119' ' ' CYS . 6.7 ttpt -172.46 134.5 0.67 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.222 -0.924 . . . . 1.25 110.284 178.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.691 ' O ' HG23 ' A' ' 116' ' ' VAL . 9.8 tp -111.15 132.65 54.13 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 106.833 -1.543 . . . . 0.62 106.833 177.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.468 ' HB ' ' HB2' ' A' ' 51' ' ' LYS . 8.4 mt -133.71 113.78 19.04 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 O-C-N 121.128 -0.983 . . . . 0.63 110.972 -177.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.71 ' HA3' HG21 ' A' ' 47' ' ' THR . . . -76.88 -110.76 0.14 Allowed Glycine 0 N--CA 1.486 1.993 0 N-CA-C 107.944 -2.062 . . . . 0.65 107.944 178.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -142.48 9.39 1.82 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.531 -1.285 . . . . 1.63 107.531 178.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.507 ' OD1' ' HB2' ' A' ' 45' ' ' GLN . 0.3 OUTLIER -123.88 -31.86 3.35 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.693 0.759 . . . . 3.9 109.362 -178.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -171.37 -142.87 3.81 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 108.708 -1.757 . . . . 0.76 108.708 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 110' ' ' LEU . 2.4 p -114.87 131.83 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.087 -1.243 . . . . 0.74 109.121 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.984 HD13 HD22 ' A' ' 80' ' ' LEU . 4.0 mt -78.85 -49.42 12.95 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.435 -0.791 . . . . 0.38 109.78 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.446 ' HA ' ' HB2' ' A' ' 9' ' ' ALA . . . -161.4 130.61 4.61 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.302 -0.874 . . . . 2.06 109.688 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 0.538 ' HA ' ' HA ' ' A' ' 109' ' ' LYS . 16.4 p -129.19 -172.11 2.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.207 -0.933 . . . . 0.93 110.01 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.491 ' HB2' ' O ' ' A' ' 119' ' ' CYS . . . 175.18 127.06 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.34 -0.85 . . . . 0.26 109.206 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.451 ' N ' HD12 ' A' ' 121' ' ' ILE . 5.2 mp -127.66 139.78 50.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.183 -0.948 . . . . 0.41 110.385 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.857 ' HB3' ' HB ' ' A' ' 106' ' ' VAL . . . -144.71 33.32 1.15 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.061 -1.089 . . . . 1.06 108.061 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.49 ' O ' ' O ' ' A' ' 122' ' ' ALA . 3.2 m -40.5 168.02 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.536 0.684 . . . . 4.52 110.662 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . 0.462 ' H ' HG22 ' A' ' 123' ' ' THR . 0.2 OUTLIER 59.26 66.94 0.96 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.513 -0.742 . . . . 1.66 109.457 179.768 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.618 ' O ' HG23 ' A' ' 104' ' ' VAL . . . -94.86 147.2 18.51 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.313 -1.515 . . . . 1.06 109.313 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.516 ' CG ' ' HE3' ' A' ' 100' ' ' LYS . 7.6 mtmt -153.9 121.58 5.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.427 -1.043 . . . . 2.73 108.509 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.545 ' O ' ' CD ' ' A' ' 100' ' ' LYS . 1.6 mp -90.37 118.39 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.11 -0.994 . . . . 1.05 112.102 -177.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.628 ' HB2' ' HG2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER 176.14 -62.22 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.771 -1.206 . . . . 3.02 109.302 177.595 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.756 ' HB3' HG21 ' A' ' 28' ' ' ILE . 6.9 t70 . . . . . 0 N--CA 1.494 1.74 0 CA-C-O 117.953 -1.023 . . . . 4.09 109.339 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . 0.503 ' O ' ' HB3' ' A' ' 17' ' ' MET . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.524 0.678 . . . . 5.04 109.643 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.515 ' HA ' ' HB3' ' A' ' 17' ' ' MET . 31.1 mt-30 -94.77 178.77 5.47 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.901 0.858 . . . . 4.24 110.169 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.977 HG21 ' CG2' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -133.58 -169.2 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.035 -1.098 . . . . 1.38 108.035 179.494 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -117.88 52.76 0.98 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.909 -1.119 . . . . 1.08 109.017 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 26.9 m -73.33 159.34 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.414 -0.804 . . . . 1.07 110.143 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.14 74.49 9.59 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.448 -0.782 . . . . 3.85 109.278 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.505 ' OD1' ' N ' ' A' ' 8' ' ' CYS . 0.7 OUTLIER -75.22 -170.03 1.08 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.257 -0.902 . . . . 1.86 109.55 -179.866 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.505 ' N ' ' OD1' ' A' ' 7' ' ' ASP . 16.6 p 179.25 33.76 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.112 -0.993 . . . . 2.24 109.58 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.615 ' HB1' ' O ' ' A' ' 117' ' ' LEU . . . -62.88 -58.66 6.62 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.296 -0.877 . . . . 0.68 109.607 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.503 ' CB ' ' O ' ' A' ' 9' ' ' ALA . 1.7 m-80 166.59 36.73 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.612 -0.835 . . . . 3.19 109.398 -178.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.8 t30 51.19 34.39 11.2 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.14 -0.975 . . . . 1.69 108.716 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.485 ' HG2' ' OD1' ' A' ' 44' ' ' ASN . 6.6 tp10 -128.73 -21.85 3.35 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.366 -0.834 . . . . 3.25 110.034 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.96 HG23 ' O ' ' A' ' 40' ' ' LEU . 5.9 mt -42.51 139.25 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.146 -0.971 . . . . 0.97 108.931 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.438 ' HD2' ' OD1' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -100.59 -31.38 11.27 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-O 121.956 0.884 . . . . 1.67 108.813 -179.783 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.08 120.09 12.07 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 119.909 -0.716 . . . . 2.13 109.667 -178.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.632 ' O ' HG13 ' A' ' 16' ' ' VAL . 11.3 p -136.82 118.12 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.272 -0.892 . . . . 1.15 108.845 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.515 ' HB3' ' HA ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -156.05 173.41 16.84 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.426 -0.796 . . . . 5.09 109.606 -179.258 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.977 ' CG2' HG21 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -132.55 9.54 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 O-C-N 121.085 -1.009 . . . . 3.91 108.975 178.34 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.556 ' CB ' ' HA ' ' A' ' 35' ' ' PHE . 7.9 t70 77.55 58.54 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 112.551 0.575 . . . . 3.1 112.551 178.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' A' ' 29' ' ' ILE . . . 70.67 31.42 67.75 Favored Glycine 0 N--CA 1.499 2.876 0 O-C-N 120.777 -1.202 . . . . 2.69 111.811 177.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.852 ' HA ' HG23 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -92.96 -19.44 21.6 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.889 -1.359 . . . . 1.21 108.247 178.839 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.792 ' HA ' HG12 ' A' ' 3' ' ' VAL . 4.2 m170 67.65 109.69 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.515 -0.741 . . . . 4.38 109.447 -179.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.46 ' O ' ' HB3' ' A' ' 24' ' ' SER . . . -80.88 178.18 54.11 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 110.175 -1.17 . . . . 0.47 110.175 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.46 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 41.0 t 62.3 151.73 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.351 -1.088 . . . . 2.68 108.509 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.61 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.2 OUTLIER 59.6 179.92 0.04 OUTLIER Pre-proline 0 C--N 1.306 -1.302 0 N-CA-C 107.336 -1.357 . . . . 5.49 107.336 -179.644 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.61 ' HD2' ' CB ' ' A' ' 25' ' ' ASP . 26.8 Cg_endo -70.78 83.74 0.86 Allowed 'Trans proline' 0 C--N 1.296 -2.228 0 C-N-CA 121.94 1.76 . . . . 0.92 108.404 178.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.462 ' O ' ' HA2' ' A' ' 125' ' ' GLY . 0.0 OUTLIER -33.37 115.54 0.22 Allowed 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 115.422 -0.808 . . . . 0.63 111.982 -178.009 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.803 HG23 ' O ' ' A' ' 126' ' ' LYS . 25.2 mm -107.72 139.56 29.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 107.46 -1.311 . . . . 0.58 107.46 176.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.852 HG23 ' HA ' ' A' ' 21' ' ' CYS . 0.7 OUTLIER -122.55 -175.57 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 O-C-N 120.981 -1.074 . . . . 0.9 111.572 -177.442 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.508 ' O ' ' CE1' ' A' ' 35' ' ' PHE . 98.1 m-70 -111.92 -171.55 1.87 Allowed 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.528 0.68 . . . . 1.67 110.366 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.564 ' CD ' ' O ' ' A' ' 98' ' ' ALA . 0.1 OUTLIER -130.39 -160.8 1.07 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.515 -0.74 . . . . 2.55 109.103 179.51 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.469 ' O ' ' HG3' ' A' ' 33' ' ' LYS . . . 40.23 34.86 0.66 Allowed Glycine 0 N--CA 1.495 2.581 0 N-CA-C 110.08 -1.208 . . . . 0.74 110.08 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.735 ' O ' HG11 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -167.96 129.02 1.16 Allowed Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.277 -1.131 . . . . 4.72 108.999 -179.921 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.502 ' HA ' ' CG2' ' A' ' 94' ' ' VAL . 20.3 Cg_endo -58.74 129.43 32.23 Favored 'Trans proline' 0 C--N 1.302 -1.883 0 C-N-CA 121.603 1.535 . . . . 1.91 109.869 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.654 ' H ' HG21 ' A' ' 94' ' ' VAL . 19.9 m-85 -79.36 40.95 0.45 Allowed 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 116.234 -0.439 . . . . 6.71 110.611 -178.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.482 ' C ' ' O ' ' A' ' 35' ' ' PHE . 24.4 m -35.01 91.45 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.534 -0.729 . . . . 1.48 110.585 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.681 HD21 ' HB2' ' A' ' 90' ' ' TYR . 1.0 OUTLIER -89.9 122.49 32.99 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.941 -1.133 . . . . 0.93 107.941 179.264 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.553 ' HG2' ' HG2' ' A' ' 89' ' ' LYS . 55.9 mt-10 -121.29 177.57 5.12 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 120.818 -1.176 . . . . 1.0 111.092 -178.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.518 ' O ' ' CD1' ' A' ' 41' ' ' PHE . . . 177.05 63.96 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 106.683 -1.599 . . . . 0.89 106.683 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.96 ' O ' HG23 ' A' ' 13' ' ' ILE . 0.6 OUTLIER -69.83 168.24 15.55 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 115.337 -0.847 . . . . 0.48 110.31 -178.281 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.658 ' CE2' ' CE2' ' A' ' 86' ' ' TYR . 6.3 p90 -178.73 146.97 0.36 Allowed 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.299 -0.875 . . . . 0.36 109.229 179.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.589 ' O ' ' C ' ' A' ' 43' ' ' ALA . 0.4 OUTLIER -94.44 98.22 10.72 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 106.314 -1.735 . . . . 4.87 106.314 177.664 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.716 ' HB1' ' O ' ' A' ' 81' ' ' VAL . . . -17.83 122.38 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 115.38 -0.827 . . . . 1.21 110.722 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.485 ' OD1' ' HG2' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -118.97 30.74 7.01 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.317 -0.865 . . . . 2.16 111.017 -177.866 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.962 ' OE1' HD21 ' A' ' 117' ' ' LEU . 2.0 pt20 -126.59 -142.15 0.28 Allowed 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.988 -1.115 . . . . 0.6 107.988 179.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.774 ' HA ' ' HB ' ' A' ' 81' ' ' VAL . 0.1 OUTLIER -154.04 68.31 0.75 Allowed 'General case' 0 C--N 1.292 -1.917 0 O-C-N 121.058 -1.026 . . . . 2.31 108.675 177.889 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.765 HG23 ' O ' ' A' ' 47' ' ' THR . 10.7 t -145.69 120.89 10.17 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 120.101 -1.624 . . . . 0.57 111.96 -177.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.614 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -67.59 -25.63 65.87 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.608 -1.307 . . . . 2.18 107.812 177.336 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.452 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 66.0 p -82.63 -163.57 0.72 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.695 -0.628 . . . . 0.7 109.373 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.957 ' CB ' ' HB3' ' A' ' 72' ' ' ALA . . . 175.63 160.46 0.26 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.284 -0.885 . . . . 0.27 109.817 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 1.026 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -126.66 -160.14 0.97 Allowed 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 106.516 -1.661 . . . . 3.25 106.516 177.581 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.469 ' HB ' ' O ' ' A' ' 51' ' ' LYS . 20.6 tt -177.56 164.41 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 C-N-CA 117.914 -1.515 . . . . 0.58 111.641 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.522 ' O ' ' HE2' ' A' ' 55' ' ' LYS . 2.3 mt-10 -165.46 59.28 0.12 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.124 -1.065 . . . . 0.9 108.124 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.896 ' HB ' HG21 ' A' ' 65' ' ' VAL . 0.4 OUTLIER -96.99 139.77 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.352 -0.842 . . . . 0.6 109.997 -179.462 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.693 ' HG3' ' O ' ' A' ' 54' ' ' ILE . 1.9 mtmt -150.96 93.38 1.93 Allowed 'General case' 0 C--N 1.284 -2.274 0 C-N-CA 119.833 -0.747 . . . . 0.88 109.781 178.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.507 ' HB3' ' HB ' ' A' ' 63' ' ' ILE . . . -110.35 150.4 28.83 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 108.022 -1.103 . . . . 0.58 108.022 178.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.494 ' HA ' ' HA ' ' A' ' 62' ' ' GLU . 0.8 OUTLIER -131.03 122.81 27.45 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.774 -1.204 . . . . 1.26 111.392 -178.622 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.969 HD13 ' N ' ' A' ' 59' ' ' ASP . 2.0 tm? -110.37 158.23 18.67 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.034 -1.099 . . . . 1.93 108.034 178.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.969 ' N ' HD13 ' A' ' 58' ' ' LEU . 23.4 t0 -40.89 -72.25 0.07 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.155 -0.966 . . . . 3.23 109.792 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -106.29 30.39 9.66 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.496 -1.442 . . . . 0.74 109.496 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.493 ' HB3' ' HB3' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -150.28 60.53 0.97 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.347 -1.09 . . . . 1.09 108.996 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 0.1 OUTLIER -63.42 86.82 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.661 -0.649 . . . . 3.4 110.653 -179.31 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.507 ' HB ' ' HB3' ' A' ' 56' ' ' ALA . 2.0 mt -54.69 160.96 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 107.442 -1.318 . . . . 0.42 107.442 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -168.42 146.95 4.29 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.678 -1.264 . . . . 2.6 110.097 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.896 HG21 ' HB ' ' A' ' 54' ' ' ILE . 4.9 t -149.0 74.83 9.99 Favored Pre-proline 0 N--CA 1.488 1.44 0 O-C-N 121.631 -0.668 . . . . 0.41 109.285 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -80.33 -7.59 13.92 Favored 'Trans proline' 0 C--N 1.302 -1.886 0 C-N-CA 123.028 2.486 . . . . 1.05 110.465 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 135.39 56.12 0.06 OUTLIER Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.464 -1.454 . . . . 0.88 109.464 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 21.0 mt -81.46 -59.48 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.273 -1.133 . . . . 1.7 109.729 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.507 ' HB3' ' HB2' ' A' ' 74' ' ' HIS . 8.9 p30 -66.75 142.74 57.28 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.117 -0.989 . . . . 1.65 109.228 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.416 ' O ' ' CG ' ' A' ' 71' ' ' ASN . 5.8 t -67.69 -10.27 50.91 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.084 -1.01 . . . . 2.89 108.848 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.588 ' CA ' ' O ' ' A' ' 50' ' ' ALA . 7.4 m-20 178.02 66.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.918 . . . . 0.31 110.347 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 1.026 ' HB2' ' O ' ' A' ' 51' ' ' LYS . . . 39.77 27.54 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 121.456 0.646 . . . . 0.28 110.674 177.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.478 ' N ' ' O ' ' A' ' 71' ' ' ASN . 6.7 t -102.76 -22.34 13.93 Favored 'General case' 0 C--N 1.293 -1.885 0 O-C-N 121.447 -0.783 . . . . 0.64 109.88 -179.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.507 ' HB2' ' HB3' ' A' ' 69' ' ' ASP . 0.4 OUTLIER -84.93 5.87 27.29 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.228 -0.92 . . . . 3.69 109.783 -179.881 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.683 ' C ' HG12 ' A' ' 76' ' ' VAL . 76.5 m-85 -135.37 0.79 2.83 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.044 -1.035 . . . . 0.85 110.841 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.777 ' HB ' ' CE1' ' A' ' 86' ' ' TYR . 0.2 OUTLIER -167.92 173.66 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.362 -1.461 . . . . 0.64 111.139 -178.094 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.635 ' N ' HG23 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -55.03 94.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 106.264 -1.754 . . . . 4.32 106.264 177.447 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . 0.605 ' HB2' ' HD3' ' A' ' 79' ' ' PRO . 2.4 m -33.47 -53.27 0.75 Allowed Pre-proline 0 N--CA 1.504 2.236 0 O-C-N 121.789 -0.569 . . . . 0.95 112.382 -176.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.614 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 33.9 Cg_endo -79.75 113.08 3.0 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 120.93 1.086 . . . . 0.86 110.193 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 1.089 HD12 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -97.37 -65.7 0.95 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.229 -0.919 . . . . 0.68 108.58 -179.59 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.774 ' HB ' ' HA ' ' A' ' 46' ' ' ASN . 1.3 m 41.38 -168.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 C-N-CA 120.32 -0.552 . . . . 0.8 109.701 178.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.74 ' H ' HG23 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -102.53 42.38 1.15 Allowed 'General case' 0 C--N 1.29 -1.982 0 O-C-N 120.133 -1.604 . . . . 1.27 110.999 -175.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.492 ' O ' ' OE1' ' A' ' 84' ' ' GLN . . . -151.83 31.73 0.9 Allowed Glycine 0 C--N 1.285 -2.264 0 N-CA-C 108.995 -1.642 . . . . 1.39 108.995 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.492 ' OE1' ' O ' ' A' ' 83' ' ' GLY . 0.2 OUTLIER -137.3 121.69 18.23 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.284 -1.127 . . . . 3.96 110.726 -179.018 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -97.01 125.56 41.52 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 105.435 -2.061 . . . . 2.39 105.435 176.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.945 ' OH ' HD13 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -153.51 161.08 42.59 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 117.657 -1.617 . . . . 0.65 109.759 -177.445 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.642 ' CB ' ' HG ' ' A' ' 40' ' ' LEU . 3.1 p-10 -129.23 101.09 5.85 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.97 -1.081 . . . . 0.84 113.285 -175.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.945 HD13 ' OH ' ' A' ' 86' ' ' TYR . 3.2 tp -69.17 -160.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 107.722 -1.214 . . . . 1.0 107.722 176.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.734 ' N ' HG23 ' A' ' 88' ' ' ILE . 0.0 OUTLIER 159.75 170.14 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.196 -0.94 . . . . 1.59 109.993 179.689 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.681 ' HB2' HD21 ' A' ' 37' ' ' LEU . 10.0 m-85 -162.48 67.83 0.24 Allowed 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.944 -0.762 . . . . 1.52 108.944 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.54 ' C ' ' CD1' ' A' ' 92' ' ' TRP . 3.0 t -56.39 176.19 0.09 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.474 -0.766 . . . . 2.42 109.94 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.667 ' CD1' ' N ' ' A' ' 92' ' ' TRP . 0.0 OUTLIER -142.36 147.79 36.85 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.229 -0.919 . . . . 5.33 109.914 -179.377 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.551 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 25.3 m-20 -74.93 94.64 2.85 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 104.338 -2.468 . . . . 5.51 104.338 175.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.976 HG13 ' CD1' ' A' ' 97' ' ' ILE . 60.8 t -106.3 96.04 12.72 Favored Pre-proline 0 N--CA 1.488 1.466 0 C-N-CA 118.817 -1.153 . . . . 2.29 113.777 -175.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.826 ' HD2' HD11 ' A' ' 97' ' ' ILE . 35.2 Cg_endo -77.42 -150.11 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.538 2.158 . . . . 2.64 107.319 174.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.553 ' O ' ' CB ' ' A' ' 31' ' ' ARG . 0.7 OUTLIER -72.12 -25.23 61.65 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.426 -1.421 . . . . 2.35 108.561 178.485 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.976 ' CD1' HG13 ' A' ' 94' ' ' VAL . 4.0 mt 43.25 14.49 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.505 -0.747 . . . . 1.34 112.842 179.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 1.049 ' HB1' ' HD2' ' A' ' 99' ' ' PRO . . . 52.64 175.38 0.03 OUTLIER Pre-proline 0 C--N 1.304 -1.403 0 O-C-N 119.769 -1.832 . . . . 1.27 109.226 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 1.049 ' HD2' ' HB1' ' A' ' 98' ' ' ALA . 37.3 Cg_endo -73.1 -7.17 20.21 Favored 'Trans proline' 0 C--N 1.299 -2.055 0 C-N-CA 123.293 2.662 . . . . 4.06 110.995 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.648 ' HD3' ' CB ' ' A' ' 128' ' ' ARG . 1.1 mmmt -149.73 126.58 11.12 Favored 'General case' 0 C--N 1.276 -2.623 0 C-N-CA 119.462 -0.895 . . . . 0.81 109.859 -178.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.647 ' HB3' HD13 ' A' ' 127' ' ' ILE . 4.3 t -89.3 159.09 17.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.187 -0.945 . . . . 1.03 109.642 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.63 -10.65 48.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.444 -0.785 . . . . 1.4 110.362 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.507 ' C ' ' CG2' ' A' ' 104' ' ' VAL . 0.1 OUTLIER 175.1 146.05 0.07 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.814 -1.178 . . . . 3.07 110.177 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.656 ' O ' HG23 ' A' ' 105' ' ' VAL . 0.2 OUTLIER -156.68 168.36 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.556 -0.715 . . . . 0.94 109.804 -179.781 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 104' ' ' VAL . 0.9 OUTLIER 161.87 125.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.261 -1.015 . . . . 1.16 108.261 -179.934 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.483 HG22 ' HH2' ' A' ' 92' ' ' TRP . 42.6 t -119.53 96.4 4.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 120.986 -1.071 . . . . 1.75 110.664 -179.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.539 ' O ' HG23 ' A' ' 108' ' ' VAL . 7.4 m -105.43 150.56 25.16 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.246 -1.39 . . . . 0.61 107.246 178.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.546 HG12 ' N ' ' A' ' 109' ' ' LYS . 75.6 t -157.84 160.76 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 C-N-CA 118.281 -1.368 . . . . 1.14 111.545 -178.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.546 ' N ' HG12 ' A' ' 108' ' ' VAL . 1.8 ttpt 177.54 126.39 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.524 -0.917 . . . . 1.16 108.524 178.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.492 ' HB3' ' HB2' ' A' ' 117' ' ' LEU . 11.5 tp -118.35 127.6 53.84 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 107.275 -1.38 . . . . 1.08 107.275 178.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.543 HD11 ' HG2' ' A' ' 109' ' ' LYS . 1.7 mt -124.97 116.93 48.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 O-C-N 121.262 -0.899 . . . . 1.09 111.503 -177.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.473 ' HA2' ' HA ' ' A' ' 50' ' ' ALA . . . -86.1 -110.1 0.78 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.122 -1.991 . . . . 0.36 108.122 177.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.407 ' O ' ' CG ' ' A' ' 113' ' ' ASP . 7.4 t70 -136.54 1.71 2.63 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.066 -1.255 . . . . 2.11 107.71 178.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.441 ' ND2' ' N ' ' A' ' 114' ' ' ASN . 0.6 OUTLIER -116.1 -20.42 9.88 Favored 'General case' 0 C--N 1.31 -1.139 0 O-C-N 121.491 -0.756 . . . . 0.65 109.601 -179.614 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 169.76 -161.32 34.63 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.35 -1.5 . . . . 0.49 109.35 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.51 HG21 ' HB3' ' A' ' 119' ' ' CYS . 2.5 p -90.8 105.34 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.101 -1.235 . . . . 0.88 109.517 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 1.089 HD22 HD12 ' A' ' 80' ' ' LEU . 1.4 mt -49.58 -53.23 25.02 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.219 -0.926 . . . . 0.81 110.8 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.559 ' HA ' ' HA ' ' A' ' 9' ' ' ALA . . . -158.24 129.08 6.33 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.219 -0.926 . . . . 2.13 110.245 -178.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 0.51 ' HB3' HG21 ' A' ' 116' ' ' VAL . 10.2 p -134.29 169.2 17.56 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.484 -0.76 . . . . 1.07 109.439 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.446 ' O ' HG13 ' A' ' 121' ' ' ILE . . . -173.31 138.75 0.73 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.375 -0.828 . . . . 0.62 109.0 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 120' ' ' ALA . 2.7 mp -139.44 132.45 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.975 -1.078 . . . . 0.49 110.437 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.466 ' O ' ' C ' ' A' ' 123' ' ' THR . . . -114.74 93.5 4.35 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.994 -1.113 . . . . 0.43 107.994 179.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.466 ' C ' ' O ' ' A' ' 122' ' ' ALA . 98.6 m -33.47 99.2 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.489 0.661 . . . . 1.74 110.835 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . 0.41 ' N ' ' O ' ' A' ' 122' ' ' ALA . 0.1 OUTLIER 53.92 176.32 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.627 -0.671 . . . . 3.54 110.111 179.704 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.498 ' O ' ' HB ' ' A' ' 104' ' ' VAL . . . -160.31 119.35 0.88 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.546 -1.422 . . . . 0.73 109.546 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.803 ' O ' HG23 ' A' ' 28' ' ' ILE . 0.4 OUTLIER -128.61 104.72 7.83 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.14 -1.212 . . . . 2.02 109.461 -179.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.647 HD13 ' HB3' ' A' ' 101' ' ' SER . 2.8 mp -54.77 157.26 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.249 -0.907 . . . . 1.33 109.28 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.648 ' CB ' ' HD3' ' A' ' 100' ' ' LYS . 0.0 OUTLIER 134.66 -86.2 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.446 0 N-CA-C 108.266 -1.013 . . . . 3.85 108.266 179.37 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.62 ' C ' HG21 ' A' ' 28' ' ' ILE . 1.7 t0 . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 118.077 -0.963 . . . . 2.65 109.543 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 1' ' ' ASP . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.484 0.659 . . . . 2.31 109.817 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.574 ' HA ' ' HB3' ' A' ' 17' ' ' MET . 66.7 mt-30 53.99 -179.31 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.888 0.852 . . . . 3.85 110.887 178.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.852 HG13 ' N ' ' A' ' 4' ' ' ASP . 0.8 OUTLIER -170.94 -155.26 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 108.78 -0.822 . . . . 3.59 108.78 179.85 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.852 ' N ' HG13 ' A' ' 3' ' ' VAL . 17.7 m-20 -146.58 114.95 6.69 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.9 -1.125 . . . . 3.12 110.245 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.49 HG23 ' OD1' ' A' ' 7' ' ' ASP . 15.7 m -142.21 146.42 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 120.965 -1.085 . . . . 0.85 109.792 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.488 ' O ' HG12 ' A' ' 121' ' ' ILE . 8.5 mmtt -69.59 105.3 2.62 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.319 -0.863 . . . . 3.48 109.877 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.49 ' OD1' HG23 ' A' ' 5' ' ' VAL . 0.8 OUTLIER -95.91 167.42 11.26 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.145 -0.972 . . . . 3.44 108.641 179.335 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.561 ' HB2' HG21 ' A' ' 116' ' ' VAL . 6.3 m -140.07 7.98 2.26 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.052 -1.03 . . . . 1.19 109.755 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.529 ' CA ' ' HA ' ' A' ' 118' ' ' ALA . . . -49.62 -75.34 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.163 -0.961 . . . . 0.94 109.587 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.449 ' CB ' ' O ' ' A' ' 9' ' ' ALA . 0.9 OUTLIER 167.34 37.29 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.885 -0.783 . . . . 1.5 108.885 -178.478 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 58.41 26.27 13.93 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.908 -1.145 . . . . 2.72 107.908 -178.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.484 ' O ' ' C ' ' A' ' 13' ' ' ILE . 0.3 OUTLIER -116.98 -21.72 8.79 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.507 -0.746 . . . . 2.59 110.414 -179.16 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.88 HG23 ' O ' ' A' ' 40' ' ' LEU . 5.7 mt -43.09 139.87 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 108.144 -1.058 . . . . 1.15 108.144 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.27 -25.59 16.97 Favored 'General case' 0 C--N 1.292 -1.931 0 O-C-N 121.513 -0.742 . . . . 2.1 109.585 -178.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.7 mtmt -167.48 105.51 0.54 Allowed 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 118.006 -1.478 . . . . 1.34 111.981 -178.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.53 ' HA ' ' HA ' ' A' ' 39' ' ' ALA . 2.2 p -116.97 94.72 3.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 N-CA-C 106.152 -1.795 . . . . 0.94 106.152 177.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.574 ' HB3' ' HA ' ' A' ' 2' ' ' GLN . 12.3 mmt -132.46 142.51 49.27 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.558 -0.713 . . . . 3.13 111.392 -176.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.668 HG13 ' HG ' ' A' ' 37' ' ' LEU . 16.7 t -110.84 141.02 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 107.935 -1.135 . . . . 1.2 107.935 178.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.47 ' HB3' ' HA ' ' A' ' 35' ' ' PHE . 7.4 t70 -62.95 -40.93 99.16 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.094 -1.004 . . . . 2.52 110.538 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.542 ' O ' ' CB ' ' A' ' 21' ' ' CYS . . . -156.01 139.82 6.84 Favored Glycine 0 N--CA 1.489 2.212 0 C-N-CA 119.351 -1.404 . . . . 1.57 110.286 -179.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.897 ' CA ' HG23 ' A' ' 29' ' ' ILE . 0.0 OUTLIER 155.01 -56.76 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.572 -0.958 . . . . 0.84 108.812 179.288 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.614 ' HA ' HG23 ' A' ' 3' ' ' VAL . 1.6 t60 80.66 120.57 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 107.689 -1.226 . . . . 2.98 107.689 -177.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.735 ' H ' HG22 ' A' ' 3' ' ' VAL . . . -106.26 -166.88 22.97 Favored Glycine 0 N--CA 1.493 2.481 0 C-N-CA 119.25 -1.453 . . . . 0.76 111.341 -178.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.439 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 0.5 OUTLIER 69.86 -87.9 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.499 -1.0 . . . . 0.86 108.602 -179.241 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.653 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 3.0 p-10 -63.66 -163.61 0.01 OUTLIER Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 107.14 -1.43 . . . . 1.35 107.14 178.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.653 ' HD2' ' CB ' ' A' ' 25' ' ' ASP . 29.6 Cg_endo -72.32 106.09 1.99 Allowed 'Trans proline' 0 C--N 1.313 -1.323 0 N-CA-C 108.545 -1.367 . . . . 1.63 108.545 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.533 ' HB2' ' O ' ' A' ' 22' ' ' HIS . 1.3 t -62.44 92.47 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.756 -0.59 . . . . 0.96 112.579 -176.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.549 HD12 ' O ' ' A' ' 26' ' ' PRO . 1.7 mp -91.1 135.0 27.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 105.182 -2.155 . . . . 1.97 105.182 174.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.897 HG23 ' CA ' ' A' ' 21' ' ' CYS . 0.1 OUTLIER -108.82 173.79 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.196 0 O-C-N 120.666 -1.272 . . . . 0.46 111.147 -177.476 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.429 ' O ' ' CZ ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -102.43 132.51 48.4 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 122.2 1.0 . . . . 3.23 111.708 -178.467 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.724 ' HD3' ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -99.21 109.9 22.51 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 115.634 -0.712 . . . . 9.23 109.265 179.21 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' A' ' 95' ' ' PRO . . . 136.18 0.71 3.02 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.556 -1.307 . . . . 1.28 110.336 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.502 ' C ' ' HB ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -139.32 139.07 21.72 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 120.868 -1.372 . . . . 2.41 109.631 179.891 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.412 ' HA ' ' HB ' ' A' ' 94' ' ' VAL . 30.5 Cg_endo -70.99 123.32 9.59 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.713 2.275 . . . . 2.47 110.224 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.47 ' HA ' ' HB3' ' A' ' 19' ' ' ASP . 19.6 m-30 -103.91 -164.65 1.08 Allowed 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.777 0.799 . . . . 7.1 110.32 -178.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.72 HG22 ' O ' ' A' ' 36' ' ' THR . 1.3 m -179.84 90.36 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.679 -0.86 . . . . 0.7 108.679 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.668 ' HG ' HG13 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -57.35 152.7 13.71 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.086 -1.009 . . . . 3.84 108.438 179.729 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.53 ' HG3' ' O ' ' A' ' 36' ' ' THR . 72.8 mt-10 -154.13 176.6 12.05 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.89 -1.131 . . . . 0.42 111.015 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.53 ' HA ' ' HA ' ' A' ' 16' ' ' VAL . . . 168.71 85.89 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.252 -1.388 . . . . 0.62 107.252 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.88 ' O ' HG23 ' A' ' 13' ' ' ILE . 4.3 mp -88.22 144.52 26.4 Favored 'General case' 0 C--N 1.291 -1.97 0 O-C-N 121.85 -0.531 . . . . 1.11 110.095 -178.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.801 ' CE2' ' CD2' ' A' ' 86' ' ' TYR . 0.1 OUTLIER -136.2 174.69 10.34 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.942 -1.099 . . . . 0.89 108.26 176.841 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.495 ' O ' ' C ' ' A' ' 43' ' ' ALA . 0.2 OUTLIER -126.24 102.24 7.1 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 106.651 -1.611 . . . . 2.76 106.651 178.582 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.887 ' HB1' ' O ' ' A' ' 81' ' ' VAL . . . -34.79 117.59 0.38 Allowed 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 115.548 -0.751 . . . . 0.38 109.33 -179.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.492 ' O ' ' HB3' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -126.8 0.15 6.69 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.36 0.6 . . . . 0.63 109.68 -178.473 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.971 ' OE1' HD21 ' A' ' 117' ' ' LEU . 3.3 pt20 -90.86 -141.64 0.17 Allowed 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.405 -0.961 . . . . 0.9 108.405 179.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.827 ' HA ' ' HB ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -156.86 71.76 0.69 Allowed 'General case' 0 C--N 1.293 -1.848 0 O-C-N 120.962 -1.086 . . . . 0.9 109.641 178.94 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.715 HG23 ' O ' ' A' ' 47' ' ' THR . 7.5 t -150.33 122.19 8.15 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.17 -1.581 . . . . 1.14 111.003 -178.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.636 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 1.7 mtpt -69.17 -17.97 63.87 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.89 -1.131 . . . . 3.32 109.131 178.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.474 ' OG1' ' OG1' ' A' ' 47' ' ' THR . 1.1 p -76.32 176.41 8.18 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.16 -0.963 . . . . 1.33 109.719 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.774 ' HB1' ' HB3' ' A' ' 72' ' ' ALA . . . -176.23 136.89 0.29 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.242 -0.911 . . . . 0.6 109.962 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 1.059 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -121.1 -156.26 0.67 Allowed 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.723 -1.214 . . . . 2.4 107.723 178.393 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.521 ' CG1' HD13 ' A' ' 54' ' ' ILE . 17.3 tt -175.31 165.59 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 C-N-CA 118.616 -1.234 . . . . 0.42 111.293 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.542 ' C ' HD12 ' A' ' 54' ' ' ILE . 0.4 OUTLIER -168.09 68.94 0.08 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.718 -0.845 . . . . 3.18 108.718 179.778 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.978 HG21 ' CZ ' ' A' ' 90' ' ' TYR . 0.7 OUTLIER -109.17 149.76 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.308 -0.87 . . . . 0.62 110.066 -178.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.606 ' HG3' ' O ' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -164.98 100.73 0.76 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.331 -0.856 . . . . 1.43 109.602 178.16 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.516 ' HB3' ' HB ' ' A' ' 63' ' ' ILE . . . -106.74 147.9 29.07 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.114 -0.991 . . . . 0.95 108.375 178.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.546 ' HA ' ' HA ' ' A' ' 62' ' ' GLU . 37.2 t -132.5 129.12 38.73 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.868 -1.145 . . . . 1.7 110.315 -179.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.668 HD22 ' H ' ' A' ' 59' ' ' ASP . 0.1 OUTLIER -114.15 -152.13 0.5 Allowed 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.081 -1.081 . . . . 3.28 108.081 179.42 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.668 ' H ' HD22 ' A' ' 58' ' ' LEU . 48.4 t0 -106.72 87.73 2.59 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.71 -1.244 . . . . 4.15 108.403 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.71 -6.93 62.94 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 108.326 -1.91 . . . . 1.94 108.326 -178.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -128.02 49.66 2.13 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 107.581 -1.266 . . . . 1.28 107.581 179.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.546 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 1.8 tt0 -59.65 91.24 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.862 -0.524 . . . . 3.43 109.967 -179.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.591 HG21 ' HD2' ' A' ' 90' ' ' TYR . 8.3 mt -55.98 159.85 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 C-N-CA 118.773 -1.171 . . . . 1.27 107.952 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.431 ' C ' ' OD1' ' A' ' 64' ' ' ASP . 40.2 p-10 -156.27 162.92 40.08 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.174 -0.954 . . . . 5.12 110.202 -179.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.719 HG21 ' HB ' ' A' ' 54' ' ' ILE . 35.4 t -146.92 66.37 10.42 Favored Pre-proline 0 C--N 1.303 -1.442 0 O-C-N 121.499 -0.751 . . . . 1.77 109.11 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.523 ' O ' ' C ' ' A' ' 67' ' ' GLY . 37.3 Cg_endo -80.25 102.72 1.46 Allowed 'Trans proline' 0 C--N 1.3 -1.979 0 C-N-CA 123.329 2.686 . . . . 4.47 111.34 -179.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.523 ' C ' ' O ' ' A' ' 66' ' ' PRO . . . 22.99 51.8 0.02 OUTLIER Glycine 0 N--CA 1.5 2.914 0 N-CA-C 111.511 -0.635 . . . . 1.13 111.511 179.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.415 ' N ' ' O ' ' A' ' 66' ' ' PRO . 6.6 mt -60.73 -81.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.072 -1.252 . . . . 2.74 109.442 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.625 ' HB3' ' CG ' ' A' ' 74' ' ' HIS . 52.3 p30 -68.69 -167.62 0.1 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.342 -0.849 . . . . 2.25 109.957 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.462 ' O ' ' OD1' ' A' ' 71' ' ' ASN . 1.1 p -111.11 5.1 19.88 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.982 -0.747 . . . . 1.07 108.982 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.543 ' CA ' ' O ' ' A' ' 50' ' ' ALA . 2.2 m-20 172.95 69.1 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.177 -0.952 . . . . 1.36 110.972 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 1.059 ' HB2' ' O ' ' A' ' 51' ' ' LYS . . . 38.75 23.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 112.627 0.602 . . . . 0.45 112.627 177.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.508 ' N ' ' O ' ' A' ' 71' ' ' ASN . 22.9 t -99.19 4.56 46.8 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.651 -1.281 . . . . 1.74 111.422 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.625 ' CG ' ' HB3' ' A' ' 69' ' ' ASP . 4.2 m170 -95.63 -18.25 20.69 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.419 -1.425 . . . . 2.67 109.56 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.513 ' CD1' ' N ' ' A' ' 75' ' ' PHE . 5.4 m-85 -97.85 -26.69 14.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.346 -0.846 . . . . 2.23 108.884 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 1.278 HG21 ' CZ ' ' A' ' 86' ' ' TYR . 15.4 m -147.48 -139.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.811 -0.811 . . . . 3.16 108.811 -178.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.736 ' N ' HG23 ' A' ' 76' ' ' VAL . 15.0 mmmt -93.03 162.74 13.92 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.141 -1.429 . . . . 4.16 107.141 177.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . 0.53 ' N ' ' HD2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -83.16 -51.3 0.67 Allowed Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 120.469 -1.394 . . . . 1.15 109.949 -179.829 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.636 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 29.1 Cg_endo -76.77 120.7 5.6 Favored 'Trans proline' 0 C--N 1.302 -1.918 0 N-CA-C 108.447 -1.405 . . . . 1.14 108.447 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 1.061 HD12 HD22 ' A' ' 117' ' ' LEU . 0.3 OUTLIER -98.19 -67.38 0.85 Allowed 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.918 -1.142 . . . . 1.15 107.918 -178.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.887 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 1.4 m 41.26 -167.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 C-N-CA 120.353 -0.539 . . . . 0.62 109.872 177.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.737 ' H ' HG23 ' A' ' 81' ' ' VAL . 0.6 OUTLIER -99.96 42.23 1.12 Allowed 'General case' 0 C--N 1.293 -1.881 0 O-C-N 120.529 -1.357 . . . . 3.32 110.195 -177.4 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -148.79 44.78 0.74 Allowed Glycine 0 C--N 1.288 -2.12 0 N-CA-C 109.152 -1.579 . . . . 0.64 109.152 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -152.47 162.33 41.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.057 -1.26 . . . . 4.89 110.259 -179.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -117.26 141.63 48.06 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.099 -1.074 . . . . 5.2 108.099 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 1.278 ' CZ ' HG21 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -108.33 -173.55 2.31 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.908 -1.12 . . . . 3.02 112.27 -177.542 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.65 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 2.9 t70 159.52 74.45 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.28 0 CA-C-O 121.826 0.822 . . . . 2.04 109.54 178.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.563 HG22 ' CG1' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -106.92 137.49 37.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 107.581 -1.266 . . . . 2.53 107.581 179.37 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.57 ' O ' ' CD1' ' A' ' 90' ' ' TYR . 8.6 mttt -142.88 -166.42 2.29 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.613 -1.304 . . . . 1.17 111.57 -178.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.978 ' CZ ' HG21 ' A' ' 54' ' ' ILE . 77.3 m-85 -155.86 77.83 0.97 Allowed 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 108.62 -0.881 . . . . 0.8 108.62 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.554 HG22 ' H ' ' A' ' 92' ' ' TRP . 12.4 m -45.58 171.17 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.365 -0.834 . . . . 3.04 109.533 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.618 ' CZ2' ' HG ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -150.34 107.99 3.67 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 118.97 -1.092 . . . . 2.97 111.535 -179.311 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.459 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 0.7 OUTLIER -72.8 98.93 2.52 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 106.23 -1.767 . . . . 3.32 106.23 177.042 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.978 HG13 HD13 ' A' ' 97' ' ' ILE . 69.6 t -109.74 95.56 20.55 Favored Pre-proline 0 C--N 1.301 -1.504 0 C-N-CA 119.037 -1.065 . . . . 1.22 113.159 -176.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.77 ' HD2' HD11 ' A' ' 97' ' ' ILE . 31.1 Cg_endo -75.21 -92.86 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.833 2.356 . . . . 1.09 108.441 175.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.523 ' O ' ' HB3' ' A' ' 31' ' ' ARG . 1.3 mmtp -121.06 -53.12 2.06 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 105.223 -2.14 . . . . 4.13 105.223 176.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.978 HD13 HG13 ' A' ' 94' ' ' VAL . 1.6 mp 61.35 28.8 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 112.632 0.605 . . . . 1.01 112.632 175.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.587 ' O ' ' HG3' ' A' ' 31' ' ' ARG . . . 58.64 160.52 0.09 OUTLIER Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 120.949 -1.095 . . . . 2.13 111.011 177.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.633 ' O ' ' HA ' ' A' ' 128' ' ' ARG . 46.2 Cg_endo -84.69 4.99 6.52 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 124.087 3.191 . . . . 2.79 110.801 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.601 ' HD3' ' CB ' ' A' ' 128' ' ' ARG . 4.6 mmmt -161.78 139.27 8.74 Favored 'General case' 0 C--N 1.283 -2.285 0 C-N-CA 119.332 -0.947 . . . . 1.28 110.647 -177.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 1.063 ' CB ' HD13 ' A' ' 127' ' ' ILE . 32.3 t -109.06 2.59 21.28 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.417 -0.802 . . . . 1.55 109.043 178.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.529 ' O ' ' CB ' ' A' ' 103' ' ' ASN . 72.9 mt-10 64.54 2.05 1.5 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.557 -0.715 . . . . 5.54 110.144 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.529 ' CB ' ' O ' ' A' ' 102' ' ' GLU . 0.9 OUTLIER 163.94 152.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.02 -1.05 . . . . 3.01 109.919 179.908 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.462 ' CG2' ' C ' ' A' ' 103' ' ' ASN . 0.3 OUTLIER -153.78 168.52 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.686 -0.857 . . . . 1.76 108.686 179.52 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.425 ' O ' HG12 ' A' ' 105' ' ' VAL . 1.1 t -161.81 131.13 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.946 -1.097 . . . . 0.81 109.66 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.966 ' HB ' ' HB3' ' A' ' 122' ' ' ALA . 3.4 t -132.24 124.98 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.24 -0.913 . . . . 1.2 109.287 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.812 ' O ' HG23 ' A' ' 108' ' ' VAL . 1.9 m -147.46 156.36 42.79 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.378 -0.826 . . . . 0.68 108.838 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.812 HG23 ' O ' ' A' ' 107' ' ' THR . 7.5 t -165.9 162.76 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.146 -0.971 . . . . 0.5 109.773 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.562 ' N ' ' CG1' ' A' ' 108' ' ' VAL . 0.3 OUTLIER 174.95 139.02 0.05 OUTLIER 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.419 -0.8 . . . . 0.64 109.527 179.302 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.703 HD21 ' OH ' ' A' ' 86' ' ' TYR . 7.7 tp -126.57 129.28 48.26 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.289 -1.374 . . . . 0.78 107.289 178.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 12.5 mt -125.03 128.18 72.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 121.189 -0.945 . . . . 0.69 111.283 -177.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.41 ' HA3' HG21 ' A' ' 47' ' ' THR . . . -103.51 -114.16 3.9 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 107.443 -2.263 . . . . 1.19 107.443 177.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -137.64 4.35 2.58 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.138 -1.431 . . . . 1.21 107.138 177.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.446 ' ND2' ' N ' ' A' ' 114' ' ' ASN . 0.7 OUTLIER -124.03 13.92 9.12 Favored 'General case' 0 C--N 1.308 -1.238 0 O-C-N 121.545 -0.722 . . . . 1.13 109.402 -179.688 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 132.77 -158.97 23.32 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.653 -1.379 . . . . 0.67 109.653 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.561 HG21 ' HB2' ' A' ' 8' ' ' CYS . 0.2 OUTLIER -99.37 117.04 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.296 -1.12 . . . . 0.51 109.394 179.702 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 1.061 HD22 HD12 ' A' ' 80' ' ' LEU . 1.3 mt -61.63 -41.49 97.56 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.606 -0.684 . . . . 0.8 110.875 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.529 ' HA ' ' CA ' ' A' ' 9' ' ' ALA . . . -168.51 136.16 2.08 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.114 -0.991 . . . . 1.66 110.235 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 0.548 ' SG ' ' N ' ' A' ' 8' ' ' CYS . 0.5 OUTLIER -137.32 177.72 7.65 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.533 -0.729 . . . . 0.95 109.452 179.852 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.591 ' C ' HD13 ' A' ' 121' ' ' ILE . . . -173.95 123.49 0.33 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.238 -0.914 . . . . 0.39 108.804 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.591 HD13 ' C ' ' A' ' 120' ' ' ALA . 0.0 OUTLIER -127.48 140.87 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.055 -1.028 . . . . 1.69 111.429 -178.633 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.966 ' HB3' ' HB ' ' A' ' 106' ' ' VAL . . . -119.37 136.52 54.24 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.771 -1.196 . . . . 1.61 107.771 177.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.412 ' O ' ' O ' ' A' ' 124' ' ' HIS . 17.7 m -89.62 94.69 9.95 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.813 -1.18 . . . . 1.22 110.695 -178.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . 0.412 ' O ' ' O ' ' A' ' 123' ' ' THR . 1.6 t60 54.26 166.04 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.693 0.758 . . . . 3.52 110.991 178.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -156.05 170.22 33.75 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 108.348 -1.901 . . . . 2.11 108.348 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.54 ' HB2' HG13 ' A' ' 28' ' ' ILE . 0.4 OUTLIER -150.65 81.37 1.34 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.766 -1.432 . . . . 1.67 109.806 -179.932 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 1.063 HD13 ' CB ' ' A' ' 101' ' ' SER . 3.3 mp -41.63 138.07 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.65 -0.656 . . . . 0.82 110.573 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.674 ' HB3' ' O ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER 167.4 -165.58 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 122.274 1.035 . . . . 1.92 111.266 177.76 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.615 ' N ' ' CG ' ' A' ' 128' ' ' ARG . 3.5 m-20 . . . . . 0 C--N 1.299 -1.604 0 CA-C-O 117.982 -1.009 . . . . 6.87 109.703 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . 0.473 ' O ' ' HB3' ' A' ' 17' ' ' MET . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 121.358 0.599 . . . . 4.64 109.728 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.523 ' HB3' ' HG2' ' A' ' 17' ' ' MET . 1.3 pt20 -105.33 34.78 3.09 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.316 -0.994 . . . . 3.69 108.316 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.678 HG11 ' HA ' ' A' ' 22' ' ' HIS . 0.6 OUTLIER -28.51 123.51 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 CA-C-O 121.487 0.66 . . . . 2.07 110.239 -179.672 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -65.23 154.08 39.14 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.451 -0.781 . . . . 3.65 110.408 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.418 HG12 ' O ' ' A' ' 121' ' ' ILE . 0.0 OUTLIER -154.88 170.55 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.446 -0.946 . . . . 1.52 108.446 179.571 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.474 ' HB3' HD12 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -77.24 92.77 3.89 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.889 -1.132 . . . . 5.93 109.499 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' A' ' 119' ' ' CYS . 0.7 OUTLIER -88.13 -177.7 5.78 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.284 -0.885 . . . . 2.97 109.134 179.806 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.492 ' O ' ' C ' ' A' ' 9' ' ' ALA . 37.4 m -151.04 -29.55 0.19 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.198 -0.939 . . . . 2.29 110.794 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.547 ' CA ' ' HA ' ' A' ' 118' ' ' ALA . . . -32.8 -77.23 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.425 -0.797 . . . . 1.3 110.938 -179.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.467 ' OD1' ' O ' ' A' ' 9' ' ' ALA . 0.9 OUTLIER 175.33 -77.33 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.415 -0.803 . . . . 3.19 109.265 -178.747 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.459 ' HB3' ' O ' ' A' ' 10' ' ' ASN . 17.8 p-10 173.56 36.28 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.523 -0.918 . . . . 4.04 108.523 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.443 ' O ' ' C ' ' A' ' 13' ' ' ILE . 0.3 OUTLIER -129.18 -4.77 4.94 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.386 -0.821 . . . . 1.77 109.78 -179.507 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.953 HG23 ' O ' ' A' ' 40' ' ' LEU . 18.5 mt -43.97 148.48 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.221 -0.924 . . . . 0.99 109.091 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.427 ' HE2' ' OD2' ' A' ' 42' ' ' ASP . 2.0 mmtt -96.86 -17.7 20.01 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.921 -0.77 . . . . 1.72 108.921 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.738 ' H ' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -170.03 100.89 0.29 Allowed 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 119.211 -0.995 . . . . 1.95 110.404 -178.164 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.558 ' HB ' HG21 ' A' ' 13' ' ' ILE . 1.4 p -124.75 97.09 4.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 107.897 -1.149 . . . . 1.25 107.897 179.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.523 ' HG2' ' HB3' ' A' ' 2' ' ' GLN . 2.4 mpt? -150.77 155.45 39.29 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.127 -0.983 . . . . 1.64 110.793 -178.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.591 HG13 ' HA ' ' A' ' 37' ' ' LEU . 2.1 t -112.06 128.9 68.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 106.982 -1.488 . . . . 1.29 106.982 178.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.534 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -87.75 89.29 7.94 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.852 -1.155 . . . . 2.67 111.191 -177.848 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.509 ' O ' ' CB ' ' A' ' 21' ' ' CYS . . . 90.6 112.41 1.59 Allowed Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.816 -1.183 . . . . 0.92 110.879 178.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.87 ' HA ' HG23 ' A' ' 29' ' ' ILE . 0.0 OUTLIER 159.12 -50.37 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.445 -1.032 . . . . 0.8 109.436 179.002 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.678 ' HA ' HG11 ' A' ' 3' ' ' VAL . 2.3 m-70 85.19 118.72 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 109.267 -0.642 . . . . 4.83 109.267 -178.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.448 ' O ' ' HB2' ' A' ' 24' ' ' SER . . . -95.74 -176.91 36.85 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 109.752 -1.339 . . . . 1.02 109.752 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.496 ' O ' ' O ' ' A' ' 25' ' ' ASP . 15.0 m 60.19 -89.41 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.236 -1.155 . . . . 1.48 109.414 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.638 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.2 OUTLIER -50.68 -176.56 0.02 OUTLIER Pre-proline 0 C--N 1.304 -1.37 0 N-CA-C 108.149 -1.056 . . . . 1.39 108.149 179.244 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.638 ' HD2' ' CB ' ' A' ' 25' ' ' ASP . 28.4 Cg_endo -70.24 82.9 0.81 Allowed 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 121.889 1.726 . . . . 1.6 109.29 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.54 ' HA ' ' O ' ' A' ' 22' ' ' HIS . 2.3 t -31.69 89.54 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 115.297 -0.865 . . . . 1.21 112.415 -178.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.492 HG21 ' C ' ' A' ' 129' ' ' ASP . 28.7 mm -90.6 132.37 35.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 104.783 -2.303 . . . . 1.16 104.783 175.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.87 HG23 ' HA ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -109.52 179.07 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.291 0 C-N-CA 118.666 -1.213 . . . . 0.66 111.319 -176.86 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.597 ' HE2' ' CE1' ' A' ' 22' ' ' HIS . 2.3 m-70 -128.08 154.34 45.81 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 119.767 -0.773 . . . . 0.59 110.881 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.545 ' CB ' ' O ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -100.54 155.54 17.79 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.886 -1.153 . . . . 4.6 107.886 178.404 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.22 0.79 76.52 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.84 -1.304 . . . . 0.85 109.84 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.713 ' N ' HG11 ' A' ' 94' ' ' VAL . 2.1 mtmm -129.66 145.7 58.07 Favored Pre-proline 0 N--CA 1.493 1.71 0 N-CA-C 107.564 -1.273 . . . . 1.68 107.564 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -71.35 82.71 1.07 Allowed 'Trans proline' 0 C--N 1.303 -1.846 0 C-N-CA 122.354 2.036 . . . . 1.07 112.152 -177.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.534 ' HA ' ' O ' ' A' ' 19' ' ' ASP . 12.3 t80 -52.01 114.13 1.22 Allowed 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 107.352 -1.351 . . . . 2.22 107.352 178.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.62 HG22 ' O ' ' A' ' 36' ' ' THR . 7.4 m -132.53 88.8 2.57 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 118.892 -1.123 . . . . 1.9 111.3 -178.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.683 HD12 ' C ' ' A' ' 37' ' ' LEU . 0.8 OUTLIER -80.56 126.48 31.3 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.236 -1.394 . . . . 2.21 107.236 177.975 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.582 ' CG ' HG22 ' A' ' 36' ' ' THR . 0.0 OUTLIER -140.22 -163.5 1.53 Allowed 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.578 -1.327 . . . . 3.2 110.728 -178.274 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.461 ' HB2' ' O ' ' A' ' 38' ' ' GLU . . . 170.02 101.65 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.886 -1.153 . . . . 1.07 107.886 179.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.953 ' O ' HG23 ' A' ' 13' ' ' ILE . 1.5 mp -93.29 173.17 7.85 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.295 -0.878 . . . . 0.71 109.818 -178.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.636 ' CE1' ' CE2' ' A' ' 86' ' ' TYR . 10.6 p90 175.05 139.9 0.05 OUTLIER 'General case' 0 C--N 1.305 -1.333 0 O-C-N 120.955 -1.09 . . . . 0.49 109.298 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.53 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 3.9 m-20 -86.28 108.49 18.42 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 107.334 -1.358 . . . . 3.65 107.334 178.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.736 ' HB1' ' O ' ' A' ' 81' ' ' VAL . . . -32.94 127.9 0.28 Allowed 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.727 -0.669 . . . . 0.31 109.602 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -122.58 1.65 9.51 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.221 -0.925 . . . . 1.04 110.221 -178.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.981 ' OE1' HD21 ' A' ' 117' ' ' LEU . 1.9 pt20 -93.53 -142.17 0.22 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.259 -0.9 . . . . 0.61 108.657 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.808 ' HA ' ' HB ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -154.31 66.66 0.71 Allowed 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.331 -0.856 . . . . 1.03 109.084 178.266 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.651 HG23 ' O ' ' A' ' 47' ' ' THR . 8.8 t -140.73 126.22 18.89 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.143 -1.598 . . . . 0.86 112.081 -177.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.667 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -72.19 -2.11 17.55 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.749 -1.219 . . . . 0.99 110.099 178.463 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.4 p -115.98 -175.44 2.73 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.906 -1.121 . . . . 2.19 111.546 -178.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 1.076 ' CB ' ' HB3' ' A' ' 72' ' ' ALA . . . -153.54 170.39 20.91 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.641 -0.874 . . . . 1.22 108.641 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.509 ' HG2' ' C ' ' A' ' 50' ' ' ALA . 0.4 OUTLIER -152.53 28.27 0.56 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.775 -1.203 . . . . 3.16 109.26 179.892 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.755 ' H ' ' HB2' ' A' ' 72' ' ' ALA . 20.5 tt -29.12 155.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.285 -2.23 0 CA-C-O 122.02 0.914 . . . . 1.68 112.206 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.463 ' O ' ' HB ' ' A' ' 54' ' ' ILE . 4.5 tt0 -117.06 -69.92 0.82 Allowed 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.005 -1.109 . . . . 3.13 108.005 178.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.697 HD12 HG13 ' A' ' 108' ' ' VAL . 0.3 OUTLIER 59.25 150.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.412 -0.805 . . . . 1.0 111.065 178.105 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.672 ' HG3' ' O ' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -178.23 94.08 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.976 -0.75 . . . . 1.4 108.976 178.373 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 105' ' ' VAL . . . -120.43 160.76 22.45 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.915 -1.115 . . . . 1.31 109.221 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.485 ' HB3' HG23 ' A' ' 105' ' ' VAL . 0.1 OUTLIER -130.19 123.89 31.31 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.97 -1.081 . . . . 1.55 109.789 -179.754 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.996 HD12 ' CZ2' ' A' ' 92' ' ' TRP . 0.1 OUTLIER -102.63 -147.99 0.38 Allowed 'General case' 0 N--CA 1.484 1.226 0 O-C-N 121.089 -1.007 . . . . 2.77 108.561 179.898 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.666 ' H ' HD13 ' A' ' 58' ' ' LEU . 24.2 t0 -94.11 81.62 4.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.067 -1.021 . . . . 3.32 109.084 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.5 1.63 90.19 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 108.936 -1.665 . . . . 4.17 108.936 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.413 ' O ' ' C ' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -115.25 57.1 0.73 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.331 -1.099 . . . . 3.1 108.566 179.606 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 61' ' ' LEU . 0.9 OUTLIER -40.79 115.9 0.64 Allowed 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 121.353 0.597 . . . . 2.58 110.724 -179.291 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.559 ' CG2' ' O ' ' A' ' 63' ' ' ILE . 0.5 OUTLIER -76.4 -3.11 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-O 122.125 0.964 . . . . 2.48 108.673 177.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.501 ' C ' ' O ' ' A' ' 63' ' ' ILE . 29.7 m-20 -25.6 134.56 0.02 OUTLIER 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 115.199 -0.91 . . . . 3.18 111.649 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.6 HG21 ' CG2' ' A' ' 54' ' ' ILE . 93.6 t -113.67 92.91 26.0 Favored Pre-proline 0 C--N 1.302 -1.476 0 N-CA-C 108.373 -0.973 . . . . 1.32 108.373 179.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 64' ' ' ASP . 36.4 Cg_endo -75.52 -94.84 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.535 2.157 . . . . 1.26 110.528 -178.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 68' ' ' ILE . . . -134.2 48.72 0.93 Allowed Glycine 0 N--CA 1.488 2.121 0 N-CA-C 110.108 -1.197 . . . . 2.07 110.108 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.429 ' O ' ' O ' ' A' ' 67' ' ' GLY . 13.5 mm -58.28 -104.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.148 -1.207 . . . . 1.34 108.63 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.489 ' OD2' ' HB2' ' A' ' 74' ' ' HIS . 0.4 OUTLIER -79.65 133.75 36.41 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.466 -1.396 . . . . 5.24 108.043 178.622 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.8 t -67.6 -13.84 62.42 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.254 -0.904 . . . . 5.26 111.864 -177.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.521 ' O ' ' N ' ' A' ' 73' ' ' CYS . 4.9 m-20 -138.28 49.42 1.92 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.328 -1.483 . . . . 0.84 111.803 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 1.076 ' HB3' ' CB ' ' A' ' 50' ' ' ALA . . . 40.67 19.48 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.843 0 O-C-N 121.116 -0.99 . . . . 1.39 112.879 176.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.521 ' N ' ' O ' ' A' ' 71' ' ' ASN . 80.8 m -68.45 -59.88 2.84 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 119.845 -1.784 . . . . 2.26 110.256 -179.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.489 ' HB2' ' OD2' ' A' ' 69' ' ' ASP . 11.9 t-160 -53.06 -27.25 19.08 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.321 -0.862 . . . . 2.96 111.025 -178.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.588 ' HB3' HD11 ' A' ' 88' ' ' ILE . 31.0 m-85 -83.95 -25.85 29.74 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.039 -1.038 . . . . 1.47 110.83 -179.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.795 ' HB ' ' CE1' ' A' ' 86' ' ' TYR . 0.2 OUTLIER -158.19 171.87 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 120.749 -1.22 . . . . 0.6 111.041 -177.961 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.658 ' N ' ' CG2' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -59.29 94.06 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 105.709 -1.96 . . . . 3.21 105.709 176.148 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . 0.516 ' SG ' ' O ' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -37.02 -51.85 2.11 Favored Pre-proline 0 C--N 1.297 -1.683 0 O-C-N 121.67 -0.644 . . . . 3.27 111.565 -177.182 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.667 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 29.6 Cg_endo -73.4 103.12 1.57 Allowed 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 120.886 1.058 . . . . 0.83 109.544 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.936 HD22 HD22 ' A' ' 117' ' ' LEU . 0.5 OUTLIER -97.85 -62.64 1.22 Allowed 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.99 -0.744 . . . . 2.48 108.99 -178.812 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.808 ' HB ' ' HA ' ' A' ' 46' ' ' ASN . 1.5 m 40.16 -166.64 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-N 116.176 -0.465 . . . . 0.76 109.846 178.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.729 ' H ' HG23 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -104.91 42.22 1.24 Allowed 'General case' 0 C--N 1.289 -2.036 0 O-C-N 120.302 -1.499 . . . . 1.65 110.126 -177.089 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -146.92 31.73 1.45 Allowed Glycine 0 C--N 1.288 -2.115 0 N-CA-C 109.439 -1.464 . . . . 0.6 109.439 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -153.46 132.12 12.27 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 120.89 -1.359 . . . . 3.15 110.554 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.53 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 3.6 pt20 -104.22 132.99 49.88 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 106.447 -1.686 . . . . 4.21 106.447 177.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.798 ' CE2' HD21 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -152.09 169.15 23.09 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 118.241 -1.383 . . . . 0.48 109.709 -178.377 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.614 ' CB ' ' HG ' ' A' ' 40' ' ' LEU . 6.9 p-10 -134.0 91.86 2.87 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.71 -1.243 . . . . 0.39 113.669 -175.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.588 HD11 ' HB3' ' A' ' 75' ' ' PHE . 4.4 tp -57.84 -172.3 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 106.333 -1.729 . . . . 1.06 106.333 175.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.577 ' O ' ' CD2' ' A' ' 90' ' ' TYR . 12.7 mttt 167.03 174.37 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.393 -1.442 . . . . 1.48 112.049 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.577 ' CD2' ' O ' ' A' ' 89' ' ' LYS . 82.5 m-85 -158.86 44.97 0.28 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.111 -1.07 . . . . 0.62 108.111 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.488 ' HA ' ' OG1' ' A' ' 36' ' ' THR . 74.4 p -51.94 -168.96 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.771 -0.581 . . . . 2.79 110.19 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.996 ' CZ2' HD12 ' A' ' 58' ' ' LEU . 1.4 t90 176.55 90.73 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.303 0 O-C-N 121.091 -1.006 . . . . 4.74 110.683 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.417 ' C ' ' O ' ' A' ' 92' ' ' TRP . 20.5 t-20 -49.47 98.53 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 106.463 -1.68 . . . . 4.71 106.463 178.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.903 HG13 ' CD1' ' A' ' 97' ' ' ILE . 1.0 OUTLIER -79.73 125.36 82.52 Favored Pre-proline 0 C--N 1.298 -1.635 0 O-C-N 121.343 -0.848 . . . . 1.36 112.297 -176.614 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.708 ' HD2' HD11 ' A' ' 97' ' ' ILE . 34.3 Cg_endo -82.62 -84.68 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 123.347 2.698 . . . . 1.54 108.853 176.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.545 ' O ' ' CB ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -138.05 -51.17 0.6 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 106.155 -1.794 . . . . 1.24 106.155 178.241 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.903 ' CD1' HG13 ' A' ' 94' ' ' VAL . 1.4 mp 62.81 5.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.756 -0.59 . . . . 1.52 111.956 176.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 1.012 ' HB1' ' HD2' ' A' ' 99' ' ' PRO . . . 51.87 173.63 0.03 OUTLIER Pre-proline 0 C--N 1.305 -1.346 0 O-C-N 120.778 -1.201 . . . . 1.73 110.176 179.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 1.012 ' HD2' ' HB1' ' A' ' 98' ' ' ALA . 50.1 Cg_endo -82.34 149.25 14.94 Favored 'Trans proline' 0 C--N 1.301 -1.928 0 C-N-CA 123.658 2.905 . . . . 1.72 109.744 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.626 ' HD3' ' CB ' ' A' ' 128' ' ' ARG . 1.1 mmmp? 55.79 114.56 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.033 0 C-N-CA 119.454 -0.899 . . . . 2.22 111.063 176.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 1.007 ' HB2' HD13 ' A' ' 127' ' ' ILE . 3.2 m -93.87 166.23 12.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.16 -0.962 . . . . 2.01 109.149 179.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.415 ' O ' ' CB ' ' A' ' 103' ' ' ASN . 0.2 OUTLIER -53.59 -19.08 3.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.278 -0.889 . . . . 2.49 109.139 179.603 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.459 ' O ' ' OG ' ' A' ' 57' ' ' SER . 0.5 OUTLIER 168.67 154.06 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.554 -0.906 . . . . 0.98 108.554 -179.996 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.949 HG21 HD12 ' A' ' 127' ' ' ILE . 0.1 OUTLIER -147.05 134.67 14.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 120.903 -1.123 . . . . 1.24 110.402 -179.649 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.485 HG23 ' HB3' ' A' ' 57' ' ' SER . 0.2 OUTLIER -155.01 145.47 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 107.973 -1.121 . . . . 2.21 107.973 179.629 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.563 ' HB ' ' HB3' ' A' ' 122' ' ' ALA . 71.1 t -129.01 128.96 67.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 120.641 -1.287 . . . . 1.06 110.401 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.504 ' O ' HG22 ' A' ' 108' ' ' VAL . 0.3 OUTLIER -150.43 140.56 22.11 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.19 -1.041 . . . . 0.63 108.19 179.305 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.697 HG13 HD12 ' A' ' 54' ' ' ILE . 2.4 t -157.16 156.75 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.748 -1.22 . . . . 1.69 110.463 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.513 ' HA ' ' HA ' ' A' ' 119' ' ' CYS . 0.1 OUTLIER 177.96 119.42 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.696 -0.853 . . . . 1.48 108.696 178.961 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.545 ' HB3' ' HB2' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -102.14 117.67 35.28 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 109.146 -0.686 . . . . 2.78 109.146 -179.866 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.486 ' O ' ' HG3' ' A' ' 51' ' ' LYS . 24.1 mt -110.34 139.78 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.333 -0.854 . . . . 1.15 110.331 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -108.39 -111.97 3.53 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 108.672 -1.771 . . . . 0.43 108.672 178.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.462 ' HB2' ' HB ' ' A' ' 47' ' ' THR . 2.3 m-20 -139.2 4.46 2.23 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.722 -1.214 . . . . 3.26 107.722 178.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.404 ' ND2' ' HB2' ' A' ' 45' ' ' GLN . 2.0 m-80 -118.49 -35.65 3.7 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.592 0.71 . . . . 0.89 109.36 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -173.43 -141.56 3.56 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.411 -1.476 . . . . 0.52 109.411 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.633 HG22 ' O ' ' A' ' 116' ' ' VAL . 0.1 OUTLIER -109.58 107.6 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.19 -1.183 . . . . 0.68 109.9 -179.87 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.981 HD21 ' OE1' ' A' ' 45' ' ' GLN . 1.1 mt -49.66 -49.7 46.3 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.252 -0.905 . . . . 0.78 109.113 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.547 ' HA ' ' CA ' ' A' ' 9' ' ' ALA . . . -161.98 -167.47 1.67 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.403 -0.811 . . . . 1.22 109.247 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 0.513 ' HA ' ' HA ' ' A' ' 109' ' ' LYS . 0.1 OUTLIER 172.91 170.59 0.13 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.257 -0.902 . . . . 0.67 109.605 179.781 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.416 ' N ' ' SG ' ' A' ' 119' ' ' CYS . . . -175.44 127.18 0.25 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.836 -0.801 . . . . 0.92 108.836 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.475 HG23 HG23 ' A' ' 107' ' ' THR . 2.5 mp -133.46 147.29 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.158 -0.964 . . . . 0.72 110.787 -179.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.563 ' HB3' ' HB ' ' A' ' 106' ' ' VAL . . . -112.72 -159.58 0.69 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.414 -0.803 . . . . 3.03 108.991 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.742 HG22 ' NE2' ' A' ' 124' ' ' HIS . 0.2 OUTLIER -161.66 115.49 1.91 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.933 -1.104 . . . . 1.16 110.495 -179.837 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . 0.742 ' NE2' HG22 ' A' ' 123' ' ' THR . 0.2 OUTLIER 57.67 118.4 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.387 -0.82 . . . . 4.14 110.562 178.882 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 27' ' ' CYS . . . -129.46 167.88 21.22 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 108.975 -1.65 . . . . 2.07 108.975 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.403 ' HB3' ' CD1' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -172.25 86.01 0.07 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.042 -1.269 . . . . 3.04 109.984 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 1.007 HD13 ' HB2' ' A' ' 101' ' ' SER . 2.4 mp -46.35 138.7 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.352 -0.843 . . . . 1.19 109.822 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.643 ' CB ' ' O ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER 147.07 -93.88 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.859 -0.793 . . . . 3.79 108.859 179.003 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.504 ' N ' ' CG ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.964 -1.017 . . . . 4.08 109.457 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.2 t0 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.328 0.585 . . . . 5.81 109.508 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.462 ' HB3' ' HG2' ' A' ' 17' ' ' MET . 0.0 OUTLIER -122.46 23.18 9.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.193 -0.942 . . . . 3.88 108.679 179.406 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.868 HG12 ' H ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER 38.71 -159.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-O 121.188 0.518 . . . . 1.07 109.908 179.376 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -141.28 32.86 1.7 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.093 -1.004 . . . . 1.44 109.48 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.474 ' H ' HG22 ' A' ' 5' ' ' VAL . 1.1 m -53.16 136.85 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.423 -0.798 . . . . 0.67 109.359 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -67.5 94.98 0.44 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.21 -0.931 . . . . 3.96 109.704 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.527 ' OD2' ' CD1' ' A' ' 13' ' ' ILE . 0.2 OUTLIER -93.25 -176.16 4.05 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.112 -0.992 . . . . 4.49 109.037 179.5 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 21.6 p -176.96 41.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.001 -1.062 . . . . 2.15 109.762 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.556 ' CB ' HG13 ' A' ' 13' ' ' ILE . . . -77.13 -72.43 0.35 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.37 -0.831 . . . . 0.65 109.244 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.453 ' O ' ' HG2' ' A' ' 12' ' ' GLU . 0.9 OUTLIER -157.18 25.02 0.31 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.456 -0.777 . . . . 2.96 109.561 -179.778 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.451 ' CB ' ' O ' ' A' ' 10' ' ' ASN . 0.5 OUTLIER 72.14 22.51 3.63 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.306 -0.871 . . . . 2.83 109.485 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.519 ' O ' ' HB ' ' A' ' 13' ' ' ILE . 0.6 OUTLIER -145.04 -83.52 0.14 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.849 -0.797 . . . . 3.78 108.849 179.834 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.718 HG22 ' H ' ' A' ' 15' ' ' LYS . 0.4 OUTLIER 71.44 -6.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.509 -0.744 . . . . 3.66 111.486 178.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.574 ' HB2' ' O ' ' A' ' 13' ' ' ILE . 1.7 mtpt 68.21 -21.79 0.13 Allowed 'General case' 0 C--N 1.293 -1.864 0 O-C-N 121.504 -0.747 . . . . 4.69 111.328 179.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.718 ' H ' HG22 ' A' ' 13' ' ' ILE . 0.1 OUTLIER 170.6 126.41 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 O-C-N 120.59 -1.319 . . . . 1.42 109.566 -177.581 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.627 ' O ' HG13 ' A' ' 16' ' ' VAL . 6.4 p -140.96 114.64 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.128 -0.983 . . . . 0.91 108.845 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.512 ' HG3' ' C ' ' A' ' 16' ' ' VAL . 1.8 mtt -153.47 168.49 25.93 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.063 -1.055 . . . . 1.91 110.63 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.674 HG12 ' H ' ' A' ' 19' ' ' ASP . 16.5 t -129.29 177.66 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 107.388 -1.338 . . . . 1.24 107.388 178.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.674 ' H ' HG12 ' A' ' 18' ' ' VAL . 3.6 t0 -117.54 66.44 0.74 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.597 -1.314 . . . . 2.11 112.019 -178.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 29' ' ' ILE . . . 120.53 -26.77 6.83 Favored Glycine 0 N--CA 1.493 2.497 0 C-N-CA 119.063 -1.541 . . . . 3.13 112.39 177.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.99 ' CA ' HG23 ' A' ' 29' ' ' ILE . 3.9 t -60.21 -118.6 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.484 -1.597 . . . . 1.97 109.572 -178.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.581 ' HA ' ' CG1' ' A' ' 3' ' ' VAL . 2.7 m-70 155.48 123.27 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.771 -1.206 . . . . 2.27 108.836 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.868 ' H ' HG12 ' A' ' 3' ' ' VAL . . . -75.67 155.24 46.48 Favored Glycine 0 N--CA 1.494 2.519 0 O-C-N 121.027 -1.046 . . . . 0.78 110.718 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.433 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 5.4 m 70.22 155.87 0.14 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.356 -1.085 . . . . 2.62 108.887 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.608 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.1 OUTLIER 57.9 175.36 0.04 OUTLIER Pre-proline 0 C--N 1.304 -1.378 0 N-CA-C 107.678 -1.23 . . . . 5.42 107.678 -179.824 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.608 ' HD2' ' CB ' ' A' ' 25' ' ' ASP . 25.3 Cg_endo -67.31 85.06 0.35 Allowed 'Trans proline' 0 C--N 1.295 -2.281 0 C-N-CA 122.037 1.825 . . . . 1.29 109.763 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.606 ' HB2' ' HB1' ' A' ' 122' ' ' ALA . 3.9 t -23.62 86.45 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.973 0 CA-C-N 115.332 -0.849 . . . . 1.82 111.808 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.507 ' HA ' ' O ' ' A' ' 126' ' ' LYS . 29.3 mm -77.97 143.43 12.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 C-N-CA 118.649 -1.22 . . . . 0.88 107.968 178.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.99 HG23 ' CA ' ' A' ' 21' ' ' CYS . 0.2 OUTLIER -129.67 -177.53 2.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 O-C-N 120.981 -1.074 . . . . 0.81 112.142 -177.194 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 36.5 m-70 -114.51 166.57 11.57 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.415 0.626 . . . . 1.63 110.496 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.885 ' O ' HD12 ' A' ' 97' ' ' ILE . 0.1 OUTLIER -122.13 10.54 10.05 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.732 0.777 . . . . 11.01 108.966 178.863 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.491 ' HA2' ' O ' ' A' ' 95' ' ' PRO . . . -116.93 -5.88 14.81 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.649 -1.381 . . . . 1.52 109.649 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.589 ' C ' ' HB ' ' A' ' 94' ' ' VAL . 6.9 mtpt -116.78 147.04 39.1 Favored Pre-proline 0 C--N 1.303 -1.441 0 N-CA-C 106.977 -1.49 . . . . 3.42 106.977 178.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.552 ' O ' ' N ' ' A' ' 36' ' ' THR . 28.3 Cg_endo -66.65 102.98 0.65 Allowed 'Trans proline' 0 C--N 1.299 -2.039 0 C-N-CA 122.178 1.919 . . . . 1.25 111.919 -177.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.54 ' O ' ' HA ' ' A' ' 91' ' ' THR . 49.4 t80 -41.65 94.66 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.822 -1.177 . . . . 3.65 107.822 178.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.816 HG23 ' CG2' ' A' ' 91' ' ' THR . 19.3 m -114.51 78.11 1.12 Allowed 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.529 -0.868 . . . . 2.39 110.548 -178.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.767 HD12 ' N ' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -77.46 131.25 37.87 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 106.294 -1.743 . . . . 1.42 106.294 177.91 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.767 ' N ' HD12 ' A' ' 37' ' ' LEU . 3.8 mt-10 -142.83 178.82 7.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.683 -1.261 . . . . 2.94 111.149 -177.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.449 ' HB2' ' O ' ' A' ' 38' ' ' GLU . . . 171.67 95.94 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.298 -1.371 . . . . 0.31 107.298 178.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.61 ' HG ' ' CB ' ' A' ' 87' ' ' ASP . 0.0 OUTLIER -90.38 174.13 7.73 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.464 -0.773 . . . . 0.41 109.652 -178.418 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.792 ' HZ ' ' HH ' ' A' ' 86' ' ' TYR . 20.8 p90 173.01 141.7 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.776 -1.202 . . . . 0.41 110.184 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.508 ' O ' ' C ' ' A' ' 43' ' ' ALA . 9.1 p-10 -90.87 112.86 24.87 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 107.445 -1.317 . . . . 4.11 107.445 178.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.711 ' HB1' ' O ' ' A' ' 81' ' ' VAL . . . -33.31 123.89 0.4 Allowed 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 115.613 -0.721 . . . . 0.42 110.012 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -120.08 3.88 10.92 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.497 -0.752 . . . . 3.66 110.822 -177.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.877 ' OE1' HD21 ' A' ' 117' ' ' LEU . 2.0 pt20 -97.69 -142.77 0.3 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.186 -0.946 . . . . 0.67 108.598 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.786 ' HA ' ' HB ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -153.16 68.17 0.8 Allowed 'General case' 0 C--N 1.295 -1.781 0 O-C-N 121.285 -0.884 . . . . 0.4 108.631 178.551 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.789 HG23 ' O ' ' A' ' 47' ' ' THR . 9.1 t -145.67 111.38 5.5 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.01 -1.681 . . . . 0.51 112.042 -177.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.66 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -59.69 -23.04 62.8 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.348 -1.353 . . . . 2.84 107.348 177.152 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.41 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 1.1 p -82.86 -165.09 0.97 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.856 -0.528 . . . . 0.83 109.6 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.805 ' CB ' ' HB3' ' A' ' 72' ' ' ALA . . . 178.14 155.5 0.37 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.277 -0.889 . . . . 0.42 109.128 -179.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.582 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 19.7 mtmt -127.75 171.13 12.0 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.061 -1.459 . . . . 1.45 107.061 178.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.874 HG12 HG11 ' A' ' 65' ' ' VAL . 3.0 tt -158.65 156.43 3.88 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 C-N-CA 118.221 -1.392 . . . . 0.89 110.949 -179.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.52 ' O ' ' NZ ' ' A' ' 55' ' ' LYS . 4.1 tp10 -159.71 48.93 0.3 Allowed 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.267 -1.382 . . . . 3.62 107.267 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.802 ' HB ' HG21 ' A' ' 65' ' ' VAL . 1.3 mt -85.7 136.92 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 CA-C-O 122.354 1.074 . . . . 1.84 111.201 -178.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.562 ' HG3' ' O ' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -144.01 98.05 3.16 Favored 'General case' 0 C--N 1.282 -2.365 0 O-C-N 121.0 -1.062 . . . . 0.98 109.972 178.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.631 ' HB3' HD12 ' A' ' 63' ' ' ILE . . . -107.35 132.5 53.07 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 107.814 -1.18 . . . . 0.44 107.814 178.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.454 ' HA ' ' HA ' ' A' ' 62' ' ' GLU . 58.6 m -117.66 113.66 22.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.819 -1.176 . . . . 2.32 110.598 -178.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.45 ' O ' ' C ' ' A' ' 59' ' ' ASP . 0.2 OUTLIER -94.63 176.99 6.07 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.153 -1.054 . . . . 4.55 108.153 178.909 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.493 ' HB2' ' HB2' ' A' ' 101' ' ' SER . 0.0 OUTLIER -44.12 -60.74 1.74 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.922 -1.111 . . . . 3.34 109.235 -179.752 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.66 ' C ' HD22 ' A' ' 61' ' ' LEU . . . -129.27 10.24 6.19 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.517 -1.433 . . . . 2.34 109.517 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.814 ' N ' HD22 ' A' ' 61' ' ' LEU . 2.9 mm? -110.11 47.06 0.98 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.06 -1.259 . . . . 3.02 107.851 178.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.454 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 1.4 mt-10 -42.67 87.77 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 115.61 -0.723 . . . . 2.3 110.929 -179.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.631 HD12 ' HB3' ' A' ' 56' ' ' ALA . 6.8 mt -62.93 164.9 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 N-CA-C 106.696 -1.594 . . . . 0.47 106.696 177.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.405 ' C ' HG23 ' A' ' 65' ' ' VAL . 1.7 t0 -168.26 153.29 6.53 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.614 -1.304 . . . . 2.01 110.186 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.874 HG11 HG12 ' A' ' 52' ' ' ILE . 23.7 t -150.89 62.79 5.4 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.636 -0.665 . . . . 0.44 110.04 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.596 ' HD3' ' N ' ' A' ' 65' ' ' VAL . 37.7 Cg_endo -84.96 95.45 0.66 Allowed 'Trans proline' 0 C--N 1.301 -1.938 0 C-N-CA 123.296 2.664 . . . . 1.16 110.979 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.478 ' C ' ' O ' ' A' ' 66' ' ' PRO . . . 38.31 57.9 1.72 Allowed Glycine 0 N--CA 1.495 2.61 0 N-CA-C 109.621 -1.392 . . . . 2.04 109.621 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.57 HG22 ' N ' ' A' ' 69' ' ' ASP . 22.7 mm -84.32 -94.04 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.278 -1.131 . . . . 2.99 109.948 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.57 ' N ' HG22 ' A' ' 68' ' ' ILE . 35.5 p30 -51.64 166.06 0.15 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.175 -0.953 . . . . 1.5 110.038 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -69.27 -20.02 63.92 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.363 -0.836 . . . . 2.19 109.607 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.604 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 6.6 m-20 -175.57 73.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.785 -1.197 . . . . 0.71 111.307 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.805 ' HB3' ' CB ' ' A' ' 50' ' ' ALA . . . 40.33 26.89 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.562 -0.711 . . . . 0.81 111.478 176.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.545 ' HB3' ' HB2' ' A' ' 78' ' ' CYS . 4.0 m -88.41 -49.25 7.05 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.909 -1.119 . . . . 3.09 110.046 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.497 ' HB2' ' HB3' ' A' ' 69' ' ' ASP . 0.2 OUTLIER -59.17 -7.14 1.07 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.348 -0.845 . . . . 1.18 111.957 -178.044 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.592 ' C ' HG12 ' A' ' 76' ' ' VAL . 83.8 m-85 -115.62 -10.12 11.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.489 -1.382 . . . . 0.42 110.644 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.795 HG21 ' CZ ' ' A' ' 86' ' ' TYR . 0.2 OUTLIER -164.51 175.91 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.871 -1.143 . . . . 0.38 110.153 -178.483 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.664 ' N ' ' CG2' ' A' ' 76' ' ' VAL . 11.8 mmmt -61.55 93.15 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 106.226 -1.768 . . . . 2.65 106.226 176.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . 0.545 ' HB2' ' HB3' ' A' ' 73' ' ' CYS . 4.1 t -37.91 -50.37 3.04 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.359 -0.838 . . . . 3.53 111.79 -177.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.66 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 30.6 Cg_endo -74.71 108.27 2.66 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 N-CA-C 108.674 -1.318 . . . . 0.54 108.674 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.966 HD22 HD22 ' A' ' 117' ' ' LEU . 0.6 OUTLIER -103.28 -66.71 0.92 Allowed 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 108.378 -0.971 . . . . 2.42 108.378 -178.701 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.786 ' HB ' ' HA ' ' A' ' 46' ' ' ASN . 1.4 m 41.45 -167.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 109.221 -0.659 . . . . 0.36 109.221 178.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.733 ' H ' HG23 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -101.82 42.71 1.11 Allowed 'General case' 0 C--N 1.284 -2.267 0 O-C-N 120.261 -1.524 . . . . 3.21 109.704 -176.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -146.62 37.3 1.21 Allowed Glycine 0 C--N 1.287 -2.143 0 N-CA-C 108.712 -1.755 . . . . 0.42 108.712 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 35.3 tp60 -152.52 143.44 22.99 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 121.157 -1.202 . . . . 2.33 110.78 -179.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.42 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 0.3 OUTLIER -117.59 134.5 54.81 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 105.596 -2.002 . . . . 3.14 105.596 177.653 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.798 ' HE2' HD21 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -163.4 163.58 24.95 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 117.514 -1.675 . . . . 0.58 109.95 -177.42 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.61 ' CB ' ' HG ' ' A' ' 40' ' ' LEU . 12.7 p-10 -133.14 102.29 5.53 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.852 -1.155 . . . . 0.59 112.968 -176.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.536 ' CD1' ' O ' ' A' ' 75' ' ' PHE . 3.0 tp -70.26 -175.9 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 107.423 -1.325 . . . . 1.66 107.423 176.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.544 ' O ' ' CD2' ' A' ' 90' ' ' TYR . 3.1 mttt 174.13 173.65 0.18 Allowed 'General case' 0 N--CA 1.5 2.07 0 O-C-N 120.852 -1.155 . . . . 0.77 110.83 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.544 ' CD2' ' O ' ' A' ' 89' ' ' LYS . 5.8 m-85 -172.43 60.56 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 106.908 -1.516 . . . . 2.41 106.908 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.816 ' CG2' HG23 ' A' ' 36' ' ' THR . 0.3 OUTLIER -90.25 -169.19 2.33 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.518 -0.739 . . . . 3.08 111.667 -177.306 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.564 ' CH2' ' HB3' ' A' ' 61' ' ' LEU . 0.2 OUTLIER -171.2 151.63 3.21 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.581 -0.699 . . . . 7.17 110.323 -178.973 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -81.89 142.73 32.23 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.908 -1.145 . . . . 2.25 107.908 178.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 1.068 HG13 ' CD1' ' A' ' 97' ' ' ILE . 51.5 t -147.89 112.97 3.92 Favored Pre-proline 0 C--N 1.305 -1.335 0 O-C-N 120.805 -1.185 . . . . 2.18 111.667 -177.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.943 ' HD2' HD11 ' A' ' 97' ' ' ILE . 29.9 Cg_endo -74.56 -67.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 123.259 2.639 . . . . 3.41 111.513 178.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.634 ' O ' ' HB3' ' A' ' 31' ' ' ARG . 0.4 OUTLIER -162.44 -33.65 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 107.368 -1.345 . . . . 5.74 107.368 -179.826 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 1.068 ' CD1' HG13 ' A' ' 94' ' ' VAL . 1.4 mt 34.48 24.37 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 114.02 1.118 . . . . 2.28 114.02 176.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 1.023 ' HB1' ' HD2' ' A' ' 99' ' ' PRO . . . 61.28 -177.2 0.03 OUTLIER Pre-proline 0 C--N 1.301 -1.513 0 O-C-N 120.279 -1.513 . . . . 1.35 109.926 178.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 1.023 ' HD2' ' HB1' ' A' ' 98' ' ' ALA . 46.8 Cg_endo -86.53 151.23 8.97 Favored 'Trans proline' 0 C--N 1.302 -1.896 0 C-N-CA 123.645 2.896 . . . . 0.74 111.052 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.521 ' HD2' ' HA ' ' A' ' 128' ' ' ARG . 2.0 mptm? 64.08 142.91 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.965 0.888 . . . . 3.05 112.419 175.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.725 ' HB3' HD13 ' A' ' 127' ' ' ILE . 2.9 p -111.15 12.31 21.89 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.918 -0.771 . . . . 3.5 108.918 179.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.549 ' O ' ' CB ' ' A' ' 103' ' ' ASN . 0.8 OUTLIER 76.66 -5.98 2.09 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.603 -0.685 . . . . 3.1 109.342 -179.425 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.549 ' CB ' ' O ' ' A' ' 102' ' ' GLU . 3.6 t-20 159.19 146.04 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.453 -0.78 . . . . 2.83 109.45 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 1.092 HG21 HD12 ' A' ' 127' ' ' ILE . 0.1 OUTLIER -157.55 -174.3 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.255 -0.903 . . . . 0.65 110.065 -179.76 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.525 ' CB ' ' O ' ' A' ' 104' ' ' VAL . 1.2 t 159.27 125.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.2 -1.037 . . . . 0.6 108.2 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.742 ' O ' HG12 ' A' ' 106' ' ' VAL . 2.1 t -125.13 97.39 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 120.833 -1.167 . . . . 1.59 110.555 -178.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.515 ' HB ' ' HE3' ' A' ' 55' ' ' LYS . 25.6 m -116.52 143.61 45.37 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.504 -1.295 . . . . 0.69 107.504 178.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.753 HG13 ' CD1' ' A' ' 54' ' ' ILE . 88.0 t -151.15 152.89 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.59 -1.319 . . . . 1.0 110.585 -178.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -173.62 118.05 0.27 Allowed 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.798 0.809 . . . . 0.75 109.472 178.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.588 ' HB3' ' HB2' ' A' ' 117' ' ' LEU . 9.8 tp -106.26 121.8 44.93 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 106.777 -1.564 . . . . 1.34 106.777 178.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.511 ' HB ' ' HB2' ' A' ' 51' ' ' LYS . 4.0 mt -121.11 117.49 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.25 -0.906 . . . . 0.74 112.296 -176.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.499 ' HA3' HG21 ' A' ' 47' ' ' THR . . . -86.23 -112.37 0.83 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 107.806 -2.117 . . . . 0.75 107.806 176.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -141.1 -0.1 1.49 Allowed 'General case' 0 C--N 1.307 -1.268 0 O-C-N 120.928 -1.337 . . . . 1.46 108.123 178.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.463 ' ND2' ' N ' ' A' ' 114' ' ' ASN . 0.2 OUTLIER -120.98 -5.59 9.56 Favored 'General case' 0 C--N 1.313 -0.985 0 O-C-N 121.163 -0.961 . . . . 1.17 109.955 -179.923 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 160.56 164.47 15.6 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 109.641 -1.383 . . . . 1.4 109.641 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.41 HG13 ' O ' ' A' ' 116' ' ' VAL . 2.1 p -70.62 110.54 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.112 -1.228 . . . . 0.92 109.455 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.966 HD22 HD22 ' A' ' 80' ' ' LEU . 1.3 mt -48.52 -51.46 27.28 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.465 -0.772 . . . . 1.15 110.156 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -168.97 135.49 1.76 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.223 -0.923 . . . . 2.19 109.597 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 0.53 ' O ' ' HB2' ' A' ' 120' ' ' ALA . 22.0 p -126.13 -162.31 1.12 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.916 -1.115 . . . . 0.94 110.637 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.53 ' HB2' ' O ' ' A' ' 119' ' ' CYS . . . 171.24 124.86 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.38 -0.97 . . . . 0.37 108.38 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.523 HD12 ' C ' ' A' ' 120' ' ' ALA . 1.2 mp -133.69 126.62 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 120.976 -1.078 . . . . 1.5 110.798 -178.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.606 ' HB1' ' HB2' ' A' ' 27' ' ' CYS . . . -111.43 82.16 1.56 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.208 -1.034 . . . . 0.54 108.208 178.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.54 ' CG2' ' O ' ' A' ' 123' ' ' THR . 0.5 OUTLIER -33.52 125.04 0.42 Allowed 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.563 0.697 . . . . 2.68 110.666 -179.083 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . 0.475 ' O ' ' O ' ' A' ' 123' ' ' THR . 8.1 m170 54.41 163.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.555 -0.716 . . . . 2.17 109.786 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -153.88 129.72 2.73 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.401 -1.48 . . . . 1.66 109.401 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.507 ' O ' ' HA ' ' A' ' 28' ' ' ILE . 5.7 mtmt -153.23 119.17 5.39 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.328 -1.101 . . . . 1.85 108.536 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 1.092 HD12 HG21 ' A' ' 104' ' ' VAL . 1.5 mp -94.12 160.67 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.234 -0.916 . . . . 1.32 110.506 -178.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.528 ' HG2' ' O ' ' A' ' 127' ' ' ILE . 1.4 mtm180 -150.8 -174.72 4.87 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 109.016 -0.735 . . . . 2.69 109.016 178.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.541 ' N ' ' HB3' ' A' ' 99' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 117.917 -1.04 . . . . 7.78 109.708 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . 0.513 ' O ' ' HG3' ' A' ' 2' ' ' GLN . 14.5 m-20 . . . . . 0 N--CA 1.492 1.644 0 N-CA-C 109.6 -0.518 . . . . 4.36 109.6 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.513 ' HG3' ' O ' ' A' ' 1' ' ' ASP . 4.4 pt20 37.41 31.93 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.691 -0.485 . . . . 3.19 109.691 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.777 HG12 ' HA ' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -33.74 144.95 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-O 121.367 0.603 . . . . 2.0 110.402 -179.562 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.489 ' O ' ' N ' ' A' ' 24' ' ' SER . 5.3 t70 -89.64 148.83 23.09 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.419 -0.801 . . . . 2.47 109.437 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.421 HG13 ' O ' ' A' ' 4' ' ' ASP . 0.0 OUTLIER -156.08 167.24 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.353 -0.842 . . . . 1.65 108.988 179.961 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.564 ' HD3' ' N ' ' A' ' 6' ' ' LYS . 1.4 mptt -80.02 76.92 6.74 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.073 -1.084 . . . . 3.62 108.073 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.525 ' HB2' ' O ' ' A' ' 119' ' ' CYS . 51.6 p30 -94.35 168.38 10.93 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.832 0.825 . . . . 0.77 110.436 -178.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.54 ' N ' ' SG ' ' A' ' 119' ' ' CYS . 29.2 m -113.17 -36.1 5.16 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.031 -1.47 . . . . 3.26 107.031 178.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.835 ' HB2' ' CB ' ' A' ' 118' ' ' ALA . . . -64.14 -144.84 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.358 -0.979 . . . . 5.02 108.358 177.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.559 ' CB ' ' O ' ' A' ' 9' ' ' ALA . 0.1 OUTLIER 80.45 -42.92 0.22 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 120.506 -0.477 . . . . 9.64 110.874 177.372 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -63.38 -17.73 62.94 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.957 -1.089 . . . . 4.23 108.23 178.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.448 ' HG2' ' HB3' ' A' ' 44' ' ' ASN . 13.1 tp10 -132.37 -28.78 1.64 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.673 -0.642 . . . . 2.78 109.575 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.813 HG13 ' HB1' ' A' ' 9' ' ' ALA . 10.4 mt -48.43 154.7 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.09 -1.006 . . . . 1.61 109.825 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.444 ' N ' ' CG2' ' A' ' 13' ' ' ILE . 0.0 OUTLIER -110.91 -23.21 11.11 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.784 -0.821 . . . . 0.92 108.784 179.776 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -156.99 122.07 4.57 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 119.202 -0.999 . . . . 2.42 109.657 -178.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.631 ' O ' HG13 ' A' ' 16' ' ' VAL . 4.5 p -155.3 104.65 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.074 -1.016 . . . . 1.23 109.412 -179.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.497 ' HG2' ' HB3' ' A' ' 2' ' ' GLN . 3.0 mpp? -150.42 152.74 34.78 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.202 -0.936 . . . . 1.36 110.493 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.874 HG12 ' CE1' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -121.4 106.04 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 108.087 -1.079 . . . . 0.79 108.087 178.535 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.442 ' HB3' ' O ' ' A' ' 34' ' ' PRO . 1.2 t0 -52.49 86.92 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.644 -0.66 . . . . 1.87 110.928 -178.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.554 ' O ' ' HB3' ' A' ' 21' ' ' CYS . . . 98.46 -169.96 24.04 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 120.035 -1.078 . . . . 2.01 110.928 178.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.95 ' CA ' HG23 ' A' ' 29' ' ' ILE . 36.2 t 86.14 -25.52 0.11 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 122.268 -0.548 . . . . 1.53 110.193 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.777 ' HA ' HG12 ' A' ' 3' ' ' VAL . 0.3 OUTLIER 42.2 83.99 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.858 -1.151 . . . . 1.74 108.973 -179.192 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.497 ' O ' ' CB ' ' A' ' 24' ' ' SER . . . -83.39 -144.56 5.77 Favored Glycine 0 N--CA 1.498 2.811 0 O-C-N 121.489 -0.757 . . . . 1.26 112.327 -178.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.497 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 0.1 OUTLIER 78.46 -79.38 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 107.45 -1.315 . . . . 1.4 107.45 -177.818 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.691 ' HB2' ' CD ' ' A' ' 26' ' ' PRO . 7.3 p30 -84.87 -149.4 0.0 OUTLIER Pre-proline 0 C--N 1.298 -1.67 0 N-CA-C 105.263 -2.125 . . . . 2.39 105.263 177.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.691 ' CD ' ' HB2' ' A' ' 25' ' ' ASP . 25.9 Cg_endo -70.07 102.36 1.07 Allowed 'Trans proline' 0 C--N 1.32 -0.969 0 CA-C-N 121.168 1.453 . . . . 1.49 108.601 179.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.599 ' HA ' ' O ' ' A' ' 22' ' ' HIS . 3.2 t -54.72 81.23 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 115.42 -0.809 . . . . 1.63 113.07 -176.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.534 ' O ' ' O ' ' A' ' 21' ' ' CYS . 0.6 OUTLIER -83.09 145.29 8.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 106.863 -1.532 . . . . 2.11 106.863 176.475 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.95 HG23 ' CA ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -113.35 -175.95 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 O-C-N 120.756 -1.215 . . . . 1.11 111.827 -176.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 34.5 m-70 -127.04 107.25 9.88 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 119.952 -0.699 . . . . 1.95 111.269 -178.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.583 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -53.86 149.1 9.22 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.492 -0.755 . . . . 3.21 109.038 178.353 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.518 ' HA2' ' O ' ' A' ' 95' ' ' PRO . . . 92.06 -1.97 74.78 Favored Glycine 0 N--CA 1.493 2.478 0 C-N-CA 119.814 -1.184 . . . . 2.11 110.61 178.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.584 ' O ' HG21 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -124.12 139.97 33.83 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 120.963 -1.316 . . . . 2.36 109.479 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.442 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 27.0 Cg_endo -64.93 134.72 41.21 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.398 2.065 . . . . 2.51 110.935 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.874 ' CE1' HG12 ' A' ' 18' ' ' VAL . 5.1 t80 -114.41 60.72 0.67 Allowed 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.466 -0.568 . . . . 1.33 109.466 -178.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.492 HG22 ' OE1' ' A' ' 38' ' ' GLU . 81.5 m -73.08 81.97 1.26 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.303 -0.873 . . . . 2.52 109.09 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.52 ' O ' ' CG ' ' A' ' 38' ' ' GLU . 3.0 mp -52.7 -178.21 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.189 -0.945 . . . . 4.85 108.653 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.536 ' CG ' ' HG2' ' A' ' 89' ' ' LYS . 0.1 OUTLIER 166.73 158.56 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.916 -1.115 . . . . 2.7 109.795 -179.602 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.522 ' HB2' ' O ' ' A' ' 38' ' ' GLU . . . 171.81 83.41 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.697 0.76 . . . . 1.19 109.506 178.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.73 ' O ' HG23 ' A' ' 13' ' ' ILE . 0.6 OUTLIER -82.12 165.05 20.89 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 108.269 -1.011 . . . . 2.17 108.269 179.031 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.763 ' CZ ' ' CD2' ' A' ' 86' ' ' TYR . 0.4 OUTLIER -156.79 164.85 37.63 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.323 -1.362 . . . . 1.2 107.323 176.285 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.411 ' O ' ' C ' ' A' ' 43' ' ' ALA . 1.0 OUTLIER -116.85 116.38 27.34 Favored 'General case' 0 C--N 1.29 -2.013 0 C-N-CA 119.309 -0.957 . . . . 2.49 108.584 -179.8 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.869 ' HB1' ' O ' ' A' ' 81' ' ' VAL . . . -46.81 119.59 2.57 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 107.386 -1.339 . . . . 0.44 107.386 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.461 ' C ' ' HB3' ' A' ' 82' ' ' LYS . 0.1 OUTLIER -130.63 19.38 5.16 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.699 0.761 . . . . 3.32 108.999 -178.15 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.788 ' CD ' HD21 ' A' ' 117' ' ' LEU . 3.0 pt20 -109.37 -139.41 0.38 Allowed 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.512 -0.742 . . . . 0.82 110.408 -178.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.689 ' C ' HG22 ' A' ' 81' ' ' VAL . 3.4 m120 -158.55 53.43 0.43 Allowed 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.531 -0.914 . . . . 3.98 108.531 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.798 ' N ' HG22 ' A' ' 81' ' ' VAL . 10.4 t -134.78 127.47 30.95 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.386 -1.446 . . . . 2.09 110.555 -178.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.648 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -70.71 -20.15 62.69 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.012 -1.055 . . . . 5.26 108.934 178.744 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 24.7 p -73.79 178.81 4.59 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.922 0.868 . . . . 3.19 111.077 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 1.062 ' HB1' ' HB3' ' A' ' 72' ' ' ALA . . . 177.52 131.06 0.06 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.258 -1.386 . . . . 1.48 107.258 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.522 ' O ' ' C ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -136.11 48.55 2.16 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 120.104 -1.623 . . . . 3.08 109.91 -178.628 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.883 ' H ' ' HB2' ' A' ' 72' ' ' ALA . 2.0 tt -28.29 146.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.178 0 CA-C-N 115.451 -0.795 . . . . 2.37 110.361 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.461 ' C ' HD12 ' A' ' 54' ' ' ILE . 0.3 OUTLIER -137.95 82.96 1.95 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.301 -0.874 . . . . 3.09 109.474 -179.818 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.896 ' HB ' HG21 ' A' ' 65' ' ' VAL . 0.5 OUTLIER -108.57 141.51 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.293 -0.879 . . . . 0.87 109.278 179.651 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.696 ' HG3' ' O ' ' A' ' 54' ' ' ILE . 0.2 OUTLIER -152.4 90.18 1.48 Allowed 'General case' 0 C--N 1.285 -2.204 0 O-C-N 121.348 -0.845 . . . . 1.15 109.175 178.462 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.793 ' HB3' ' HB ' ' A' ' 63' ' ' ILE . . . -109.36 145.21 36.44 Favored 'General case' 0 C--N 1.292 -1.897 0 O-C-N 121.512 -0.743 . . . . 0.24 109.551 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.476 ' O ' ' CG1' ' A' ' 104' ' ' VAL . 30.3 m -128.12 137.13 51.99 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.972 -1.08 . . . . 2.44 109.142 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.856 HD13 ' H ' ' A' ' 59' ' ' ASP . 0.2 OUTLIER -135.39 158.33 44.64 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.28 -0.887 . . . . 1.82 109.198 -179.604 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.856 ' H ' HD13 ' A' ' 58' ' ' LEU . 18.1 t70 -48.86 -63.89 0.96 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.274 -0.892 . . . . 3.24 108.608 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -108.17 24.89 21.85 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 108.862 -1.695 . . . . 1.15 108.862 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.608 ' CB ' ' HB3' ' A' ' 58' ' ' LEU . 0.4 OUTLIER -146.33 66.48 1.19 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.269 -1.136 . . . . 3.44 109.118 -179.709 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.09 82.44 0.51 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.469 -0.769 . . . . 2.18 109.985 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.793 ' HB ' ' HB3' ' A' ' 56' ' ' ALA . 8.5 mt -66.85 169.44 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 120.866 -1.146 . . . . 0.34 108.091 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.581 ' N ' HG22 ' A' ' 63' ' ' ILE . 0.5 OUTLIER 175.9 145.75 0.08 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.018 -1.052 . . . . 1.06 109.469 -179.791 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.896 HG21 ' HB ' ' A' ' 54' ' ' ILE . 14.5 t -144.39 63.93 11.59 Favored Pre-proline 0 N--CA 1.488 1.425 0 O-C-N 121.318 -0.864 . . . . 1.0 110.01 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.547 ' HD3' ' N ' ' A' ' 65' ' ' VAL . 36.4 Cg_endo -79.34 94.61 1.05 Allowed 'Trans proline' 0 C--N 1.298 -2.105 0 C-N-CA 122.918 2.412 . . . . 2.03 110.328 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.466 ' C ' ' O ' ' A' ' 66' ' ' PRO . . . 36.45 46.96 1.11 Allowed Glycine 0 N--CA 1.496 2.688 0 N-CA-C 110.119 -1.192 . . . . 1.13 110.119 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.745 HG22 ' N ' ' A' ' 69' ' ' ASP . 1.9 mm -63.5 -75.05 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.245 -1.15 . . . . 1.9 109.721 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.745 ' N ' HG22 ' A' ' 68' ' ' ILE . 6.4 p-10 -77.96 162.81 26.5 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.113 -0.992 . . . . 1.82 109.369 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.536 ' O ' ' ND2' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -57.11 -55.57 33.0 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.435 -0.791 . . . . 2.51 110.318 -179.449 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.562 ' CA ' ' O ' ' A' ' 50' ' ' ALA . 2.7 m120 -147.45 87.69 1.66 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.913 -1.117 . . . . 3.05 111.488 -178.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 1.062 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . . . 37.2 26.77 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.895 -0.503 . . . . 0.4 111.986 176.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.525 ' N ' ' O ' ' A' ' 71' ' ' ASN . 4.3 t -99.46 0.73 43.16 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 120.88 -1.137 . . . . 1.14 111.23 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.613 ' CG ' ' HB3' ' A' ' 69' ' ' ASP . 0.3 OUTLIER -90.7 -29.54 17.64 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.757 -1.214 . . . . 2.98 109.687 179.811 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.508 ' O ' ' HB ' ' A' ' 76' ' ' VAL . 13.5 m-85 -103.6 14.07 31.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.362 -0.836 . . . . 1.73 109.29 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 1.198 HG11 ' CZ ' ' A' ' 86' ' ' TYR . 5.4 p 178.27 -142.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-O 121.787 0.804 . . . . 2.55 109.512 -177.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.841 ' N ' HG13 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -99.03 158.69 15.48 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 106.304 -1.739 . . . . 3.36 106.304 177.049 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . 0.568 ' N ' ' HD2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -81.96 -48.62 0.94 Allowed Pre-proline 0 N--CA 1.493 1.694 0 C-N-CA 118.054 -1.458 . . . . 2.17 109.544 179.866 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.648 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 32.0 Cg_endo -77.2 114.92 3.87 Favored 'Trans proline' 0 C--N 1.302 -1.904 0 N-CA-C 107.498 -1.77 . . . . 2.29 107.498 178.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.758 HD11 HD21 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -85.96 -69.19 0.68 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 106.588 -1.634 . . . . 1.39 106.588 -179.11 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.869 ' O ' ' HB1' ' A' ' 43' ' ' ALA 0.256 48.4 t 50.06 -174.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 C-N-CA 118.276 -1.37 . . . . 2.91 109.262 175.488 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.61 ' N ' HG12 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -104.56 47.32 0.88 Allowed 'General case' 0 C--N 1.293 -1.884 0 O-C-N 121.143 -0.973 . . . . 2.54 110.008 -179.381 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -137.43 11.19 3.78 Favored Glycine 0 N--CA 1.491 2.309 0 C-N-CA 118.734 -1.698 . . . . 0.5 113.059 -178.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.482 ' NE2' ' O ' ' A' ' 79' ' ' PRO . 1.2 pt20 -148.92 171.05 16.95 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 120.452 2.126 . . . . 5.53 111.334 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -108.02 142.1 38.68 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.775 0.798 . . . . 5.07 110.956 -178.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 1.198 ' CZ ' HG11 ' A' ' 76' ' ' VAL . 0.4 OUTLIER -99.62 173.18 6.85 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.069 0.462 . . . . 2.67 110.576 -179.61 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.626 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 9.9 p-10 176.83 83.64 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.464 -0.773 . . . . 3.47 110.918 178.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.548 HG12 ' N ' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -127.87 146.06 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 107.313 -1.366 . . . . 2.54 107.313 178.409 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.548 ' N ' HG12 ' A' ' 88' ' ' ILE . 1.7 mtmt -147.62 -169.37 3.3 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.955 -1.091 . . . . 3.15 111.797 -177.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.639 ' CZ ' HG21 ' A' ' 54' ' ' ILE . 67.4 m-85 -156.7 126.64 6.36 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 107.728 -1.212 . . . . 1.19 107.728 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.31 156.67 30.81 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.587 -1.32 . . . . 3.39 110.842 -178.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.753 ' CD2' HG22 ' A' ' 94' ' ' VAL . 3.3 t90 -143.19 109.97 5.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.548 -0.72 . . . . 5.33 109.168 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -61.08 120.13 9.68 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.685 -1.228 . . . . 3.09 107.685 178.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.813 HG13 HD13 ' A' ' 97' ' ' ILE . 18.4 t -114.68 95.94 42.34 Favored Pre-proline 0 N--CA 1.489 1.499 0 C-N-CA 119.028 -1.069 . . . . 2.63 111.573 -178.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.703 ' HD2' HD11 ' A' ' 97' ' ' ILE . 31.0 Cg_endo -75.88 -79.52 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.939 2.426 . . . . 2.84 109.269 177.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.599 ' C ' HD12 ' A' ' 97' ' ' ILE . 5.5 tptt -137.52 -59.63 0.67 Allowed 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 104.662 -2.347 . . . . 3.01 104.662 177.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.813 HD13 HG13 ' A' ' 94' ' ' VAL . 1.2 mp 66.59 5.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 O-C-N 121.679 -0.638 . . . . 1.75 112.711 174.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 1.075 ' HB1' ' HD2' ' A' ' 99' ' ' PRO . . . 54.86 177.96 0.03 OUTLIER Pre-proline 0 C--N 1.302 -1.459 0 O-C-N 120.408 -1.433 . . . . 1.3 109.256 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 1.075 ' HD2' ' HB1' ' A' ' 98' ' ' ALA . 46.4 Cg_endo -80.5 155.46 21.48 Favored 'Trans proline' 0 C--N 1.3 -1.984 0 C-N-CA 123.525 2.816 . . . . 1.26 110.345 -179.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.792 ' N ' HG22 ' A' ' 127' ' ' ILE . 1.4 mmmp? 56.91 149.47 0.01 OUTLIER 'General case' 0 C--N 1.29 -1.987 0 CA-C-O 122.157 0.98 . . . . 2.85 112.184 176.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.816 ' OG ' HD13 ' A' ' 127' ' ' ILE . 78.0 p -129.68 164.72 23.32 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.118 -0.697 . . . . 1.63 109.118 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.556 ' O ' ' CB ' ' A' ' 103' ' ' ASN . 4.3 mt-10 -51.04 -22.22 2.25 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.147 -0.971 . . . . 2.97 109.023 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.556 ' CB ' ' O ' ' A' ' 102' ' ' GLU . 0.3 OUTLIER 157.1 157.02 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.563 -0.903 . . . . 3.2 108.563 -179.713 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.642 HG21 ' CD1' ' A' ' 127' ' ' ILE . 0.2 OUTLIER -152.07 174.58 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.05 -1.031 . . . . 0.91 109.611 -179.919 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 56' ' ' ALA . 1.2 t 164.57 130.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 108.06 -1.089 . . . . 0.86 108.06 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.565 ' O ' HG12 ' A' ' 106' ' ' VAL . 3.6 t -128.56 102.98 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.899 -1.125 . . . . 1.68 110.562 -179.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.412 ' C ' ' CG2' ' A' ' 108' ' ' VAL . 0.2 OUTLIER -108.64 147.45 31.85 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.366 -0.975 . . . . 1.11 108.366 178.905 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.427 HG13 HG13 ' A' ' 54' ' ' ILE . 1.5 t -151.69 153.32 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.696 -1.252 . . . . 1.88 110.546 -179.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.522 ' HA ' ' HA ' ' A' ' 119' ' ' CYS . 0.4 OUTLIER 172.48 116.15 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.503 -0.748 . . . . 1.81 110.334 178.796 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.758 HD21 HD11 ' A' ' 80' ' ' LEU . 32.7 tp -104.04 127.89 51.61 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.684 -1.228 . . . . 1.37 107.684 177.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.508 ' O ' ' HG3' ' A' ' 51' ' ' LYS . 10.3 mt -125.88 136.83 59.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 O-C-N 121.277 -0.89 . . . . 0.9 110.431 -178.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.737 ' HA3' HG21 ' A' ' 47' ' ' THR . . . -100.07 -109.86 3.13 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 108.099 -2.0 . . . . 1.43 108.099 178.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -145.34 11.91 1.34 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.353 -1.351 . . . . 3.14 107.353 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.419 ' OD1' ' NE2' ' A' ' 45' ' ' GLN . 1.3 p30 -127.53 -33.17 2.35 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.547 0.689 . . . . 4.15 109.483 -178.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -179.91 156.61 18.45 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.107 -1.597 . . . . 1.69 109.107 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.484 ' O ' HG22 ' A' ' 116' ' ' VAL . 0.2 OUTLIER -57.02 112.54 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.147 -1.208 . . . . 0.9 109.918 -179.642 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.788 HD21 ' CD ' ' A' ' 45' ' ' GLN . 2.9 mt -55.54 -68.02 0.23 Allowed 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.608 -0.886 . . . . 1.08 108.608 179.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.835 ' CB ' ' HB2' ' A' ' 9' ' ' ALA . . . -130.39 -177.98 4.56 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.296 -1.002 . . . . 0.66 108.296 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 0.566 ' HB3' ' O ' ' A' ' 118' ' ' ALA . 0.1 OUTLIER 169.15 155.8 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.08 -1.013 . . . . 0.86 110.145 179.777 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.474 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . . . -176.88 129.68 0.18 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.314 -0.866 . . . . 1.22 109.416 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.3 mt -122.73 131.72 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.138 -0.977 . . . . 0.77 109.886 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.46 ' HB1' ' HB2' ' A' ' 27' ' ' CYS . . . -85.79 -35.81 20.48 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.337 -0.986 . . . . 2.26 108.337 179.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.408 ' O ' ' O ' ' A' ' 124' ' ' HIS . 2.4 m 64.77 121.41 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.61 -0.681 . . . . 1.74 110.372 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . 0.408 ' O ' ' O ' ' A' ' 123' ' ' THR . 3.9 m170 48.02 98.03 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.543 -0.723 . . . . 3.09 110.771 178.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.477 ' O ' ' HB ' ' A' ' 104' ' ' VAL . . . -116.83 119.38 4.46 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 108.294 -1.922 . . . . 1.14 108.294 178.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.455 ' O ' HG23 ' A' ' 28' ' ' ILE . 0.8 OUTLIER -137.27 140.02 41.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.949 -1.324 . . . . 2.76 110.587 -178.892 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.816 HD13 ' OG ' ' A' ' 101' ' ' SER . 2.2 mp -83.16 149.53 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 108.292 -1.003 . . . . 1.15 108.292 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.685 ' CB ' ' O ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER 137.22 -82.11 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 108.96 -0.755 . . . . 3.86 108.96 179.355 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.442 ' N ' ' CD ' ' A' ' 128' ' ' ARG . 13.1 t70 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 117.948 -1.025 . . . . 4.22 109.382 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . 0.526 ' C ' ' CG ' ' A' ' 2' ' ' GLN . 5.2 m-20 . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.31 -0.626 . . . . 3.24 109.31 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.561 ' HA ' ' CG ' ' A' ' 17' ' ' MET . 0.8 OUTLIER 37.35 30.07 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.647 -0.658 . . . . 4.54 110.589 179.166 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.778 HG11 ' H ' ' A' ' 22' ' ' HIS . 28.8 m -44.46 122.17 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.28 -0.887 . . . . 2.42 108.815 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.48 ' O ' ' HA3' ' A' ' 23' ' ' GLY . 8.3 t70 -55.39 134.61 50.39 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.449 -0.782 . . . . 2.17 110.586 -179.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.3 171.16 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 108.224 -1.028 . . . . 1.13 108.224 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 120' ' ' ALA . 27.4 mtpt -105.33 101.47 11.0 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.787 -1.196 . . . . 3.3 110.007 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.491 ' HA ' ' O ' ' A' ' 119' ' ' CYS . 65.1 m-20 -97.19 170.69 8.93 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.472 -0.768 . . . . 4.04 109.362 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.515 ' N ' ' SG ' ' A' ' 119' ' ' CYS . 3.8 m -138.69 4.64 2.36 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.34 -0.85 . . . . 1.49 109.639 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.595 ' HB2' ' HA ' ' A' ' 118' ' ' ALA . . . -47.09 -62.73 1.28 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.07 -1.019 . . . . 0.56 109.586 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.444 ' OD1' ' OD1' ' A' ' 11' ' ' ASN . 1.1 t-20 178.83 -81.85 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.919 -0.712 . . . . 4.78 109.301 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.444 ' OD1' ' OD1' ' A' ' 10' ' ' ASN . 14.3 p-10 -164.45 42.26 0.09 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.55 -0.719 . . . . 4.35 109.214 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.532 ' O ' ' HB ' ' A' ' 13' ' ' ILE . 0.7 OUTLIER -163.68 -81.94 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.231 -0.918 . . . . 3.78 109.566 -179.819 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.654 HG22 ' H ' ' A' ' 15' ' ' LYS . 0.1 OUTLIER 74.22 -2.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 CA-C-O 121.784 0.802 . . . . 3.79 110.257 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.524 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 15.1 mttm 65.99 -19.21 0.1 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.043 -1.036 . . . . 1.86 111.771 178.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.654 ' H ' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER 166.14 151.24 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.399 0 O-C-N 120.685 -1.26 . . . . 1.65 109.029 -178.073 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.794 ' O ' HG13 ' A' ' 16' ' ' VAL . 12.6 p -169.46 100.8 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.129 -0.982 . . . . 0.82 109.019 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.561 ' CG ' ' HA ' ' A' ' 2' ' ' GLN . 2.1 mpp? -151.19 150.16 30.28 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.589 -0.845 . . . . 1.34 110.196 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.677 HG11 ' CE1' ' A' ' 35' ' ' PHE . 19.2 t -117.0 160.24 16.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 107.794 -1.188 . . . . 1.35 107.794 178.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.569 ' CB ' ' O ' ' A' ' 34' ' ' PRO . 16.3 m-20 -94.91 36.17 1.21 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.835 -1.166 . . . . 1.69 110.021 -179.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.547 ' O ' ' CB ' ' A' ' 21' ' ' CYS . . . 130.45 128.9 3.04 Favored Glycine 0 N--CA 1.487 2.079 0 C-N-CA 119.523 -1.322 . . . . 1.05 110.131 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.877 ' CA ' HG23 ' A' ' 29' ' ' ILE . 0.0 OUTLIER 154.67 -36.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.538 -0.912 . . . . 0.91 108.538 179.132 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.778 ' H ' HG11 ' A' ' 3' ' ' VAL . 7.2 t-160 66.44 116.27 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.181 -1.044 . . . . 3.74 108.181 -178.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.537 ' O ' ' CB ' ' A' ' 24' ' ' SER . . . -103.67 176.2 23.9 Favored Glycine 0 N--CA 1.496 2.657 0 C-N-CA 119.064 -1.541 . . . . 0.79 110.392 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.537 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 1.3 t 84.75 -69.4 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.677 -0.896 . . . . 0.92 110.164 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.692 ' CB ' ' CD ' ' A' ' 26' ' ' PRO . 0.8 OUTLIER -83.57 -157.2 0.01 OUTLIER Pre-proline 0 C--N 1.304 -1.388 0 N-CA-C 108.274 -1.01 . . . . 4.49 108.274 -179.779 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.692 ' CD ' ' CB ' ' A' ' 25' ' ' ASP . 28.4 Cg_endo -74.38 89.53 1.07 Allowed 'Trans proline' 0 C--N 1.324 -0.76 0 N-CA-C 108.483 -1.391 . . . . 0.68 108.483 179.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.562 ' HA ' ' O ' ' A' ' 22' ' ' HIS . 1.6 t -38.4 95.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 113.244 0.831 . . . . 0.83 113.244 -177.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.493 ' O ' ' O ' ' A' ' 21' ' ' CYS . 24.1 mm -89.9 141.29 14.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 104.784 -2.302 . . . . 0.7 104.784 174.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.877 HG23 ' CA ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -119.45 179.94 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 O-C-N 120.215 -1.553 . . . . 0.79 112.886 -176.086 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.511 ' NE2' ' OD2' ' A' ' 129' ' ' ASP . 14.3 m170 -117.55 157.18 26.79 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.787 0.803 . . . . 2.87 110.828 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.583 ' HD3' ' CA ' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -115.43 154.55 29.06 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 107.76 -1.2 . . . . 1.54 107.76 178.285 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.415 ' H ' ' CG1' ' A' ' 94' ' ' VAL . . . 89.51 -1.01 81.3 Favored Glycine 0 N--CA 1.495 2.602 0 C-N-CA 119.582 -1.294 . . . . 0.35 110.073 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.753 ' N ' HG11 ' A' ' 94' ' ' VAL . 12.6 mtmt -128.65 146.72 61.28 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.257 -1.143 . . . . 1.74 108.284 179.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.569 ' O ' ' CB ' ' A' ' 19' ' ' ASP . 28.9 Cg_endo -66.26 109.89 1.66 Allowed 'Trans proline' 0 C--N 1.303 -1.855 0 C-N-CA 122.487 2.125 . . . . 0.43 110.199 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.677 ' CE1' HG11 ' A' ' 18' ' ' VAL . 47.5 t80 -81.11 70.3 7.91 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.414 0.626 . . . . 1.57 109.602 -179.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.605 HG22 ' O ' ' A' ' 36' ' ' THR . 32.9 m -90.91 76.69 6.25 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.439 -0.788 . . . . 0.8 109.816 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.523 ' CA ' HG13 ' A' ' 18' ' ' VAL . 1.6 pp -68.48 141.79 55.5 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.611 -1.255 . . . . 1.13 107.611 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.678 ' O ' ' HB2' ' A' ' 39' ' ' ALA . 14.2 mt-10 -142.21 -160.17 1.06 Allowed 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.82 -1.175 . . . . 1.04 110.995 -178.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.678 ' HB2' ' O ' ' A' ' 38' ' ' GLU . . . 156.35 96.44 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.153 -1.425 . . . . 0.59 107.153 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.686 ' HG ' ' CB ' ' A' ' 87' ' ' ASP . 0.3 OUTLIER -91.4 -176.88 4.68 Favored 'General case' 0 C--N 1.294 -1.82 0 O-C-N 121.546 -0.721 . . . . 0.57 110.371 -177.813 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.654 ' CE1' ' CE2' ' A' ' 86' ' ' TYR . 12.0 p90 175.37 147.74 0.09 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.393 -0.817 . . . . 0.38 109.147 177.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.465 ' O ' ' OD1' ' A' ' 44' ' ' ASN . 0.6 OUTLIER -98.72 112.41 24.49 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.441 -0.948 . . . . 4.36 108.441 179.747 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.791 ' HB1' ' O ' ' A' ' 81' ' ' VAL . . . -36.78 125.32 0.88 Allowed 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 115.932 -0.576 . . . . 0.45 110.245 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.465 ' OD1' ' O ' ' A' ' 42' ' ' ASP . 1.7 m-80 -125.77 38.98 4.05 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.23 -0.919 . . . . 1.09 109.417 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.829 ' CD ' HD21 ' A' ' 117' ' ' LEU . 3.4 pt20 -128.1 -129.72 0.22 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.417 -0.802 . . . . 0.87 110.327 -178.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.701 ' C ' HG22 ' A' ' 81' ' ' VAL . 0.8 OUTLIER -169.78 54.61 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.644 -0.873 . . . . 4.96 108.644 179.469 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.643 ' N ' HG22 ' A' ' 81' ' ' VAL . 10.1 t -133.68 138.21 45.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.809 -1.182 . . . . 0.88 110.57 -178.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.659 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 0.6 OUTLIER -83.91 -11.55 56.74 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 120.897 -1.127 . . . . 2.59 108.251 177.625 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.429 ' O ' ' O ' ' A' ' 78' ' ' CYS . 2.6 p -95.67 -155.87 0.49 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.394 -0.816 . . . . 1.02 109.449 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.828 ' CB ' ' HB3' ' A' ' 72' ' ' ALA . . . 177.64 154.14 0.29 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.389 -0.819 . . . . 0.41 109.963 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.876 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 19.9 mtpt -115.92 -175.38 2.72 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 106.385 -1.709 . . . . 1.53 106.385 177.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.642 HG13 HD13 ' A' ' 54' ' ' ILE . 3.1 tt -164.87 158.67 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 C-N-CA 117.692 -1.603 . . . . 0.89 111.343 -179.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.473 ' C ' ' HE2' ' A' ' 55' ' ' LYS . 0.8 OUTLIER -157.89 48.79 0.4 Allowed 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.35 -0.982 . . . . 1.61 108.35 179.845 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 1.007 ' HB ' HG21 ' A' ' 65' ' ' VAL . 0.4 OUTLIER -83.02 155.48 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.665 -0.647 . . . . 0.47 109.492 -179.533 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.661 ' HG3' ' O ' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -170.79 100.69 0.23 Allowed 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.109 -0.7 . . . . 1.59 109.109 178.577 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.518 ' O ' ' HB ' ' A' ' 63' ' ' ILE . . . -126.66 124.04 38.95 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.363 -0.836 . . . . 0.5 110.02 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -108.76 128.28 54.74 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.187 -0.946 . . . . 1.92 109.241 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.851 HD13 ' N ' ' A' ' 59' ' ' ASP . 1.8 tm? -122.94 154.64 38.11 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.132 -0.98 . . . . 1.67 109.078 -179.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.851 ' N ' HD13 ' A' ' 58' ' ' LEU . 0.4 OUTLIER -47.27 -59.31 3.26 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.262 -0.899 . . . . 4.07 110.262 -179.205 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -104.07 24.02 30.48 Favored Glycine 0 N--CA 1.493 2.444 0 C-N-CA 119.731 -1.223 . . . . 1.39 110.46 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.439 ' O ' ' HB3' ' A' ' 58' ' ' LEU . 0.5 OUTLIER -164.51 87.69 0.48 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.024 -1.28 . . . . 3.02 109.327 179.666 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.426 ' O ' ' C ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -79.09 70.88 5.52 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.732 -0.605 . . . . 2.85 110.301 -179.666 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.518 ' HB ' ' O ' ' A' ' 56' ' ' ALA . 6.0 mt -48.1 160.62 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 107.115 -1.439 . . . . 0.56 107.115 178.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.421 ' C ' ' HD3' ' A' ' 66' ' ' PRO . 23.3 t0 -170.4 142.77 2.2 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.867 -1.146 . . . . 2.69 109.215 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 1.007 HG21 ' HB ' ' A' ' 54' ' ' ILE . 11.7 t -132.82 69.42 79.24 Favored Pre-proline 0 C--N 1.298 -1.647 0 O-C-N 121.353 -0.842 . . . . 0.7 109.223 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.421 ' HD3' ' C ' ' A' ' 64' ' ' ASP . 34.8 Cg_endo -76.37 -2.08 12.23 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 122.994 2.462 . . . . 1.0 110.625 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 136.44 42.22 0.11 Allowed Glycine 0 N--CA 1.489 2.199 0 C-N-CA 119.864 -1.16 . . . . 1.06 110.308 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.466 HD13 ' HA ' ' A' ' 68' ' ' ILE . 35.4 mm -52.92 -77.32 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 O-C-N 120.964 -1.315 . . . . 1.46 108.875 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -87.77 160.13 18.17 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.062 -1.024 . . . . 4.6 108.866 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.432 ' O ' ' CG ' ' A' ' 71' ' ' ASN . 13.8 t -78.51 -12.23 60.0 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.242 -0.911 . . . . 5.22 109.968 -179.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.58 ' CA ' ' O ' ' A' ' 50' ' ' ALA . 5.7 m120 -164.31 77.0 0.34 Allowed 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 118.661 -1.216 . . . . 2.93 112.324 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.876 ' HB2' ' O ' ' A' ' 51' ' ' LYS . . . 22.34 46.01 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 121.492 0.663 . . . . 0.88 112.032 175.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.543 ' N ' ' O ' ' A' ' 71' ' ' ASN . 6.1 t -106.6 -42.12 5.07 Favored 'General case' 0 C--N 1.285 -2.219 0 O-C-N 121.346 -0.846 . . . . 0.95 110.531 -178.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 4.6 m170 -78.46 -1.2 32.52 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.993 -1.067 . . . . 3.94 109.79 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.518 ' HB3' HD11 ' A' ' 88' ' ' ILE . 57.9 m-85 -110.47 -14.7 14.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.233 -0.917 . . . . 0.45 109.898 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.82 ' HB ' ' CE1' ' A' ' 86' ' ' TYR . 0.2 OUTLIER -157.39 175.28 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 120.81 -1.181 . . . . 0.43 110.731 -177.316 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.647 ' N ' ' CG2' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -57.73 93.3 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 105.373 -2.084 . . . . 1.67 105.373 176.758 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . 0.553 ' HB2' ' HD3' ' A' ' 79' ' ' PRO . 2.7 m -34.57 -51.51 1.03 Allowed Pre-proline 0 N--CA 1.5 2.033 0 O-C-N 121.628 -0.67 . . . . 1.04 112.021 -176.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.659 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 32.1 Cg_endo -79.1 108.79 2.43 Favored 'Trans proline' 0 C--N 1.303 -1.842 0 N-CA-C 109.401 -1.038 . . . . 0.46 109.401 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.883 HD12 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -92.26 -65.47 1.0 Allowed 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.518 -1.29 . . . . 0.46 107.518 -179.86 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.791 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 14.0 t 54.84 -178.26 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 C-N-CA 119.29 -0.964 . . . . 2.89 109.134 177.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.569 ' N ' HG12 ' A' ' 81' ' ' VAL . 13.0 ptmt -102.2 37.01 1.96 Allowed 'General case' 0 C--N 1.296 -1.759 0 O-C-N 120.467 -1.395 . . . . 1.52 110.206 -178.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -145.65 37.22 1.29 Allowed Glycine 0 C--N 1.288 -2.105 0 N-CA-C 108.664 -1.774 . . . . 1.05 108.664 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -146.58 142.62 28.17 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 121.23 -1.159 . . . . 3.1 110.627 -178.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.457 ' O ' ' CG ' ' A' ' 85' ' ' GLN . 11.2 pt20 -115.88 130.69 56.94 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 105.977 -1.86 . . . . 2.56 105.977 177.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.82 ' CE1' ' HB ' ' A' ' 76' ' ' VAL . 0.1 OUTLIER -152.71 156.91 40.08 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 117.74 -1.584 . . . . 0.36 109.968 -177.641 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.686 ' CB ' ' HG ' ' A' ' 40' ' ' LEU . 7.2 p-10 -127.89 96.95 4.65 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 113.915 1.08 . . . . 0.36 113.915 -175.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.579 HG23 ' N ' ' A' ' 89' ' ' LYS . 6.2 tp -62.99 -163.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 N-CA-C 106.362 -1.718 . . . . 1.06 106.362 175.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.587 ' O ' ' CG ' ' A' ' 90' ' ' TYR . 1.0 OUTLIER 161.83 179.49 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.718 -1.239 . . . . 2.25 111.519 179.74 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.674 ' CZ ' HG21 ' A' ' 54' ' ' ILE . 62.9 m-85 -162.81 61.14 0.2 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 107.027 -1.472 . . . . 0.55 107.027 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.564 ' HA ' HG23 ' A' ' 36' ' ' THR . 7.1 p -43.36 178.05 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.132 0 CA-C-O 121.402 0.62 . . . . 1.19 111.382 -178.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.704 ' CZ2' ' HB2' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -173.82 116.35 0.24 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 118.71 -1.196 . . . . 3.44 112.516 -179.345 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -84.31 126.81 33.54 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 105.729 -1.952 . . . . 2.12 105.729 176.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.805 HG13 HD12 ' A' ' 97' ' ' ILE . 1.7 t -112.42 102.78 54.81 Favored Pre-proline 0 C--N 1.302 -1.481 0 O-C-N 120.626 -1.297 . . . . 0.88 113.033 -176.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.993 ' HD2' HD11 ' A' ' 97' ' ' ILE . 31.8 Cg_endo -79.04 44.2 1.64 Allowed 'Trans proline' 0 C--N 1.314 -1.255 0 C-N-CA 123.088 2.525 . . . . 2.3 110.905 176.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.539 ' O ' ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER 82.32 -70.03 0.06 Allowed 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 107.458 -1.312 . . . . 3.52 107.458 -178.48 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.993 HD11 ' HD2' ' A' ' 95' ' ' PRO . 2.7 mp 69.16 17.95 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 112.745 0.646 . . . . 0.98 112.745 176.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 1.059 ' HB1' ' HD2' ' A' ' 99' ' ' PRO . . . 49.06 177.65 0.01 OUTLIER Pre-proline 0 C--N 1.304 -1.377 0 O-C-N 120.774 -1.204 . . . . 0.58 110.477 178.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 1.059 ' HD2' ' HB1' ' A' ' 98' ' ' ALA . 50.8 Cg_endo -85.17 165.09 11.25 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 123.746 2.964 . . . . 0.67 110.044 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.634 ' HD3' ' CB ' ' A' ' 128' ' ' ARG . 3.8 mmmm 43.04 115.69 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 113.23 0.826 . . . . 2.06 113.23 175.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.836 ' CB ' HD13 ' A' ' 127' ' ' ILE . 10.1 t -92.31 161.61 14.62 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.961 -1.087 . . . . 0.4 108.242 177.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.473 ' O ' ' CB ' ' A' ' 103' ' ' ASN . 0.3 OUTLIER -61.93 -10.4 9.47 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.05 -1.031 . . . . 4.04 110.055 -179.77 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.501 ' N ' ' OD1' ' A' ' 103' ' ' ASN . 1.1 p30 167.27 158.63 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.058 -1.026 . . . . 4.69 109.569 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.573 ' O ' HG23 ' A' ' 105' ' ' VAL . 0.1 OUTLIER -158.65 -178.48 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.107 -0.995 . . . . 0.76 109.677 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 104' ' ' VAL . 0.9 OUTLIER 159.79 123.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 108.561 -0.903 . . . . 0.35 108.561 -179.758 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.649 ' HB ' ' HB3' ' A' ' 122' ' ' ALA . 2.4 t -118.99 144.6 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 120.883 -1.136 . . . . 0.56 110.197 -179.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.474 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -159.16 175.67 13.17 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.263 -1.014 . . . . 0.65 108.263 179.789 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.877 HG22 ' CD1' ' A' ' 54' ' ' ILE . 1.1 t 171.33 169.0 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 120.721 -1.237 . . . . 0.83 110.528 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.655 ' N ' HG13 ' A' ' 108' ' ' VAL . 11.2 ttpt 164.28 121.91 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.634 0.73 . . . . 0.81 109.091 178.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.732 HD11 ' HB1' ' A' ' 72' ' ' ALA . 7.7 tp -108.92 125.44 52.02 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.585 -1.265 . . . . 0.75 107.585 178.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.53 ' HB ' ' HB2' ' A' ' 51' ' ' LYS . 4.0 mt -130.31 114.7 29.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.162 -0.961 . . . . 0.92 110.71 -178.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.461 ' HA3' HG21 ' A' ' 47' ' ' THR . . . -70.84 -116.18 0.04 OUTLIER Glycine 0 N--CA 1.485 1.947 0 N-CA-C 107.75 -2.14 . . . . 0.37 107.75 177.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -135.07 -0.56 2.75 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.023 -1.281 . . . . 2.43 107.546 178.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -109.85 -24.81 10.65 Favored 'General case' 0 C--N 1.312 -1.057 0 O-C-N 121.35 -0.844 . . . . 0.96 109.428 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -179.85 176.72 47.69 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.401 -1.479 . . . . 1.26 109.401 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.48 ' HA ' ' HA ' ' A' ' 111' ' ' ILE . 0.9 OUTLIER -81.38 106.61 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.195 -1.18 . . . . 0.5 109.834 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.883 HD22 HD12 ' A' ' 80' ' ' LEU . 4.0 mt -52.3 -54.61 29.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.419 -0.801 . . . . 0.44 110.543 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.595 ' HA ' ' HB2' ' A' ' 9' ' ' ALA . . . -140.63 -170.9 3.11 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.061 -1.024 . . . . 0.44 110.847 -178.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 0.531 ' SG ' ' N ' ' A' ' 120' ' ' ALA . 0.0 OUTLIER 175.5 159.61 0.24 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.578 -0.701 . . . . 0.48 109.563 -179.652 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.531 ' N ' ' SG ' ' A' ' 119' ' ' CYS . . . -176.91 126.96 0.16 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.274 -0.891 . . . . 0.64 109.055 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.586 HG22 ' H ' ' A' ' 123' ' ' THR . 6.4 mt -129.37 132.24 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.175 -0.953 . . . . 0.74 109.902 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.649 ' HB3' ' HB ' ' A' ' 106' ' ' VAL . . . -115.8 20.89 14.28 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.156 -0.965 . . . . 1.43 108.759 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.586 ' H ' HG22 ' A' ' 121' ' ' ILE . 82.5 p 47.02 -160.7 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.413 -0.804 . . . . 3.69 109.272 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . 0.574 ' CE1' ' HB3' ' A' ' 26' ' ' PRO . 42.2 p-80 -71.06 160.09 33.53 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.223 -0.923 . . . . 4.29 109.115 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.49 ' HA2' ' O ' ' A' ' 27' ' ' CYS . . . -120.24 -169.76 14.1 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.621 -1.392 . . . . 1.79 109.621 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.414 ' O ' ' C ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER 178.41 74.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.285 -1.127 . . . . 1.48 109.574 179.736 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.836 HD13 ' CB ' ' A' ' 101' ' ' SER . 2.5 mp -39.41 157.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.6 -0.688 . . . . 0.47 110.463 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.662 ' CB ' ' O ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER 132.97 -87.19 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.142 0 CA-C-O 121.357 0.599 . . . . 2.82 109.956 178.476 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.511 ' OD2' ' NE2' ' A' ' 30' ' ' HIS . 1.7 t0 . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 118.112 -0.946 . . . . 4.27 109.693 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.501 0.667 . . . . 3.2 109.574 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.572 ' HA ' ' CG ' ' A' ' 17' ' ' MET . 12.2 pt20 -133.92 41.89 2.97 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.498 -0.751 . . . . 3.33 108.984 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.56 HG23 HG23 ' A' ' 18' ' ' VAL . 2.0 m -45.86 120.89 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 108.16 -1.052 . . . . 3.03 108.16 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.473 ' C ' ' HA3' ' A' ' 23' ' ' GLY . 71.3 m-20 -94.41 127.84 40.56 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.379 -0.826 . . . . 5.39 110.913 -178.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.643 HG13 ' HA2' ' A' ' 23' ' ' GLY . 0.1 OUTLIER -95.72 -170.67 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.013 -1.106 . . . . 1.5 108.013 178.655 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.81 94.62 9.19 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.83 -1.169 . . . . 2.14 109.153 179.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.479 ' HA ' ' O ' ' A' ' 119' ' ' CYS . 1.6 m-20 -99.07 174.35 6.38 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.537 -0.727 . . . . 4.44 109.286 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.514 ' N ' ' SG ' ' A' ' 119' ' ' CYS . 31.6 p -163.62 49.14 0.14 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.238 -0.913 . . . . 2.23 109.725 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.553 ' HA ' ' HA ' ' A' ' 118' ' ' ALA . . . -83.3 -66.33 0.9 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.112 -0.993 . . . . 0.61 109.859 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.522 ' CB ' ' O ' ' A' ' 9' ' ' ALA . 0.9 OUTLIER 164.34 42.33 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.46 -0.896 . . . . 1.65 109.788 -178.779 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.2 m120 49.88 23.93 1.18 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.937 -1.102 . . . . 3.04 108.042 -179.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 13' ' ' ILE . 0.0 OUTLIER -105.76 -28.54 10.62 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.574 -0.704 . . . . 3.38 109.234 -179.764 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 1.038 HG23 ' O ' ' A' ' 40' ' ' LEU . 11.9 mt -41.81 143.7 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 109.077 -0.712 . . . . 0.6 109.077 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -105.02 -19.2 13.91 Favored 'General case' 0 C--N 1.295 -1.767 0 O-C-N 121.402 -0.811 . . . . 3.89 108.998 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.403 ' H ' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -160.35 104.98 1.46 Allowed 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 119.031 -1.067 . . . . 2.74 110.363 -177.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.546 ' O ' HG13 ' A' ' 16' ' ' VAL . 2.6 p -120.87 95.82 3.81 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 107.075 -1.454 . . . . 1.48 107.075 178.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.572 ' CG ' ' HA ' ' A' ' 2' ' ' GLN . 2.3 mpt? -144.7 145.57 31.78 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.63 -0.669 . . . . 2.24 109.751 -178.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.992 HG13 ' HA ' ' A' ' 37' ' ' LEU . 1.7 t -110.93 120.36 61.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 108.255 -1.017 . . . . 0.61 108.255 179.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -41.93 -26.1 0.08 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.39 -0.819 . . . . 2.76 109.714 -179.44 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -158.1 -148.42 5.14 Favored Glycine 0 N--CA 1.488 2.116 0 C-N-CA 119.615 -1.279 . . . . 2.0 109.964 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.634 ' HA ' ' HA ' ' A' ' 29' ' ' ILE . 50.4 t 65.15 -111.47 0.24 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.629 -0.924 . . . . 2.27 109.664 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.572 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 0.3 OUTLIER 155.2 139.7 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 106.621 -1.622 . . . . 2.26 106.621 -178.723 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.643 ' HA2' HG13 ' A' ' 5' ' ' VAL . . . -107.99 157.59 15.29 Favored Glycine 0 C--N 1.288 -2.119 0 N-CA-C 109.409 -1.477 . . . . 1.51 109.409 -179.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.457 ' O ' ' CB ' ' A' ' 25' ' ' ASP . 0.2 OUTLIER 66.61 137.2 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.216 -1.167 . . . . 2.86 108.279 -179.163 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.558 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.2 OUTLIER 66.48 177.29 0.05 OUTLIER Pre-proline 0 C--N 1.304 -1.385 0 O-C-N 120.455 -1.403 . . . . 5.52 107.998 -179.815 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.558 ' HD2' ' CB ' ' A' ' 25' ' ' ASP . 30.7 Cg_endo -74.8 123.67 8.15 Favored 'Trans proline' 0 C--N 1.299 -2.055 0 C-N-CA 122.747 2.298 . . . . 2.11 109.397 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.572 ' HB2' ' O ' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -97.08 113.94 25.55 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.291 -0.881 . . . . 1.44 111.491 -177.819 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.637 HD13 ' HG3' ' A' ' 126' ' ' LYS . 20.1 mm -86.77 83.72 2.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 107.147 -1.427 . . . . 1.97 107.147 176.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.634 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -50.08 -177.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 O-C-N 121.699 -0.626 . . . . 2.02 109.977 -179.138 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 79.5 m-70 -134.2 160.44 37.84 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.507 -0.877 . . . . 1.3 110.659 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.586 ' HD3' ' CA ' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -108.83 113.02 25.6 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.528 -0.732 . . . . 1.74 109.399 179.626 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 134.42 0.2 3.75 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 110.206 -1.158 . . . . 0.8 110.206 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.579 ' O ' HG21 ' A' ' 94' ' ' VAL . 13.3 mttt -130.23 144.43 53.17 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 120.93 -1.335 . . . . 1.46 110.184 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -69.41 81.08 0.75 Allowed 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 123.166 2.577 . . . . 0.81 111.19 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.728 ' H ' HG21 ' A' ' 94' ' ' VAL . 5.2 t80 -55.42 122.13 10.52 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 109.433 -0.581 . . . . 2.37 109.433 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 37.5 m -134.04 85.44 2.2 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.075 -1.015 . . . . 1.5 109.571 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.992 ' HA ' HG13 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -62.66 141.38 58.55 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.235 -0.915 . . . . 1.94 108.891 179.746 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.963 ' N ' HD12 ' A' ' 37' ' ' LEU . 87.2 mt-10 -139.17 -171.23 3.06 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.147 -0.971 . . . . 2.21 110.06 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.703 ' HB2' ' O ' ' A' ' 38' ' ' GLU . . . 155.13 70.7 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.906 -1.146 . . . . 1.36 107.906 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 1.038 ' O ' HG23 ' A' ' 13' ' ' ILE . 0.8 OUTLIER -71.98 171.73 11.3 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 115.912 -0.585 . . . . 0.5 110.162 -178.841 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.746 ' HZ ' ' HH ' ' A' ' 86' ' ' TYR . 5.5 p90 -176.01 148.39 0.82 Allowed 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.583 -0.895 . . . . 0.37 108.583 179.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.509 ' O ' ' C ' ' A' ' 43' ' ' ALA . 6.7 t70 -95.28 112.19 23.94 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 107.286 -1.375 . . . . 2.09 107.286 178.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.699 ' HB1' ' O ' ' A' ' 81' ' ' VAL . . . -36.1 125.53 0.76 Allowed 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 115.61 -0.723 . . . . 0.66 109.1 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -124.04 15.02 9.19 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.171 -0.956 . . . . 4.08 110.33 -177.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.959 ' OE1' HD21 ' A' ' 117' ' ' LEU . 2.3 pt20 -105.56 -139.41 0.37 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.379 -0.971 . . . . 0.31 108.379 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.794 ' HA ' ' HB ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -156.73 67.98 0.57 Allowed 'General case' 0 C--N 1.294 -1.845 0 O-C-N 121.08 -1.013 . . . . 1.1 109.306 178.59 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.753 HG23 ' O ' ' A' ' 47' ' ' THR . 10.3 t -146.33 118.47 8.31 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.263 -1.523 . . . . 0.52 111.607 -178.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.611 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 0.6 OUTLIER -66.4 -10.6 45.3 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.66 -1.275 . . . . 2.37 107.847 177.262 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.482 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 30.5 p -98.44 -161.3 0.86 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.335 -0.853 . . . . 0.77 108.807 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.912 ' CB ' ' HB3' ' A' ' 72' ' ' ALA . . . 174.67 160.4 0.19 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.168 -0.958 . . . . 0.3 109.863 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 1.011 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 20.3 mtmt -123.14 169.04 11.64 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 107.227 -1.398 . . . . 0.98 107.227 177.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.572 HD13 ' CD1' ' A' ' 75' ' ' PHE . 11.1 tt -148.19 144.74 18.89 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.239 0 C-N-CA 118.413 -1.315 . . . . 0.55 110.558 -178.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.456 ' O ' ' CE ' ' A' ' 55' ' ' LYS . 6.1 mt-10 -139.84 56.42 1.64 Allowed 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 107.101 -1.444 . . . . 1.67 107.101 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.948 ' HB ' HG21 ' A' ' 65' ' ' VAL . 0.3 OUTLIER -87.62 151.91 3.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 O-C-N 121.312 -0.867 . . . . 1.13 110.096 -178.392 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.686 ' HG3' ' O ' ' A' ' 54' ' ' ILE . 0.1 OUTLIER -166.51 95.22 0.54 Allowed 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 109.053 -0.721 . . . . 1.02 109.053 178.305 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.726 ' HB3' ' HB ' ' A' ' 63' ' ' ILE . . . -118.78 138.66 52.53 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.394 -0.816 . . . . 0.54 109.563 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.455 ' O ' ' CG1' ' A' ' 104' ' ' VAL . 1.6 t -124.4 124.8 43.14 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.925 -1.109 . . . . 1.11 110.125 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 1.011 HD13 ' N ' ' A' ' 59' ' ' ASP . 2.6 tm? -117.85 152.86 34.52 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.255 -1.017 . . . . 1.46 108.255 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 1.011 ' N ' HD13 ' A' ' 58' ' ' LEU . 5.4 t0 -43.61 -66.06 0.42 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.061 -1.025 . . . . 2.17 109.938 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.496 ' O ' HD12 ' A' ' 61' ' ' LEU . . . -101.09 20.18 48.63 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.058 -1.217 . . . . 0.75 110.058 -179.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.496 HD12 ' O ' ' A' ' 60' ' ' GLY . 1.9 tp -152.69 79.13 1.21 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.141 -1.211 . . . . 2.46 108.935 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.445 ' O ' ' C ' ' A' ' 63' ' ' ILE . 0.5 OUTLIER -74.9 76.05 2.15 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 116.203 -0.453 . . . . 3.91 110.869 -179.19 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.726 ' HB ' ' HB3' ' A' ' 56' ' ' ALA . 3.2 mt -49.08 162.81 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 106.54 -1.652 . . . . 0.58 106.54 178.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -176.02 147.43 0.75 Allowed 'General case' 0 C--N 1.297 -1.707 0 O-C-N 120.424 -1.423 . . . . 0.9 109.004 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.948 HG21 ' HB ' ' A' ' 54' ' ' ILE . 17.1 t -140.77 62.28 17.27 Favored Pre-proline 0 C--N 1.299 -1.598 0 C-N-CA 119.279 -0.969 . . . . 1.21 110.215 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.562 ' HD3' ' N ' ' A' ' 65' ' ' VAL . 36.2 Cg_endo -78.32 -5.05 14.76 Favored 'Trans proline' 0 C--N 1.301 -1.964 0 C-N-CA 122.82 2.347 . . . . 1.27 109.094 178.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 68' ' ' ILE . . . -177.62 -110.25 0.27 Allowed Glycine 0 N--CA 1.487 2.073 0 N-CA-C 108.14 -1.984 . . . . 1.94 108.14 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.45 ' C ' ' O ' ' A' ' 67' ' ' GLY . 0.0 OUTLIER 39.97 85.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.421 -1.046 . . . . 2.42 109.779 179.103 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 46.28 80.38 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.003 -1.061 . . . . 5.99 108.856 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.37 50.17 1.95 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.361 -0.837 . . . . 7.87 109.467 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.529 ' CA ' ' O ' ' A' ' 50' ' ' ALA . 8.6 m-20 -136.86 38.04 2.6 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.195 -0.941 . . . . 1.97 109.935 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 1.011 ' HB2' ' O ' ' A' ' 51' ' ' LYS . . . 37.92 29.18 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 121.419 0.628 . . . . 0.94 110.466 177.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.499 ' N ' ' O ' ' A' ' 71' ' ' ASN . 9.8 t -105.2 -52.29 2.87 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.455 -0.778 . . . . 0.96 110.003 -179.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -67.27 -16.91 64.56 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.957 -1.089 . . . . 1.05 109.706 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.655 ' C ' HG12 ' A' ' 76' ' ' VAL . 91.7 m-85 -101.05 -9.14 21.69 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.173 -0.954 . . . . 0.95 110.169 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.789 ' HB ' ' CE1' ' A' ' 86' ' ' TYR . 0.2 OUTLIER -165.66 173.98 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 120.591 -1.318 . . . . 0.55 111.366 -177.298 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.64 ' N ' ' CG2' ' A' ' 76' ' ' VAL . 2.5 mmmt -56.23 92.3 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.119 -1.437 . . . . 1.54 107.119 177.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . 0.509 ' N ' ' O ' ' A' ' 76' ' ' VAL . 0.4 OUTLIER -35.22 -52.53 1.22 Allowed Pre-proline 0 N--CA 1.502 2.15 0 CA-C-N 116.323 -0.399 . . . . 0.97 110.955 -177.596 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.611 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 31.2 Cg_endo -76.59 109.52 2.88 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 121.115 1.21 . . . . 0.64 109.269 179.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 1.092 HD22 HD22 ' A' ' 117' ' ' LEU . 0.5 OUTLIER -103.15 -63.51 1.17 Allowed 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 121.41 0.624 . . . . 2.55 109.399 -178.519 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.794 ' HB ' ' HA ' ' A' ' 46' ' ' ASN . 1.3 m 40.18 -167.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 C-N-CA 120.56 -0.456 . . . . 0.52 109.884 178.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.711 ' H ' HG23 ' A' ' 81' ' ' VAL . 1.0 OUTLIER -104.38 41.96 1.25 Allowed 'General case' 0 C--N 1.289 -2.054 0 O-C-N 120.39 -1.444 . . . . 2.7 110.411 -176.848 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -146.65 35.88 1.28 Allowed Glycine 0 C--N 1.287 -2.19 0 N-CA-C 108.583 -1.807 . . . . 0.85 108.583 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.53 ' NE2' ' HG3' ' A' ' 77' ' ' LYS . 12.6 tp60 -150.0 140.1 22.08 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 121.237 -1.155 . . . . 3.09 110.578 -179.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.504 ' HG2' ' HB2' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -112.42 129.31 56.36 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 105.566 -2.013 . . . . 2.42 105.566 177.048 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.789 ' CE1' ' HB ' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -151.21 160.94 43.55 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 117.525 -1.67 . . . . 0.51 110.124 -177.371 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.636 ' CB ' ' HG ' ' A' ' 40' ' ' LEU . 1.8 m-20 -129.03 99.5 5.29 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.948 -1.095 . . . . 4.08 113.456 -175.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.638 HG23 ' N ' ' A' ' 89' ' ' LYS . 3.8 tp -66.78 -163.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 106.839 -1.541 . . . . 1.14 106.839 176.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.638 ' N ' HG23 ' A' ' 88' ' ' ILE . 10.4 mttt 161.39 175.4 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.271 0 O-C-N 120.927 -1.108 . . . . 1.26 111.071 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.592 ' CG ' ' O ' ' A' ' 89' ' ' LYS . 41.9 m-85 -165.37 103.11 0.73 Allowed 'General case' 0 N--CA 1.504 2.269 0 N-CA-C 108.154 -1.054 . . . . 0.75 108.154 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.415 HG22 ' H ' ' A' ' 92' ' ' TRP . 0.2 OUTLIER -96.03 179.18 5.16 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.282 -0.887 . . . . 3.11 111.467 -177.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.828 ' O ' HG23 ' A' ' 94' ' ' VAL . 1.7 t90 -167.62 101.57 0.49 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.759 -0.588 . . . . 4.35 109.472 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.507 ' O ' ' CD1' ' A' ' 92' ' ' TRP . 49.4 t-20 -47.47 123.33 5.58 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 106.842 -1.54 . . . . 1.79 106.842 178.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.874 HG13 ' CD1' ' A' ' 97' ' ' ILE . 58.2 t -116.21 90.5 29.28 Favored Pre-proline 0 C--N 1.3 -1.547 0 C-N-CA 118.568 -1.253 . . . . 1.39 111.934 -177.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.709 ' HD2' HD11 ' A' ' 97' ' ' ILE . 33.7 Cg_endo -83.07 58.65 6.38 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 123.423 2.749 . . . . 2.72 109.809 178.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.729 ' C ' HD12 ' A' ' 97' ' ' ILE . 0.1 OUTLIER 71.04 -80.37 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.386 -1.339 . . . . 3.05 107.386 -177.843 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.874 ' CD1' HG13 ' A' ' 94' ' ' VAL . 2.6 mp 76.44 34.58 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.638 -0.664 . . . . 1.04 112.24 177.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.959 ' HB1' ' HD2' ' A' ' 99' ' ' PRO . . . 53.32 171.4 0.04 OUTLIER Pre-proline 0 C--N 1.3 -1.578 0 O-C-N 120.98 -1.075 . . . . 0.45 110.991 178.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.959 ' HD2' ' HB1' ' A' ' 98' ' ' ALA . 61.4 Cg_endo -87.45 83.91 0.92 Allowed 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 123.951 3.101 . . . . 1.7 110.487 -178.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.728 ' CB ' ' O ' ' A' ' 99' ' ' PRO . 0.1 OUTLIER 116.25 121.14 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 118.896 0.771 . . . . 2.0 111.02 178.279 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.455 ' O ' ' N ' ' A' ' 103' ' ' ASN . 1.9 p -92.29 148.7 21.93 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.754 -1.202 . . . . 2.11 107.754 177.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 101' ' ' SER . 0.0 OUTLIER -42.58 -26.47 0.12 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.947 -1.096 . . . . 4.38 109.727 -179.231 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.478 ' C ' ' CG2' ' A' ' 104' ' ' VAL . 1.4 t-20 171.23 160.22 0.08 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.317 -0.864 . . . . 2.22 109.246 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.478 ' CG2' ' C ' ' A' ' 103' ' ' ASN . 0.1 OUTLIER -155.99 140.38 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.157 -0.964 . . . . 1.05 109.64 179.942 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -143.09 134.37 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.352 -0.843 . . . . 0.96 109.179 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.85 ' HB ' ' HB3' ' A' ' 122' ' ' ALA . 49.5 t -126.04 125.03 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.033 -1.042 . . . . 0.58 109.775 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.529 ' O ' HG22 ' A' ' 108' ' ' VAL . 74.6 m -147.18 136.11 22.26 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.881 -1.155 . . . . 1.08 107.881 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.637 HG12 ' CD1' ' A' ' 54' ' ' ILE . 0.3 OUTLIER -157.19 162.18 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 120.419 -1.426 . . . . 2.18 110.881 -179.284 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.558 ' HA ' ' HA ' ' A' ' 119' ' ' CYS . 2.4 tttt 175.19 118.6 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.726 0.774 . . . . 3.03 110.215 178.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.605 ' HB3' ' HB2' ' A' ' 117' ' ' LEU . 4.6 tp -92.89 122.26 35.09 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.367 -1.346 . . . . 0.97 107.367 178.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.526 ' HB ' ' HB2' ' A' ' 51' ' ' LYS . 5.7 mt -122.12 114.99 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.766 -1.209 . . . . 0.49 111.932 -177.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -80.01 -127.58 0.67 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 107.91 -2.076 . . . . 1.07 107.91 177.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -135.2 -2.97 2.48 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.878 -1.366 . . . . 2.67 107.881 178.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.401 ' CG ' ' ND2' ' A' ' 46' ' ' ASN . 1.2 m-80 -115.03 -7.54 12.51 Favored 'General case' 0 C--N 1.313 -0.991 0 O-C-N 121.24 -0.913 . . . . 1.3 110.082 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 163.91 139.85 2.73 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 110.015 -1.234 . . . . 2.12 110.015 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.529 ' CG2' ' HE3' ' A' ' 109' ' ' LYS . 0.1 OUTLIER -52.29 119.42 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.36 -1.082 . . . . 0.9 109.823 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 1.092 HD22 HD22 ' A' ' 80' ' ' LEU . 1.7 mt -62.73 -59.98 4.13 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.274 -0.891 . . . . 0.55 109.329 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.553 ' HA ' ' HA ' ' A' ' 9' ' ' ALA . . . -158.23 -173.02 4.12 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.54 -0.725 . . . . 0.96 109.274 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 0.558 ' HA ' ' HA ' ' A' ' 109' ' ' LYS . 13.5 p 176.96 170.16 0.52 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.343 -0.848 . . . . 1.11 109.422 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -164.21 131.45 3.26 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.495 -0.753 . . . . 0.5 109.057 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.489 ' O ' HG12 ' A' ' 5' ' ' VAL . 2.7 mp -128.18 142.82 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.089 -1.007 . . . . 0.68 110.57 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.85 ' HB3' ' HB ' ' A' ' 106' ' ' VAL . . . -138.19 64.41 1.5 Allowed 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.028 -1.101 . . . . 0.8 108.028 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.484 ' O ' ' O ' ' A' ' 124' ' ' HIS . 0.4 OUTLIER -38.74 132.28 1.22 Allowed 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.681 0.753 . . . . 2.39 111.533 -178.472 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . 0.484 ' O ' ' O ' ' A' ' 123' ' ' THR . 1.4 m-70 47.74 173.0 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.866 0.841 . . . . 2.81 111.495 178.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 167.49 141.83 3.28 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.39 -1.484 . . . . 0.64 109.39 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.637 ' HG3' HD13 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -147.01 134.11 20.42 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.116 -1.226 . . . . 1.66 109.343 179.683 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.591 ' CD1' HG13 ' A' ' 29' ' ' ILE . 0.8 OUTLIER -79.27 124.1 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.408 -0.808 . . . . 1.67 111.172 -178.306 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.623 ' HB2' ' HG2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER 168.64 -89.78 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.887 -1.133 . . . . 2.26 109.491 177.172 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.608 ' N ' HG21 ' A' ' 28' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 118.013 -0.994 . . . . 3.65 109.212 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.183 -0.673 . . . . 4.3 109.183 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.556 ' HB3' ' CG ' ' A' ' 17' ' ' MET . 1.2 pt20 -100.6 -172.97 2.29 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.063 -1.023 . . . . 2.37 109.508 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 1.0 HG12 ' HA ' ' A' ' 22' ' ' HIS . 5.5 m -128.92 -168.26 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.348 -0.845 . . . . 1.74 109.409 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -130.87 77.8 1.8 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.178 -0.951 . . . . 1.44 109.305 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.8 m -100.6 150.78 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.162 -0.961 . . . . 1.43 109.596 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.507 ' O ' HD12 ' A' ' 121' ' ' ILE . 12.8 mtpp -75.05 93.68 2.77 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.496 -0.752 . . . . 2.31 109.701 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.523 ' HB2' HD12 ' A' ' 13' ' ' ILE . 35.4 p-10 -82.81 176.08 9.59 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.197 -0.939 . . . . 2.3 109.122 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.517 ' N ' ' SG ' ' A' ' 119' ' ' CYS . 7.8 m -138.59 9.09 2.64 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.124 -0.985 . . . . 1.32 109.919 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.668 ' HB2' HG13 ' A' ' 13' ' ' ILE . . . -56.55 -43.99 80.48 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.932 -1.105 . . . . 0.69 109.035 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.51 ' CB ' ' O ' ' A' ' 9' ' ' ALA . 0.5 OUTLIER 163.61 -58.09 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.948 -0.76 . . . . 5.01 108.948 -179.185 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 10' ' ' ASN . 1.9 t-20 174.46 38.0 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.921 -0.77 . . . . 3.63 108.921 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -171.56 -62.71 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.025 -1.047 . . . . 4.65 110.859 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.668 HG13 ' HB2' ' A' ' 9' ' ' ALA . 0.1 OUTLIER 67.76 4.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.122 -0.987 . . . . 3.91 110.155 -179.047 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.548 ' HB2' ' O ' ' A' ' 13' ' ' ILE . 0.0 OUTLIER 75.08 -31.95 0.22 Allowed 'General case' 0 C--N 1.293 -1.876 0 O-C-N 121.386 -0.821 . . . . 2.23 111.036 178.747 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.532 ' CB ' ' O ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER 165.81 109.93 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 118.785 -1.166 . . . . 2.93 110.569 -178.622 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.656 ' O ' HG13 ' A' ' 16' ' ' VAL . 6.8 p -120.07 107.85 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.096 -1.002 . . . . 1.2 108.76 178.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.556 ' CG ' ' HB3' ' A' ' 2' ' ' GLN . 0.5 OUTLIER -145.83 146.91 31.33 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.366 -0.934 . . . . 1.43 110.332 -179.605 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.71 HG22 ' HA ' ' A' ' 37' ' ' LEU . 42.1 t -117.62 148.95 20.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 108.255 -1.017 . . . . 1.3 108.255 179.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.439 ' HB3' ' HA ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -81.17 71.2 8.14 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.069 -1.086 . . . . 1.0 108.069 179.446 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.542 ' O ' ' CB ' ' A' ' 21' ' ' CYS . . . 108.02 -167.85 13.56 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 109.157 -1.577 . . . . 1.76 109.157 -178.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 1.002 ' CA ' HG23 ' A' ' 29' ' ' ILE . 15.5 t 83.54 -57.71 0.14 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.782 -0.834 . . . . 1.42 109.984 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 1.0 ' HA ' HG12 ' A' ' 3' ' ' VAL . 0.3 OUTLIER 58.14 107.39 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.561 -1.337 . . . . 4.12 109.145 -178.799 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.573 ' O ' ' CB ' ' A' ' 24' ' ' SER . . . -92.54 -143.8 13.18 Favored Glycine 0 N--CA 1.497 2.737 0 O-C-N 121.163 -0.961 . . . . 1.12 111.236 -178.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.573 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 1.0 OUTLIER 86.09 -48.73 0.06 Allowed 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.38 -0.97 . . . . 2.33 108.38 -178.823 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.701 ' CB ' ' CD ' ' A' ' 26' ' ' PRO . 5.2 m-20 -120.11 -149.86 0.01 OUTLIER Pre-proline 0 C--N 1.303 -1.426 0 N-CA-C 105.665 -1.976 . . . . 4.45 105.665 178.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.701 ' CD ' ' CB ' ' A' ' 25' ' ' ASP . 30.9 Cg_endo -74.34 85.69 1.39 Allowed 'Trans proline' 0 C--O 1.208 -1.012 0 N-CA-C 107.169 -1.896 . . . . 0.48 107.169 178.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.542 ' HA ' ' O ' ' A' ' 22' ' ' HIS . 4.1 t -34.51 80.17 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 113.697 0.999 . . . . 1.69 113.697 -176.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.762 HG23 ' O ' ' A' ' 126' ' ' LYS . 0.7 OUTLIER -71.68 144.51 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 N-CA-C 106.772 -1.566 . . . . 1.46 106.772 176.343 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 1.002 HG23 ' CA ' ' A' ' 21' ' ' CYS . 0.1 OUTLIER -122.99 -159.9 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 O-C-N 120.371 -1.456 . . . . 0.89 112.706 -176.425 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.481 ' H ' HG22 ' A' ' 29' ' ' ILE . 40.5 m-70 -131.07 166.55 20.82 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.657 0.742 . . . . 1.45 110.418 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.563 ' HD3' ' HA ' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -116.05 -167.15 1.22 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.617 -0.677 . . . . 2.57 109.464 -179.98 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.431 ' HA2' ' O ' ' A' ' 95' ' ' PRO . . . 42.74 27.96 0.6 Allowed Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.692 -0.963 . . . . 0.99 110.692 179.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.493 ' O ' HG11 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -151.76 133.87 8.4 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 120.754 -1.439 . . . . 1.55 109.493 179.789 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.423 ' HA ' ' HB ' ' A' ' 94' ' ' VAL . 28.8 Cg_endo -68.26 78.99 0.6 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.601 2.2 . . . . 1.66 111.325 -179.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.483 ' CD1' ' C ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -62.05 149.52 40.81 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.281 -1.007 . . . . 3.29 108.281 178.944 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.732 HG23 HG22 ' A' ' 91' ' ' THR . 6.4 m -153.71 95.81 1.93 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.918 -1.114 . . . . 0.75 110.211 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.71 ' HA ' HG22 ' A' ' 18' ' ' VAL . 2.3 pp -61.1 142.28 56.8 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.818 -1.179 . . . . 0.67 107.818 178.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.532 ' HG3' ' CG ' ' A' ' 89' ' ' LYS . 2.0 tt0 -136.04 131.6 35.14 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.995 -1.066 . . . . 3.95 109.882 -179.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.526 ' O ' HG22 ' A' ' 88' ' ' ILE . . . -141.28 90.58 2.32 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.765 -1.198 . . . . 0.95 107.765 178.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.618 ' HG ' ' CB ' ' A' ' 87' ' ' ASP . 0.2 OUTLIER -83.07 -176.36 6.29 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 109.236 -0.653 . . . . 1.17 109.236 -178.567 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.596 ' O ' ' CD1' ' A' ' 41' ' ' PHE . 6.2 p90 171.08 133.86 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.361 -1.348 . . . . 1.24 107.361 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.585 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 0.0 OUTLIER -90.13 119.88 30.84 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 107.969 -1.122 . . . . 3.71 107.969 179.86 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.78 ' HB3' ' O ' ' A' ' 84' ' ' GLN . . . -38.79 112.44 0.24 Allowed 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 109.47 -0.567 . . . . 0.42 109.47 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.501 ' CG ' ' O ' ' A' ' 42' ' ' ASP . 2.5 m-80 -122.14 45.75 2.27 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.479 -0.763 . . . . 1.75 109.023 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.638 ' OE1' ' HB2' ' A' ' 80' ' ' LEU . 3.5 pt20 -133.5 -133.12 0.17 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.267 -0.896 . . . . 1.35 110.198 -178.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.685 ' C ' HG22 ' A' ' 81' ' ' VAL . 47.3 t30 -169.89 53.0 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.441 -0.787 . . . . 4.34 109.604 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.712 ' N ' HG22 ' A' ' 81' ' ' VAL . 3.9 t -139.18 138.25 36.77 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.613 -1.304 . . . . 0.88 110.576 -178.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.612 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 1.2 mtmp? -78.84 -0.84 32.23 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.81 -1.181 . . . . 3.06 108.478 177.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.5 p -107.55 165.9 11.07 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.262 -0.899 . . . . 0.82 108.962 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.839 ' CB ' ' HB3' ' A' ' 72' ' ' ALA . . . -144.21 148.21 34.65 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.402 -0.962 . . . . 0.92 108.402 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.898 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 56.6 mttt -118.03 -169.45 1.69 Allowed 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.17 -1.418 . . . . 1.75 107.17 177.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.417 ' HB ' ' O ' ' A' ' 51' ' ' LYS . 5.5 tt -176.4 151.4 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 C-N-CA 118.731 -1.188 . . . . 0.63 110.179 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.49 ' O ' ' NZ ' ' A' ' 55' ' ' LYS . 0.4 OUTLIER -148.45 57.54 1.06 Allowed 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.583 -0.895 . . . . 2.86 108.583 179.916 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.907 ' CD1' HG13 ' A' ' 108' ' ' VAL . 1.6 mm -73.58 160.39 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.486 -0.759 . . . . 2.75 109.675 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.576 ' N ' ' CG2' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -173.14 81.57 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.252 0.548 . . . . 1.14 110.055 178.548 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.475 ' HB3' ' HB ' ' A' ' 63' ' ' ILE . . . -122.16 155.42 35.82 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 108.78 -0.822 . . . . 1.54 108.78 179.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.442 ' OG ' ' HA ' ' A' ' 104' ' ' VAL . 0.0 OUTLIER -129.7 136.56 49.83 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.035 -1.041 . . . . 1.23 109.402 -179.609 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.541 ' HG ' ' CE3' ' A' ' 92' ' ' TRP . 0.0 OUTLIER -128.0 164.49 22.23 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.286 -0.884 . . . . 3.89 109.202 -179.506 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.498 ' OD2' ' N ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -39.47 -68.03 0.19 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.38 -0.825 . . . . 4.27 109.617 -179.796 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.624 ' O ' HD22 ' A' ' 61' ' ' LEU . . . -118.81 30.1 6.03 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.146 -1.582 . . . . 0.96 109.146 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.624 HD22 ' O ' ' A' ' 60' ' ' GLY . 0.2 OUTLIER -139.81 61.24 1.54 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.257 -1.143 . . . . 0.9 110.049 -179.578 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.483 ' HG3' ' O ' ' A' ' 62' ' ' GLU . 0.3 OUTLIER -55.69 100.2 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.967 -1.083 . . . . 3.46 108.162 179.348 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.572 HG22 ' O ' ' A' ' 63' ' ' ILE . 2.9 mt -71.8 -2.68 3.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.364 -0.835 . . . . 2.47 111.087 -178.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.507 ' C ' ' O ' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -30.97 137.65 0.04 OUTLIER 'General case' 0 C--N 1.285 -2.213 0 CA-C-O 121.532 0.682 . . . . 2.85 110.009 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.705 HG21 ' HB ' ' A' ' 54' ' ' ILE . 70.1 t -126.01 90.26 50.62 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.396 -0.815 . . . . 1.61 109.755 -178.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.89 -4.53 13.42 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.92 2.413 . . . . 1.41 110.757 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 68' ' ' ILE . . . 167.83 -92.09 0.1 Allowed Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.617 -1.393 . . . . 2.99 109.617 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.482 ' O ' ' O ' ' A' ' 69' ' ' ASP . 1.2 mm 49.95 99.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.216 -1.167 . . . . 3.21 109.791 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.524 ' CG ' ' HB2' ' A' ' 74' ' ' HIS . 13.0 m-20 53.23 104.91 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.337 -0.852 . . . . 5.5 108.91 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -82.32 31.55 0.4 Allowed 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.383 -0.823 . . . . 5.26 111.113 -178.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.611 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -154.16 40.16 0.47 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.449 -1.407 . . . . 4.78 111.445 179.79 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.898 ' HB2' ' O ' ' A' ' 51' ' ' LYS . . . 32.27 31.71 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.173 0.511 . . . . 0.55 111.894 176.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.562 ' N ' ' O ' ' A' ' 71' ' ' ASN . 16.6 t -98.0 -21.34 16.87 Favored 'General case' 0 C--N 1.293 -1.857 0 O-C-N 121.142 -0.974 . . . . 0.69 111.256 -178.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.524 ' HB2' ' CG ' ' A' ' 69' ' ' ASP . 11.4 t-160 -71.57 -25.89 62.39 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.898 -1.126 . . . . 2.03 111.434 -178.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.444 ' CD1' ' N ' ' A' ' 75' ' ' PHE . 8.2 m-85 -95.62 -29.47 14.31 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.533 -1.354 . . . . 2.08 111.375 -178.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 1.039 HG21 ' CE2' ' A' ' 86' ' ' TYR . 3.3 m -148.37 -149.46 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.915 -1.116 . . . . 3.06 111.259 -177.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.783 ' N ' HG23 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -85.49 105.37 16.05 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.727 -0.842 . . . . 2.69 108.727 179.445 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . 0.612 ' N ' ' HD2' ' A' ' 79' ' ' PRO . 0.1 OUTLIER -47.78 -44.62 58.02 Favored Pre-proline 0 N--CA 1.493 1.722 0 C-N-CA 118.277 -1.369 . . . . 0.78 109.066 179.897 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.612 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 28.9 Cg_endo -72.78 104.1 1.69 Allowed 'Trans proline' 0 C--N 1.317 -1.125 0 N-CA-C 108.471 -1.396 . . . . 0.64 108.471 177.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.839 HD13 ' CD1' ' A' ' 117' ' ' LEU . 0.2 OUTLIER -96.31 -64.49 1.05 Allowed 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 108.914 -0.773 . . . . 2.44 108.914 -178.214 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.755 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 24.5 t 53.54 177.68 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 C-N-CA 118.784 -1.166 . . . . 2.95 108.748 177.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.581 ' HA ' ' O ' ' A' ' 43' ' ' ALA . 0.6 OUTLIER -96.52 31.01 2.38 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 120.797 -1.189 . . . . 2.69 109.029 -179.315 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -132.49 27.4 3.56 Favored Glycine 0 C--N 1.289 -2.039 0 N-CA-C 108.14 -1.984 . . . . 0.84 108.14 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.78 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 9.0 tp-100 -142.39 159.55 42.0 Favored 'General case' 0 C--N 1.308 -1.229 0 O-C-N 121.486 -1.008 . . . . 1.26 108.37 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.585 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -154.53 137.28 15.27 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.452 -0.944 . . . . 1.99 108.452 179.606 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 1.039 ' CE2' HG21 ' A' ' 76' ' ' VAL . 12.1 p90 -158.55 177.41 11.25 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 117.581 -1.648 . . . . 3.34 111.386 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.618 ' CB ' ' HG ' ' A' ' 40' ' ' LEU . 8.9 p-10 -121.08 89.02 3.05 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 119.664 -0.815 . . . . 1.1 112.49 -177.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.846 HD12 ' CG1' ' A' ' 76' ' ' VAL . 0.6 OUTLIER -59.05 -164.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 106.761 -1.57 . . . . 0.91 106.761 176.751 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.819 ' N ' HG23 ' A' ' 88' ' ' ILE . 0.2 OUTLIER 163.15 174.15 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.955 -1.091 . . . . 1.75 110.725 179.286 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.636 ' CE2' ' CD1' ' A' ' 54' ' ' ILE . 13.6 m-85 -160.87 75.4 0.53 Allowed 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.524 -0.917 . . . . 1.01 108.524 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.732 HG22 HG23 ' A' ' 36' ' ' THR . 1.6 p -74.36 -167.62 0.56 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.421 -0.799 . . . . 1.72 110.151 -179.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 1.001 ' O ' HG23 ' A' ' 94' ' ' VAL . 3.0 t90 -171.62 112.5 0.33 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.425 -0.797 . . . . 4.51 110.065 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.534 ' O ' ' NE1' ' A' ' 92' ' ' TRP . 1.6 t30 -49.31 122.27 5.9 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 106.02 -1.845 . . . . 1.86 106.02 177.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 1.001 HG23 ' O ' ' A' ' 92' ' ' TRP . 60.6 t -123.28 101.51 37.85 Favored Pre-proline 0 C--N 1.301 -1.515 0 C-N-CA 117.888 -1.525 . . . . 1.64 113.277 -176.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 1.044 ' HD2' HD11 ' A' ' 97' ' ' ILE . 31.4 Cg_endo -72.33 -149.36 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.806 2.338 . . . . 1.77 108.734 176.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.5 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -69.39 -49.48 54.97 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.443 -1.411 . . . . 2.57 108.098 178.514 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 1.044 HD11 ' HD2' ' A' ' 95' ' ' PRO . 2.8 mp 62.32 -2.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 113.227 0.825 . . . . 1.18 113.227 177.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 1.028 ' HB1' ' HD2' ' A' ' 99' ' ' PRO . . . 57.53 178.31 0.04 OUTLIER Pre-proline 0 C--N 1.3 -1.568 0 O-C-N 119.942 -1.724 . . . . 0.34 108.49 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 1.028 ' HD2' ' HB1' ' A' ' 98' ' ' ALA . 52.9 Cg_endo -82.52 151.77 15.27 Favored 'Trans proline' 0 C--N 1.299 -2.06 0 C-N-CA 123.454 2.769 . . . . 0.45 110.204 -178.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.611 ' CD ' ' O ' ' A' ' 127' ' ' ILE . 0.3 OUTLIER 55.02 115.27 0.01 OUTLIER 'General case' 0 C--N 1.288 -2.079 0 C-N-CA 119.403 -0.919 . . . . 2.1 111.413 176.213 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 1.001 ' OG ' HD13 ' A' ' 127' ' ' ILE . 67.6 m -86.91 158.74 19.24 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.186 -0.946 . . . . 2.47 108.686 178.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -50.29 -21.29 1.33 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.009 -1.057 . . . . 5.17 109.582 -179.499 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.475 ' C ' ' CG2' ' A' ' 104' ' ' VAL . 15.4 t-20 -179.22 159.95 0.99 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.127 -0.983 . . . . 1.3 109.597 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.698 ' O ' HG23 ' A' ' 105' ' ' VAL . 0.9 OUTLIER -154.76 171.6 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.33 -0.856 . . . . 0.96 110.003 179.793 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.698 HG23 ' O ' ' A' ' 104' ' ' VAL . 0.9 OUTLIER 170.61 147.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 108.019 -1.104 . . . . 1.4 108.019 -179.863 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 1.5 t -143.56 137.42 25.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 120.331 -1.48 . . . . 1.25 110.29 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.992 HG23 HG23 ' A' ' 121' ' ' ILE . 0.9 OUTLIER -167.88 148.98 5.24 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.159 -1.052 . . . . 0.79 108.159 179.691 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.907 HG13 ' CD1' ' A' ' 54' ' ' ILE . 2.7 t -157.19 163.6 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.848 -1.158 . . . . 1.31 110.83 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.56 ' HG3' ' N ' ' A' ' 110' ' ' LEU . 0.3 OUTLIER -169.87 146.39 3.16 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.721 -0.844 . . . . 1.31 108.721 178.801 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.56 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 11.5 tp -139.03 126.45 21.64 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 106.774 -1.565 . . . . 0.63 106.774 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.52 ' HB ' ' HB2' ' A' ' 51' ' ' LYS . 7.6 mt -134.24 120.02 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.214 -0.929 . . . . 0.9 111.586 -177.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.585 ' CA ' HG21 ' A' ' 47' ' ' THR . . . -83.94 -108.37 0.57 Allowed Glycine 0 N--CA 1.486 2.016 0 N-CA-C 108.026 -2.03 . . . . 0.72 108.026 177.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -145.62 7.87 1.13 Allowed 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.072 -1.252 . . . . 1.54 107.951 178.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.459 ' ND2' ' N ' ' A' ' 114' ' ' ASN . 0.5 OUTLIER -124.8 -17.35 5.9 Favored 'General case' 0 C--N 1.308 -1.196 0 O-C-N 121.466 -0.771 . . . . 1.48 109.922 -179.766 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 169.37 144.88 4.41 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.695 -1.362 . . . . 2.35 109.695 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.611 HG22 ' O ' ' A' ' 116' ' ' VAL . 0.1 OUTLIER -53.35 111.16 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.174 -1.192 . . . . 1.0 109.975 -179.644 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.839 ' CD1' HD13 ' A' ' 80' ' ' LEU . 10.7 mt -54.42 -51.66 64.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.633 -0.667 . . . . 0.83 111.064 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.583 ' HA ' ' CA ' ' A' ' 9' ' ' ALA . . . -166.59 147.19 6.06 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.841 -1.162 . . . . 1.33 111.269 -178.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 0.525 ' SG ' ' N ' ' A' ' 120' ' ' ALA . 0.5 OUTLIER -139.89 178.31 7.34 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 109.026 -0.731 . . . . 0.8 109.026 179.279 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.525 ' N ' ' SG ' ' A' ' 119' ' ' CYS . . . -179.12 125.93 0.09 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.097 -1.002 . . . . 0.89 109.423 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.992 HG23 HG23 ' A' ' 107' ' ' THR . 1.0 OUTLIER -129.78 138.36 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.162 -0.961 . . . . 1.04 109.799 -179.875 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -107.36 -23.27 12.28 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.213 -0.929 . . . . 2.77 109.321 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.462 ' O ' ' HB2' ' A' ' 124' ' ' HIS . 6.9 m 66.32 98.65 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.564 -0.71 . . . . 0.96 110.442 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . 0.462 ' HB2' ' O ' ' A' ' 123' ' ' THR . 0.0 OUTLIER 71.95 177.67 0.26 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.226 -0.921 . . . . 2.05 110.573 178.899 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -176.45 137.41 3.61 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.006 -1.638 . . . . 0.79 109.006 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.762 ' O ' HG23 ' A' ' 28' ' ' ILE . 22.7 mtmt -144.0 95.94 2.81 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.959 -1.318 . . . . 2.96 110.284 -179.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 1.001 HD13 ' OG ' ' A' ' 101' ' ' SER . 1.2 mp -58.32 143.44 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.151 -0.968 . . . . 0.98 109.41 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.607 ' HB2' ' HD3' ' A' ' 100' ' ' LYS . 13.7 ttt-85 149.45 -94.68 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 108.557 -0.905 . . . . 2.19 108.557 178.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.526 ' N ' ' HG2' ' A' ' 128' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.497 1.875 0 CA-C-O 117.984 -1.008 . . . . 4.55 110.247 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.1 p30 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.418 0.628 . . . . 3.95 109.713 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.522 ' HB3' ' HG2' ' A' ' 17' ' ' MET . 1.4 pt20 -117.4 -168.36 1.47 Allowed 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.369 -0.832 . . . . 1.78 109.436 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.614 HG12 ' HA ' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -135.84 -173.4 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 108.53 -0.915 . . . . 0.7 108.53 179.024 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.87 41.58 1.58 Allowed 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.203 -0.935 . . . . 1.01 109.057 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.9 m -54.02 161.9 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.372 -0.83 . . . . 1.22 109.408 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.47 ' O ' ' C ' ' A' ' 7' ' ' ASP . 11.2 mmtm -87.61 52.44 2.49 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.151 -0.968 . . . . 2.67 109.574 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.47 ' C ' ' O ' ' A' ' 6' ' ' LYS . 5.3 p30 -38.78 156.1 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 109.327 -0.62 . . . . 1.46 109.327 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -153.08 34.35 0.47 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.986 -1.072 . . . . 1.22 110.531 -179.253 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.542 ' HA ' ' HA ' ' A' ' 118' ' ' ALA . . . -69.59 -174.05 0.66 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.592 -1.317 . . . . 2.12 109.048 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.583 ' O ' ' CB ' ' A' ' 11' ' ' ASN . 0.7 OUTLIER -54.56 -53.33 55.96 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 108.342 -0.985 . . . . 2.81 108.342 178.174 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.583 ' CB ' ' O ' ' A' ' 10' ' ' ASN . 12.3 p30 147.19 40.88 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.036 -1.098 . . . . 6.47 108.036 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.479 ' HB2' ' OD2' ' A' ' 42' ' ' ASP . 7.2 mt-10 -147.33 8.3 0.91 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.178 -0.951 . . . . 2.68 110.654 -178.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 1.009 HG23 ' O ' ' A' ' 40' ' ' LEU . 36.1 mt -44.59 148.35 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.891 -1.13 . . . . 0.29 108.798 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.82 -19.33 18.21 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.423 -0.798 . . . . 2.46 109.462 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.611 ' H ' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -172.65 134.95 0.65 Allowed 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 118.725 -1.19 . . . . 1.02 110.631 -177.854 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.753 ' O ' HG12 ' A' ' 16' ' ' VAL . 0.9 OUTLIER -139.02 104.26 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 107.246 -1.39 . . . . 2.1 107.246 179.158 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.522 ' HG2' ' HB3' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -149.46 140.73 23.15 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 118.901 -1.12 . . . . 1.64 111.234 -177.805 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.876 HG22 ' HA ' ' A' ' 37' ' ' LEU . 39.6 t -118.2 132.53 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 108.236 -1.024 . . . . 1.31 108.236 178.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -76.84 79.65 3.43 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.193 -0.942 . . . . 1.61 110.213 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.553 ' O ' ' CB ' ' A' ' 21' ' ' CYS . . . 87.9 121.98 1.72 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 110.014 -1.234 . . . . 0.59 110.014 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.851 ' CA ' HG23 ' A' ' 29' ' ' ILE . 0.0 OUTLIER 157.24 -41.46 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.629 -0.924 . . . . 0.37 109.298 179.319 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.614 ' HA ' HG12 ' A' ' 3' ' ' VAL . 0.9 OUTLIER 80.73 122.69 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.293 -0.879 . . . . 1.1 110.248 -179.547 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.467 ' O ' ' HB3' ' A' ' 24' ' ' SER . . . -96.85 178.74 33.75 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.622 -1.391 . . . . 0.44 109.622 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.505 ' O ' ' O ' ' A' ' 25' ' ' ASP . 27.7 t 63.63 -91.32 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.223 -1.163 . . . . 1.45 110.217 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.638 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.1 OUTLIER -50.18 -175.33 0.01 OUTLIER Pre-proline 0 C--N 1.305 -1.369 0 N-CA-C 108.83 -0.804 . . . . 0.4 108.83 179.681 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.638 ' HD2' ' CB ' ' A' ' 25' ' ' ASP . 28.4 Cg_endo -70.14 84.8 0.7 Allowed 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 121.462 1.442 . . . . 0.47 108.552 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.488 ' SG ' ' O ' ' A' ' 27' ' ' CYS . 0.9 OUTLIER -28.54 95.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 115.325 -0.852 . . . . 0.23 112.453 -178.039 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.617 HG23 ' O ' ' A' ' 126' ' ' LYS . 23.3 mm -90.92 137.6 21.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 105.289 -2.115 . . . . 0.26 105.289 175.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.851 HG23 ' CA ' ' A' ' 21' ' ' CYS . 0.2 OUTLIER -119.69 177.69 2.79 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 O-C-N 120.553 -1.342 . . . . 0.29 112.898 -175.556 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 51.2 m-70 -112.37 158.13 20.18 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.916 0.865 . . . . 1.09 110.817 -179.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.545 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -111.3 141.32 44.99 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.123 -1.066 . . . . 2.95 108.123 178.408 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' A' ' 95' ' ' PRO . . . 101.11 3.34 54.48 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.469 -1.452 . . . . 0.67 109.469 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.715 ' N ' HG11 ' A' ' 94' ' ' VAL . 1.9 mtmt -133.87 144.51 52.04 Favored Pre-proline 0 C--N 1.305 -1.355 0 O-C-N 121.42 -1.047 . . . . 0.49 108.328 179.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -69.62 81.4 0.79 Allowed 'Trans proline' 0 C--N 1.301 -1.944 0 C-N-CA 122.346 2.031 . . . . 0.9 111.175 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.585 ' CD1' ' O ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -59.58 122.84 15.07 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.998 -1.112 . . . . 2.54 107.998 178.974 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.756 HG23 ' HA ' ' A' ' 91' ' ' THR . 88.0 m -141.19 91.83 2.43 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.11 -0.994 . . . . 1.24 110.226 -178.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.876 ' HA ' HG22 ' A' ' 18' ' ' VAL . 1.2 pp -64.26 137.78 58.1 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.294 -0.879 . . . . 1.02 108.714 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.559 ' HG2' ' CG ' ' A' ' 89' ' ' LYS . 4.3 mt-10 -128.0 168.17 15.66 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.134 -0.979 . . . . 1.95 109.731 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.437 ' HB2' ' O ' ' A' ' 38' ' ' GLU . . . 176.83 74.01 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.984 0.897 . . . . 0.88 109.407 178.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 1.009 ' O ' HG23 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -67.76 169.98 8.72 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 109.529 -0.545 . . . . 0.35 109.529 179.931 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.748 ' CE2' ' CD2' ' A' ' 86' ' ' TYR . 1.4 p90 -165.85 162.42 18.36 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.156 -0.965 . . . . 0.64 108.674 177.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.479 ' OD2' ' HB2' ' A' ' 12' ' ' GLU . 4.3 p30 -120.03 115.93 24.72 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 122.037 0.923 . . . . 4.95 109.022 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.907 ' HB1' ' O ' ' A' ' 81' ' ' VAL . . . -42.2 115.43 0.68 Allowed 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 108.854 -0.795 . . . . 0.31 108.854 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.4 ' OD1' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -124.31 -0.87 8.2 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.364 -0.835 . . . . 0.8 109.968 -178.608 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.79 ' OE1' HD21 ' A' ' 117' ' ' LEU . 2.5 pt20 -92.59 -142.63 0.21 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.384 -0.822 . . . . 0.69 109.017 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.792 ' HA ' ' HB ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -155.62 71.41 0.76 Allowed 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.174 -0.954 . . . . 0.7 109.561 179.002 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.639 HG23 ' O ' ' A' ' 47' ' ' THR . 4.8 t -150.15 121.6 7.93 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 119.959 -1.713 . . . . 0.93 111.123 -178.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.608 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 7.0 mtmt -68.63 -7.55 34.08 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.785 -1.197 . . . . 2.05 109.186 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.85 158.88 18.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.176 -0.952 . . . . 1.6 109.492 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.796 ' HB1' ' HB3' ' A' ' 72' ' ' ALA . . . -151.66 135.08 16.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.369 -0.832 . . . . 0.38 108.882 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 1.083 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 0.1 OUTLIER -117.64 -158.99 0.73 Allowed 'General case' 0 C--N 1.298 -1.662 0 O-C-N 120.564 -1.335 . . . . 1.78 108.028 178.475 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.485 HG13 HD13 ' A' ' 54' ' ' ILE . 1.5 tt -177.93 161.74 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 C-N-CA 118.647 -1.221 . . . . 0.58 110.481 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.535 ' O ' ' CE ' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -160.33 40.0 0.17 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.804 -0.813 . . . . 0.54 108.804 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.95 ' HB ' HG21 ' A' ' 65' ' ' VAL . 0.3 OUTLIER -72.77 148.01 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.138 -0.976 . . . . 0.38 109.801 -179.656 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.595 ' HG3' ' O ' ' A' ' 54' ' ' ILE . 0.3 OUTLIER -163.19 94.62 0.82 Allowed 'General case' 0 C--N 1.287 -2.121 0 O-C-N 121.282 -0.886 . . . . 1.17 109.005 178.515 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.525 ' O ' HG13 ' A' ' 63' ' ' ILE . . . -119.77 120.01 35.28 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 119.639 -0.824 . . . . 0.67 110.584 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.47 124.62 47.44 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.012 -1.107 . . . . 0.68 108.012 178.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.577 HD21 ' CD1' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.87 169.1 10.46 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.844 -1.16 . . . . 4.25 110.109 -178.517 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.482 ' HB2' ' CB ' ' A' ' 101' ' ' SER . 67.4 t0 -77.79 80.4 4.25 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.546 -0.909 . . . . 4.91 108.546 179.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.601 ' O ' HD22 ' A' ' 61' ' ' LEU . . . 105.08 1.41 41.77 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 108.537 -1.825 . . . . 1.08 108.537 -178.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.601 HD22 ' O ' ' A' ' 60' ' ' GLY . 0.4 OUTLIER -136.64 59.53 1.69 Allowed 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.027 -1.101 . . . . 1.46 108.027 179.397 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -69.11 81.87 0.33 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.714 -0.616 . . . . 1.05 110.229 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.525 HG13 ' O ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -82.98 125.61 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 118.445 -1.302 . . . . 2.08 108.682 178.895 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -128.58 164.42 22.88 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.699 -0.852 . . . . 1.49 108.699 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.95 HG21 ' HB ' ' A' ' 54' ' ' ILE . 43.3 t -143.4 68.7 17.32 Favored Pre-proline 0 C--N 1.3 -1.551 0 O-C-N 121.01 -1.056 . . . . 0.77 110.114 -179.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.501 ' HD2' ' CG1' ' A' ' 68' ' ' ILE . 36.4 Cg_endo -80.72 95.94 0.99 Allowed 'Trans proline' 0 C--N 1.301 -1.938 0 C-N-CA 123.063 2.509 . . . . 2.67 110.264 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.499 ' C ' ' O ' ' A' ' 66' ' ' PRO . . . 33.53 50.08 0.54 Allowed Glycine 0 N--CA 1.497 2.702 0 N-CA-C 109.85 -1.3 . . . . 0.75 109.85 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.501 ' CG1' ' HD2' ' A' ' 66' ' ' PRO . 5.8 mt -76.08 -76.7 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.376 -1.073 . . . . 1.24 109.842 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.63 ' HB3' ' HB2' ' A' ' 74' ' ' HIS . 15.1 p30 -59.26 157.62 10.46 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.329 -0.857 . . . . 1.27 109.262 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.464 ' O ' ' CG ' ' A' ' 71' ' ' ASN . 20.0 p -77.4 -20.2 54.99 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.843 -1.169 . . . . 0.89 107.843 178.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.712 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 3.3 m120 -173.96 73.93 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.369 0.604 . . . . 2.5 109.661 179.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 1.083 ' HB2' ' O ' ' A' ' 51' ' ' LYS . . . 38.85 26.59 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.547 -0.72 . . . . 0.74 111.56 177.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.517 ' SG ' ' N ' ' A' ' 78' ' ' CYS . 2.4 t -100.85 -17.77 16.71 Favored 'General case' 0 C--N 1.29 -2.013 0 O-C-N 121.151 -0.968 . . . . 1.36 110.433 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.63 ' HB2' ' HB3' ' A' ' 69' ' ' ASP . 3.1 t-80 -61.23 -28.97 69.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.801 -1.187 . . . . 2.07 109.829 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -99.74 -54.83 2.81 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.696 -1.253 . . . . 2.36 110.319 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 1.173 HG21 ' CZ ' ' A' ' 86' ' ' TYR . 8.3 m -108.67 -145.52 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 CA-C-O 121.775 0.798 . . . . 2.82 109.186 -178.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.769 ' N ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -93.1 167.68 11.62 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.124 -1.436 . . . . 2.86 107.124 177.629 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . 0.735 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -91.36 -43.76 0.38 Allowed Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 120.476 -1.39 . . . . 1.1 110.469 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.608 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 31.0 Cg_endo -78.65 117.02 3.89 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 121.211 1.274 . . . . 0.99 109.385 178.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.997 HD12 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -97.11 -68.12 0.81 Allowed 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.375 -0.972 . . . . 0.73 108.375 -179.074 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.907 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 1.1 m 40.9 -168.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 116.051 -0.522 . . . . 0.47 109.812 178.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.722 ' H ' HG23 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -99.22 41.13 1.16 Allowed 'General case' 0 C--N 1.295 -1.803 0 O-C-N 120.378 -1.451 . . . . 0.93 109.972 -177.649 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -143.94 39.73 1.24 Allowed Glycine 0 C--N 1.293 -1.812 0 N-CA-C 109.95 -1.26 . . . . 0.76 109.95 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.439 ' NE2' ' HA ' ' A' ' 84' ' ' GLN . 7.8 tp-100 -158.88 154.12 25.5 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.93 -1.335 . . . . 1.5 110.001 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -111.85 160.44 17.37 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.65 -0.87 . . . . 2.38 108.65 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 1.173 ' CZ ' HG21 ' A' ' 76' ' ' VAL . 0.9 OUTLIER -127.45 -170.25 2.19 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.798 -1.189 . . . . 3.4 110.546 -179.005 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.572 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 3.2 p30 174.68 39.12 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.65 -0.87 . . . . 1.61 108.65 178.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.754 HD12 HG13 ' A' ' 76' ' ' VAL . 0.4 OUTLIER -53.01 -170.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.867 -0.79 . . . . 0.82 108.867 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.68 ' N ' HG23 ' A' ' 88' ' ' ILE . 0.2 OUTLIER 165.81 -179.32 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 119.07 -1.052 . . . . 1.3 110.442 -179.323 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.667 ' CZ ' HG21 ' A' ' 54' ' ' ILE . 31.1 m-85 -167.35 93.62 0.43 Allowed 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.122 -1.066 . . . . 1.06 108.122 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.756 ' HA ' HG23 ' A' ' 36' ' ' THR . 0.6 OUTLIER -87.17 -162.86 0.84 Allowed 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.773 0.797 . . . . 1.75 110.959 -178.183 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.566 ' CE3' HD21 ' A' ' 58' ' ' LEU . 7.1 t90 -175.18 90.48 0.05 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.531 -0.731 . . . . 4.32 109.599 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.461 ' C ' ' O ' ' A' ' 92' ' ' TRP . 3.1 t-20 -45.48 108.76 0.14 Allowed 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 106.8 -1.555 . . . . 1.29 106.8 178.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.873 HG13 ' CD1' ' A' ' 97' ' ' ILE . 2.4 t -104.58 116.21 61.47 Favored Pre-proline 0 C--N 1.301 -1.508 0 C-N-CA 118.854 -1.139 . . . . 0.57 113.128 -176.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.773 ' HD2' HD11 ' A' ' 97' ' ' ILE . 33.4 Cg_endo -81.08 -86.12 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 123.206 2.604 . . . . 0.49 108.538 176.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.545 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -135.7 -56.14 0.78 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 105.679 -1.971 . . . . 2.36 105.679 177.766 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.873 ' CD1' HG13 ' A' ' 94' ' ' VAL . 1.5 mp 67.91 7.32 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 113.203 0.816 . . . . 0.53 113.203 175.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 1.016 ' HB1' ' HD2' ' A' ' 99' ' ' PRO . . . 52.96 177.87 0.03 OUTLIER Pre-proline 0 C--N 1.302 -1.482 0 O-C-N 120.241 -1.537 . . . . 0.6 109.626 179.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 1.016 ' HD2' ' HB1' ' A' ' 98' ' ' ALA . 51.8 Cg_endo -83.59 152.78 13.46 Favored 'Trans proline' 0 C--N 1.303 -1.867 0 C-N-CA 123.751 2.968 . . . . 0.81 110.086 -179.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.646 ' HD3' ' CB ' ' A' ' 128' ' ' ARG . 1.7 mmmp? 55.98 127.35 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.97 0 C-N-CA 119.683 -0.807 . . . . 0.9 111.674 176.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.908 ' CB ' HD13 ' A' ' 127' ' ' ILE . 12.3 t -97.67 154.6 17.46 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.196 -0.94 . . . . 0.97 108.595 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.438 ' O ' ' CB ' ' A' ' 103' ' ' ASN . 76.1 mt-10 -48.85 -22.45 0.83 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.118 -0.989 . . . . 1.31 109.624 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.438 ' CB ' ' O ' ' A' ' 102' ' ' GLU . 0.4 OUTLIER 165.02 152.0 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.036 -1.098 . . . . 3.17 108.036 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.466 ' C ' HG23 ' A' ' 105' ' ' VAL . 0.1 OUTLIER -142.76 153.76 17.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 120.814 -1.179 . . . . 0.83 110.949 -178.944 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.466 HG23 ' C ' ' A' ' 104' ' ' VAL . 25.4 t -157.64 104.04 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 107.561 -1.274 . . . . 1.4 107.561 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.704 ' HB ' ' HB3' ' A' ' 122' ' ' ALA . 15.7 t -103.55 111.06 31.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 120.988 -1.07 . . . . 0.92 109.484 -178.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.587 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -129.98 175.27 9.02 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 120.877 -1.139 . . . . 1.21 108.269 179.269 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.797 HG22 ' CD1' ' A' ' 54' ' ' ILE . 1.2 t 175.07 168.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 C-N-CA 118.835 -1.146 . . . . 0.58 110.318 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.633 ' N ' HG13 ' A' ' 108' ' ' VAL . 1.1 ttpt 162.94 134.63 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.838 0.828 . . . . 1.36 109.67 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.561 ' HB3' ' HB2' ' A' ' 117' ' ' LEU . 9.4 tp -113.22 130.04 56.34 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 106.873 -1.528 . . . . 0.59 106.873 178.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.464 ' HB ' ' HB2' ' A' ' 51' ' ' LYS . 9.4 mt -127.25 120.12 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.154 -0.966 . . . . 0.68 111.737 -177.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.414 ' HA3' HG21 ' A' ' 47' ' ' THR . . . -92.4 -114.25 2.11 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 108.812 -1.715 . . . . 0.83 108.812 178.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -138.21 1.94 2.26 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.044 -1.268 . . . . 1.09 108.004 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -112.58 -39.31 4.38 Favored 'General case' 0 C--N 1.31 -1.129 0 O-C-N 121.415 -0.803 . . . . 0.75 109.048 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -177.38 155.38 17.65 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.07 -1.612 . . . . 1.54 109.07 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.533 ' CG2' ' O ' ' A' ' 118' ' ' ALA . 0.2 OUTLIER -50.18 111.88 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.167 -1.196 . . . . 0.7 109.82 -179.647 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.997 HD22 HD12 ' A' ' 80' ' ' LEU . 1.4 mt -57.49 -62.89 1.46 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.294 -0.879 . . . . 0.72 109.666 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.542 ' HA ' ' HA ' ' A' ' 9' ' ' ALA . . . -123.97 -175.26 3.19 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.13 -0.981 . . . . 0.22 110.083 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.542 ' HA ' ' HA ' ' A' ' 109' ' ' LYS . 1.9 t 172.37 150.51 0.06 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.155 -0.966 . . . . 0.85 110.15 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.444 ' C ' HG13 ' A' ' 121' ' ' ILE . . . -170.02 130.98 1.0 Allowed 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.79 -0.818 . . . . 0.58 108.79 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.444 HG13 ' C ' ' A' ' 120' ' ' ALA . 2.8 mt -134.15 139.47 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.177 -0.952 . . . . 0.46 110.075 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.704 ' HB3' ' HB ' ' A' ' 106' ' ' VAL . . . -106.77 -17.92 14.08 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.487 -0.931 . . . . 2.08 108.487 179.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.516 HG22 ' CD2' ' A' ' 124' ' ' HIS . 0.3 OUTLIER 58.51 89.08 0.06 Allowed 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 121.519 0.676 . . . . 1.43 110.196 179.718 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.516 ' CD2' HG22 ' A' ' 123' ' ' THR . 15.8 m-70 61.9 -160.93 0.3 Allowed 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.724 0.773 . . . . 3.56 110.378 179.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 153.91 150.61 5.52 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.346 -1.902 . . . . 1.11 108.346 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.617 ' O ' HG23 ' A' ' 28' ' ' ILE . 69.0 mttt -140.38 96.56 3.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.95 -1.323 . . . . 1.78 109.987 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.908 HD13 ' CB ' ' A' ' 101' ' ' SER . 2.1 mp -46.05 152.43 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.649 -0.657 . . . . 0.37 109.843 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.646 ' CB ' ' HD3' ' A' ' 100' ' ' LYS . 0.0 OUTLIER 141.79 -77.3 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.692 0.758 . . . . 0.58 109.132 178.823 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.587 ' CB ' HG21 ' A' ' 28' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--N 1.301 -1.533 0 CA-C-O 118.017 -0.992 . . . . 3.57 109.63 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.478 ' O ' ' O ' ' A' ' 2' ' ' GLN . 65.7 m-20 . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.5 0.667 . . . . 4.81 109.804 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.549 ' HA ' ' HB3' ' A' ' 17' ' ' MET . 93.6 mt-30 47.91 179.08 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 122.158 0.98 . . . . 3.84 110.999 178.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.839 HG13 ' N ' ' A' ' 4' ' ' ASP . 2.2 p -162.72 -149.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 108.642 -0.873 . . . . 4.17 108.642 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.839 ' N ' HG13 ' A' ' 3' ' ' VAL . 32.2 t0 -163.73 54.74 0.16 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.652 -1.28 . . . . 2.24 110.222 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.621 HG12 ' HB2' ' A' ' 122' ' ' ALA . 19.4 m -89.12 152.39 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.031 -1.043 . . . . 0.9 109.83 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.48 95.57 3.31 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.319 -0.863 . . . . 2.79 109.238 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -89.88 173.97 7.95 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.358 -0.839 . . . . 1.47 109.582 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.487 ' N ' ' SG ' ' A' ' 119' ' ' CYS . 24.8 p -164.76 47.79 0.1 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.258 -0.901 . . . . 2.03 109.696 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.591 ' HB1' ' O ' ' A' ' 117' ' ' LEU . . . -76.4 -67.31 0.7 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.304 -0.873 . . . . 0.38 109.244 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.554 ' CB ' ' O ' ' A' ' 9' ' ' ALA . 0.7 OUTLIER 160.37 39.5 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.487 -0.931 . . . . 0.98 108.487 -178.285 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 54.4 t30 55.87 21.67 5.03 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.316 -0.994 . . . . 1.75 108.316 -178.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -104.48 -22.18 13.34 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.21 -0.663 . . . . 2.02 109.21 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.917 HG23 ' O ' ' A' ' 40' ' ' LEU . 3.8 mt -52.03 143.16 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.073 -1.017 . . . . 0.59 108.925 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.89 -22.7 13.11 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.351 -0.843 . . . . 1.91 109.223 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -168.75 108.95 0.49 Allowed 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 118.426 -1.31 . . . . 1.81 111.595 -178.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.622 ' O ' HG13 ' A' ' 16' ' ' VAL . 3.2 p -118.12 94.09 2.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 N-CA-C 106.819 -1.549 . . . . 0.78 106.819 177.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.549 ' HB3' ' HA ' ' A' ' 2' ' ' GLN . 7.0 mmt -134.87 118.32 16.83 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.487 -0.885 . . . . 2.63 111.356 -177.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.535 HG23 HG11 ' A' ' 3' ' ' VAL . 11.2 t -85.86 126.25 40.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 107.171 -1.418 . . . . 1.36 107.171 177.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.592 ' HB3' ' CB ' ' A' ' 35' ' ' PHE . 2.0 t0 -45.8 -22.17 0.17 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.071 -1.018 . . . . 2.35 110.396 -178.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.61 ' C ' HG23 ' A' ' 29' ' ' ILE . . . -177.82 135.32 2.68 Favored Glycine 0 N--CA 1.49 2.299 0 C-N-CA 118.947 -1.597 . . . . 1.76 110.857 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.972 ' CA ' HG23 ' A' ' 29' ' ' ILE . 0.0 OUTLIER 153.12 -37.0 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.881 -0.776 . . . . 0.91 109.614 178.671 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.636 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 42.6 t-80 53.76 102.85 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.78 -1.2 . . . . 3.46 109.362 -179.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.705 ' H ' HG22 ' A' ' 3' ' ' VAL . . . -90.03 -147.18 16.73 Favored Glycine 0 N--CA 1.499 2.867 0 O-C-N 121.044 -1.035 . . . . 1.03 111.407 -178.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.525 ' N ' ' O ' ' A' ' 4' ' ' ASP . 0.1 OUTLIER 80.92 -77.9 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.626 -0.926 . . . . 1.08 108.667 -178.986 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.676 ' HB2' ' CD ' ' A' ' 26' ' ' PRO . 7.4 p30 -86.17 -152.84 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.51 0 N-CA-C 105.727 -1.953 . . . . 1.84 105.727 178.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.676 ' CD ' ' HB2' ' A' ' 25' ' ' ASP . 28.7 Cg_endo -72.99 91.72 0.82 Allowed 'Trans proline' 0 C--N 1.319 -1.016 0 N-CA-C 108.395 -1.425 . . . . 0.43 108.395 179.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.636 ' HA ' ' O ' ' A' ' 22' ' ' HIS . 0.3 OUTLIER -34.36 101.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.559 0.695 . . . . 0.3 112.036 -177.202 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.756 HG21 ' HB3' ' A' ' 129' ' ' ASP . 28.4 mm -97.05 135.82 29.91 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 106.829 -1.545 . . . . 0.47 106.829 176.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.972 HG23 ' CA ' ' A' ' 21' ' ' CYS . 0.5 OUTLIER -122.87 -166.77 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 O-C-N 121.005 -1.06 . . . . 0.76 111.676 -177.468 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.61 ' N ' ' CD2' ' A' ' 30' ' ' HIS . 0.0 OUTLIER -123.77 168.67 12.41 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 115.863 -0.608 . . . . 2.94 109.446 179.628 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.565 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -115.6 -163.96 0.92 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.089 -1.007 . . . . 1.56 109.453 179.43 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 31' ' ' ARG . . . 39.19 44.62 2.17 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.902 -1.279 . . . . 1.43 109.902 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.483 ' C ' ' HB ' ' A' ' 94' ' ' VAL . 0.1 OUTLIER -172.08 109.7 0.37 Allowed Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.153 -1.204 . . . . 2.37 109.577 -179.742 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.538 ' HA ' ' HB ' ' A' ' 94' ' ' VAL . 29.3 Cg_endo -70.37 115.5 4.21 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.821 2.348 . . . . 3.46 110.949 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.592 ' CB ' ' HB3' ' A' ' 19' ' ' ASP . 22.5 m-85 -100.13 -157.41 0.6 Allowed 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.773 -0.825 . . . . 7.48 108.773 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.551 ' O ' ' HG3' ' A' ' 38' ' ' GLU . 1.8 m -175.63 102.22 0.07 Allowed 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.368 -0.833 . . . . 0.78 108.768 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.468 ' HA ' HG13 ' A' ' 18' ' ' VAL . 0.2 OUTLIER -52.2 153.25 2.88 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.235 -1.024 . . . . 3.48 108.235 179.8 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.575 ' O ' ' HB2' ' A' ' 39' ' ' ALA . 63.0 mt-10 -154.38 166.75 32.24 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.791 -1.193 . . . . 0.64 110.96 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.575 ' HB2' ' O ' ' A' ' 38' ' ' GLU . . . 168.18 96.6 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.58 -0.896 . . . . 0.45 108.58 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.917 ' O ' HG23 ' A' ' 13' ' ' ILE . 0.5 OUTLIER -90.12 154.82 19.49 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.394 -0.595 . . . . 0.9 109.394 -179.517 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.762 ' CE2' ' CD2' ' A' ' 86' ' ' TYR . 0.2 OUTLIER -152.52 169.87 21.56 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.056 -1.027 . . . . 0.78 109.349 178.41 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.463 ' OD2' ' OE1' ' A' ' 85' ' ' GLN . 6.7 t0 -119.46 112.45 19.41 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 122.195 0.998 . . . . 1.5 109.206 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.884 ' HB1' ' O ' ' A' ' 81' ' ' VAL . . . -42.28 116.39 0.83 Allowed 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 115.431 -0.804 . . . . 0.73 109.198 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.491 ' O ' ' HB3' ' A' ' 82' ' ' LYS . 11.3 p30 -126.17 -0.1 7.11 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.243 -0.911 . . . . 4.4 109.731 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.89 ' CD ' HD21 ' A' ' 117' ' ' LEU . 3.1 pt20 -90.68 -137.61 0.14 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.413 -0.805 . . . . 0.69 109.01 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.858 ' HA ' ' HB ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -159.23 68.87 0.44 Allowed 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 119.59 -0.844 . . . . 1.6 109.637 179.215 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.71 HG21 ' HA3' ' A' ' 112' ' ' GLY . 3.5 t -145.25 120.01 9.88 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.045 -1.659 . . . . 0.56 110.764 -178.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.638 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 0.2 OUTLIER -68.74 -5.53 21.09 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.841 -1.162 . . . . 1.92 109.075 178.553 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.0 p -98.79 -177.6 3.7 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.058 -1.026 . . . . 1.14 109.893 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.922 ' HB1' ' HB3' ' A' ' 72' ' ' ALA . . . -163.94 145.62 9.01 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.442 -0.948 . . . . 0.55 108.442 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.477 ' HG2' ' OD1' ' A' ' 71' ' ' ASN . 16.6 mtmt -138.36 91.97 2.6 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 122.964 1.364 . . . . 2.27 109.506 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.674 ' HA ' HD12 ' A' ' 110' ' ' LEU . 1.2 tt -67.98 158.15 5.85 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.474 0 CA-C-N 114.063 -1.426 . . . . 1.47 110.086 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -150.93 49.16 0.85 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.33 -0.857 . . . . 2.0 109.127 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.958 ' HB ' HG21 ' A' ' 65' ' ' VAL . 0.2 OUTLIER -75.64 159.49 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.42 -0.8 . . . . 0.77 108.925 -179.869 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.555 ' HD3' ' O ' ' A' ' 54' ' ' ILE . 0.4 OUTLIER -166.13 29.71 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.178 -1.009 . . . . 1.46 110.774 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 1.029 ' HB3' HG21 ' A' ' 63' ' ' ILE . . . -66.7 159.04 28.63 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 108.809 -0.811 . . . . 1.27 108.809 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.15 130.08 24.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.032 -1.043 . . . . 0.87 109.736 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 1.066 HD13 ' N ' ' A' ' 59' ' ' ASP . 2.5 tm? -119.91 154.92 33.69 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.212 -0.93 . . . . 1.35 108.78 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 1.066 ' N ' HD13 ' A' ' 58' ' ' LEU . 5.6 t70 -76.93 79.24 3.49 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 107.818 -1.179 . . . . 3.91 107.818 178.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.703 ' O ' HD22 ' A' ' 61' ' ' LEU . . . 125.8 -5.83 7.92 Favored Glycine 0 N--CA 1.485 1.91 0 N-CA-C 108.787 -1.725 . . . . 0.9 108.787 -178.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.703 HD22 ' O ' ' A' ' 60' ' ' GLY . 0.4 OUTLIER -141.86 53.48 1.49 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.238 -1.154 . . . . 1.42 109.263 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 61' ' ' LEU . 36.1 mm-40 -41.18 97.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.544 -0.722 . . . . 3.07 109.625 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 1.029 HG21 ' HB3' ' A' ' 56' ' ' ALA . 0.3 OUTLIER -75.09 -2.93 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 CA-C-O 121.952 0.882 . . . . 2.88 110.133 -179.986 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.462 ' C ' ' O ' ' A' ' 63' ' ' ILE . 0.6 OUTLIER -40.03 140.13 0.61 Allowed 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 108.925 -0.768 . . . . 1.83 108.925 179.317 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.958 HG21 ' HB ' ' A' ' 54' ' ' ILE . 98.8 t -123.0 86.2 50.92 Favored Pre-proline 0 C--N 1.301 -1.533 0 O-C-N 121.168 -0.957 . . . . 1.44 110.556 -178.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.465 ' O ' ' C ' ' A' ' 67' ' ' GLY . 35.7 Cg_endo -79.29 89.34 1.36 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.791 2.327 . . . . 3.72 110.422 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.465 ' C ' ' O ' ' A' ' 66' ' ' PRO . . . 37.14 68.94 0.31 Allowed Glycine 0 N--CA 1.495 2.585 0 N-CA-C 110.117 -1.193 . . . . 1.33 110.117 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 21.2 mt -83.94 -78.03 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.13 -1.217 . . . . 2.45 109.613 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.469 ' OD2' ' CE1' ' A' ' 75' ' ' PHE . 5.2 p30 -78.47 130.58 36.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.212 -0.93 . . . . 2.45 109.233 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.516 ' O ' ' ND2' ' A' ' 71' ' ' ASN . 13.7 t -51.58 -23.02 3.72 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.09 -1.006 . . . . 2.82 109.715 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.574 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 23.3 m-80 -168.32 76.05 0.12 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.953 -1.092 . . . . 1.32 111.225 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.922 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . . . 32.02 33.75 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.283 0.563 . . . . 0.8 111.921 176.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.535 ' N ' ' O ' ' A' ' 71' ' ' ASN . 31.0 t -109.79 21.64 16.66 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 121.179 -0.95 . . . . 1.0 110.393 -179.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 17.6 t-160 -121.64 -18.26 7.22 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.374 -1.454 . . . . 2.83 109.45 178.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' A' ' 75' ' ' PHE . 7.3 m-85 -104.67 -15.09 15.37 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -0.887 . . . . 2.49 108.695 179.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 1.076 HG21 ' CE2' ' A' ' 86' ' ' TYR . 18.2 m -150.73 -153.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 N-CA-C 107.097 -1.445 . . . . 3.17 107.097 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.843 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -81.65 -177.65 6.63 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 106.287 -1.745 . . . . 2.36 106.287 176.325 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . 0.588 ' H ' ' HD2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -109.1 -51.87 0.07 OUTLIER Pre-proline 0 C--N 1.293 -1.86 0 O-C-N 120.64 -1.287 . . . . 0.88 110.796 -179.559 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.638 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 29.6 Cg_endo -77.83 111.6 3.14 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 N-CA-C 108.506 -1.382 . . . . 0.85 108.506 178.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.984 HD22 HD13 ' A' ' 117' ' ' LEU . 0.6 OUTLIER -93.6 -67.54 0.85 Allowed 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.622 -0.673 . . . . 2.63 109.363 -178.1 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.884 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 1.4 m 40.8 -167.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 C-N-CA 120.46 -0.496 . . . . 0.6 110.072 177.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.734 ' H ' HG23 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -98.47 41.62 1.13 Allowed 'General case' 0 C--N 1.292 -1.91 0 O-C-N 120.629 -1.294 . . . . 0.76 109.81 -177.45 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -150.68 46.4 0.62 Allowed Glycine 0 C--N 1.288 -2.123 0 N-CA-C 108.863 -1.695 . . . . 0.99 108.863 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.5 ' OE1' ' O ' ' A' ' 85' ' ' GLN . 3.0 tp-100 -159.4 150.07 19.46 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.132 -1.217 . . . . 1.96 110.18 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.5 ' O ' ' OE1' ' A' ' 84' ' ' GLN . 0.0 OUTLIER -104.25 157.37 17.18 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.569 -1.271 . . . . 2.43 107.569 178.412 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 1.076 ' CE2' HG21 ' A' ' 76' ' ' VAL . 0.4 OUTLIER -125.64 -167.65 1.72 Allowed 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.313 -1.492 . . . . 3.95 111.592 -178.928 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.616 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER 170.98 38.44 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.409 -0.814 . . . . 3.04 109.088 179.342 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.7 HD12 ' CG1' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -49.52 -178.01 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 108.256 -1.016 . . . . 0.64 108.256 179.129 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.57 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 1.2 mtmt 170.5 164.56 0.07 Allowed 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 119.069 -1.052 . . . . 0.83 109.957 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.616 ' CE2' HG12 ' A' ' 54' ' ' ILE . 17.0 m-85 -150.58 91.21 1.71 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.467 -0.771 . . . . 0.87 109.246 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.476 ' O ' ' O ' ' A' ' 90' ' ' TYR . 1.4 t -44.71 171.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.7 -0.625 . . . . 3.34 109.612 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.586 ' O ' HG23 ' A' ' 94' ' ' VAL . 0.3 OUTLIER -146.36 92.53 2.19 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.147 -0.971 . . . . 3.8 110.131 -179.938 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -65.43 112.43 3.54 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.126 -1.435 . . . . 4.53 107.126 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.849 HG13 ' CD1' ' A' ' 97' ' ' ILE . 59.5 t -125.05 93.94 44.74 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 120.917 -1.115 . . . . 2.48 112.451 -177.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.908 ' HD2' HD11 ' A' ' 97' ' ' ILE . 33.3 Cg_endo -73.65 -151.42 0.03 OUTLIER 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 122.105 1.87 . . . . 3.32 108.26 176.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.565 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 2.7 mmtt -67.54 -32.61 73.51 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.215 -1.553 . . . . 2.44 109.184 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.908 HD11 ' HD2' ' A' ' 95' ' ' PRO . 4.0 mt 42.39 15.87 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.125 -0.984 . . . . 1.77 112.354 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.982 ' HB1' ' HD2' ' A' ' 99' ' ' PRO . . . 50.65 173.37 0.03 OUTLIER Pre-proline 0 C--N 1.307 -1.242 0 O-C-N 120.292 -1.505 . . . . 1.6 109.93 179.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.982 ' HD2' ' HB1' ' A' ' 98' ' ' ALA . 57.4 Cg_endo -81.66 76.29 4.43 Favored 'Trans proline' 0 C--N 1.296 -2.208 0 C-N-CA 123.163 2.575 . . . . 2.62 108.418 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.698 ' CB ' ' O ' ' A' ' 99' ' ' PRO . 4.6 mmmm 119.2 127.11 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 123.8 0.687 . . . . 2.54 109.751 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.507 ' O ' ' HB2' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -87.38 11.49 14.38 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.271 -0.893 . . . . 1.51 109.392 179.638 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.562 ' O ' ' CB ' ' A' ' 103' ' ' ASN . 2.1 mp0 67.63 -0.42 1.94 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.656 -0.652 . . . . 6.1 109.906 -179.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.562 ' CB ' ' O ' ' A' ' 102' ' ' GLU . 3.3 t30 160.91 143.23 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.275 -0.89 . . . . 2.28 109.928 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 125' ' ' GLY . 0.1 OUTLIER -159.9 158.67 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.423 -0.798 . . . . 1.05 109.295 -179.772 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.435 ' O ' HG12 ' A' ' 105' ' ' VAL . 1.2 t -149.33 131.22 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.042 -1.036 . . . . 0.58 109.66 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.857 ' HB ' ' HB3' ' A' ' 122' ' ' ALA . 10.5 t -119.87 130.3 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.135 -0.978 . . . . 1.28 109.62 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.542 ' HB ' ' HB2' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -154.34 140.19 18.16 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.529 -0.915 . . . . 1.08 108.529 179.711 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.955 HG13 ' CD1' ' A' ' 54' ' ' ILE . 34.7 t -158.49 151.14 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.872 -1.143 . . . . 1.26 110.266 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.538 ' HA ' ' HA ' ' A' ' 119' ' ' CYS . 6.7 ttpt -172.46 134.5 0.67 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.222 -0.924 . . . . 1.25 110.284 178.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.691 ' O ' HG23 ' A' ' 116' ' ' VAL . 9.8 tp -111.15 132.65 54.13 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 106.833 -1.543 . . . . 0.62 106.833 177.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.468 ' HB ' ' HB2' ' A' ' 51' ' ' LYS . 8.4 mt -133.71 113.78 19.04 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 O-C-N 121.128 -0.983 . . . . 0.63 110.972 -177.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.71 ' HA3' HG21 ' A' ' 47' ' ' THR . . . -76.88 -110.76 0.14 Allowed Glycine 0 N--CA 1.486 1.993 0 N-CA-C 107.944 -2.062 . . . . 0.65 107.944 178.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -142.48 9.39 1.82 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.531 -1.285 . . . . 1.63 107.531 178.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.507 ' OD1' ' HB2' ' A' ' 45' ' ' GLN . 0.3 OUTLIER -123.88 -31.86 3.35 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.693 0.759 . . . . 3.9 109.362 -178.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -171.37 -142.87 3.81 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 108.708 -1.757 . . . . 0.76 108.708 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 110' ' ' LEU . 2.4 p -114.87 131.83 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.087 -1.243 . . . . 0.74 109.121 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.984 HD13 HD22 ' A' ' 80' ' ' LEU . 4.0 mt -78.85 -49.42 12.95 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.435 -0.791 . . . . 0.38 109.78 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.446 ' HA ' ' HB2' ' A' ' 9' ' ' ALA . . . -161.4 130.61 4.61 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.302 -0.874 . . . . 2.06 109.688 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.538 ' HA ' ' HA ' ' A' ' 109' ' ' LYS . 16.4 p -129.19 -172.11 2.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.207 -0.933 . . . . 0.93 110.01 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.491 ' HB2' ' O ' ' A' ' 119' ' ' CYS . . . 175.18 127.06 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.34 -0.85 . . . . 0.26 109.206 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.451 ' N ' HD12 ' A' ' 121' ' ' ILE . 5.2 mp -127.66 139.78 50.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.183 -0.948 . . . . 0.41 110.385 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.857 ' HB3' ' HB ' ' A' ' 106' ' ' VAL . . . -144.71 33.32 1.15 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.061 -1.089 . . . . 1.06 108.061 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.49 ' O ' ' O ' ' A' ' 122' ' ' ALA . 3.2 m -40.5 168.02 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.536 0.684 . . . . 4.52 110.662 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.462 ' H ' HG22 ' A' ' 123' ' ' THR . 0.2 OUTLIER 59.26 66.94 0.96 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.513 -0.742 . . . . 1.66 109.457 179.768 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.618 ' O ' HG23 ' A' ' 104' ' ' VAL . . . -94.86 147.2 18.51 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.313 -1.515 . . . . 1.06 109.313 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.516 ' CG ' ' HE3' ' A' ' 100' ' ' LYS . 7.6 mtmt -153.9 121.58 5.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.427 -1.043 . . . . 2.73 108.509 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.545 ' O ' ' CD ' ' A' ' 100' ' ' LYS . 1.6 mp -90.37 118.39 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.11 -0.994 . . . . 1.05 112.102 -177.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.628 ' HB2' ' HG2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER 176.14 -62.22 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.771 -1.206 . . . . 3.02 109.302 177.595 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.756 ' HB3' HG21 ' A' ' 28' ' ' ILE . 6.9 t70 . . . . . 0 N--CA 1.494 1.74 0 CA-C-O 117.953 -1.023 . . . . 4.09 109.339 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.503 ' O ' ' HB3' ' A' ' 17' ' ' MET . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.524 0.678 . . . . 5.04 109.643 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.515 ' HA ' ' HB3' ' A' ' 17' ' ' MET . 31.1 mt-30 -94.77 178.77 5.47 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.901 0.858 . . . . 4.24 110.169 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.977 HG21 ' CG2' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -133.58 -169.2 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.035 -1.098 . . . . 1.38 108.035 179.494 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -117.88 52.76 0.98 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.909 -1.119 . . . . 1.08 109.017 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 26.9 m -73.33 159.34 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.414 -0.804 . . . . 1.07 110.143 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.14 74.49 9.59 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.448 -0.782 . . . . 3.85 109.278 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.505 ' OD1' ' N ' ' A' ' 8' ' ' CYS . 0.7 OUTLIER -75.22 -170.03 1.08 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.257 -0.902 . . . . 1.86 109.55 -179.866 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.505 ' N ' ' OD1' ' A' ' 7' ' ' ASP . 16.6 p 179.25 33.76 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.112 -0.993 . . . . 2.24 109.58 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.615 ' HB1' ' O ' ' A' ' 117' ' ' LEU . . . -62.88 -58.66 6.62 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.296 -0.877 . . . . 0.68 109.607 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.503 ' CB ' ' O ' ' A' ' 9' ' ' ALA . 1.7 m-80 166.59 36.73 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.612 -0.835 . . . . 3.19 109.398 -178.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.8 t30 51.19 34.39 11.2 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.14 -0.975 . . . . 1.69 108.716 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.485 ' HG2' ' OD1' ' A' ' 44' ' ' ASN . 6.6 tp10 -128.73 -21.85 3.35 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.366 -0.834 . . . . 3.25 110.034 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.96 HG23 ' O ' ' A' ' 40' ' ' LEU . 5.9 mt -42.51 139.25 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.146 -0.971 . . . . 0.97 108.931 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.438 ' HD2' ' OD1' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -100.59 -31.38 11.27 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-O 121.956 0.884 . . . . 1.67 108.813 -179.783 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.08 120.09 12.07 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 119.909 -0.716 . . . . 2.13 109.667 -178.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.632 ' O ' HG13 ' A' ' 16' ' ' VAL . 11.3 p -136.82 118.12 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.272 -0.892 . . . . 1.15 108.845 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.515 ' HB3' ' HA ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -156.05 173.41 16.84 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.426 -0.796 . . . . 5.09 109.606 -179.258 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.977 ' CG2' HG21 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -132.55 9.54 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 O-C-N 121.085 -1.009 . . . . 3.91 108.975 178.34 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.556 ' CB ' ' HA ' ' A' ' 35' ' ' PHE . 7.9 t70 77.55 58.54 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 112.551 0.575 . . . . 3.1 112.551 178.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' A' ' 29' ' ' ILE . . . 70.67 31.42 67.75 Favored Glycine 0 N--CA 1.499 2.876 0 O-C-N 120.777 -1.202 . . . . 2.69 111.811 177.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.852 ' HA ' HG23 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -92.96 -19.44 21.6 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.889 -1.359 . . . . 1.21 108.247 178.839 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.792 ' HA ' HG12 ' A' ' 3' ' ' VAL . 4.2 m170 67.65 109.69 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.515 -0.741 . . . . 4.38 109.447 -179.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.46 ' O ' ' HB3' ' A' ' 24' ' ' SER . . . -80.88 178.18 54.11 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 110.175 -1.17 . . . . 0.47 110.175 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.46 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 41.0 t 62.3 151.73 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.351 -1.088 . . . . 2.68 108.509 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.61 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.2 OUTLIER 59.6 179.92 0.04 OUTLIER Pre-proline 0 C--N 1.306 -1.302 0 N-CA-C 107.336 -1.357 . . . . 5.49 107.336 -179.644 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.61 ' HD2' ' CB ' ' A' ' 25' ' ' ASP . 26.8 Cg_endo -70.78 83.74 0.86 Allowed 'Trans proline' 0 C--N 1.296 -2.228 0 C-N-CA 121.94 1.76 . . . . 0.92 108.404 178.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.462 ' O ' ' HA2' ' A' ' 125' ' ' GLY . 0.0 OUTLIER -33.37 115.54 0.22 Allowed 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 115.422 -0.808 . . . . 0.63 111.982 -178.009 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.803 HG23 ' O ' ' A' ' 126' ' ' LYS . 25.2 mm -107.72 139.56 29.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 107.46 -1.311 . . . . 0.58 107.46 176.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.852 HG23 ' HA ' ' A' ' 21' ' ' CYS . 0.7 OUTLIER -122.55 -175.57 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 O-C-N 120.981 -1.074 . . . . 0.9 111.572 -177.442 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.508 ' O ' ' CE1' ' A' ' 35' ' ' PHE . 98.1 m-70 -111.92 -171.55 1.87 Allowed 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.528 0.68 . . . . 1.67 110.366 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.564 ' CD ' ' O ' ' A' ' 98' ' ' ALA . 0.1 OUTLIER -130.39 -160.8 1.07 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.515 -0.74 . . . . 2.55 109.103 179.51 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.469 ' O ' ' HG3' ' A' ' 33' ' ' LYS . . . 40.23 34.86 0.66 Allowed Glycine 0 N--CA 1.495 2.581 0 N-CA-C 110.08 -1.208 . . . . 0.74 110.08 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.735 ' O ' HG11 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -167.96 129.02 1.16 Allowed Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.277 -1.131 . . . . 4.72 108.999 -179.921 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.502 ' HA ' ' CG2' ' A' ' 94' ' ' VAL . 20.3 Cg_endo -58.74 129.43 32.23 Favored 'Trans proline' 0 C--N 1.302 -1.883 0 C-N-CA 121.603 1.535 . . . . 1.91 109.869 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.654 ' H ' HG21 ' A' ' 94' ' ' VAL . 19.9 m-85 -79.36 40.95 0.45 Allowed 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 116.234 -0.439 . . . . 6.71 110.611 -178.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.482 ' C ' ' O ' ' A' ' 35' ' ' PHE . 24.4 m -35.01 91.45 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.534 -0.729 . . . . 1.48 110.585 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.681 HD21 ' HB2' ' A' ' 90' ' ' TYR . 1.0 OUTLIER -89.9 122.49 32.99 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.941 -1.133 . . . . 0.93 107.941 179.264 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.553 ' HG2' ' HG2' ' A' ' 89' ' ' LYS . 55.9 mt-10 -121.29 177.57 5.12 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 120.818 -1.176 . . . . 1.0 111.092 -178.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.518 ' O ' ' CD1' ' A' ' 41' ' ' PHE . . . 177.05 63.96 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 106.683 -1.599 . . . . 0.89 106.683 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.96 ' O ' HG23 ' A' ' 13' ' ' ILE . 0.6 OUTLIER -69.83 168.24 15.55 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 115.337 -0.847 . . . . 0.48 110.31 -178.281 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.658 ' CE2' ' CE2' ' A' ' 86' ' ' TYR . 6.3 p90 -178.73 146.97 0.36 Allowed 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.299 -0.875 . . . . 0.36 109.229 179.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.589 ' O ' ' C ' ' A' ' 43' ' ' ALA . 0.4 OUTLIER -94.44 98.22 10.72 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 106.314 -1.735 . . . . 4.87 106.314 177.664 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.716 ' HB1' ' O ' ' A' ' 81' ' ' VAL . . . -17.83 122.38 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 115.38 -0.827 . . . . 1.21 110.722 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.485 ' OD1' ' HG2' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -118.97 30.74 7.01 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.317 -0.865 . . . . 2.16 111.017 -177.866 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.962 ' OE1' HD21 ' A' ' 117' ' ' LEU . 2.0 pt20 -126.59 -142.15 0.28 Allowed 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.988 -1.115 . . . . 0.6 107.988 179.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.774 ' HA ' ' HB ' ' A' ' 81' ' ' VAL . 0.1 OUTLIER -154.04 68.31 0.75 Allowed 'General case' 0 C--N 1.292 -1.917 0 O-C-N 121.058 -1.026 . . . . 2.31 108.675 177.889 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.765 HG23 ' O ' ' A' ' 47' ' ' THR . 10.7 t -145.69 120.89 10.17 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 120.101 -1.624 . . . . 0.57 111.96 -177.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.614 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -67.59 -25.63 65.87 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.608 -1.307 . . . . 2.18 107.812 177.336 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.452 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 66.0 p -82.63 -163.57 0.72 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.695 -0.628 . . . . 0.7 109.373 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.957 ' CB ' ' HB3' ' A' ' 72' ' ' ALA . . . 175.63 160.46 0.26 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.284 -0.885 . . . . 0.27 109.817 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 1.026 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -126.66 -160.14 0.97 Allowed 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 106.516 -1.661 . . . . 3.25 106.516 177.581 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.469 ' HB ' ' O ' ' A' ' 51' ' ' LYS . 20.6 tt -177.56 164.41 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 C-N-CA 117.914 -1.515 . . . . 0.58 111.641 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.522 ' O ' ' HE2' ' A' ' 55' ' ' LYS . 2.3 mt-10 -165.46 59.28 0.12 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.124 -1.065 . . . . 0.9 108.124 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.896 ' HB ' HG21 ' A' ' 65' ' ' VAL . 0.4 OUTLIER -96.99 139.77 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.352 -0.842 . . . . 0.6 109.997 -179.462 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.693 ' HG3' ' O ' ' A' ' 54' ' ' ILE . 1.9 mtmt -150.96 93.38 1.93 Allowed 'General case' 0 C--N 1.284 -2.274 0 C-N-CA 119.833 -0.747 . . . . 0.88 109.781 178.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.507 ' HB3' ' HB ' ' A' ' 63' ' ' ILE . . . -110.35 150.4 28.83 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 108.022 -1.103 . . . . 0.58 108.022 178.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.494 ' HA ' ' HA ' ' A' ' 62' ' ' GLU . 0.8 OUTLIER -131.03 122.81 27.45 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.774 -1.204 . . . . 1.26 111.392 -178.622 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.969 HD13 ' N ' ' A' ' 59' ' ' ASP . 2.0 tm? -110.37 158.23 18.67 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.034 -1.099 . . . . 1.93 108.034 178.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.969 ' N ' HD13 ' A' ' 58' ' ' LEU . 23.4 t0 -40.89 -72.25 0.07 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.155 -0.966 . . . . 3.23 109.792 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -106.29 30.39 9.66 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.496 -1.442 . . . . 0.74 109.496 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.493 ' HB3' ' HB3' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -150.28 60.53 0.97 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.347 -1.09 . . . . 1.09 108.996 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 0.1 OUTLIER -63.42 86.82 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.661 -0.649 . . . . 3.4 110.653 -179.31 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.507 ' HB ' ' HB3' ' A' ' 56' ' ' ALA . 2.0 mt -54.69 160.96 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 107.442 -1.318 . . . . 0.42 107.442 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -168.42 146.95 4.29 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.678 -1.264 . . . . 2.6 110.097 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.896 HG21 ' HB ' ' A' ' 54' ' ' ILE . 4.9 t -149.0 74.83 9.99 Favored Pre-proline 0 N--CA 1.488 1.44 0 O-C-N 121.631 -0.668 . . . . 0.41 109.285 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -80.33 -7.59 13.92 Favored 'Trans proline' 0 C--N 1.302 -1.886 0 C-N-CA 123.028 2.486 . . . . 1.05 110.465 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 135.39 56.12 0.06 OUTLIER Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.464 -1.454 . . . . 0.88 109.464 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 21.0 mt -81.46 -59.48 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.273 -1.133 . . . . 1.7 109.729 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.507 ' HB3' ' HB2' ' A' ' 74' ' ' HIS . 8.9 p30 -66.75 142.74 57.28 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.117 -0.989 . . . . 1.65 109.228 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.416 ' O ' ' CG ' ' A' ' 71' ' ' ASN . 5.8 t -67.69 -10.27 50.91 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.084 -1.01 . . . . 2.89 108.848 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.588 ' CA ' ' O ' ' A' ' 50' ' ' ALA . 7.4 m-20 178.02 66.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.918 . . . . 0.31 110.347 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 1.026 ' HB2' ' O ' ' A' ' 51' ' ' LYS . . . 39.77 27.54 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 121.456 0.646 . . . . 0.28 110.674 177.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.478 ' N ' ' O ' ' A' ' 71' ' ' ASN . 6.7 t -102.76 -22.34 13.93 Favored 'General case' 0 C--N 1.293 -1.885 0 O-C-N 121.447 -0.783 . . . . 0.64 109.88 -179.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.507 ' HB2' ' HB3' ' A' ' 69' ' ' ASP . 0.4 OUTLIER -84.93 5.87 27.29 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.228 -0.92 . . . . 3.69 109.783 -179.881 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.683 ' C ' HG12 ' A' ' 76' ' ' VAL . 76.5 m-85 -135.37 0.79 2.83 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.044 -1.035 . . . . 0.85 110.841 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.777 ' HB ' ' CE1' ' A' ' 86' ' ' TYR . 0.2 OUTLIER -167.92 173.66 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.362 -1.461 . . . . 0.64 111.139 -178.094 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.635 ' N ' HG23 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -55.03 94.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 106.264 -1.754 . . . . 4.32 106.264 177.447 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . 0.605 ' HB2' ' HD3' ' A' ' 79' ' ' PRO . 2.4 m -33.47 -53.27 0.75 Allowed Pre-proline 0 N--CA 1.504 2.236 0 O-C-N 121.789 -0.569 . . . . 0.95 112.382 -176.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.614 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 33.9 Cg_endo -79.75 113.08 3.0 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 120.93 1.086 . . . . 0.86 110.193 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 1.089 HD12 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -97.37 -65.7 0.95 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.229 -0.919 . . . . 0.68 108.58 -179.59 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.774 ' HB ' ' HA ' ' A' ' 46' ' ' ASN . 1.3 m 41.38 -168.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 C-N-CA 120.32 -0.552 . . . . 0.8 109.701 178.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.74 ' H ' HG23 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -102.53 42.38 1.15 Allowed 'General case' 0 C--N 1.29 -1.982 0 O-C-N 120.133 -1.604 . . . . 1.27 110.999 -175.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.492 ' O ' ' OE1' ' A' ' 84' ' ' GLN . . . -151.83 31.73 0.9 Allowed Glycine 0 C--N 1.285 -2.264 0 N-CA-C 108.995 -1.642 . . . . 1.39 108.995 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.492 ' OE1' ' O ' ' A' ' 83' ' ' GLY . 0.2 OUTLIER -137.3 121.69 18.23 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.284 -1.127 . . . . 3.96 110.726 -179.018 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -97.01 125.56 41.52 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 105.435 -2.061 . . . . 2.39 105.435 176.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.945 ' OH ' HD13 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -153.51 161.08 42.59 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 117.657 -1.617 . . . . 0.65 109.759 -177.445 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.642 ' CB ' ' HG ' ' A' ' 40' ' ' LEU . 3.1 p-10 -129.23 101.09 5.85 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.97 -1.081 . . . . 0.84 113.285 -175.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.945 HD13 ' OH ' ' A' ' 86' ' ' TYR . 3.2 tp -69.17 -160.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 107.722 -1.214 . . . . 1.0 107.722 176.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.734 ' N ' HG23 ' A' ' 88' ' ' ILE . 0.0 OUTLIER 159.75 170.14 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.196 -0.94 . . . . 1.59 109.993 179.689 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.681 ' HB2' HD21 ' A' ' 37' ' ' LEU . 10.0 m-85 -162.48 67.83 0.24 Allowed 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.944 -0.762 . . . . 1.52 108.944 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.54 ' C ' ' CD1' ' A' ' 92' ' ' TRP . 3.0 t -56.39 176.19 0.09 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.474 -0.766 . . . . 2.42 109.94 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.667 ' CD1' ' N ' ' A' ' 92' ' ' TRP . 0.0 OUTLIER -142.36 147.79 36.85 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.229 -0.919 . . . . 5.33 109.914 -179.377 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.551 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 25.3 m-20 -74.93 94.64 2.85 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 104.338 -2.468 . . . . 5.51 104.338 175.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.976 HG13 ' CD1' ' A' ' 97' ' ' ILE . 60.8 t -106.3 96.04 12.72 Favored Pre-proline 0 N--CA 1.488 1.466 0 C-N-CA 118.817 -1.153 . . . . 2.29 113.777 -175.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.826 ' HD2' HD11 ' A' ' 97' ' ' ILE . 35.2 Cg_endo -77.42 -150.11 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.538 2.158 . . . . 2.64 107.319 174.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.553 ' O ' ' CB ' ' A' ' 31' ' ' ARG . 0.7 OUTLIER -72.12 -25.23 61.65 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.426 -1.421 . . . . 2.35 108.561 178.485 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.976 ' CD1' HG13 ' A' ' 94' ' ' VAL . 4.0 mt 43.25 14.49 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.505 -0.747 . . . . 1.34 112.842 179.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 1.049 ' HB1' ' HD2' ' A' ' 99' ' ' PRO . . . 52.64 175.38 0.03 OUTLIER Pre-proline 0 C--N 1.304 -1.403 0 O-C-N 119.769 -1.832 . . . . 1.27 109.226 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 1.049 ' HD2' ' HB1' ' A' ' 98' ' ' ALA . 37.3 Cg_endo -73.1 -7.17 20.21 Favored 'Trans proline' 0 C--N 1.299 -2.055 0 C-N-CA 123.293 2.662 . . . . 4.06 110.995 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.648 ' HD3' ' CB ' ' A' ' 128' ' ' ARG . 1.1 mmmt -149.73 126.58 11.12 Favored 'General case' 0 C--N 1.276 -2.623 0 C-N-CA 119.462 -0.895 . . . . 0.81 109.859 -178.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.647 ' HB3' HD13 ' A' ' 127' ' ' ILE . 4.3 t -89.3 159.09 17.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.187 -0.945 . . . . 1.03 109.642 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.63 -10.65 48.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.444 -0.785 . . . . 1.4 110.362 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.507 ' C ' ' CG2' ' A' ' 104' ' ' VAL . 0.1 OUTLIER 175.1 146.05 0.07 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.814 -1.178 . . . . 3.07 110.177 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.656 ' O ' HG23 ' A' ' 105' ' ' VAL . 0.2 OUTLIER -156.68 168.36 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.556 -0.715 . . . . 0.94 109.804 -179.781 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 104' ' ' VAL . 0.9 OUTLIER 161.87 125.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.261 -1.015 . . . . 1.16 108.261 -179.934 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.483 HG22 ' HH2' ' A' ' 92' ' ' TRP . 42.6 t -119.53 96.4 4.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 120.986 -1.071 . . . . 1.75 110.664 -179.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.539 ' O ' HG23 ' A' ' 108' ' ' VAL . 7.4 m -105.43 150.56 25.16 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.246 -1.39 . . . . 0.61 107.246 178.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.546 HG12 ' N ' ' A' ' 109' ' ' LYS . 75.6 t -157.84 160.76 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 C-N-CA 118.281 -1.368 . . . . 1.14 111.545 -178.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.546 ' N ' HG12 ' A' ' 108' ' ' VAL . 1.8 ttpt 177.54 126.39 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.524 -0.917 . . . . 1.16 108.524 178.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.492 ' HB3' ' HB2' ' A' ' 117' ' ' LEU . 11.5 tp -118.35 127.6 53.84 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 107.275 -1.38 . . . . 1.08 107.275 178.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.543 HD11 ' HG2' ' A' ' 109' ' ' LYS . 1.7 mt -124.97 116.93 48.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 O-C-N 121.262 -0.899 . . . . 1.09 111.503 -177.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.473 ' HA2' ' HA ' ' A' ' 50' ' ' ALA . . . -86.1 -110.1 0.78 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.122 -1.991 . . . . 0.36 108.122 177.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.407 ' O ' ' CG ' ' A' ' 113' ' ' ASP . 7.4 t70 -136.54 1.71 2.63 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.066 -1.255 . . . . 2.11 107.71 178.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.441 ' ND2' ' N ' ' A' ' 114' ' ' ASN . 0.6 OUTLIER -116.1 -20.42 9.88 Favored 'General case' 0 C--N 1.31 -1.139 0 O-C-N 121.491 -0.756 . . . . 0.65 109.601 -179.614 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 169.76 -161.32 34.63 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.35 -1.5 . . . . 0.49 109.35 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.51 HG21 ' HB3' ' A' ' 119' ' ' CYS . 2.5 p -90.8 105.34 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.101 -1.235 . . . . 0.88 109.517 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 1.089 HD22 HD12 ' A' ' 80' ' ' LEU . 1.4 mt -49.58 -53.23 25.02 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.219 -0.926 . . . . 0.81 110.8 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.559 ' HA ' ' HA ' ' A' ' 9' ' ' ALA . . . -158.24 129.08 6.33 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.219 -0.926 . . . . 2.13 110.245 -178.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.51 ' HB3' HG21 ' A' ' 116' ' ' VAL . 10.2 p -134.29 169.2 17.56 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.484 -0.76 . . . . 1.07 109.439 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.446 ' O ' HG13 ' A' ' 121' ' ' ILE . . . -173.31 138.75 0.73 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.375 -0.828 . . . . 0.62 109.0 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 120' ' ' ALA . 2.7 mp -139.44 132.45 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.975 -1.078 . . . . 0.49 110.437 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.466 ' O ' ' C ' ' A' ' 123' ' ' THR . . . -114.74 93.5 4.35 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.994 -1.113 . . . . 0.43 107.994 179.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.466 ' C ' ' O ' ' A' ' 122' ' ' ALA . 98.6 m -33.47 99.2 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.489 0.661 . . . . 1.74 110.835 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.41 ' N ' ' O ' ' A' ' 122' ' ' ALA . 0.1 OUTLIER 53.92 176.32 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.627 -0.671 . . . . 3.54 110.111 179.704 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.498 ' O ' ' HB ' ' A' ' 104' ' ' VAL . . . -160.31 119.35 0.88 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.546 -1.422 . . . . 0.73 109.546 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.803 ' O ' HG23 ' A' ' 28' ' ' ILE . 0.4 OUTLIER -128.61 104.72 7.83 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.14 -1.212 . . . . 2.02 109.461 -179.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.647 HD13 ' HB3' ' A' ' 101' ' ' SER . 2.8 mp -54.77 157.26 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.249 -0.907 . . . . 1.33 109.28 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.648 ' CB ' ' HD3' ' A' ' 100' ' ' LYS . 0.0 OUTLIER 134.66 -86.2 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.446 0 N-CA-C 108.266 -1.013 . . . . 3.85 108.266 179.37 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.62 ' C ' HG21 ' A' ' 28' ' ' ILE . 1.7 t0 . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 118.077 -0.963 . . . . 2.65 109.543 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 1' ' ' ASP . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.484 0.659 . . . . 2.31 109.817 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.574 ' HA ' ' HB3' ' A' ' 17' ' ' MET . 66.7 mt-30 53.99 -179.31 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.888 0.852 . . . . 3.85 110.887 178.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.852 HG13 ' N ' ' A' ' 4' ' ' ASP . 0.8 OUTLIER -170.94 -155.26 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 108.78 -0.822 . . . . 3.59 108.78 179.85 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.852 ' N ' HG13 ' A' ' 3' ' ' VAL . 17.7 m-20 -146.58 114.95 6.69 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.9 -1.125 . . . . 3.12 110.245 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.49 HG23 ' OD1' ' A' ' 7' ' ' ASP . 15.7 m -142.21 146.42 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 120.965 -1.085 . . . . 0.85 109.792 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.488 ' O ' HG12 ' A' ' 121' ' ' ILE . 8.5 mmtt -69.59 105.3 2.62 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.319 -0.863 . . . . 3.48 109.877 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.49 ' OD1' HG23 ' A' ' 5' ' ' VAL . 0.8 OUTLIER -95.91 167.42 11.26 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.145 -0.972 . . . . 3.44 108.641 179.335 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.561 ' HB2' HG21 ' A' ' 116' ' ' VAL . 6.3 m -140.07 7.98 2.26 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.052 -1.03 . . . . 1.19 109.755 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.529 ' CA ' ' HA ' ' A' ' 118' ' ' ALA . . . -49.62 -75.34 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.163 -0.961 . . . . 0.94 109.587 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.449 ' CB ' ' O ' ' A' ' 9' ' ' ALA . 0.9 OUTLIER 167.34 37.29 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.885 -0.783 . . . . 1.5 108.885 -178.478 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 58.41 26.27 13.93 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.908 -1.145 . . . . 2.72 107.908 -178.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.484 ' O ' ' C ' ' A' ' 13' ' ' ILE . 0.3 OUTLIER -116.98 -21.72 8.79 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.507 -0.746 . . . . 2.59 110.414 -179.16 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.88 HG23 ' O ' ' A' ' 40' ' ' LEU . 5.7 mt -43.09 139.87 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 108.144 -1.058 . . . . 1.15 108.144 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.27 -25.59 16.97 Favored 'General case' 0 C--N 1.292 -1.931 0 O-C-N 121.513 -0.742 . . . . 2.1 109.585 -178.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.7 mtmt -167.48 105.51 0.54 Allowed 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 118.006 -1.478 . . . . 1.34 111.981 -178.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.53 ' HA ' ' HA ' ' A' ' 39' ' ' ALA . 2.2 p -116.97 94.72 3.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 N-CA-C 106.152 -1.795 . . . . 0.94 106.152 177.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.574 ' HB3' ' HA ' ' A' ' 2' ' ' GLN . 12.3 mmt -132.46 142.51 49.27 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.558 -0.713 . . . . 3.13 111.392 -176.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.668 HG13 ' HG ' ' A' ' 37' ' ' LEU . 16.7 t -110.84 141.02 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 107.935 -1.135 . . . . 1.2 107.935 178.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.47 ' HB3' ' HA ' ' A' ' 35' ' ' PHE . 7.4 t70 -62.95 -40.93 99.16 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.094 -1.004 . . . . 2.52 110.538 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.542 ' O ' ' CB ' ' A' ' 21' ' ' CYS . . . -156.01 139.82 6.84 Favored Glycine 0 N--CA 1.489 2.212 0 C-N-CA 119.351 -1.404 . . . . 1.57 110.286 -179.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.897 ' CA ' HG23 ' A' ' 29' ' ' ILE . 0.0 OUTLIER 155.01 -56.76 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.572 -0.958 . . . . 0.84 108.812 179.288 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.614 ' HA ' HG23 ' A' ' 3' ' ' VAL . 1.6 t60 80.66 120.57 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 107.689 -1.226 . . . . 2.98 107.689 -177.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.735 ' H ' HG22 ' A' ' 3' ' ' VAL . . . -106.26 -166.88 22.97 Favored Glycine 0 N--CA 1.493 2.481 0 C-N-CA 119.25 -1.453 . . . . 0.76 111.341 -178.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.439 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 0.5 OUTLIER 69.86 -87.9 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.499 -1.0 . . . . 0.86 108.602 -179.241 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.653 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 3.0 p-10 -63.66 -163.61 0.01 OUTLIER Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 107.14 -1.43 . . . . 1.35 107.14 178.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.653 ' HD2' ' CB ' ' A' ' 25' ' ' ASP . 29.6 Cg_endo -72.32 106.09 1.99 Allowed 'Trans proline' 0 C--N 1.313 -1.323 0 N-CA-C 108.545 -1.367 . . . . 1.63 108.545 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.533 ' HB2' ' O ' ' A' ' 22' ' ' HIS . 1.3 t -62.44 92.47 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.756 -0.59 . . . . 0.96 112.579 -176.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.549 HD12 ' O ' ' A' ' 26' ' ' PRO . 1.7 mp -91.1 135.0 27.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 105.182 -2.155 . . . . 1.97 105.182 174.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.897 HG23 ' CA ' ' A' ' 21' ' ' CYS . 0.1 OUTLIER -108.82 173.79 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.196 0 O-C-N 120.666 -1.272 . . . . 0.46 111.147 -177.476 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.429 ' O ' ' CZ ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -102.43 132.51 48.4 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 122.2 1.0 . . . . 3.23 111.708 -178.467 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.724 ' HD3' ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -99.21 109.9 22.51 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 115.634 -0.712 . . . . 9.23 109.265 179.21 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' A' ' 95' ' ' PRO . . . 136.18 0.71 3.02 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.556 -1.307 . . . . 1.28 110.336 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.502 ' C ' ' HB ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -139.32 139.07 21.72 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 120.868 -1.372 . . . . 2.41 109.631 179.891 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.412 ' HA ' ' HB ' ' A' ' 94' ' ' VAL . 30.5 Cg_endo -70.99 123.32 9.59 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.713 2.275 . . . . 2.47 110.224 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.47 ' HA ' ' HB3' ' A' ' 19' ' ' ASP . 19.6 m-30 -103.91 -164.65 1.08 Allowed 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.777 0.799 . . . . 7.1 110.32 -178.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.72 HG22 ' O ' ' A' ' 36' ' ' THR . 1.3 m -179.84 90.36 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.679 -0.86 . . . . 0.7 108.679 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.668 ' HG ' HG13 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -57.35 152.7 13.71 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.086 -1.009 . . . . 3.84 108.438 179.729 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.53 ' HG3' ' O ' ' A' ' 36' ' ' THR . 72.8 mt-10 -154.13 176.6 12.05 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.89 -1.131 . . . . 0.42 111.015 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.53 ' HA ' ' HA ' ' A' ' 16' ' ' VAL . . . 168.71 85.89 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.252 -1.388 . . . . 0.62 107.252 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.88 ' O ' HG23 ' A' ' 13' ' ' ILE . 4.3 mp -88.22 144.52 26.4 Favored 'General case' 0 C--N 1.291 -1.97 0 O-C-N 121.85 -0.531 . . . . 1.11 110.095 -178.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.801 ' CE2' ' CD2' ' A' ' 86' ' ' TYR . 0.1 OUTLIER -136.2 174.69 10.34 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.942 -1.099 . . . . 0.89 108.26 176.841 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.495 ' O ' ' C ' ' A' ' 43' ' ' ALA . 0.2 OUTLIER -126.24 102.24 7.1 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 106.651 -1.611 . . . . 2.76 106.651 178.582 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.887 ' HB1' ' O ' ' A' ' 81' ' ' VAL . . . -34.79 117.59 0.38 Allowed 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 115.548 -0.751 . . . . 0.38 109.33 -179.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.492 ' O ' ' HB3' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -126.8 0.15 6.69 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.36 0.6 . . . . 0.63 109.68 -178.473 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.971 ' OE1' HD21 ' A' ' 117' ' ' LEU . 3.3 pt20 -90.86 -141.64 0.17 Allowed 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.405 -0.961 . . . . 0.9 108.405 179.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.827 ' HA ' ' HB ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -156.86 71.76 0.69 Allowed 'General case' 0 C--N 1.293 -1.848 0 O-C-N 120.962 -1.086 . . . . 0.9 109.641 178.94 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.715 HG23 ' O ' ' A' ' 47' ' ' THR . 7.5 t -150.33 122.19 8.15 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.17 -1.581 . . . . 1.14 111.003 -178.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.636 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 1.7 mtpt -69.17 -17.97 63.87 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.89 -1.131 . . . . 3.32 109.131 178.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.474 ' OG1' ' OG1' ' A' ' 47' ' ' THR . 1.1 p -76.32 176.41 8.18 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.16 -0.963 . . . . 1.33 109.719 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.774 ' HB1' ' HB3' ' A' ' 72' ' ' ALA . . . -176.23 136.89 0.29 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.242 -0.911 . . . . 0.6 109.962 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 1.059 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -121.1 -156.26 0.67 Allowed 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.723 -1.214 . . . . 2.4 107.723 178.393 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.521 ' CG1' HD13 ' A' ' 54' ' ' ILE . 17.3 tt -175.31 165.59 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 C-N-CA 118.616 -1.234 . . . . 0.42 111.293 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.542 ' C ' HD12 ' A' ' 54' ' ' ILE . 0.4 OUTLIER -168.09 68.94 0.08 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.718 -0.845 . . . . 3.18 108.718 179.778 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.978 HG21 ' CZ ' ' A' ' 90' ' ' TYR . 0.7 OUTLIER -109.17 149.76 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.308 -0.87 . . . . 0.62 110.066 -178.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.606 ' HG3' ' O ' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -164.98 100.73 0.76 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.331 -0.856 . . . . 1.43 109.602 178.16 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.516 ' HB3' ' HB ' ' A' ' 63' ' ' ILE . . . -106.74 147.9 29.07 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.114 -0.991 . . . . 0.95 108.375 178.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.546 ' HA ' ' HA ' ' A' ' 62' ' ' GLU . 37.2 t -132.5 129.12 38.73 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.868 -1.145 . . . . 1.7 110.315 -179.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.668 HD22 ' H ' ' A' ' 59' ' ' ASP . 0.1 OUTLIER -114.15 -152.13 0.5 Allowed 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.081 -1.081 . . . . 3.28 108.081 179.42 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.668 ' H ' HD22 ' A' ' 58' ' ' LEU . 48.4 t0 -106.72 87.73 2.59 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.71 -1.244 . . . . 4.15 108.403 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.71 -6.93 62.94 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 108.326 -1.91 . . . . 1.94 108.326 -178.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -128.02 49.66 2.13 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 107.581 -1.266 . . . . 1.28 107.581 179.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.546 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 1.8 tt0 -59.65 91.24 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.862 -0.524 . . . . 3.43 109.967 -179.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.591 HG21 ' HD2' ' A' ' 90' ' ' TYR . 8.3 mt -55.98 159.85 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 C-N-CA 118.773 -1.171 . . . . 1.27 107.952 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.431 ' C ' ' OD1' ' A' ' 64' ' ' ASP . 40.2 p-10 -156.27 162.92 40.08 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.174 -0.954 . . . . 5.12 110.202 -179.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.719 HG21 ' HB ' ' A' ' 54' ' ' ILE . 35.4 t -146.92 66.37 10.42 Favored Pre-proline 0 C--N 1.303 -1.442 0 O-C-N 121.499 -0.751 . . . . 1.77 109.11 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.523 ' O ' ' C ' ' A' ' 67' ' ' GLY . 37.3 Cg_endo -80.25 102.72 1.46 Allowed 'Trans proline' 0 C--N 1.3 -1.979 0 C-N-CA 123.329 2.686 . . . . 4.47 111.34 -179.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.523 ' C ' ' O ' ' A' ' 66' ' ' PRO . . . 22.99 51.8 0.02 OUTLIER Glycine 0 N--CA 1.5 2.914 0 N-CA-C 111.511 -0.635 . . . . 1.13 111.511 179.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.415 ' N ' ' O ' ' A' ' 66' ' ' PRO . 6.6 mt -60.73 -81.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.072 -1.252 . . . . 2.74 109.442 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.625 ' HB3' ' CG ' ' A' ' 74' ' ' HIS . 52.3 p30 -68.69 -167.62 0.1 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.342 -0.849 . . . . 2.25 109.957 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.462 ' O ' ' OD1' ' A' ' 71' ' ' ASN . 1.1 p -111.11 5.1 19.88 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.982 -0.747 . . . . 1.07 108.982 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.543 ' CA ' ' O ' ' A' ' 50' ' ' ALA . 2.2 m-20 172.95 69.1 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.177 -0.952 . . . . 1.36 110.972 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 1.059 ' HB2' ' O ' ' A' ' 51' ' ' LYS . . . 38.75 23.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 112.627 0.602 . . . . 0.45 112.627 177.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.508 ' N ' ' O ' ' A' ' 71' ' ' ASN . 22.9 t -99.19 4.56 46.8 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.651 -1.281 . . . . 1.74 111.422 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.625 ' CG ' ' HB3' ' A' ' 69' ' ' ASP . 4.2 m170 -95.63 -18.25 20.69 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.419 -1.425 . . . . 2.67 109.56 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.513 ' CD1' ' N ' ' A' ' 75' ' ' PHE . 5.4 m-85 -97.85 -26.69 14.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.346 -0.846 . . . . 2.23 108.884 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 1.278 HG21 ' CZ ' ' A' ' 86' ' ' TYR . 15.4 m -147.48 -139.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.811 -0.811 . . . . 3.16 108.811 -178.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.736 ' N ' HG23 ' A' ' 76' ' ' VAL . 15.0 mmmt -93.03 162.74 13.92 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.141 -1.429 . . . . 4.16 107.141 177.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . 0.53 ' N ' ' HD2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -83.16 -51.3 0.67 Allowed Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 120.469 -1.394 . . . . 1.15 109.949 -179.829 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.636 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 29.1 Cg_endo -76.77 120.7 5.6 Favored 'Trans proline' 0 C--N 1.302 -1.918 0 N-CA-C 108.447 -1.405 . . . . 1.14 108.447 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 1.061 HD12 HD22 ' A' ' 117' ' ' LEU . 0.3 OUTLIER -98.19 -67.38 0.85 Allowed 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.918 -1.142 . . . . 1.15 107.918 -178.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.887 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 1.4 m 41.26 -167.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 C-N-CA 120.353 -0.539 . . . . 0.62 109.872 177.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.737 ' H ' HG23 ' A' ' 81' ' ' VAL . 0.6 OUTLIER -99.96 42.23 1.12 Allowed 'General case' 0 C--N 1.293 -1.881 0 O-C-N 120.529 -1.357 . . . . 3.32 110.195 -177.4 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -148.79 44.78 0.74 Allowed Glycine 0 C--N 1.288 -2.12 0 N-CA-C 109.152 -1.579 . . . . 0.64 109.152 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -152.47 162.33 41.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.057 -1.26 . . . . 4.89 110.259 -179.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -117.26 141.63 48.06 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.099 -1.074 . . . . 5.2 108.099 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 1.278 ' CZ ' HG21 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -108.33 -173.55 2.31 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.908 -1.12 . . . . 3.02 112.27 -177.542 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.65 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 2.9 t70 159.52 74.45 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.28 0 CA-C-O 121.826 0.822 . . . . 2.04 109.54 178.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.563 HG22 ' CG1' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -106.92 137.49 37.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 107.581 -1.266 . . . . 2.53 107.581 179.37 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.57 ' O ' ' CD1' ' A' ' 90' ' ' TYR . 8.6 mttt -142.88 -166.42 2.29 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.613 -1.304 . . . . 1.17 111.57 -178.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.978 ' CZ ' HG21 ' A' ' 54' ' ' ILE . 77.3 m-85 -155.86 77.83 0.97 Allowed 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 108.62 -0.881 . . . . 0.8 108.62 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.554 HG22 ' H ' ' A' ' 92' ' ' TRP . 12.4 m -45.58 171.17 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.365 -0.834 . . . . 3.04 109.533 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.618 ' CZ2' ' HG ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -150.34 107.99 3.67 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 118.97 -1.092 . . . . 2.97 111.535 -179.311 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.459 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 0.7 OUTLIER -72.8 98.93 2.52 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 106.23 -1.767 . . . . 3.32 106.23 177.042 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.978 HG13 HD13 ' A' ' 97' ' ' ILE . 69.6 t -109.74 95.56 20.55 Favored Pre-proline 0 C--N 1.301 -1.504 0 C-N-CA 119.037 -1.065 . . . . 1.22 113.159 -176.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.77 ' HD2' HD11 ' A' ' 97' ' ' ILE . 31.1 Cg_endo -75.21 -92.86 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.833 2.356 . . . . 1.09 108.441 175.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.523 ' O ' ' HB3' ' A' ' 31' ' ' ARG . 1.3 mmtp -121.06 -53.12 2.06 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 105.223 -2.14 . . . . 4.13 105.223 176.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.978 HD13 HG13 ' A' ' 94' ' ' VAL . 1.6 mp 61.35 28.8 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 112.632 0.605 . . . . 1.01 112.632 175.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.587 ' O ' ' HG3' ' A' ' 31' ' ' ARG . . . 58.64 160.52 0.09 OUTLIER Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 120.949 -1.095 . . . . 2.13 111.011 177.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.633 ' O ' ' HA ' ' A' ' 128' ' ' ARG . 46.2 Cg_endo -84.69 4.99 6.52 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 124.087 3.191 . . . . 2.79 110.801 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.601 ' HD3' ' CB ' ' A' ' 128' ' ' ARG . 4.6 mmmt -161.78 139.27 8.74 Favored 'General case' 0 C--N 1.283 -2.285 0 C-N-CA 119.332 -0.947 . . . . 1.28 110.647 -177.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 1.063 ' CB ' HD13 ' A' ' 127' ' ' ILE . 32.3 t -109.06 2.59 21.28 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.417 -0.802 . . . . 1.55 109.043 178.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.529 ' O ' ' CB ' ' A' ' 103' ' ' ASN . 72.9 mt-10 64.54 2.05 1.5 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.557 -0.715 . . . . 5.54 110.144 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.529 ' CB ' ' O ' ' A' ' 102' ' ' GLU . 0.9 OUTLIER 163.94 152.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.02 -1.05 . . . . 3.01 109.919 179.908 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.462 ' CG2' ' C ' ' A' ' 103' ' ' ASN . 0.3 OUTLIER -153.78 168.52 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.686 -0.857 . . . . 1.76 108.686 179.52 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.425 ' O ' HG12 ' A' ' 105' ' ' VAL . 1.1 t -161.81 131.13 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.946 -1.097 . . . . 0.81 109.66 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.966 ' HB ' ' HB3' ' A' ' 122' ' ' ALA . 3.4 t -132.24 124.98 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.24 -0.913 . . . . 1.2 109.287 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.812 ' O ' HG23 ' A' ' 108' ' ' VAL . 1.9 m -147.46 156.36 42.79 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.378 -0.826 . . . . 0.68 108.838 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.812 HG23 ' O ' ' A' ' 107' ' ' THR . 7.5 t -165.9 162.76 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.146 -0.971 . . . . 0.5 109.773 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.562 ' N ' ' CG1' ' A' ' 108' ' ' VAL . 0.3 OUTLIER 174.95 139.02 0.05 OUTLIER 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.419 -0.8 . . . . 0.64 109.527 179.302 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.703 HD21 ' OH ' ' A' ' 86' ' ' TYR . 7.7 tp -126.57 129.28 48.26 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.289 -1.374 . . . . 0.78 107.289 178.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 12.5 mt -125.03 128.18 72.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 121.189 -0.945 . . . . 0.69 111.283 -177.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.41 ' HA3' HG21 ' A' ' 47' ' ' THR . . . -103.51 -114.16 3.9 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 107.443 -2.263 . . . . 1.19 107.443 177.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -137.64 4.35 2.58 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.138 -1.431 . . . . 1.21 107.138 177.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.446 ' ND2' ' N ' ' A' ' 114' ' ' ASN . 0.7 OUTLIER -124.03 13.92 9.12 Favored 'General case' 0 C--N 1.308 -1.238 0 O-C-N 121.545 -0.722 . . . . 1.13 109.402 -179.688 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 132.77 -158.97 23.32 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.653 -1.379 . . . . 0.67 109.653 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.561 HG21 ' HB2' ' A' ' 8' ' ' CYS . 0.2 OUTLIER -99.37 117.04 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.296 -1.12 . . . . 0.51 109.394 179.702 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 1.061 HD22 HD12 ' A' ' 80' ' ' LEU . 1.3 mt -61.63 -41.49 97.56 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.606 -0.684 . . . . 0.8 110.875 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.529 ' HA ' ' CA ' ' A' ' 9' ' ' ALA . . . -168.51 136.16 2.08 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.114 -0.991 . . . . 1.66 110.235 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.548 ' SG ' ' N ' ' A' ' 8' ' ' CYS . 0.5 OUTLIER -137.32 177.72 7.65 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.533 -0.729 . . . . 0.95 109.452 179.852 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.591 ' C ' HD13 ' A' ' 121' ' ' ILE . . . -173.95 123.49 0.33 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.238 -0.914 . . . . 0.39 108.804 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.591 HD13 ' C ' ' A' ' 120' ' ' ALA . 0.0 OUTLIER -127.48 140.87 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.055 -1.028 . . . . 1.69 111.429 -178.633 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.966 ' HB3' ' HB ' ' A' ' 106' ' ' VAL . . . -119.37 136.52 54.24 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.771 -1.196 . . . . 1.61 107.771 177.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.412 ' O ' ' O ' ' A' ' 124' ' ' HIS . 17.7 m -89.62 94.69 9.95 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.813 -1.18 . . . . 1.22 110.695 -178.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.412 ' O ' ' O ' ' A' ' 123' ' ' THR . 1.6 t60 54.26 166.04 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.693 0.758 . . . . 3.52 110.991 178.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -156.05 170.22 33.75 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 108.348 -1.901 . . . . 2.11 108.348 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.54 ' HB2' HG13 ' A' ' 28' ' ' ILE . 0.4 OUTLIER -150.65 81.37 1.34 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.766 -1.432 . . . . 1.67 109.806 -179.932 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 1.063 HD13 ' CB ' ' A' ' 101' ' ' SER . 3.3 mp -41.63 138.07 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.65 -0.656 . . . . 0.82 110.573 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.674 ' HB3' ' O ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER 167.4 -165.58 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 122.274 1.035 . . . . 1.92 111.266 177.76 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.615 ' N ' ' CG ' ' A' ' 128' ' ' ARG . 3.5 m-20 . . . . . 0 C--N 1.299 -1.604 0 CA-C-O 117.982 -1.009 . . . . 6.87 109.703 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.473 ' O ' ' HB3' ' A' ' 17' ' ' MET . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 121.358 0.599 . . . . 4.64 109.728 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.523 ' HB3' ' HG2' ' A' ' 17' ' ' MET . 1.3 pt20 -105.33 34.78 3.09 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.316 -0.994 . . . . 3.69 108.316 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.678 HG11 ' HA ' ' A' ' 22' ' ' HIS . 0.6 OUTLIER -28.51 123.51 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 CA-C-O 121.487 0.66 . . . . 2.07 110.239 -179.672 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -65.23 154.08 39.14 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.451 -0.781 . . . . 3.65 110.408 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.418 HG12 ' O ' ' A' ' 121' ' ' ILE . 0.0 OUTLIER -154.88 170.55 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.446 -0.946 . . . . 1.52 108.446 179.571 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.474 ' HB3' HD12 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -77.24 92.77 3.89 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.889 -1.132 . . . . 5.93 109.499 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' A' ' 119' ' ' CYS . 0.7 OUTLIER -88.13 -177.7 5.78 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.284 -0.885 . . . . 2.97 109.134 179.806 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.492 ' O ' ' C ' ' A' ' 9' ' ' ALA . 37.4 m -151.04 -29.55 0.19 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.198 -0.939 . . . . 2.29 110.794 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.547 ' CA ' ' HA ' ' A' ' 118' ' ' ALA . . . -32.8 -77.23 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.425 -0.797 . . . . 1.3 110.938 -179.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.467 ' OD1' ' O ' ' A' ' 9' ' ' ALA . 0.9 OUTLIER 175.33 -77.33 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.415 -0.803 . . . . 3.19 109.265 -178.747 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.459 ' HB3' ' O ' ' A' ' 10' ' ' ASN . 17.8 p-10 173.56 36.28 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.523 -0.918 . . . . 4.04 108.523 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.443 ' O ' ' C ' ' A' ' 13' ' ' ILE . 0.3 OUTLIER -129.18 -4.77 4.94 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.386 -0.821 . . . . 1.77 109.78 -179.507 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.953 HG23 ' O ' ' A' ' 40' ' ' LEU . 18.5 mt -43.97 148.48 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.221 -0.924 . . . . 0.99 109.091 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.427 ' HE2' ' OD2' ' A' ' 42' ' ' ASP . 2.0 mmtt -96.86 -17.7 20.01 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.921 -0.77 . . . . 1.72 108.921 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.738 ' H ' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -170.03 100.89 0.29 Allowed 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 119.211 -0.995 . . . . 1.95 110.404 -178.164 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.558 ' HB ' HG21 ' A' ' 13' ' ' ILE . 1.4 p -124.75 97.09 4.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 107.897 -1.149 . . . . 1.25 107.897 179.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.523 ' HG2' ' HB3' ' A' ' 2' ' ' GLN . 2.4 mpt? -150.77 155.45 39.29 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.127 -0.983 . . . . 1.64 110.793 -178.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.591 HG13 ' HA ' ' A' ' 37' ' ' LEU . 2.1 t -112.06 128.9 68.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 106.982 -1.488 . . . . 1.29 106.982 178.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.534 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -87.75 89.29 7.94 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.852 -1.155 . . . . 2.67 111.191 -177.848 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.509 ' O ' ' CB ' ' A' ' 21' ' ' CYS . . . 90.6 112.41 1.59 Allowed Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.816 -1.183 . . . . 0.92 110.879 178.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.87 ' HA ' HG23 ' A' ' 29' ' ' ILE . 0.0 OUTLIER 159.12 -50.37 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.445 -1.032 . . . . 0.8 109.436 179.002 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.678 ' HA ' HG11 ' A' ' 3' ' ' VAL . 2.3 m-70 85.19 118.72 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 109.267 -0.642 . . . . 4.83 109.267 -178.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.448 ' O ' ' HB2' ' A' ' 24' ' ' SER . . . -95.74 -176.91 36.85 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 109.752 -1.339 . . . . 1.02 109.752 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.496 ' O ' ' O ' ' A' ' 25' ' ' ASP . 15.0 m 60.19 -89.41 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.236 -1.155 . . . . 1.48 109.414 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.638 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.2 OUTLIER -50.68 -176.56 0.02 OUTLIER Pre-proline 0 C--N 1.304 -1.37 0 N-CA-C 108.149 -1.056 . . . . 1.39 108.149 179.244 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.638 ' HD2' ' CB ' ' A' ' 25' ' ' ASP . 28.4 Cg_endo -70.24 82.9 0.81 Allowed 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 121.889 1.726 . . . . 1.6 109.29 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.54 ' HA ' ' O ' ' A' ' 22' ' ' HIS . 2.3 t -31.69 89.54 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 115.297 -0.865 . . . . 1.21 112.415 -178.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.492 HG21 ' C ' ' A' ' 129' ' ' ASP . 28.7 mm -90.6 132.37 35.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 104.783 -2.303 . . . . 1.16 104.783 175.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.87 HG23 ' HA ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -109.52 179.07 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.291 0 C-N-CA 118.666 -1.213 . . . . 0.66 111.319 -176.86 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.597 ' HE2' ' CE1' ' A' ' 22' ' ' HIS . 2.3 m-70 -128.08 154.34 45.81 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 119.767 -0.773 . . . . 0.59 110.881 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.545 ' CB ' ' O ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -100.54 155.54 17.79 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.886 -1.153 . . . . 4.6 107.886 178.404 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.22 0.79 76.52 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.84 -1.304 . . . . 0.85 109.84 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.713 ' N ' HG11 ' A' ' 94' ' ' VAL . 2.1 mtmm -129.66 145.7 58.07 Favored Pre-proline 0 N--CA 1.493 1.71 0 N-CA-C 107.564 -1.273 . . . . 1.68 107.564 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -71.35 82.71 1.07 Allowed 'Trans proline' 0 C--N 1.303 -1.846 0 C-N-CA 122.354 2.036 . . . . 1.07 112.152 -177.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.534 ' HA ' ' O ' ' A' ' 19' ' ' ASP . 12.3 t80 -52.01 114.13 1.22 Allowed 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 107.352 -1.351 . . . . 2.22 107.352 178.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.62 HG22 ' O ' ' A' ' 36' ' ' THR . 7.4 m -132.53 88.8 2.57 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 118.892 -1.123 . . . . 1.9 111.3 -178.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.683 HD12 ' C ' ' A' ' 37' ' ' LEU . 0.8 OUTLIER -80.56 126.48 31.3 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.236 -1.394 . . . . 2.21 107.236 177.975 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.582 ' CG ' HG22 ' A' ' 36' ' ' THR . 0.0 OUTLIER -140.22 -163.5 1.53 Allowed 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.578 -1.327 . . . . 3.2 110.728 -178.274 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.461 ' HB2' ' O ' ' A' ' 38' ' ' GLU . . . 170.02 101.65 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.886 -1.153 . . . . 1.07 107.886 179.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.953 ' O ' HG23 ' A' ' 13' ' ' ILE . 1.5 mp -93.29 173.17 7.85 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.295 -0.878 . . . . 0.71 109.818 -178.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.636 ' CE1' ' CE2' ' A' ' 86' ' ' TYR . 10.6 p90 175.05 139.9 0.05 OUTLIER 'General case' 0 C--N 1.305 -1.333 0 O-C-N 120.955 -1.09 . . . . 0.49 109.298 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.53 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 3.9 m-20 -86.28 108.49 18.42 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 107.334 -1.358 . . . . 3.65 107.334 178.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.736 ' HB1' ' O ' ' A' ' 81' ' ' VAL . . . -32.94 127.9 0.28 Allowed 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.727 -0.669 . . . . 0.31 109.602 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -122.58 1.65 9.51 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.221 -0.925 . . . . 1.04 110.221 -178.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.981 ' OE1' HD21 ' A' ' 117' ' ' LEU . 1.9 pt20 -93.53 -142.17 0.22 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.259 -0.9 . . . . 0.61 108.657 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.808 ' HA ' ' HB ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -154.31 66.66 0.71 Allowed 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.331 -0.856 . . . . 1.03 109.084 178.266 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.651 HG23 ' O ' ' A' ' 47' ' ' THR . 8.8 t -140.73 126.22 18.89 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.143 -1.598 . . . . 0.86 112.081 -177.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.667 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -72.19 -2.11 17.55 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.749 -1.219 . . . . 0.99 110.099 178.463 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.4 p -115.98 -175.44 2.73 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.906 -1.121 . . . . 2.19 111.546 -178.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 1.076 ' CB ' ' HB3' ' A' ' 72' ' ' ALA . . . -153.54 170.39 20.91 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.641 -0.874 . . . . 1.22 108.641 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.509 ' HG2' ' C ' ' A' ' 50' ' ' ALA . 0.4 OUTLIER -152.53 28.27 0.56 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.775 -1.203 . . . . 3.16 109.26 179.892 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.755 ' H ' ' HB2' ' A' ' 72' ' ' ALA . 20.5 tt -29.12 155.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.285 -2.23 0 CA-C-O 122.02 0.914 . . . . 1.68 112.206 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.463 ' O ' ' HB ' ' A' ' 54' ' ' ILE . 4.5 tt0 -117.06 -69.92 0.82 Allowed 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.005 -1.109 . . . . 3.13 108.005 178.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.697 HD12 HG13 ' A' ' 108' ' ' VAL . 0.3 OUTLIER 59.25 150.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.412 -0.805 . . . . 1.0 111.065 178.105 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.672 ' HG3' ' O ' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -178.23 94.08 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.976 -0.75 . . . . 1.4 108.976 178.373 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 105' ' ' VAL . . . -120.43 160.76 22.45 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.915 -1.115 . . . . 1.31 109.221 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.485 ' HB3' HG23 ' A' ' 105' ' ' VAL . 0.1 OUTLIER -130.19 123.89 31.31 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.97 -1.081 . . . . 1.55 109.789 -179.754 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.996 HD12 ' CZ2' ' A' ' 92' ' ' TRP . 0.1 OUTLIER -102.63 -147.99 0.38 Allowed 'General case' 0 N--CA 1.484 1.226 0 O-C-N 121.089 -1.007 . . . . 2.77 108.561 179.898 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.666 ' H ' HD13 ' A' ' 58' ' ' LEU . 24.2 t0 -94.11 81.62 4.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.067 -1.021 . . . . 3.32 109.084 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.5 1.63 90.19 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 108.936 -1.665 . . . . 4.17 108.936 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.413 ' O ' ' C ' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -115.25 57.1 0.73 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.331 -1.099 . . . . 3.1 108.566 179.606 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 61' ' ' LEU . 0.9 OUTLIER -40.79 115.9 0.64 Allowed 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 121.353 0.597 . . . . 2.58 110.724 -179.291 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.559 ' CG2' ' O ' ' A' ' 63' ' ' ILE . 0.5 OUTLIER -76.4 -3.11 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-O 122.125 0.964 . . . . 2.48 108.673 177.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.501 ' C ' ' O ' ' A' ' 63' ' ' ILE . 29.7 m-20 -25.6 134.56 0.02 OUTLIER 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 115.199 -0.91 . . . . 3.18 111.649 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.6 HG21 ' CG2' ' A' ' 54' ' ' ILE . 93.6 t -113.67 92.91 26.0 Favored Pre-proline 0 C--N 1.302 -1.476 0 N-CA-C 108.373 -0.973 . . . . 1.32 108.373 179.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 64' ' ' ASP . 36.4 Cg_endo -75.52 -94.84 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.535 2.157 . . . . 1.26 110.528 -178.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 68' ' ' ILE . . . -134.2 48.72 0.93 Allowed Glycine 0 N--CA 1.488 2.121 0 N-CA-C 110.108 -1.197 . . . . 2.07 110.108 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.429 ' O ' ' O ' ' A' ' 67' ' ' GLY . 13.5 mm -58.28 -104.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.148 -1.207 . . . . 1.34 108.63 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.489 ' OD2' ' HB2' ' A' ' 74' ' ' HIS . 0.4 OUTLIER -79.65 133.75 36.41 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.466 -1.396 . . . . 5.24 108.043 178.622 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.8 t -67.6 -13.84 62.42 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.254 -0.904 . . . . 5.26 111.864 -177.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.521 ' O ' ' N ' ' A' ' 73' ' ' CYS . 4.9 m-20 -138.28 49.42 1.92 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.328 -1.483 . . . . 0.84 111.803 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 1.076 ' HB3' ' CB ' ' A' ' 50' ' ' ALA . . . 40.67 19.48 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.843 0 O-C-N 121.116 -0.99 . . . . 1.39 112.879 176.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.521 ' N ' ' O ' ' A' ' 71' ' ' ASN . 80.8 m -68.45 -59.88 2.84 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 119.845 -1.784 . . . . 2.26 110.256 -179.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.489 ' HB2' ' OD2' ' A' ' 69' ' ' ASP . 11.9 t-160 -53.06 -27.25 19.08 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.321 -0.862 . . . . 2.96 111.025 -178.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.588 ' HB3' HD11 ' A' ' 88' ' ' ILE . 31.0 m-85 -83.95 -25.85 29.74 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.039 -1.038 . . . . 1.47 110.83 -179.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.795 ' HB ' ' CE1' ' A' ' 86' ' ' TYR . 0.2 OUTLIER -158.19 171.87 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 120.749 -1.22 . . . . 0.6 111.041 -177.961 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.658 ' N ' ' CG2' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -59.29 94.06 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 105.709 -1.96 . . . . 3.21 105.709 176.148 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . 0.516 ' SG ' ' O ' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -37.02 -51.85 2.11 Favored Pre-proline 0 C--N 1.297 -1.683 0 O-C-N 121.67 -0.644 . . . . 3.27 111.565 -177.182 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.667 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 29.6 Cg_endo -73.4 103.12 1.57 Allowed 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 120.886 1.058 . . . . 0.83 109.544 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.936 HD22 HD22 ' A' ' 117' ' ' LEU . 0.5 OUTLIER -97.85 -62.64 1.22 Allowed 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.99 -0.744 . . . . 2.48 108.99 -178.812 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.808 ' HB ' ' HA ' ' A' ' 46' ' ' ASN . 1.5 m 40.16 -166.64 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-N 116.176 -0.465 . . . . 0.76 109.846 178.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.729 ' H ' HG23 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -104.91 42.22 1.24 Allowed 'General case' 0 C--N 1.289 -2.036 0 O-C-N 120.302 -1.499 . . . . 1.65 110.126 -177.089 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -146.92 31.73 1.45 Allowed Glycine 0 C--N 1.288 -2.115 0 N-CA-C 109.439 -1.464 . . . . 0.6 109.439 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -153.46 132.12 12.27 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 120.89 -1.359 . . . . 3.15 110.554 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.53 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 3.6 pt20 -104.22 132.99 49.88 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 106.447 -1.686 . . . . 4.21 106.447 177.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.798 ' CE2' HD21 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -152.09 169.15 23.09 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 118.241 -1.383 . . . . 0.48 109.709 -178.377 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.614 ' CB ' ' HG ' ' A' ' 40' ' ' LEU . 6.9 p-10 -134.0 91.86 2.87 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.71 -1.243 . . . . 0.39 113.669 -175.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.588 HD11 ' HB3' ' A' ' 75' ' ' PHE . 4.4 tp -57.84 -172.3 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 106.333 -1.729 . . . . 1.06 106.333 175.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.577 ' O ' ' CD2' ' A' ' 90' ' ' TYR . 12.7 mttt 167.03 174.37 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.393 -1.442 . . . . 1.48 112.049 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.577 ' CD2' ' O ' ' A' ' 89' ' ' LYS . 82.5 m-85 -158.86 44.97 0.28 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.111 -1.07 . . . . 0.62 108.111 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.488 ' HA ' ' OG1' ' A' ' 36' ' ' THR . 74.4 p -51.94 -168.96 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.771 -0.581 . . . . 2.79 110.19 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.996 ' CZ2' HD12 ' A' ' 58' ' ' LEU . 1.4 t90 176.55 90.73 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.303 0 O-C-N 121.091 -1.006 . . . . 4.74 110.683 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.417 ' C ' ' O ' ' A' ' 92' ' ' TRP . 20.5 t-20 -49.47 98.53 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 106.463 -1.68 . . . . 4.71 106.463 178.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.903 HG13 ' CD1' ' A' ' 97' ' ' ILE . 1.0 OUTLIER -79.73 125.36 82.52 Favored Pre-proline 0 C--N 1.298 -1.635 0 O-C-N 121.343 -0.848 . . . . 1.36 112.297 -176.614 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.708 ' HD2' HD11 ' A' ' 97' ' ' ILE . 34.3 Cg_endo -82.62 -84.68 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 123.347 2.698 . . . . 1.54 108.853 176.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.545 ' O ' ' CB ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -138.05 -51.17 0.6 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 106.155 -1.794 . . . . 1.24 106.155 178.241 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.903 ' CD1' HG13 ' A' ' 94' ' ' VAL . 1.4 mp 62.81 5.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.756 -0.59 . . . . 1.52 111.956 176.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 1.012 ' HB1' ' HD2' ' A' ' 99' ' ' PRO . . . 51.87 173.63 0.03 OUTLIER Pre-proline 0 C--N 1.305 -1.346 0 O-C-N 120.778 -1.201 . . . . 1.73 110.176 179.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 1.012 ' HD2' ' HB1' ' A' ' 98' ' ' ALA . 50.1 Cg_endo -82.34 149.25 14.94 Favored 'Trans proline' 0 C--N 1.301 -1.928 0 C-N-CA 123.658 2.905 . . . . 1.72 109.744 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.626 ' HD3' ' CB ' ' A' ' 128' ' ' ARG . 1.1 mmmp? 55.79 114.56 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.033 0 C-N-CA 119.454 -0.899 . . . . 2.22 111.063 176.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 1.007 ' HB2' HD13 ' A' ' 127' ' ' ILE . 3.2 m -93.87 166.23 12.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.16 -0.962 . . . . 2.01 109.149 179.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.415 ' O ' ' CB ' ' A' ' 103' ' ' ASN . 0.2 OUTLIER -53.59 -19.08 3.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.278 -0.889 . . . . 2.49 109.139 179.603 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.459 ' O ' ' OG ' ' A' ' 57' ' ' SER . 0.5 OUTLIER 168.67 154.06 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.554 -0.906 . . . . 0.98 108.554 -179.996 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.949 HG21 HD12 ' A' ' 127' ' ' ILE . 0.1 OUTLIER -147.05 134.67 14.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 120.903 -1.123 . . . . 1.24 110.402 -179.649 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.485 HG23 ' HB3' ' A' ' 57' ' ' SER . 0.2 OUTLIER -155.01 145.47 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 107.973 -1.121 . . . . 2.21 107.973 179.629 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.563 ' HB ' ' HB3' ' A' ' 122' ' ' ALA . 71.1 t -129.01 128.96 67.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 120.641 -1.287 . . . . 1.06 110.401 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.504 ' O ' HG22 ' A' ' 108' ' ' VAL . 0.3 OUTLIER -150.43 140.56 22.11 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.19 -1.041 . . . . 0.63 108.19 179.305 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.697 HG13 HD12 ' A' ' 54' ' ' ILE . 2.4 t -157.16 156.75 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.748 -1.22 . . . . 1.69 110.463 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.513 ' HA ' ' HA ' ' A' ' 119' ' ' CYS . 0.1 OUTLIER 177.96 119.42 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.696 -0.853 . . . . 1.48 108.696 178.961 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.545 ' HB3' ' HB2' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -102.14 117.67 35.28 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 109.146 -0.686 . . . . 2.78 109.146 -179.866 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.486 ' O ' ' HG3' ' A' ' 51' ' ' LYS . 24.1 mt -110.34 139.78 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.333 -0.854 . . . . 1.15 110.331 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -108.39 -111.97 3.53 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 108.672 -1.771 . . . . 0.43 108.672 178.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.462 ' HB2' ' HB ' ' A' ' 47' ' ' THR . 2.3 m-20 -139.2 4.46 2.23 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.722 -1.214 . . . . 3.26 107.722 178.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.404 ' ND2' ' HB2' ' A' ' 45' ' ' GLN . 2.0 m-80 -118.49 -35.65 3.7 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.592 0.71 . . . . 0.89 109.36 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -173.43 -141.56 3.56 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.411 -1.476 . . . . 0.52 109.411 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.633 HG22 ' O ' ' A' ' 116' ' ' VAL . 0.1 OUTLIER -109.58 107.6 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.19 -1.183 . . . . 0.68 109.9 -179.87 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.981 HD21 ' OE1' ' A' ' 45' ' ' GLN . 1.1 mt -49.66 -49.7 46.3 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.252 -0.905 . . . . 0.78 109.113 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.547 ' HA ' ' CA ' ' A' ' 9' ' ' ALA . . . -161.98 -167.47 1.67 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.403 -0.811 . . . . 1.22 109.247 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.513 ' HA ' ' HA ' ' A' ' 109' ' ' LYS . 0.1 OUTLIER 172.91 170.59 0.13 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.257 -0.902 . . . . 0.67 109.605 179.781 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.416 ' N ' ' SG ' ' A' ' 119' ' ' CYS . . . -175.44 127.18 0.25 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.836 -0.801 . . . . 0.92 108.836 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.475 HG23 HG23 ' A' ' 107' ' ' THR . 2.5 mp -133.46 147.29 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.158 -0.964 . . . . 0.72 110.787 -179.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.563 ' HB3' ' HB ' ' A' ' 106' ' ' VAL . . . -112.72 -159.58 0.69 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.414 -0.803 . . . . 3.03 108.991 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.742 HG22 ' NE2' ' A' ' 124' ' ' HIS . 0.2 OUTLIER -161.66 115.49 1.91 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.933 -1.104 . . . . 1.16 110.495 -179.837 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.742 ' NE2' HG22 ' A' ' 123' ' ' THR . 0.2 OUTLIER 57.67 118.4 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.387 -0.82 . . . . 4.14 110.562 178.882 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 27' ' ' CYS . . . -129.46 167.88 21.22 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 108.975 -1.65 . . . . 2.07 108.975 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.403 ' HB3' ' CD1' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -172.25 86.01 0.07 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.042 -1.269 . . . . 3.04 109.984 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 1.007 HD13 ' HB2' ' A' ' 101' ' ' SER . 2.4 mp -46.35 138.7 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.352 -0.843 . . . . 1.19 109.822 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.643 ' CB ' ' O ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER 147.07 -93.88 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.859 -0.793 . . . . 3.79 108.859 179.003 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.504 ' N ' ' CG ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.964 -1.017 . . . . 4.08 109.457 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.2 t0 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.328 0.585 . . . . 5.81 109.508 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.462 ' HB3' ' HG2' ' A' ' 17' ' ' MET . 0.0 OUTLIER -122.46 23.18 9.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.193 -0.942 . . . . 3.88 108.679 179.406 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.868 HG12 ' H ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER 38.71 -159.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-O 121.188 0.518 . . . . 1.07 109.908 179.376 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -141.28 32.86 1.7 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.093 -1.004 . . . . 1.44 109.48 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.474 ' H ' HG22 ' A' ' 5' ' ' VAL . 1.1 m -53.16 136.85 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.423 -0.798 . . . . 0.67 109.359 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -67.5 94.98 0.44 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.21 -0.931 . . . . 3.96 109.704 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.527 ' OD2' ' CD1' ' A' ' 13' ' ' ILE . 0.2 OUTLIER -93.25 -176.16 4.05 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.112 -0.992 . . . . 4.49 109.037 179.5 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 21.6 p -176.96 41.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.001 -1.062 . . . . 2.15 109.762 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.556 ' CB ' HG13 ' A' ' 13' ' ' ILE . . . -77.13 -72.43 0.35 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.37 -0.831 . . . . 0.65 109.244 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.453 ' O ' ' HG2' ' A' ' 12' ' ' GLU . 0.9 OUTLIER -157.18 25.02 0.31 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.456 -0.777 . . . . 2.96 109.561 -179.778 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.451 ' CB ' ' O ' ' A' ' 10' ' ' ASN . 0.5 OUTLIER 72.14 22.51 3.63 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.306 -0.871 . . . . 2.83 109.485 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.519 ' O ' ' HB ' ' A' ' 13' ' ' ILE . 0.6 OUTLIER -145.04 -83.52 0.14 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.849 -0.797 . . . . 3.78 108.849 179.834 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.718 HG22 ' H ' ' A' ' 15' ' ' LYS . 0.4 OUTLIER 71.44 -6.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.509 -0.744 . . . . 3.66 111.486 178.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.574 ' HB2' ' O ' ' A' ' 13' ' ' ILE . 1.7 mtpt 68.21 -21.79 0.13 Allowed 'General case' 0 C--N 1.293 -1.864 0 O-C-N 121.504 -0.747 . . . . 4.69 111.328 179.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.718 ' H ' HG22 ' A' ' 13' ' ' ILE . 0.1 OUTLIER 170.6 126.41 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 O-C-N 120.59 -1.319 . . . . 1.42 109.566 -177.581 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.627 ' O ' HG13 ' A' ' 16' ' ' VAL . 6.4 p -140.96 114.64 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.128 -0.983 . . . . 0.91 108.845 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.512 ' HG3' ' C ' ' A' ' 16' ' ' VAL . 1.8 mtt -153.47 168.49 25.93 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.063 -1.055 . . . . 1.91 110.63 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.674 HG12 ' H ' ' A' ' 19' ' ' ASP . 16.5 t -129.29 177.66 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 107.388 -1.338 . . . . 1.24 107.388 178.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.674 ' H ' HG12 ' A' ' 18' ' ' VAL . 3.6 t0 -117.54 66.44 0.74 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.597 -1.314 . . . . 2.11 112.019 -178.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 29' ' ' ILE . . . 120.53 -26.77 6.83 Favored Glycine 0 N--CA 1.493 2.497 0 C-N-CA 119.063 -1.541 . . . . 3.13 112.39 177.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.99 ' CA ' HG23 ' A' ' 29' ' ' ILE . 3.9 t -60.21 -118.6 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.484 -1.597 . . . . 1.97 109.572 -178.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.581 ' HA ' ' CG1' ' A' ' 3' ' ' VAL . 2.7 m-70 155.48 123.27 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.771 -1.206 . . . . 2.27 108.836 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.868 ' H ' HG12 ' A' ' 3' ' ' VAL . . . -75.67 155.24 46.48 Favored Glycine 0 N--CA 1.494 2.519 0 O-C-N 121.027 -1.046 . . . . 0.78 110.718 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.433 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 5.4 m 70.22 155.87 0.14 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.356 -1.085 . . . . 2.62 108.887 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.608 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.1 OUTLIER 57.9 175.36 0.04 OUTLIER Pre-proline 0 C--N 1.304 -1.378 0 N-CA-C 107.678 -1.23 . . . . 5.42 107.678 -179.824 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.608 ' HD2' ' CB ' ' A' ' 25' ' ' ASP . 25.3 Cg_endo -67.31 85.06 0.35 Allowed 'Trans proline' 0 C--N 1.295 -2.281 0 C-N-CA 122.037 1.825 . . . . 1.29 109.763 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.606 ' HB2' ' HB1' ' A' ' 122' ' ' ALA . 3.9 t -23.62 86.45 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.973 0 CA-C-N 115.332 -0.849 . . . . 1.82 111.808 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.507 ' HA ' ' O ' ' A' ' 126' ' ' LYS . 29.3 mm -77.97 143.43 12.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 C-N-CA 118.649 -1.22 . . . . 0.88 107.968 178.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.99 HG23 ' CA ' ' A' ' 21' ' ' CYS . 0.2 OUTLIER -129.67 -177.53 2.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 O-C-N 120.981 -1.074 . . . . 0.81 112.142 -177.194 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 36.5 m-70 -114.51 166.57 11.57 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.415 0.626 . . . . 1.63 110.496 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.885 ' O ' HD12 ' A' ' 97' ' ' ILE . 0.1 OUTLIER -122.13 10.54 10.05 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.732 0.777 . . . . 11.01 108.966 178.863 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.491 ' HA2' ' O ' ' A' ' 95' ' ' PRO . . . -116.93 -5.88 14.81 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.649 -1.381 . . . . 1.52 109.649 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.589 ' C ' ' HB ' ' A' ' 94' ' ' VAL . 6.9 mtpt -116.78 147.04 39.1 Favored Pre-proline 0 C--N 1.303 -1.441 0 N-CA-C 106.977 -1.49 . . . . 3.42 106.977 178.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.552 ' O ' ' N ' ' A' ' 36' ' ' THR . 28.3 Cg_endo -66.65 102.98 0.65 Allowed 'Trans proline' 0 C--N 1.299 -2.039 0 C-N-CA 122.178 1.919 . . . . 1.25 111.919 -177.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.54 ' O ' ' HA ' ' A' ' 91' ' ' THR . 49.4 t80 -41.65 94.66 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.822 -1.177 . . . . 3.65 107.822 178.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.816 HG23 ' CG2' ' A' ' 91' ' ' THR . 19.3 m -114.51 78.11 1.12 Allowed 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.529 -0.868 . . . . 2.39 110.548 -178.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.767 HD12 ' N ' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -77.46 131.25 37.87 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 106.294 -1.743 . . . . 1.42 106.294 177.91 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.767 ' N ' HD12 ' A' ' 37' ' ' LEU . 3.8 mt-10 -142.83 178.82 7.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.683 -1.261 . . . . 2.94 111.149 -177.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.449 ' HB2' ' O ' ' A' ' 38' ' ' GLU . . . 171.67 95.94 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.298 -1.371 . . . . 0.31 107.298 178.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.61 ' HG ' ' CB ' ' A' ' 87' ' ' ASP . 0.0 OUTLIER -90.38 174.13 7.73 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.464 -0.773 . . . . 0.41 109.652 -178.418 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.792 ' HZ ' ' HH ' ' A' ' 86' ' ' TYR . 20.8 p90 173.01 141.7 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.776 -1.202 . . . . 0.41 110.184 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.508 ' O ' ' C ' ' A' ' 43' ' ' ALA . 9.1 p-10 -90.87 112.86 24.87 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 107.445 -1.317 . . . . 4.11 107.445 178.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.711 ' HB1' ' O ' ' A' ' 81' ' ' VAL . . . -33.31 123.89 0.4 Allowed 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 115.613 -0.721 . . . . 0.42 110.012 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -120.08 3.88 10.92 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.497 -0.752 . . . . 3.66 110.822 -177.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.877 ' OE1' HD21 ' A' ' 117' ' ' LEU . 2.0 pt20 -97.69 -142.77 0.3 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.186 -0.946 . . . . 0.67 108.598 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.786 ' HA ' ' HB ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -153.16 68.17 0.8 Allowed 'General case' 0 C--N 1.295 -1.781 0 O-C-N 121.285 -0.884 . . . . 0.4 108.631 178.551 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.789 HG23 ' O ' ' A' ' 47' ' ' THR . 9.1 t -145.67 111.38 5.5 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.01 -1.681 . . . . 0.51 112.042 -177.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.66 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -59.69 -23.04 62.8 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.348 -1.353 . . . . 2.84 107.348 177.152 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.41 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 1.1 p -82.86 -165.09 0.97 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.856 -0.528 . . . . 0.83 109.6 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.805 ' CB ' ' HB3' ' A' ' 72' ' ' ALA . . . 178.14 155.5 0.37 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.277 -0.889 . . . . 0.42 109.128 -179.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.582 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 19.7 mtmt -127.75 171.13 12.0 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.061 -1.459 . . . . 1.45 107.061 178.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.874 HG12 HG11 ' A' ' 65' ' ' VAL . 3.0 tt -158.65 156.43 3.88 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 C-N-CA 118.221 -1.392 . . . . 0.89 110.949 -179.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.52 ' O ' ' NZ ' ' A' ' 55' ' ' LYS . 4.1 tp10 -159.71 48.93 0.3 Allowed 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.267 -1.382 . . . . 3.62 107.267 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.802 ' HB ' HG21 ' A' ' 65' ' ' VAL . 1.3 mt -85.7 136.92 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 CA-C-O 122.354 1.074 . . . . 1.84 111.201 -178.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.562 ' HG3' ' O ' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -144.01 98.05 3.16 Favored 'General case' 0 C--N 1.282 -2.365 0 O-C-N 121.0 -1.062 . . . . 0.98 109.972 178.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.631 ' HB3' HD12 ' A' ' 63' ' ' ILE . . . -107.35 132.5 53.07 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 107.814 -1.18 . . . . 0.44 107.814 178.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.454 ' HA ' ' HA ' ' A' ' 62' ' ' GLU . 58.6 m -117.66 113.66 22.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.819 -1.176 . . . . 2.32 110.598 -178.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.45 ' O ' ' C ' ' A' ' 59' ' ' ASP . 0.2 OUTLIER -94.63 176.99 6.07 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.153 -1.054 . . . . 4.55 108.153 178.909 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.493 ' HB2' ' HB2' ' A' ' 101' ' ' SER . 0.0 OUTLIER -44.12 -60.74 1.74 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.922 -1.111 . . . . 3.34 109.235 -179.752 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.66 ' C ' HD22 ' A' ' 61' ' ' LEU . . . -129.27 10.24 6.19 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.517 -1.433 . . . . 2.34 109.517 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.814 ' N ' HD22 ' A' ' 61' ' ' LEU . 2.9 mm? -110.11 47.06 0.98 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.06 -1.259 . . . . 3.02 107.851 178.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.454 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 1.4 mt-10 -42.67 87.77 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 115.61 -0.723 . . . . 2.3 110.929 -179.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.631 HD12 ' HB3' ' A' ' 56' ' ' ALA . 6.8 mt -62.93 164.9 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 N-CA-C 106.696 -1.594 . . . . 0.47 106.696 177.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.405 ' C ' HG23 ' A' ' 65' ' ' VAL . 1.7 t0 -168.26 153.29 6.53 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.614 -1.304 . . . . 2.01 110.186 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.874 HG11 HG12 ' A' ' 52' ' ' ILE . 23.7 t -150.89 62.79 5.4 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.636 -0.665 . . . . 0.44 110.04 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.596 ' HD3' ' N ' ' A' ' 65' ' ' VAL . 37.7 Cg_endo -84.96 95.45 0.66 Allowed 'Trans proline' 0 C--N 1.301 -1.938 0 C-N-CA 123.296 2.664 . . . . 1.16 110.979 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.478 ' C ' ' O ' ' A' ' 66' ' ' PRO . . . 38.31 57.9 1.72 Allowed Glycine 0 N--CA 1.495 2.61 0 N-CA-C 109.621 -1.392 . . . . 2.04 109.621 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.57 HG22 ' N ' ' A' ' 69' ' ' ASP . 22.7 mm -84.32 -94.04 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.278 -1.131 . . . . 2.99 109.948 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.57 ' N ' HG22 ' A' ' 68' ' ' ILE . 35.5 p30 -51.64 166.06 0.15 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.175 -0.953 . . . . 1.5 110.038 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -69.27 -20.02 63.92 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.363 -0.836 . . . . 2.19 109.607 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.604 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 6.6 m-20 -175.57 73.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.785 -1.197 . . . . 0.71 111.307 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.805 ' HB3' ' CB ' ' A' ' 50' ' ' ALA . . . 40.33 26.89 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.562 -0.711 . . . . 0.81 111.478 176.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.545 ' HB3' ' HB2' ' A' ' 78' ' ' CYS . 4.0 m -88.41 -49.25 7.05 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.909 -1.119 . . . . 3.09 110.046 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.497 ' HB2' ' HB3' ' A' ' 69' ' ' ASP . 0.2 OUTLIER -59.17 -7.14 1.07 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.348 -0.845 . . . . 1.18 111.957 -178.044 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.592 ' C ' HG12 ' A' ' 76' ' ' VAL . 83.8 m-85 -115.62 -10.12 11.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.489 -1.382 . . . . 0.42 110.644 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.795 HG21 ' CZ ' ' A' ' 86' ' ' TYR . 0.2 OUTLIER -164.51 175.91 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.871 -1.143 . . . . 0.38 110.153 -178.483 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.664 ' N ' ' CG2' ' A' ' 76' ' ' VAL . 11.8 mmmt -61.55 93.15 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 106.226 -1.768 . . . . 2.65 106.226 176.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . 0.545 ' HB2' ' HB3' ' A' ' 73' ' ' CYS . 4.1 t -37.91 -50.37 3.04 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.359 -0.838 . . . . 3.53 111.79 -177.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.66 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 30.6 Cg_endo -74.71 108.27 2.66 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 N-CA-C 108.674 -1.318 . . . . 0.54 108.674 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.966 HD22 HD22 ' A' ' 117' ' ' LEU . 0.6 OUTLIER -103.28 -66.71 0.92 Allowed 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 108.378 -0.971 . . . . 2.42 108.378 -178.701 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.786 ' HB ' ' HA ' ' A' ' 46' ' ' ASN . 1.4 m 41.45 -167.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 109.221 -0.659 . . . . 0.36 109.221 178.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.733 ' H ' HG23 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -101.82 42.71 1.11 Allowed 'General case' 0 C--N 1.284 -2.267 0 O-C-N 120.261 -1.524 . . . . 3.21 109.704 -176.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -146.62 37.3 1.21 Allowed Glycine 0 C--N 1.287 -2.143 0 N-CA-C 108.712 -1.755 . . . . 0.42 108.712 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 35.3 tp60 -152.52 143.44 22.99 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 121.157 -1.202 . . . . 2.33 110.78 -179.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.42 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 0.3 OUTLIER -117.59 134.5 54.81 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 105.596 -2.002 . . . . 3.14 105.596 177.653 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.798 ' HE2' HD21 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -163.4 163.58 24.95 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 117.514 -1.675 . . . . 0.58 109.95 -177.42 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.61 ' CB ' ' HG ' ' A' ' 40' ' ' LEU . 12.7 p-10 -133.14 102.29 5.53 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.852 -1.155 . . . . 0.59 112.968 -176.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.536 ' CD1' ' O ' ' A' ' 75' ' ' PHE . 3.0 tp -70.26 -175.9 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 107.423 -1.325 . . . . 1.66 107.423 176.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.544 ' O ' ' CD2' ' A' ' 90' ' ' TYR . 3.1 mttt 174.13 173.65 0.18 Allowed 'General case' 0 N--CA 1.5 2.07 0 O-C-N 120.852 -1.155 . . . . 0.77 110.83 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.544 ' CD2' ' O ' ' A' ' 89' ' ' LYS . 5.8 m-85 -172.43 60.56 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 106.908 -1.516 . . . . 2.41 106.908 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.816 ' CG2' HG23 ' A' ' 36' ' ' THR . 0.3 OUTLIER -90.25 -169.19 2.33 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.518 -0.739 . . . . 3.08 111.667 -177.306 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.564 ' CH2' ' HB3' ' A' ' 61' ' ' LEU . 0.2 OUTLIER -171.2 151.63 3.21 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.581 -0.699 . . . . 7.17 110.323 -178.973 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -81.89 142.73 32.23 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.908 -1.145 . . . . 2.25 107.908 178.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 1.068 HG13 ' CD1' ' A' ' 97' ' ' ILE . 51.5 t -147.89 112.97 3.92 Favored Pre-proline 0 C--N 1.305 -1.335 0 O-C-N 120.805 -1.185 . . . . 2.18 111.667 -177.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.943 ' HD2' HD11 ' A' ' 97' ' ' ILE . 29.9 Cg_endo -74.56 -67.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 123.259 2.639 . . . . 3.41 111.513 178.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.634 ' O ' ' HB3' ' A' ' 31' ' ' ARG . 0.4 OUTLIER -162.44 -33.65 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 107.368 -1.345 . . . . 5.74 107.368 -179.826 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 1.068 ' CD1' HG13 ' A' ' 94' ' ' VAL . 1.4 mt 34.48 24.37 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 114.02 1.118 . . . . 2.28 114.02 176.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 1.023 ' HB1' ' HD2' ' A' ' 99' ' ' PRO . . . 61.28 -177.2 0.03 OUTLIER Pre-proline 0 C--N 1.301 -1.513 0 O-C-N 120.279 -1.513 . . . . 1.35 109.926 178.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 1.023 ' HD2' ' HB1' ' A' ' 98' ' ' ALA . 46.8 Cg_endo -86.53 151.23 8.97 Favored 'Trans proline' 0 C--N 1.302 -1.896 0 C-N-CA 123.645 2.896 . . . . 0.74 111.052 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.521 ' HD2' ' HA ' ' A' ' 128' ' ' ARG . 2.0 mptm? 64.08 142.91 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.965 0.888 . . . . 3.05 112.419 175.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.725 ' HB3' HD13 ' A' ' 127' ' ' ILE . 2.9 p -111.15 12.31 21.89 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.918 -0.771 . . . . 3.5 108.918 179.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.549 ' O ' ' CB ' ' A' ' 103' ' ' ASN . 0.8 OUTLIER 76.66 -5.98 2.09 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.603 -0.685 . . . . 3.1 109.342 -179.425 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.549 ' CB ' ' O ' ' A' ' 102' ' ' GLU . 3.6 t-20 159.19 146.04 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.453 -0.78 . . . . 2.83 109.45 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 1.092 HG21 HD12 ' A' ' 127' ' ' ILE . 0.1 OUTLIER -157.55 -174.3 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.255 -0.903 . . . . 0.65 110.065 -179.76 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.525 ' CB ' ' O ' ' A' ' 104' ' ' VAL . 1.2 t 159.27 125.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.2 -1.037 . . . . 0.6 108.2 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.742 ' O ' HG12 ' A' ' 106' ' ' VAL . 2.1 t -125.13 97.39 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 120.833 -1.167 . . . . 1.59 110.555 -178.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.515 ' HB ' ' HE3' ' A' ' 55' ' ' LYS . 25.6 m -116.52 143.61 45.37 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.504 -1.295 . . . . 0.69 107.504 178.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.753 HG13 ' CD1' ' A' ' 54' ' ' ILE . 88.0 t -151.15 152.89 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.59 -1.319 . . . . 1.0 110.585 -178.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -173.62 118.05 0.27 Allowed 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.798 0.809 . . . . 0.75 109.472 178.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.588 ' HB3' ' HB2' ' A' ' 117' ' ' LEU . 9.8 tp -106.26 121.8 44.93 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 106.777 -1.564 . . . . 1.34 106.777 178.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.511 ' HB ' ' HB2' ' A' ' 51' ' ' LYS . 4.0 mt -121.11 117.49 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.25 -0.906 . . . . 0.74 112.296 -176.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.499 ' HA3' HG21 ' A' ' 47' ' ' THR . . . -86.23 -112.37 0.83 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 107.806 -2.117 . . . . 0.75 107.806 176.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -141.1 -0.1 1.49 Allowed 'General case' 0 C--N 1.307 -1.268 0 O-C-N 120.928 -1.337 . . . . 1.46 108.123 178.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.463 ' ND2' ' N ' ' A' ' 114' ' ' ASN . 0.2 OUTLIER -120.98 -5.59 9.56 Favored 'General case' 0 C--N 1.313 -0.985 0 O-C-N 121.163 -0.961 . . . . 1.17 109.955 -179.923 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 160.56 164.47 15.6 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 109.641 -1.383 . . . . 1.4 109.641 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.41 HG13 ' O ' ' A' ' 116' ' ' VAL . 2.1 p -70.62 110.54 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.112 -1.228 . . . . 0.92 109.455 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.966 HD22 HD22 ' A' ' 80' ' ' LEU . 1.3 mt -48.52 -51.46 27.28 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.465 -0.772 . . . . 1.15 110.156 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -168.97 135.49 1.76 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.223 -0.923 . . . . 2.19 109.597 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.53 ' O ' ' HB2' ' A' ' 120' ' ' ALA . 22.0 p -126.13 -162.31 1.12 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.916 -1.115 . . . . 0.94 110.637 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.53 ' HB2' ' O ' ' A' ' 119' ' ' CYS . . . 171.24 124.86 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.38 -0.97 . . . . 0.37 108.38 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.523 HD12 ' C ' ' A' ' 120' ' ' ALA . 1.2 mp -133.69 126.62 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 120.976 -1.078 . . . . 1.5 110.798 -178.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.606 ' HB1' ' HB2' ' A' ' 27' ' ' CYS . . . -111.43 82.16 1.56 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.208 -1.034 . . . . 0.54 108.208 178.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.54 ' CG2' ' O ' ' A' ' 123' ' ' THR . 0.5 OUTLIER -33.52 125.04 0.42 Allowed 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.563 0.697 . . . . 2.68 110.666 -179.083 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.475 ' O ' ' O ' ' A' ' 123' ' ' THR . 8.1 m170 54.41 163.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.555 -0.716 . . . . 2.17 109.786 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -153.88 129.72 2.73 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.401 -1.48 . . . . 1.66 109.401 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.507 ' O ' ' HA ' ' A' ' 28' ' ' ILE . 5.7 mtmt -153.23 119.17 5.39 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.328 -1.101 . . . . 1.85 108.536 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 1.092 HD12 HG21 ' A' ' 104' ' ' VAL . 1.5 mp -94.12 160.67 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.234 -0.916 . . . . 1.32 110.506 -178.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.528 ' HG2' ' O ' ' A' ' 127' ' ' ILE . 1.4 mtm180 -150.8 -174.72 4.87 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 109.016 -0.735 . . . . 2.69 109.016 178.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.541 ' N ' ' HB3' ' A' ' 99' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 117.917 -1.04 . . . . 7.78 109.708 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.513 ' O ' ' HG3' ' A' ' 2' ' ' GLN . 14.5 m-20 . . . . . 0 N--CA 1.492 1.644 0 N-CA-C 109.6 -0.518 . . . . 4.36 109.6 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.513 ' HG3' ' O ' ' A' ' 1' ' ' ASP . 4.4 pt20 37.41 31.93 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.691 -0.485 . . . . 3.19 109.691 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.777 HG12 ' HA ' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -33.74 144.95 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-O 121.367 0.603 . . . . 2.0 110.402 -179.562 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.489 ' O ' ' N ' ' A' ' 24' ' ' SER . 5.3 t70 -89.64 148.83 23.09 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.419 -0.801 . . . . 2.47 109.437 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.421 HG13 ' O ' ' A' ' 4' ' ' ASP . 0.0 OUTLIER -156.08 167.24 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.353 -0.842 . . . . 1.65 108.988 179.961 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.564 ' HD3' ' N ' ' A' ' 6' ' ' LYS . 1.4 mptt -80.02 76.92 6.74 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.073 -1.084 . . . . 3.62 108.073 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.525 ' HB2' ' O ' ' A' ' 119' ' ' CYS . 51.6 p30 -94.35 168.38 10.93 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.832 0.825 . . . . 0.77 110.436 -178.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.54 ' N ' ' SG ' ' A' ' 119' ' ' CYS . 29.2 m -113.17 -36.1 5.16 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.031 -1.47 . . . . 3.26 107.031 178.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.835 ' HB2' ' CB ' ' A' ' 118' ' ' ALA . . . -64.14 -144.84 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.358 -0.979 . . . . 5.02 108.358 177.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.559 ' CB ' ' O ' ' A' ' 9' ' ' ALA . 0.1 OUTLIER 80.45 -42.92 0.22 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 120.506 -0.477 . . . . 9.64 110.874 177.372 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -63.38 -17.73 62.94 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.957 -1.089 . . . . 4.23 108.23 178.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.448 ' HG2' ' HB3' ' A' ' 44' ' ' ASN . 13.1 tp10 -132.37 -28.78 1.64 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.673 -0.642 . . . . 2.78 109.575 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.813 HG13 ' HB1' ' A' ' 9' ' ' ALA . 10.4 mt -48.43 154.7 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.09 -1.006 . . . . 1.61 109.825 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.444 ' N ' ' CG2' ' A' ' 13' ' ' ILE . 0.0 OUTLIER -110.91 -23.21 11.11 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.784 -0.821 . . . . 0.92 108.784 179.776 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -156.99 122.07 4.57 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 119.202 -0.999 . . . . 2.42 109.657 -178.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.631 ' O ' HG13 ' A' ' 16' ' ' VAL . 4.5 p -155.3 104.65 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.074 -1.016 . . . . 1.23 109.412 -179.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.497 ' HG2' ' HB3' ' A' ' 2' ' ' GLN . 3.0 mpp? -150.42 152.74 34.78 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.202 -0.936 . . . . 1.36 110.493 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.874 HG12 ' CE1' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -121.4 106.04 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 108.087 -1.079 . . . . 0.79 108.087 178.535 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.442 ' HB3' ' O ' ' A' ' 34' ' ' PRO . 1.2 t0 -52.49 86.92 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.644 -0.66 . . . . 1.87 110.928 -178.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.554 ' O ' ' HB3' ' A' ' 21' ' ' CYS . . . 98.46 -169.96 24.04 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 120.035 -1.078 . . . . 2.01 110.928 178.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.95 ' CA ' HG23 ' A' ' 29' ' ' ILE . 36.2 t 86.14 -25.52 0.11 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 122.268 -0.548 . . . . 1.53 110.193 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.777 ' HA ' HG12 ' A' ' 3' ' ' VAL . 0.3 OUTLIER 42.2 83.99 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.858 -1.151 . . . . 1.74 108.973 -179.192 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.497 ' O ' ' CB ' ' A' ' 24' ' ' SER . . . -83.39 -144.56 5.77 Favored Glycine 0 N--CA 1.498 2.811 0 O-C-N 121.489 -0.757 . . . . 1.26 112.327 -178.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.497 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 0.1 OUTLIER 78.46 -79.38 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 107.45 -1.315 . . . . 1.4 107.45 -177.818 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.691 ' HB2' ' CD ' ' A' ' 26' ' ' PRO . 7.3 p30 -84.87 -149.4 0.0 OUTLIER Pre-proline 0 C--N 1.298 -1.67 0 N-CA-C 105.263 -2.125 . . . . 2.39 105.263 177.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.691 ' CD ' ' HB2' ' A' ' 25' ' ' ASP . 25.9 Cg_endo -70.07 102.36 1.07 Allowed 'Trans proline' 0 C--N 1.32 -0.969 0 CA-C-N 121.168 1.453 . . . . 1.49 108.601 179.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.599 ' HA ' ' O ' ' A' ' 22' ' ' HIS . 3.2 t -54.72 81.23 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 115.42 -0.809 . . . . 1.63 113.07 -176.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.534 ' O ' ' O ' ' A' ' 21' ' ' CYS . 0.6 OUTLIER -83.09 145.29 8.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 106.863 -1.532 . . . . 2.11 106.863 176.475 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.95 HG23 ' CA ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -113.35 -175.95 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 O-C-N 120.756 -1.215 . . . . 1.11 111.827 -176.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 34.5 m-70 -127.04 107.25 9.88 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 119.952 -0.699 . . . . 1.95 111.269 -178.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.583 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -53.86 149.1 9.22 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.492 -0.755 . . . . 3.21 109.038 178.353 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.518 ' HA2' ' O ' ' A' ' 95' ' ' PRO . . . 92.06 -1.97 74.78 Favored Glycine 0 N--CA 1.493 2.478 0 C-N-CA 119.814 -1.184 . . . . 2.11 110.61 178.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.584 ' O ' HG21 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -124.12 139.97 33.83 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 120.963 -1.316 . . . . 2.36 109.479 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.442 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 27.0 Cg_endo -64.93 134.72 41.21 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.398 2.065 . . . . 2.51 110.935 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.874 ' CE1' HG12 ' A' ' 18' ' ' VAL . 5.1 t80 -114.41 60.72 0.67 Allowed 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.466 -0.568 . . . . 1.33 109.466 -178.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.492 HG22 ' OE1' ' A' ' 38' ' ' GLU . 81.5 m -73.08 81.97 1.26 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.303 -0.873 . . . . 2.52 109.09 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.52 ' O ' ' CG ' ' A' ' 38' ' ' GLU . 3.0 mp -52.7 -178.21 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.189 -0.945 . . . . 4.85 108.653 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.536 ' CG ' ' HG2' ' A' ' 89' ' ' LYS . 0.1 OUTLIER 166.73 158.56 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.916 -1.115 . . . . 2.7 109.795 -179.602 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.522 ' HB2' ' O ' ' A' ' 38' ' ' GLU . . . 171.81 83.41 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.697 0.76 . . . . 1.19 109.506 178.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.73 ' O ' HG23 ' A' ' 13' ' ' ILE . 0.6 OUTLIER -82.12 165.05 20.89 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 108.269 -1.011 . . . . 2.17 108.269 179.031 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.763 ' CZ ' ' CD2' ' A' ' 86' ' ' TYR . 0.4 OUTLIER -156.79 164.85 37.63 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.323 -1.362 . . . . 1.2 107.323 176.285 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.411 ' O ' ' C ' ' A' ' 43' ' ' ALA . 1.0 OUTLIER -116.85 116.38 27.34 Favored 'General case' 0 C--N 1.29 -2.013 0 C-N-CA 119.309 -0.957 . . . . 2.49 108.584 -179.8 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.869 ' HB1' ' O ' ' A' ' 81' ' ' VAL . . . -46.81 119.59 2.57 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 107.386 -1.339 . . . . 0.44 107.386 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.461 ' C ' ' HB3' ' A' ' 82' ' ' LYS . 0.1 OUTLIER -130.63 19.38 5.16 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.699 0.761 . . . . 3.32 108.999 -178.15 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.788 ' CD ' HD21 ' A' ' 117' ' ' LEU . 3.0 pt20 -109.37 -139.41 0.38 Allowed 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.512 -0.742 . . . . 0.82 110.408 -178.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.689 ' C ' HG22 ' A' ' 81' ' ' VAL . 3.4 m120 -158.55 53.43 0.43 Allowed 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.531 -0.914 . . . . 3.98 108.531 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.798 ' N ' HG22 ' A' ' 81' ' ' VAL . 10.4 t -134.78 127.47 30.95 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.386 -1.446 . . . . 2.09 110.555 -178.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.648 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -70.71 -20.15 62.69 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.012 -1.055 . . . . 5.26 108.934 178.744 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 24.7 p -73.79 178.81 4.59 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.922 0.868 . . . . 3.19 111.077 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 1.062 ' HB1' ' HB3' ' A' ' 72' ' ' ALA . . . 177.52 131.06 0.06 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.258 -1.386 . . . . 1.48 107.258 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.522 ' O ' ' C ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -136.11 48.55 2.16 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 120.104 -1.623 . . . . 3.08 109.91 -178.628 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.883 ' H ' ' HB2' ' A' ' 72' ' ' ALA . 2.0 tt -28.29 146.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.178 0 CA-C-N 115.451 -0.795 . . . . 2.37 110.361 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.461 ' C ' HD12 ' A' ' 54' ' ' ILE . 0.3 OUTLIER -137.95 82.96 1.95 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.301 -0.874 . . . . 3.09 109.474 -179.818 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.896 ' HB ' HG21 ' A' ' 65' ' ' VAL . 0.5 OUTLIER -108.57 141.51 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.293 -0.879 . . . . 0.87 109.278 179.651 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.696 ' HG3' ' O ' ' A' ' 54' ' ' ILE . 0.2 OUTLIER -152.4 90.18 1.48 Allowed 'General case' 0 C--N 1.285 -2.204 0 O-C-N 121.348 -0.845 . . . . 1.15 109.175 178.462 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.793 ' HB3' ' HB ' ' A' ' 63' ' ' ILE . . . -109.36 145.21 36.44 Favored 'General case' 0 C--N 1.292 -1.897 0 O-C-N 121.512 -0.743 . . . . 0.24 109.551 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.476 ' O ' ' CG1' ' A' ' 104' ' ' VAL . 30.3 m -128.12 137.13 51.99 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.972 -1.08 . . . . 2.44 109.142 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.856 HD13 ' H ' ' A' ' 59' ' ' ASP . 0.2 OUTLIER -135.39 158.33 44.64 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.28 -0.887 . . . . 1.82 109.198 -179.604 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.856 ' H ' HD13 ' A' ' 58' ' ' LEU . 18.1 t70 -48.86 -63.89 0.96 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.274 -0.892 . . . . 3.24 108.608 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -108.17 24.89 21.85 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 108.862 -1.695 . . . . 1.15 108.862 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.608 ' CB ' ' HB3' ' A' ' 58' ' ' LEU . 0.4 OUTLIER -146.33 66.48 1.19 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.269 -1.136 . . . . 3.44 109.118 -179.709 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.09 82.44 0.51 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.469 -0.769 . . . . 2.18 109.985 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.793 ' HB ' ' HB3' ' A' ' 56' ' ' ALA . 8.5 mt -66.85 169.44 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 120.866 -1.146 . . . . 0.34 108.091 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.581 ' N ' HG22 ' A' ' 63' ' ' ILE . 0.5 OUTLIER 175.9 145.75 0.08 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.018 -1.052 . . . . 1.06 109.469 -179.791 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.896 HG21 ' HB ' ' A' ' 54' ' ' ILE . 14.5 t -144.39 63.93 11.59 Favored Pre-proline 0 N--CA 1.488 1.425 0 O-C-N 121.318 -0.864 . . . . 1.0 110.01 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.547 ' HD3' ' N ' ' A' ' 65' ' ' VAL . 36.4 Cg_endo -79.34 94.61 1.05 Allowed 'Trans proline' 0 C--N 1.298 -2.105 0 C-N-CA 122.918 2.412 . . . . 2.03 110.328 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.466 ' C ' ' O ' ' A' ' 66' ' ' PRO . . . 36.45 46.96 1.11 Allowed Glycine 0 N--CA 1.496 2.688 0 N-CA-C 110.119 -1.192 . . . . 1.13 110.119 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.745 HG22 ' N ' ' A' ' 69' ' ' ASP . 1.9 mm -63.5 -75.05 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.245 -1.15 . . . . 1.9 109.721 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.745 ' N ' HG22 ' A' ' 68' ' ' ILE . 6.4 p-10 -77.96 162.81 26.5 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.113 -0.992 . . . . 1.82 109.369 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.536 ' O ' ' ND2' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -57.11 -55.57 33.0 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.435 -0.791 . . . . 2.51 110.318 -179.449 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.562 ' CA ' ' O ' ' A' ' 50' ' ' ALA . 2.7 m120 -147.45 87.69 1.66 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.913 -1.117 . . . . 3.05 111.488 -178.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 1.062 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . . . 37.2 26.77 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.895 -0.503 . . . . 0.4 111.986 176.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.525 ' N ' ' O ' ' A' ' 71' ' ' ASN . 4.3 t -99.46 0.73 43.16 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 120.88 -1.137 . . . . 1.14 111.23 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.613 ' CG ' ' HB3' ' A' ' 69' ' ' ASP . 0.3 OUTLIER -90.7 -29.54 17.64 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.757 -1.214 . . . . 2.98 109.687 179.811 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.508 ' O ' ' HB ' ' A' ' 76' ' ' VAL . 13.5 m-85 -103.6 14.07 31.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.362 -0.836 . . . . 1.73 109.29 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 1.198 HG11 ' CZ ' ' A' ' 86' ' ' TYR . 5.4 p 178.27 -142.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-O 121.787 0.804 . . . . 2.55 109.512 -177.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.841 ' N ' HG13 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -99.03 158.69 15.48 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 106.304 -1.739 . . . . 3.36 106.304 177.049 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . 0.568 ' N ' ' HD2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -81.96 -48.62 0.94 Allowed Pre-proline 0 N--CA 1.493 1.694 0 C-N-CA 118.054 -1.458 . . . . 2.17 109.544 179.866 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.648 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 32.0 Cg_endo -77.2 114.92 3.87 Favored 'Trans proline' 0 C--N 1.302 -1.904 0 N-CA-C 107.498 -1.77 . . . . 2.29 107.498 178.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.758 HD11 HD21 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -85.96 -69.19 0.68 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 106.588 -1.634 . . . . 1.39 106.588 -179.11 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.869 ' O ' ' HB1' ' A' ' 43' ' ' ALA 0.256 48.4 t 50.06 -174.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 C-N-CA 118.276 -1.37 . . . . 2.91 109.262 175.488 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.61 ' N ' HG12 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -104.56 47.32 0.88 Allowed 'General case' 0 C--N 1.293 -1.884 0 O-C-N 121.143 -0.973 . . . . 2.54 110.008 -179.381 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -137.43 11.19 3.78 Favored Glycine 0 N--CA 1.491 2.309 0 C-N-CA 118.734 -1.698 . . . . 0.5 113.059 -178.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.482 ' NE2' ' O ' ' A' ' 79' ' ' PRO . 1.2 pt20 -148.92 171.05 16.95 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 120.452 2.126 . . . . 5.53 111.334 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -108.02 142.1 38.68 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.775 0.798 . . . . 5.07 110.956 -178.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 1.198 ' CZ ' HG11 ' A' ' 76' ' ' VAL . 0.4 OUTLIER -99.62 173.18 6.85 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.069 0.462 . . . . 2.67 110.576 -179.61 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.626 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 9.9 p-10 176.83 83.64 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.464 -0.773 . . . . 3.47 110.918 178.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.548 HG12 ' N ' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -127.87 146.06 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 107.313 -1.366 . . . . 2.54 107.313 178.409 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.548 ' N ' HG12 ' A' ' 88' ' ' ILE . 1.7 mtmt -147.62 -169.37 3.3 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.955 -1.091 . . . . 3.15 111.797 -177.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.639 ' CZ ' HG21 ' A' ' 54' ' ' ILE . 67.4 m-85 -156.7 126.64 6.36 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 107.728 -1.212 . . . . 1.19 107.728 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.31 156.67 30.81 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.587 -1.32 . . . . 3.39 110.842 -178.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.753 ' CD2' HG22 ' A' ' 94' ' ' VAL . 3.3 t90 -143.19 109.97 5.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.548 -0.72 . . . . 5.33 109.168 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -61.08 120.13 9.68 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.685 -1.228 . . . . 3.09 107.685 178.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.813 HG13 HD13 ' A' ' 97' ' ' ILE . 18.4 t -114.68 95.94 42.34 Favored Pre-proline 0 N--CA 1.489 1.499 0 C-N-CA 119.028 -1.069 . . . . 2.63 111.573 -178.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.703 ' HD2' HD11 ' A' ' 97' ' ' ILE . 31.0 Cg_endo -75.88 -79.52 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.939 2.426 . . . . 2.84 109.269 177.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.599 ' C ' HD12 ' A' ' 97' ' ' ILE . 5.5 tptt -137.52 -59.63 0.67 Allowed 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 104.662 -2.347 . . . . 3.01 104.662 177.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.813 HD13 HG13 ' A' ' 94' ' ' VAL . 1.2 mp 66.59 5.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 O-C-N 121.679 -0.638 . . . . 1.75 112.711 174.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 1.075 ' HB1' ' HD2' ' A' ' 99' ' ' PRO . . . 54.86 177.96 0.03 OUTLIER Pre-proline 0 C--N 1.302 -1.459 0 O-C-N 120.408 -1.433 . . . . 1.3 109.256 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 1.075 ' HD2' ' HB1' ' A' ' 98' ' ' ALA . 46.4 Cg_endo -80.5 155.46 21.48 Favored 'Trans proline' 0 C--N 1.3 -1.984 0 C-N-CA 123.525 2.816 . . . . 1.26 110.345 -179.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.792 ' N ' HG22 ' A' ' 127' ' ' ILE . 1.4 mmmp? 56.91 149.47 0.01 OUTLIER 'General case' 0 C--N 1.29 -1.987 0 CA-C-O 122.157 0.98 . . . . 2.85 112.184 176.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.816 ' OG ' HD13 ' A' ' 127' ' ' ILE . 78.0 p -129.68 164.72 23.32 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.118 -0.697 . . . . 1.63 109.118 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.556 ' O ' ' CB ' ' A' ' 103' ' ' ASN . 4.3 mt-10 -51.04 -22.22 2.25 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.147 -0.971 . . . . 2.97 109.023 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.556 ' CB ' ' O ' ' A' ' 102' ' ' GLU . 0.3 OUTLIER 157.1 157.02 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.563 -0.903 . . . . 3.2 108.563 -179.713 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.642 HG21 ' CD1' ' A' ' 127' ' ' ILE . 0.2 OUTLIER -152.07 174.58 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.05 -1.031 . . . . 0.91 109.611 -179.919 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 56' ' ' ALA . 1.2 t 164.57 130.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 108.06 -1.089 . . . . 0.86 108.06 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.565 ' O ' HG12 ' A' ' 106' ' ' VAL . 3.6 t -128.56 102.98 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.899 -1.125 . . . . 1.68 110.562 -179.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.412 ' C ' ' CG2' ' A' ' 108' ' ' VAL . 0.2 OUTLIER -108.64 147.45 31.85 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.366 -0.975 . . . . 1.11 108.366 178.905 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.427 HG13 HG13 ' A' ' 54' ' ' ILE . 1.5 t -151.69 153.32 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.696 -1.252 . . . . 1.88 110.546 -179.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.522 ' HA ' ' HA ' ' A' ' 119' ' ' CYS . 0.4 OUTLIER 172.48 116.15 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.503 -0.748 . . . . 1.81 110.334 178.796 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.758 HD21 HD11 ' A' ' 80' ' ' LEU . 32.7 tp -104.04 127.89 51.61 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.684 -1.228 . . . . 1.37 107.684 177.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.508 ' O ' ' HG3' ' A' ' 51' ' ' LYS . 10.3 mt -125.88 136.83 59.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 O-C-N 121.277 -0.89 . . . . 0.9 110.431 -178.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.737 ' HA3' HG21 ' A' ' 47' ' ' THR . . . -100.07 -109.86 3.13 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 108.099 -2.0 . . . . 1.43 108.099 178.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -145.34 11.91 1.34 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.353 -1.351 . . . . 3.14 107.353 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.419 ' OD1' ' NE2' ' A' ' 45' ' ' GLN . 1.3 p30 -127.53 -33.17 2.35 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.547 0.689 . . . . 4.15 109.483 -178.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -179.91 156.61 18.45 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.107 -1.597 . . . . 1.69 109.107 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.484 ' O ' HG22 ' A' ' 116' ' ' VAL . 0.2 OUTLIER -57.02 112.54 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.147 -1.208 . . . . 0.9 109.918 -179.642 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.788 HD21 ' CD ' ' A' ' 45' ' ' GLN . 2.9 mt -55.54 -68.02 0.23 Allowed 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.608 -0.886 . . . . 1.08 108.608 179.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.835 ' CB ' ' HB2' ' A' ' 9' ' ' ALA . . . -130.39 -177.98 4.56 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.296 -1.002 . . . . 0.66 108.296 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.566 ' HB3' ' O ' ' A' ' 118' ' ' ALA . 0.1 OUTLIER 169.15 155.8 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.08 -1.013 . . . . 0.86 110.145 179.777 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.474 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . . . -176.88 129.68 0.18 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.314 -0.866 . . . . 1.22 109.416 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.3 mt -122.73 131.72 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.138 -0.977 . . . . 0.77 109.886 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.46 ' HB1' ' HB2' ' A' ' 27' ' ' CYS . . . -85.79 -35.81 20.48 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.337 -0.986 . . . . 2.26 108.337 179.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.408 ' O ' ' O ' ' A' ' 124' ' ' HIS . 2.4 m 64.77 121.41 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.61 -0.681 . . . . 1.74 110.372 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.408 ' O ' ' O ' ' A' ' 123' ' ' THR . 3.9 m170 48.02 98.03 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.543 -0.723 . . . . 3.09 110.771 178.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.477 ' O ' ' HB ' ' A' ' 104' ' ' VAL . . . -116.83 119.38 4.46 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 108.294 -1.922 . . . . 1.14 108.294 178.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.455 ' O ' HG23 ' A' ' 28' ' ' ILE . 0.8 OUTLIER -137.27 140.02 41.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.949 -1.324 . . . . 2.76 110.587 -178.892 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.816 HD13 ' OG ' ' A' ' 101' ' ' SER . 2.2 mp -83.16 149.53 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 108.292 -1.003 . . . . 1.15 108.292 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.685 ' CB ' ' O ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER 137.22 -82.11 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 108.96 -0.755 . . . . 3.86 108.96 179.355 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.442 ' N ' ' CD ' ' A' ' 128' ' ' ARG . 13.1 t70 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 117.948 -1.025 . . . . 4.22 109.382 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.526 ' C ' ' CG ' ' A' ' 2' ' ' GLN . 5.2 m-20 . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.31 -0.626 . . . . 3.24 109.31 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.561 ' HA ' ' CG ' ' A' ' 17' ' ' MET . 0.8 OUTLIER 37.35 30.07 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.647 -0.658 . . . . 4.54 110.589 179.166 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.778 HG11 ' H ' ' A' ' 22' ' ' HIS . 28.8 m -44.46 122.17 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.28 -0.887 . . . . 2.42 108.815 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.48 ' O ' ' HA3' ' A' ' 23' ' ' GLY . 8.3 t70 -55.39 134.61 50.39 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.449 -0.782 . . . . 2.17 110.586 -179.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.3 171.16 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 108.224 -1.028 . . . . 1.13 108.224 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 120' ' ' ALA . 27.4 mtpt -105.33 101.47 11.0 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.787 -1.196 . . . . 3.3 110.007 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.491 ' HA ' ' O ' ' A' ' 119' ' ' CYS . 65.1 m-20 -97.19 170.69 8.93 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.472 -0.768 . . . . 4.04 109.362 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.515 ' N ' ' SG ' ' A' ' 119' ' ' CYS . 3.8 m -138.69 4.64 2.36 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.34 -0.85 . . . . 1.49 109.639 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.595 ' HB2' ' HA ' ' A' ' 118' ' ' ALA . . . -47.09 -62.73 1.28 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.07 -1.019 . . . . 0.56 109.586 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.444 ' OD1' ' OD1' ' A' ' 11' ' ' ASN . 1.1 t-20 178.83 -81.85 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.919 -0.712 . . . . 4.78 109.301 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.444 ' OD1' ' OD1' ' A' ' 10' ' ' ASN . 14.3 p-10 -164.45 42.26 0.09 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.55 -0.719 . . . . 4.35 109.214 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.532 ' O ' ' HB ' ' A' ' 13' ' ' ILE . 0.7 OUTLIER -163.68 -81.94 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.231 -0.918 . . . . 3.78 109.566 -179.819 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.654 HG22 ' H ' ' A' ' 15' ' ' LYS . 0.1 OUTLIER 74.22 -2.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 CA-C-O 121.784 0.802 . . . . 3.79 110.257 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.524 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 15.1 mttm 65.99 -19.21 0.1 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.043 -1.036 . . . . 1.86 111.771 178.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.654 ' H ' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER 166.14 151.24 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.399 0 O-C-N 120.685 -1.26 . . . . 1.65 109.029 -178.073 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.794 ' O ' HG13 ' A' ' 16' ' ' VAL . 12.6 p -169.46 100.8 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.129 -0.982 . . . . 0.82 109.019 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.561 ' CG ' ' HA ' ' A' ' 2' ' ' GLN . 2.1 mpp? -151.19 150.16 30.28 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.589 -0.845 . . . . 1.34 110.196 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.677 HG11 ' CE1' ' A' ' 35' ' ' PHE . 19.2 t -117.0 160.24 16.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 107.794 -1.188 . . . . 1.35 107.794 178.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.569 ' CB ' ' O ' ' A' ' 34' ' ' PRO . 16.3 m-20 -94.91 36.17 1.21 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.835 -1.166 . . . . 1.69 110.021 -179.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.547 ' O ' ' CB ' ' A' ' 21' ' ' CYS . . . 130.45 128.9 3.04 Favored Glycine 0 N--CA 1.487 2.079 0 C-N-CA 119.523 -1.322 . . . . 1.05 110.131 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.877 ' CA ' HG23 ' A' ' 29' ' ' ILE . 0.0 OUTLIER 154.67 -36.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.538 -0.912 . . . . 0.91 108.538 179.132 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.778 ' H ' HG11 ' A' ' 3' ' ' VAL . 7.2 t-160 66.44 116.27 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.181 -1.044 . . . . 3.74 108.181 -178.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.537 ' O ' ' CB ' ' A' ' 24' ' ' SER . . . -103.67 176.2 23.9 Favored Glycine 0 N--CA 1.496 2.657 0 C-N-CA 119.064 -1.541 . . . . 0.79 110.392 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.537 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 1.3 t 84.75 -69.4 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.677 -0.896 . . . . 0.92 110.164 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.692 ' CB ' ' CD ' ' A' ' 26' ' ' PRO . 0.8 OUTLIER -83.57 -157.2 0.01 OUTLIER Pre-proline 0 C--N 1.304 -1.388 0 N-CA-C 108.274 -1.01 . . . . 4.49 108.274 -179.779 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.692 ' CD ' ' CB ' ' A' ' 25' ' ' ASP . 28.4 Cg_endo -74.38 89.53 1.07 Allowed 'Trans proline' 0 C--N 1.324 -0.76 0 N-CA-C 108.483 -1.391 . . . . 0.68 108.483 179.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.562 ' HA ' ' O ' ' A' ' 22' ' ' HIS . 1.6 t -38.4 95.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 113.244 0.831 . . . . 0.83 113.244 -177.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.493 ' O ' ' O ' ' A' ' 21' ' ' CYS . 24.1 mm -89.9 141.29 14.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 104.784 -2.302 . . . . 0.7 104.784 174.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.877 HG23 ' CA ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -119.45 179.94 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 O-C-N 120.215 -1.553 . . . . 0.79 112.886 -176.086 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.511 ' NE2' ' OD2' ' A' ' 129' ' ' ASP . 14.3 m170 -117.55 157.18 26.79 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.787 0.803 . . . . 2.87 110.828 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.583 ' HD3' ' CA ' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -115.43 154.55 29.06 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 107.76 -1.2 . . . . 1.54 107.76 178.285 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.415 ' H ' ' CG1' ' A' ' 94' ' ' VAL . . . 89.51 -1.01 81.3 Favored Glycine 0 N--CA 1.495 2.602 0 C-N-CA 119.582 -1.294 . . . . 0.35 110.073 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.753 ' N ' HG11 ' A' ' 94' ' ' VAL . 12.6 mtmt -128.65 146.72 61.28 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.257 -1.143 . . . . 1.74 108.284 179.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.569 ' O ' ' CB ' ' A' ' 19' ' ' ASP . 28.9 Cg_endo -66.26 109.89 1.66 Allowed 'Trans proline' 0 C--N 1.303 -1.855 0 C-N-CA 122.487 2.125 . . . . 0.43 110.199 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.677 ' CE1' HG11 ' A' ' 18' ' ' VAL . 47.5 t80 -81.11 70.3 7.91 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.414 0.626 . . . . 1.57 109.602 -179.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.605 HG22 ' O ' ' A' ' 36' ' ' THR . 32.9 m -90.91 76.69 6.25 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.439 -0.788 . . . . 0.8 109.816 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.523 ' CA ' HG13 ' A' ' 18' ' ' VAL . 1.6 pp -68.48 141.79 55.5 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.611 -1.255 . . . . 1.13 107.611 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.678 ' O ' ' HB2' ' A' ' 39' ' ' ALA . 14.2 mt-10 -142.21 -160.17 1.06 Allowed 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.82 -1.175 . . . . 1.04 110.995 -178.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.678 ' HB2' ' O ' ' A' ' 38' ' ' GLU . . . 156.35 96.44 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.153 -1.425 . . . . 0.59 107.153 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.686 ' HG ' ' CB ' ' A' ' 87' ' ' ASP . 0.3 OUTLIER -91.4 -176.88 4.68 Favored 'General case' 0 C--N 1.294 -1.82 0 O-C-N 121.546 -0.721 . . . . 0.57 110.371 -177.813 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.654 ' CE1' ' CE2' ' A' ' 86' ' ' TYR . 12.0 p90 175.37 147.74 0.09 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.393 -0.817 . . . . 0.38 109.147 177.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.465 ' O ' ' OD1' ' A' ' 44' ' ' ASN . 0.6 OUTLIER -98.72 112.41 24.49 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.441 -0.948 . . . . 4.36 108.441 179.747 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.791 ' HB1' ' O ' ' A' ' 81' ' ' VAL . . . -36.78 125.32 0.88 Allowed 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 115.932 -0.576 . . . . 0.45 110.245 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.465 ' OD1' ' O ' ' A' ' 42' ' ' ASP . 1.7 m-80 -125.77 38.98 4.05 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.23 -0.919 . . . . 1.09 109.417 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.829 ' CD ' HD21 ' A' ' 117' ' ' LEU . 3.4 pt20 -128.1 -129.72 0.22 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.417 -0.802 . . . . 0.87 110.327 -178.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.701 ' C ' HG22 ' A' ' 81' ' ' VAL . 0.8 OUTLIER -169.78 54.61 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.644 -0.873 . . . . 4.96 108.644 179.469 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.643 ' N ' HG22 ' A' ' 81' ' ' VAL . 10.1 t -133.68 138.21 45.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.809 -1.182 . . . . 0.88 110.57 -178.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.659 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 0.6 OUTLIER -83.91 -11.55 56.74 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 120.897 -1.127 . . . . 2.59 108.251 177.625 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.429 ' O ' ' O ' ' A' ' 78' ' ' CYS . 2.6 p -95.67 -155.87 0.49 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.394 -0.816 . . . . 1.02 109.449 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.828 ' CB ' ' HB3' ' A' ' 72' ' ' ALA . . . 177.64 154.14 0.29 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.389 -0.819 . . . . 0.41 109.963 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.876 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 19.9 mtpt -115.92 -175.38 2.72 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 106.385 -1.709 . . . . 1.53 106.385 177.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.642 HG13 HD13 ' A' ' 54' ' ' ILE . 3.1 tt -164.87 158.67 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 C-N-CA 117.692 -1.603 . . . . 0.89 111.343 -179.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.473 ' C ' ' HE2' ' A' ' 55' ' ' LYS . 0.8 OUTLIER -157.89 48.79 0.4 Allowed 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.35 -0.982 . . . . 1.61 108.35 179.845 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 1.007 ' HB ' HG21 ' A' ' 65' ' ' VAL . 0.4 OUTLIER -83.02 155.48 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.665 -0.647 . . . . 0.47 109.492 -179.533 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.661 ' HG3' ' O ' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -170.79 100.69 0.23 Allowed 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.109 -0.7 . . . . 1.59 109.109 178.577 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.518 ' O ' ' HB ' ' A' ' 63' ' ' ILE . . . -126.66 124.04 38.95 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.363 -0.836 . . . . 0.5 110.02 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -108.76 128.28 54.74 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.187 -0.946 . . . . 1.92 109.241 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.851 HD13 ' N ' ' A' ' 59' ' ' ASP . 1.8 tm? -122.94 154.64 38.11 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.132 -0.98 . . . . 1.67 109.078 -179.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.851 ' N ' HD13 ' A' ' 58' ' ' LEU . 0.4 OUTLIER -47.27 -59.31 3.26 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.262 -0.899 . . . . 4.07 110.262 -179.205 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -104.07 24.02 30.48 Favored Glycine 0 N--CA 1.493 2.444 0 C-N-CA 119.731 -1.223 . . . . 1.39 110.46 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.439 ' O ' ' HB3' ' A' ' 58' ' ' LEU . 0.5 OUTLIER -164.51 87.69 0.48 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.024 -1.28 . . . . 3.02 109.327 179.666 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.426 ' O ' ' C ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -79.09 70.88 5.52 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.732 -0.605 . . . . 2.85 110.301 -179.666 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.518 ' HB ' ' O ' ' A' ' 56' ' ' ALA . 6.0 mt -48.1 160.62 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 107.115 -1.439 . . . . 0.56 107.115 178.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.421 ' C ' ' HD3' ' A' ' 66' ' ' PRO . 23.3 t0 -170.4 142.77 2.2 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.867 -1.146 . . . . 2.69 109.215 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 1.007 HG21 ' HB ' ' A' ' 54' ' ' ILE . 11.7 t -132.82 69.42 79.24 Favored Pre-proline 0 C--N 1.298 -1.647 0 O-C-N 121.353 -0.842 . . . . 0.7 109.223 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.421 ' HD3' ' C ' ' A' ' 64' ' ' ASP . 34.8 Cg_endo -76.37 -2.08 12.23 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 122.994 2.462 . . . . 1.0 110.625 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 136.44 42.22 0.11 Allowed Glycine 0 N--CA 1.489 2.199 0 C-N-CA 119.864 -1.16 . . . . 1.06 110.308 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.466 HD13 ' HA ' ' A' ' 68' ' ' ILE . 35.4 mm -52.92 -77.32 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 O-C-N 120.964 -1.315 . . . . 1.46 108.875 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -87.77 160.13 18.17 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.062 -1.024 . . . . 4.6 108.866 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.432 ' O ' ' CG ' ' A' ' 71' ' ' ASN . 13.8 t -78.51 -12.23 60.0 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.242 -0.911 . . . . 5.22 109.968 -179.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.58 ' CA ' ' O ' ' A' ' 50' ' ' ALA . 5.7 m120 -164.31 77.0 0.34 Allowed 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 118.661 -1.216 . . . . 2.93 112.324 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.876 ' HB2' ' O ' ' A' ' 51' ' ' LYS . . . 22.34 46.01 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 121.492 0.663 . . . . 0.88 112.032 175.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.543 ' N ' ' O ' ' A' ' 71' ' ' ASN . 6.1 t -106.6 -42.12 5.07 Favored 'General case' 0 C--N 1.285 -2.219 0 O-C-N 121.346 -0.846 . . . . 0.95 110.531 -178.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 4.6 m170 -78.46 -1.2 32.52 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.993 -1.067 . . . . 3.94 109.79 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.518 ' HB3' HD11 ' A' ' 88' ' ' ILE . 57.9 m-85 -110.47 -14.7 14.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.233 -0.917 . . . . 0.45 109.898 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.82 ' HB ' ' CE1' ' A' ' 86' ' ' TYR . 0.2 OUTLIER -157.39 175.28 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 120.81 -1.181 . . . . 0.43 110.731 -177.316 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.647 ' N ' ' CG2' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -57.73 93.3 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 105.373 -2.084 . . . . 1.67 105.373 176.758 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . 0.553 ' HB2' ' HD3' ' A' ' 79' ' ' PRO . 2.7 m -34.57 -51.51 1.03 Allowed Pre-proline 0 N--CA 1.5 2.033 0 O-C-N 121.628 -0.67 . . . . 1.04 112.021 -176.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.659 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 32.1 Cg_endo -79.1 108.79 2.43 Favored 'Trans proline' 0 C--N 1.303 -1.842 0 N-CA-C 109.401 -1.038 . . . . 0.46 109.401 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.883 HD12 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -92.26 -65.47 1.0 Allowed 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.518 -1.29 . . . . 0.46 107.518 -179.86 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.791 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 14.0 t 54.84 -178.26 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 C-N-CA 119.29 -0.964 . . . . 2.89 109.134 177.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.569 ' N ' HG12 ' A' ' 81' ' ' VAL . 13.0 ptmt -102.2 37.01 1.96 Allowed 'General case' 0 C--N 1.296 -1.759 0 O-C-N 120.467 -1.395 . . . . 1.52 110.206 -178.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -145.65 37.22 1.29 Allowed Glycine 0 C--N 1.288 -2.105 0 N-CA-C 108.664 -1.774 . . . . 1.05 108.664 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -146.58 142.62 28.17 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 121.23 -1.159 . . . . 3.1 110.627 -178.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.457 ' O ' ' CG ' ' A' ' 85' ' ' GLN . 11.2 pt20 -115.88 130.69 56.94 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 105.977 -1.86 . . . . 2.56 105.977 177.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.82 ' CE1' ' HB ' ' A' ' 76' ' ' VAL . 0.1 OUTLIER -152.71 156.91 40.08 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 117.74 -1.584 . . . . 0.36 109.968 -177.641 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.686 ' CB ' ' HG ' ' A' ' 40' ' ' LEU . 7.2 p-10 -127.89 96.95 4.65 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 113.915 1.08 . . . . 0.36 113.915 -175.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.579 HG23 ' N ' ' A' ' 89' ' ' LYS . 6.2 tp -62.99 -163.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 N-CA-C 106.362 -1.718 . . . . 1.06 106.362 175.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.587 ' O ' ' CG ' ' A' ' 90' ' ' TYR . 1.0 OUTLIER 161.83 179.49 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.718 -1.239 . . . . 2.25 111.519 179.74 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.674 ' CZ ' HG21 ' A' ' 54' ' ' ILE . 62.9 m-85 -162.81 61.14 0.2 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 107.027 -1.472 . . . . 0.55 107.027 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.564 ' HA ' HG23 ' A' ' 36' ' ' THR . 7.1 p -43.36 178.05 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.132 0 CA-C-O 121.402 0.62 . . . . 1.19 111.382 -178.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.704 ' CZ2' ' HB2' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -173.82 116.35 0.24 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 118.71 -1.196 . . . . 3.44 112.516 -179.345 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -84.31 126.81 33.54 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 105.729 -1.952 . . . . 2.12 105.729 176.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.805 HG13 HD12 ' A' ' 97' ' ' ILE . 1.7 t -112.42 102.78 54.81 Favored Pre-proline 0 C--N 1.302 -1.481 0 O-C-N 120.626 -1.297 . . . . 0.88 113.033 -176.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.993 ' HD2' HD11 ' A' ' 97' ' ' ILE . 31.8 Cg_endo -79.04 44.2 1.64 Allowed 'Trans proline' 0 C--N 1.314 -1.255 0 C-N-CA 123.088 2.525 . . . . 2.3 110.905 176.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.539 ' O ' ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER 82.32 -70.03 0.06 Allowed 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 107.458 -1.312 . . . . 3.52 107.458 -178.48 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.993 HD11 ' HD2' ' A' ' 95' ' ' PRO . 2.7 mp 69.16 17.95 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 112.745 0.646 . . . . 0.98 112.745 176.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 1.059 ' HB1' ' HD2' ' A' ' 99' ' ' PRO . . . 49.06 177.65 0.01 OUTLIER Pre-proline 0 C--N 1.304 -1.377 0 O-C-N 120.774 -1.204 . . . . 0.58 110.477 178.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 1.059 ' HD2' ' HB1' ' A' ' 98' ' ' ALA . 50.8 Cg_endo -85.17 165.09 11.25 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 123.746 2.964 . . . . 0.67 110.044 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.634 ' HD3' ' CB ' ' A' ' 128' ' ' ARG . 3.8 mmmm 43.04 115.69 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 113.23 0.826 . . . . 2.06 113.23 175.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.836 ' CB ' HD13 ' A' ' 127' ' ' ILE . 10.1 t -92.31 161.61 14.62 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.961 -1.087 . . . . 0.4 108.242 177.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.473 ' O ' ' CB ' ' A' ' 103' ' ' ASN . 0.3 OUTLIER -61.93 -10.4 9.47 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.05 -1.031 . . . . 4.04 110.055 -179.77 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.501 ' N ' ' OD1' ' A' ' 103' ' ' ASN . 1.1 p30 167.27 158.63 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.058 -1.026 . . . . 4.69 109.569 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.573 ' O ' HG23 ' A' ' 105' ' ' VAL . 0.1 OUTLIER -158.65 -178.48 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.107 -0.995 . . . . 0.76 109.677 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 104' ' ' VAL . 0.9 OUTLIER 159.79 123.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 108.561 -0.903 . . . . 0.35 108.561 -179.758 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.649 ' HB ' ' HB3' ' A' ' 122' ' ' ALA . 2.4 t -118.99 144.6 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 120.883 -1.136 . . . . 0.56 110.197 -179.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.474 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -159.16 175.67 13.17 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.263 -1.014 . . . . 0.65 108.263 179.789 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.877 HG22 ' CD1' ' A' ' 54' ' ' ILE . 1.1 t 171.33 169.0 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 120.721 -1.237 . . . . 0.83 110.528 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.655 ' N ' HG13 ' A' ' 108' ' ' VAL . 11.2 ttpt 164.28 121.91 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.634 0.73 . . . . 0.81 109.091 178.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.732 HD11 ' HB1' ' A' ' 72' ' ' ALA . 7.7 tp -108.92 125.44 52.02 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.585 -1.265 . . . . 0.75 107.585 178.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.53 ' HB ' ' HB2' ' A' ' 51' ' ' LYS . 4.0 mt -130.31 114.7 29.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.162 -0.961 . . . . 0.92 110.71 -178.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.461 ' HA3' HG21 ' A' ' 47' ' ' THR . . . -70.84 -116.18 0.04 OUTLIER Glycine 0 N--CA 1.485 1.947 0 N-CA-C 107.75 -2.14 . . . . 0.37 107.75 177.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -135.07 -0.56 2.75 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.023 -1.281 . . . . 2.43 107.546 178.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -109.85 -24.81 10.65 Favored 'General case' 0 C--N 1.312 -1.057 0 O-C-N 121.35 -0.844 . . . . 0.96 109.428 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -179.85 176.72 47.69 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.401 -1.479 . . . . 1.26 109.401 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.48 ' HA ' ' HA ' ' A' ' 111' ' ' ILE . 0.9 OUTLIER -81.38 106.61 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.195 -1.18 . . . . 0.5 109.834 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.883 HD22 HD12 ' A' ' 80' ' ' LEU . 4.0 mt -52.3 -54.61 29.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.419 -0.801 . . . . 0.44 110.543 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.595 ' HA ' ' HB2' ' A' ' 9' ' ' ALA . . . -140.63 -170.9 3.11 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.061 -1.024 . . . . 0.44 110.847 -178.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.531 ' SG ' ' N ' ' A' ' 120' ' ' ALA . 0.0 OUTLIER 175.5 159.61 0.24 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.578 -0.701 . . . . 0.48 109.563 -179.652 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.531 ' N ' ' SG ' ' A' ' 119' ' ' CYS . . . -176.91 126.96 0.16 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.274 -0.891 . . . . 0.64 109.055 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.586 HG22 ' H ' ' A' ' 123' ' ' THR . 6.4 mt -129.37 132.24 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.175 -0.953 . . . . 0.74 109.902 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.649 ' HB3' ' HB ' ' A' ' 106' ' ' VAL . . . -115.8 20.89 14.28 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.156 -0.965 . . . . 1.43 108.759 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.586 ' H ' HG22 ' A' ' 121' ' ' ILE . 82.5 p 47.02 -160.7 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.413 -0.804 . . . . 3.69 109.272 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.574 ' CE1' ' HB3' ' A' ' 26' ' ' PRO . 42.2 p-80 -71.06 160.09 33.53 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.223 -0.923 . . . . 4.29 109.115 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.49 ' HA2' ' O ' ' A' ' 27' ' ' CYS . . . -120.24 -169.76 14.1 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.621 -1.392 . . . . 1.79 109.621 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.414 ' O ' ' C ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER 178.41 74.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.285 -1.127 . . . . 1.48 109.574 179.736 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.836 HD13 ' CB ' ' A' ' 101' ' ' SER . 2.5 mp -39.41 157.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.6 -0.688 . . . . 0.47 110.463 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.662 ' CB ' ' O ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER 132.97 -87.19 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.142 0 CA-C-O 121.357 0.599 . . . . 2.82 109.956 178.476 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.511 ' OD2' ' NE2' ' A' ' 30' ' ' HIS . 1.7 t0 . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 118.112 -0.946 . . . . 4.27 109.693 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.501 0.667 . . . . 3.2 109.574 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.572 ' HA ' ' CG ' ' A' ' 17' ' ' MET . 12.2 pt20 -133.92 41.89 2.97 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.498 -0.751 . . . . 3.33 108.984 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.56 HG23 HG23 ' A' ' 18' ' ' VAL . 2.0 m -45.86 120.89 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 108.16 -1.052 . . . . 3.03 108.16 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.473 ' C ' ' HA3' ' A' ' 23' ' ' GLY . 71.3 m-20 -94.41 127.84 40.56 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.379 -0.826 . . . . 5.39 110.913 -178.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.643 HG13 ' HA2' ' A' ' 23' ' ' GLY . 0.1 OUTLIER -95.72 -170.67 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.013 -1.106 . . . . 1.5 108.013 178.655 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.81 94.62 9.19 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.83 -1.169 . . . . 2.14 109.153 179.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.479 ' HA ' ' O ' ' A' ' 119' ' ' CYS . 1.6 m-20 -99.07 174.35 6.38 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.537 -0.727 . . . . 4.44 109.286 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.514 ' N ' ' SG ' ' A' ' 119' ' ' CYS . 31.6 p -163.62 49.14 0.14 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.238 -0.913 . . . . 2.23 109.725 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.553 ' HA ' ' HA ' ' A' ' 118' ' ' ALA . . . -83.3 -66.33 0.9 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.112 -0.993 . . . . 0.61 109.859 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.522 ' CB ' ' O ' ' A' ' 9' ' ' ALA . 0.9 OUTLIER 164.34 42.33 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.46 -0.896 . . . . 1.65 109.788 -178.779 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.2 m120 49.88 23.93 1.18 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.937 -1.102 . . . . 3.04 108.042 -179.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 13' ' ' ILE . 0.0 OUTLIER -105.76 -28.54 10.62 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.574 -0.704 . . . . 3.38 109.234 -179.764 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 1.038 HG23 ' O ' ' A' ' 40' ' ' LEU . 11.9 mt -41.81 143.7 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 109.077 -0.712 . . . . 0.6 109.077 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -105.02 -19.2 13.91 Favored 'General case' 0 C--N 1.295 -1.767 0 O-C-N 121.402 -0.811 . . . . 3.89 108.998 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.403 ' H ' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -160.35 104.98 1.46 Allowed 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 119.031 -1.067 . . . . 2.74 110.363 -177.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.546 ' O ' HG13 ' A' ' 16' ' ' VAL . 2.6 p -120.87 95.82 3.81 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 107.075 -1.454 . . . . 1.48 107.075 178.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.572 ' CG ' ' HA ' ' A' ' 2' ' ' GLN . 2.3 mpt? -144.7 145.57 31.78 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.63 -0.669 . . . . 2.24 109.751 -178.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.992 HG13 ' HA ' ' A' ' 37' ' ' LEU . 1.7 t -110.93 120.36 61.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 108.255 -1.017 . . . . 0.61 108.255 179.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -41.93 -26.1 0.08 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.39 -0.819 . . . . 2.76 109.714 -179.44 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -158.1 -148.42 5.14 Favored Glycine 0 N--CA 1.488 2.116 0 C-N-CA 119.615 -1.279 . . . . 2.0 109.964 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.634 ' HA ' ' HA ' ' A' ' 29' ' ' ILE . 50.4 t 65.15 -111.47 0.24 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.629 -0.924 . . . . 2.27 109.664 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.572 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 0.3 OUTLIER 155.2 139.7 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 106.621 -1.622 . . . . 2.26 106.621 -178.723 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.643 ' HA2' HG13 ' A' ' 5' ' ' VAL . . . -107.99 157.59 15.29 Favored Glycine 0 C--N 1.288 -2.119 0 N-CA-C 109.409 -1.477 . . . . 1.51 109.409 -179.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.457 ' O ' ' CB ' ' A' ' 25' ' ' ASP . 0.2 OUTLIER 66.61 137.2 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.216 -1.167 . . . . 2.86 108.279 -179.163 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.558 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.2 OUTLIER 66.48 177.29 0.05 OUTLIER Pre-proline 0 C--N 1.304 -1.385 0 O-C-N 120.455 -1.403 . . . . 5.52 107.998 -179.815 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.558 ' HD2' ' CB ' ' A' ' 25' ' ' ASP . 30.7 Cg_endo -74.8 123.67 8.15 Favored 'Trans proline' 0 C--N 1.299 -2.055 0 C-N-CA 122.747 2.298 . . . . 2.11 109.397 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.572 ' HB2' ' O ' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -97.08 113.94 25.55 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.291 -0.881 . . . . 1.44 111.491 -177.819 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.637 HD13 ' HG3' ' A' ' 126' ' ' LYS . 20.1 mm -86.77 83.72 2.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 107.147 -1.427 . . . . 1.97 107.147 176.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.634 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -50.08 -177.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 O-C-N 121.699 -0.626 . . . . 2.02 109.977 -179.138 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 79.5 m-70 -134.2 160.44 37.84 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.507 -0.877 . . . . 1.3 110.659 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.586 ' HD3' ' CA ' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -108.83 113.02 25.6 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.528 -0.732 . . . . 1.74 109.399 179.626 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 134.42 0.2 3.75 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 110.206 -1.158 . . . . 0.8 110.206 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.579 ' O ' HG21 ' A' ' 94' ' ' VAL . 13.3 mttt -130.23 144.43 53.17 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 120.93 -1.335 . . . . 1.46 110.184 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -69.41 81.08 0.75 Allowed 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 123.166 2.577 . . . . 0.81 111.19 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.728 ' H ' HG21 ' A' ' 94' ' ' VAL . 5.2 t80 -55.42 122.13 10.52 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 109.433 -0.581 . . . . 2.37 109.433 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 37.5 m -134.04 85.44 2.2 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.075 -1.015 . . . . 1.5 109.571 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.992 ' HA ' HG13 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -62.66 141.38 58.55 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.235 -0.915 . . . . 1.94 108.891 179.746 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.963 ' N ' HD12 ' A' ' 37' ' ' LEU . 87.2 mt-10 -139.17 -171.23 3.06 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.147 -0.971 . . . . 2.21 110.06 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.703 ' HB2' ' O ' ' A' ' 38' ' ' GLU . . . 155.13 70.7 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.906 -1.146 . . . . 1.36 107.906 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 1.038 ' O ' HG23 ' A' ' 13' ' ' ILE . 0.8 OUTLIER -71.98 171.73 11.3 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 115.912 -0.585 . . . . 0.5 110.162 -178.841 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.746 ' HZ ' ' HH ' ' A' ' 86' ' ' TYR . 5.5 p90 -176.01 148.39 0.82 Allowed 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.583 -0.895 . . . . 0.37 108.583 179.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.509 ' O ' ' C ' ' A' ' 43' ' ' ALA . 6.7 t70 -95.28 112.19 23.94 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 107.286 -1.375 . . . . 2.09 107.286 178.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.699 ' HB1' ' O ' ' A' ' 81' ' ' VAL . . . -36.1 125.53 0.76 Allowed 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 115.61 -0.723 . . . . 0.66 109.1 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -124.04 15.02 9.19 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.171 -0.956 . . . . 4.08 110.33 -177.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.959 ' OE1' HD21 ' A' ' 117' ' ' LEU . 2.3 pt20 -105.56 -139.41 0.37 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.379 -0.971 . . . . 0.31 108.379 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.794 ' HA ' ' HB ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -156.73 67.98 0.57 Allowed 'General case' 0 C--N 1.294 -1.845 0 O-C-N 121.08 -1.013 . . . . 1.1 109.306 178.59 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.753 HG23 ' O ' ' A' ' 47' ' ' THR . 10.3 t -146.33 118.47 8.31 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.263 -1.523 . . . . 0.52 111.607 -178.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.611 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 0.6 OUTLIER -66.4 -10.6 45.3 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.66 -1.275 . . . . 2.37 107.847 177.262 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.482 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 30.5 p -98.44 -161.3 0.86 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.335 -0.853 . . . . 0.77 108.807 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.912 ' CB ' ' HB3' ' A' ' 72' ' ' ALA . . . 174.67 160.4 0.19 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.168 -0.958 . . . . 0.3 109.863 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 1.011 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 20.3 mtmt -123.14 169.04 11.64 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 107.227 -1.398 . . . . 0.98 107.227 177.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.572 HD13 ' CD1' ' A' ' 75' ' ' PHE . 11.1 tt -148.19 144.74 18.89 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.239 0 C-N-CA 118.413 -1.315 . . . . 0.55 110.558 -178.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.456 ' O ' ' CE ' ' A' ' 55' ' ' LYS . 6.1 mt-10 -139.84 56.42 1.64 Allowed 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 107.101 -1.444 . . . . 1.67 107.101 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.948 ' HB ' HG21 ' A' ' 65' ' ' VAL . 0.3 OUTLIER -87.62 151.91 3.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 O-C-N 121.312 -0.867 . . . . 1.13 110.096 -178.392 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.686 ' HG3' ' O ' ' A' ' 54' ' ' ILE . 0.1 OUTLIER -166.51 95.22 0.54 Allowed 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 109.053 -0.721 . . . . 1.02 109.053 178.305 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.726 ' HB3' ' HB ' ' A' ' 63' ' ' ILE . . . -118.78 138.66 52.53 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.394 -0.816 . . . . 0.54 109.563 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.455 ' O ' ' CG1' ' A' ' 104' ' ' VAL . 1.6 t -124.4 124.8 43.14 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.925 -1.109 . . . . 1.11 110.125 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 1.011 HD13 ' N ' ' A' ' 59' ' ' ASP . 2.6 tm? -117.85 152.86 34.52 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.255 -1.017 . . . . 1.46 108.255 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 1.011 ' N ' HD13 ' A' ' 58' ' ' LEU . 5.4 t0 -43.61 -66.06 0.42 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.061 -1.025 . . . . 2.17 109.938 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.496 ' O ' HD12 ' A' ' 61' ' ' LEU . . . -101.09 20.18 48.63 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.058 -1.217 . . . . 0.75 110.058 -179.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.496 HD12 ' O ' ' A' ' 60' ' ' GLY . 1.9 tp -152.69 79.13 1.21 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.141 -1.211 . . . . 2.46 108.935 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.445 ' O ' ' C ' ' A' ' 63' ' ' ILE . 0.5 OUTLIER -74.9 76.05 2.15 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 116.203 -0.453 . . . . 3.91 110.869 -179.19 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.726 ' HB ' ' HB3' ' A' ' 56' ' ' ALA . 3.2 mt -49.08 162.81 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 106.54 -1.652 . . . . 0.58 106.54 178.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -176.02 147.43 0.75 Allowed 'General case' 0 C--N 1.297 -1.707 0 O-C-N 120.424 -1.423 . . . . 0.9 109.004 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.948 HG21 ' HB ' ' A' ' 54' ' ' ILE . 17.1 t -140.77 62.28 17.27 Favored Pre-proline 0 C--N 1.299 -1.598 0 C-N-CA 119.279 -0.969 . . . . 1.21 110.215 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.562 ' HD3' ' N ' ' A' ' 65' ' ' VAL . 36.2 Cg_endo -78.32 -5.05 14.76 Favored 'Trans proline' 0 C--N 1.301 -1.964 0 C-N-CA 122.82 2.347 . . . . 1.27 109.094 178.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 68' ' ' ILE . . . -177.62 -110.25 0.27 Allowed Glycine 0 N--CA 1.487 2.073 0 N-CA-C 108.14 -1.984 . . . . 1.94 108.14 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.45 ' C ' ' O ' ' A' ' 67' ' ' GLY . 0.0 OUTLIER 39.97 85.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.421 -1.046 . . . . 2.42 109.779 179.103 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 46.28 80.38 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.003 -1.061 . . . . 5.99 108.856 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.37 50.17 1.95 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.361 -0.837 . . . . 7.87 109.467 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.529 ' CA ' ' O ' ' A' ' 50' ' ' ALA . 8.6 m-20 -136.86 38.04 2.6 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.195 -0.941 . . . . 1.97 109.935 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 1.011 ' HB2' ' O ' ' A' ' 51' ' ' LYS . . . 37.92 29.18 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 121.419 0.628 . . . . 0.94 110.466 177.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.499 ' N ' ' O ' ' A' ' 71' ' ' ASN . 9.8 t -105.2 -52.29 2.87 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.455 -0.778 . . . . 0.96 110.003 -179.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -67.27 -16.91 64.56 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.957 -1.089 . . . . 1.05 109.706 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.655 ' C ' HG12 ' A' ' 76' ' ' VAL . 91.7 m-85 -101.05 -9.14 21.69 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.173 -0.954 . . . . 0.95 110.169 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.789 ' HB ' ' CE1' ' A' ' 86' ' ' TYR . 0.2 OUTLIER -165.66 173.98 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 120.591 -1.318 . . . . 0.55 111.366 -177.298 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.64 ' N ' ' CG2' ' A' ' 76' ' ' VAL . 2.5 mmmt -56.23 92.3 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.119 -1.437 . . . . 1.54 107.119 177.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . 0.509 ' N ' ' O ' ' A' ' 76' ' ' VAL . 0.4 OUTLIER -35.22 -52.53 1.22 Allowed Pre-proline 0 N--CA 1.502 2.15 0 CA-C-N 116.323 -0.399 . . . . 0.97 110.955 -177.596 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.611 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 31.2 Cg_endo -76.59 109.52 2.88 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 121.115 1.21 . . . . 0.64 109.269 179.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 1.092 HD22 HD22 ' A' ' 117' ' ' LEU . 0.5 OUTLIER -103.15 -63.51 1.17 Allowed 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 121.41 0.624 . . . . 2.55 109.399 -178.519 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.794 ' HB ' ' HA ' ' A' ' 46' ' ' ASN . 1.3 m 40.18 -167.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 C-N-CA 120.56 -0.456 . . . . 0.52 109.884 178.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.711 ' H ' HG23 ' A' ' 81' ' ' VAL . 1.0 OUTLIER -104.38 41.96 1.25 Allowed 'General case' 0 C--N 1.289 -2.054 0 O-C-N 120.39 -1.444 . . . . 2.7 110.411 -176.848 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -146.65 35.88 1.28 Allowed Glycine 0 C--N 1.287 -2.19 0 N-CA-C 108.583 -1.807 . . . . 0.85 108.583 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.53 ' NE2' ' HG3' ' A' ' 77' ' ' LYS . 12.6 tp60 -150.0 140.1 22.08 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 121.237 -1.155 . . . . 3.09 110.578 -179.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.504 ' HG2' ' HB2' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -112.42 129.31 56.36 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 105.566 -2.013 . . . . 2.42 105.566 177.048 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.789 ' CE1' ' HB ' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -151.21 160.94 43.55 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 117.525 -1.67 . . . . 0.51 110.124 -177.371 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.636 ' CB ' ' HG ' ' A' ' 40' ' ' LEU . 1.8 m-20 -129.03 99.5 5.29 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.948 -1.095 . . . . 4.08 113.456 -175.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.638 HG23 ' N ' ' A' ' 89' ' ' LYS . 3.8 tp -66.78 -163.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 106.839 -1.541 . . . . 1.14 106.839 176.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.638 ' N ' HG23 ' A' ' 88' ' ' ILE . 10.4 mttt 161.39 175.4 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.271 0 O-C-N 120.927 -1.108 . . . . 1.26 111.071 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.592 ' CG ' ' O ' ' A' ' 89' ' ' LYS . 41.9 m-85 -165.37 103.11 0.73 Allowed 'General case' 0 N--CA 1.504 2.269 0 N-CA-C 108.154 -1.054 . . . . 0.75 108.154 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.415 HG22 ' H ' ' A' ' 92' ' ' TRP . 0.2 OUTLIER -96.03 179.18 5.16 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.282 -0.887 . . . . 3.11 111.467 -177.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.828 ' O ' HG23 ' A' ' 94' ' ' VAL . 1.7 t90 -167.62 101.57 0.49 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.759 -0.588 . . . . 4.35 109.472 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.507 ' O ' ' CD1' ' A' ' 92' ' ' TRP . 49.4 t-20 -47.47 123.33 5.58 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 106.842 -1.54 . . . . 1.79 106.842 178.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.874 HG13 ' CD1' ' A' ' 97' ' ' ILE . 58.2 t -116.21 90.5 29.28 Favored Pre-proline 0 C--N 1.3 -1.547 0 C-N-CA 118.568 -1.253 . . . . 1.39 111.934 -177.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.709 ' HD2' HD11 ' A' ' 97' ' ' ILE . 33.7 Cg_endo -83.07 58.65 6.38 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 123.423 2.749 . . . . 2.72 109.809 178.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.729 ' C ' HD12 ' A' ' 97' ' ' ILE . 0.1 OUTLIER 71.04 -80.37 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.386 -1.339 . . . . 3.05 107.386 -177.843 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.874 ' CD1' HG13 ' A' ' 94' ' ' VAL . 2.6 mp 76.44 34.58 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.638 -0.664 . . . . 1.04 112.24 177.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.959 ' HB1' ' HD2' ' A' ' 99' ' ' PRO . . . 53.32 171.4 0.04 OUTLIER Pre-proline 0 C--N 1.3 -1.578 0 O-C-N 120.98 -1.075 . . . . 0.45 110.991 178.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.959 ' HD2' ' HB1' ' A' ' 98' ' ' ALA . 61.4 Cg_endo -87.45 83.91 0.92 Allowed 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 123.951 3.101 . . . . 1.7 110.487 -178.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.728 ' CB ' ' O ' ' A' ' 99' ' ' PRO . 0.1 OUTLIER 116.25 121.14 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 118.896 0.771 . . . . 2.0 111.02 178.279 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.455 ' O ' ' N ' ' A' ' 103' ' ' ASN . 1.9 p -92.29 148.7 21.93 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.754 -1.202 . . . . 2.11 107.754 177.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 101' ' ' SER . 0.0 OUTLIER -42.58 -26.47 0.12 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.947 -1.096 . . . . 4.38 109.727 -179.231 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.478 ' C ' ' CG2' ' A' ' 104' ' ' VAL . 1.4 t-20 171.23 160.22 0.08 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.317 -0.864 . . . . 2.22 109.246 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.478 ' CG2' ' C ' ' A' ' 103' ' ' ASN . 0.1 OUTLIER -155.99 140.38 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.157 -0.964 . . . . 1.05 109.64 179.942 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -143.09 134.37 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.352 -0.843 . . . . 0.96 109.179 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.85 ' HB ' ' HB3' ' A' ' 122' ' ' ALA . 49.5 t -126.04 125.03 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.033 -1.042 . . . . 0.58 109.775 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.529 ' O ' HG22 ' A' ' 108' ' ' VAL . 74.6 m -147.18 136.11 22.26 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.881 -1.155 . . . . 1.08 107.881 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.637 HG12 ' CD1' ' A' ' 54' ' ' ILE . 0.3 OUTLIER -157.19 162.18 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 120.419 -1.426 . . . . 2.18 110.881 -179.284 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.558 ' HA ' ' HA ' ' A' ' 119' ' ' CYS . 2.4 tttt 175.19 118.6 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.726 0.774 . . . . 3.03 110.215 178.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.605 ' HB3' ' HB2' ' A' ' 117' ' ' LEU . 4.6 tp -92.89 122.26 35.09 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.367 -1.346 . . . . 0.97 107.367 178.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.526 ' HB ' ' HB2' ' A' ' 51' ' ' LYS . 5.7 mt -122.12 114.99 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.766 -1.209 . . . . 0.49 111.932 -177.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -80.01 -127.58 0.67 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 107.91 -2.076 . . . . 1.07 107.91 177.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -135.2 -2.97 2.48 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.878 -1.366 . . . . 2.67 107.881 178.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.401 ' CG ' ' ND2' ' A' ' 46' ' ' ASN . 1.2 m-80 -115.03 -7.54 12.51 Favored 'General case' 0 C--N 1.313 -0.991 0 O-C-N 121.24 -0.913 . . . . 1.3 110.082 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 163.91 139.85 2.73 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 110.015 -1.234 . . . . 2.12 110.015 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.529 ' CG2' ' HE3' ' A' ' 109' ' ' LYS . 0.1 OUTLIER -52.29 119.42 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.36 -1.082 . . . . 0.9 109.823 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 1.092 HD22 HD22 ' A' ' 80' ' ' LEU . 1.7 mt -62.73 -59.98 4.13 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.274 -0.891 . . . . 0.55 109.329 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.553 ' HA ' ' HA ' ' A' ' 9' ' ' ALA . . . -158.23 -173.02 4.12 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.54 -0.725 . . . . 0.96 109.274 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.558 ' HA ' ' HA ' ' A' ' 109' ' ' LYS . 13.5 p 176.96 170.16 0.52 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.343 -0.848 . . . . 1.11 109.422 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -164.21 131.45 3.26 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.495 -0.753 . . . . 0.5 109.057 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.489 ' O ' HG12 ' A' ' 5' ' ' VAL . 2.7 mp -128.18 142.82 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.089 -1.007 . . . . 0.68 110.57 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.85 ' HB3' ' HB ' ' A' ' 106' ' ' VAL . . . -138.19 64.41 1.5 Allowed 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.028 -1.101 . . . . 0.8 108.028 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.484 ' O ' ' O ' ' A' ' 124' ' ' HIS . 0.4 OUTLIER -38.74 132.28 1.22 Allowed 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.681 0.753 . . . . 2.39 111.533 -178.472 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.484 ' O ' ' O ' ' A' ' 123' ' ' THR . 1.4 m-70 47.74 173.0 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.866 0.841 . . . . 2.81 111.495 178.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 167.49 141.83 3.28 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.39 -1.484 . . . . 0.64 109.39 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.637 ' HG3' HD13 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -147.01 134.11 20.42 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.116 -1.226 . . . . 1.66 109.343 179.683 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.591 ' CD1' HG13 ' A' ' 29' ' ' ILE . 0.8 OUTLIER -79.27 124.1 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.408 -0.808 . . . . 1.67 111.172 -178.306 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.623 ' HB2' ' HG2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER 168.64 -89.78 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.887 -1.133 . . . . 2.26 109.491 177.172 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.608 ' N ' HG21 ' A' ' 28' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 118.013 -0.994 . . . . 3.65 109.212 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.183 -0.673 . . . . 4.3 109.183 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.556 ' HB3' ' CG ' ' A' ' 17' ' ' MET . 1.2 pt20 -100.6 -172.97 2.29 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.063 -1.023 . . . . 2.37 109.508 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 1.0 HG12 ' HA ' ' A' ' 22' ' ' HIS . 5.5 m -128.92 -168.26 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.348 -0.845 . . . . 1.74 109.409 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -130.87 77.8 1.8 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.178 -0.951 . . . . 1.44 109.305 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.8 m -100.6 150.78 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.162 -0.961 . . . . 1.43 109.596 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.507 ' O ' HD12 ' A' ' 121' ' ' ILE . 12.8 mtpp -75.05 93.68 2.77 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.496 -0.752 . . . . 2.31 109.701 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.523 ' HB2' HD12 ' A' ' 13' ' ' ILE . 35.4 p-10 -82.81 176.08 9.59 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.197 -0.939 . . . . 2.3 109.122 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.517 ' N ' ' SG ' ' A' ' 119' ' ' CYS . 7.8 m -138.59 9.09 2.64 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.124 -0.985 . . . . 1.32 109.919 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.668 ' HB2' HG13 ' A' ' 13' ' ' ILE . . . -56.55 -43.99 80.48 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.932 -1.105 . . . . 0.69 109.035 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.51 ' CB ' ' O ' ' A' ' 9' ' ' ALA . 0.5 OUTLIER 163.61 -58.09 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.948 -0.76 . . . . 5.01 108.948 -179.185 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 10' ' ' ASN . 1.9 t-20 174.46 38.0 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.921 -0.77 . . . . 3.63 108.921 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -171.56 -62.71 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.025 -1.047 . . . . 4.65 110.859 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.668 HG13 ' HB2' ' A' ' 9' ' ' ALA . 0.1 OUTLIER 67.76 4.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.122 -0.987 . . . . 3.91 110.155 -179.047 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.548 ' HB2' ' O ' ' A' ' 13' ' ' ILE . 0.0 OUTLIER 75.08 -31.95 0.22 Allowed 'General case' 0 C--N 1.293 -1.876 0 O-C-N 121.386 -0.821 . . . . 2.23 111.036 178.747 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.532 ' CB ' ' O ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER 165.81 109.93 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 118.785 -1.166 . . . . 2.93 110.569 -178.622 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.656 ' O ' HG13 ' A' ' 16' ' ' VAL . 6.8 p -120.07 107.85 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.096 -1.002 . . . . 1.2 108.76 178.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.556 ' CG ' ' HB3' ' A' ' 2' ' ' GLN . 0.5 OUTLIER -145.83 146.91 31.33 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.366 -0.934 . . . . 1.43 110.332 -179.605 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.71 HG22 ' HA ' ' A' ' 37' ' ' LEU . 42.1 t -117.62 148.95 20.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 108.255 -1.017 . . . . 1.3 108.255 179.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.439 ' HB3' ' HA ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -81.17 71.2 8.14 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.069 -1.086 . . . . 1.0 108.069 179.446 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.542 ' O ' ' CB ' ' A' ' 21' ' ' CYS . . . 108.02 -167.85 13.56 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 109.157 -1.577 . . . . 1.76 109.157 -178.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 1.002 ' CA ' HG23 ' A' ' 29' ' ' ILE . 15.5 t 83.54 -57.71 0.14 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.782 -0.834 . . . . 1.42 109.984 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 1.0 ' HA ' HG12 ' A' ' 3' ' ' VAL . 0.3 OUTLIER 58.14 107.39 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.561 -1.337 . . . . 4.12 109.145 -178.799 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.573 ' O ' ' CB ' ' A' ' 24' ' ' SER . . . -92.54 -143.8 13.18 Favored Glycine 0 N--CA 1.497 2.737 0 O-C-N 121.163 -0.961 . . . . 1.12 111.236 -178.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.573 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 1.0 OUTLIER 86.09 -48.73 0.06 Allowed 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.38 -0.97 . . . . 2.33 108.38 -178.823 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.701 ' CB ' ' CD ' ' A' ' 26' ' ' PRO . 5.2 m-20 -120.11 -149.86 0.01 OUTLIER Pre-proline 0 C--N 1.303 -1.426 0 N-CA-C 105.665 -1.976 . . . . 4.45 105.665 178.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.701 ' CD ' ' CB ' ' A' ' 25' ' ' ASP . 30.9 Cg_endo -74.34 85.69 1.39 Allowed 'Trans proline' 0 C--O 1.208 -1.012 0 N-CA-C 107.169 -1.896 . . . . 0.48 107.169 178.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.542 ' HA ' ' O ' ' A' ' 22' ' ' HIS . 4.1 t -34.51 80.17 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 113.697 0.999 . . . . 1.69 113.697 -176.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.762 HG23 ' O ' ' A' ' 126' ' ' LYS . 0.7 OUTLIER -71.68 144.51 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 N-CA-C 106.772 -1.566 . . . . 1.46 106.772 176.343 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 1.002 HG23 ' CA ' ' A' ' 21' ' ' CYS . 0.1 OUTLIER -122.99 -159.9 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 O-C-N 120.371 -1.456 . . . . 0.89 112.706 -176.425 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.481 ' H ' HG22 ' A' ' 29' ' ' ILE . 40.5 m-70 -131.07 166.55 20.82 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.657 0.742 . . . . 1.45 110.418 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.563 ' HD3' ' HA ' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -116.05 -167.15 1.22 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.617 -0.677 . . . . 2.57 109.464 -179.98 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.431 ' HA2' ' O ' ' A' ' 95' ' ' PRO . . . 42.74 27.96 0.6 Allowed Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.692 -0.963 . . . . 0.99 110.692 179.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.493 ' O ' HG11 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -151.76 133.87 8.4 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 120.754 -1.439 . . . . 1.55 109.493 179.789 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.423 ' HA ' ' HB ' ' A' ' 94' ' ' VAL . 28.8 Cg_endo -68.26 78.99 0.6 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.601 2.2 . . . . 1.66 111.325 -179.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.483 ' CD1' ' C ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -62.05 149.52 40.81 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.281 -1.007 . . . . 3.29 108.281 178.944 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.732 HG23 HG22 ' A' ' 91' ' ' THR . 6.4 m -153.71 95.81 1.93 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.918 -1.114 . . . . 0.75 110.211 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.71 ' HA ' HG22 ' A' ' 18' ' ' VAL . 2.3 pp -61.1 142.28 56.8 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.818 -1.179 . . . . 0.67 107.818 178.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.532 ' HG3' ' CG ' ' A' ' 89' ' ' LYS . 2.0 tt0 -136.04 131.6 35.14 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.995 -1.066 . . . . 3.95 109.882 -179.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.526 ' O ' HG22 ' A' ' 88' ' ' ILE . . . -141.28 90.58 2.32 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.765 -1.198 . . . . 0.95 107.765 178.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.618 ' HG ' ' CB ' ' A' ' 87' ' ' ASP . 0.2 OUTLIER -83.07 -176.36 6.29 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 109.236 -0.653 . . . . 1.17 109.236 -178.567 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.596 ' O ' ' CD1' ' A' ' 41' ' ' PHE . 6.2 p90 171.08 133.86 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.361 -1.348 . . . . 1.24 107.361 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.585 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 0.0 OUTLIER -90.13 119.88 30.84 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 107.969 -1.122 . . . . 3.71 107.969 179.86 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.78 ' HB3' ' O ' ' A' ' 84' ' ' GLN . . . -38.79 112.44 0.24 Allowed 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 109.47 -0.567 . . . . 0.42 109.47 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.501 ' CG ' ' O ' ' A' ' 42' ' ' ASP . 2.5 m-80 -122.14 45.75 2.27 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.479 -0.763 . . . . 1.75 109.023 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.638 ' OE1' ' HB2' ' A' ' 80' ' ' LEU . 3.5 pt20 -133.5 -133.12 0.17 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.267 -0.896 . . . . 1.35 110.198 -178.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.685 ' C ' HG22 ' A' ' 81' ' ' VAL . 47.3 t30 -169.89 53.0 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.441 -0.787 . . . . 4.34 109.604 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.712 ' N ' HG22 ' A' ' 81' ' ' VAL . 3.9 t -139.18 138.25 36.77 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.613 -1.304 . . . . 0.88 110.576 -178.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.612 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 1.2 mtmp? -78.84 -0.84 32.23 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.81 -1.181 . . . . 3.06 108.478 177.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.5 p -107.55 165.9 11.07 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.262 -0.899 . . . . 0.82 108.962 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.839 ' CB ' ' HB3' ' A' ' 72' ' ' ALA . . . -144.21 148.21 34.65 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.402 -0.962 . . . . 0.92 108.402 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.898 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 56.6 mttt -118.03 -169.45 1.69 Allowed 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.17 -1.418 . . . . 1.75 107.17 177.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.417 ' HB ' ' O ' ' A' ' 51' ' ' LYS . 5.5 tt -176.4 151.4 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 C-N-CA 118.731 -1.188 . . . . 0.63 110.179 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.49 ' O ' ' NZ ' ' A' ' 55' ' ' LYS . 0.4 OUTLIER -148.45 57.54 1.06 Allowed 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.583 -0.895 . . . . 2.86 108.583 179.916 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.907 ' CD1' HG13 ' A' ' 108' ' ' VAL . 1.6 mm -73.58 160.39 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.486 -0.759 . . . . 2.75 109.675 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.576 ' N ' ' CG2' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -173.14 81.57 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.252 0.548 . . . . 1.14 110.055 178.548 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.475 ' HB3' ' HB ' ' A' ' 63' ' ' ILE . . . -122.16 155.42 35.82 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 108.78 -0.822 . . . . 1.54 108.78 179.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.442 ' OG ' ' HA ' ' A' ' 104' ' ' VAL . 0.0 OUTLIER -129.7 136.56 49.83 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.035 -1.041 . . . . 1.23 109.402 -179.609 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.541 ' HG ' ' CE3' ' A' ' 92' ' ' TRP . 0.0 OUTLIER -128.0 164.49 22.23 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.286 -0.884 . . . . 3.89 109.202 -179.506 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.498 ' OD2' ' N ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -39.47 -68.03 0.19 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.38 -0.825 . . . . 4.27 109.617 -179.796 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.624 ' O ' HD22 ' A' ' 61' ' ' LEU . . . -118.81 30.1 6.03 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.146 -1.582 . . . . 0.96 109.146 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.624 HD22 ' O ' ' A' ' 60' ' ' GLY . 0.2 OUTLIER -139.81 61.24 1.54 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.257 -1.143 . . . . 0.9 110.049 -179.578 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.483 ' HG3' ' O ' ' A' ' 62' ' ' GLU . 0.3 OUTLIER -55.69 100.2 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.967 -1.083 . . . . 3.46 108.162 179.348 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.572 HG22 ' O ' ' A' ' 63' ' ' ILE . 2.9 mt -71.8 -2.68 3.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.364 -0.835 . . . . 2.47 111.087 -178.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.507 ' C ' ' O ' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -30.97 137.65 0.04 OUTLIER 'General case' 0 C--N 1.285 -2.213 0 CA-C-O 121.532 0.682 . . . . 2.85 110.009 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.705 HG21 ' HB ' ' A' ' 54' ' ' ILE . 70.1 t -126.01 90.26 50.62 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.396 -0.815 . . . . 1.61 109.755 -178.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.89 -4.53 13.42 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.92 2.413 . . . . 1.41 110.757 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 68' ' ' ILE . . . 167.83 -92.09 0.1 Allowed Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.617 -1.393 . . . . 2.99 109.617 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.482 ' O ' ' O ' ' A' ' 69' ' ' ASP . 1.2 mm 49.95 99.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.216 -1.167 . . . . 3.21 109.791 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.524 ' CG ' ' HB2' ' A' ' 74' ' ' HIS . 13.0 m-20 53.23 104.91 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.337 -0.852 . . . . 5.5 108.91 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -82.32 31.55 0.4 Allowed 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.383 -0.823 . . . . 5.26 111.113 -178.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.611 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -154.16 40.16 0.47 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.449 -1.407 . . . . 4.78 111.445 179.79 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.898 ' HB2' ' O ' ' A' ' 51' ' ' LYS . . . 32.27 31.71 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.173 0.511 . . . . 0.55 111.894 176.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.562 ' N ' ' O ' ' A' ' 71' ' ' ASN . 16.6 t -98.0 -21.34 16.87 Favored 'General case' 0 C--N 1.293 -1.857 0 O-C-N 121.142 -0.974 . . . . 0.69 111.256 -178.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.524 ' HB2' ' CG ' ' A' ' 69' ' ' ASP . 11.4 t-160 -71.57 -25.89 62.39 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.898 -1.126 . . . . 2.03 111.434 -178.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.444 ' CD1' ' N ' ' A' ' 75' ' ' PHE . 8.2 m-85 -95.62 -29.47 14.31 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.533 -1.354 . . . . 2.08 111.375 -178.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 1.039 HG21 ' CE2' ' A' ' 86' ' ' TYR . 3.3 m -148.37 -149.46 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.915 -1.116 . . . . 3.06 111.259 -177.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.783 ' N ' HG23 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -85.49 105.37 16.05 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.727 -0.842 . . . . 2.69 108.727 179.445 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . 0.612 ' N ' ' HD2' ' A' ' 79' ' ' PRO . 0.1 OUTLIER -47.78 -44.62 58.02 Favored Pre-proline 0 N--CA 1.493 1.722 0 C-N-CA 118.277 -1.369 . . . . 0.78 109.066 179.897 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.612 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 28.9 Cg_endo -72.78 104.1 1.69 Allowed 'Trans proline' 0 C--N 1.317 -1.125 0 N-CA-C 108.471 -1.396 . . . . 0.64 108.471 177.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.839 HD13 ' CD1' ' A' ' 117' ' ' LEU . 0.2 OUTLIER -96.31 -64.49 1.05 Allowed 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 108.914 -0.773 . . . . 2.44 108.914 -178.214 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.755 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 24.5 t 53.54 177.68 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 C-N-CA 118.784 -1.166 . . . . 2.95 108.748 177.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.581 ' HA ' ' O ' ' A' ' 43' ' ' ALA . 0.6 OUTLIER -96.52 31.01 2.38 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 120.797 -1.189 . . . . 2.69 109.029 -179.315 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -132.49 27.4 3.56 Favored Glycine 0 C--N 1.289 -2.039 0 N-CA-C 108.14 -1.984 . . . . 0.84 108.14 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.78 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 9.0 tp-100 -142.39 159.55 42.0 Favored 'General case' 0 C--N 1.308 -1.229 0 O-C-N 121.486 -1.008 . . . . 1.26 108.37 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.585 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -154.53 137.28 15.27 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.452 -0.944 . . . . 1.99 108.452 179.606 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 1.039 ' CE2' HG21 ' A' ' 76' ' ' VAL . 12.1 p90 -158.55 177.41 11.25 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 117.581 -1.648 . . . . 3.34 111.386 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.618 ' CB ' ' HG ' ' A' ' 40' ' ' LEU . 8.9 p-10 -121.08 89.02 3.05 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 119.664 -0.815 . . . . 1.1 112.49 -177.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.846 HD12 ' CG1' ' A' ' 76' ' ' VAL . 0.6 OUTLIER -59.05 -164.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 106.761 -1.57 . . . . 0.91 106.761 176.751 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.819 ' N ' HG23 ' A' ' 88' ' ' ILE . 0.2 OUTLIER 163.15 174.15 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.955 -1.091 . . . . 1.75 110.725 179.286 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.636 ' CE2' ' CD1' ' A' ' 54' ' ' ILE . 13.6 m-85 -160.87 75.4 0.53 Allowed 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.524 -0.917 . . . . 1.01 108.524 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.732 HG22 HG23 ' A' ' 36' ' ' THR . 1.6 p -74.36 -167.62 0.56 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.421 -0.799 . . . . 1.72 110.151 -179.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 1.001 ' O ' HG23 ' A' ' 94' ' ' VAL . 3.0 t90 -171.62 112.5 0.33 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.425 -0.797 . . . . 4.51 110.065 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.534 ' O ' ' NE1' ' A' ' 92' ' ' TRP . 1.6 t30 -49.31 122.27 5.9 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 106.02 -1.845 . . . . 1.86 106.02 177.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 1.001 HG23 ' O ' ' A' ' 92' ' ' TRP . 60.6 t -123.28 101.51 37.85 Favored Pre-proline 0 C--N 1.301 -1.515 0 C-N-CA 117.888 -1.525 . . . . 1.64 113.277 -176.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 1.044 ' HD2' HD11 ' A' ' 97' ' ' ILE . 31.4 Cg_endo -72.33 -149.36 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.806 2.338 . . . . 1.77 108.734 176.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.5 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -69.39 -49.48 54.97 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.443 -1.411 . . . . 2.57 108.098 178.514 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 1.044 HD11 ' HD2' ' A' ' 95' ' ' PRO . 2.8 mp 62.32 -2.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 113.227 0.825 . . . . 1.18 113.227 177.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 1.028 ' HB1' ' HD2' ' A' ' 99' ' ' PRO . . . 57.53 178.31 0.04 OUTLIER Pre-proline 0 C--N 1.3 -1.568 0 O-C-N 119.942 -1.724 . . . . 0.34 108.49 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 1.028 ' HD2' ' HB1' ' A' ' 98' ' ' ALA . 52.9 Cg_endo -82.52 151.77 15.27 Favored 'Trans proline' 0 C--N 1.299 -2.06 0 C-N-CA 123.454 2.769 . . . . 0.45 110.204 -178.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.611 ' CD ' ' O ' ' A' ' 127' ' ' ILE . 0.3 OUTLIER 55.02 115.27 0.01 OUTLIER 'General case' 0 C--N 1.288 -2.079 0 C-N-CA 119.403 -0.919 . . . . 2.1 111.413 176.213 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 1.001 ' OG ' HD13 ' A' ' 127' ' ' ILE . 67.6 m -86.91 158.74 19.24 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.186 -0.946 . . . . 2.47 108.686 178.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -50.29 -21.29 1.33 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.009 -1.057 . . . . 5.17 109.582 -179.499 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.475 ' C ' ' CG2' ' A' ' 104' ' ' VAL . 15.4 t-20 -179.22 159.95 0.99 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.127 -0.983 . . . . 1.3 109.597 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.698 ' O ' HG23 ' A' ' 105' ' ' VAL . 0.9 OUTLIER -154.76 171.6 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.33 -0.856 . . . . 0.96 110.003 179.793 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.698 HG23 ' O ' ' A' ' 104' ' ' VAL . 0.9 OUTLIER 170.61 147.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 108.019 -1.104 . . . . 1.4 108.019 -179.863 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 1.5 t -143.56 137.42 25.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 120.331 -1.48 . . . . 1.25 110.29 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.992 HG23 HG23 ' A' ' 121' ' ' ILE . 0.9 OUTLIER -167.88 148.98 5.24 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.159 -1.052 . . . . 0.79 108.159 179.691 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.907 HG13 ' CD1' ' A' ' 54' ' ' ILE . 2.7 t -157.19 163.6 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.848 -1.158 . . . . 1.31 110.83 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.56 ' HG3' ' N ' ' A' ' 110' ' ' LEU . 0.3 OUTLIER -169.87 146.39 3.16 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.721 -0.844 . . . . 1.31 108.721 178.801 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.56 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 11.5 tp -139.03 126.45 21.64 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 106.774 -1.565 . . . . 0.63 106.774 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.52 ' HB ' ' HB2' ' A' ' 51' ' ' LYS . 7.6 mt -134.24 120.02 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.214 -0.929 . . . . 0.9 111.586 -177.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.585 ' CA ' HG21 ' A' ' 47' ' ' THR . . . -83.94 -108.37 0.57 Allowed Glycine 0 N--CA 1.486 2.016 0 N-CA-C 108.026 -2.03 . . . . 0.72 108.026 177.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -145.62 7.87 1.13 Allowed 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.072 -1.252 . . . . 1.54 107.951 178.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.459 ' ND2' ' N ' ' A' ' 114' ' ' ASN . 0.5 OUTLIER -124.8 -17.35 5.9 Favored 'General case' 0 C--N 1.308 -1.196 0 O-C-N 121.466 -0.771 . . . . 1.48 109.922 -179.766 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 169.37 144.88 4.41 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.695 -1.362 . . . . 2.35 109.695 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.611 HG22 ' O ' ' A' ' 116' ' ' VAL . 0.1 OUTLIER -53.35 111.16 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.174 -1.192 . . . . 1.0 109.975 -179.644 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.839 ' CD1' HD13 ' A' ' 80' ' ' LEU . 10.7 mt -54.42 -51.66 64.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.633 -0.667 . . . . 0.83 111.064 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.583 ' HA ' ' CA ' ' A' ' 9' ' ' ALA . . . -166.59 147.19 6.06 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.841 -1.162 . . . . 1.33 111.269 -178.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.525 ' SG ' ' N ' ' A' ' 120' ' ' ALA . 0.5 OUTLIER -139.89 178.31 7.34 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 109.026 -0.731 . . . . 0.8 109.026 179.279 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.525 ' N ' ' SG ' ' A' ' 119' ' ' CYS . . . -179.12 125.93 0.09 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.097 -1.002 . . . . 0.89 109.423 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.992 HG23 HG23 ' A' ' 107' ' ' THR . 1.0 OUTLIER -129.78 138.36 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.162 -0.961 . . . . 1.04 109.799 -179.875 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -107.36 -23.27 12.28 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.213 -0.929 . . . . 2.77 109.321 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.462 ' O ' ' HB2' ' A' ' 124' ' ' HIS . 6.9 m 66.32 98.65 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.564 -0.71 . . . . 0.96 110.442 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.462 ' HB2' ' O ' ' A' ' 123' ' ' THR . 0.0 OUTLIER 71.95 177.67 0.26 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.226 -0.921 . . . . 2.05 110.573 178.899 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -176.45 137.41 3.61 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.006 -1.638 . . . . 0.79 109.006 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.762 ' O ' HG23 ' A' ' 28' ' ' ILE . 22.7 mtmt -144.0 95.94 2.81 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.959 -1.318 . . . . 2.96 110.284 -179.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 1.001 HD13 ' OG ' ' A' ' 101' ' ' SER . 1.2 mp -58.32 143.44 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.151 -0.968 . . . . 0.98 109.41 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.607 ' HB2' ' HD3' ' A' ' 100' ' ' LYS . 13.7 ttt-85 149.45 -94.68 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 108.557 -0.905 . . . . 2.19 108.557 178.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.526 ' N ' ' HG2' ' A' ' 128' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.497 1.875 0 CA-C-O 117.984 -1.008 . . . . 4.55 110.247 179.514 . . . . . . . . 2 2 . 1 stop_ save_